data_2jsy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jsy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.5 pt -135.56 175.66 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 m -119.32 152.53 36.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -136.32 123.83 22.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 173.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.8 mttt 50.36 36.15 12.4 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.53 85.97 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 119.417 -1.373 . . . . 0.0 113.406 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.68 124.32 6.34 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.076 1.938 . . . . 0.0 108.364 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.05 144.5 99.47 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 CA-C-N 120.217 2.009 . . . . 0.0 109.994 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -145.47 145.27 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.175 0.99 . . . . 0.0 109.765 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -90.63 159.82 16.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.543 1.137 . . . . 0.0 109.93 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD11 ' HA ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -111.81 153.27 26.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.338 1.455 . . . . 0.0 109.189 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -81.9 -56.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 121.96 -0.463 . . . . 0.0 110.427 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.42 12.72 33.33 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.034 -167.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 28.76 174.58 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 133.456 4.703 . . . . 0.0 120.657 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 12.82 62.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 129.786 3.234 . . . . 0.0 117.607 144.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 157.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 149.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -150.37 171.78 16.45 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 120.923 -1.111 . . . . 0.0 108.485 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.32 131.74 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.839 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.9 -10.01 72.11 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 116.922 -2.043 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.96 -13.0 61.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.537 1.668 . . . . 0.0 113.42 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 65.16 160.86 0.12 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.33 1.852 . . . . 0.0 110.544 -172.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.92 132.24 22.42 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.21 1.804 . . . . 0.0 109.013 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.5 -28.65 86.21 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.1 2.533 . . . . 0.0 118.459 -169.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 t70 75.12 99.8 0.07 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.169 -157.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 112' ' ' SER . 2.2 p90 -125.87 -174.47 3.1 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 126.077 1.751 . . . . 0.0 106.702 169.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 m -115.94 153.89 30.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.746 2.018 . . . . 0.0 106.95 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.03 168.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 1.2 tp -112.07 147.02 36.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 172.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -79.17 172.53 13.67 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.37 -29.5 66.05 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.973 1.309 . . . . 0.0 110.933 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -80.52 -0.04 35.8 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.403 1.481 . . . . 0.0 112.968 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.1 mt 62.37 36.51 14.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.176 1.79 . . . . 0.0 112.526 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.54 144.28 28.82 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 171.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.92 132.4 45.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.113 0.959 . . . . 0.0 108.956 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -136.08 148.39 48.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.38 167.4 12.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.29 -37.29 67.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.626 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.43 63.64 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.894 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.12 -26.6 59.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.199 0.909 . . . . 0.0 111.625 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 mtt -78.21 -31.18 49.28 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.413 -0.804 . . . . 0.0 111.419 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -62.38 152.74 33.23 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.226 0.536 . . . . 0.0 110.0 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.16 -7.66 44.2 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -154.51 160.99 41.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.541 1.171 . . . . 0.0 109.15 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.16 137.59 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.5 m -132.28 147.23 52.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.351 1.46 . . . . 0.0 107.956 -173.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.65 137.44 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -137.46 117.62 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.3 m -93.09 150.74 20.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 163.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.05 133.95 55.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.23 151.73 62.42 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.31 -43.12 4.73 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.62 1.547 . . . . 0.0 110.747 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.2 m -150.75 171.5 17.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.583 2.353 . . . . 0.0 106.839 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -99.99 -20.45 5.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 123.147 0.579 . . . . 0.0 111.669 166.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.8 -22.4 66.89 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.215 -1.553 . . . . 0.0 112.122 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -65.57 1.82 1.12 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.107 1.763 . . . . 0.0 115.024 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.59 -18.64 3.58 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 121.363 1.892 . . . . 0.0 114.113 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.522 ' HB ' HH21 ' A' ' 129' ' ' ARG . 1.6 m -57.56 -23.09 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.59 1.695 . . . . 0.0 113.109 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . 0.265 61.2 m -36.82 -61.57 0.53 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.736 1.214 . . . . 0.0 110.259 165.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -75.35 -50.05 17.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 126.527 2.392 . . . . 0.0 105.866 -156.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.24 83.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.801 -166.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.503 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.1 tm0? -145.33 -47.37 0.22 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.675 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -63.26 -43.26 98.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.831 1.65 . . . . 0.0 111.65 -163.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -48.4 -56.26 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.702 2.001 . . . . 0.0 109.205 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -69.52 -45.64 68.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.813 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CB ' HE21 ' A' ' 63' ' ' GLN . 38.5 t80 -58.45 -45.64 88.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.005 0.522 . . . . 0.0 110.979 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.21 -39.87 93.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.117 0.967 . . . . 0.0 109.888 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.2 -46.29 84.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -63.22 -47.21 83.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.961 0.504 . . . . 0.0 110.538 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.24 -48.41 68.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.47 1.108 . . . . 0.0 110.508 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.52 -16.87 27.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.66 -15.59 17.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.874 1.27 . . . . 0.0 112.846 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.43 -33.09 72.03 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.332 0.514 . . . . 0.0 109.984 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.37 35.47 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.74 21.01 0.42 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.862 -0.787 . . . . 0.0 112.96 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 m -52.2 145.34 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.123 1.369 . . . . 0.0 110.589 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -70.35 143.6 51.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 134.29 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -138.96 154.24 48.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.56 0.744 . . . . 0.0 109.523 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -129.74 115.64 17.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.85 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.1 m -135.46 166.88 22.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.17 0 O-C-N 122.105 -0.372 . . . . 0.0 110.216 164.552 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.217 -0.643 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -35.18 44.82 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.34 -28.21 70.24 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.197 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 93' ' ' TRP . . . -111.54 24.66 12.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.785 2.834 . . . . 0.0 111.96 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -115.08 106.68 14.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.65 -16.52 51.6 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.671 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.21 86.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.55 -22.68 13.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.7 -27.4 68.31 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.668 -1.27 . . . . 0.0 113.255 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.79 145.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -129.19 142.24 50.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.11 139.72 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.739 1.216 . . . . 0.0 109.021 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.5 mp -124.56 158.74 32.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.405 1.482 . . . . 0.0 108.999 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.81 73.22 1.51 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 127.05 2.14 . . . . 0.0 107.385 -169.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.71 -32.77 71.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.526 -1.359 . . . . 0.0 111.53 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -54.57 -17.31 3.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.195 1.798 . . . . 0.0 113.583 -167.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.534 ' HD3' ' CD2' ' A' ' 30' ' ' LEU . 5.3 ttt180 -65.27 -26.99 68.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -134.38 -17.15 2.06 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 124.914 1.384 . . . . 0.0 107.964 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 6.0 mmm 59.66 6.88 0.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.477 2.311 . . . . 0.0 111.513 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 27' ' ' PHE . 20.8 m -59.07 -49.18 78.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.742 1.61 . . . . 0.0 110.012 -170.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -62.57 -42.07 99.32 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.304 1.411 . . . . 0.0 109.916 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.21 -47.02 50.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 123.864 0.745 . . . . 0.0 113.237 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -73.85 -46.91 42.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.512 0.725 . . . . 0.0 109.247 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.7 78.49 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -104.09 7.13 36.29 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.844 1.258 . . . . 0.0 109.467 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.02 25.33 56.49 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 118.149 -1.361 . . . . 0.0 113.101 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.596 HG11 ' HG ' ' A' ' 130' ' ' SER . 17.1 m -90.83 -9.1 10.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.688 1.744 . . . . 0.0 111.488 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -63.32 115.97 5.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.446 ' HA ' HD11 ' A' ' 13' ' ' LEU . 65.7 mt -75.14 120.92 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -61.17 -49.77 75.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.844 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.24 -31.2 43.51 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.432 0.457 . . . . 0.0 112.014 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.41 ' H ' HG21 ' A' ' 121' ' ' ILE . 21.8 tp -109.63 -18.21 13.53 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.116 0.966 . . . . 0.0 111.576 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 53.63 42.35 31.89 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.744 1.618 . . . . 0.0 114.507 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt -123.54 162.96 21.9 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.38 135.85 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.42 154.49 41.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.779 1.275 . . . . 0.0 110.091 167.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.522 HH21 ' HB ' ' A' ' 59' ' ' VAL . 17.1 tpt85 -77.38 112.0 13.65 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.683 166.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.596 ' HG ' HG11 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -151.06 173.38 14.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.98 140.07 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -142.27 155.88 45.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.056 1.342 . . . . 0.0 108.477 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.38 139.77 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -130.19 133.95 46.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -171.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.22 163.43 15.24 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 125.314 1.445 . . . . 0.0 110.877 164.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -48.61 -35.19 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.254 1.822 . . . . 0.0 113.998 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -2.66 39.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.659 1.572 . . . . 0.0 111.97 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.96 3.11 70.73 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.174 -1.579 . . . . 0.0 112.5 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -71.48 122.26 20.1 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.982 1.891 . . . . 0.0 109.36 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.41 126.49 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.38 -11.22 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 129.448 3.099 . . . . 0.0 107.767 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -152.61 152.48 31.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.227 1.411 . . . . 0.0 107.454 163.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.18 139.93 18.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -150.2 148.8 29.35 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.26 117.51 24.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.859 1.663 . . . . 0.0 106.906 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.71 129.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -57.56 -19.15 23.5 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.904 0.881 . . . . 0.0 113.165 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -138.54 124.23 19.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.12 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -84.12 6.4 22.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.419 1.487 . . . . 0.0 111.11 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.46 174.2 6.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.732 2.013 . . . . 0.0 107.235 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -128.53 152.87 79.13 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 120.716 -1.24 . . . . 0.0 110.861 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -80.96 170.35 15.38 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.591 2.194 . . . . 0.0 110.082 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -69.46 120.82 15.84 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 161.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -93.68 -8.09 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.698 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.12 -36.69 83.81 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.297 1.408 . . . . 0.0 108.847 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -63.12 -48.75 83.27 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 125.341 1.456 . . . . 0.0 112.254 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.71 -34.86 49.15 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 CA-C-N 119.59 0.889 . . . . 0.0 111.974 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 20.6 mm -60.02 -45.47 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 120.658 1.572 . . . . 0.0 110.507 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.86 -42.34 97.57 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 120.746 1.612 . . . . 0.0 109.263 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.04 95.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.882 0.473 . . . . 0.0 110.78 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.84 80.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.083 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -53.74 -49.65 67.69 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 117.077 -1.44 . . . . 0.0 108.368 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -52.82 -29.68 29.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.408 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.45 -49.18 7.38 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.1 t -60.6 -41.39 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.533 0.683 . . . . 0.0 111.827 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.439 -1.018 0 C-N-CA 130.64 3.576 . . . . 0.0 117.265 -161.116 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 120.672 0.272 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.94 -175.76 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.379 1.072 . . . . 0.0 108.834 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -118.5 152.15 36.5 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -136.04 109.42 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 42.89 41.83 2.77 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 111.825 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.23 -9.5 61.21 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.134 -0.814 . . . . 0.0 115.04 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.1 125.53 8.56 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.189 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.43 138.62 39.34 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 CA-C-N 120.859 2.33 . . . . 0.0 110.208 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.16 135.21 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.154 0.982 . . . . 0.0 110.453 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -75.91 155.17 35.42 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.834 1.653 . . . . 0.0 110.388 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.64 144.63 40.6 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.405 1.482 . . . . 0.0 107.877 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.24 -65.19 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 118.502 0.592 . . . . 0.0 111.299 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.09 35.17 4.85 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.627 1.108 . . . . 0.0 111.206 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -52.12 166.44 0.16 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.247 2.219 . . . . 0.0 116.075 -169.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 69.07 34.19 3.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.614 1.966 . . . . 0.0 113.379 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.54 144.78 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -150.12 162.93 39.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.802 0.841 . . . . 0.0 109.156 -169.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 p -52.89 132.82 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 109.541 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.19 -5.22 83.03 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.85 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.37 -11.28 59.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.457 1.628 . . . . 0.0 112.64 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 57.44 178.36 0.05 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.649 1.58 . . . . 0.0 111.952 -169.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.38 136.09 20.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.931 1.693 . . . . 0.0 109.016 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.26 157.49 45.8 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.483 2.122 . . . . 0.0 109.77 172.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -77.47 67.91 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.02 1.728 . . . . 0.0 110.117 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -59.27 162.3 4.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.442 170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.5 m -124.65 144.45 50.19 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.38 168.05 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.343 2.257 . . . . 0.0 107.528 -171.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.97 143.45 45.7 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.48 178.45 8.11 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.523 0.729 . . . . 0.0 109.949 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.98 -23.33 67.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.146 -0.971 . . . . 0.0 110.734 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 m -86.41 3.34 44.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.4 mt 55.62 33.1 20.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.82 2.048 . . . . 0.0 112.937 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.55 147.11 24.77 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.84 143.8 39.47 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 109.439 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -154.02 155.08 34.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.315 2.246 . . . . 0.0 105.547 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.2 m -139.58 166.57 24.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.119 0.872 . . . . 0.0 108.927 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.6 tp -50.15 -40.67 47.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.242 0.474 . . . . 0.0 111.026 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.1 62.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -77.4 -28.47 52.76 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.768 0.713 . . . . 0.0 111.133 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.8 mtt -80.36 -55.14 5.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.877 1.271 . . . . 0.0 110.513 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -59.74 134.01 56.62 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.06 -20.61 3.2 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.955 2.216 . . . . 0.0 110.512 -169.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -150.33 158.34 44.05 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.92 2.088 . . . . 0.0 107.219 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -56.65 144.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.4 m -137.09 145.82 44.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.2 mt -133.31 137.19 53.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mt -136.75 133.88 48.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m -114.98 147.44 40.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -136.5 133.32 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.25 150.35 51.69 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.55 1.14 . . . . 0.0 109.278 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.92 -50.13 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.558 1.505 . . . . 0.0 109.709 169.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -152.87 168.67 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.311 1.444 . . . . 0.0 108.108 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.85 -23.93 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.53 -27.06 62.93 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 0.0 111.839 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 32.2 0.08 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.12 2.168 . . . . 0.0 113.736 -174.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.68 -3.23 69.88 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 120.432 -1.418 . . . . 0.0 114.269 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.83 -12.28 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.498 1.149 . . . . 0.0 112.406 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.69 -0.04 2.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.458 1.503 . . . . 0.0 113.724 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -48.97 148.66 2.18 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 0.0 110.348 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.03 -28.69 10.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.914 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -50.06 -57.33 7.85 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.265 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -65.71 -42.86 90.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.493 1.497 . . . . 0.0 110.085 -170.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -63.81 -53.96 42.65 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 122.725 0.41 . . . . 0.0 110.169 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.27 -37.6 80.88 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.688 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -55.93 -51.93 65.92 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 119.438 1.017 . . . . 0.0 110.102 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -66.22 -33.61 76.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 0.0 110.572 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -64.25 -50.55 67.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.735 -0.603 . . . . 0.0 110.477 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -60.8 -41.73 96.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.167 0.894 . . . . 0.0 110.406 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.86 73.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.918 0.887 . . . . 0.0 110.316 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.1 -13.57 62.51 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -100.86 -17.31 16.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.859 1.264 . . . . 0.0 112.419 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -60.07 -37.87 81.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.051 1.296 . . . . 0.0 110.56 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.89 -173.09 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -74.0 22.69 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.89 0.876 . . . . 0.0 112.902 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.15 154.34 2.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.379 1.472 . . . . 0.0 110.733 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.82 143.75 52.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.45 130.45 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.36 153.05 46.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.136 0.574 . . . . 0.0 110.886 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 m -120.57 154.6 35.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.1 mt -136.55 134.85 49.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.2 m -131.71 160.79 34.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 109.86 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 121.205 0.526 . . . . 0.0 110.933 169.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m0 . . . . . 0 C--O 1.233 0.193 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 m 65.22 -48.13 0.36 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.571 2.748 . . . . 0.0 116.089 169.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.45 -48.67 8.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.99 38.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.742 1.617 . . . . 0.0 108.637 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -149.37 33.16 0.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.0 111.24 -170.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.74 -1.26 5.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.293 0.949 . . . . 0.0 113.103 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 mt -75.11 87.87 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -54.38 -30.22 51.28 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 114.013 -169.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.91 -25.17 67.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.585 0.754 . . . . 0.0 112.88 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -74.42 152.95 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.823 0.738 . . . . 0.0 109.87 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -137.44 151.2 48.25 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.1 m -121.95 96.57 5.11 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.82 160.98 31.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.945 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -127.8 37.43 4.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.025 2.13 . . . . 0.0 109.088 -169.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -47.65 -39.73 17.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.798 1.239 . . . . 0.0 114.098 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.96 -17.79 11.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.117 0.967 . . . . 0.0 113.487 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -62.82 -22.0 66.32 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.221 -0.925 . . . . 0.0 112.661 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.7 -26.15 1.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.718 1.607 . . . . 0.0 111.898 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 69.44 10.83 7.88 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.444 2.698 . . . . 0.0 113.741 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 m -61.69 -47.76 83.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.25 -38.15 88.16 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.509 1.504 . . . . 0.0 109.407 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.53 -59.02 4.39 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 126.386 1.946 . . . . 0.0 112.872 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.34 -42.32 65.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.68 95.46 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.0 0.92 . . . . 0.0 112.258 -169.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -107.11 5.13 27.61 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.716 1.206 . . . . 0.0 110.653 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.99 85.95 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.648 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.6 m -105.64 -1.79 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.531 1.132 . . . . 0.0 111.199 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.75 116.97 17.91 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.5 mt -74.11 124.37 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.27 -46.82 78.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.307 0.643 . . . . 0.0 110.453 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -84.2 -51.92 6.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.365 0.266 . . . . 0.0 110.746 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -22.93 60.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.276 0.63 . . . . 0.0 111.031 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 49.97 57.59 6.38 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.432 1.093 . . . . 0.0 110.284 -171.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.99 173.45 11.7 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.045 1.338 . . . . 0.0 107.85 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.18 135.29 33.36 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.133 0.973 . . . . 0.0 108.381 172.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.79 165.32 18.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -83.21 113.22 20.51 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.8 m -155.19 166.49 33.4 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.661 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -147.05 142.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -144.06 158.12 43.91 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.293 1.037 . . . . 0.0 110.045 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.3 140.76 41.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -131.34 140.14 49.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.119 1.368 . . . . 0.0 108.122 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 166.0 17.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.924 1.289 . . . . 0.0 110.279 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -47.77 -38.43 15.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.436 1.495 . . . . 0.0 112.563 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.95 7.4 13.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.643 1.11 . . . . 0.0 113.663 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.52 -7.53 80.59 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 120.971 -1.08 . . . . 0.0 112.853 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -65.38 130.65 44.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 118.66 1.23 . . . . 0.0 108.937 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.1 132.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.582 0.753 . . . . 0.0 109.84 171.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.15 -18.0 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.059 2.144 . . . . 0.0 109.811 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -148.57 150.19 32.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.63 133.31 11.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.764 1.626 . . . . 0.0 107.249 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -146.59 147.1 30.75 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.79 107.87 14.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.11 131.34 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -57.74 -20.58 35.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.845 1.258 . . . . 0.0 113.829 -169.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.13 130.81 25.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.22 12.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.725 1.61 . . . . 0.0 114.219 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -88.47 -1.9 58.3 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 118.542 0.61 . . . . 0.0 112.225 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -82.45 178.84 8.02 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.77 -1.206 . . . . 0.0 110.062 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -129.72 133.51 25.13 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.656 1.583 . . . . 0.0 109.077 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.6 173.59 11.26 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.508 2.805 . . . . 0.0 110.572 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -73.46 129.51 38.14 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 168.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -100.06 -4.66 29.4 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.96 -38.04 57.97 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -50.45 -58.24 10.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.52 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.35 -35.81 38.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 121.449 1.553 . . . . 0.0 112.133 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.97 -44.76 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.523 1.056 . . . . 0.0 110.302 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.65 -37.83 87.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 119.506 1.048 . . . . 0.0 110.247 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.9 96.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.359 0.264 . . . . 0.0 110.706 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.92 72.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.955 0.502 . . . . 0.0 111.414 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.81 -41.67 74.54 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.54 1.063 . . . . 0.0 110.214 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.15 67.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.27 0.628 . . . . 0.0 111.948 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.55 -46.43 14.47 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.365 0.666 . . . . 0.0 111.313 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.8 -44.73 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.801 0.84 . . . . 0.0 111.127 -169.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.357 1.063 . . . . 0.0 109.708 178.224 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.3 pt -119.35 174.06 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.226 1.013 . . . . 0.0 110.546 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -112.61 155.77 23.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -135.38 115.43 13.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? 37.53 53.87 1.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.89 1.676 . . . . 0.0 113.298 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.22 2.43 87.3 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.68 -0.511 . . . . 0.0 114.349 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.6 110.25 3.02 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.782 1.658 . . . . 0.0 109.888 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.75 137.59 74.82 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.13 2.553 . . . . 0.0 111.623 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -142.62 131.59 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.791 0.836 . . . . 0.0 109.759 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -82.29 147.07 29.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.474 1.51 . . . . 0.0 111.462 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.35 148.72 23.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.548 1.139 . . . . 0.0 109.222 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 t -78.15 -52.97 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 121.962 -0.461 . . . . 0.0 109.791 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.77 24.61 27.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.526 1.06 . . . . 0.0 112.096 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 52.5 -171.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.713 2.005 . . . . 0.0 113.38 -173.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -78.26 132.98 37.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.15 165.18 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -126.35 155.07 42.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.46 137.18 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.48 85.97 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 118.678 -1.068 . . . . 0.0 113.54 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.79 1.68 16.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.632 1.716 . . . . 0.0 113.907 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 54.39 65.62 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.287 1.035 . . . . 0.0 111.383 169.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.02 134.03 5.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.02 1.728 . . . . 0.0 112.651 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.04 154.63 26.86 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.491 2.794 . . . . 0.0 113.349 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -73.95 70.03 1.47 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.806 2.043 . . . . 0.0 109.676 169.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -62.95 167.24 4.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.418 1.487 . . . . 0.0 110.753 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -122.79 152.16 40.94 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.81 171.15 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.446 1.898 . . . . 0.0 107.38 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.4 mt -111.56 152.42 27.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -83.48 179.28 7.69 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.414 0.685 . . . . 0.0 109.608 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -51.01 -35.7 35.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.046 0.938 . . . . 0.0 110.454 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.9 m -101.55 16.15 26.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.549 1.54 . . . . 0.0 110.7 -170.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.2 mt 62.55 23.7 14.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.256 2.222 . . . . 0.0 113.628 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.35 142.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 169.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.22 142.19 47.31 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -147.73 155.4 41.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.5 p -139.69 168.3 20.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.0 tp -54.36 -42.52 70.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 169.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.33 -23.93 66.08 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.01 -31.67 64.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.836 0.743 . . . . 0.0 110.876 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 mtt -75.21 -35.9 61.44 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -53.67 151.45 6.09 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.902 0.858 . . . . 0.0 111.944 -171.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.7 57.23 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.005 1.288 . . . . 0.0 113.272 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -155.03 149.8 26.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.759 1.624 . . . . 0.0 107.27 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.5 t -58.23 136.69 21.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -130.68 145.58 51.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -140.96 137.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -138.97 133.09 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.2 m -119.98 150.77 39.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.84 136.96 53.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.3 pt -136.51 139.37 29.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.855 1.662 . . . . 0.0 107.911 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.27 -7.51 18.05 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.083 2.522 . . . . 0.0 112.888 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.0 m -160.87 177.33 10.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.601 2.36 . . . . 0.0 106.268 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.89 -14.3 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.36 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.52 -23.66 50.13 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.376 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -57.67 155.81 9.41 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.581 1.552 . . . . 0.0 111.887 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.97 -17.28 70.28 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.1 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.15 -24.33 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.603 1.702 . . . . 0.0 113.316 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 15.3 p -61.57 -29.17 69.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.269 0.94 . . . . 0.0 112.544 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.84 -34.61 30.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.034 -0.416 . . . . 0.0 110.137 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.05 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.602 0.761 . . . . 0.0 110.765 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -152.56 131.09 12.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.8 m 138.76 -56.75 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 1 C-N-CA 132.819 4.448 . . . . 0.0 105.52 169.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -60.25 -63.84 1.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.854 0.752 . . . . 0.0 110.993 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -65.06 -40.11 94.22 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.904 -0.497 . . . . 0.0 111.122 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -58.07 -50.34 73.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.07 0.548 . . . . 0.0 111.583 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.04 -37.51 87.69 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.276 0.63 . . . . 0.0 109.674 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -58.36 -51.14 71.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.477 0.711 . . . . 0.0 110.166 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.35 -38.21 74.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.806 0.442 . . . . 0.0 110.635 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.38 88.87 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.58 -0.7 . . . . 0.0 111.139 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.77 -19.64 62.71 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.981 0.81 . . . . 0.0 112.62 173.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -76.7 -34.73 58.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 110.839 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.37 -40.62 91.47 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.407 0.683 . . . . 0.0 109.949 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.14 -170.64 43.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -75.57 38.22 0.15 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 111.861 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.91 144.45 14.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 O-C-N 120.853 -1.154 . . . . 0.0 109.806 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -73.15 141.26 47.43 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.05 128.7 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -136.8 155.19 50.14 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.662 0.664 . . . . 0.0 111.531 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -125.5 97.84 5.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.98 122.63 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -109.49 164.72 12.25 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.002 1.321 . . . . 0.0 109.206 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 110.295 169.591 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p -52.97 -37.47 61.21 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.549 -0.719 . . . . 0.0 112.681 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.96 -16.36 59.47 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.312 -0.715 . . . . 0.0 114.308 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.23 -15.91 15.85 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 112.412 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -75.05 94.49 2.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.652 0.66 . . . . 0.0 111.246 -169.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.73 -20.05 2.19 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.609 1.576 . . . . 0.0 111.105 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.6 92.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.516 1.527 . . . . 0.0 107.973 -172.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.61 -33.89 7.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.299 1.84 . . . . 0.0 113.988 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.84 -20.06 65.86 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.479 1.111 . . . . 0.0 113.717 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.89 152.81 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.168 0.895 . . . . 0.0 108.945 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -129.34 146.24 51.25 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.0 m -97.26 135.11 39.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.98 162.98 16.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.988 1.715 . . . . 0.0 108.089 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -138.28 44.25 2.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.41 1.484 . . . . 0.0 109.573 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.12 -44.08 7.37 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.516 1.127 . . . . 0.0 112.848 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -59.97 -14.72 17.27 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -76.31 -6.71 52.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.077 -1.015 . . . . 0.0 112.416 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -139.07 -41.31 0.47 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.39 1.476 . . . . 0.0 111.294 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.4 tpt 78.34 2.1 2.69 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.149 2.98 . . . . 0.0 113.667 169.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 m -63.94 -46.51 84.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.852 1.66 . . . . 0.0 111.471 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.89 -39.56 89.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.227 1.376 . . . . 0.0 109.307 172.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.2 -53.69 18.31 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.41 1.957 . . . . 0.0 113.255 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.98 -34.89 50.69 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.989 0.516 . . . . 0.0 110.433 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.57 -39.54 93.93 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.217 0.607 . . . . 0.0 111.587 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -97.98 3.03 49.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.053 1.341 . . . . 0.0 110.31 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 60.79 8.4 10.12 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.348 1.452 . . . . 0.0 114.826 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 m -63.62 -23.04 32.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 C-N-CA 125.902 1.681 . . . . 0.0 110.94 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.38 118.51 4.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.43 HG23 ' H ' ' A' ' 124' ' ' LEU . 47.2 mm -87.47 124.12 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -61.35 -53.15 60.31 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.466 1.506 . . . . 0.0 110.718 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.97 -49.47 11.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.039 0.447 . . . . 0.0 110.5 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.43 ' H ' HG23 ' A' ' 121' ' ' ILE . 29.4 tp -72.83 -23.11 60.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.508 1.123 . . . . 0.0 112.779 -171.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 51.17 50.28 19.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 110.768 -169.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.5 mt -138.12 -173.25 3.47 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -113.24 146.69 38.91 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.199 1.0 . . . . 0.0 111.327 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.61 140.86 57.96 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.919 1.688 . . . . 0.0 113.805 -169.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -65.87 110.86 3.02 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 p -156.13 168.22 27.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.454 0.57 . . . . 0.0 111.166 -170.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.04 148.26 18.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.92 1.288 . . . . 0.0 108.129 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -145.7 154.5 42.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.503 1.121 . . . . 0.0 109.296 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.91 139.87 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -132.21 141.02 48.91 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.009 1.323 . . . . 0.0 108.233 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.39 162.43 20.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.351 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.5 -32.63 41.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.901 1.281 . . . . 0.0 113.228 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -80.25 -10.32 59.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.7 -2.71 49.08 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.388 0.994 . . . . 0.0 113.605 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.85 137.94 58.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.55 1.675 . . . . 0.0 108.753 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 129.46 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 80.6 t -113.26 -20.79 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.825 2.05 . . . . 0.0 109.541 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -143.84 148.34 35.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.351 1.06 . . . . 0.0 108.194 169.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.75 132.18 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.513 1.525 . . . . 0.0 107.701 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -149.77 147.59 28.19 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.662 1.185 . . . . 0.0 108.444 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.12 116.07 14.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.47 134.69 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 m -58.95 -18.68 35.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.154 0.982 . . . . 0.0 112.956 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -140.04 122.5 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.2 p -83.16 14.87 3.16 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.654 1.115 . . . . 0.0 111.983 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -125.77 -177.06 3.79 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.567 1.947 . . . . 0.0 108.91 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -137.78 151.5 70.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.244 1.418 . . . . 0.0 109.901 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.96 170.75 7.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.67 2.913 . . . . 0.0 111.606 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -77.33 87.1 3.73 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -68.32 1.12 3.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.3 1.44 . . . . 0.0 114.118 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -31.63 72.47 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -62.02 -53.07 62.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.324 1.049 . . . . 0.0 111.801 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -65.83 -31.26 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.742 1.658 . . . . 0.0 112.422 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.6 mm -58.3 -48.89 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.131 1.332 . . . . 0.0 109.35 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.17 -33.47 76.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.821 0.737 . . . . 0.0 110.81 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.28 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.734 0.414 . . . . 0.0 111.192 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.77 -49.51 65.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.895 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -63.64 -30.46 71.57 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.94 69.35 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.442 1.019 . . . . 0.0 111.835 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.19 -45.77 17.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.147 0.579 . . . . 0.0 111.478 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.74 -46.69 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.235 0.614 . . . . 0.0 111.024 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.5 tttm . . . . . 0 C--O 1.248 0.985 0 C-N-CA 124.401 1.081 . . . . 0.0 109.903 -179.706 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.443 -0.804 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.76 -178.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -115.19 147.67 40.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -134.18 120.67 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 43.83 39.69 2.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.053 1.341 . . . . 0.0 111.916 -173.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.57 12.6 79.96 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.74 117.44 3.95 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.174 -1.348 . . . . 0.0 109.846 173.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.21 139.34 89.74 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.342 2.695 . . . . 0.0 112.222 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.66 130.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.225 1.41 . . . . 0.0 109.889 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -75.63 161.67 28.91 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.351 1.86 . . . . 0.0 110.462 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.68 160.0 19.09 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.31 1.444 . . . . 0.0 110.173 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.78 -59.71 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.837 -0.539 . . . . 0.0 111.242 -169.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.2 32.61 6.94 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.397 0.998 . . . . 0.0 113.439 -169.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.43 -167.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.54 107.07 17.89 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.482 1.513 . . . . 0.0 109.748 -169.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.41 145.75 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -143.52 160.79 39.97 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.595 0.758 . . . . 0.0 109.028 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.75 134.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.31 3.37 89.81 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.796 -1.002 . . . . 0.0 113.988 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.03 -7.02 59.47 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.463 1.631 . . . . 0.0 112.298 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 58.07 178.18 0.06 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.369 1.467 . . . . 0.0 111.516 -169.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.09 24.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.792 1.637 . . . . 0.0 108.729 -171.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.18 158.04 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.708 2.272 . . . . 0.0 109.907 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.41 68.82 7.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.378 1.471 . . . . 0.0 110.538 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -63.1 163.25 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.977 171.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.5 m -121.79 148.95 44.01 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -152.66 167.67 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.106 2.162 . . . . 0.0 105.76 -173.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.49 156.05 29.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 120.787 -1.195 . . . . 0.0 108.231 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.3 p -81.36 173.59 12.32 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.767 1.227 . . . . 0.0 110.016 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -63.77 -26.71 68.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.933 -1.104 . . . . 0.0 110.798 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 p -77.54 1.43 19.49 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.512 1.525 . . . . 0.0 111.94 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt 56.94 47.78 17.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.968 2.107 . . . . 0.0 111.986 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.01 141.96 47.43 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -64.52 144.09 57.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.464 1.105 . . . . 0.0 109.485 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -146.52 157.66 43.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.499 2.32 . . . . 0.0 105.477 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 p -146.62 167.82 22.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.5 tp -53.83 -43.78 69.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.37 66.52 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.85 -30.6 58.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.878 0.763 . . . . 0.0 111.114 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.3 mtt -73.88 -39.69 63.74 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.388 1.075 . . . . 0.0 110.945 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -53.56 140.91 27.13 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 109.862 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.6 -22.1 8.89 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.958 1.266 . . . . 0.0 112.738 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -148.36 152.83 37.71 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.888 1.275 . . . . 0.0 108.681 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.63 142.43 15.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.2 m -135.54 148.95 49.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.883 0.873 . . . . 0.0 109.036 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.4 mt -134.73 138.31 49.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.01 124.62 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 p -106.59 148.42 28.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 168.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.05 127.88 40.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.16 146.83 38.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 110.357 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.69 -39.69 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.072 1.848 . . . . 0.0 111.484 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.4 m -152.5 173.06 15.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 0.0 109.097 -169.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 pt -121.01 -29.8 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.51 1.124 . . . . 0.0 111.45 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.09 -11.64 31.75 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.537 0.735 . . . . 0.0 111.669 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -22.07 54.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.807 2.043 . . . . 0.0 112.532 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.23 -0.12 25.24 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.265 0.936 . . . . 0.0 112.942 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.55 -15.6 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 118.67 1.235 . . . . 0.0 112.856 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.3 m -54.95 -25.96 33.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.171 1.388 . . . . 0.0 113.289 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -124.58 32.24 5.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.142 1.377 . . . . 0.0 109.395 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.31 -166.98 2.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.414 1.486 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -43.57 -45.66 6.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.375 1.87 . . . . 0.0 113.938 -171.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 m -56.03 -42.36 76.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.279 1.4 . . . . 0.0 112.424 -169.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -65.94 -53.0 44.89 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.969 0.804 . . . . 0.0 110.398 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -64.69 -41.0 96.35 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.146 0.884 . . . . 0.0 111.146 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.2 -50.29 71.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.781 . . . . 0.0 110.269 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -62.56 -37.86 87.8 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.486 0.314 . . . . 0.0 110.692 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.76 -36.83 85.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.604 0.762 . . . . 0.0 110.695 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -74.82 -42.6 57.72 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.001 -1.062 . . . . 0.0 110.196 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.91 -49.35 66.11 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.82 1.248 . . . . 0.0 110.463 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.84 -12.56 25.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 0.0 113.563 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -108.36 -9.04 15.5 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 113.037 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.6 mt -64.96 -32.41 74.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.164 1.347 . . . . 0.0 110.584 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.08 -169.95 43.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.17 29.84 0.1 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.976 0.888 . . . . 0.0 112.451 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.72 149.76 3.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.68 -1.263 . . . . 0.0 110.34 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -71.78 141.18 49.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -142.55 131.55 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -139.01 156.67 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.841 0.856 . . . . 0.0 110.562 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.6 m -133.32 105.26 6.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.7 128.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 m -124.33 160.81 27.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.572 1.149 . . . . 0.0 109.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.037 169.339 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.41 -30.5 71.61 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.92 -10.88 73.49 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.622 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.15 32.47 5.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 110.293 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -137.56 132.06 32.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.8 -9.57 65.18 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.683 0.658 . . . . 0.0 111.544 -169.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mt -134.87 76.8 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -51.7 -31.69 27.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.3 1.44 . . . . 0.0 114.821 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -63.9 -27.96 69.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.04 151.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -133.37 143.97 49.3 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 m -93.07 143.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.84 158.72 25.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.073 1.349 . . . . 0.0 108.753 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 m -128.88 67.02 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.997 2.119 . . . . 0.0 108.449 -169.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.0 -35.9 48.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.257 0.623 . . . . 0.0 112.219 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -11.37 49.49 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.961 -1.087 . . . . 0.0 113.591 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -76.95 -29.75 55.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.887 1.221 . . . . 0.0 111.545 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -149.01 88.58 1.61 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 4.83 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.262 1.425 . . . . 0.0 113.581 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.3 m -55.92 -42.57 76.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.92 1.236 . . . . 0.0 110.722 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.68 -48.92 79.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.636 1.107 . . . . 0.0 110.84 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.5 98.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 123.66 0.648 . . . . 0.0 111.992 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.77 -42.01 67.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.454 0.627 . . . . 0.0 110.323 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.58 86.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.348 1.059 . . . . 0.0 111.913 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -92.01 3.53 55.03 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.925 0.89 . . . . 0.0 111.22 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.94 -4.84 8.97 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.625 1.107 . . . . 0.0 115.057 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.9 m -66.99 -8.94 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.986 2.114 . . . . 0.0 112.212 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.03 109.59 3.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 124' ' ' LEU . 67.7 mt -66.88 127.87 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -66.49 -49.76 65.52 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.298 1.039 . . . . 0.0 110.636 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -76.74 -49.56 15.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' H ' HG22 ' A' ' 121' ' ' ILE . 17.8 tp -80.26 -17.61 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 50.0 48.78 21.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.662 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.8 tp -137.84 161.67 35.99 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 108.426 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -72.91 129.76 38.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 110.722 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.41 168.07 18.23 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.864 1.266 . . . . 0.0 113.634 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -91.67 115.21 27.86 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.108 1.363 . . . . 0.0 108.191 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.7 m -154.48 166.84 32.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.105 0.562 . . . . 0.0 109.672 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.38 146.86 18.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -148.36 156.66 42.79 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.066 1.347 . . . . 0.0 109.105 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.96 144.97 30.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.2 mp -132.46 139.68 48.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.345 1.058 . . . . 0.0 108.661 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.95 166.62 13.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.223 1.409 . . . . 0.0 110.038 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -52.49 -31.38 34.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.149 1.38 . . . . 0.0 112.393 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.05 2.25 27.95 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.566 1.147 . . . . 0.0 112.7 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.4 -5.94 75.03 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 120.966 -1.084 . . . . 0.0 112.959 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.38 126.47 27.46 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.638 1.219 . . . . 0.0 108.964 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.77 128.94 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 109.625 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.5 t -116.83 -17.46 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.391 1.876 . . . . 0.0 109.851 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -145.38 147.68 32.53 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.26 135.58 15.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.161 1.385 . . . . 0.0 108.481 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.42 149.49 30.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.811 0.844 . . . . 0.0 109.299 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.05 106.44 9.28 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.434 2.294 . . . . 0.0 104.922 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 t -69.3 134.53 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -60.95 -19.5 60.96 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.945 1.298 . . . . 0.0 113.855 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -138.77 127.77 23.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.82 39.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.2 p -98.57 -5.79 31.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.431 1.092 . . . . 0.0 112.048 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -83.57 -174.47 5.3 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.373 1.469 . . . . 0.0 109.347 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -135.6 154.22 78.09 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.641 1.176 . . . . 0.0 109.905 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.55 172.71 10.08 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.938 2.426 . . . . 0.0 109.768 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -69.23 120.58 15.29 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 168.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -93.45 -2.49 54.47 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -76.02 -34.93 59.71 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.25 -54.36 55.58 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.766 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.65 -35.47 58.26 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.883 1.708 . . . . 0.0 111.885 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 mm -61.38 -50.39 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.465 1.029 . . . . 0.0 109.736 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.14 -36.95 84.49 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.986 0.812 . . . . 0.0 110.219 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.44 92.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.056 0.543 . . . . 0.0 111.068 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.43 -50.28 27.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.488 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.74 -27.24 69.07 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.235 1.38 . . . . 0.0 111.469 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.8 -31.68 68.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.668 1.122 . . . . 0.0 112.02 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.42 -44.21 36.91 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.193 0.597 . . . . 0.0 110.873 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.85 -48.42 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.365 0.666 . . . . 0.0 110.689 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 124.873 1.269 . . . . 0.0 110.031 179.742 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.46 179.58 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.723 0.809 . . . . 0.0 109.933 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.18 150.85 42.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -137.25 -84.26 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.455 1.025 . . . . 0.0 109.818 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.4 43.34 0.54 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.064 1.346 . . . . 0.0 110.97 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.78 70.52 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.261 0.934 . . . . 0.0 112.141 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 152.64 24.75 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.33 145.6 34.45 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.872 2.382 . . . . 0.0 110.65 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.97 139.04 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.53 1.132 . . . . 0.0 109.798 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -79.14 158.78 27.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.038 1.735 . . . . 0.0 110.038 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.93 149.77 43.82 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.05 1.74 . . . . 0.0 107.441 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.1 t -80.25 -83.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 118.364 0.529 . . . . 0.0 110.54 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 41.54 2.61 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.447 1.498 . . . . 0.0 111.908 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -60.84 171.66 1.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.648 1.979 . . . . 0.0 114.098 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 68.25 34.88 3.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.239 1.816 . . . . 0.0 113.82 169.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.91 142.99 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -151.11 162.09 41.51 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.428 0.691 . . . . 0.0 109.392 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.54 133.96 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.505 0.722 . . . . 0.0 109.76 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.67 1.74 90.57 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.156 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.11 -8.91 58.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.923 1.862 . . . . 0.0 112.297 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 57.35 174.39 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.755 1.622 . . . . 0.0 111.322 -169.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.43 139.98 26.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.111 1.364 . . . . 0.0 109.001 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.81 -27.91 80.12 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.205 2.604 . . . . 0.0 114.853 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 t70 84.39 116.25 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.284 2.634 . . . . 0.0 106.934 -169.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -131.22 161.74 31.55 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.856 1.263 . . . . 0.0 110.451 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -96.56 157.98 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.06 171.38 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.029 2.532 . . . . 0.0 106.641 172.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 tp -129.2 134.21 47.91 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.0 p -73.49 164.96 25.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -64.26 -13.83 51.94 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.758 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 m -83.25 1.07 42.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.452 1.501 . . . . 0.0 112.04 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp 57.31 53.12 7.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.797 2.039 . . . . 0.0 111.602 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.3 141.45 52.06 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.178 0.991 . . . . 0.0 108.433 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.22 143.53 40.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.16 0.981 . . . . 0.0 109.195 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -149.56 159.91 43.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.877 2.471 . . . . 0.0 105.039 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.0 m -142.32 163.78 31.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 tp -53.72 -38.11 63.97 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.321 -0.237 . . . . 0.0 110.659 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.66 -23.64 64.96 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.71 -32.23 57.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.937 0.789 . . . . 0.0 110.951 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.5 mtt -72.71 -38.31 67.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.378 1.071 . . . . 0.0 110.694 176.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -53.24 142.34 21.22 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.63 0.772 . . . . 0.0 109.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.32 -20.74 8.34 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.413 1.483 . . . . 0.0 112.293 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -150.16 154.69 38.45 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.197 1.399 . . . . 0.0 108.797 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.89 138.19 19.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 m -133.44 142.81 48.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.19 132.69 49.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -138.91 121.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.17 150.97 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.21 134.25 61.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.67 152.15 58.91 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.67 -46.94 4.47 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.446 1.431 . . . . 0.0 110.341 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.1 m -144.29 173.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 108.931 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.42 -26.27 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.13 -32.53 73.12 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 112.158 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -65.97 133.63 51.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.991 0.916 . . . . 0.0 109.888 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.0 -21.95 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.412 1.006 . . . . 0.0 114.476 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.85 -15.49 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.653 1.226 . . . . 0.0 112.262 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -26.84 57.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.332 0.969 . . . . 0.0 111.708 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -125.21 -34.93 2.68 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.775 1.23 . . . . 0.0 110.782 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.23 66.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.214 0.605 . . . . 0.0 112.081 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.97 -41.71 0.31 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.469 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . 0.252 3.4 m -65.54 -37.17 85.94 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -167.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -64.77 -53.7 42.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.014 1.279 . . . . 0.0 110.407 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -66.04 -42.27 89.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.368 0.531 . . . . 0.0 111.607 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.53 -50.43 73.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.719 0.808 . . . . 0.0 110.284 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -64.25 -38.19 90.17 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.833 0.288 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.15 -47.42 83.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.094 0.958 . . . . 0.0 110.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -70.04 -44.87 68.35 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.435 0.561 . . . . 0.0 110.525 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.29 79.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.725 0.693 . . . . 0.0 111.134 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.54 -14.57 43.54 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -102.92 -15.37 16.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.489 1.516 . . . . 0.0 112.02 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.67 -37.71 79.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.638 1.108 . . . . 0.0 110.718 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.57 -167.89 40.64 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.07 25.13 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.843 -0.798 . . . . 0.0 112.829 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -53.51 151.37 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.329 1.452 . . . . 0.0 111.449 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -77.08 139.62 40.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.13 123.3 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -139.47 156.48 46.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.181 0.592 . . . . 0.0 110.755 -175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -131.41 116.56 17.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.61 140.67 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.272 1.029 . . . . 0.0 108.27 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 m -140.99 175.38 9.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.313 1.445 . . . . 0.0 112.054 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 124.924 1.29 . . . . 0.0 113.646 -177.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.3 m -52.11 -34.89 46.27 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -171.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.41 -8.31 64.35 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.602 -1.11 . . . . 0.0 113.918 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.83 29.19 3.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.03 1.415 . . . . 0.0 111.546 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -135.88 69.21 1.43 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.593 1.157 . . . . 0.0 108.131 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.7 -27.04 0.26 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.357 0.98 . . . . 0.0 111.641 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 98.61 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.759 1.624 . . . . 0.0 106.867 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.83 -28.69 57.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.994 1.718 . . . . 0.0 114.267 -169.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -61.69 -32.12 72.29 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.12 0.568 . . . . 0.0 112.49 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.08 152.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.89 145.97 42.79 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -88.52 138.47 31.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.0 mp -128.64 167.63 16.92 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.085 2.154 . . . . 0.0 106.973 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.2 m -146.83 172.37 13.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.248 1.419 . . . . 0.0 107.585 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.81 2.6 3.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.429 0.633 . . . . 0.0 111.534 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -16.59 1.1 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -30.99 72.02 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.377 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -153.42 -7.48 0.17 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 tpt 56.45 27.6 12.39 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.182 1.393 . . . . 0.0 111.377 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.8 t -63.46 -62.36 1.72 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.542 1.537 . . . . 0.0 109.732 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -59.86 -38.93 83.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.9 0.48 . . . . 0.0 110.464 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.11 -56.66 13.51 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.619 2.057 . . . . 0.0 112.12 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.73 -36.73 62.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.686 0.743 . . . . 0.0 110.343 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.08 98.25 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.208 0.603 . . . . 0.0 111.773 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -102.23 3.84 38.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.297 1.039 . . . . 0.0 110.672 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.81 5.0 29.44 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 118.35 -1.25 . . . . 0.0 114.677 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.43 -13.68 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 119.139 1.47 . . . . 0.0 111.161 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.37 102.41 0.68 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.434 HG23 ' H ' ' A' ' 124' ' ' LEU . 81.3 mt -63.17 124.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -64.99 -45.37 85.88 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.958 0.903 . . . . 0.0 110.978 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.32 -49.45 12.42 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.917 0.326 . . . . 0.0 110.669 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.434 ' H ' HG23 ' A' ' 121' ' ' ILE . 15.0 tp -81.59 -14.21 57.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -170.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 47.84 48.38 17.71 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.06 1.344 . . . . 0.0 110.58 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.24 25.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.827 0.851 . . . . 0.0 108.843 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 129.22 37.34 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.08 160.68 26.15 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 111.646 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 104.63 16.61 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -145.74 163.17 35.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.596 0.759 . . . . 0.0 108.959 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.27 145.11 18.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -145.32 154.96 42.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 109.321 -169.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.82 136.54 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 171.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.31 139.63 51.7 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.868 1.267 . . . . 0.0 108.013 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 165.22 11.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.077 1.351 . . . . 0.0 110.245 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.6 -34.35 25.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.22 1.408 . . . . 0.0 112.816 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.8 12.1 20.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.059 0.943 . . . . 0.0 113.113 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.46 -6.17 82.8 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.451 1.024 . . . . 0.0 113.132 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 138.55 58.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.57 1.185 . . . . 0.0 109.518 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.89 133.18 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.17 -25.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.928 1.291 . . . . 0.0 109.91 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -150.59 151.8 33.11 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.51 138.41 16.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.578 1.551 . . . . 0.0 107.916 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -147.5 148.33 31.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.763 0.825 . . . . 0.0 108.824 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -127.43 112.54 15.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 t -66.88 133.11 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -60.58 -16.13 34.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.562 1.145 . . . . 0.0 112.66 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -139.33 111.67 7.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.36 -18.23 64.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -174.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.6 p -83.58 9.39 11.56 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.136 0.974 . . . . 0.0 110.976 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -132.68 174.02 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.231 2.612 . . . . 0.0 108.12 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -122.83 158.64 56.53 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.749 1.219 . . . . 0.0 111.553 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.75 179.34 3.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.206 2.604 . . . . 0.0 110.225 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -80.35 85.5 5.82 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -67.61 -0.46 3.94 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.438 1.495 . . . . 0.0 113.114 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.67 -25.8 49.82 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.169 -0.957 . . . . 0.0 109.364 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.53 -52.65 72.62 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.476 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.95 -33.73 73.62 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.585 1.602 . . . . 0.0 112.573 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 mm -59.79 -47.2 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.708 1.14 . . . . 0.0 109.525 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.66 -35.63 81.19 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.326 0.967 . . . . 0.0 110.931 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.76 -42.17 97.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.227 0.211 . . . . 0.0 110.801 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -40.23 80.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.321 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -57.53 -42.3 82.62 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.448 1.022 . . . . 0.0 110.242 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.31 -31.66 69.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.149 0.431 . . . . 0.0 111.965 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.75 -55.44 5.64 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.247 0.476 . . . . 0.0 110.745 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.19 -51.95 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 111.177 -169.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 21.1 pttm . . . . . 0 C--O 1.25 1.128 0 C-N-CA 127.792 2.437 . . . . 0.0 112.219 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.236 0.349 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.21 -175.22 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.161 1.384 . . . . 0.0 107.606 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -123.17 160.39 26.61 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -147.71 127.11 13.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 169.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 43.33 39.68 2.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.942 1.297 . . . . 0.0 112.908 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.24 15.27 74.76 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.167 0.889 . . . . 0.0 114.674 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.49 120.74 4.52 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.22 142.95 86.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.93 2.42 . . . . 0.0 111.259 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.43 135.02 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.231 1.013 . . . . 0.0 109.5 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -76.55 164.35 26.02 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.828 2.051 . . . . 0.0 109.261 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.83 165.15 23.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.869 0.868 . . . . 0.0 109.829 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.6 134.83 57.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.809 1.644 . . . . 0.0 107.207 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.2 -12.57 63.61 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.122 0.868 . . . . 0.0 114.002 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 53.26 164.92 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.354 3.061 . . . . 0.0 115.375 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -67.03 164.88 16.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.215 1.006 . . . . 0.0 113.319 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.69 166.26 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 126.607 1.963 . . . . 0.0 106.589 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -149.15 165.59 31.35 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.695 0.798 . . . . 0.0 109.061 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -52.26 131.72 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 122.76 0.424 . . . . 0.0 109.893 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.84 71.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.654 1.121 . . . . 0.0 113.322 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.01 -10.78 59.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.329 1.565 . . . . 0.0 114.113 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 62.39 104.42 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.919 1.688 . . . . 0.0 112.5 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.13 134.57 68.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.523 1.129 . . . . 0.0 111.833 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.44 -27.01 83.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.541 2.827 . . . . 0.0 115.392 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.78 112.44 0.05 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.954 2.502 . . . . 0.0 111.34 -169.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -143.27 168.88 18.73 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.477 1.511 . . . . 0.0 109.73 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 159.58 33.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.089 1.755 . . . . 0.0 111.592 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.79 178.14 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 129.184 2.994 . . . . 0.0 105.833 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.85 133.54 53.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -79.81 -176.8 5.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.309 0.576 . . . . 0.0 110.413 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -46.94 -36.57 7.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.752 1.221 . . . . 0.0 111.722 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m -111.73 20.67 16.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.318 1.447 . . . . 0.0 110.556 -171.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.9 mt 56.24 32.59 20.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.96 2.104 . . . . 0.0 113.265 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.61 142.99 46.54 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.13 57.61 3.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.87 1.268 . . . . 0.0 110.136 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -59.54 158.21 10.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 108.107 169.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -137.57 166.76 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.89 -30.6 64.05 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.014 -0.429 . . . . 0.0 111.527 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.99 -20.99 64.47 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.626 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.06 -28.86 43.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.271 0.941 . . . . 0.0 110.754 172.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 mtt -71.38 -39.11 71.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.056 0.942 . . . . 0.0 110.497 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.47 135.39 39.8 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.86 -26.52 3.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.17 1.367 . . . . 0.0 112.169 -171.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -151.28 159.86 44.11 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.337 1.055 . . . . 0.0 109.722 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.9 t -58.48 136.67 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 170.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 45.8 m -136.96 148.74 47.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.952 1.301 . . . . 0.0 108.295 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 94.7 mt -133.63 135.45 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -136.96 104.79 3.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 149.6 25.5 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.5 t -136.85 141.25 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.99 154.51 54.9 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.299 1.04 . . . . 0.0 111.205 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -76.09 -50.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.775 1.65 . . . . 0.0 108.316 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -159.95 170.25 21.76 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.54 -7.13 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.991 1.717 . . . . 0.0 109.783 168.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -51.74 -26.13 8.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.394 1.877 . . . . 0.0 113.141 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 p -61.49 -9.57 5.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.813 2.045 . . . . 0.0 113.156 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.72 16.38 75.52 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.183 0.901 . . . . 0.0 112.124 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.17 -7.33 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.547 1.539 . . . . 0.0 113.165 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 91.9 m -47.99 -30.0 3.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.557 1.543 . . . . 0.0 114.405 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.91 -30.23 70.79 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.22 8.81 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.517 ' HG3' ' H ' ' A' ' 65' ' ' ARG . 4.6 pt20 -66.57 -169.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -42.96 -24.55 0.07 Allowed 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 127.392 2.277 . . . . 0.0 113.092 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.517 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 13.7 tpt180 -43.52 -50.93 7.03 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.934 1.294 . . . . 0.0 111.073 169.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -60.76 -50.11 74.78 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.06 0.846 . . . . 0.0 109.589 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -60.21 -47.02 87.74 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.3 -40.31 77.59 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.153 1.781 . . . . 0.0 110.255 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -69.23 -33.3 73.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.98 1.312 . . . . 0.0 110.817 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -72.34 -45.78 58.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.047 0.839 . . . . 0.0 109.675 169.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.66 -44.36 90.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.824 1.249 . . . . 0.0 111.882 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.52 -20.98 63.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 112.441 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -84.85 -16.73 40.3 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.314 0.961 . . . . 0.0 112.805 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.19 -29.95 69.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.629 1.104 . . . . 0.0 112.237 -169.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.26 -162.03 35.19 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.86 17.73 0.16 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.731 1.212 . . . . 0.0 112.509 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 m -55.42 145.38 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.601 1.561 . . . . 0.0 110.855 -172.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -71.38 138.88 49.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.45 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -127.44 153.22 46.55 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.889 0.875 . . . . 0.0 109.575 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -128.52 116.54 19.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.9 mt -99.72 140.17 19.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -140.25 173.18 11.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.124 0.97 . . . . 0.0 111.663 -171.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 167.52 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 118.612 -0.708 . . . . 0.0 112.074 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.0 m -146.2 -69.21 0.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.516 1.126 . . . . 0.0 111.223 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.3 -33.25 15.49 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 127.494 2.473 . . . . 0.0 115.6 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.49 18.97 5.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.156 1.382 . . . . 0.0 110.834 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -80.55 140.55 35.75 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.123 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -49.29 2.97 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.143 0.878 . . . . 0.0 112.184 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 pt -76.11 67.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 125.663 1.585 . . . . 0.0 109.859 169.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.79 -22.63 3.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.986 2.514 . . . . 0.0 114.319 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -59.58 -38.26 80.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.625 0.77 . . . . 0.0 111.547 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 t -69.42 141.26 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.41 144.78 47.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.7 m -98.95 135.45 40.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.47 164.48 21.81 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 128.194 2.598 . . . . 0.0 106.55 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.0 m -131.27 167.46 19.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -138.79 -26.51 0.86 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.459 -0.781 . . . . 0.0 112.506 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -51.81 -29.91 21.1 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -63.81 -24.64 67.84 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.53 -0.731 . . . . 0.0 112.919 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -122.56 -26.37 4.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.538 1.135 . . . . 0.0 111.688 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.1 tpt 65.67 2.66 2.16 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.566 3.146 . . . . 0.0 114.293 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -72.4 -39.47 67.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.562 -1.209 . . . . 0.0 112.433 -170.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.35 -39.5 94.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.683 1.583 . . . . 0.0 109.501 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.46 -48.24 77.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 124.253 0.93 . . . . 0.0 111.116 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.9 -46.05 76.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 117.876 0.838 . . . . 0.0 110.175 174.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.92 68.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.39 1.076 . . . . 0.0 113.355 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.84 3.69 22.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.372 1.069 . . . . 0.0 111.545 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.53 31.01 77.42 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 119.531 1.059 . . . . 0.0 112.767 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.63 -2.78 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -70.79 105.56 3.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.62 133.1 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -72.65 -50.45 24.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.253 0.621 . . . . 0.0 110.191 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.94 -56.32 4.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.929 0.492 . . . . 0.0 110.767 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.0 tp -68.8 -21.09 64.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.399 0.68 . . . . 0.0 111.912 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 52.79 42.57 31.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.559 1.543 . . . . 0.0 112.19 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.72 170.51 14.24 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.718 1.207 . . . . 0.0 108.234 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.7 134.94 46.62 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.37 41.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.333 0.653 . . . . 0.0 111.262 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -72.78 124.16 24.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.1 m -164.31 169.91 16.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.373 1.069 . . . . 0.0 108.221 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.38 147.95 18.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.75 156.74 45.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.562 1.545 . . . . 0.0 108.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.77 142.47 42.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 tp -137.27 127.65 26.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.726 1.211 . . . . 0.0 109.412 -168.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 168.38 17.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.466 1.106 . . . . 0.0 111.14 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -57.67 -26.17 61.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.858 1.663 . . . . 0.0 113.296 -173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.18 35.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.496 1.518 . . . . 0.0 111.418 -176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.62 10.01 53.89 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 121.258 -0.901 . . . . 0.0 112.847 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -75.43 114.6 14.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.706 1.753 . . . . 0.0 107.937 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.04 129.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.24 -11.53 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.319 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -150.6 151.0 31.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.0 133.99 13.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.187 1.795 . . . . 0.0 106.397 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -144.98 138.19 26.62 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.22 114.82 23.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.66 144.49 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.6 m -59.32 -23.27 62.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 111.759 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -145.77 126.31 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 5.61 1.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.294 1.438 . . . . 0.0 114.385 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -114.77 24.37 11.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.336 1.454 . . . . 0.0 109.693 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -138.25 162.74 33.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 129.317 3.047 . . . . 0.0 106.377 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -115.44 153.7 47.65 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 119.764 1.166 . . . . 0.0 113.022 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.07 179.18 6.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.065 3.177 . . . . 0.0 111.576 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -65.44 152.69 43.34 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.173 0.589 . . . . 0.0 110.101 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -109.78 -3.11 16.93 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.152 0.981 . . . . 0.0 112.149 -171.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -128.71 -40.81 1.53 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.803 0.729 . . . . 0.0 110.719 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -55.11 -46.19 99.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.136 -1.411 . . . . 0.0 112.159 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.69 -34.17 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.832 1.69 . . . . 0.0 112.515 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.07 -46.51 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.523 1.056 . . . . 0.0 109.742 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.95 -38.79 92.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.67 0.788 . . . . 0.0 110.011 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.17 96.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.1 66.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.912 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -55.85 -40.02 72.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.006 0.821 . . . . 0.0 110.692 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.65 67.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.235 0.614 . . . . 0.0 111.843 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.34 -48.79 9.34 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 122.951 0.5 . . . . 0.0 111.572 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.89 -49.68 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.818 . . . . 0.0 110.073 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 78.7 tttt . . . . . 0 C--O 1.249 1.065 0 C-N-CA 127.791 2.436 . . . . 0.0 111.04 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.0 pt -139.54 -177.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -115.83 153.55 31.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.13 110.69 9.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt 41.49 45.18 2.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.317 1.847 . . . . 0.0 111.974 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.75 -10.79 62.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.29 0.876 . . . . 0.0 115.29 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.47 120.38 6.45 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.031 -1.427 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.86 139.43 84.1 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.191 2.594 . . . . 0.0 112.113 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 m -145.94 159.62 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.18 1.392 . . . . 0.0 110.117 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.5 m -110.88 162.22 15.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.387 1.475 . . . . 0.0 109.461 -170.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.36 139.26 50.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 109.348 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.61 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.951 0.901 . . . . 0.0 110.784 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.47 71.37 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.984 0.802 . . . . 0.0 113.877 -171.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 52.89 -176.47 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.431 2.693 . . . . 0.0 116.907 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -68.01 111.25 4.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.528 1.931 . . . . 0.0 112.742 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -73.46 152.76 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 168.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -134.32 160.53 37.65 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -58.91 136.49 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.18 -4.17 85.99 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.81 1.195 . . . . 0.0 113.796 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.25 -9.35 59.18 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.72 1.76 . . . . 0.0 114.216 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 67.51 122.77 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.665 1.986 . . . . 0.0 111.838 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.01 127.77 91.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.702 -1.142 . . . . 0.0 108.069 173.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.62 -46.78 13.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.635 2.223 . . . . 0.0 113.846 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 t70 128.52 122.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 131.329 3.851 . . . . 0.0 105.554 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -146.96 169.18 19.71 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.273 1.429 . . . . 0.0 108.509 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.9 m -123.57 151.6 42.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 m -139.75 174.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 128.051 2.54 . . . . 0.0 106.548 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.91 153.16 40.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.4 p -80.49 176.9 9.37 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.495 1.118 . . . . 0.0 110.091 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.2 -26.49 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.022 -1.049 . . . . 0.0 110.891 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -79.14 0.57 27.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 111.863 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt 51.79 51.07 17.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.627 1.971 . . . . 0.0 111.985 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.16 141.94 47.96 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -70.08 148.1 49.18 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.612 1.165 . . . . 0.0 110.546 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -153.35 153.72 33.12 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.573 2.349 . . . . 0.0 105.488 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -137.54 164.83 27.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.926 0.785 . . . . 0.0 109.475 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.1 tp -49.89 -41.29 45.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 110.961 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.11 -18.61 65.45 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.53 -29.67 56.82 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.721 0.691 . . . . 0.0 110.949 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.5 mtt -74.84 -42.44 57.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.454 1.102 . . . . 0.0 110.364 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 144.62 24.33 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.432 0.693 . . . . 0.0 110.166 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.72 -17.55 22.95 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.766 1.175 . . . . 0.0 112.879 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -146.65 155.2 42.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.945 1.298 . . . . 0.0 108.874 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.42 141.23 16.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.5 m -134.7 146.74 49.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.088 0.955 . . . . 0.0 108.599 -174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.41 133.62 57.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.0 mt -138.82 131.0 37.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.98 143.35 46.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 169.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.72 137.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -141.9 156.8 65.36 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 108.032 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.54 -49.33 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 120.87 1.047 . . . . 0.0 109.448 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.0 m -162.53 144.93 10.89 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 120.931 -1.106 . . . . 0.0 109.967 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.67 -28.26 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 122.924 0.49 . . . . 0.0 111.251 170.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.22 -25.61 48.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.456 1.102 . . . . 0.0 113.55 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 79.7 p -64.09 -24.99 67.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.34 -4.12 74.06 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.772 -1.016 . . . . 0.0 112.712 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.86 -28.27 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.112 1.956 . . . . 0.0 110.008 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.5 p -57.89 -33.95 69.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.997 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.26 -33.56 24.01 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.92 0.782 . . . . 0.0 110.693 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.97 70.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.307 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.85 -49.06 0.19 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -54.38 -48.71 71.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -167.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -4.63 12.53 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.61 -39.88 2.82 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 123.861 0.864 . . . . 0.0 109.161 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.43 -47.47 72.8 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.712 0.805 . . . . 0.0 110.751 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -67.05 -31.21 71.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.797 0.439 . . . . 0.0 111.984 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -70.65 -51.46 27.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.4 -41.55 89.68 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.145 0.578 . . . . 0.0 110.181 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.02 75.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.164 0.986 . . . . 0.0 110.613 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.48 66.47 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -72.84 -27.81 62.16 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.802 1.183 . . . . 0.0 111.826 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 mt -63.91 -37.32 86.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.731 0.696 . . . . 0.0 111.17 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.2 -170.63 43.78 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.17 19.06 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.824 0.849 . . . . 0.0 113.273 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.1 m -55.42 153.84 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 111.464 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.48 143.04 44.79 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.89 126.78 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.49 151.55 50.48 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.412 0.551 . . . . 0.0 110.951 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.6 m -122.26 139.06 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.05 133.35 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -128.84 161.43 29.82 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.835 0.854 . . . . 0.0 110.67 -173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -169.794 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.1 p90 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 t 48.95 50.25 18.07 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.476 1.111 . . . . 0.0 110.227 -171.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.69 -139.8 4.66 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -169.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.0 69.47 1.45 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.23 1.412 . . . . 0.0 111.45 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.39 142.1 23.66 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 108.926 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.04 50.16 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.114 0.864 . . . . 0.0 112.897 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.26 94.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.32 -29.33 61.15 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.843 1.257 . . . . 0.0 114.117 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -64.37 -29.06 70.14 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.91 148.9 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.36 148.11 39.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.16 141.74 28.42 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.308 1.843 . . . . 0.0 108.28 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.63 155.2 36.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.749 1.619 . . . . 0.0 108.543 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.5 m -127.3 47.38 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.411 2.284 . . . . 0.0 109.204 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.41 -26.6 42.67 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.698 -0.626 . . . . 0.0 112.2 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -49.25 -26.44 2.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -70.15 -15.92 63.02 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.69 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -140.73 -22.07 0.8 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.827 1.194 . . . . 0.0 113.745 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 82.3 mmm 58.79 2.99 0.27 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.309 3.044 . . . . 0.0 116.021 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -62.89 -44.07 97.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.466 1.485 . . . . 0.0 111.994 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -64.87 -42.34 94.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.562 1.528 . . . . 0.0 109.756 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.27 -44.75 96.27 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 123.68 0.657 . . . . 0.0 111.773 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.44 -46.08 67.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.983 0.513 . . . . 0.0 109.843 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -38.92 78.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.082 0.953 . . . . 0.0 112.46 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -99.38 4.53 46.33 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.68 1.192 . . . . 0.0 111.824 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.22 37.5 64.82 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 118.454 0.57 . . . . 0.0 112.803 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.73 -7.55 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.358 1.063 . . . . 0.0 109.841 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.86 108.41 1.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.78 120.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.16 -43.81 98.0 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.618 1.167 . . . . 0.0 111.423 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -92.32 -4.78 53.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.466 0.707 . . . . 0.0 112.872 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.62 -11.59 2.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.919 . . . . 0.0 111.977 -170.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 41.6 ptt85 49.3 31.61 3.86 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.15 2.18 . . . . 0.0 114.599 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.3 mt -116.9 167.11 11.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.33 130.6 37.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 164.1 24.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.786 1.234 . . . . 0.0 112.809 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 99.25 11.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.8 m -144.06 162.69 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.885 0.874 . . . . 0.0 109.158 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.55 144.42 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -146.98 155.9 42.62 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.088 1.355 . . . . 0.0 109.068 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.8 t -139.5 143.77 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.88 136.15 36.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.841 0.856 . . . . 0.0 109.7 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.14 164.53 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.368 1.467 . . . . 0.0 109.133 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.4 -29.65 10.58 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.04 1.736 . . . . 0.0 113.253 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.35 1.79 12.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.688 1.195 . . . . 0.0 113.015 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.33 30.09 65.31 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 120.837 -1.165 . . . . 0.0 110.245 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -106.85 116.23 31.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.794 1.297 . . . . 0.0 108.494 -173.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.17 124.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.216 1.006 . . . . 0.0 110.679 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.07 -8.42 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.376 1.47 . . . . 0.0 111.131 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -147.99 147.45 29.65 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.81 15.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.456 1.502 . . . . 0.0 108.272 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.79 149.63 33.73 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.105 0.962 . . . . 0.0 109.216 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.16 104.93 7.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.761 2.424 . . . . 0.0 105.055 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.74 137.86 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.2 m -62.25 -11.95 17.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.149 1.38 . . . . 0.0 113.727 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -142.69 123.92 14.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -54.39 -27.02 33.72 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.863 1.265 . . . . 0.0 113.958 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.9 p -91.72 14.54 14.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.754 1.161 . . . . 0.0 112.368 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -123.66 170.84 10.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.632 1.573 . . . . 0.0 109.763 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -125.96 155.43 73.16 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.589 1.156 . . . . 0.0 110.953 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -91.65 179.93 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.082 3.188 . . . . 0.0 110.271 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -79.5 111.89 16.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -81.73 -0.68 44.03 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -76.57 -29.44 56.61 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.795 -1.191 . . . . 0.0 108.919 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -59.46 -50.66 86.1 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 117.663 -1.16 . . . . 0.0 111.456 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.65 -34.27 52.05 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.269 1.489 . . . . 0.0 112.44 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.57 -45.31 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.203 1.365 . . . . 0.0 109.933 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.87 -36.04 83.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.12 0.873 . . . . 0.0 110.797 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.386 -0.196 . . . . 0.0 111.068 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.4 77.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.985 0.514 . . . . 0.0 110.899 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -57.18 -40.47 77.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.168 0.894 . . . . 0.0 110.603 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.77 68.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.999 0.52 . . . . 0.0 111.912 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.51 -59.95 2.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.045 0.384 . . . . 0.0 110.921 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.53 -40.28 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.257 1.023 . . . . 0.0 112.14 -169.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? . . . . . 0 C--O 1.25 1.095 0 C-N-CA 127.217 2.207 . . . . 0.0 112.143 -176.386 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.9 pt -126.37 173.18 12.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.619 1.199 . . . . 0.0 111.217 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -116.16 138.3 51.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -90.72 -132.97 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.17 56.36 0.46 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.656 1.982 . . . . 0.0 111.317 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 22.63 45.02 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.341 0.972 . . . . 0.0 113.506 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.54 140.42 11.06 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.03 144.55 52.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.617 2.212 . . . . 0.0 109.572 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.85 126.73 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.412 0.685 . . . . 0.0 109.415 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -66.73 151.12 48.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.222 1.409 . . . . 0.0 110.509 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.66 145.73 47.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.0 1.72 . . . . 0.0 107.611 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.65 -23.06 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.85 31.31 0.51 Allowed Glycine 0 N--CA 1.464 0.549 0 CA-C-N 118.689 0.677 . . . . 0.0 111.648 -172.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.41 152.12 3.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 9.4 tt0 94.66 33.17 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.504 2.721 . . . . 0.0 113.997 169.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -64.0 152.99 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.47 167.88 25.84 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -169.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.54 129.87 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.209 0.604 . . . . 0.0 109.695 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -2.79 87.58 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.715 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.53 -11.4 59.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.485 1.642 . . . . 0.0 112.235 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 57.08 178.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.563 1.545 . . . . 0.0 112.291 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.85 138.82 33.39 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 127.001 2.12 . . . . 0.0 107.856 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -58.38 -44.39 38.46 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.813 2.342 . . . . 0.0 114.201 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 114.99 124.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 131.218 3.807 . . . . 0.0 105.439 -169.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -133.49 165.37 25.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 109.088 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -126.22 139.44 53.34 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.48 146.11 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.032 1.333 . . . . 0.0 108.276 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.44 166.15 22.31 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.6 p -130.62 -177.54 4.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.932 1.293 . . . . 0.0 108.419 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -47.27 -34.28 6.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.559 0.744 . . . . 0.0 111.537 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -112.77 14.53 19.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.819 1.248 . . . . 0.0 111.531 -170.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.6 mt 51.64 44.16 29.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.742 . . . . 0.0 112.123 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -73.29 -18.12 61.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 112.81 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.12 54.56 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 123.084 1.421 . . . . 0.0 108.604 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -58.76 161.0 5.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.066 1.746 . . . . 0.0 108.869 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.2 p -141.59 170.23 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 tp -54.55 -40.95 69.21 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.63 -20.66 63.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.64 -33.46 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.728 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 37.0 mtt -71.36 -39.73 71.08 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.301 1.041 . . . . 0.0 110.609 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -54.36 138.37 39.69 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 123.317 0.647 . . . . 0.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.24 7.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.01 1.29 . . . . 0.0 112.553 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -147.92 155.77 41.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.598 1.159 . . . . 0.0 109.258 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.41 139.67 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.1 m -135.36 147.83 49.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.231 1.012 . . . . 0.0 108.738 -172.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.09 136.78 54.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.3 mt -135.27 128.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.0 m -108.9 141.33 41.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -135.48 125.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.9 pt -150.06 159.6 35.12 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.201 1.8 . . . . 0.0 107.178 -170.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.71 -40.39 79.95 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.123 1.882 . . . . 0.0 112.234 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.07 165.53 15.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.812 1.645 . . . . 0.0 109.099 169.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pp -67.23 41.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 125.915 1.686 . . . . 0.0 112.861 169.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -158.18 -29.03 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.148 . . . . 0.0 113.208 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -72.57 32.51 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -168.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.82 -29.6 1.8 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.006 1.289 . . . . 0.0 114.591 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.3 -3.72 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.379 1.472 . . . . 0.0 113.202 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 29.2 m -74.45 33.36 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.975 -1.078 . . . . 0.0 110.65 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.38 179.84 1.18 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.099 1.36 . . . . 0.0 111.259 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.38 31.61 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.567 1.147 . . . . 0.0 113.235 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -62.94 -56.76 14.32 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.714 1.143 . . . . 0.0 109.437 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -62.16 -42.55 99.37 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 109.779 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -61.71 -53.95 49.14 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.829 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -64.11 -45.88 86.67 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.846 0.748 . . . . 0.0 110.268 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -54.09 -52.17 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.175 0.99 . . . . 0.0 110.853 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.18 -35.95 81.8 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.915 0.388 . . . . 0.0 110.823 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -69.98 -37.25 75.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.257 0.623 . . . . 0.0 111.838 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -74.49 -34.34 63.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.171 0.896 . . . . 0.0 110.919 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.32 -46.41 76.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.708 0.685 . . . . 0.0 110.794 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.97 -16.44 51.29 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.838 0.855 . . . . 0.0 113.293 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -83.21 -27.09 30.23 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.067 0.849 . . . . 0.0 111.847 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.0 -33.82 76.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.581 0.628 . . . . 0.0 110.987 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.36 -168.01 40.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -75.71 28.16 0.11 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.745 -0.856 . . . . 0.0 112.217 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -54.76 138.42 14.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.528 1.131 . . . . 0.0 109.059 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -66.13 137.97 57.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.07 119.53 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.61 149.62 52.18 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.915 0.486 . . . . 0.0 110.745 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 m -133.76 116.1 15.34 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mt -92.14 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -133.72 162.08 32.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.094 2.158 . . . . 0.0 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.204 1.402 . . . . 0.0 112.95 -178.055 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 62.9 m95 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.7 p -63.72 -15.05 57.51 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.675 -0.64 . . . . 0.0 112.393 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.36 -148.85 5.88 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 127.205 2.336 . . . . 0.0 107.738 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 54.69 41.43 31.94 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.702 1.201 . . . . 0.0 111.659 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -141.14 148.15 39.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.962 1.705 . . . . 0.0 107.278 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.04 -60.37 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 77.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 122.696 1.236 . . . . 0.0 108.898 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.88 -20.11 14.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.338 1.855 . . . . 0.0 113.974 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -58.38 -30.98 67.21 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.734 -0.604 . . . . 0.0 112.098 173.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.56 142.24 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.67 138.24 44.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.47 143.05 32.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.825 0.85 . . . . 0.0 108.817 -173.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -124.07 156.39 36.64 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.78 1.632 . . . . 0.0 108.247 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -136.41 144.44 44.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -134.26 -16.23 2.16 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -64.29 -14.32 55.21 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.717 -1.24 . . . . 0.0 114.143 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -65.55 -18.88 65.65 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.276 -0.89 . . . . 0.0 112.155 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -147.19 -15.64 0.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 35.6 mmm 50.15 37.33 14.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.245 1.818 . . . . 0.0 111.99 -169.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -56.94 15.43 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -63.3 -37.85 88.87 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.687 0.676 . . . . 0.0 109.812 175.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.77 -55.48 8.21 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.482 1.991 . . . . 0.0 113.216 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.47 -35.2 40.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.154 0.477 . . . . 0.0 110.506 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.47 79.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.186 0.595 . . . . 0.0 112.334 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.62 2.43 16.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.915 1.286 . . . . 0.0 110.684 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 8.08 62.55 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.289 -0.882 . . . . 0.0 114.276 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 m -79.47 -4.55 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.043 1.737 . . . . 0.0 112.175 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -67.0 115.76 7.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.5 mt -75.48 106.86 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -54.72 -40.63 69.45 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.805 0.842 . . . . 0.0 110.85 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -86.88 -5.1 59.21 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.02 -7.03 2.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.168 0.894 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 15.8 ptm180 40.2 43.33 1.36 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.89 2.076 . . . . 0.0 113.763 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt -131.74 175.83 8.85 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.04 129.55 34.78 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.758 0.823 . . . . 0.0 109.318 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 139.24 57.86 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.998 1.319 . . . . 0.0 111.1 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.49 113.14 3.1 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.4 p -154.15 164.13 39.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.284 0.564 . . . . 0.0 109.873 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 t -141.74 136.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -142.85 152.09 41.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.564 0.745 . . . . 0.0 109.229 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.65 136.25 52.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -130.85 136.74 48.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.86 1.264 . . . . 0.0 108.372 -169.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.06 165.46 15.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.22 1.408 . . . . 0.0 110.514 169.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.51 -33.22 20.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 113.182 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.32 5.74 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.172 0.897 . . . . 0.0 113.304 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.3 -7.59 75.49 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.607 1.099 . . . . 0.0 113.091 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.48 125.32 24.79 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.613 1.207 . . . . 0.0 109.034 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.86 128.75 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.94 -8.53 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.122 1.369 . . . . 0.0 111.04 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -153.86 150.48 28.45 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.7 133.74 11.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.522 1.529 . . . . 0.0 107.913 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -143.57 149.8 37.92 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.327 0.651 . . . . 0.0 110.138 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -128.09 112.74 14.92 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.09 133.47 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -57.9 -20.3 36.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.043 0.937 . . . . 0.0 112.633 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.43 124.47 13.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.49 -32.04 72.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.394 0.678 . . . . 0.0 112.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -79.41 17.28 0.87 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.483 1.113 . . . . 0.0 111.65 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -134.31 171.27 14.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 107.054 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.84 151.13 76.83 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 111.435 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -86.64 176.09 4.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.064 3.176 . . . . 0.0 110.421 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -71.52 133.37 45.77 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -110.7 3.07 18.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.0 0.52 . . . . 0.0 112.192 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.59 -40.27 42.75 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -54.65 -50.79 83.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.315 -1.326 . . . . 0.0 112.403 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.46 -36.64 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 CA-C-N 121.84 1.693 . . . . 0.0 112.431 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.5 mm -59.48 -46.75 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.315 0.961 . . . . 0.0 109.588 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.45 -35.85 82.15 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.304 -0.872 . . . . 0.0 110.845 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.87 98.46 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.356 0.262 . . . . 0.0 110.642 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.27 -47.04 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.919 0.488 . . . . 0.0 110.682 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.96 -42.5 72.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.211 0.914 . . . . 0.0 110.484 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.4 -31.12 67.39 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.346 0.658 . . . . 0.0 111.881 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -84.74 -44.01 13.74 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.763 0.425 . . . . 0.0 111.612 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.87 -51.35 24.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 123.774 0.83 . . . . 0.0 111.55 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.249 1.068 0 C-N-CA 123.948 0.899 . . . . 0.0 109.666 -178.455 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.57 172.81 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 122.397 1.094 . . . . 0.0 110.07 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 m -134.01 143.82 48.34 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.81 -2.292 . . . . 0.0 104.81 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -138.39 127.18 23.7 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 47.34 38.77 7.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.922 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.6 20.35 79.57 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.309 -0.717 . . . . 0.0 114.526 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.08 121.35 4.41 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 172.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.34 140.91 82.32 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.827 2.351 . . . . 0.0 110.715 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.25 135.81 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -74.78 157.7 34.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.597 1.559 . . . . 0.0 109.406 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 144.64 48.71 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.0 t -60.88 -52.18 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.495 0.718 . . . . 0.0 112.33 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.66 37.57 3.17 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.707 1.146 . . . . 0.0 112.41 -170.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.15 169.95 0.16 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.537 1.935 . . . . 0.0 115.018 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 77.18 28.21 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.769 2.028 . . . . 0.0 113.306 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -64.0 145.82 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -150.43 164.57 35.56 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.936 0.895 . . . . 0.0 109.555 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 p -53.0 133.04 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.305 0.642 . . . . 0.0 109.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.62 1.21 90.49 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.737 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.63 -12.93 60.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.439 1.619 . . . . 0.0 112.314 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.17 176.4 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.81 1.644 . . . . 0.0 112.025 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.72 147.58 63.33 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.647 1.579 . . . . 0.0 110.363 -173.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.02 -51.39 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.776 2.317 . . . . 0.0 112.277 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t70 118.11 127.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 1 C-N-CA 131.844 4.058 . . . . 0.0 105.88 -169.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.75 166.51 23.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.832 1.653 . . . . 0.0 108.844 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 m -132.13 138.2 47.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.52 174.47 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 127.778 2.431 . . . . 0.0 107.686 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.3 140.93 46.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.8 p -70.84 174.87 5.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.143 1.777 . . . . 0.0 110.846 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.52 -22.08 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.505 -0.747 . . . . 0.0 110.928 169.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 m -84.11 0.18 49.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.485 1.514 . . . . 0.0 111.859 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.3 mt 52.73 49.74 19.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.427 1.891 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.33 159.95 26.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.358 1.463 . . . . 0.0 107.451 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.66 144.46 47.75 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.915 0.864 . . . . 0.0 111.026 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -142.11 151.39 42.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.619 2.368 . . . . 0.0 105.129 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 p -135.08 165.08 26.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -56.85 -37.53 71.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 174.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.88 67.59 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -78.95 -30.48 44.59 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.794 0.725 . . . . 0.0 111.259 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 48.6 mtt -72.03 -41.1 67.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.966 0.906 . . . . 0.0 110.887 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -54.3 146.06 16.38 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.238 1.015 . . . . 0.0 110.057 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.11 -21.15 12.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.937 1.256 . . . . 0.0 112.612 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -146.8 152.98 39.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.321 1.448 . . . . 0.0 108.443 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.77 141.14 17.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.4 m -135.02 146.8 49.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -172.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 90.1 mt -128.51 135.23 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.4 102.94 3.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.8 m -79.84 151.22 30.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.74 126.86 39.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.5 pt -137.84 147.75 57.99 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.742 0.417 . . . . 0.0 110.132 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.56 -34.41 7.34 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.187 1.925 . . . . 0.0 111.565 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -163.95 172.38 14.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.739 1.615 . . . . 0.0 109.179 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 pp -105.54 -9.36 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.77 1.228 . . . . 0.0 110.794 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -69.17 -34.57 75.17 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.651 -0.656 . . . . 0.0 110.282 169.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.36 146.82 52.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.478 1.511 . . . . 0.0 110.726 173.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.24 -3.25 52.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.223 0.916 . . . . 0.0 114.618 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.93 -22.72 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.966 1.307 . . . . 0.0 112.412 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 90.9 m -51.6 -65.07 0.62 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.872 1.269 . . . . 0.0 110.342 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.13 -33.05 50.68 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.054 0.541 . . . . 0.0 110.903 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.19 86.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.908 -0.568 . . . . 0.0 111.966 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -159.11 -39.16 0.06 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -64.78 -46.16 83.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.549 1.068 . . . . 0.0 112.567 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -69.92 -29.58 66.78 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.858 -1.151 . . . . 0.0 112.444 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -78.52 -45.27 22.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.274 0.943 . . . . 0.0 109.971 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.24 -44.96 96.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.175 -0.44 . . . . 0.0 111.376 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -63.04 -40.44 97.72 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.232 0.613 . . . . 0.0 110.417 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.37 -51.46 67.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.678 0.791 . . . . 0.0 109.851 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -64.16 -37.01 85.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.541 0.736 . . . . 0.0 110.973 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.87 76.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.468 1.507 . . . . 0.0 110.108 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -26.83 68.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.573 0.349 . . . . 0.0 111.932 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.13 -20.55 55.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.077 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.34 -36.54 84.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.267 1.394 . . . . 0.0 111.596 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.71 -170.91 43.48 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -74.22 21.62 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.26 150.56 2.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 O-C-N 120.7 -1.25 . . . . 0.0 110.786 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.17 143.41 47.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 125.01 43.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.57 156.37 45.87 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.601 0.76 . . . . 0.0 109.94 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.9 m -132.48 114.59 14.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -97.44 132.79 41.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 m -142.59 169.16 18.09 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.839 1.255 . . . . 0.0 109.305 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 110.738 173.193 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.6 p -72.23 -45.06 61.78 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.961 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.15 -10.3 59.1 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.578 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.9 -6.91 12.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.93 1.365 . . . . 0.0 112.352 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 109.84 2.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.381 0.537 . . . . 0.0 109.945 -170.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.24 -1.43 60.64 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.391 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.22 90.38 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.951 1.875 . . . . 0.0 109.313 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.35 -30.85 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.447 1.899 . . . . 0.0 114.547 -173.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.57 -30.21 71.36 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 t -76.98 144.78 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.01 131.26 28.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.592 0.71 . . . . 0.0 109.448 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.37 144.94 32.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.576 1.151 . . . . 0.0 109.304 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -132.6 155.36 48.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.332 1.453 . . . . 0.0 109.477 -170.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -112.94 138.26 50.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.388 1.075 . . . . 0.0 108.467 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.57 -17.93 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -61.79 -11.17 11.14 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.11 -0.994 . . . . 0.0 113.414 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -46.62 -45.31 18.98 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.529 1.532 . . . . 0.0 110.608 169.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.54 3.75 0.57 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 43.0 mmm 51.27 37.53 18.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.692 1.597 . . . . 0.0 112.127 -172.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -57.35 -59.77 4.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.423 1.089 . . . . 0.0 110.61 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -62.75 -36.5 83.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.072 0.949 . . . . 0.0 109.459 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.9 -60.56 3.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 126.195 1.855 . . . . 0.0 113.023 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.01 -35.26 57.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.194 0.497 . . . . 0.0 110.354 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.46 85.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.45 5.38 15.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.202 1.401 . . . . 0.0 110.782 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.45 64.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.282 -0.886 . . . . 0.0 112.834 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.95 0.2 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.483 1.113 . . . . 0.0 111.366 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -71.12 106.51 3.77 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.62 121.19 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -65.45 -41.35 93.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.909 0.484 . . . . 0.0 110.553 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.78 -61.77 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.865 0.466 . . . . 0.0 110.156 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 21.9 tp -71.76 -19.27 62.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.646 0.778 . . . . 0.0 112.452 -172.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 54.11 41.52 31.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.148 1.379 . . . . 0.0 111.658 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.7 mt -128.07 179.01 5.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.775 1.23 . . . . 0.0 108.371 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.11 133.83 41.45 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.171 0.989 . . . . 0.0 108.831 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.78 152.67 38.76 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.58 1.152 . . . . 0.0 111.177 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.03 110.58 16.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 169.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -150.41 172.11 15.94 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -149.79 144.5 17.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.08 158.0 44.75 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.243 1.417 . . . . 0.0 108.781 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.86 144.36 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.03 126.57 20.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.219 1.008 . . . . 0.0 109.738 -168.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.01 161.51 24.17 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.465 1.506 . . . . 0.0 110.658 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -48.67 -33.93 10.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 112.686 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.5 5.23 36.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.157 1.383 . . . . 0.0 112.733 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.92 -5.72 83.16 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 120.885 -1.134 . . . . 0.0 112.74 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -72.76 121.27 19.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.006 1.403 . . . . 0.0 108.729 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.22 125.72 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.06 -10.89 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.462 1.105 . . . . 0.0 110.223 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -152.42 152.28 31.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.434 1.094 . . . . 0.0 108.268 170.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.21 137.46 14.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.86 1.664 . . . . 0.0 107.493 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -144.83 139.61 27.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -113.48 109.49 18.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.0 t -64.45 115.17 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.2 m -53.21 -25.66 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.994 1.318 . . . . 0.0 113.205 -170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.05 107.65 6.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.19 -25.37 68.04 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.333 1.853 . . . . 0.0 112.462 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.72 15.02 1.48 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.097 1.359 . . . . 0.0 111.695 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.53 175.94 9.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.767 2.827 . . . . 0.0 106.692 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -122.87 154.2 64.02 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.656 1.117 . . . . 0.0 112.135 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.67 177.05 2.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.397 3.398 . . . . 0.0 111.15 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -76.58 130.92 38.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -104.8 -3.98 22.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -33.97 69.97 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.59 -55.67 42.26 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.782 1.233 . . . . 0.0 112.588 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.97 -34.45 59.35 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.74 1.657 . . . . 0.0 111.963 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 mm -60.22 -46.39 94.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.824 1.193 . . . . 0.0 109.707 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.95 -31.86 71.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.716 1.143 . . . . 0.0 110.93 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.15 -39.46 94.73 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.052 0.387 . . . . 0.0 111.012 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.11 68.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.633 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -55.4 -38.61 69.14 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.274 0.943 . . . . 0.0 110.968 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.24 -28.39 64.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.562 0.745 . . . . 0.0 112.299 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.93 -48.3 7.08 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.553 . . . . 0.0 111.334 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.86 -45.46 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.362 1.065 . . . . 0.0 110.837 -171.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt . . . . . 0 C--O 1.25 1.113 0 C-N-CA 126.825 2.05 . . . . 0.0 110.793 179.371 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 pt -136.98 173.33 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 123.478 1.609 . . . . 0.0 110.941 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 m -118.82 154.45 32.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -137.61 121.45 17.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.25 40.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.595 1.558 . . . . 0.0 113.641 -172.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.34 5.48 89.55 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.698 -0.626 . . . . 0.0 114.087 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.03 113.64 4.09 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.639 1.59 . . . . 0.0 109.541 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.1 139.59 71.25 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.942 2.428 . . . . 0.0 111.06 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.6 127.5 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.521 0.677 . . . . 0.0 109.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -69.48 151.73 45.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.998 1.319 . . . . 0.0 110.112 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.68 158.47 23.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.069 1.747 . . . . 0.0 108.694 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.71 -51.66 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.54 29.77 3.75 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.468 1.032 . . . . 0.0 111.92 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.84 164.51 1.51 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.595 1.158 . . . . 0.0 113.348 -172.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 103.64 20.64 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.321 3.048 . . . . 0.0 111.138 170.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.81 136.8 21.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -145.93 166.75 25.1 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.529 1.131 . . . . 0.0 108.131 -171.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.7 130.66 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.39 90.25 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.766 -1.019 . . . . 0.0 114.082 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.51 -8.15 58.95 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.548 1.674 . . . . 0.0 112.37 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 59.92 175.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.501 1.52 . . . . 0.0 112.097 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.22 115.5 13.98 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.89 1.676 . . . . 0.0 108.293 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.4 144.79 99.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.369 2.046 . . . . 0.0 112.699 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -82.07 62.1 5.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -94.09 173.4 7.67 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.4 m -118.55 151.32 38.09 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.718 0.77 . . . . 0.0 111.559 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.49 166.8 20.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.282 2.233 . . . . 0.0 106.996 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mp -109.56 154.49 22.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -83.46 178.81 7.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.053 0.941 . . . . 0.0 109.592 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.19 -26.88 68.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.728 -1.232 . . . . 0.0 110.938 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -80.62 1.49 29.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.313 1.445 . . . . 0.0 111.784 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.0 mt 55.12 35.82 25.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.857 2.063 . . . . 0.0 112.336 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.09 149.58 22.35 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.53 143.7 46.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.544 0.738 . . . . 0.0 110.095 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -144.9 102.19 3.74 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.6 m -70.97 154.24 41.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 27.2 tp -52.53 -39.65 61.62 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.671 -0.643 . . . . 0.0 111.05 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -18.85 40.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.7 -32.29 63.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.593 1.088 . . . . 0.0 110.886 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.4 mtt -73.41 -39.75 64.81 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.629 1.172 . . . . 0.0 110.229 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -55.81 150.48 12.91 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.814 0.816 . . . . 0.0 110.406 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.13 23.15 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.203 1.382 . . . . 0.0 112.216 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -149.14 153.86 38.33 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 108.749 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.22 138.5 16.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.4 m -134.82 148.4 50.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.068 0.947 . . . . 0.0 108.885 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.9 mt -132.81 132.84 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.99 105.99 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -84.46 149.65 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 168.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 t -134.0 128.99 53.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.5 pt -143.84 144.33 26.47 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.673 0.789 . . . . 0.0 109.374 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.75 -33.64 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.061 1.841 . . . . 0.0 111.709 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -154.01 173.15 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.594 1.958 . . . . 0.0 108.692 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.1 pt -132.91 -31.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.11 1.364 . . . . 0.0 110.94 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.64 -12.08 50.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.648 0.737 . . . . 0.0 110.979 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -64.11 -19.63 65.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.825 2.05 . . . . 0.0 112.762 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.71 65.56 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.852 0.739 . . . . 0.0 112.841 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.35 -19.61 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.0 1.4 . . . . 0.0 112.026 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.66 -58.09 9.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 170.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.11 -32.72 72.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.284 0.633 . . . . 0.0 111.131 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -47.86 84.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.005 -0.521 . . . . 0.0 111.383 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -165.86 -35.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -43.55 97.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 112.343 -169.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -62.49 -51.44 67.42 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.436 1.016 . . . . 0.0 109.763 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -62.65 -48.47 79.19 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.617 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -57.36 -51.3 69.96 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.494 0.588 . . . . 0.0 110.86 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -61.41 -40.08 93.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.964 0.906 . . . . 0.0 111.499 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.82 -46.73 71.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.518 0.727 . . . . 0.0 110.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.87 -36.24 81.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.184 0.902 . . . . 0.0 110.672 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.34 77.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.748 0.819 . . . . 0.0 110.292 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.4 -24.47 67.41 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -80.49 -19.12 46.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 112.539 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.59 -39.56 93.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.957 1.253 . . . . 0.0 111.86 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.71 -167.35 39.15 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.19 25.72 0.1 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.468 1.107 . . . . 0.0 112.912 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -57.24 142.32 13.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.206 1.402 . . . . 0.0 110.715 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -72.83 137.87 46.0 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 168.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.28 124.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -137.82 153.94 49.58 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.828 0.851 . . . . 0.0 110.323 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 m -126.16 103.94 7.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.7 mt -77.32 131.76 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.6 m -132.25 165.34 24.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.164 1.385 . . . . 0.0 109.314 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.798 0.808 . . . . 0.0 110.621 169.727 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.9 p -59.62 -28.57 67.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.15 -14.22 57.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.961 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.68 33.59 5.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.827 1.314 . . . . 0.0 110.395 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -141.24 135.58 30.82 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.46 -15.59 7.17 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.334 -0.704 . . . . 0.0 112.642 -170.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mt -128.83 76.93 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.2 -26.25 38.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -63.67 -27.66 69.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.502 1.121 . . . . 0.0 112.642 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.75 154.13 3.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.27 146.81 39.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.4 148.81 24.04 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.37 157.05 35.97 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.461 1.505 . . . . 0.0 108.554 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -128.82 49.25 2.24 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.193 2.197 . . . . 0.0 108.947 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -47.18 -41.82 18.68 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.567 0.747 . . . . 0.0 111.358 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -56.15 -19.89 15.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.166 0.986 . . . . 0.0 113.631 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -68.7 -22.33 64.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.048 -1.033 . . . . 0.0 111.618 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -133.72 -26.14 1.6 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.085 0.954 . . . . 0.0 112.999 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.79 -4.03 0.27 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.789 3.235 . . . . 0.0 115.731 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -57.25 -52.57 64.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.718 1.144 . . . . 0.0 110.965 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.67 -35.14 78.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.593 0.633 . . . . 0.0 111.129 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.24 -43.22 98.71 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.63 0.633 . . . . 0.0 112.119 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.66 -38.88 80.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.634 0.717 . . . . 0.0 110.31 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.82 84.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.644 0.778 . . . . 0.0 111.88 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.83 -6.19 58.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.72 0.808 . . . . 0.0 111.08 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.46 1.9 62.2 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.119 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.89 -19.74 26.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 124.638 1.175 . . . . 0.0 111.137 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.66 118.35 6.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.313 0.961 . . . . 0.0 108.651 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -81.61 105.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 126.197 1.799 . . . . 0.0 106.425 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.24 -40.59 61.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.752 1.221 . . . . 0.0 110.869 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -88.79 -4.74 58.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.34 0.656 . . . . 0.0 112.714 -170.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.6 tp -137.37 -5.8 1.8 Allowed 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.117 -0.989 . . . . 0.0 113.047 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 32.2 ptt-85 42.5 45.8 3.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.949 1.7 . . . . 0.0 112.767 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -134.87 176.59 8.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.119 1.768 . . . . 0.0 106.358 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.261 0.0 OUTLIER -106.49 147.5 29.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 121.884 2.129 . . . . 0.0 111.862 170.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.03 156.58 35.67 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.741 2.016 . . . . 0.0 112.785 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -82.54 116.34 21.92 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.2 m -150.79 167.06 28.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 108.96 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.93 142.96 19.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.22 151.83 42.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.775 1.23 . . . . 0.0 108.111 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.9 t -135.07 135.44 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -130.26 135.53 48.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.361 1.064 . . . . 0.0 109.239 -169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.48 167.25 5.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 109.502 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -51.13 -34.12 29.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.041 1.336 . . . . 0.0 112.711 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -80.24 -0.57 36.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.473 1.109 . . . . 0.0 112.547 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.66 79.33 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.896 1.236 . . . . 0.0 112.606 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.64 117.3 5.6 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.244 1.522 . . . . 0.0 109.469 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.84 115.67 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.848 0.859 . . . . 0.0 109.447 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.6 -12.21 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.657 1.183 . . . . 0.0 110.664 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -147.17 144.68 29.13 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.31 126.36 7.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.317 1.447 . . . . 0.0 107.283 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.82 145.56 29.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -114.47 111.08 20.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 t -61.95 125.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -172.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -59.42 -13.32 8.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.472 1.109 . . . . 0.0 113.663 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.6 128.13 21.42 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.98 63.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.065 . . . . 0.0 113.667 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.2 p -84.68 -4.49 59.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.083 1.31 . . . . 0.0 112.637 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -98.07 177.24 5.48 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.438 1.495 . . . . 0.0 109.974 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -133.51 151.57 77.57 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.015 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.0 -176.68 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.663 2.908 . . . . 0.0 109.249 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -76.85 119.47 20.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -91.29 -0.87 57.74 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.28 -36.05 40.33 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -51.21 -55.45 28.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.134 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.27 -33.88 47.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.584 1.601 . . . . 0.0 112.728 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.81 -45.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.185 1.357 . . . . 0.0 109.879 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.54 -36.84 85.0 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.376 0.989 . . . . 0.0 110.596 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.12 96.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.082 0.553 . . . . 0.0 111.178 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.15 -41.89 76.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.28 0.945 . . . . 0.0 110.302 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.29 -31.89 70.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.162 0.585 . . . . 0.0 112.012 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.59 -40.45 23.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.076 0.55 . . . . 0.0 111.807 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.55 -54.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.454 0.702 . . . . 0.0 109.483 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.1 pttt . . . . . 0 C--O 1.25 1.083 0 C-N-CA 127.722 2.409 . . . . 0.0 112.036 -178.231 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.6 pt -130.33 -178.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 122.172 0.987 . . . . 0.0 110.92 -169.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -127.1 146.35 50.41 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -143.68 133.25 23.56 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm 43.7 42.38 4.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.586 1.555 . . . . 0.0 112.138 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.18 28.5 70.04 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.161 -0.799 . . . . 0.0 114.54 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 139.6 10.52 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 169.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.39 145.33 42.73 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.592 2.195 . . . . 0.0 110.151 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.27 134.72 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.242 1.017 . . . . 0.0 110.28 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -75.29 152.81 38.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.156 1.782 . . . . 0.0 110.448 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.78 148.76 42.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.98 1.712 . . . . 0.0 108.08 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.15 -84.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.361 0.528 . . . . 0.0 110.935 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 40.48 2.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.296 1.427 . . . . 0.0 112.019 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -58.06 171.05 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.196 2.198 . . . . 0.0 114.593 -169.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 78.52 28.27 0.46 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.817 2.047 . . . . 0.0 114.032 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.6 138.88 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -148.4 164.08 35.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.451 1.1 . . . . 0.0 108.578 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.8 132.97 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 -0.52 89.65 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.219 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -76.55 -13.65 60.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.544 1.672 . . . . 0.0 112.657 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 60.95 157.15 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.813 2.045 . . . . 0.0 112.959 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.58 133.37 46.95 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.342 1.057 . . . . 0.0 109.049 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.3 -27.66 76.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.493 2.795 . . . . 0.0 114.772 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 62.43 98.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.381 2.272 . . . . 0.0 112.113 -170.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -129.49 170.47 13.68 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.901 1.68 . . . . 0.0 108.316 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.9 167.32 11.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.53 1.132 . . . . 0.0 109.279 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.9 -176.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 128.053 2.541 . . . . 0.0 104.215 168.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.05 139.16 35.87 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.6 p -87.64 171.08 10.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 118.821 0.737 . . . . 0.0 109.744 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.443 -0.785 . . . . 0.0 110.733 168.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m -79.35 1.58 24.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.717 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt 61.47 32.58 18.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.684 2.394 . . . . 0.0 112.201 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -91.89 140.33 29.78 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.91 55.83 2.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.085 1.754 . . . . 0.0 110.184 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.41 157.03 5.33 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.065 1.346 . . . . 0.0 108.394 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -133.5 163.8 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.03 -28.5 66.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.022 -0.424 . . . . 0.0 111.958 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.63 -19.71 51.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.085 -1.009 . . . . 0.0 113.647 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.2 -28.49 61.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.443 1.019 . . . . 0.0 110.941 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -74.01 -41.7 61.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.725 1.21 . . . . 0.0 110.039 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 133.48 49.49 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.54 -23.28 4.28 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.992 1.282 . . . . 0.0 112.426 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -154.99 157.38 37.58 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.663 1.185 . . . . 0.0 108.371 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -59.24 143.06 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -137.68 148.04 45.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.269 1.028 . . . . 0.0 108.243 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.2 mt -129.07 137.95 55.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.7 mt -132.17 124.13 51.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.2 t -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.99 131.37 64.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -139.78 136.99 17.86 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.591 0.757 . . . . 0.0 111.451 -170.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.8 -28.71 2.01 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.167 2.578 . . . . 0.0 112.146 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -163.42 170.69 17.06 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.072 1.749 . . . . 0.0 107.739 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -126.13 -18.91 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.109 1.364 . . . . 0.0 110.528 169.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.38 -13.39 58.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.866 0.867 . . . . 0.0 111.362 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 p -61.12 -22.22 64.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.08 1.752 . . . . 0.0 112.252 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.77 -10.24 65.76 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.017 0.817 . . . . 0.0 112.4 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.92 -29.11 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.663 1.231 . . . . 0.0 109.707 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.48 -55.4 35.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.933 0.333 . . . . 0.0 110.11 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -38.79 80.37 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.334 0.253 . . . . 0.0 111.038 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.63 -32.74 73.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.763 -0.636 . . . . 0.0 112.523 -175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -149.62 -46.36 0.13 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.361 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -60.51 -34.64 74.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.994 1.725 . . . . 0.0 111.531 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -50.69 -65.79 0.5 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.274 0.63 . . . . 0.0 109.844 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.89 -40.73 87.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.006 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -58.25 -54.91 41.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 122.502 0.321 . . . . 0.0 110.395 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -76.21 -27.77 56.96 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.918 -171.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.88 -53.08 62.08 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.658 1.183 . . . . 0.0 109.701 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.48 -39.68 88.92 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.324 0.511 . . . . 0.0 110.573 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.82 81.05 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.438 0.695 . . . . 0.0 110.828 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.13 -20.44 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -93.59 -14.86 26.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.413 1.006 . . . . 0.0 112.7 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.75 -31.88 73.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.666 1.121 . . . . 0.0 111.929 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.41 -158.69 31.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.89 26.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.286 1.434 . . . . 0.0 112.533 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.44 135.98 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.105 1.362 . . . . 0.0 108.022 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.95 146.57 52.65 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.72 127.19 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.11 151.34 51.34 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.615 0.766 . . . . 0.0 110.796 -173.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.8 m -133.72 100.34 4.74 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.34 128.71 39.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -125.64 150.18 47.79 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 121.402 0.62 . . . . 0.0 111.947 176.133 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.4 -34.17 73.53 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.361 0.664 . . . . 0.0 111.608 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.57 13.52 62.18 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.814 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.11 26.42 5.18 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.875 1.337 . . . . 0.0 110.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.85 135.64 36.39 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.25 -13.72 43.78 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.879 -173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.43 76.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 125.822 1.649 . . . . 0.0 107.284 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.6 -21.55 10.75 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.489 1.916 . . . . 0.0 113.951 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.45 -27.3 67.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.435 1.094 . . . . 0.0 112.385 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.21 144.73 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.768 0.827 . . . . 0.0 109.227 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.3 129.2 48.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 p -97.67 141.74 30.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.458 1.103 . . . . 0.0 108.682 -172.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -125.47 156.62 38.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 110.077 -169.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -136.12 44.6 2.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.331 2.652 . . . . 0.0 109.11 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.07 -24.92 60.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.396 0.678 . . . . 0.0 112.311 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -51.12 -19.63 1.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.481 1.512 . . . . 0.0 114.387 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -59.52 -27.11 65.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.663 1.119 . . . . 0.0 112.457 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -135.77 -6.96 2.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.78 1.173 . . . . 0.0 113.251 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 86.6 mmm 52.83 26.9 4.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.632 1.573 . . . . 0.0 111.919 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -65.55 0.67 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.006 1.322 . . . . 0.0 111.298 -171.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.9 -36.7 79.92 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.151 0.58 . . . . 0.0 109.507 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.4 -51.56 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 124.249 0.928 . . . . 0.0 111.953 -172.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.39 -41.06 70.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.965 0.506 . . . . 0.0 109.938 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.02 79.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.472 0.709 . . . . 0.0 112.17 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -85.73 -4.84 59.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.762 0.825 . . . . 0.0 111.245 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.07 10.95 62.86 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.015 -0.881 . . . . 0.0 114.223 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.2 m -65.44 -16.98 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.465 1.133 . . . . 0.0 109.982 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.13 106.62 0.45 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.97 125.05 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.27 -37.19 86.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.41 0.684 . . . . 0.0 111.628 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -98.23 -50.71 4.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.284 0.634 . . . . 0.0 111.716 -169.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.7 -24.59 62.68 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.257 0.481 . . . . 0.0 111.306 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 97.3 mtt180 52.54 47.75 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.337 1.455 . . . . 0.0 111.393 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 71.6 mt -129.14 171.06 12.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.027 1.331 . . . . 0.0 107.854 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.62 117.56 22.08 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.42 141.8 40.85 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 111.0 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.86 108.6 1.81 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 m -144.31 164.38 30.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -150.09 139.77 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -142.5 156.11 45.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.554 1.141 . . . . 0.0 108.447 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.9 134.73 48.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -129.5 134.5 47.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.18 165.95 10.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.01 1.324 . . . . 0.0 109.565 169.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -50.24 -37.32 35.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.657 1.183 . . . . 0.0 112.679 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.46 2.91 46.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.76 61.6 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.516 1.055 . . . . 0.0 113.596 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -61.2 118.41 6.82 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.905 1.353 . . . . 0.0 109.166 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.53 113.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.73 0.812 . . . . 0.0 109.054 170.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.08 -26.48 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 0.0 109.459 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -153.38 152.2 30.79 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 107.063 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.68 127.58 5.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -147.08 149.66 33.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -121.59 113.55 19.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.77 119.43 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m -59.12 -19.21 42.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.457 1.503 . . . . 0.0 112.881 -171.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.69 95.72 3.11 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.05 -20.86 65.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.883 0.873 . . . . 0.0 112.599 -172.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 6.17 3.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.722 1.209 . . . . 0.0 112.222 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.98 162.26 30.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.999 2.12 . . . . 0.0 107.854 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -96.99 145.54 29.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.929 -0.482 . . . . 0.0 111.506 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.0 174.15 11.2 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.867 3.045 . . . . 0.0 111.333 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -82.12 129.6 34.86 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -84.03 -11.89 56.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -80.46 -34.57 35.86 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -55.74 -52.05 75.33 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.798 -1.096 . . . . 0.0 112.042 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.6 -37.2 17.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.107 1.431 . . . . 0.0 111.777 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.11 -44.51 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.027 0.831 . . . . 0.0 109.972 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.63 -38.61 91.61 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.156 0.889 . . . . 0.0 110.637 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.54 85.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.26 0.224 . . . . 0.0 111.241 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.28 -47.72 55.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.882 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.62 -39.74 65.18 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.34 0.973 . . . . 0.0 110.796 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.39 -29.66 58.92 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.899 . . . . 0.0 112.267 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.55 -40.42 8.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.488 0.715 . . . . 0.0 111.934 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.94 -39.68 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.362 1.065 . . . . 0.0 111.355 -169.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 C--O 1.248 0.986 0 C-N-CA 123.953 0.901 . . . . 0.0 109.49 179.262 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 C--O 1.238 0.46 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 pt -134.15 -179.61 3.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -127.58 149.93 49.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -139.7 126.95 21.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 46.54 34.66 2.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.444 1.098 . . . . 0.0 112.303 -172.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.97 81.93 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.325 -0.86 . . . . 0.0 114.538 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.24 119.25 4.78 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.54 140.53 89.82 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.951 2.434 . . . . 0.0 111.331 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.1 152.93 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.389 1.076 . . . . 0.0 109.559 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -101.71 163.42 12.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.553 1.541 . . . . 0.0 110.307 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.3 mt -113.31 140.51 47.94 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.029 1.331 . . . . 0.0 108.319 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.4 t -75.35 -61.8 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.76 34.04 3.0 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.568 1.08 . . . . 0.0 113.371 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 52.76 -138.21 1.15 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.296 1.438 . . . . 0.0 110.132 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -135.79 132.23 36.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.479 1.112 . . . . 0.0 110.559 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.66 169.08 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 162.69 40.51 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -52.65 130.41 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.86 -3.76 83.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.745 -1.03 . . . . 0.0 114.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -84.31 -3.13 58.06 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.694 1.747 . . . . 0.0 112.726 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 61.65 171.2 0.12 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.4 1.88 . . . . 0.0 112.935 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -119.29 106.49 42.75 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.449 1.5 . . . . 0.0 108.56 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 144.86 99.08 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.393 2.062 . . . . 0.0 113.13 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.96 65.33 7.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.873 2.069 . . . . 0.0 110.937 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -97.47 158.12 15.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.448 170.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.91 163.77 27.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 112.983 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.29 134.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 168.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -76.26 155.18 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.5 p -123.1 174.05 7.47 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -46.49 -32.19 3.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.333 1.053 . . . . 0.0 112.127 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -113.82 15.89 18.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.111 1.364 . . . . 0.0 111.436 -171.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 53.03 45.01 29.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.773 2.029 . . . . 0.0 112.172 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.4 -12.4 58.97 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.311 12.8 pt-20 44.8 48.88 9.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.433 1.893 . . . . 0.0 111.714 -169.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -46.57 122.03 3.89 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.388 2.275 . . . . 0.0 108.646 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.37 146.35 40.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -39.58 57.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.012 0.824 . . . . 0.0 111.093 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.51 -18.84 21.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.35 -29.06 70.43 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.446 1.021 . . . . 0.0 111.241 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.6 mtt -70.62 -32.76 70.22 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.695 1.198 . . . . 0.0 111.701 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -64.39 133.98 53.68 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.64 -25.88 2.94 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.903 1.24 . . . . 0.0 112.168 -171.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -149.47 157.6 43.43 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.288 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.1 135.99 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.0 m -135.36 146.09 48.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.519 1.128 . . . . 0.0 108.165 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.87 135.84 54.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.02 135.8 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.8 p -115.02 151.27 34.5 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.4 t -134.77 133.01 54.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -137.09 146.42 54.46 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.555 1.142 . . . . 0.0 108.67 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.14 -34.14 23.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.527 2.151 . . . . 0.0 111.914 -176.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -143.29 154.23 43.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.758 1.623 . . . . 0.0 106.979 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 tp -90.64 -32.11 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.263 0.625 . . . . 0.0 111.471 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.77 -17.99 27.17 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.371 0.668 . . . . 0.0 112.232 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.3 p -65.74 163.96 15.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.1 1.36 . . . . 0.0 111.707 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.94 -24.2 33.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.937 1.256 . . . . 0.0 114.864 -171.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.45 -29.47 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.906 1.353 . . . . 0.0 112.203 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.6 t -51.74 -51.33 56.99 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.111 1.365 . . . . 0.0 110.762 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.42 -34.6 12.04 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.078 0.551 . . . . 0.0 111.523 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.24 70.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.752 0.821 . . . . 0.0 112.367 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.473 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.0 tm0? -152.62 -39.51 0.1 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-O 117.762 -1.114 . . . . 0.0 112.513 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -60.59 -42.67 97.18 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.177 1.353 . . . . 0.0 112.357 -169.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -56.45 -56.2 24.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.146 0.884 . . . . 0.0 110.469 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.65 -40.96 93.05 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.406 0.548 . . . . 0.0 111.05 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.473 ' CB ' HE21 ' A' ' 63' ' ' GLN . 25.5 t80 -56.48 -52.67 63.82 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.796 0.438 . . . . 0.0 110.785 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -67.52 -34.88 78.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.164 0.186 . . . . 0.0 111.259 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -64.61 -53.26 50.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.357 1.463 . . . . 0.0 109.763 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -63.53 -38.77 92.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.493 0.717 . . . . 0.0 109.456 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.84 78.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.521 0.728 . . . . 0.0 110.738 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.94 -27.09 67.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.083 0.553 . . . . 0.0 112.31 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -76.26 -24.17 54.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.185 175.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.9 mt -63.89 -40.84 97.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.678 1.126 . . . . 0.0 110.475 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.41 -169.43 42.55 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.35 19.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.155 1.382 . . . . 0.0 113.418 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.05 145.19 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.41 1.484 . . . . 0.0 110.923 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -70.43 144.82 51.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.27 132.69 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -145.54 156.75 43.9 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.885 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.5 m -136.1 116.72 13.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 173.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.95 142.22 14.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.711 1.605 . . . . 0.0 107.499 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -136.23 173.39 11.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 110.136 -170.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.433 0.635 . . . . 0.0 109.944 169.069 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 131.47 50.41 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 173.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.6 73.25 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.158 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.88 3.08 1.39 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.028 1.331 . . . . 0.0 113.064 -169.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -85.0 144.53 28.23 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.47 -49.39 3.84 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.636 1.112 . . . . 0.0 110.856 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 pt -76.63 70.19 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 125.747 1.619 . . . . 0.0 109.435 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.61 -23.82 0.75 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.665 2.786 . . . . 0.0 114.961 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -62.37 -30.65 71.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.369 1.068 . . . . 0.0 111.997 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 t -74.57 156.89 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.98 0.912 . . . . 0.0 108.866 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.32 142.29 41.86 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -86.36 134.65 33.71 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -125.01 164.43 20.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.051 2.14 . . . . 0.0 106.724 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.51 169.9 17.45 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.161 0.984 . . . . 0.0 108.749 169.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -149.02 -17.77 0.3 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -58.77 -17.24 21.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.811 -1.181 . . . . 0.0 113.449 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -53.62 -30.04 40.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.452 1.101 . . . . 0.0 112.625 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -142.18 -6.9 0.93 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.549 1.068 . . . . 0.0 112.975 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.08 30.75 5.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.822 2.049 . . . . 0.0 112.714 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -65.29 0.68 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.785 1.634 . . . . 0.0 111.669 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.77 -34.5 75.97 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.684 0.794 . . . . 0.0 110.28 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.43 98.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 124.305 0.955 . . . . 0.0 112.783 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.38 -35.86 71.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.383 1.091 . . . . 0.0 109.946 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.21 74.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.26 2.46 11.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.468 1.507 . . . . 0.0 111.656 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.96 72.09 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 119.321 0.964 . . . . 0.0 112.399 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . 0.253 33.5 m -107.14 3.04 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.397 0.679 . . . . 0.0 111.429 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.65 105.67 12.07 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.61 127.85 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -66.37 -48.51 69.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.939 0.896 . . . . 0.0 111.109 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -80.27 -49.55 11.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.603 0.239 . . . . 0.0 110.574 -170.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.4 tp -78.71 -18.16 54.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 112.084 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 45.14 52.02 8.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.384 1.474 . . . . 0.0 111.371 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.9 tp -139.25 168.93 18.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.04 138.14 47.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.463 0.574 . . . . 0.0 110.056 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.43 155.95 40.01 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.386 1.075 . . . . 0.0 110.737 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -84.66 109.96 18.39 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.0 m -149.88 168.18 24.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.722 0.409 . . . . 0.0 110.519 -173.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.13 147.1 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.599 1.16 . . . . 0.0 108.22 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -146.77 154.82 41.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.353 1.061 . . . . 0.0 109.036 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.92 140.37 40.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 171.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 mp -130.81 137.18 49.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.57 1.548 . . . . 0.0 107.337 -171.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.44 169.12 6.32 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.158 1.383 . . . . 0.0 109.855 169.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -49.58 -37.93 29.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.741 1.217 . . . . 0.0 112.174 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -75.29 -3.16 31.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.193 0.997 . . . . 0.0 112.677 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.1 -6.96 77.41 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.927 -1.108 . . . . 0.0 112.89 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 113.6 3.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 118.871 1.335 . . . . 0.0 108.365 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.4 129.73 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.27 -12.57 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.661 1.584 . . . . 0.0 109.925 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -151.47 150.15 30.07 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.434 1.093 . . . . 0.0 108.413 172.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.2 135.54 13.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.263 1.825 . . . . 0.0 107.168 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 150.28 30.99 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.451 0.7 . . . . 0.0 109.391 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -124.36 116.24 22.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.779 2.032 . . . . 0.0 105.637 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.24 128.68 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -60.05 -26.69 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.537 1.135 . . . . 0.0 113.268 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.01 105.66 6.46 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.7 66.29 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.124 1.37 . . . . 0.0 113.905 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.21 15.93 2.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.89 -175.63 3.84 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.005 2.122 . . . . 0.0 107.978 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -116.96 155.05 49.73 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.006 1.275 . . . . 0.0 112.689 -170.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.24 163.82 32.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -80.07 87.3 5.45 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 168.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -68.57 -5.72 21.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -71.3 -30.01 65.73 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.08 0.855 . . . . 0.0 109.302 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -63.9 -50.74 68.63 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.496 -1.24 . . . . 0.0 111.621 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.58 -32.46 48.29 Favored 'Trans proline' 0 C--N 1.35 0.622 0 CA-C-N 121.707 1.646 . . . . 0.0 112.111 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.5 mm -59.78 -44.82 94.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.998 1.272 . . . . 0.0 109.816 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.97 -37.15 86.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.262 0.937 . . . . 0.0 110.9 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.62 91.64 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.396 -0.19 . . . . 0.0 111.24 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.17 -46.49 70.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.59 173.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -53.78 -40.87 66.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.277 0.944 . . . . 0.0 110.545 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.0 65.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 112.204 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.9 mt -90.94 -41.81 10.93 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.954 0.502 . . . . 0.0 112.074 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.5 t -70.37 -42.43 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.952 0.901 . . . . 0.0 111.2 -171.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.035 0 C-N-CA 124.233 1.013 . . . . 0.0 109.594 179.319 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.11 174.45 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -112.19 151.57 29.39 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -133.52 116.55 16.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 172.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp 44.36 41.84 4.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.382 1.473 . . . . 0.0 111.69 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.32 5.0 80.23 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.59 116.74 4.13 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.319 174.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.61 84.37 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.291 2.66 . . . . 0.0 112.1 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.35 141.69 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.632 1.173 . . . . 0.0 110.402 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -82.01 162.11 22.74 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.208 1.803 . . . . 0.0 110.358 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.42 145.26 45.35 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.912 1.285 . . . . 0.0 108.118 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.3 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.182 0.593 . . . . 0.0 109.701 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.42 34.16 2.7 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.668 1.128 . . . . 0.0 113.677 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 52.27 -148.94 0.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.865 1.666 . . . . 0.0 112.435 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -123.96 116.3 22.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.029 1.732 . . . . 0.0 108.309 -169.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 m -72.43 171.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -144.08 164.01 31.88 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.79 138.16 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.56 -3.76 76.9 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.941 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.38 -15.54 61.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.145 1.472 . . . . 0.0 114.214 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.05 104.5 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.985 1.714 . . . . 0.0 111.159 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.24 131.79 90.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.651 0.78 . . . . 0.0 111.259 -175.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.59 149.51 81.86 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.764 2.309 . . . . 0.0 113.773 173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -77.31 67.93 3.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.321 1.848 . . . . 0.0 108.849 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.78 160.42 14.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.314 1.046 . . . . 0.0 109.134 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.8 163.89 27.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.997 1.319 . . . . 0.0 111.793 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.36 173.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 129.934 3.294 . . . . 0.0 105.02 168.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -131.53 139.51 49.28 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -86.68 176.02 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.555 0.616 . . . . 0.0 111.517 -172.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -60.91 -25.53 66.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.972 0.909 . . . . 0.0 110.331 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m -81.29 1.72 31.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.053 1.341 . . . . 0.0 111.646 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.8 mt 60.01 38.99 20.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 127.162 2.185 . . . . 0.0 111.893 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.08 160.75 27.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.756 0.823 . . . . 0.0 110.887 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.09 146.09 47.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.205 1.002 . . . . 0.0 110.576 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -147.42 157.79 43.72 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.442 2.697 . . . . 0.0 103.82 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -135.54 158.98 43.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.72 -25.91 63.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.81 66.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.396 1.453 . . . . 0.0 112.9 173.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.57 -27.09 58.46 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.868 0.758 . . . . 0.0 110.996 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.3 mtt -73.5 -34.98 65.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.214 1.006 . . . . 0.0 110.544 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -55.99 152.07 10.87 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.53 0.732 . . . . 0.0 110.413 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.44 33.22 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.134 1.35 . . . . 0.0 112.58 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -147.89 150.75 34.68 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.473 1.509 . . . . 0.0 108.022 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.37 142.27 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 m -135.69 147.58 48.57 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.328 1.051 . . . . 0.0 108.383 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.84 134.24 58.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -139.95 116.73 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -95.08 153.25 17.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -136.04 134.87 50.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.04 147.59 51.34 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.776 1.63 . . . . 0.0 108.299 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -38.73 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.519 2.146 . . . . 0.0 111.833 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -146.74 169.96 17.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.393 2.277 . . . . 0.0 105.916 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.263 0.0 OUTLIER -117.62 -15.58 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 122.673 0.389 . . . . 0.0 111.322 -175.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.36 -29.88 68.7 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.375 -0.828 . . . . 0.0 110.717 169.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.21 143.57 57.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.1 1.36 . . . . 0.0 110.764 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -17.34 50.81 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.535 1.064 . . . . 0.0 114.762 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -54.5 -25.24 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.788 1.294 . . . . 0.0 112.694 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.9 p -60.1 -32.93 71.45 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.939 0.79 . . . . 0.0 111.904 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.67 -28.21 6.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.752 0.821 . . . . 0.0 111.58 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.31 69.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.989 0.915 . . . . 0.0 112.428 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -152.6 -39.5 0.1 Allowed 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.749 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -57.84 -45.19 86.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.847 1.203 . . . . 0.0 111.897 -169.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -59.21 -52.32 66.19 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -60.48 -42.79 97.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.665 0.666 . . . . 0.0 111.076 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.6 -51.0 70.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.078 0.551 . . . . 0.0 110.661 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -66.48 -27.4 67.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.01 0.124 . . . . 0.0 111.078 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -65.67 -44.44 86.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.085 1.354 . . . . 0.0 110.082 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.8 -43.97 82.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.457 0.571 . . . . 0.0 110.206 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -45.62 77.62 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.93 -11.12 44.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.678 1.191 . . . . 0.0 113.237 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -118.68 -1.86 11.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.639 1.176 . . . . 0.0 113.828 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -60.18 -37.36 79.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.133 1.333 . . . . 0.0 109.493 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.98 -172.53 41.67 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 127.969 2.7 . . . . 0.0 106.942 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -75.82 27.66 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.362 1.081 . . . . 0.0 112.564 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.4 144.2 11.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 120.756 -1.215 . . . . 0.0 109.958 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.48 145.34 54.15 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.12 121.8 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -172.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -137.31 154.14 50.13 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.318 0.647 . . . . 0.0 111.327 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -130.62 105.69 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.72 131.56 33.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -129.2 173.17 10.73 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.266 1.827 . . . . 0.0 108.048 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.64 0.733 . . . . 0.0 110.363 169.583 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 3.3 p90 . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 p -54.94 -28.46 51.26 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.62 -12.18 55.7 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.593 1.088 . . . . 0.0 113.976 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.32 -10.37 4.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.049 1.74 . . . . 0.0 112.721 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -64.7 125.94 26.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.914 0.486 . . . . 0.0 111.358 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.76 -21.18 20.24 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.199 0.904 . . . . 0.0 112.46 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mt -84.85 -31.69 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.457 1.129 . . . . 0.0 110.514 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.41 -35.4 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 131.65 3.98 . . . . 0.0 116.341 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -66.78 -35.21 79.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.517 1.127 . . . . 0.0 111.571 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.86 150.8 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.632 1.173 . . . . 0.0 107.959 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.44 143.78 35.75 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 p -79.8 155.44 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.402 0.62 . . . . 0.0 109.523 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.1 mt -129.2 162.78 27.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.927 1.691 . . . . 0.0 107.312 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.5 m -137.17 44.58 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.572 1.549 . . . . 0.0 110.323 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -48.32 -36.03 13.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -169.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -50.82 -25.96 5.12 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.801 1.182 . . . . 0.0 114.182 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.7 ttt85 -60.19 -22.65 63.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.072 0.851 . . . . 0.0 112.376 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -127.79 -19.16 4.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.758 1.623 . . . . 0.0 111.955 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 58.25 11.54 1.62 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 129.928 3.291 . . . . 0.0 114.402 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.6 m -69.6 -42.81 73.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.456 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.25 -37.03 81.62 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.654 1.57 . . . . 0.0 109.379 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.35 -53.16 21.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.617 1.579 . . . . 0.0 112.865 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.11 -37.02 69.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.351 0.575 . . . . 0.0 110.477 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.84 -32.91 73.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.009 0.924 . . . . 0.0 112.911 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.35 1.04 13.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.648 1.179 . . . . 0.0 111.744 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.53 37.81 94.08 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 119.123 0.874 . . . . 0.0 112.047 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.37 -1.94 9.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.678 . . . . 0.0 110.91 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.87 106.1 5.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 168.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.9 mt -69.42 120.9 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -64.49 -43.13 95.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -89.07 -6.08 57.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -170.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -132.76 -13.23 2.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.582 0.753 . . . . 0.0 112.701 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.251 39.3 ptt180 41.65 43.44 2.37 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.711 1.604 . . . . 0.0 113.036 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 mt -124.98 172.54 9.33 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 170.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.85 140.02 45.46 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.885 0.874 . . . . 0.0 109.634 173.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.65 157.56 35.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.366 1.067 . . . . 0.0 110.793 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.16 112.12 19.96 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -153.76 167.05 30.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.78 147.18 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -143.61 155.27 44.22 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.305 1.442 . . . . 0.0 108.575 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.16 139.76 45.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -129.5 129.87 45.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.237 1.415 . . . . 0.0 108.334 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.28 166.71 9.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.015 0.926 . . . . 0.0 108.997 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -50.4 -31.03 13.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.754 174.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -81.84 -4.43 56.47 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.483 1.113 . . . . 0.0 113.217 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.86 62.9 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.209 -0.932 . . . . 0.0 111.596 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -86.55 118.09 25.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.56 114.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 170.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 p -97.44 -14.44 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.167 0.987 . . . . 0.0 109.886 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 152.32 32.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.274 1.029 . . . . 0.0 108.659 169.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.25 137.55 13.85 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.378 1.871 . . . . 0.0 107.251 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.21 149.97 31.85 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.187 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -123.71 114.52 20.05 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.39 135.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.3 m -58.64 -21.48 54.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.539 1.136 . . . . 0.0 113.509 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -140.08 129.6 24.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -53.83 -35.04 61.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -80.67 -6.93 59.07 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.516 1.053 . . . . 0.0 112.715 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.57 -173.67 4.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -137.89 156.33 74.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 110.104 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.38 168.29 16.67 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.836 2.357 . . . . 0.0 110.287 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -74.89 113.99 12.83 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -80.76 -6.71 58.86 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.11 -32.29 64.86 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 120.995 -1.065 . . . . 0.0 108.572 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -60.4 -51.32 80.9 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.147 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.14 -33.0 41.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.453 1.555 . . . . 0.0 112.747 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.2 mm -59.9 -47.47 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 120.455 1.479 . . . . 0.0 109.51 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.52 -38.88 92.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.027 0.83 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.78 92.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.324 0.249 . . . . 0.0 111.271 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.12 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.686 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -53.9 -41.64 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.069 0.849 . . . . 0.0 110.569 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.05 -30.45 64.27 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.571 0.749 . . . . 0.0 112.174 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 62.6 mt -90.43 -43.12 10.49 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.004 0.522 . . . . 0.0 111.68 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.6 t -71.49 -45.1 69.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.978 0.911 . . . . 0.0 111.331 -170.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.69 0.796 . . . . 0.0 109.642 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.243 0.741 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.8 pt -142.08 171.9 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 122.575 1.179 . . . . 0.0 110.366 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -109.96 157.41 19.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.51 113.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 45.51 43.95 9.4 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.66 1.584 . . . . 0.0 111.556 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 4.61 82.03 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.46 126.15 7.59 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 145.9 63.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.643 2.222 . . . . 0.0 110.148 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -136.39 179.48 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 108.778 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -127.54 158.98 35.98 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.5 mt -112.88 172.93 6.63 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.833 1.253 . . . . 0.0 109.35 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.74 149.82 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 56.99 19.09 29.02 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.925 1.726 . . . . 0.0 115.884 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -67.59 176.78 2.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.764 2.025 . . . . 0.0 114.976 -169.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.254 6.1 tt0 87.8 30.85 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.105 2.562 . . . . 0.0 113.325 169.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.16 143.44 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 168.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -149.45 165.19 32.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.872 1.269 . . . . 0.0 108.068 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 p -54.6 133.88 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.15 81.38 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.492 1.044 . . . . 0.0 113.806 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.71 -10.52 59.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.483 1.641 . . . . 0.0 114.177 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 71.37 127.71 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.463 1.905 . . . . 0.0 112.385 169.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.42 126.5 88.2 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.287 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -62.29 -30.31 81.03 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 114.147 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.6 t70 94.79 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 130.468 3.507 . . . . 0.0 106.838 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.04 174.2 10.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.821 2.049 . . . . 0.0 107.779 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 m -131.81 120.76 23.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -105.01 165.24 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.394 1.478 . . . . 0.0 107.506 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.07 143.32 38.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 p -76.58 179.29 6.06 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.087 0.955 . . . . 0.0 110.155 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.91 -24.46 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.162 -0.961 . . . . 0.0 111.114 168.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -89.93 3.79 52.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.784 2.034 . . . . 0.0 112.158 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 57.44 29.3 16.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.908 2.083 . . . . 0.0 113.188 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.24 144.48 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.61 142.23 42.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.469 0.708 . . . . 0.0 109.431 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -148.32 113.79 5.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 107.391 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 p -72.38 154.78 40.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.466 0.65 . . . . 0.0 109.321 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.52 -39.21 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.27 -25.69 15.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.101 0.961 . . . . 0.0 113.483 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.86 -28.5 55.45 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.791 1.178 . . . . 0.0 111.499 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.9 mtt -69.69 -30.93 68.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.045 0.938 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -57.76 152.61 15.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.526 0.679 . . . . 0.0 110.467 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.93 -8.23 38.94 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.482 1.039 . . . . 0.0 113.094 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -152.66 152.76 32.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.815 1.646 . . . . 0.0 107.861 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.21 144.93 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.8 m -136.01 148.15 48.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.399 1.08 . . . . 0.0 108.582 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.5 mt -130.62 137.74 55.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.5 mt -135.1 102.78 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -174.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -84.84 149.86 25.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -139.23 136.67 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -141.71 146.82 42.93 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.915 1.286 . . . . 0.0 109.316 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.48 -38.81 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.188 1.925 . . . . 0.0 111.496 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 p -162.77 148.66 12.34 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.26 1.424 . . . . 0.0 108.065 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.23 -19.33 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.652 0.781 . . . . 0.0 111.014 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.6 -26.17 68.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.342 1.057 . . . . 0.0 112.087 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 p -62.8 138.97 58.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.313 0.578 . . . . 0.0 110.686 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.63 -4.29 69.91 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.729 0.68 . . . . 0.0 113.392 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.86 -25.99 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.523 1.129 . . . . 0.0 111.968 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.78 -42.75 85.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.856 0.753 . . . . 0.0 111.83 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.35 -37.52 80.56 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.409 0.549 . . . . 0.0 110.134 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.21 72.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.404 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.7 tm0? -155.3 -53.6 0.09 Allowed 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -39.76 79.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.631 1.559 . . . . 0.0 114.486 -167.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -64.91 -48.91 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.536 1.517 . . . . 0.0 110.179 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -61.33 -49.16 78.11 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 118.846 0.748 . . . . 0.0 109.806 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CB ' HE21 ' A' ' 63' ' ' GLN . 61.1 t80 -56.98 -48.64 77.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.259 0.624 . . . . 0.0 110.797 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -61.98 -39.68 93.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.511 0.724 . . . . 0.0 110.856 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.84 -38.83 80.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.124 0.97 . . . . 0.0 111.075 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.94 -45.16 71.47 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.201 0.91 . . . . 0.0 110.309 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.86 69.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.929 1.291 . . . . 0.0 110.856 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.93 -21.35 61.01 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.949 0.9 . . . . 0.0 113.127 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -120.13 7.67 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.41 -30.79 68.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.851 1.205 . . . . 0.0 111.626 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.65 -74.25 0.06 OUTLIER Glycine 0 C--N 1.336 0.551 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -162.91 110.16 1.23 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.48 155.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.889 1.276 . . . . 0.0 107.987 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -76.45 144.26 40.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.66 129.66 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.56 157.69 45.38 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.27 1.028 . . . . 0.0 110.08 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 45.6 m -127.13 98.02 5.15 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 mt -76.69 128.61 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 m -139.32 170.03 16.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.617 1.567 . . . . 0.0 108.862 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.98 0.895 . . . . 0.0 111.612 176.024 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.3 m -77.78 46.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.659 1.583 . . . . 0.0 114.024 -169.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 97' ' ' ASN . . . 168.45 -34.33 0.19 Allowed Glycine 0 C--N 1.333 0.397 0 O-C-N 121.276 -0.89 . . . . 0.0 112.486 172.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 16.73 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.56 1.144 . . . . 0.0 114.071 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 95' ' ' GLY . 15.7 t-20 -136.1 65.85 1.52 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.871 1.668 . . . . 0.0 107.177 170.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.76 -37.57 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.805 1.193 . . . . 0.0 111.016 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.22 89.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.24 -23.55 9.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.494 1.918 . . . . 0.0 113.983 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.37 -32.26 72.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.858 0.863 . . . . 0.0 112.29 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.92 147.05 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -148.99 145.27 27.24 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 p -80.41 151.71 29.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.394 0.616 . . . . 0.0 109.586 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.44 156.64 29.79 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.171 1.388 . . . . 0.0 107.695 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 m -120.45 46.44 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.629 1.972 . . . . 0.0 110.326 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -55.52 -32.1 62.63 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.967 -1.083 . . . . 0.0 113.217 -170.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -55.87 -17.26 5.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -58.37 -27.38 64.16 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.305 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -141.88 -3.35 1.12 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.801 1.182 . . . . 0.0 113.808 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.86 28.66 6.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.5 2.32 . . . . 0.0 113.802 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 m -59.33 -58.9 6.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.923 0.889 . . . . 0.0 110.773 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.97 -33.92 75.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.803 0.841 . . . . 0.0 109.792 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.19 -57.77 8.65 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 125.141 1.353 . . . . 0.0 112.08 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.4 -39.77 58.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.149 0.474 . . . . 0.0 110.15 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.17 85.6 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.99 3.07 30.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.916 1.286 . . . . 0.0 110.672 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.62 29.06 71.56 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 121.553 -0.717 . . . . 0.0 113.625 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.06 -1.73 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.107 0.963 . . . . 0.0 110.612 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.44 105.73 1.24 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.638 1.108 . . . . 0.0 108.086 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.38 115.89 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -57.36 -43.42 83.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 111.028 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -92.9 -4.62 52.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -169.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.79 -14.75 2.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.648 0.779 . . . . 0.0 112.402 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 48.92 40.4 16.6 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.84 1.656 . . . . 0.0 112.144 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 mt -126.27 173.9 8.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.73 126.97 31.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.394 1.478 . . . . 0.0 108.972 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 137.32 58.24 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.749 1.219 . . . . 0.0 110.637 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.55 108.63 0.85 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.322 1.049 . . . . 0.0 108.318 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.2 p -156.58 170.16 23.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.012 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.03 147.37 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -144.18 153.01 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.05 136.07 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.9 mp -129.56 133.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.728 1.211 . . . . 0.0 107.801 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.44 161.08 14.94 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.659 1.183 . . . . 0.0 109.825 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -33.14 -41.82 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.428 2.691 . . . . 0.0 115.413 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -91.1 -8.15 49.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.51 3.38 43.76 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.202 0.906 . . . . 0.0 113.567 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -71.47 118.69 14.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.85 1.825 . . . . 0.0 108.691 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.96 116.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 170.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.52 -15.41 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.294 1.038 . . . . 0.0 109.967 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -149.87 150.08 31.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 108.081 171.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.72 127.02 5.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.126 1.77 . . . . 0.0 106.93 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -149.23 149.83 31.6 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.031 0.832 . . . . 0.0 110.076 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.28 113.82 20.96 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.69 126.87 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.6 m -63.98 -2.6 2.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.66 1.184 . . . . 0.0 114.168 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -141.52 124.39 16.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.08 -31.0 66.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.768 1.227 . . . . 0.0 113.501 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.5 p -86.73 15.81 5.37 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.004 0.82 . . . . 0.0 111.771 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -127.53 179.44 5.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.468 1.507 . . . . 0.0 110.085 -174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -137.81 159.16 69.88 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.772 1.229 . . . . 0.0 110.592 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -89.4 -178.64 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.436 2.758 . . . . 0.0 110.55 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -75.53 94.14 3.11 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -72.45 -6.3 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.708 0.803 . . . . 0.0 112.913 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.67 -28.59 61.84 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 119.658 1.117 . . . . 0.0 108.982 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -61.1 -49.96 86.42 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.11 -33.86 59.85 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.53 1.582 . . . . 0.0 112.732 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.92 -45.85 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.348 1.431 . . . . 0.0 109.639 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.67 -38.84 92.64 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.412 1.006 . . . . 0.0 110.53 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.43 91.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.53 0.332 . . . . 0.0 111.207 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.29 61.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.981 0.513 . . . . 0.0 110.761 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.21 -39.45 69.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.059 0.845 . . . . 0.0 110.957 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.01 65.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.463 0.705 . . . . 0.0 111.89 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 63.1 mt -91.87 -43.89 9.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.353 0.524 . . . . 0.0 111.452 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.51 -39.6 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 0.0 110.767 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 mttp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 126.488 1.915 . . . . 0.0 110.069 -174.016 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.9 pt -133.62 179.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.655 0.74 . . . . 0.0 109.53 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -129.04 145.14 51.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -144.54 130.02 18.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 45.93 38.9 4.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.634 1.174 . . . . 0.0 112.175 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.44 26.32 73.54 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.274 -0.737 . . . . 0.0 114.374 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 139.91 11.33 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.22 144.74 42.34 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.369 2.046 . . . . 0.0 110.25 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.94 134.0 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.246 1.018 . . . . 0.0 109.767 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -81.2 166.22 20.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.618 1.967 . . . . 0.0 110.62 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.2 154.87 30.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.862 1.665 . . . . 0.0 109.539 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -85.65 -65.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.662 0.665 . . . . 0.0 110.24 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.63 4.22 86.38 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.68 0.657 . . . . 0.0 114.225 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 52.59 176.31 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.779 2.831 . . . . 0.0 116.45 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.93 113.51 3.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.591 1.956 . . . . 0.0 111.573 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.71 160.62 4.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -137.93 157.89 45.47 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.57 132.49 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.38 -2.1 87.43 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.667 -1.074 . . . . 0.0 114.279 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.57 -4.72 58.07 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.765 1.783 . . . . 0.0 112.596 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 59.16 177.2 0.08 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.561 1.544 . . . . 0.0 112.058 -169.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.09 135.29 21.08 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.287 1.835 . . . . 0.0 108.328 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -72.23 156.4 55.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.179 1.919 . . . . 0.0 109.453 172.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -74.59 66.02 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.676 1.99 . . . . 0.0 110.66 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -61.33 155.21 21.88 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.295 1.438 . . . . 0.0 109.561 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 m -94.86 155.1 16.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.37 171.66 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.161 2.184 . . . . 0.0 106.955 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.9 mt -132.93 130.2 39.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -72.85 -176.89 2.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.697 1.199 . . . . 0.0 111.981 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -57.37 -32.35 66.7 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 110.485 169.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -85.62 2.98 42.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.867 1.667 . . . . 0.0 112.047 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt 52.22 36.82 20.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.507 1.923 . . . . 0.0 112.315 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -91.75 149.53 21.56 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.3 144.81 49.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.159 0.981 . . . . 0.0 110.148 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -153.97 159.15 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.45 2.7 . . . . 0.0 104.838 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 m -142.53 166.45 24.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.9 tp -49.79 -42.03 45.86 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.683 0.393 . . . . 0.0 111.311 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.56 -21.9 63.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.38 -30.25 60.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.821 0.737 . . . . 0.0 111.06 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.8 mtt -72.45 -37.39 68.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.566 1.146 . . . . 0.0 110.662 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -55.98 152.77 9.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.008 0.908 . . . . 0.0 111.517 -173.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.53 11.59 66.05 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.977 1.275 . . . . 0.0 113.251 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -154.17 148.21 25.71 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.559 1.544 . . . . 0.0 107.699 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.17 141.49 16.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.8 m -133.19 143.09 48.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.1 mt -135.92 132.55 50.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -172.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -139.56 134.28 38.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -169.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.92 144.76 42.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 168.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 t -121.7 126.8 75.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.35 127.82 5.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -173.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.97 -41.98 71.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.261 1.974 . . . . 0.0 112.43 -169.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.7 t -157.5 145.98 19.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -17.82 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 122.438 0.295 . . . . 0.0 111.129 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.19 -21.37 63.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 112.672 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.5 p -59.15 -24.62 63.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.659 0.784 . . . . 0.0 112.431 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.54 -10.29 59.68 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.881 0.753 . . . . 0.0 112.144 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.93 -18.21 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 118.85 1.325 . . . . 0.0 110.069 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.6 p -51.77 -43.63 63.07 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.34 -41.13 63.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.849 0.749 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.23 -30.88 71.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 -173.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -146.76 -49.02 0.19 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.317 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 m -55.49 -45.32 77.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.643 1.11 . . . . 0.0 113.451 -167.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -48.8 80.22 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.703 0.683 . . . . 0.0 109.892 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.65 -45.94 73.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.843 0.747 . . . . 0.0 109.548 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.64 -53.49 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.432 0.693 . . . . 0.0 110.276 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -29.78 53.49 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -63.75 -55.32 24.11 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.334 1.054 . . . . 0.0 109.915 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.71 -37.35 87.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.6 0.76 . . . . 0.0 109.559 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.58 69.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.76 0.824 . . . . 0.0 110.799 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.79 68.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.467 0.307 . . . . 0.0 111.65 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -75.44 -22.74 57.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.007 -0.997 . . . . 0.0 112.641 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.57 -40.63 95.91 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.204 1.365 . . . . 0.0 110.944 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.47 -168.15 41.06 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -173.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -74.15 29.02 0.08 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.024 1.33 . . . . 0.0 113.311 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.9 m -62.08 154.6 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.482 -1.386 . . . . 0.0 110.832 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.62 149.71 29.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.58 123.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -133.91 149.02 51.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.097 0.559 . . . . 0.0 111.396 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -127.81 99.09 5.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -84.67 130.48 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 m -142.95 172.99 11.95 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.013 1.325 . . . . 0.0 110.639 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 123.895 0.878 . . . . 0.0 111.5 177.804 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m0 . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 p -158.78 171.87 19.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.018 1.727 . . . . 0.0 108.371 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.76 -84.41 1.11 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.94 36.9 0.64 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 -172.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -139.66 137.96 35.68 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.019 1.328 . . . . 0.0 108.197 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.99 -14.18 65.01 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.01 0.814 . . . . 0.0 112.024 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.91 93.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 126.335 1.854 . . . . 0.0 106.269 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.27 -25.63 48.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.501 1.52 . . . . 0.0 113.196 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -55.59 -36.67 67.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.987 1.315 . . . . 0.0 112.694 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.2 t -70.86 147.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -129.55 141.92 50.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.2 p -87.44 136.81 32.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.9 146.08 46.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 m -121.65 51.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.742 1.217 . . . . 0.0 109.687 -168.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.21 -31.48 43.32 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -56.66 -21.68 29.2 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.941 1.701 . . . . 0.0 114.05 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -76.49 -6.23 50.91 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.146 -0.971 . . . . 0.0 112.551 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.17 -39.88 0.6 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.028 1.331 . . . . 0.0 112.44 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.75 4.29 3.9 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 130.054 3.342 . . . . 0.0 114.815 170.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -58.81 -44.51 90.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.259 -1.353 . . . . 0.0 111.957 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.06 -41.58 90.6 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 121.064 1.756 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.61 -43.11 96.35 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 123.996 0.808 . . . . 0.0 111.772 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -72.76 -46.72 51.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.271 0.536 . . . . 0.0 109.994 173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.19 81.06 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.241 1.016 . . . . 0.0 112.532 -172.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.04 5.83 26.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.0 110.618 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.6 32.45 58.34 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.717 0.675 . . . . 0.0 113.563 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.35 -8.75 9.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 123.45 0.7 . . . . 0.0 110.097 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -68.96 111.32 4.91 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.32 128.13 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -66.87 -47.36 72.12 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 110.933 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -90.83 0.05 57.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 tp -129.82 -13.55 4.14 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.629 1.172 . . . . 0.0 111.591 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 47.15 47.91 16.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.922 1.689 . . . . 0.0 111.193 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.3 tp -139.88 156.88 46.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.468 1.107 . . . . 0.0 108.206 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.08 131.24 45.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.326 0.65 . . . . 0.0 109.519 173.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.85 164.32 25.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.993 1.317 . . . . 0.0 112.407 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -86.03 113.5 22.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.5 m -148.14 173.53 12.87 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.709 0.804 . . . . 0.0 109.681 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 144.7 17.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.886 1.274 . . . . 0.0 108.454 177.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -148.34 158.87 44.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.573 1.149 . . . . 0.0 109.998 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.04 140.65 40.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mp -131.75 135.73 47.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.235 1.414 . . . . 0.0 107.591 -173.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.35 166.67 7.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 110.04 169.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.32 -31.96 23.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.116 1.367 . . . . 0.0 113.012 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -80.91 -0.86 41.06 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.432 1.093 . . . . 0.0 112.67 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.12 -6.75 82.76 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.625 1.107 . . . . 0.0 112.608 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.2 124.9 22.37 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.719 1.259 . . . . 0.0 109.232 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.81 128.24 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.737 0.815 . . . . 0.0 110.112 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.79 -19.51 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 109.917 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -145.08 147.05 32.13 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.81 131.94 12.69 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.037 1.335 . . . . 0.0 108.237 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.26 149.66 31.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.606 0.762 . . . . 0.0 109.365 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -128.06 117.19 21.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.823 2.049 . . . . 0.0 105.55 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.5 125.32 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -59.09 -25.02 63.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.693 1.197 . . . . 0.0 112.86 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -134.58 100.77 4.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.09 66.64 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.563 1.145 . . . . 0.0 112.757 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.82 8.7 2.26 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.652 1.181 . . . . 0.0 112.422 170.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.68 162.48 30.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.252 1.821 . . . . 0.0 108.699 173.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -90.12 145.46 32.98 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.69 166.55 29.09 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.991 2.461 . . . . 0.0 111.579 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -85.44 139.39 31.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -104.07 -8.73 19.3 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.39 -39.29 59.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -51.36 -58.03 12.12 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.987 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.94 -34.41 23.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 121.493 1.569 . . . . 0.0 112.393 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 mm -59.58 -42.66 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.142 1.337 . . . . 0.0 109.998 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.39 -36.96 84.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.413 1.006 . . . . 0.0 110.716 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.45 87.24 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.376 -0.202 . . . . 0.0 110.884 175.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.59 -40.73 69.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.623 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.91 -40.65 76.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.92 1.236 . . . . 0.0 110.26 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.81 66.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.177 0.591 . . . . 0.0 112.317 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.09 -60.37 2.32 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.961 0.504 . . . . 0.0 110.46 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.39 -45.04 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.145 1.378 . . . . 0.0 111.905 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm . . . . . 0 C--O 1.25 1.094 0 C-N-CA 126.802 2.041 . . . . 0.0 110.936 -176.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 pt -131.43 171.82 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 123.18 1.467 . . . . 0.0 110.37 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -115.82 153.95 30.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -140.29 122.79 16.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.17 39.13 1.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.365 1.466 . . . . 0.0 113.492 -171.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.33 6.18 89.47 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.674 -0.641 . . . . 0.0 114.396 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.77 125.42 7.93 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.185 1.374 . . . . 0.0 109.863 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.76 141.17 48.68 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 CA-C-N 120.995 2.397 . . . . 0.0 110.062 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.57 138.96 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.777 0.831 . . . . 0.0 109.844 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -86.02 155.59 20.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.119 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mt -118.9 153.38 34.66 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.194 1.398 . . . . 0.0 107.94 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.87 -15.58 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.58 33.8 0.45 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.971 0.805 . . . . 0.0 111.79 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -51.74 151.15 3.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.401 0.681 . . . . 0.0 112.209 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.262 8.6 tt0 108.44 23.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 129.242 3.017 . . . . 0.0 112.727 169.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.68 141.21 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -148.7 165.47 31.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.101 0.96 . . . . 0.0 109.167 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 p -54.01 132.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.02 -0.2 89.93 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.081 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.66 -12.04 59.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.546 1.673 . . . . 0.0 112.545 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 59.68 167.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.449 1.9 . . . . 0.0 113.101 -171.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.04 128.25 31.31 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.351 1.46 . . . . 0.0 108.466 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.39 -25.06 63.92 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.304 2.669 . . . . 0.0 114.428 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 66.81 100.67 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.995 2.518 . . . . 0.0 112.441 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -142.46 172.34 12.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.522 1.529 . . . . 0.0 109.274 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -89.21 154.38 20.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.76 1.224 . . . . 0.0 111.427 -169.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.83 164.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 128.087 2.555 . . . . 0.0 104.995 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 tp -116.85 140.4 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.11 168.12 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.23 -24.65 66.51 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.736 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -80.33 0.65 32.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.976 1.71 . . . . 0.0 112.011 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.6 mt 64.83 44.32 3.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.097 2.159 . . . . 0.0 111.946 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -119.73 145.98 46.04 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.26 1.024 . . . . 0.0 108.886 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.42 139.4 45.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.674 0.79 . . . . 0.0 109.312 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -142.01 102.18 4.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 m -71.03 153.59 42.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -58.94 -30.85 68.18 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.169 -0.957 . . . . 0.0 110.863 170.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.07 8.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.397 1.479 . . . . 0.0 113.286 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.06 -28.12 35.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.991 0.916 . . . . 0.0 111.676 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.2 mtt -72.41 -48.56 40.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.129 0.971 . . . . 0.0 110.496 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.36 171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.966 0.888 . . . . 0.0 110.291 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 -15.2 48.19 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.451 1.5 . . . . 0.0 110.575 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -153.02 159.81 42.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.542 2.737 . . . . 0.0 106.29 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.4 144.29 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 m -132.74 149.37 52.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.207 1.003 . . . . 0.0 109.551 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.5 138.64 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.3 mt -139.49 113.68 7.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 m -89.32 144.95 25.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.31 134.81 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 pt -147.67 159.39 41.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 107.928 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.02 -52.24 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 N-CA-C 108.513 -1.38 . . . . 0.0 108.513 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 m -150.9 146.72 26.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.703 1.601 . . . . 0.0 108.643 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -20.7 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 111.047 171.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -60.1 -14.25 15.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.14 0.976 . . . . 0.0 113.319 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 p -56.65 -27.47 58.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.641 0.776 . . . . 0.0 111.866 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.43 4.67 84.79 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.167 0.889 . . . . 0.0 112.266 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.02 -13.88 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 119.065 1.433 . . . . 0.0 111.976 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.6 m -57.75 -47.47 82.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.118 0.967 . . . . 0.0 110.539 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.38 -28.83 64.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.318 0.647 . . . . 0.0 111.35 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.82 -59.5 5.05 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -161.51 -14.22 0.04 OUTLIER 'General case' 0 C--N 1.341 0.203 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -69.59 -31.01 68.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.283 1.401 . . . . 0.0 112.825 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -61.88 -50.57 71.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.269 0.941 . . . . 0.0 108.841 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -62.37 -48.05 81.45 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.587 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.15 -50.75 71.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.641 0.777 . . . . 0.0 110.562 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -68.46 -33.03 73.46 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.388 -0.195 . . . . 0.0 110.757 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.7 -42.03 78.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 111.426 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.33 -44.92 96.4 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.397 0.998 . . . . 0.0 109.678 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.02 -38.58 70.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.441 0.696 . . . . 0.0 111.402 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.89 -5.71 22.88 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -116.02 -12.3 11.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.689 1.596 . . . . 0.0 112.66 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -57.88 -32.47 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.643 1.11 . . . . 0.0 111.64 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.91 -159.69 32.88 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.61 22.21 0.14 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.469 -1.018 . . . . 0.0 112.386 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.82 134.83 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.979 1.712 . . . . 0.0 108.817 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.79 135.85 53.26 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -144.08 133.22 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -170.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.72 162.4 35.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.616 0.766 . . . . 0.0 110.926 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.8 m -133.03 124.46 27.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.22 133.27 53.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -141.12 169.09 18.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.152 0.981 . . . . 0.0 110.484 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 112.003 174.718 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.9 p90 . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.185 0.516 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.93 -28.58 13.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.33 -65.52 1.85 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.95 34.29 0.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.365 1.066 . . . . 0.0 111.981 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -67.18 -5.37 13.34 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.991 1.316 . . . . 0.0 114.272 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.32 -17.81 1.89 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.132 1.825 . . . . 0.0 109.376 -169.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.22 91.8 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.4 -27.44 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -66.75 -22.16 66.05 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.073 0.949 . . . . 0.0 112.256 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 t -91.37 154.09 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.3 147.43 47.45 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.9 m -104.14 138.98 39.84 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.6 mp -118.44 160.97 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.108 1.763 . . . . 0.0 108.233 -170.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.7 54.31 1.88 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.231 1.412 . . . . 0.0 108.776 -168.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.13 -24.92 57.55 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -56.39 -19.73 16.2 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 120.299 1.409 . . . . 0.0 112.895 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -81.64 -4.3 55.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.857 1.263 . . . . 0.0 112.845 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -141.87 -41.98 0.35 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.032 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.44 -3.07 1.41 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 129.529 3.132 . . . . 0.0 114.83 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -64.91 -45.76 84.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.586 1.539 . . . . 0.0 110.691 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.25 -42.66 95.77 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.18 0.9 . . . . 0.0 110.51 174.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.87 96.28 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.82 -43.74 92.15 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.521 0.66 . . . . 0.0 109.707 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.78 -47.06 86.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.583 0.753 . . . . 0.0 112.188 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -83.8 -1.9 55.24 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.093 0.957 . . . . 0.0 111.504 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.31 38.04 95.32 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.402 -0.666 . . . . 0.0 111.936 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.2 -0.2 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.292 1.437 . . . . 0.0 110.584 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -76.82 114.88 16.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.28 113.0 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -59.15 -40.95 87.1 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.285 1.034 . . . . 0.0 110.595 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -91.72 -4.46 55.05 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 tp -140.51 -0.38 1.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.027 0.831 . . . . 0.0 113.178 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 43.28 41.51 3.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.697 1.999 . . . . 0.0 114.431 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -132.06 167.94 18.83 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.861 0.865 . . . . 0.0 108.847 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.72 134.48 47.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 162.78 15.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.332 1.453 . . . . 0.0 111.22 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -88.75 116.98 27.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -159.88 171.32 19.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.216 0.531 . . . . 0.0 110.096 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 t -143.5 142.15 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -141.18 155.33 46.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 109.442 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -137.42 135.67 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 42.8 mt -122.51 136.76 54.96 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.36 175.64 5.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.977 0.894 . . . . 0.0 110.208 169.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -56.88 -11.33 1.39 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.913 1.685 . . . . 0.0 114.897 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.96 14.83 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.487 1.494 . . . . 0.0 112.359 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.46 -1.87 67.12 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.418 1.009 . . . . 0.0 113.267 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -65.64 118.05 8.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.294 1.547 . . . . 0.0 108.114 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.06 110.95 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 p -91.73 -16.59 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 109.536 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -150.64 151.45 32.53 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.013 1.325 . . . . 0.0 107.504 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.96 132.94 9.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 107.149 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -142.02 150.01 40.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.636 0.653 . . . . 0.0 110.472 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -122.83 111.23 16.42 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 127.226 2.21 . . . . 0.0 105.041 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 t -72.5 140.04 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -58.94 -21.62 58.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.656 1.182 . . . . 0.0 113.892 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.42 134.07 30.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.3 -31.64 63.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.9 p -83.78 -6.73 59.5 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.317 0.962 . . . . 0.0 112.606 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -93.6 179.95 5.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.886 1.274 . . . . 0.0 109.921 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -133.92 157.36 77.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.256 1.422 . . . . 0.0 110.898 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.72 -176.87 3.1 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.166 2.578 . . . . 0.0 110.188 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -69.74 138.06 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -82.53 -9.32 59.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -107.22 -32.28 7.86 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.077 0.853 . . . . 0.0 110.887 -169.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -52.47 -49.14 87.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 -36.33 21.13 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 CA-C-N 121.631 1.618 . . . . 0.0 111.43 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.76 -45.36 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.476 0.71 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.83 -34.01 75.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 120.081 1.309 . . . . 0.0 110.498 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.61 91.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.482 0.313 . . . . 0.0 111.18 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.81 -47.34 59.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.075 174.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -55.91 -37.93 69.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.258 0.936 . . . . 0.0 110.901 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.8 -29.31 54.2 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.625 0.77 . . . . 0.0 112.005 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.6 mt -95.87 -43.84 7.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.681 0.792 . . . . 0.0 112.194 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.7 t -73.71 -43.82 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 111.57 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 C--O 1.249 1.074 0 C-N-CA 124.108 0.963 . . . . 0.0 109.676 179.875 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--O 1.237 0.412 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 pt -140.37 179.09 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 122.012 0.91 . . . . 0.0 109.458 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -126.36 156.82 39.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.01 1.724 . . . . 0.0 106.632 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -147.45 128.33 14.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 43.31 40.92 2.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.827 1.251 . . . . 0.0 112.924 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 24.22 69.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.364 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 136.81 8.92 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.49 146.25 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.26 1.973 . . . . 0.0 109.904 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.67 150.17 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.272 1.029 . . . . 0.0 109.291 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.5 m -98.62 163.09 12.8 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.961 1.304 . . . . 0.0 108.902 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.18 170.44 8.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.936 1.295 . . . . 0.0 109.239 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.36 133.07 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.55 -13.75 66.57 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.858 0.742 . . . . 0.0 114.202 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 53.44 167.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.935 3.294 . . . . 0.0 117.71 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.43 137.08 43.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.925 2.89 . . . . 0.0 112.639 -168.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.53 153.1 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.81 170.55 18.5 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 121.16 -0.962 . . . . 0.0 109.781 -171.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -50.12 131.92 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.372 0.669 . . . . 0.0 110.769 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.87 79.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.595 1.093 . . . . 0.0 113.502 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -94.32 6.88 47.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.259 1.529 . . . . 0.0 113.516 -169.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 57.85 111.95 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.218 2.207 . . . . 0.0 114.915 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.33 89.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.876 169.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.03 -46.83 14.3 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.586 2.191 . . . . 0.0 113.49 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 121.57 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 1 C-N-CA 131.73 4.012 . . . . 0.0 105.451 -169.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.76 168.03 19.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.632 1.573 . . . . 0.0 109.067 -175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 m -122.27 146.15 47.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.751 1.22 . . . . 0.0 107.803 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.91 164.32 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.908 2.083 . . . . 0.0 107.731 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.3 mt -100.43 141.36 33.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -71.79 173.67 7.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.406 1.482 . . . . 0.0 110.941 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -67.49 -8.84 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.538 -0.726 . . . . 0.0 111.723 169.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.3 m -97.01 4.4 51.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.22 1.408 . . . . 0.0 111.835 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.97 51.98 13.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.388 1.875 . . . . 0.0 111.633 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.59 152.45 41.87 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -72.42 143.24 48.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.938 0.875 . . . . 0.0 110.301 -175.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -147.46 158.22 43.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.355 2.662 . . . . 0.0 105.73 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 p -137.25 166.64 23.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -55.47 -40.09 71.2 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 171.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -24.16 61.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.17 -33.08 50.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.924 0.784 . . . . 0.0 111.345 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.4 mtt -70.58 -36.35 73.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.426 1.09 . . . . 0.0 111.018 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -53.49 146.87 11.87 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.976 0.91 . . . . 0.0 110.784 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -17.79 11.43 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.106 1.336 . . . . 0.0 112.73 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -149.04 155.7 41.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.265 1.426 . . . . 0.0 108.87 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.2 136.94 19.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 76.8 m -133.19 145.0 50.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.22 134.31 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.0 mt -135.23 108.12 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 m -86.42 152.07 23.01 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 134.45 53.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 pt -144.06 154.88 58.62 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.001 1.72 . . . . 0.0 108.074 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.88 -44.04 6.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.906 1.737 . . . . 0.0 111.262 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 t -151.2 170.88 18.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.281 1.832 . . . . 0.0 107.344 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 pp -96.47 -20.16 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.482 1.113 . . . . 0.0 109.387 168.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -81.71 -25.89 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.91 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -61.51 -17.6 55.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.057 1.343 . . . . 0.0 112.551 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.69 84.37 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.032 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.23 -18.42 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.096 1.448 . . . . 0.0 112.245 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 m -64.78 -16.42 63.02 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.548 1.139 . . . . 0.0 113.361 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.79 -20.49 57.09 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.503 1.121 . . . . 0.0 112.938 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.44 32.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.751 1.221 . . . . 0.0 108.72 171.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? 61.34 -65.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.686 2.394 . . . . 0.0 114.579 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.46 -48.36 81.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.351 1.432 . . . . 0.0 114.649 -167.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -64.81 -52.32 57.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.175 1.352 . . . . 0.0 109.537 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.87 -45.88 89.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 110.464 -173.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -56.4 -53.46 57.08 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.321 1.048 . . . . 0.0 110.988 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -72.19 -34.54 68.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.148 0.431 . . . . 0.0 111.033 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.74 -39.19 80.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.888 0.875 . . . . 0.0 109.63 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.62 -45.23 76.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.774 0.829 . . . . 0.0 109.925 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.17 80.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.434 1.093 . . . . 0.0 110.943 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.96 -15.4 43.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.039 0.936 . . . . 0.0 113.082 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -95.58 -16.08 22.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.91 0.884 . . . . 0.0 112.373 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.78 -37.71 87.76 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.757 1.162 . . . . 0.0 110.846 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.47 -172.26 44.81 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.463 1.982 . . . . 0.0 108.269 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -77.71 36.06 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.0 0.92 . . . . 0.0 112.809 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.8 m -56.82 146.38 6.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 120.759 -1.213 . . . . 0.0 110.824 -177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -76.93 138.63 39.81 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.58 121.65 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.24 157.14 47.53 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.693 0.797 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 m -134.3 108.01 7.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.1 mt -91.01 138.3 19.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.8 m -137.5 172.56 12.79 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.705 2.002 . . . . 0.0 109.947 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.822 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.9 m -130.32 146.65 51.94 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.097 1.359 . . . . 0.0 109.752 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.77 -45.59 1.92 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.618 1.58 . . . . 0.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.58 36.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.308 2.243 . . . . 0.0 112.616 172.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.88 23.52 2.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.95 2.1 . . . . 0.0 110.531 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.89 -20.34 0.19 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.236 0.922 . . . . 0.0 111.485 -171.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.45 84.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.53 -27.31 48.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.637 1.175 . . . . 0.0 113.606 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -62.88 -32.84 74.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.0 112.416 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.81 146.54 11.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.32 136.22 27.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 p -80.39 141.34 35.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -128.25 155.79 44.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.541 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -124.19 133.87 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.31 -16.85 12.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.596 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -63.17 -11.37 20.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -51.2 -37.32 46.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.422 169.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -148.28 -5.15 0.45 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.7 mmm 56.19 26.86 10.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.773 1.629 . . . . 0.0 112.671 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 m -58.91 -55.34 36.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.869 0.867 . . . . 0.0 111.021 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -63.41 -41.66 98.74 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.068 0.547 . . . . 0.0 109.735 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.94 -47.97 88.04 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 119.339 -0.7 . . . . 0.0 111.396 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.68 -45.31 68.6 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.832 0.816 . . . . 0.0 109.805 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.8 67.76 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.86 0.864 . . . . 0.0 113.097 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -112.39 3.2 16.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.942 1.297 . . . . 0.0 111.544 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.74 33.34 85.7 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 119.591 1.087 . . . . 0.0 112.92 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.8 m -115.13 -2.69 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.358 1.063 . . . . 0.0 111.021 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -69.63 108.74 3.98 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.22 128.78 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -65.77 -46.75 77.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.498 1.119 . . . . 0.0 111.245 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.47 -56.84 3.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.07 0.395 . . . . 0.0 110.391 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.62 -19.94 64.27 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.837 0.455 . . . . 0.0 112.078 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 53.83 38.92 29.66 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 110.967 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 mt -136.87 170.63 15.76 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.566 1.146 . . . . 0.0 108.649 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.14 133.67 41.44 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.15 154.54 41.88 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.612 0.765 . . . . 0.0 111.544 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.4 tpt85 -71.8 117.61 13.6 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -160.74 170.44 20.76 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.352 0.978 . . . . 0.0 108.488 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.49 146.41 17.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 118.741 0.701 . . . . 0.0 109.278 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -144.75 156.02 43.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.229 1.412 . . . . 0.0 109.21 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.7 t -136.32 140.91 42.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.1 mp -133.26 139.0 46.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.169 1.388 . . . . 0.0 108.79 -169.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.62 166.71 8.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.228 1.811 . . . . 0.0 109.941 169.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.28 -32.01 35.44 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 112.664 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -80.64 -2.99 48.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.582 1.153 . . . . 0.0 112.707 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.53 89.18 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.31 0.957 . . . . 0.0 112.724 -174.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -68.07 124.78 24.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.312 1.556 . . . . 0.0 108.285 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.84 132.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.99 -9.87 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.919 1.288 . . . . 0.0 110.956 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 150.94 30.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.175 0.99 . . . . 0.0 108.51 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.16 137.61 15.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.373 1.869 . . . . 0.0 107.457 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.0 143.93 30.76 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.32 105.47 7.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.546 -2.391 . . . . 0.0 104.546 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.6 144.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.158 -0.339 . . . . 0.0 110.416 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 m -62.22 -20.58 64.36 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.671 0.788 . . . . 0.0 112.007 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -144.48 122.88 12.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.77 65.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.965 1.306 . . . . 0.0 113.466 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.92 16.35 2.88 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.06 0.944 . . . . 0.0 111.55 173.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.73 161.3 35.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.025 2.53 . . . . 0.0 106.638 172.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -122.6 149.92 56.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 119.342 0.974 . . . . 0.0 112.468 -169.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.77 162.79 29.51 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.454 2.769 . . . . 0.0 112.247 -177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -70.94 112.85 7.43 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -75.39 -11.97 60.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.23 -32.91 69.34 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.923 1.238 . . . . 0.0 109.022 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -60.39 -53.36 65.45 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 117.533 -1.222 . . . . 0.0 112.063 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.37 -31.62 42.65 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-N 121.96 1.736 . . . . 0.0 112.256 172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.22 -42.73 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 120.169 1.35 . . . . 0.0 109.757 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.501 1.046 . . . . 0.0 110.937 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.15 93.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.68 0.218 . . . . 0.0 110.92 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.71 77.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.398 174.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -55.44 -43.73 75.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.069 0.85 . . . . 0.0 110.395 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.99 -31.48 66.97 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.081 0.552 . . . . 0.0 112.085 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.35 -46.95 11.22 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.767 0.427 . . . . 0.0 111.801 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.71 -50.0 47.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 123.971 0.908 . . . . 0.0 111.745 -169.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.65 -171.895 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.756 0.312 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.79 179.04 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.004 0.921 . . . . 0.0 109.677 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 148.6 45.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -141.88 127.62 19.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 44.88 35.84 1.66 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.444 1.098 . . . . 0.0 112.397 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.98 21.47 78.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 121.393 -0.817 . . . . 0.0 114.294 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.68 8.82 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.44 139.93 35.59 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.355 2.037 . . . . 0.0 110.083 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.35 154.59 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.479 1.112 . . . . 0.0 109.186 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -109.11 158.93 17.31 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.075 1.35 . . . . 0.0 107.841 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.29 158.46 22.34 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.093 0.86 . . . . 0.0 109.247 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.35 -18.33 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.59 33.57 0.63 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.816 0.735 . . . . 0.0 111.329 -174.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -50.79 151.31 2.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.7 1.2 . . . . 0.0 113.069 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.252 10.7 tt0 93.19 30.07 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.306 2.643 . . . . 0.0 112.26 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.14 144.24 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -148.88 160.61 43.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.83 131.46 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.395 0.678 . . . . 0.0 109.648 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.55 82.1 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.04 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.55 -6.5 59.47 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.554 1.677 . . . . 0.0 112.596 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.72 176.21 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.965 1.706 . . . . 0.0 112.451 -169.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.1 129.13 18.84 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 126.711 2.004 . . . . 0.0 107.723 -170.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.83 150.64 61.64 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.184 1.922 . . . . 0.0 112.133 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -75.8 68.66 2.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.288 1.835 . . . . 0.0 110.314 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -60.37 162.81 5.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.162 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -123.51 143.48 50.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.12 170.68 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.545 1.938 . . . . 0.0 108.703 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.4 119.49 22.8 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 125.47 1.508 . . . . 0.0 107.019 -170.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -73.97 173.25 10.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.543 1.137 . . . . 0.0 111.977 -171.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -21.88 66.16 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.086 -1.009 . . . . 0.0 111.226 170.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -80.76 0.19 35.78 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.727 1.611 . . . . 0.0 111.972 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.1 mt 55.27 52.84 10.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.955 2.102 . . . . 0.0 111.719 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.8 153.13 42.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 108.801 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.3 143.5 42.93 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.427 0.691 . . . . 0.0 109.325 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -150.26 160.26 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.252 2.221 . . . . 0.0 105.959 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 p -144.15 167.6 22.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.459 -0.775 . . . . 0.0 109.381 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 tp -53.98 -42.23 68.77 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.74 65.12 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.06 -30.7 55.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.886 0.766 . . . . 0.0 111.013 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.1 mtt -72.14 -40.31 68.17 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.446 1.098 . . . . 0.0 110.546 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -53.06 131.88 37.14 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.7 -23.29 4.0 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.009 1.29 . . . . 0.0 112.334 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -151.75 157.78 42.47 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.39 1.076 . . . . 0.0 109.415 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -56.83 140.86 14.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -134.75 146.79 49.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.899 0.88 . . . . 0.0 108.924 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.6 mt -136.46 135.71 49.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.7 mt -137.05 128.62 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -170.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -107.71 143.36 36.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.16 143.32 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.18 -0.95 . . . . 0.0 108.437 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 pt -144.5 161.36 44.38 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.781 2.032 . . . . 0.0 108.163 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -48.04 2.15 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.573 1.515 . . . . 0.0 110.631 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -162.55 156.72 21.21 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.074 1.35 . . . . 0.0 107.36 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.72 -30.72 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.981 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.81 -13.85 57.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 0.0 112.081 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.71 -20.47 64.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.276 0.631 . . . . 0.0 111.416 175.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 -25.57 3.8 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 124.31 0.957 . . . . 0.0 112.769 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.48 -17.03 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 119.019 1.409 . . . . 0.0 111.594 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.9 p -74.72 -30.07 61.4 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 120.768 -1.207 . . . . 0.0 111.558 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.5 -38.72 40.09 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.448 1.022 . . . . 0.0 109.839 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.63 67.17 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -136.28 -62.71 0.66 Allowed 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.676 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -57.76 -35.43 70.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.341 1.428 . . . . 0.0 113.159 -168.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -27.95 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 118.06 -0.972 . . . . 0.0 112.447 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -103.41 -48.93 3.84 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.842 1.201 . . . . 0.0 109.94 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -51.92 -49.17 63.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 119.497 1.044 . . . . 0.0 111.249 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -79.95 -23.89 41.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.189 -0.319 . . . . 0.0 111.223 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.7 -43.25 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.422 0.689 . . . . 0.0 110.12 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -64.3 -45.63 87.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.818 1.247 . . . . 0.0 108.919 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.87 68.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.556 1.142 . . . . 0.0 110.435 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -9.93 23.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.212 1.005 . . . . 0.0 113.092 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.2 -1.38 10.86 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.6 -34.13 77.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.227 1.376 . . . . 0.0 109.146 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.35 -169.83 40.33 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.494 1.997 . . . . 0.0 108.66 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.96 17.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 113.01 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.53 149.46 5.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.235 1.814 . . . . 0.0 111.272 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -68.75 144.14 54.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 123.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.59 152.8 48.47 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.054 0.542 . . . . 0.0 110.754 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -124.18 143.14 50.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.2 mt -127.4 135.99 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -135.49 168.19 19.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.325 1.45 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.834 0.826 . . . . 0.0 111.406 172.948 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.8 t90 . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.1 p 30.04 -90.19 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.147 2.979 . . . . 0.0 114.149 174.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.25 -21.28 46.79 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.389 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.58 11.03 9.15 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.051 1.426 . . . . 0.0 111.754 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -60.12 -27.81 67.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.0 25.3 0.71 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -173.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.88 91.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.71 -28.93 58.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.462 1.505 . . . . 0.0 113.477 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.7 -17.56 64.7 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -75.99 155.82 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.163 0.892 . . . . 0.0 109.975 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.72 151.68 49.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.2 m -118.1 139.82 50.67 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.93 155.12 30.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.72 0.808 . . . . 0.0 110.094 -172.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -126.57 43.15 3.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.137 1.775 . . . . 0.0 109.139 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -46.13 -41.75 12.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 114.201 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -57.62 -17.58 15.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.275 1.03 . . . . 0.0 113.672 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -61.59 -24.84 66.95 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.004 -1.06 . . . . 0.0 111.832 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -128.39 -28.4 2.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.833 1.653 . . . . 0.0 112.034 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.0 tpt 75.04 10.8 3.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.403 2.681 . . . . 0.0 113.911 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.45 -53.14 61.54 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.846 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.4 -39.62 91.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.193 1.361 . . . . 0.0 109.906 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -50.06 -53.16 24.07 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 125.537 1.541 . . . . 0.0 112.478 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.76 -40.95 63.1 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.053 0.427 . . . . 0.0 110.309 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.23 98.18 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.156 0.982 . . . . 0.0 112.371 -169.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -102.09 -0.12 33.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.381 1.072 . . . . 0.0 110.62 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.53 94.23 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -114.72 0.11 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.98 1.312 . . . . 0.0 110.874 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -76.36 119.09 19.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.46 122.3 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.2 -44.5 97.19 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.94 1.296 . . . . 0.0 110.723 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -95.5 -50.9 4.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.971 0.35 . . . . 0.0 111.16 -172.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.95 -19.03 65.73 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.728 -0.608 . . . . 0.0 112.001 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 53.15 51.79 14.98 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.904 1.281 . . . . 0.0 109.6 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -145.2 162.8 36.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.665 1.586 . . . . 0.0 107.577 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 tp -78.77 132.41 36.9 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.43 -0.794 . . . . 0.0 109.038 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.87 174.92 6.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.045 0.938 . . . . 0.0 112.858 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.91 117.77 34.87 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 169.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -151.19 177.51 10.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.38 145.81 18.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -147.57 156.75 43.12 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.36 1.064 . . . . 0.0 110.051 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.54 139.2 43.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.6 mt -128.55 143.53 50.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.76 1.224 . . . . 0.0 108.619 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -71.51 175.52 5.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.116 0.967 . . . . 0.0 110.252 169.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.06 -23.89 36.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.326 1.451 . . . . 0.0 113.566 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.409 ' H ' ' CG ' ' A' ' 135' ' ' ASP . 32.0 m-80 -98.31 5.46 48.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.854 1.662 . . . . 0.0 111.411 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.64 -0.51 88.17 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.837 -0.98 . . . . 0.0 113.021 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.49 127.49 32.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.696 1.748 . . . . 0.0 108.198 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.85 125.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.47 0.708 . . . . 0.0 109.324 171.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.59 -21.04 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.803 2.041 . . . . 0.0 109.208 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -146.87 150.25 34.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.74 132.63 10.58 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.942 1.697 . . . . 0.0 106.873 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.19 145.48 28.31 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 169.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -115.12 116.41 28.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 t -68.49 126.43 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -57.78 -27.31 62.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.606 1.163 . . . . 0.0 112.617 -173.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.35 103.1 6.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.787 -2.671 . . . . 0.0 103.787 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.33 67.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.615 1.166 . . . . 0.0 112.471 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 p -87.44 19.95 3.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.229 1.012 . . . . 0.0 111.379 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.45 160.46 38.7 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.998 2.119 . . . . 0.0 107.665 175.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -86.66 147.29 43.41 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 121.755 -0.591 . . . . 0.0 112.076 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.03 167.6 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.398 2.732 . . . . 0.0 111.212 169.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -81.21 97.82 7.79 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 169.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -74.29 -4.55 36.85 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.81 -35.35 78.47 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.173 -0.954 . . . . 0.0 109.194 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -56.3 -57.36 23.28 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.34 1.456 . . . . 0.0 111.667 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.62 -33.18 46.25 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.486 1.566 . . . . 0.0 112.312 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 mm -59.05 -48.95 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.837 1.199 . . . . 0.0 109.613 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.54 -41.56 94.73 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.708 0.686 . . . . 0.0 110.537 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.14 87.72 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.686 0.395 . . . . 0.0 110.965 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.44 19.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.517 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -64.22 -26.65 68.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.048 1.294 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.71 70.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.647 1.112 . . . . 0.0 112.073 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.79 -43.87 35.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.646 0.657 . . . . 0.0 110.912 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.36 -48.94 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.38 0.672 . . . . 0.0 110.739 -173.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.057 0 C-N-CA 124.797 1.239 . . . . 0.0 109.969 178.829 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.3 pt -137.1 -177.86 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 109.57 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -126.83 152.49 46.92 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -140.06 128.97 23.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt 43.95 36.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.267 1.427 . . . . 0.0 112.739 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.91 16.95 79.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.55 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.63 120.9 4.92 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 171.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.37 138.64 84.59 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.019 2.479 . . . . 0.0 111.357 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 m -143.41 162.06 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.36 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -118.78 161.83 19.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.463 1.505 . . . . 0.0 108.73 -169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.96 163.06 14.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.659 1.584 . . . . 0.0 109.69 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.36 -62.39 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.524 0.602 . . . . 0.0 111.689 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.45 12.45 69.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -168.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 56.48 154.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.29 2.636 . . . . 0.0 114.602 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -71.78 139.77 49.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.856 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.93 165.74 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -152.11 162.09 41.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.347 -0.846 . . . . 0.0 109.174 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.43 130.44 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.04 0.44 90.29 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.928 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -5.73 59.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.664 . . . . 0.0 112.332 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 58.38 180.0 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 111.527 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.56 146.35 52.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.541 1.536 . . . . 0.0 110.015 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -56.41 -21.84 39.22 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.439 3.426 . . . . 0.0 116.114 174.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 73.49 66.63 0.1 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 108.621 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -69.69 169.12 13.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.401 1.88 . . . . 0.0 111.748 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.5 m -110.48 155.73 21.84 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.23 166.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 127.501 2.32 . . . . 0.0 106.387 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 tp -118.22 135.71 54.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.7 p -75.84 168.36 20.17 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.024 0.53 . . . . 0.0 110.195 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -62.94 -18.85 63.65 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.887 -0.508 . . . . 0.0 110.744 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -81.91 -0.64 44.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.61 1.564 . . . . 0.0 111.693 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.8 mt 62.1 47.12 5.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.277 2.231 . . . . 0.0 111.838 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.22 150.89 49.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.667 1.187 . . . . 0.0 108.971 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.93 145.23 44.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 109.588 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -152.75 163.34 39.89 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.208 2.203 . . . . 0.0 106.064 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 p -143.51 168.6 19.46 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.302 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.6 tp -55.38 -35.92 65.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.251 -0.281 . . . . 0.0 110.541 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.06 -23.71 48.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.83 -32.19 67.29 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.435 1.016 . . . . 0.0 110.795 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 29.7 mtt -80.26 -37.33 33.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.776 1.63 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -53.27 145.31 14.19 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.841 0.857 . . . . 0.0 110.288 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.86 -18.49 14.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.369 1.461 . . . . 0.0 112.588 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.65 153.28 35.34 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 108.06 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -58.37 145.16 10.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 m -138.44 149.15 45.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.578 0.751 . . . . 0.0 109.4 -169.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.42 136.68 54.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.28 112.71 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 m -93.8 155.12 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.74 139.21 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.62 158.52 75.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -48.93 5.9 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.326 1.351 . . . . 0.0 110.799 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 m -165.06 156.87 15.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.595 1.158 . . . . 0.0 109.224 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 tp -66.61 -21.42 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.07 -24.75 65.99 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.968 0.907 . . . . 0.0 111.895 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -72.12 151.29 43.13 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.039 -0.413 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.17 -24.9 75.81 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.731 -0.606 . . . . 0.0 113.374 -172.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 m -60.9 -21.63 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.515 1.157 . . . . 0.0 112.662 -174.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.0 p -60.75 -31.47 70.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.988 0.813 . . . . 0.0 111.929 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -115.29 -33.89 5.16 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.086 0.954 . . . . 0.0 110.773 -172.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -29.87 70.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.593 0.757 . . . . 0.0 112.083 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -148.37 -36.46 0.19 Allowed 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 113.296 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -64.62 -43.5 93.53 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.054 1.752 . . . . 0.0 111.031 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -54.9 -50.51 68.59 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.084 0.954 . . . . 0.0 111.083 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -61.21 -47.8 84.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 110.956 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.1 -46.43 90.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.106 0.412 . . . . 0.0 110.566 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -61.95 -39.13 91.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.758 0.823 . . . . 0.0 110.632 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.53 -49.27 77.37 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.617 0.767 . . . . 0.0 109.806 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -65.57 -39.9 92.18 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.963 0.505 . . . . 0.0 110.804 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.85 82.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 110.954 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.4 66.18 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -79.37 -25.39 42.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.206 0.912 . . . . 0.0 112.104 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.6 mt -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.192 0.906 . . . . 0.0 109.908 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.18 -170.02 43.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.53 37.99 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.671 0.788 . . . . 0.0 112.34 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -58.07 140.38 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 120.899 -1.125 . . . . 0.0 108.069 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.34 138.48 53.77 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 169.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.74 127.58 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.5 156.58 48.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.301 1.04 . . . . 0.0 109.362 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -140.18 119.86 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -100.75 141.71 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -145.19 167.42 22.84 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.177 0.991 . . . . 0.0 110.176 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 CA-C-O 121.268 0.556 . . . . 0.0 109.965 169.278 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -40.33 71.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.14 0.976 . . . . 0.0 111.953 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.09 -14.8 54.81 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.73 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.38 13.96 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.362 1.465 . . . . 0.0 112.289 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -79.54 76.29 6.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.231 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.08 -18.23 0.54 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.26 1.409 . . . . 0.0 111.406 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.15 89.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.604 1.562 . . . . 0.0 107.438 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.61 -24.44 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.138 1.775 . . . . 0.0 113.607 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.65 -32.16 65.1 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.353 1.061 . . . . 0.0 112.892 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.55 137.89 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -121.67 124.82 45.19 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -80.52 141.88 34.72 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -129.52 148.63 51.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.727 1.611 . . . . 0.0 107.022 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -128.69 54.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.206 1.402 . . . . 0.0 108.494 -168.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -49.1 -34.5 14.01 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.788 1.235 . . . . 0.0 113.723 -169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -49.64 -25.06 2.54 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -62.69 -21.9 66.09 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.55 -21.64 2.8 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.461 1.504 . . . . 0.0 112.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 tpt 61.94 5.0 1.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.12 3.368 . . . . 0.0 114.725 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.3 m -66.59 -44.56 81.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.46 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.48 -40.31 96.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 121.298 1.863 . . . . 0.0 109.887 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.85 -46.44 92.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 123.918 0.77 . . . . 0.0 111.469 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.64 -41.78 65.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.672 0.736 . . . . 0.0 110.477 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.02 94.16 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.216 1.006 . . . . 0.0 111.986 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -95.15 4.67 53.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.83 0.852 . . . . 0.0 110.4 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.78 -10.27 14.06 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.306 176.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.75 -13.4 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.816 1.647 . . . . 0.0 112.79 -169.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.79 108.41 1.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.3 118.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.68 -45.31 85.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.952 1.701 . . . . 0.0 111.144 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -89.87 -1.56 58.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.292 0.637 . . . . 0.0 112.427 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -136.56 -6.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.772 0.829 . . . . 0.0 112.492 -171.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 40.96 42.6 1.55 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.892 2.077 . . . . 0.0 113.337 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.6 tp -132.67 153.84 50.72 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -169.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.73 123.34 22.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.36 137.61 56.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.115 0.566 . . . . 0.0 110.511 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.76 119.24 7.78 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.1 p -156.85 166.16 34.15 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.939 1.296 . . . . 0.0 107.555 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.29 146.31 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -144.65 154.93 43.31 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.786 1.234 . . . . 0.0 108.772 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.93 137.81 48.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -131.91 137.78 48.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.831 1.253 . . . . 0.0 108.201 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.94 164.71 14.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.631 1.572 . . . . 0.0 110.748 170.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -50.05 -35.58 25.62 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.691 1.596 . . . . 0.0 113.043 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 7.71 33.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.848 0.859 . . . . 0.0 113.002 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.95 -6.33 76.46 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.592 1.092 . . . . 0.0 113.278 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.31 128.83 37.86 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.029 1.414 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.74 123.44 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.137 0.975 . . . . 0.0 109.415 172.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.23 -12.55 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.354 1.462 . . . . 0.0 110.133 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -148.12 148.59 30.77 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.32 17.25 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.639 1.576 . . . . 0.0 107.709 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -145.3 148.0 32.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.789 0.836 . . . . 0.0 109.5 170.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -135.7 107.1 6.85 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.749 2.42 . . . . 0.0 105.496 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.28 136.26 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -169.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -62.13 -21.98 65.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.605 1.162 . . . . 0.0 112.993 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -136.97 94.87 3.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.03 -13.95 60.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.577 1.151 . . . . 0.0 113.818 -170.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -0.49 18.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.201 0.909 . . . . 0.0 112.143 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.65 170.44 13.8 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 108.588 175.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -115.01 158.49 40.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.698 0.799 . . . . 0.0 112.325 -169.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.27 -179.72 4.88 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.218 2.612 . . . . 0.0 110.866 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -73.51 140.36 46.32 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -100.42 -8.18 23.52 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -79.79 -36.1 37.55 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.032 -1.042 . . . . 0.0 108.378 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -51.42 -56.27 22.05 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.71 -1.138 . . . . 0.0 111.816 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -66.95 -32.5 35.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 CA-C-N 121.535 1.584 . . . . 0.0 112.846 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.6 mm -58.94 -44.24 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.43 1.468 . . . . 0.0 109.865 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.64 -37.62 87.07 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.454 1.025 . . . . 0.0 110.602 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.24 89.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.444 -0.16 . . . . 0.0 111.298 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.59 66.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.333 0.653 . . . . 0.0 110.869 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.75 -40.97 66.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.164 0.893 . . . . 0.0 110.58 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.16 63.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.629 0.772 . . . . 0.0 112.33 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 48.4 mt -97.55 -36.79 10.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.261 0.624 . . . . 0.0 112.279 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.84 -48.29 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.452 1.101 . . . . 0.0 110.417 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--O 1.249 1.034 0 C-N-CA 124.583 1.153 . . . . 0.0 109.745 178.297 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.7 pt -135.78 -175.75 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.267 1.027 . . . . 0.0 108.938 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.91 154.72 50.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.17 126.13 17.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 43.07 45.45 4.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.109 1.364 . . . . 0.0 112.344 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.62 19.61 79.82 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.16 0.886 . . . . 0.0 114.925 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.17 120.29 4.03 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.53 140.48 89.67 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.918 2.412 . . . . 0.0 111.366 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.03 165.24 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.998 1.319 . . . . 0.0 108.684 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -126.65 154.92 43.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.107 0.963 . . . . 0.0 110.781 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.9 147.48 23.33 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.1 1.36 . . . . 0.0 110.964 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -77.13 -55.19 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 123.931 0.892 . . . . 0.0 109.887 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.45 32.68 7.19 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.197 0.903 . . . . 0.0 112.102 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 55.09 -146.79 0.55 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.023 0.929 . . . . 0.0 110.157 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.99 123.87 29.74 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.589 1.155 . . . . 0.0 110.755 -172.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -70.41 160.09 5.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.11 165.66 25.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -174.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -56.54 131.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.46 -5.67 72.36 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.786 1.184 . . . . 0.0 113.563 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.81 -5.9 57.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.525 1.662 . . . . 0.0 113.738 -170.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 66.7 112.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.381 1.872 . . . . 0.0 112.38 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.17 135.61 93.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.28 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.53 -46.74 13.43 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.579 2.186 . . . . 0.0 113.733 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 t70 122.51 126.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 131.471 3.908 . . . . 0.0 105.827 -169.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -138.84 165.74 26.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.691 1.596 . . . . 0.0 109.247 -175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.7 m -131.51 141.47 49.76 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.03 167.7 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.653 1.981 . . . . 0.0 108.41 -172.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.95 143.43 31.11 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 p -80.63 -179.64 7.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.29 1.436 . . . . 0.0 111.571 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -63.49 -24.52 67.86 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.425 -0.797 . . . . 0.0 110.836 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m -82.98 2.84 32.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.218 1.407 . . . . 0.0 111.768 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.2 mt 51.23 42.7 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.966 2.107 . . . . 0.0 112.774 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.82 160.55 21.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.182 0.993 . . . . 0.0 109.121 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.21 143.68 45.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.827 0.822 . . . . 0.0 110.691 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.463 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 42.0 tttp -148.81 153.83 38.67 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.765 2.426 . . . . 0.0 105.894 176.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 p -137.5 167.69 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.689 0.677 . . . . 0.0 110.124 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.64 -39.57 65.1 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.75 -25.75 60.88 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.18 -30.5 43.48 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.777 0.717 . . . . 0.0 111.436 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.2 mtt -71.76 -37.61 70.48 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.447 1.099 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.93 146.61 13.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.763 0.825 . . . . 0.0 110.27 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.99 2.77 48.92 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.548 1.071 . . . . 0.0 114.051 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -150.45 157.24 42.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.894 1.278 . . . . 0.0 108.814 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.56 139.59 19.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -136.77 146.19 45.47 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.28 135.51 62.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.1 mt -132.33 101.28 4.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -174.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -80.85 146.28 30.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.21 135.62 54.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.0 pt -145.82 159.06 48.22 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 125.001 1.321 . . . . 0.0 109.104 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.81 -53.03 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 N-CA-C 107.978 -1.586 . . . . 0.0 107.978 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -157.83 -177.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.413 2.285 . . . . 0.0 106.199 170.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 pt -86.94 -42.89 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.839 0.856 . . . . 0.0 109.724 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.36 -18.72 63.82 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.445 1.098 . . . . 0.0 111.095 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -20.15 61.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.572 1.149 . . . . 0.0 112.73 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.85 -15.42 3.08 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.29 0.95 . . . . 0.0 114.229 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.16 -7.26 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.929 1.364 . . . . 0.0 113.684 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.7 m -61.6 -33.75 74.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.442 1.019 . . . . 0.0 110.821 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.07 -18.75 45.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.934 0.894 . . . . 0.0 111.463 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.01 -173.9 2.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.331 1.053 . . . . 0.0 110.45 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -15.84 58.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.892 1.277 . . . . 0.0 113.688 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.91 64.75 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.324 1.449 . . . . 0.0 112.275 -169.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.8 tpt85 -57.94 -30.5 66.01 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.112 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 -42.93 7.53 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.833 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -59.36 -47.4 85.56 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.382 1.446 . . . . 0.0 111.914 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -67.3 -33.73 75.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.123 0.42 . . . . 0.0 110.377 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -65.12 -49.25 70.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.991 0.516 . . . . 0.0 109.678 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -61.32 -41.54 97.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.852 1.261 . . . . 0.0 110.195 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.52 -52.63 59.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.046 0.938 . . . . 0.0 110.62 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.91 67.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -83.1 -18.53 39.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.822 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.89 -38.43 91.06 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.324 1.42 . . . . 0.0 110.982 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.7 -169.27 42.33 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.35 23.84 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.017 0.909 . . . . 0.0 113.212 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -57.03 144.84 8.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.643 1.177 . . . . 0.0 109.72 -173.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.95 139.35 56.39 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.66 126.14 57.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.463 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 59.9 m-85 -128.1 150.77 49.82 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.615 0.766 . . . . 0.0 109.157 -177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.0 m -132.51 95.4 3.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -84.09 136.03 23.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.8 m -135.62 165.39 25.67 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.794 1.237 . . . . 0.0 110.905 -169.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.188 0.995 . . . . 0.0 113.63 -173.376 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.2 m95 . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p -153.84 170.65 20.46 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.738 1.215 . . . . 0.0 108.728 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.55 -18.17 1.37 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.661 -1.077 . . . . 0.0 115.073 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 28.89 1.83 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.035 1.417 . . . . 0.0 111.787 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -136.94 146.84 45.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.97 -18.83 33.41 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.084 -0.842 . . . . 0.0 112.71 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.05 88.86 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 125.7 1.6 . . . . 0.0 107.839 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.58 -19.09 56.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.597 1.559 . . . . 0.0 114.049 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -60.43 -30.17 69.47 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.625 -0.672 . . . . 0.0 111.834 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 t -71.93 140.44 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -129.0 147.01 50.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 169.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 p -106.84 132.19 53.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.07 155.29 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -170.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.2 m -125.77 134.03 51.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -121.4 -34.24 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -56.68 -15.2 4.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.711 1.205 . . . . 0.0 113.399 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -56.3 -35.46 67.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.763 0.825 . . . . 0.0 112.003 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -140.78 -4.05 1.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.34 17.62 8.48 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.648 2.379 . . . . 0.0 114.493 173.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.5 m -60.51 -57.15 13.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.776 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.86 -40.9 97.64 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.541 0.61 . . . . 0.0 109.627 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.01 -43.68 99.15 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -74.58 -39.59 62.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.713 1.256 . . . . 0.0 110.461 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.06 -45.97 92.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.132 0.973 . . . . 0.0 111.932 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.27 -10.63 43.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.317 1.047 . . . . 0.0 110.538 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.42 -5.44 73.2 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.286 1.898 . . . . 0.0 113.874 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.55 -9.7 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.736 2.014 . . . . 0.0 112.954 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.88 112.97 2.26 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 168.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.419 HG23 ' H ' ' A' ' 124' ' ' LEU . 91.2 mt -76.02 133.18 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.53 -59.76 4.89 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.577 1.151 . . . . 0.0 110.585 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -74.66 -47.69 30.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.377 0.671 . . . . 0.0 111.579 -169.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.419 ' H ' HG23 ' A' ' 121' ' ' ILE . 14.4 tp -78.05 -15.24 59.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.325 0.65 . . . . 0.0 112.024 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 47.5 44.04 16.4 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.999 1.72 . . . . 0.0 111.993 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 tp -139.04 165.04 28.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.279 1.032 . . . . 0.0 108.245 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 127.18 32.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.36 150.43 48.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.054 0.454 . . . . 0.0 110.484 170.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 124.55 25.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.1 m -156.99 168.5 27.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.74 137.47 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -141.23 154.15 45.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.63 138.16 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.3 mp -130.64 135.95 48.36 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.032 0.933 . . . . 0.0 109.671 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.36 163.69 15.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.79 1.636 . . . . 0.0 109.313 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -52.21 -29.76 24.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.579 1.552 . . . . 0.0 113.265 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -71.56 -6.22 39.14 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.506 1.122 . . . . 0.0 113.09 177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.99 47.71 18.21 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -170.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.94 126.87 42.28 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.47 121.38 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.521 0.728 . . . . 0.0 109.439 -170.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.18 -7.68 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.05 1.34 . . . . 0.0 110.747 170.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -150.69 149.2 29.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.99 125.78 7.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.264 1.425 . . . . 0.0 108.177 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -140.84 149.78 42.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.453 0.569 . . . . 0.0 109.954 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.65 116.91 17.97 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.56 133.52 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -171.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -55.27 -28.33 52.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.398 1.079 . . . . 0.0 111.667 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.78 111.98 9.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.85 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.423 1.489 . . . . 0.0 113.152 -176.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 8.64 6.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.874 0.87 . . . . 0.0 112.438 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.39 -174.91 3.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.952 1.301 . . . . 0.0 110.258 172.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -103.87 147.36 34.15 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.21 -0.931 . . . . 0.0 113.426 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.04 178.8 6.07 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.693 2.929 . . . . 0.0 109.967 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.74 133.73 49.79 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -123.31 16.82 9.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 111.684 -170.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.43 -42.28 4.38 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -51.17 -46.35 88.95 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.341 -1.314 . . . . 0.0 112.851 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.87 -38.39 30.03 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 121.943 1.73 . . . . 0.0 111.644 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.7 mm -61.3 -42.37 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.34 -38.45 91.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.556 1.071 . . . . 0.0 111.088 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.09 99.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.56 0.344 . . . . 0.0 110.667 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.9 73.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.977 0.511 . . . . 0.0 110.823 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -55.09 -43.1 73.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.151 0.887 . . . . 0.0 110.285 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.255 0.622 . . . . 0.0 112.104 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.05 -41.9 18.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.871 0.469 . . . . 0.0 111.74 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.06 -52.54 32.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.975 0.91 . . . . 0.0 110.649 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 123.879 0.872 . . . . 0.0 110.004 177.361 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 CA--C 1.543 0.683 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 pt -129.86 172.75 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 123.225 1.488 . . . . 0.0 112.515 -175.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -118.56 156.67 28.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.597 2.759 . . . . 0.0 104.963 170.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.3 122.23 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? 48.1 36.69 6.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.927 1.291 . . . . 0.0 111.51 -175.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.93 85.47 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.39 -0.819 . . . . 0.0 114.694 176.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.47 118.1 5.07 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.41 143.42 77.2 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.808 2.339 . . . . 0.0 111.355 173.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.86 -175.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.958 1.303 . . . . 0.0 108.655 175.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -132.58 151.45 51.93 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.641 1.176 . . . . 0.0 108.154 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.12 155.59 17.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.71 1.604 . . . . 0.0 109.046 176.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -74.83 -25.36 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.65 17.29 1.11 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.247 -0.752 . . . . 0.0 112.91 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 47.65 -168.61 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.682 1.993 . . . . 0.0 113.838 178.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 145' ' ' TYR . 6.8 pm0 -80.76 128.76 34.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.705 -1.247 . . . . 0.0 113.414 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.3 170.31 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 165.01 34.01 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 120.998 -1.064 . . . . 0.0 109.514 -172.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.46 132.36 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 -2.21 87.56 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.836 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.05 -13.29 59.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.311 1.556 . . . . 0.0 112.4 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.51 176.64 0.06 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.208 1.803 . . . . 0.0 112.192 -169.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.99 137.75 30.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.163 1.385 . . . . 0.0 110.451 -171.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.17 -20.13 45.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.727 3.618 . . . . 0.0 117.122 176.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.33 72.37 0.13 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.63 1.972 . . . . 0.0 109.287 -169.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -72.82 175.89 6.11 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.65 1.58 . . . . 0.0 110.709 177.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.1 m -131.97 144.56 50.9 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.86 176.42 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 108.169 -177.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.9 mt -113.52 140.31 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.273 1.029 . . . . 0.0 109.474 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -72.59 176.23 5.65 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.383 1.473 . . . . 0.0 111.174 175.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -59.84 -22.58 62.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.154 0.582 . . . . 0.0 111.15 169.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.7 m -92.1 4.1 53.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.551 1.54 . . . . 0.0 112.212 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.6 mp 53.05 47.16 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.305 1.842 . . . . 0.0 112.164 -175.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -112.44 148.41 34.43 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.16 146.67 34.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.802 0.811 . . . . 0.0 111.1 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -150.41 114.98 5.21 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.79 1.636 . . . . 0.0 107.14 -172.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -79.93 161.89 25.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.209 0.603 . . . . 0.0 109.999 176.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.37 -36.5 73.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.68 44.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.924 0.89 . . . . 0.0 113.353 177.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -74.08 -32.64 63.35 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.444 1.02 . . . . 0.0 110.965 174.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.6 mtt -75.81 -34.61 60.16 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 111.371 177.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -54.67 158.29 2.65 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.607 1.163 . . . . 0.0 111.368 -177.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.85 67.01 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.335 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -146.33 159.67 43.05 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.038 2.135 . . . . 0.0 106.964 169.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.74 113.96 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 168.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.3 m -92.44 138.44 31.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.4 mt -132.84 133.05 59.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.19 139.93 41.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -172.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -123.04 152.51 40.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.61 124.92 35.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 pt -139.2 147.27 52.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.93 -47.87 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 120.723 0.948 . . . . 0.0 110.794 174.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.04 173.25 16.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -169.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.38 -42.96 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.616 1.566 . . . . 0.0 107.661 174.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.41 -28.16 68.41 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.625 1.17 . . . . 0.0 112.36 -175.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.37 -4.95 9.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 176.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.41 -29.75 2.84 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 121.082 -1.011 . . . . 0.0 114.174 169.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.79 -25.38 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.972 1.386 . . . . 0.0 112.599 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.47 -39.86 61.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.091 1.356 . . . . 0.0 111.769 169.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -107.13 -36.8 6.47 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.814 0.846 . . . . 0.0 111.172 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.54 68.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.811 0.844 . . . . 0.0 112.564 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -145.44 -41.27 0.23 Allowed 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.038 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -67.22 -44.41 79.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.654 1.116 . . . . 0.0 110.649 -169.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -59.35 -30.44 68.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 113.449 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -85.25 -43.62 13.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.948 0.794 . . . . 0.0 110.193 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.47 -50.67 72.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.428 0.691 . . . . 0.0 110.421 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -60.66 -38.38 84.7 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.991 0.516 . . . . 0.0 110.888 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.64 -33.18 75.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.166 0.986 . . . . 0.0 112.135 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.75 -46.29 15.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.169 0.895 . . . . 0.0 109.945 172.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -45.1 87.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.383 1.073 . . . . 0.0 111.017 -174.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.03 -15.06 55.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.082 0.953 . . . . 0.0 112.797 -173.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -117.14 3.99 12.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.14 -35.71 79.6 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.969 1.259 . . . . 0.0 110.719 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.03 -161.44 30.81 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.694 1.14 . . . . 0.0 110.278 -176.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -74.04 27.97 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.892 1.277 . . . . 0.0 112.42 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.06 144.83 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 108.362 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -84.04 155.31 22.78 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.44 124.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -172.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -139.35 157.73 45.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.057 0.543 . . . . 0.0 110.443 -176.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.6 m -136.29 103.98 5.48 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.97 150.16 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.624 1.17 . . . . 0.0 108.295 -174.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.3 m -127.27 158.41 37.25 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.195 1.798 . . . . 0.0 111.223 -169.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 124.34 1.056 . . . . 0.0 111.933 -178.442 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.6 m95 . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 m 61.16 18.22 8.86 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.923 1.689 . . . . 0.0 114.808 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.12 -43.52 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.1 8.55 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.22 0.24 12.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.709 1.204 . . . . 0.0 112.144 176.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.68 -18.88 0.6 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.716 1.15 . . . . 0.0 112.38 177.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.93 95.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.13 -16.75 54.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.22 1.408 . . . . 0.0 114.049 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -60.23 -30.39 69.37 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.689 -0.632 . . . . 0.0 111.314 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.1 t -75.34 147.45 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.18 142.98 40.04 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.1 p -87.54 132.41 34.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.02 168.86 11.06 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.546 1.938 . . . . 0.0 107.547 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.3 m -136.63 147.66 47.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.126 0.97 . . . . 0.0 109.091 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -125.86 -19.09 4.95 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.523 0.729 . . . . 0.0 111.466 173.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -55.45 -24.62 31.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -173.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -73.1 -16.17 61.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.373 -0.822 . . . . 0.0 112.815 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -139.9 -21.99 0.87 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.546 1.066 . . . . 0.0 113.636 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.9 mmm 57.55 7.44 0.52 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.327 2.651 . . . . 0.0 115.816 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.2 m -62.39 -48.01 81.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.859 1.209 . . . . 0.0 111.846 -177.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -64.27 -40.33 95.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.445 1.475 . . . . 0.0 110.027 177.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.81 -57.28 9.93 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 125.749 1.642 . . . . 0.0 112.274 176.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.86 -42.58 81.1 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.134 0.467 . . . . 0.0 110.049 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.81 92.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.848 0.859 . . . . 0.0 112.2 -172.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.84 8.2 37.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.224 1.01 . . . . 0.0 110.896 -176.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.37 34.43 74.75 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.146 0.884 . . . . 0.0 111.704 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.3 m -108.87 -4.3 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.742 1.617 . . . . 0.0 110.316 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.63 113.52 8.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 168.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 84.3 mt -70.94 111.27 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 175.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -54.37 -40.91 68.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.442 1.497 . . . . 0.0 111.43 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.95 -4.02 55.18 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.69 -16.97 1.99 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.938 0.79 . . . . 0.0 112.763 -170.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.4 ttm105 47.46 42.41 14.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.82 1.648 . . . . 0.0 111.989 -173.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -122.09 163.03 20.17 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.04 131.52 36.3 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 138.8 56.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.162 1.385 . . . . 0.0 111.541 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -58.57 113.64 2.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.377 1.071 . . . . 0.0 108.78 171.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.3 p -156.23 173.63 16.56 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.927 0.394 . . . . 0.0 110.667 -176.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.93 149.12 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.439 1.496 . . . . 0.0 107.85 174.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -147.79 155.45 41.69 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.773 1.229 . . . . 0.0 110.119 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.59 142.87 33.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 mp -138.93 142.29 38.47 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -173.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.65 165.06 5.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.28 1.432 . . . . 0.0 110.038 169.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -51.13 -32.53 23.1 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.982 1.313 . . . . 0.0 112.848 176.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -79.5 0.41 29.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.835 1.254 . . . . 0.0 112.834 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.05 88.62 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.004 -1.06 . . . . 0.0 112.884 -175.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -67.75 121.88 16.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.068 1.434 . . . . 0.0 107.236 172.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.07 132.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.295 0.638 . . . . 0.0 109.446 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.53 -18.75 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.664 1.985 . . . . 0.0 109.662 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -147.27 149.45 32.89 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.04 138.84 17.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.105 1.762 . . . . 0.0 107.475 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -146.91 146.78 30.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.31 0.644 . . . . 0.0 109.796 170.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 17' ' ' GLU . 12.8 m-85 -139.13 93.42 2.69 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.6 2.76 . . . . 0.0 104.837 -173.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.7 m -62.52 147.37 11.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 O-C-N 121.769 -0.582 . . . . 0.0 110.415 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -66.45 -11.09 50.19 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -143.35 125.64 15.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.36 -24.13 58.91 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -176.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 38.3 p -89.78 -4.17 57.78 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.001 0.819 . . . . 0.0 112.298 176.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -84.62 176.49 8.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.248 1.419 . . . . 0.0 109.268 173.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -148.05 146.54 23.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.46 176.83 7.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.414 2.743 . . . . 0.0 110.451 177.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -76.8 119.53 20.7 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -67.82 -14.36 62.89 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -70.0 -30.02 67.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.015 1.279 . . . . 0.0 109.435 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -66.34 -49.78 52.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.357 -175.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -65.58 -35.79 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 121.366 1.524 . . . . 0.0 111.541 170.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.14 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 119.755 1.161 . . . . 0.0 110.154 179.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.84 -30.15 67.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.59 1.086 . . . . 0.0 110.741 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.09 97.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.004 0.366 . . . . 0.0 110.544 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.33 -45.05 85.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.944 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -56.7 -41.32 77.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.202 0.91 . . . . 0.0 110.498 176.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.22 71.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.65 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.85 -47.59 14.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.566 0.621 . . . . 0.0 111.89 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.05 -39.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 110.718 -172.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.2 mttm . . . . . 0 C--O 1.249 1.049 0 C-N-CA 126.039 1.735 . . . . 0.0 109.592 -175.829 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HA ' ' OE1' ' A' ' 17' ' ' GLU 0.335 0.6 OUTLIER . . . . . 0 CA--C 1.496 -1.121 0 CA-C-O 122.72 1.248 . . . . 0.0 113.08 . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.43 74.34 1.11 Allowed 'General case' 0 N--CA 1.425 -1.678 1 N-CA-C 99.147 -4.39 . . . . 0.0 99.147 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.81 153.14 24.81 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 158.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.5 pt -135.56 175.66 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 m -119.32 152.53 36.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -136.32 123.83 22.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 173.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.8 mttt 50.36 36.15 12.4 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.53 85.97 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 119.417 -1.373 . . . . 0.0 113.406 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.68 124.32 6.34 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.076 1.938 . . . . 0.0 108.364 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.05 144.5 99.47 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 CA-C-N 120.217 2.009 . . . . 0.0 109.994 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -145.47 145.27 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.175 0.99 . . . . 0.0 109.765 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -90.63 159.82 16.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.543 1.137 . . . . 0.0 109.93 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD11 ' HA ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -111.81 153.27 26.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.338 1.455 . . . . 0.0 109.189 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -81.9 -56.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 121.96 -0.463 . . . . 0.0 110.427 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.42 12.72 33.33 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.034 -167.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 28.76 174.58 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 133.456 4.703 . . . . 0.0 120.657 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 17.1 tt0 12.82 62.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 129.786 3.234 . . . . 0.0 117.607 144.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 157.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 149.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -150.37 171.78 16.45 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 120.923 -1.111 . . . . 0.0 108.485 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.32 131.74 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.839 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.9 -10.01 72.11 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 116.922 -2.043 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.96 -13.0 61.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.537 1.668 . . . . 0.0 113.42 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 65.16 160.86 0.12 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.33 1.852 . . . . 0.0 110.544 -172.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.92 132.24 22.42 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.21 1.804 . . . . 0.0 109.013 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.5 -28.65 86.21 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.1 2.533 . . . . 0.0 118.459 -169.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 t70 75.12 99.8 0.07 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.169 -157.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 112' ' ' SER . 2.2 p90 -125.87 -174.47 3.1 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 126.077 1.751 . . . . 0.0 106.702 169.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 m -115.94 153.89 30.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.746 2.018 . . . . 0.0 106.95 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.03 168.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 1.2 tp -112.07 147.02 36.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 172.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -79.17 172.53 13.67 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.37 -29.5 66.05 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.973 1.309 . . . . 0.0 110.933 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -80.52 -0.04 35.8 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.403 1.481 . . . . 0.0 112.968 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.1 mt 62.37 36.51 14.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.176 1.79 . . . . 0.0 112.526 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.54 144.28 28.82 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 171.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.92 132.4 45.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.113 0.959 . . . . 0.0 108.956 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -136.08 148.39 48.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.38 167.4 12.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.29 -37.29 67.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.626 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.43 63.64 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.894 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.12 -26.6 59.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.199 0.909 . . . . 0.0 111.625 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 mtt -78.21 -31.18 49.28 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.413 -0.804 . . . . 0.0 111.419 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -62.38 152.74 33.23 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.226 0.536 . . . . 0.0 110.0 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.16 -7.66 44.2 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -154.51 160.99 41.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.541 1.171 . . . . 0.0 109.15 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.16 137.59 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.5 m -132.28 147.23 52.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.351 1.46 . . . . 0.0 107.956 -173.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.65 137.44 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -137.46 117.62 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.3 m -93.09 150.74 20.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 163.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.05 133.95 55.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.23 151.73 62.42 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.31 -43.12 4.73 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.62 1.547 . . . . 0.0 110.747 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.2 m -150.75 171.5 17.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.583 2.353 . . . . 0.0 106.839 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.478 ' H ' ' HA ' ' A' ' 89' ' ' ALA . 1.1 pt -99.99 -20.45 5.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 123.147 0.579 . . . . 0.0 111.669 166.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.8 -22.4 66.89 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.215 -1.553 . . . . 0.0 112.122 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -65.57 1.82 1.12 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.107 1.763 . . . . 0.0 115.024 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.59 -18.64 3.58 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 121.363 1.892 . . . . 0.0 114.113 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.522 ' HB ' HH21 ' A' ' 129' ' ' ARG . 1.6 m -57.56 -23.09 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.59 1.695 . . . . 0.0 113.109 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . 0.265 61.2 m -36.82 -61.57 0.53 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.736 1.214 . . . . 0.0 110.259 165.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -75.35 -50.05 17.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 126.527 2.392 . . . . 0.0 105.866 -156.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.24 83.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.801 -166.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.503 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.1 tm0? -145.33 -47.37 0.22 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.675 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -63.26 -43.26 98.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.831 1.65 . . . . 0.0 111.65 -163.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -48.4 -56.26 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.702 2.001 . . . . 0.0 109.205 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -69.52 -45.64 68.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.813 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CB ' HE21 ' A' ' 63' ' ' GLN . 38.5 t80 -58.45 -45.64 88.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.005 0.522 . . . . 0.0 110.979 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.21 -39.87 93.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.117 0.967 . . . . 0.0 109.888 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.2 -46.29 84.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -63.22 -47.21 83.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.961 0.504 . . . . 0.0 110.538 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.24 -48.41 68.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.47 1.108 . . . . 0.0 110.508 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.52 -16.87 27.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.66 -15.59 17.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.874 1.27 . . . . 0.0 112.846 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.43 -33.09 72.03 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.332 0.514 . . . . 0.0 109.984 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.37 35.47 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.74 21.01 0.42 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.862 -0.787 . . . . 0.0 112.96 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 m -52.2 145.34 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.123 1.369 . . . . 0.0 110.589 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -70.35 143.6 51.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 134.29 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -138.96 154.24 48.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.56 0.744 . . . . 0.0 109.523 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -129.74 115.64 17.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.85 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.1 m -135.46 166.88 22.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.97 170.69 7.83 Favored 'General case' 0 CA--C 1.555 1.17 0 O-C-N 122.105 -0.372 . . . . 0.0 110.216 164.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -66.65 -35.82 81.08 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 126.428 1.891 . . . . 0.0 108.246 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 tp -29.96 122.98 0.3 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 130.138 3.375 . . . . 0.0 110.712 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.83 -30.69 30.71 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.322 2.681 . . . . 0.0 114.999 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -67.86 -4.3 12.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.024 1.329 . . . . 0.0 113.349 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 55' ' ' ILE . . . -119.02 -14.79 9.33 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -150.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.418 HE22 ' CA ' ' A' ' 106' ' ' SER . 20.7 mt-30 -128.43 -8.96 5.19 Favored 'General case' 0 CA--C 1.466 -2.288 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.511 ' O ' ' CH2' ' A' ' 93' ' ' TRP . . . -61.59 -30.3 70.58 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 115.824 -2.036 . . . . 0.0 107.022 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -155.79 8.81 0.25 Allowed 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 117.83 2.529 . . . . 0.0 117.83 -149.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.511 ' CH2' ' O ' ' A' ' 91' ' ' ALA . 1.1 p90 57.81 37.01 26.97 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 115.205 -2.598 . . . . 0.0 108.74 123.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -35.18 44.82 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.34 -28.21 70.24 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.197 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 93' ' ' TRP . . . -111.54 24.66 12.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.785 2.834 . . . . 0.0 111.96 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -115.08 106.68 14.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.65 -16.52 51.6 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.671 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.21 86.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.55 -22.68 13.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.7 -27.4 68.31 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.668 -1.27 . . . . 0.0 113.255 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.79 145.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -129.19 142.24 50.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.11 139.72 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.739 1.216 . . . . 0.0 109.021 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.5 mp -124.56 158.74 32.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.405 1.482 . . . . 0.0 108.999 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.418 ' CA ' HE22 ' A' ' 90' ' ' GLN . 0.8 OUTLIER -132.81 73.22 1.51 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 127.05 2.14 . . . . 0.0 107.385 -169.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.71 -32.77 71.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.526 -1.359 . . . . 0.0 111.53 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -54.57 -17.31 3.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.195 1.798 . . . . 0.0 113.583 -167.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.534 ' HD3' ' CD2' ' A' ' 30' ' ' LEU . 5.3 ttt180 -65.27 -26.99 68.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -134.38 -17.15 2.06 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 124.914 1.384 . . . . 0.0 107.964 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 6.0 mmm 59.66 6.88 0.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.477 2.311 . . . . 0.0 111.513 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 27' ' ' PHE . 20.8 m -59.07 -49.18 78.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.742 1.61 . . . . 0.0 110.012 -170.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -62.57 -42.07 99.32 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.304 1.411 . . . . 0.0 109.916 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.21 -47.02 50.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 123.864 0.745 . . . . 0.0 113.237 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -73.85 -46.91 42.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.512 0.725 . . . . 0.0 109.247 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.7 78.49 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -104.09 7.13 36.29 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.844 1.258 . . . . 0.0 109.467 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.02 25.33 56.49 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 118.149 -1.361 . . . . 0.0 113.101 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.596 HG11 ' HG ' ' A' ' 130' ' ' SER . 17.1 m -90.83 -9.1 10.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.688 1.744 . . . . 0.0 111.488 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -63.32 115.97 5.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.446 ' HA ' HD11 ' A' ' 13' ' ' LEU . 65.7 mt -75.14 120.92 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -61.17 -49.77 75.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.844 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.24 -31.2 43.51 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.432 0.457 . . . . 0.0 112.014 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.41 ' H ' HG21 ' A' ' 121' ' ' ILE . 21.8 tp -109.63 -18.21 13.53 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.116 0.966 . . . . 0.0 111.576 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 53.63 42.35 31.89 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.744 1.618 . . . . 0.0 114.507 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt -123.54 162.96 21.9 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.38 135.85 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.42 154.49 41.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.779 1.275 . . . . 0.0 110.091 167.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.522 HH21 ' HB ' ' A' ' 59' ' ' VAL . 17.1 tpt85 -77.38 112.0 13.65 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.683 166.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.596 ' HG ' HG11 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -151.06 173.38 14.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.98 140.07 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -142.27 155.88 45.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.056 1.342 . . . . 0.0 108.477 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.38 139.77 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -130.19 133.95 46.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -171.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.22 163.43 15.24 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 125.314 1.445 . . . . 0.0 110.877 164.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -48.61 -35.19 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.254 1.822 . . . . 0.0 113.998 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -2.66 39.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.659 1.572 . . . . 0.0 111.97 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.96 3.11 70.73 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.174 -1.579 . . . . 0.0 112.5 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -71.48 122.26 20.1 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.982 1.891 . . . . 0.0 109.36 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.41 126.49 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.38 -11.22 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 129.448 3.099 . . . . 0.0 107.767 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -152.61 152.48 31.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.227 1.411 . . . . 0.0 107.454 163.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.18 139.93 18.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -150.2 148.8 29.35 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.26 117.51 24.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.859 1.663 . . . . 0.0 106.906 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.71 129.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -57.56 -19.15 23.5 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.904 0.881 . . . . 0.0 113.165 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -138.54 124.23 19.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.12 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -84.12 6.4 22.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.419 1.487 . . . . 0.0 111.11 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.46 174.2 6.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.732 2.013 . . . . 0.0 107.235 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -128.53 152.87 79.13 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 120.716 -1.24 . . . . 0.0 110.861 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -80.96 170.35 15.38 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.591 2.194 . . . . 0.0 110.082 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -69.46 120.82 15.84 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 161.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -93.68 -8.09 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.698 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.12 -36.69 83.81 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.297 1.408 . . . . 0.0 108.847 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -63.12 -48.75 83.27 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 125.341 1.456 . . . . 0.0 112.254 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.71 -34.86 49.15 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 CA-C-N 119.59 0.889 . . . . 0.0 111.974 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 20.6 mm -60.02 -45.47 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 120.658 1.572 . . . . 0.0 110.507 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.86 -42.34 97.57 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 120.746 1.612 . . . . 0.0 109.263 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.04 95.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.882 0.473 . . . . 0.0 110.78 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.84 80.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.083 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -53.74 -49.65 67.69 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 117.077 -1.44 . . . . 0.0 108.368 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -52.82 -29.68 29.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.408 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.45 -49.18 7.38 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.1 t -60.6 -41.39 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.533 0.683 . . . . 0.0 111.827 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.439 -1.018 0 C-N-CA 130.64 3.576 . . . . 0.0 117.265 -161.116 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.77 0.319 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.03 50.43 1.73 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.596 1.559 . . . . 0.0 109.621 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.39 170.23 5.06 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.474 169.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.94 -175.76 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.379 1.072 . . . . 0.0 108.834 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -118.5 152.15 36.5 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -136.04 109.42 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 42.89 41.83 2.77 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 111.825 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.23 -9.5 61.21 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.134 -0.814 . . . . 0.0 115.04 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.1 125.53 8.56 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.189 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.43 138.62 39.34 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 CA-C-N 120.859 2.33 . . . . 0.0 110.208 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.16 135.21 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.154 0.982 . . . . 0.0 110.453 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -75.91 155.17 35.42 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.834 1.653 . . . . 0.0 110.388 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.64 144.63 40.6 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.405 1.482 . . . . 0.0 107.877 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.24 -65.19 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 118.502 0.592 . . . . 0.0 111.299 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.09 35.17 4.85 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.627 1.108 . . . . 0.0 111.206 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -52.12 166.44 0.16 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.247 2.219 . . . . 0.0 116.075 -169.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 69.07 34.19 3.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.614 1.966 . . . . 0.0 113.379 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.54 144.78 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -150.12 162.93 39.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.802 0.841 . . . . 0.0 109.156 -169.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 p -52.89 132.82 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 109.541 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.19 -5.22 83.03 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.85 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.37 -11.28 59.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.457 1.628 . . . . 0.0 112.64 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 57.44 178.36 0.05 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.649 1.58 . . . . 0.0 111.952 -169.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.38 136.09 20.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.931 1.693 . . . . 0.0 109.016 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.26 157.49 45.8 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.483 2.122 . . . . 0.0 109.77 172.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -77.47 67.91 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.02 1.728 . . . . 0.0 110.117 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -59.27 162.3 4.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.442 170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.5 m -124.65 144.45 50.19 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.38 168.05 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.343 2.257 . . . . 0.0 107.528 -171.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.97 143.45 45.7 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.48 178.45 8.11 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.523 0.729 . . . . 0.0 109.949 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.98 -23.33 67.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.146 -0.971 . . . . 0.0 110.734 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 m -86.41 3.34 44.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.4 mt 55.62 33.1 20.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.82 2.048 . . . . 0.0 112.937 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.55 147.11 24.77 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.84 143.8 39.47 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 109.439 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -154.02 155.08 34.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.315 2.246 . . . . 0.0 105.547 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.2 m -139.58 166.57 24.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.119 0.872 . . . . 0.0 108.927 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.6 tp -50.15 -40.67 47.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.242 0.474 . . . . 0.0 111.026 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.1 62.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -77.4 -28.47 52.76 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.768 0.713 . . . . 0.0 111.133 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.8 mtt -80.36 -55.14 5.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.877 1.271 . . . . 0.0 110.513 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -59.74 134.01 56.62 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.06 -20.61 3.2 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.955 2.216 . . . . 0.0 110.512 -169.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -150.33 158.34 44.05 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.92 2.088 . . . . 0.0 107.219 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -56.65 144.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.4 m -137.09 145.82 44.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.2 mt -133.31 137.19 53.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mt -136.75 133.88 48.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m -114.98 147.44 40.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -136.5 133.32 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.25 150.35 51.69 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.55 1.14 . . . . 0.0 109.278 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.92 -50.13 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.558 1.505 . . . . 0.0 109.709 169.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -152.87 168.67 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.311 1.444 . . . . 0.0 108.108 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.85 -23.93 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.53 -27.06 62.93 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 0.0 111.839 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 32.2 0.08 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.12 2.168 . . . . 0.0 113.736 -174.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.68 -3.23 69.88 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 120.432 -1.418 . . . . 0.0 114.269 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.83 -12.28 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.498 1.149 . . . . 0.0 112.406 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.69 -0.04 2.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.458 1.503 . . . . 0.0 113.724 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -48.97 148.66 2.18 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 0.0 110.348 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.03 -28.69 10.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.914 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -50.06 -57.33 7.85 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.265 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -65.71 -42.86 90.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.493 1.497 . . . . 0.0 110.085 -170.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -63.81 -53.96 42.65 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 122.725 0.41 . . . . 0.0 110.169 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.27 -37.6 80.88 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.688 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -55.93 -51.93 65.92 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 119.438 1.017 . . . . 0.0 110.102 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -66.22 -33.61 76.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 0.0 110.572 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -64.25 -50.55 67.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.735 -0.603 . . . . 0.0 110.477 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -60.8 -41.73 96.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.167 0.894 . . . . 0.0 110.406 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.86 73.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.918 0.887 . . . . 0.0 110.316 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.1 -13.57 62.51 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -100.86 -17.31 16.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.859 1.264 . . . . 0.0 112.419 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -60.07 -37.87 81.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.051 1.296 . . . . 0.0 110.56 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.89 -173.09 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -74.0 22.69 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.89 0.876 . . . . 0.0 112.902 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.15 154.34 2.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.379 1.472 . . . . 0.0 110.733 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.82 143.75 52.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.45 130.45 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.36 153.05 46.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.136 0.574 . . . . 0.0 110.886 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 m -120.57 154.6 35.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.1 mt -136.55 134.85 49.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.2 m -131.71 160.79 34.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 109.86 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.68 170.86 5.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.205 0.526 . . . . 0.0 110.933 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -13.85 60.11 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.48 0.712 . . . . 0.0 112.18 175.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.0 tp -49.56 127.54 18.18 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.859 1.264 . . . . 0.0 109.602 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.58 -37.39 74.0 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.966 2.444 . . . . 0.0 114.531 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -68.16 -16.65 64.08 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.519 0.728 . . . . 0.0 112.856 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.72 -4.32 42.68 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -169.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -138.21 139.2 39.17 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.77 -179.69 7.01 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.231 1.812 . . . . 0.0 108.008 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -83.42 24.83 0.79 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.244 1.018 . . . . 0.0 110.127 169.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -134.97 160.64 37.65 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.868 1.267 . . . . 0.0 109.727 -170.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 m 65.22 -48.13 0.36 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.571 2.748 . . . . 0.0 116.089 169.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.45 -48.67 8.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.99 38.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.742 1.617 . . . . 0.0 108.637 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -149.37 33.16 0.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.0 111.24 -170.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.74 -1.26 5.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.293 0.949 . . . . 0.0 113.103 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 mt -75.11 87.87 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -54.38 -30.22 51.28 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 114.013 -169.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.91 -25.17 67.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.585 0.754 . . . . 0.0 112.88 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -74.42 152.95 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.823 0.738 . . . . 0.0 109.87 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -137.44 151.2 48.25 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.1 m -121.95 96.57 5.11 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.82 160.98 31.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.945 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -127.8 37.43 4.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.025 2.13 . . . . 0.0 109.088 -169.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -47.65 -39.73 17.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.798 1.239 . . . . 0.0 114.098 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.96 -17.79 11.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.117 0.967 . . . . 0.0 113.487 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -62.82 -22.0 66.32 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.221 -0.925 . . . . 0.0 112.661 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.7 -26.15 1.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.718 1.607 . . . . 0.0 111.898 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 69.44 10.83 7.88 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.444 2.698 . . . . 0.0 113.741 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 m -61.69 -47.76 83.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.25 -38.15 88.16 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.509 1.504 . . . . 0.0 109.407 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.53 -59.02 4.39 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 126.386 1.946 . . . . 0.0 112.872 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.34 -42.32 65.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.68 95.46 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.0 0.92 . . . . 0.0 112.258 -169.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -107.11 5.13 27.61 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.716 1.206 . . . . 0.0 110.653 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.99 85.95 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.648 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.6 m -105.64 -1.79 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.531 1.132 . . . . 0.0 111.199 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.75 116.97 17.91 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.5 mt -74.11 124.37 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.27 -46.82 78.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.307 0.643 . . . . 0.0 110.453 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -84.2 -51.92 6.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.365 0.266 . . . . 0.0 110.746 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -22.93 60.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.276 0.63 . . . . 0.0 111.031 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 49.97 57.59 6.38 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.432 1.093 . . . . 0.0 110.284 -171.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.99 173.45 11.7 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.045 1.338 . . . . 0.0 107.85 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.18 135.29 33.36 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.133 0.973 . . . . 0.0 108.381 172.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.79 165.32 18.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -83.21 113.22 20.51 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.8 m -155.19 166.49 33.4 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.661 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -147.05 142.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -144.06 158.12 43.91 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.293 1.037 . . . . 0.0 110.045 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.3 140.76 41.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -131.34 140.14 49.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.119 1.368 . . . . 0.0 108.122 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 166.0 17.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.924 1.289 . . . . 0.0 110.279 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -47.77 -38.43 15.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.436 1.495 . . . . 0.0 112.563 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.95 7.4 13.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.643 1.11 . . . . 0.0 113.663 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.52 -7.53 80.59 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 120.971 -1.08 . . . . 0.0 112.853 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -65.38 130.65 44.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 118.66 1.23 . . . . 0.0 108.937 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.1 132.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.582 0.753 . . . . 0.0 109.84 171.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.15 -18.0 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.059 2.144 . . . . 0.0 109.811 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -148.57 150.19 32.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.63 133.31 11.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.764 1.626 . . . . 0.0 107.249 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -146.59 147.1 30.75 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.79 107.87 14.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.11 131.34 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -57.74 -20.58 35.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.845 1.258 . . . . 0.0 113.829 -169.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.13 130.81 25.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.22 12.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.725 1.61 . . . . 0.0 114.219 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -88.47 -1.9 58.3 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 118.542 0.61 . . . . 0.0 112.225 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -82.45 178.84 8.02 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.77 -1.206 . . . . 0.0 110.062 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -129.72 133.51 25.13 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.656 1.583 . . . . 0.0 109.077 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.6 173.59 11.26 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.508 2.805 . . . . 0.0 110.572 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -73.46 129.51 38.14 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 168.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -100.06 -4.66 29.4 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.96 -38.04 57.97 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -50.45 -58.24 10.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.52 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.35 -35.81 38.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 121.449 1.553 . . . . 0.0 112.133 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.97 -44.76 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.523 1.056 . . . . 0.0 110.302 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.65 -37.83 87.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 119.506 1.048 . . . . 0.0 110.247 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.9 96.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.359 0.264 . . . . 0.0 110.706 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.92 72.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.955 0.502 . . . . 0.0 111.414 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.81 -41.67 74.54 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.54 1.063 . . . . 0.0 110.214 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.15 67.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.27 0.628 . . . . 0.0 111.948 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.55 -46.43 14.47 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.365 0.666 . . . . 0.0 111.313 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.8 -44.73 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.801 0.84 . . . . 0.0 111.127 -169.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.357 1.063 . . . . 0.0 109.708 178.224 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.48 67.27 1.53 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.01 0.924 . . . . 0.0 109.805 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.86 154.77 14.38 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.368 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.3 pt -119.35 174.06 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.226 1.013 . . . . 0.0 110.546 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -112.61 155.77 23.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -135.38 115.43 13.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? 37.53 53.87 1.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.89 1.676 . . . . 0.0 113.298 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.22 2.43 87.3 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.68 -0.511 . . . . 0.0 114.349 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.6 110.25 3.02 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.782 1.658 . . . . 0.0 109.888 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.75 137.59 74.82 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.13 2.553 . . . . 0.0 111.623 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -142.62 131.59 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.791 0.836 . . . . 0.0 109.759 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -82.29 147.07 29.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.474 1.51 . . . . 0.0 111.462 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.35 148.72 23.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.548 1.139 . . . . 0.0 109.222 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 t -78.15 -52.97 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 121.962 -0.461 . . . . 0.0 109.791 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.77 24.61 27.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.526 1.06 . . . . 0.0 112.096 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 52.5 -171.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.713 2.005 . . . . 0.0 113.38 -173.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -78.26 132.98 37.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.15 165.18 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -126.35 155.07 42.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.46 137.18 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.48 85.97 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 118.678 -1.068 . . . . 0.0 113.54 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.79 1.68 16.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.632 1.716 . . . . 0.0 113.907 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 54.39 65.62 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.287 1.035 . . . . 0.0 111.383 169.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.02 134.03 5.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.02 1.728 . . . . 0.0 112.651 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.04 154.63 26.86 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.491 2.794 . . . . 0.0 113.349 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -73.95 70.03 1.47 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.806 2.043 . . . . 0.0 109.676 169.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -62.95 167.24 4.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.418 1.487 . . . . 0.0 110.753 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -122.79 152.16 40.94 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.81 171.15 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.446 1.898 . . . . 0.0 107.38 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.4 mt -111.56 152.42 27.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -83.48 179.28 7.69 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.414 0.685 . . . . 0.0 109.608 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -51.01 -35.7 35.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.046 0.938 . . . . 0.0 110.454 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.9 m -101.55 16.15 26.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.549 1.54 . . . . 0.0 110.7 -170.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.2 mt 62.55 23.7 14.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.256 2.222 . . . . 0.0 113.628 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.35 142.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 169.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.22 142.19 47.31 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -147.73 155.4 41.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.5 p -139.69 168.3 20.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 47.0 tp -54.36 -42.52 70.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 169.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.33 -23.93 66.08 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.01 -31.67 64.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.836 0.743 . . . . 0.0 110.876 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 mtt -75.21 -35.9 61.44 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -53.67 151.45 6.09 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.902 0.858 . . . . 0.0 111.944 -171.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.7 57.23 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.005 1.288 . . . . 0.0 113.272 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -155.03 149.8 26.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.759 1.624 . . . . 0.0 107.27 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.5 t -58.23 136.69 21.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -130.68 145.58 51.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -140.96 137.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -138.97 133.09 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.2 m -119.98 150.77 39.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.84 136.96 53.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.3 pt -136.51 139.37 29.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.855 1.662 . . . . 0.0 107.911 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.27 -7.51 18.05 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.083 2.522 . . . . 0.0 112.888 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.0 m -160.87 177.33 10.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.601 2.36 . . . . 0.0 106.268 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.89 -14.3 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.36 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.52 -23.66 50.13 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.376 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -57.67 155.81 9.41 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.581 1.552 . . . . 0.0 111.887 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.97 -17.28 70.28 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.1 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.15 -24.33 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.603 1.702 . . . . 0.0 113.316 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 15.3 p -61.57 -29.17 69.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.269 0.94 . . . . 0.0 112.544 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.84 -34.61 30.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.034 -0.416 . . . . 0.0 110.137 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.05 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.602 0.761 . . . . 0.0 110.765 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -152.56 131.09 12.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.8 m 138.76 -56.75 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 1 C-N-CA 132.819 4.448 . . . . 0.0 105.52 169.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -60.25 -63.84 1.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.854 0.752 . . . . 0.0 110.993 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -65.06 -40.11 94.22 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.904 -0.497 . . . . 0.0 111.122 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -58.07 -50.34 73.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.07 0.548 . . . . 0.0 111.583 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.04 -37.51 87.69 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.276 0.63 . . . . 0.0 109.674 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -58.36 -51.14 71.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.477 0.711 . . . . 0.0 110.166 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.35 -38.21 74.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.806 0.442 . . . . 0.0 110.635 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.38 88.87 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.58 -0.7 . . . . 0.0 111.139 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.77 -19.64 62.71 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.981 0.81 . . . . 0.0 112.62 173.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -76.7 -34.73 58.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 110.839 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.37 -40.62 91.47 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.407 0.683 . . . . 0.0 109.949 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.14 -170.64 43.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -75.57 38.22 0.15 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 111.861 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.91 144.45 14.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 O-C-N 120.853 -1.154 . . . . 0.0 109.806 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -73.15 141.26 47.43 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.05 128.7 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -136.8 155.19 50.14 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.662 0.664 . . . . 0.0 111.531 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -125.5 97.84 5.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.98 122.63 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -109.49 164.72 12.25 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.002 1.321 . . . . 0.0 109.206 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.16 176.04 3.49 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 110.295 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.21 -27.84 68.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.239 0.616 . . . . 0.0 111.734 171.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.6 mt -47.77 106.63 0.62 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.01 1.724 . . . . 0.0 110.398 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.1 1.52 7.27 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.094 2.529 . . . . 0.0 113.501 -169.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -43.7 -35.02 1.66 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.645 1.978 . . . . 0.0 115.588 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.1 31.38 0.93 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.767 -0.635 . . . . 0.0 110.917 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -61.65 -30.66 70.86 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 120.785 1.63 . . . . 0.0 111.997 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.87 -19.17 62.35 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.727 1.211 . . . . 0.0 113.994 172.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -67.54 -35.95 80.05 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 110.355 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER 30.84 52.89 0.15 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.045 2.138 . . . . 0.0 113.049 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p -52.97 -37.47 61.21 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.549 -0.719 . . . . 0.0 112.681 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.96 -16.36 59.47 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.312 -0.715 . . . . 0.0 114.308 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.23 -15.91 15.85 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 112.412 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -75.05 94.49 2.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.652 0.66 . . . . 0.0 111.246 -169.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.73 -20.05 2.19 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.609 1.576 . . . . 0.0 111.105 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.6 92.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.516 1.527 . . . . 0.0 107.973 -172.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.61 -33.89 7.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.299 1.84 . . . . 0.0 113.988 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.84 -20.06 65.86 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.479 1.111 . . . . 0.0 113.717 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.89 152.81 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.168 0.895 . . . . 0.0 108.945 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -129.34 146.24 51.25 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.0 m -97.26 135.11 39.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.98 162.98 16.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.988 1.715 . . . . 0.0 108.089 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -138.28 44.25 2.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.41 1.484 . . . . 0.0 109.573 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.12 -44.08 7.37 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.516 1.127 . . . . 0.0 112.848 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -59.97 -14.72 17.27 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -76.31 -6.71 52.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.077 -1.015 . . . . 0.0 112.416 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -139.07 -41.31 0.47 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.39 1.476 . . . . 0.0 111.294 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.4 tpt 78.34 2.1 2.69 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.149 2.98 . . . . 0.0 113.667 169.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 m -63.94 -46.51 84.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.852 1.66 . . . . 0.0 111.471 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.89 -39.56 89.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.227 1.376 . . . . 0.0 109.307 172.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.2 -53.69 18.31 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.41 1.957 . . . . 0.0 113.255 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.98 -34.89 50.69 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.989 0.516 . . . . 0.0 110.433 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.57 -39.54 93.93 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.217 0.607 . . . . 0.0 111.587 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -97.98 3.03 49.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.053 1.341 . . . . 0.0 110.31 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 60.79 8.4 10.12 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.348 1.452 . . . . 0.0 114.826 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 m -63.62 -23.04 32.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 C-N-CA 125.902 1.681 . . . . 0.0 110.94 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.38 118.51 4.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.43 HG23 ' H ' ' A' ' 124' ' ' LEU . 47.2 mm -87.47 124.12 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -61.35 -53.15 60.31 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.466 1.506 . . . . 0.0 110.718 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.97 -49.47 11.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.039 0.447 . . . . 0.0 110.5 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.43 ' H ' HG23 ' A' ' 121' ' ' ILE . 29.4 tp -72.83 -23.11 60.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.508 1.123 . . . . 0.0 112.779 -171.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 51.17 50.28 19.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 110.768 -169.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.5 mt -138.12 -173.25 3.47 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -113.24 146.69 38.91 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.199 1.0 . . . . 0.0 111.327 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.61 140.86 57.96 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.919 1.688 . . . . 0.0 113.805 -169.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -65.87 110.86 3.02 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 p -156.13 168.22 27.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.454 0.57 . . . . 0.0 111.166 -170.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.04 148.26 18.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.92 1.288 . . . . 0.0 108.129 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -145.7 154.5 42.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.503 1.121 . . . . 0.0 109.296 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.91 139.87 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -132.21 141.02 48.91 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.009 1.323 . . . . 0.0 108.233 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.39 162.43 20.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.351 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.5 -32.63 41.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.901 1.281 . . . . 0.0 113.228 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -80.25 -10.32 59.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.7 -2.71 49.08 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.388 0.994 . . . . 0.0 113.605 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.85 137.94 58.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.55 1.675 . . . . 0.0 108.753 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 129.46 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 80.6 t -113.26 -20.79 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.825 2.05 . . . . 0.0 109.541 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -143.84 148.34 35.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.351 1.06 . . . . 0.0 108.194 169.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.75 132.18 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.513 1.525 . . . . 0.0 107.701 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -149.77 147.59 28.19 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.662 1.185 . . . . 0.0 108.444 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.12 116.07 14.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.47 134.69 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 m -58.95 -18.68 35.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.154 0.982 . . . . 0.0 112.956 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -140.04 122.5 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.2 p -83.16 14.87 3.16 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.654 1.115 . . . . 0.0 111.983 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -125.77 -177.06 3.79 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.567 1.947 . . . . 0.0 108.91 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -137.78 151.5 70.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.244 1.418 . . . . 0.0 109.901 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.96 170.75 7.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.67 2.913 . . . . 0.0 111.606 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -77.33 87.1 3.73 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -68.32 1.12 3.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.3 1.44 . . . . 0.0 114.118 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -31.63 72.47 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -62.02 -53.07 62.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.324 1.049 . . . . 0.0 111.801 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -65.83 -31.26 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.742 1.658 . . . . 0.0 112.422 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.6 mm -58.3 -48.89 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.131 1.332 . . . . 0.0 109.35 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.17 -33.47 76.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.821 0.737 . . . . 0.0 110.81 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.28 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.734 0.414 . . . . 0.0 111.192 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.77 -49.51 65.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.895 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -63.64 -30.46 71.57 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.94 69.35 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.442 1.019 . . . . 0.0 111.835 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.19 -45.77 17.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.147 0.579 . . . . 0.0 111.478 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.74 -46.69 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.235 0.614 . . . . 0.0 111.024 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.5 tttm . . . . . 0 C--O 1.248 0.985 0 C-N-CA 124.401 1.081 . . . . 0.0 109.903 -179.706 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.55 58.17 2.63 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.31 1.053 . . . . 0.0 109.961 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -148.41 140.64 24.14 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.76 -178.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -115.19 147.67 40.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -134.18 120.67 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 43.83 39.69 2.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.053 1.341 . . . . 0.0 111.916 -173.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.57 12.6 79.96 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.74 117.44 3.95 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.174 -1.348 . . . . 0.0 109.846 173.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.21 139.34 89.74 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.342 2.695 . . . . 0.0 112.222 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.66 130.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.225 1.41 . . . . 0.0 109.889 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -75.63 161.67 28.91 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.351 1.86 . . . . 0.0 110.462 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.68 160.0 19.09 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.31 1.444 . . . . 0.0 110.173 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.78 -59.71 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.837 -0.539 . . . . 0.0 111.242 -169.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.2 32.61 6.94 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.397 0.998 . . . . 0.0 113.439 -169.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.43 -167.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.54 107.07 17.89 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.482 1.513 . . . . 0.0 109.748 -169.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.41 145.75 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -143.52 160.79 39.97 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.595 0.758 . . . . 0.0 109.028 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.75 134.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.31 3.37 89.81 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.796 -1.002 . . . . 0.0 113.988 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.03 -7.02 59.47 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.463 1.631 . . . . 0.0 112.298 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 58.07 178.18 0.06 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.369 1.467 . . . . 0.0 111.516 -169.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.09 24.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.792 1.637 . . . . 0.0 108.729 -171.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.18 158.04 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.708 2.272 . . . . 0.0 109.907 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.41 68.82 7.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.378 1.471 . . . . 0.0 110.538 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -63.1 163.25 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.977 171.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.5 m -121.79 148.95 44.01 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -152.66 167.67 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.106 2.162 . . . . 0.0 105.76 -173.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.49 156.05 29.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 120.787 -1.195 . . . . 0.0 108.231 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.3 p -81.36 173.59 12.32 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.767 1.227 . . . . 0.0 110.016 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -63.77 -26.71 68.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.933 -1.104 . . . . 0.0 110.798 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 p -77.54 1.43 19.49 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.512 1.525 . . . . 0.0 111.94 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt 56.94 47.78 17.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.968 2.107 . . . . 0.0 111.986 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.01 141.96 47.43 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -64.52 144.09 57.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.464 1.105 . . . . 0.0 109.485 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -146.52 157.66 43.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.499 2.32 . . . . 0.0 105.477 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 p -146.62 167.82 22.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.5 tp -53.83 -43.78 69.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.37 66.52 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.85 -30.6 58.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.878 0.763 . . . . 0.0 111.114 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.3 mtt -73.88 -39.69 63.74 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.388 1.075 . . . . 0.0 110.945 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -53.56 140.91 27.13 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 109.862 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.6 -22.1 8.89 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.958 1.266 . . . . 0.0 112.738 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -148.36 152.83 37.71 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.888 1.275 . . . . 0.0 108.681 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.63 142.43 15.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.2 m -135.54 148.95 49.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.883 0.873 . . . . 0.0 109.036 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.4 mt -134.73 138.31 49.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.01 124.62 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 p -106.59 148.42 28.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 168.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.05 127.88 40.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.16 146.83 38.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 110.357 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.69 -39.69 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.072 1.848 . . . . 0.0 111.484 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.4 m -152.5 173.06 15.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 0.0 109.097 -169.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 pt -121.01 -29.8 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.51 1.124 . . . . 0.0 111.45 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.09 -11.64 31.75 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.537 0.735 . . . . 0.0 111.669 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -22.07 54.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.807 2.043 . . . . 0.0 112.532 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.23 -0.12 25.24 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.265 0.936 . . . . 0.0 112.942 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.55 -15.6 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 118.67 1.235 . . . . 0.0 112.856 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.3 m -54.95 -25.96 33.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.171 1.388 . . . . 0.0 113.289 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -124.58 32.24 5.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.142 1.377 . . . . 0.0 109.395 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.31 -166.98 2.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.414 1.486 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -43.57 -45.66 6.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.375 1.87 . . . . 0.0 113.938 -171.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 m -56.03 -42.36 76.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.279 1.4 . . . . 0.0 112.424 -169.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -65.94 -53.0 44.89 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.969 0.804 . . . . 0.0 110.398 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -64.69 -41.0 96.35 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.146 0.884 . . . . 0.0 111.146 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.2 -50.29 71.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.781 . . . . 0.0 110.269 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -62.56 -37.86 87.8 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.486 0.314 . . . . 0.0 110.692 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.76 -36.83 85.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.604 0.762 . . . . 0.0 110.695 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -74.82 -42.6 57.72 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.001 -1.062 . . . . 0.0 110.196 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.91 -49.35 66.11 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.82 1.248 . . . . 0.0 110.463 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.84 -12.56 25.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 0.0 113.563 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -108.36 -9.04 15.5 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 113.037 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.6 mt -64.96 -32.41 74.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.164 1.347 . . . . 0.0 110.584 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.08 -169.95 43.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.17 29.84 0.1 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.976 0.888 . . . . 0.0 112.451 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.72 149.76 3.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.68 -1.263 . . . . 0.0 110.34 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -71.78 141.18 49.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -142.55 131.55 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -139.01 156.67 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.841 0.856 . . . . 0.0 110.562 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.6 m -133.32 105.26 6.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.7 128.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 m -124.33 160.81 27.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.572 1.149 . . . . 0.0 109.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.46 -163.73 0.13 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.037 169.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -124.37 21.65 8.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.52 1.128 . . . . 0.0 111.02 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.91 154.18 77.33 Favored Pre-proline 0 CA--C 1.537 0.481 0 O-C-N 121.282 -0.886 . . . . 0.0 108.888 169.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.72 -32.11 53.73 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.711 2.274 . . . . 0.0 112.886 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -75.63 -3.82 36.61 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.578 1.551 . . . . 0.0 113.241 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.28 146.43 44.31 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.947 1.299 . . . . 0.0 109.907 -170.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 45.38 -9.19 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 130.293 3.437 . . . . 0.0 119.765 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.2 60.55 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 121.32 1.873 . . . . 0.0 114.391 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -124.54 3.05 8.33 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.278 1.431 . . . . 0.0 111.337 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.6 p90 35.36 42.85 0.12 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.409 2.284 . . . . 0.0 113.784 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.41 -30.5 71.61 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.92 -10.88 73.49 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.622 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.15 32.47 5.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 110.293 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -137.56 132.06 32.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.8 -9.57 65.18 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.683 0.658 . . . . 0.0 111.544 -169.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mt -134.87 76.8 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -51.7 -31.69 27.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.3 1.44 . . . . 0.0 114.821 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -63.9 -27.96 69.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.04 151.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -133.37 143.97 49.3 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 m -93.07 143.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.84 158.72 25.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.073 1.349 . . . . 0.0 108.753 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 m -128.88 67.02 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.997 2.119 . . . . 0.0 108.449 -169.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.0 -35.9 48.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.257 0.623 . . . . 0.0 112.219 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -11.37 49.49 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.961 -1.087 . . . . 0.0 113.591 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -76.95 -29.75 55.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.887 1.221 . . . . 0.0 111.545 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -149.01 88.58 1.61 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 4.83 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.262 1.425 . . . . 0.0 113.581 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.3 m -55.92 -42.57 76.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.92 1.236 . . . . 0.0 110.722 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.68 -48.92 79.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.636 1.107 . . . . 0.0 110.84 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.5 98.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 123.66 0.648 . . . . 0.0 111.992 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.77 -42.01 67.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.454 0.627 . . . . 0.0 110.323 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.58 86.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.348 1.059 . . . . 0.0 111.913 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -92.01 3.53 55.03 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.925 0.89 . . . . 0.0 111.22 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.94 -4.84 8.97 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.625 1.107 . . . . 0.0 115.057 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.9 m -66.99 -8.94 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.986 2.114 . . . . 0.0 112.212 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.03 109.59 3.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 124' ' ' LEU . 67.7 mt -66.88 127.87 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -66.49 -49.76 65.52 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.298 1.039 . . . . 0.0 110.636 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -76.74 -49.56 15.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' H ' HG22 ' A' ' 121' ' ' ILE . 17.8 tp -80.26 -17.61 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 50.0 48.78 21.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.662 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.8 tp -137.84 161.67 35.99 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 108.426 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -72.91 129.76 38.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 110.722 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.41 168.07 18.23 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.864 1.266 . . . . 0.0 113.634 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -91.67 115.21 27.86 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.108 1.363 . . . . 0.0 108.191 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.7 m -154.48 166.84 32.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.105 0.562 . . . . 0.0 109.672 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.38 146.86 18.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -148.36 156.66 42.79 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.066 1.347 . . . . 0.0 109.105 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.96 144.97 30.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.2 mp -132.46 139.68 48.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.345 1.058 . . . . 0.0 108.661 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.95 166.62 13.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.223 1.409 . . . . 0.0 110.038 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -52.49 -31.38 34.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.149 1.38 . . . . 0.0 112.393 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.05 2.25 27.95 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.566 1.147 . . . . 0.0 112.7 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.4 -5.94 75.03 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 120.966 -1.084 . . . . 0.0 112.959 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.38 126.47 27.46 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.638 1.219 . . . . 0.0 108.964 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.77 128.94 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 109.625 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.5 t -116.83 -17.46 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.391 1.876 . . . . 0.0 109.851 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -145.38 147.68 32.53 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.26 135.58 15.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.161 1.385 . . . . 0.0 108.481 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.42 149.49 30.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.811 0.844 . . . . 0.0 109.299 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.05 106.44 9.28 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.434 2.294 . . . . 0.0 104.922 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 t -69.3 134.53 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -60.95 -19.5 60.96 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.945 1.298 . . . . 0.0 113.855 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -138.77 127.77 23.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.82 39.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.2 p -98.57 -5.79 31.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.431 1.092 . . . . 0.0 112.048 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -83.57 -174.47 5.3 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.373 1.469 . . . . 0.0 109.347 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -135.6 154.22 78.09 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.641 1.176 . . . . 0.0 109.905 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.55 172.71 10.08 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.938 2.426 . . . . 0.0 109.768 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -69.23 120.58 15.29 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 168.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -93.45 -2.49 54.47 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -76.02 -34.93 59.71 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.25 -54.36 55.58 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.766 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.65 -35.47 58.26 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.883 1.708 . . . . 0.0 111.885 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 mm -61.38 -50.39 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.465 1.029 . . . . 0.0 109.736 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.14 -36.95 84.49 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.986 0.812 . . . . 0.0 110.219 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.44 92.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.056 0.543 . . . . 0.0 111.068 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.43 -50.28 27.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.488 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.74 -27.24 69.07 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.235 1.38 . . . . 0.0 111.469 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.8 -31.68 68.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.668 1.122 . . . . 0.0 112.02 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.42 -44.21 36.91 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.193 0.597 . . . . 0.0 110.873 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.85 -48.42 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.365 0.666 . . . . 0.0 110.689 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 124.873 1.269 . . . . 0.0 110.031 179.742 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.867 0.365 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.7 44.6 2.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.075 1.75 . . . . 0.0 109.323 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -63.29 155.52 28.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.79 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.46 179.58 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.723 0.809 . . . . 0.0 109.933 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.18 150.85 42.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -137.25 -84.26 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.455 1.025 . . . . 0.0 109.818 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.4 43.34 0.54 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.064 1.346 . . . . 0.0 110.97 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.78 70.52 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.261 0.934 . . . . 0.0 112.141 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 152.64 24.75 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.33 145.6 34.45 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.872 2.382 . . . . 0.0 110.65 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.97 139.04 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.53 1.132 . . . . 0.0 109.798 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -79.14 158.78 27.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.038 1.735 . . . . 0.0 110.038 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.93 149.77 43.82 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.05 1.74 . . . . 0.0 107.441 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.1 t -80.25 -83.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 118.364 0.529 . . . . 0.0 110.54 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 41.54 2.61 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.447 1.498 . . . . 0.0 111.908 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -60.84 171.66 1.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.648 1.979 . . . . 0.0 114.098 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 68.25 34.88 3.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.239 1.816 . . . . 0.0 113.82 169.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.91 142.99 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -151.11 162.09 41.51 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.428 0.691 . . . . 0.0 109.392 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.54 133.96 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.505 0.722 . . . . 0.0 109.76 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.67 1.74 90.57 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.156 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.11 -8.91 58.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.923 1.862 . . . . 0.0 112.297 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 57.35 174.39 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.755 1.622 . . . . 0.0 111.322 -169.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.43 139.98 26.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.111 1.364 . . . . 0.0 109.001 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.81 -27.91 80.12 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.205 2.604 . . . . 0.0 114.853 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 t70 84.39 116.25 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.284 2.634 . . . . 0.0 106.934 -169.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -131.22 161.74 31.55 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.856 1.263 . . . . 0.0 110.451 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -96.56 157.98 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.06 171.38 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.029 2.532 . . . . 0.0 106.641 172.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 tp -129.2 134.21 47.91 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.0 p -73.49 164.96 25.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -64.26 -13.83 51.94 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.758 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 m -83.25 1.07 42.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.452 1.501 . . . . 0.0 112.04 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp 57.31 53.12 7.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.797 2.039 . . . . 0.0 111.602 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.3 141.45 52.06 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.178 0.991 . . . . 0.0 108.433 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.22 143.53 40.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.16 0.981 . . . . 0.0 109.195 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -149.56 159.91 43.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.877 2.471 . . . . 0.0 105.039 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.0 m -142.32 163.78 31.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 tp -53.72 -38.11 63.97 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.321 -0.237 . . . . 0.0 110.659 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.66 -23.64 64.96 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.71 -32.23 57.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.937 0.789 . . . . 0.0 110.951 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.5 mtt -72.71 -38.31 67.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.378 1.071 . . . . 0.0 110.694 176.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -53.24 142.34 21.22 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.63 0.772 . . . . 0.0 109.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.32 -20.74 8.34 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.413 1.483 . . . . 0.0 112.293 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -150.16 154.69 38.45 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.197 1.399 . . . . 0.0 108.797 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.89 138.19 19.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 m -133.44 142.81 48.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.19 132.69 49.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -138.91 121.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.17 150.97 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.21 134.25 61.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.67 152.15 58.91 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.67 -46.94 4.47 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.446 1.431 . . . . 0.0 110.341 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.1 m -144.29 173.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 108.931 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.42 -26.27 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.13 -32.53 73.12 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 112.158 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -65.97 133.63 51.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.991 0.916 . . . . 0.0 109.888 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.0 -21.95 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.412 1.006 . . . . 0.0 114.476 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.85 -15.49 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.653 1.226 . . . . 0.0 112.262 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -26.84 57.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.332 0.969 . . . . 0.0 111.708 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -125.21 -34.93 2.68 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.775 1.23 . . . . 0.0 110.782 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.23 66.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.214 0.605 . . . . 0.0 112.081 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.97 -41.71 0.31 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.469 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . 0.252 3.4 m -65.54 -37.17 85.94 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -167.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -64.77 -53.7 42.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.014 1.279 . . . . 0.0 110.407 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -66.04 -42.27 89.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.368 0.531 . . . . 0.0 111.607 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.53 -50.43 73.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.719 0.808 . . . . 0.0 110.284 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -64.25 -38.19 90.17 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.833 0.288 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.15 -47.42 83.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.094 0.958 . . . . 0.0 110.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -70.04 -44.87 68.35 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.435 0.561 . . . . 0.0 110.525 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.29 79.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.725 0.693 . . . . 0.0 111.134 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.54 -14.57 43.54 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -102.92 -15.37 16.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.489 1.516 . . . . 0.0 112.02 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.67 -37.71 79.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.638 1.108 . . . . 0.0 110.718 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.57 -167.89 40.64 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.07 25.13 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.843 -0.798 . . . . 0.0 112.829 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -53.51 151.37 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.329 1.452 . . . . 0.0 111.449 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -77.08 139.62 40.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.13 123.3 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -139.47 156.48 46.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.181 0.592 . . . . 0.0 110.755 -175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -131.41 116.56 17.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.61 140.67 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.272 1.029 . . . . 0.0 108.27 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 m -140.99 175.38 9.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.313 1.445 . . . . 0.0 112.054 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.26 -176.94 6.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.924 1.29 . . . . 0.0 113.646 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.31 -28.0 68.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.325 1.85 . . . . 0.0 113.711 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.5 148.93 63.47 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.928 0.891 . . . . 0.0 111.194 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.66 -36.04 65.96 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.745 1.63 . . . . 0.0 110.438 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -61.85 -5.93 2.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.968 1.707 . . . . 0.0 113.311 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.14 3.71 12.02 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.956 1.702 . . . . 0.0 111.44 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -138.83 21.41 2.66 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.405 1.002 . . . . 0.0 111.786 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.74 175.21 10.34 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.892 1.677 . . . . 0.0 108.437 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 73.56 -20.52 0.29 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.243 2.617 . . . . 0.0 113.488 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 36.05 47.6 0.45 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.014 2.526 . . . . 0.0 115.633 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.3 m -52.11 -34.89 46.27 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -171.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.41 -8.31 64.35 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.602 -1.11 . . . . 0.0 113.918 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.83 29.19 3.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.03 1.415 . . . . 0.0 111.546 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -135.88 69.21 1.43 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.593 1.157 . . . . 0.0 108.131 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.7 -27.04 0.26 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.357 0.98 . . . . 0.0 111.641 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 98.61 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.759 1.624 . . . . 0.0 106.867 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.83 -28.69 57.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.994 1.718 . . . . 0.0 114.267 -169.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -61.69 -32.12 72.29 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.12 0.568 . . . . 0.0 112.49 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.08 152.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.89 145.97 42.79 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -88.52 138.47 31.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.0 mp -128.64 167.63 16.92 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.085 2.154 . . . . 0.0 106.973 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.2 m -146.83 172.37 13.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.248 1.419 . . . . 0.0 107.585 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.81 2.6 3.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.429 0.633 . . . . 0.0 111.534 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -16.59 1.1 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -30.99 72.02 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.377 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -153.42 -7.48 0.17 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 tpt 56.45 27.6 12.39 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.182 1.393 . . . . 0.0 111.377 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.8 t -63.46 -62.36 1.72 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.542 1.537 . . . . 0.0 109.732 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -59.86 -38.93 83.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.9 0.48 . . . . 0.0 110.464 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.11 -56.66 13.51 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.619 2.057 . . . . 0.0 112.12 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.73 -36.73 62.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.686 0.743 . . . . 0.0 110.343 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.08 98.25 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.208 0.603 . . . . 0.0 111.773 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -102.23 3.84 38.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.297 1.039 . . . . 0.0 110.672 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.81 5.0 29.44 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 118.35 -1.25 . . . . 0.0 114.677 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.43 -13.68 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 119.139 1.47 . . . . 0.0 111.161 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.37 102.41 0.68 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.434 HG23 ' H ' ' A' ' 124' ' ' LEU . 81.3 mt -63.17 124.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -64.99 -45.37 85.88 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.958 0.903 . . . . 0.0 110.978 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.32 -49.45 12.42 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.917 0.326 . . . . 0.0 110.669 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.434 ' H ' HG23 ' A' ' 121' ' ' ILE . 15.0 tp -81.59 -14.21 57.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -170.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 47.84 48.38 17.71 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.06 1.344 . . . . 0.0 110.58 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.24 25.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.827 0.851 . . . . 0.0 108.843 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 129.22 37.34 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.08 160.68 26.15 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 111.646 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 104.63 16.61 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -145.74 163.17 35.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.596 0.759 . . . . 0.0 108.959 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.27 145.11 18.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -145.32 154.96 42.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 109.321 -169.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.82 136.54 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 171.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.31 139.63 51.7 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.868 1.267 . . . . 0.0 108.013 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 165.22 11.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.077 1.351 . . . . 0.0 110.245 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.6 -34.35 25.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.22 1.408 . . . . 0.0 112.816 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.8 12.1 20.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.059 0.943 . . . . 0.0 113.113 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.46 -6.17 82.8 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.451 1.024 . . . . 0.0 113.132 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 138.55 58.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.57 1.185 . . . . 0.0 109.518 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.89 133.18 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.17 -25.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.928 1.291 . . . . 0.0 109.91 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -150.59 151.8 33.11 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.51 138.41 16.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.578 1.551 . . . . 0.0 107.916 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -147.5 148.33 31.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.763 0.825 . . . . 0.0 108.824 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -127.43 112.54 15.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 t -66.88 133.11 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -60.58 -16.13 34.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.562 1.145 . . . . 0.0 112.66 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -139.33 111.67 7.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.36 -18.23 64.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -174.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.6 p -83.58 9.39 11.56 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.136 0.974 . . . . 0.0 110.976 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -132.68 174.02 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.231 2.612 . . . . 0.0 108.12 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -122.83 158.64 56.53 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.749 1.219 . . . . 0.0 111.553 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.75 179.34 3.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.206 2.604 . . . . 0.0 110.225 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -80.35 85.5 5.82 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -67.61 -0.46 3.94 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.438 1.495 . . . . 0.0 113.114 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.67 -25.8 49.82 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.169 -0.957 . . . . 0.0 109.364 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.53 -52.65 72.62 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.476 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.95 -33.73 73.62 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.585 1.602 . . . . 0.0 112.573 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 mm -59.79 -47.2 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.708 1.14 . . . . 0.0 109.525 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.66 -35.63 81.19 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.326 0.967 . . . . 0.0 110.931 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.76 -42.17 97.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.227 0.211 . . . . 0.0 110.801 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -40.23 80.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.321 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -57.53 -42.3 82.62 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.448 1.022 . . . . 0.0 110.242 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.31 -31.66 69.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.149 0.431 . . . . 0.0 111.965 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.75 -55.44 5.64 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.247 0.476 . . . . 0.0 110.745 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.19 -51.95 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 111.177 -169.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 21.1 pttm . . . . . 0 C--O 1.25 1.128 0 C-N-CA 127.792 2.437 . . . . 0.0 112.219 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.99 117.56 2.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.823 1.249 . . . . 0.0 110.009 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -154.94 140.81 18.21 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.21 -175.22 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.161 1.384 . . . . 0.0 107.606 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -123.17 160.39 26.61 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -147.71 127.11 13.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 169.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 43.33 39.68 2.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.942 1.297 . . . . 0.0 112.908 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.24 15.27 74.76 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.167 0.889 . . . . 0.0 114.674 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.49 120.74 4.52 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.22 142.95 86.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.93 2.42 . . . . 0.0 111.259 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.43 135.02 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.231 1.013 . . . . 0.0 109.5 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -76.55 164.35 26.02 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.828 2.051 . . . . 0.0 109.261 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.83 165.15 23.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.869 0.868 . . . . 0.0 109.829 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.6 134.83 57.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.809 1.644 . . . . 0.0 107.207 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.2 -12.57 63.61 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.122 0.868 . . . . 0.0 114.002 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 53.26 164.92 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.354 3.061 . . . . 0.0 115.375 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -67.03 164.88 16.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.215 1.006 . . . . 0.0 113.319 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.69 166.26 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 126.607 1.963 . . . . 0.0 106.589 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -149.15 165.59 31.35 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.695 0.798 . . . . 0.0 109.061 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -52.26 131.72 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 122.76 0.424 . . . . 0.0 109.893 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.84 71.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.654 1.121 . . . . 0.0 113.322 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.01 -10.78 59.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.329 1.565 . . . . 0.0 114.113 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 62.39 104.42 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.919 1.688 . . . . 0.0 112.5 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.13 134.57 68.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.523 1.129 . . . . 0.0 111.833 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.44 -27.01 83.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.541 2.827 . . . . 0.0 115.392 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.78 112.44 0.05 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.954 2.502 . . . . 0.0 111.34 -169.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -143.27 168.88 18.73 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.477 1.511 . . . . 0.0 109.73 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 159.58 33.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.089 1.755 . . . . 0.0 111.592 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.79 178.14 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 129.184 2.994 . . . . 0.0 105.833 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.85 133.54 53.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -79.81 -176.8 5.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.309 0.576 . . . . 0.0 110.413 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -46.94 -36.57 7.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.752 1.221 . . . . 0.0 111.722 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m -111.73 20.67 16.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.318 1.447 . . . . 0.0 110.556 -171.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.9 mt 56.24 32.59 20.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.96 2.104 . . . . 0.0 113.265 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.61 142.99 46.54 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.13 57.61 3.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.87 1.268 . . . . 0.0 110.136 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -59.54 158.21 10.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 108.107 169.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -137.57 166.76 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.89 -30.6 64.05 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.014 -0.429 . . . . 0.0 111.527 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.99 -20.99 64.47 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.626 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.06 -28.86 43.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.271 0.941 . . . . 0.0 110.754 172.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 mtt -71.38 -39.11 71.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.056 0.942 . . . . 0.0 110.497 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.47 135.39 39.8 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.86 -26.52 3.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.17 1.367 . . . . 0.0 112.169 -171.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -151.28 159.86 44.11 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.337 1.055 . . . . 0.0 109.722 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.9 t -58.48 136.67 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 170.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 45.8 m -136.96 148.74 47.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.952 1.301 . . . . 0.0 108.295 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 94.7 mt -133.63 135.45 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -136.96 104.79 3.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 149.6 25.5 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.5 t -136.85 141.25 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.99 154.51 54.9 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.299 1.04 . . . . 0.0 111.205 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -76.09 -50.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.775 1.65 . . . . 0.0 108.316 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -159.95 170.25 21.76 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.54 -7.13 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.991 1.717 . . . . 0.0 109.783 168.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -51.74 -26.13 8.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.394 1.877 . . . . 0.0 113.141 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 p -61.49 -9.57 5.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.813 2.045 . . . . 0.0 113.156 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.72 16.38 75.52 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.183 0.901 . . . . 0.0 112.124 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.17 -7.33 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.547 1.539 . . . . 0.0 113.165 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 91.9 m -47.99 -30.0 3.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.557 1.543 . . . . 0.0 114.405 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.91 -30.23 70.79 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.22 8.81 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.517 ' HG3' ' H ' ' A' ' 65' ' ' ARG . 4.6 pt20 -66.57 -169.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -42.96 -24.55 0.07 Allowed 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 127.392 2.277 . . . . 0.0 113.092 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.517 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 13.7 tpt180 -43.52 -50.93 7.03 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.934 1.294 . . . . 0.0 111.073 169.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -60.76 -50.11 74.78 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.06 0.846 . . . . 0.0 109.589 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -60.21 -47.02 87.74 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.3 -40.31 77.59 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.153 1.781 . . . . 0.0 110.255 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -69.23 -33.3 73.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.98 1.312 . . . . 0.0 110.817 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -72.34 -45.78 58.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.047 0.839 . . . . 0.0 109.675 169.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.66 -44.36 90.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.824 1.249 . . . . 0.0 111.882 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.52 -20.98 63.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 112.441 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -84.85 -16.73 40.3 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.314 0.961 . . . . 0.0 112.805 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.19 -29.95 69.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.629 1.104 . . . . 0.0 112.237 -169.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.26 -162.03 35.19 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.86 17.73 0.16 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.731 1.212 . . . . 0.0 112.509 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 m -55.42 145.38 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.601 1.561 . . . . 0.0 110.855 -172.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -71.38 138.88 49.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.45 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -127.44 153.22 46.55 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.889 0.875 . . . . 0.0 109.575 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -128.52 116.54 19.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.9 mt -99.72 140.17 19.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -140.25 173.18 11.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.124 0.97 . . . . 0.0 111.663 -171.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.7 168.3 20.32 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 167.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -70.45 -10.51 59.34 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.452 -0.78 . . . . 0.0 112.923 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.4 tp -52.53 134.51 44.21 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.058 1.343 . . . . 0.0 110.709 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.8 -41.02 77.85 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.159 2.573 . . . . 0.0 112.464 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -82.86 26.81 0.57 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.732 1.213 . . . . 0.0 112.305 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.78 -3.62 5.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.822 1.649 . . . . 0.0 109.485 168.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -77.93 89.03 4.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.456 1.122 . . . . 0.0 108.358 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.04 -9.74 2.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.511 1.924 . . . . 0.0 115.148 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.0 ttm-85 -53.76 -23.09 10.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.727 1.603 . . . . 0.0 111.616 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 -27.96 66.09 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.773 0.715 . . . . 0.0 112.074 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.0 m -146.2 -69.21 0.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.516 1.126 . . . . 0.0 111.223 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.3 -33.25 15.49 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 127.494 2.473 . . . . 0.0 115.6 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.49 18.97 5.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.156 1.382 . . . . 0.0 110.834 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -80.55 140.55 35.75 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.123 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -49.29 2.97 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.143 0.878 . . . . 0.0 112.184 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 pt -76.11 67.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 125.663 1.585 . . . . 0.0 109.859 169.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.79 -22.63 3.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.986 2.514 . . . . 0.0 114.319 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -59.58 -38.26 80.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.625 0.77 . . . . 0.0 111.547 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 t -69.42 141.26 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.41 144.78 47.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.7 m -98.95 135.45 40.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.47 164.48 21.81 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 128.194 2.598 . . . . 0.0 106.55 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.0 m -131.27 167.46 19.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -138.79 -26.51 0.86 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.459 -0.781 . . . . 0.0 112.506 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -51.81 -29.91 21.1 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -63.81 -24.64 67.84 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.53 -0.731 . . . . 0.0 112.919 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -122.56 -26.37 4.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.538 1.135 . . . . 0.0 111.688 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.1 tpt 65.67 2.66 2.16 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.566 3.146 . . . . 0.0 114.293 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -72.4 -39.47 67.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.562 -1.209 . . . . 0.0 112.433 -170.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.35 -39.5 94.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.683 1.583 . . . . 0.0 109.501 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.46 -48.24 77.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 124.253 0.93 . . . . 0.0 111.116 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.9 -46.05 76.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 117.876 0.838 . . . . 0.0 110.175 174.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.92 68.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.39 1.076 . . . . 0.0 113.355 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.84 3.69 22.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.372 1.069 . . . . 0.0 111.545 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.53 31.01 77.42 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 119.531 1.059 . . . . 0.0 112.767 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.63 -2.78 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -70.79 105.56 3.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.62 133.1 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -72.65 -50.45 24.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.253 0.621 . . . . 0.0 110.191 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.94 -56.32 4.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.929 0.492 . . . . 0.0 110.767 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.0 tp -68.8 -21.09 64.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.399 0.68 . . . . 0.0 111.912 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 52.79 42.57 31.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.559 1.543 . . . . 0.0 112.19 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.72 170.51 14.24 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.718 1.207 . . . . 0.0 108.234 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.7 134.94 46.62 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.37 41.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.333 0.653 . . . . 0.0 111.262 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -72.78 124.16 24.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.1 m -164.31 169.91 16.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.373 1.069 . . . . 0.0 108.221 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.38 147.95 18.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.75 156.74 45.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.562 1.545 . . . . 0.0 108.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.77 142.47 42.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 tp -137.27 127.65 26.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.726 1.211 . . . . 0.0 109.412 -168.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 168.38 17.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.466 1.106 . . . . 0.0 111.14 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -57.67 -26.17 61.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.858 1.663 . . . . 0.0 113.296 -173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.18 35.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.496 1.518 . . . . 0.0 111.418 -176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.62 10.01 53.89 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 121.258 -0.901 . . . . 0.0 112.847 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -75.43 114.6 14.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.706 1.753 . . . . 0.0 107.937 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.04 129.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.24 -11.53 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.319 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -150.6 151.0 31.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.0 133.99 13.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.187 1.795 . . . . 0.0 106.397 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -144.98 138.19 26.62 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.22 114.82 23.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.66 144.49 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.6 m -59.32 -23.27 62.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 111.759 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -145.77 126.31 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 5.61 1.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.294 1.438 . . . . 0.0 114.385 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -114.77 24.37 11.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.336 1.454 . . . . 0.0 109.693 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -138.25 162.74 33.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 129.317 3.047 . . . . 0.0 106.377 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -115.44 153.7 47.65 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 119.764 1.166 . . . . 0.0 113.022 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.07 179.18 6.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.065 3.177 . . . . 0.0 111.576 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -65.44 152.69 43.34 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.173 0.589 . . . . 0.0 110.101 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -109.78 -3.11 16.93 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.152 0.981 . . . . 0.0 112.149 -171.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -128.71 -40.81 1.53 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.803 0.729 . . . . 0.0 110.719 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -55.11 -46.19 99.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.136 -1.411 . . . . 0.0 112.159 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.69 -34.17 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.832 1.69 . . . . 0.0 112.515 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.07 -46.51 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.523 1.056 . . . . 0.0 109.742 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.95 -38.79 92.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.67 0.788 . . . . 0.0 110.011 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.17 96.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.1 66.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.912 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -55.85 -40.02 72.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.006 0.821 . . . . 0.0 110.692 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.65 67.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.235 0.614 . . . . 0.0 111.843 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.34 -48.79 9.34 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 122.951 0.5 . . . . 0.0 111.572 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.89 -49.68 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.818 . . . . 0.0 110.073 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 78.7 tttt . . . . . 0 C--O 1.249 1.065 0 C-N-CA 127.791 2.436 . . . . 0.0 111.04 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 ttp . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.82 122.16 21.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.2 144.29 24.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.0 pt -139.54 -177.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -115.83 153.55 31.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.13 110.69 9.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt 41.49 45.18 2.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.317 1.847 . . . . 0.0 111.974 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.75 -10.79 62.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.29 0.876 . . . . 0.0 115.29 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.47 120.38 6.45 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.031 -1.427 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.86 139.43 84.1 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.191 2.594 . . . . 0.0 112.113 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 m -145.94 159.62 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.18 1.392 . . . . 0.0 110.117 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.5 m -110.88 162.22 15.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.387 1.475 . . . . 0.0 109.461 -170.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.36 139.26 50.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 109.348 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.61 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.951 0.901 . . . . 0.0 110.784 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.47 71.37 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.984 0.802 . . . . 0.0 113.877 -171.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 52.89 -176.47 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.431 2.693 . . . . 0.0 116.907 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -68.01 111.25 4.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.528 1.931 . . . . 0.0 112.742 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -73.46 152.76 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 168.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -134.32 160.53 37.65 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -58.91 136.49 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.18 -4.17 85.99 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.81 1.195 . . . . 0.0 113.796 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.25 -9.35 59.18 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.72 1.76 . . . . 0.0 114.216 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 67.51 122.77 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.665 1.986 . . . . 0.0 111.838 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.01 127.77 91.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.702 -1.142 . . . . 0.0 108.069 173.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.62 -46.78 13.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.635 2.223 . . . . 0.0 113.846 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 t70 128.52 122.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 131.329 3.851 . . . . 0.0 105.554 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -146.96 169.18 19.71 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.273 1.429 . . . . 0.0 108.509 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.9 m -123.57 151.6 42.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 m -139.75 174.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 128.051 2.54 . . . . 0.0 106.548 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.91 153.16 40.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.4 p -80.49 176.9 9.37 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.495 1.118 . . . . 0.0 110.091 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.2 -26.49 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.022 -1.049 . . . . 0.0 110.891 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -79.14 0.57 27.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 111.863 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt 51.79 51.07 17.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.627 1.971 . . . . 0.0 111.985 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.16 141.94 47.96 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -70.08 148.1 49.18 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.612 1.165 . . . . 0.0 110.546 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -153.35 153.72 33.12 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.573 2.349 . . . . 0.0 105.488 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -137.54 164.83 27.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.926 0.785 . . . . 0.0 109.475 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.1 tp -49.89 -41.29 45.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 110.961 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.11 -18.61 65.45 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.53 -29.67 56.82 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.721 0.691 . . . . 0.0 110.949 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.5 mtt -74.84 -42.44 57.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.454 1.102 . . . . 0.0 110.364 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 144.62 24.33 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.432 0.693 . . . . 0.0 110.166 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.72 -17.55 22.95 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.766 1.175 . . . . 0.0 112.879 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -146.65 155.2 42.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.945 1.298 . . . . 0.0 108.874 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.42 141.23 16.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.5 m -134.7 146.74 49.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.088 0.955 . . . . 0.0 108.599 -174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.41 133.62 57.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.0 mt -138.82 131.0 37.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.98 143.35 46.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 169.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.72 137.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -141.9 156.8 65.36 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 108.032 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.54 -49.33 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 120.87 1.047 . . . . 0.0 109.448 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.0 m -162.53 144.93 10.89 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 120.931 -1.106 . . . . 0.0 109.967 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.67 -28.26 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 122.924 0.49 . . . . 0.0 111.251 170.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.22 -25.61 48.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.456 1.102 . . . . 0.0 113.55 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 79.7 p -64.09 -24.99 67.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.34 -4.12 74.06 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.772 -1.016 . . . . 0.0 112.712 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.86 -28.27 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.112 1.956 . . . . 0.0 110.008 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.5 p -57.89 -33.95 69.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.997 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.26 -33.56 24.01 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.92 0.782 . . . . 0.0 110.693 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.97 70.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.307 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.85 -49.06 0.19 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -54.38 -48.71 71.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -167.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -4.63 12.53 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.61 -39.88 2.82 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 123.861 0.864 . . . . 0.0 109.161 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.43 -47.47 72.8 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.712 0.805 . . . . 0.0 110.751 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -67.05 -31.21 71.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.797 0.439 . . . . 0.0 111.984 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -70.65 -51.46 27.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.4 -41.55 89.68 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.145 0.578 . . . . 0.0 110.181 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.02 75.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.164 0.986 . . . . 0.0 110.613 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.48 66.47 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -72.84 -27.81 62.16 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.802 1.183 . . . . 0.0 111.826 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 mt -63.91 -37.32 86.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.731 0.696 . . . . 0.0 111.17 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.2 -170.63 43.78 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.17 19.06 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.824 0.849 . . . . 0.0 113.273 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.1 m -55.42 153.84 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 111.464 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.48 143.04 44.79 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.89 126.78 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.49 151.55 50.48 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.412 0.551 . . . . 0.0 110.951 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.6 m -122.26 139.06 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.05 133.35 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -128.84 161.43 29.82 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.835 0.854 . . . . 0.0 110.67 -173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.73 -166.16 1.43 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -80.59 -8.95 59.78 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.29 151.54 93.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 118.818 0.735 . . . . 0.0 110.946 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.35 -12.26 35.18 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.774 2.316 . . . . 0.0 113.448 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -110.42 17.19 21.07 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.027 1.331 . . . . 0.0 110.866 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.39 -33.5 75.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -171.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -139.61 156.14 47.03 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.531 1.132 . . . . 0.0 109.674 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.41 172.76 17.69 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.424 2.69 . . . . 0.0 105.101 169.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -92.63 37.03 1.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.413 -0.804 . . . . 0.0 109.225 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -151.43 165.94 32.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.054 1.342 . . . . 0.0 107.846 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 t 48.95 50.25 18.07 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.476 1.111 . . . . 0.0 110.227 -171.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.69 -139.8 4.66 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -169.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.0 69.47 1.45 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.23 1.412 . . . . 0.0 111.45 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.39 142.1 23.66 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 108.926 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.04 50.16 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.114 0.864 . . . . 0.0 112.897 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.26 94.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.32 -29.33 61.15 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.843 1.257 . . . . 0.0 114.117 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -64.37 -29.06 70.14 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.91 148.9 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.36 148.11 39.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.16 141.74 28.42 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.308 1.843 . . . . 0.0 108.28 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.63 155.2 36.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.749 1.619 . . . . 0.0 108.543 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.5 m -127.3 47.38 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.411 2.284 . . . . 0.0 109.204 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.41 -26.6 42.67 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.698 -0.626 . . . . 0.0 112.2 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -49.25 -26.44 2.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -70.15 -15.92 63.02 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.69 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -140.73 -22.07 0.8 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.827 1.194 . . . . 0.0 113.745 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 82.3 mmm 58.79 2.99 0.27 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.309 3.044 . . . . 0.0 116.021 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -62.89 -44.07 97.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.466 1.485 . . . . 0.0 111.994 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -64.87 -42.34 94.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.562 1.528 . . . . 0.0 109.756 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.27 -44.75 96.27 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 123.68 0.657 . . . . 0.0 111.773 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.44 -46.08 67.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.983 0.513 . . . . 0.0 109.843 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -38.92 78.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.082 0.953 . . . . 0.0 112.46 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -99.38 4.53 46.33 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.68 1.192 . . . . 0.0 111.824 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.22 37.5 64.82 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 118.454 0.57 . . . . 0.0 112.803 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.73 -7.55 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.358 1.063 . . . . 0.0 109.841 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.86 108.41 1.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.78 120.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.16 -43.81 98.0 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.618 1.167 . . . . 0.0 111.423 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -92.32 -4.78 53.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.466 0.707 . . . . 0.0 112.872 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.62 -11.59 2.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.919 . . . . 0.0 111.977 -170.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 41.6 ptt85 49.3 31.61 3.86 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.15 2.18 . . . . 0.0 114.599 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.3 mt -116.9 167.11 11.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.33 130.6 37.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 164.1 24.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.786 1.234 . . . . 0.0 112.809 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 99.25 11.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.8 m -144.06 162.69 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.885 0.874 . . . . 0.0 109.158 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.55 144.42 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -146.98 155.9 42.62 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.088 1.355 . . . . 0.0 109.068 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.8 t -139.5 143.77 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.88 136.15 36.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.841 0.856 . . . . 0.0 109.7 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.14 164.53 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.368 1.467 . . . . 0.0 109.133 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.4 -29.65 10.58 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.04 1.736 . . . . 0.0 113.253 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.35 1.79 12.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.688 1.195 . . . . 0.0 113.015 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.33 30.09 65.31 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 120.837 -1.165 . . . . 0.0 110.245 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -106.85 116.23 31.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.794 1.297 . . . . 0.0 108.494 -173.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.17 124.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.216 1.006 . . . . 0.0 110.679 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.07 -8.42 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.376 1.47 . . . . 0.0 111.131 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -147.99 147.45 29.65 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.81 15.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.456 1.502 . . . . 0.0 108.272 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.79 149.63 33.73 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.105 0.962 . . . . 0.0 109.216 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.16 104.93 7.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.761 2.424 . . . . 0.0 105.055 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.74 137.86 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.2 m -62.25 -11.95 17.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.149 1.38 . . . . 0.0 113.727 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -142.69 123.92 14.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -54.39 -27.02 33.72 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.863 1.265 . . . . 0.0 113.958 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.9 p -91.72 14.54 14.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.754 1.161 . . . . 0.0 112.368 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -123.66 170.84 10.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.632 1.573 . . . . 0.0 109.763 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -125.96 155.43 73.16 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.589 1.156 . . . . 0.0 110.953 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -91.65 179.93 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.082 3.188 . . . . 0.0 110.271 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -79.5 111.89 16.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -81.73 -0.68 44.03 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -76.57 -29.44 56.61 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.795 -1.191 . . . . 0.0 108.919 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -59.46 -50.66 86.1 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 117.663 -1.16 . . . . 0.0 111.456 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.65 -34.27 52.05 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.269 1.489 . . . . 0.0 112.44 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.57 -45.31 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.203 1.365 . . . . 0.0 109.933 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.87 -36.04 83.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.12 0.873 . . . . 0.0 110.797 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.386 -0.196 . . . . 0.0 111.068 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.4 77.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.985 0.514 . . . . 0.0 110.899 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -57.18 -40.47 77.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.168 0.894 . . . . 0.0 110.603 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.77 68.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.999 0.52 . . . . 0.0 111.912 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.51 -59.95 2.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.045 0.384 . . . . 0.0 110.921 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.53 -40.28 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.257 1.023 . . . . 0.0 112.14 -169.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? . . . . . 0 C--O 1.25 1.095 0 C-N-CA 127.217 2.207 . . . . 0.0 112.143 -176.386 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.859 0.362 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.13 41.34 3.49 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.032 1.733 . . . . 0.0 109.78 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -64.31 163.52 12.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.799 0.84 . . . . 0.0 109.707 169.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.9 pt -126.37 173.18 12.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.619 1.199 . . . . 0.0 111.217 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -116.16 138.3 51.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -90.72 -132.97 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.17 56.36 0.46 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.656 1.982 . . . . 0.0 111.317 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 22.63 45.02 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.341 0.972 . . . . 0.0 113.506 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.54 140.42 11.06 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.03 144.55 52.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.617 2.212 . . . . 0.0 109.572 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.85 126.73 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.412 0.685 . . . . 0.0 109.415 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -66.73 151.12 48.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.222 1.409 . . . . 0.0 110.509 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.66 145.73 47.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.0 1.72 . . . . 0.0 107.611 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.65 -23.06 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.85 31.31 0.51 Allowed Glycine 0 N--CA 1.464 0.549 0 CA-C-N 118.689 0.677 . . . . 0.0 111.648 -172.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.41 152.12 3.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 9.4 tt0 94.66 33.17 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.504 2.721 . . . . 0.0 113.997 169.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -64.0 152.99 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.47 167.88 25.84 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -169.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.54 129.87 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.209 0.604 . . . . 0.0 109.695 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -2.79 87.58 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.715 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.53 -11.4 59.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.485 1.642 . . . . 0.0 112.235 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 57.08 178.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.563 1.545 . . . . 0.0 112.291 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.85 138.82 33.39 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 127.001 2.12 . . . . 0.0 107.856 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -58.38 -44.39 38.46 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.813 2.342 . . . . 0.0 114.201 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 114.99 124.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 131.218 3.807 . . . . 0.0 105.439 -169.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -133.49 165.37 25.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 109.088 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -126.22 139.44 53.34 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.48 146.11 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.032 1.333 . . . . 0.0 108.276 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.44 166.15 22.31 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.6 p -130.62 -177.54 4.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.932 1.293 . . . . 0.0 108.419 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -47.27 -34.28 6.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.559 0.744 . . . . 0.0 111.537 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -112.77 14.53 19.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.819 1.248 . . . . 0.0 111.531 -170.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.6 mt 51.64 44.16 29.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.742 . . . . 0.0 112.123 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -73.29 -18.12 61.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 112.81 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.12 54.56 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 123.084 1.421 . . . . 0.0 108.604 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -58.76 161.0 5.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.066 1.746 . . . . 0.0 108.869 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.2 p -141.59 170.23 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 tp -54.55 -40.95 69.21 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.63 -20.66 63.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.64 -33.46 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.728 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 37.0 mtt -71.36 -39.73 71.08 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.301 1.041 . . . . 0.0 110.609 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -54.36 138.37 39.69 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 123.317 0.647 . . . . 0.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.24 7.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.01 1.29 . . . . 0.0 112.553 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -147.92 155.77 41.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.598 1.159 . . . . 0.0 109.258 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.41 139.67 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.1 m -135.36 147.83 49.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.231 1.012 . . . . 0.0 108.738 -172.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.09 136.78 54.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.3 mt -135.27 128.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.0 m -108.9 141.33 41.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -135.48 125.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.9 pt -150.06 159.6 35.12 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.201 1.8 . . . . 0.0 107.178 -170.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.71 -40.39 79.95 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.123 1.882 . . . . 0.0 112.234 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.07 165.53 15.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.812 1.645 . . . . 0.0 109.099 169.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pp -67.23 41.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 125.915 1.686 . . . . 0.0 112.861 169.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -158.18 -29.03 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.148 . . . . 0.0 113.208 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -72.57 32.51 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -168.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.82 -29.6 1.8 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.006 1.289 . . . . 0.0 114.591 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.3 -3.72 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.379 1.472 . . . . 0.0 113.202 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 29.2 m -74.45 33.36 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.975 -1.078 . . . . 0.0 110.65 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.38 179.84 1.18 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.099 1.36 . . . . 0.0 111.259 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.38 31.61 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.567 1.147 . . . . 0.0 113.235 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -62.94 -56.76 14.32 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.714 1.143 . . . . 0.0 109.437 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -62.16 -42.55 99.37 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 109.779 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -61.71 -53.95 49.14 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.829 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -64.11 -45.88 86.67 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.846 0.748 . . . . 0.0 110.268 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -54.09 -52.17 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.175 0.99 . . . . 0.0 110.853 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.18 -35.95 81.8 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.915 0.388 . . . . 0.0 110.823 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -69.98 -37.25 75.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.257 0.623 . . . . 0.0 111.838 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -74.49 -34.34 63.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.171 0.896 . . . . 0.0 110.919 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.32 -46.41 76.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.708 0.685 . . . . 0.0 110.794 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.97 -16.44 51.29 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.838 0.855 . . . . 0.0 113.293 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -83.21 -27.09 30.23 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.067 0.849 . . . . 0.0 111.847 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.0 -33.82 76.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.581 0.628 . . . . 0.0 110.987 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.36 -168.01 40.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -75.71 28.16 0.11 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.745 -0.856 . . . . 0.0 112.217 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -54.76 138.42 14.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.528 1.131 . . . . 0.0 109.059 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -66.13 137.97 57.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.07 119.53 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.61 149.62 52.18 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.915 0.486 . . . . 0.0 110.745 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 m -133.76 116.1 15.34 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mt -92.14 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -133.72 162.08 32.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.094 2.158 . . . . 0.0 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.06 -20.28 0.18 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.204 1.402 . . . . 0.0 112.95 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -80.39 70.85 7.15 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.6 mp -48.52 -35.1 8.12 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.59 -28.22 21.48 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.61 2.206 . . . . 0.0 114.834 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -117.38 -16.61 10.24 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.09 0.859 . . . . 0.0 112.26 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.73 148.22 20.87 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.582 0.753 . . . . 0.0 110.503 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 51.39 21.9 1.31 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.541 1.536 . . . . 0.0 113.778 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.02 -36.02 0.43 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -109.97 7.11 23.64 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.875 1.216 . . . . 0.0 114.173 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 62.9 m95 24.2 72.58 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.723 2.809 . . . . 0.0 116.309 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.7 p -63.72 -15.05 57.51 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.675 -0.64 . . . . 0.0 112.393 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.36 -148.85 5.88 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 127.205 2.336 . . . . 0.0 107.738 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 54.69 41.43 31.94 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.702 1.201 . . . . 0.0 111.659 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -141.14 148.15 39.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.962 1.705 . . . . 0.0 107.278 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.04 -60.37 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 77.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 122.696 1.236 . . . . 0.0 108.898 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.88 -20.11 14.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.338 1.855 . . . . 0.0 113.974 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -58.38 -30.98 67.21 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.734 -0.604 . . . . 0.0 112.098 173.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.56 142.24 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.67 138.24 44.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.47 143.05 32.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.825 0.85 . . . . 0.0 108.817 -173.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -124.07 156.39 36.64 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.78 1.632 . . . . 0.0 108.247 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -136.41 144.44 44.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -134.26 -16.23 2.16 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -64.29 -14.32 55.21 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.717 -1.24 . . . . 0.0 114.143 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -65.55 -18.88 65.65 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.276 -0.89 . . . . 0.0 112.155 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -147.19 -15.64 0.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 35.6 mmm 50.15 37.33 14.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.245 1.818 . . . . 0.0 111.99 -169.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -56.94 15.43 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -63.3 -37.85 88.87 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.687 0.676 . . . . 0.0 109.812 175.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.77 -55.48 8.21 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.482 1.991 . . . . 0.0 113.216 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.47 -35.2 40.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.154 0.477 . . . . 0.0 110.506 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.47 79.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.186 0.595 . . . . 0.0 112.334 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.62 2.43 16.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.915 1.286 . . . . 0.0 110.684 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 8.08 62.55 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.289 -0.882 . . . . 0.0 114.276 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 m -79.47 -4.55 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.043 1.737 . . . . 0.0 112.175 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -67.0 115.76 7.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.5 mt -75.48 106.86 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -54.72 -40.63 69.45 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.805 0.842 . . . . 0.0 110.85 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -86.88 -5.1 59.21 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.02 -7.03 2.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.168 0.894 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 15.8 ptm180 40.2 43.33 1.36 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.89 2.076 . . . . 0.0 113.763 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt -131.74 175.83 8.85 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.04 129.55 34.78 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.758 0.823 . . . . 0.0 109.318 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 139.24 57.86 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.998 1.319 . . . . 0.0 111.1 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.49 113.14 3.1 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.4 p -154.15 164.13 39.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.284 0.564 . . . . 0.0 109.873 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 t -141.74 136.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -142.85 152.09 41.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.564 0.745 . . . . 0.0 109.229 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.65 136.25 52.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -130.85 136.74 48.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.86 1.264 . . . . 0.0 108.372 -169.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.06 165.46 15.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.22 1.408 . . . . 0.0 110.514 169.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.51 -33.22 20.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 113.182 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.32 5.74 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.172 0.897 . . . . 0.0 113.304 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.3 -7.59 75.49 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.607 1.099 . . . . 0.0 113.091 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.48 125.32 24.79 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.613 1.207 . . . . 0.0 109.034 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.86 128.75 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.94 -8.53 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.122 1.369 . . . . 0.0 111.04 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -153.86 150.48 28.45 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.7 133.74 11.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.522 1.529 . . . . 0.0 107.913 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -143.57 149.8 37.92 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.327 0.651 . . . . 0.0 110.138 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -128.09 112.74 14.92 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.09 133.47 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -57.9 -20.3 36.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.043 0.937 . . . . 0.0 112.633 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.43 124.47 13.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.49 -32.04 72.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.394 0.678 . . . . 0.0 112.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -79.41 17.28 0.87 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.483 1.113 . . . . 0.0 111.65 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -134.31 171.27 14.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 107.054 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.84 151.13 76.83 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 111.435 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -86.64 176.09 4.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.064 3.176 . . . . 0.0 110.421 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -71.52 133.37 45.77 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -110.7 3.07 18.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.0 0.52 . . . . 0.0 112.192 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.59 -40.27 42.75 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -54.65 -50.79 83.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.315 -1.326 . . . . 0.0 112.403 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.46 -36.64 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 CA-C-N 121.84 1.693 . . . . 0.0 112.431 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.5 mm -59.48 -46.75 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.315 0.961 . . . . 0.0 109.588 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.45 -35.85 82.15 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.304 -0.872 . . . . 0.0 110.845 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.87 98.46 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.356 0.262 . . . . 0.0 110.642 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.27 -47.04 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.919 0.488 . . . . 0.0 110.682 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.96 -42.5 72.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.211 0.914 . . . . 0.0 110.484 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.4 -31.12 67.39 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.346 0.658 . . . . 0.0 111.881 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -84.74 -44.01 13.74 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.763 0.425 . . . . 0.0 111.612 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.87 -51.35 24.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 123.774 0.83 . . . . 0.0 111.55 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.249 1.068 0 C-N-CA 123.948 0.899 . . . . 0.0 109.666 -178.455 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 118.973 -0.536 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.46 11.94 4.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.442 1.097 . . . . 0.0 112.001 169.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.13 169.49 18.62 Favored 'General case' 0 N--CA 1.435 -1.218 1 C-N-CA 132.077 4.151 . . . . 0.0 106.275 178.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.57 172.81 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 122.397 1.094 . . . . 0.0 110.07 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 m -134.01 143.82 48.34 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.81 -2.292 . . . . 0.0 104.81 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -138.39 127.18 23.7 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 47.34 38.77 7.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.922 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.6 20.35 79.57 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.309 -0.717 . . . . 0.0 114.526 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.08 121.35 4.41 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 172.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.34 140.91 82.32 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.827 2.351 . . . . 0.0 110.715 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.25 135.81 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -74.78 157.7 34.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.597 1.559 . . . . 0.0 109.406 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 144.64 48.71 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.0 t -60.88 -52.18 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.495 0.718 . . . . 0.0 112.33 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.66 37.57 3.17 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.707 1.146 . . . . 0.0 112.41 -170.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.15 169.95 0.16 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.537 1.935 . . . . 0.0 115.018 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 77.18 28.21 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.769 2.028 . . . . 0.0 113.306 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -64.0 145.82 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -150.43 164.57 35.56 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.936 0.895 . . . . 0.0 109.555 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 p -53.0 133.04 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.305 0.642 . . . . 0.0 109.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.62 1.21 90.49 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.737 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.63 -12.93 60.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.439 1.619 . . . . 0.0 112.314 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.17 176.4 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.81 1.644 . . . . 0.0 112.025 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.72 147.58 63.33 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.647 1.579 . . . . 0.0 110.363 -173.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.02 -51.39 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.776 2.317 . . . . 0.0 112.277 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t70 118.11 127.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 1 C-N-CA 131.844 4.058 . . . . 0.0 105.88 -169.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.75 166.51 23.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.832 1.653 . . . . 0.0 108.844 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 m -132.13 138.2 47.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.52 174.47 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 127.778 2.431 . . . . 0.0 107.686 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.3 140.93 46.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.8 p -70.84 174.87 5.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.143 1.777 . . . . 0.0 110.846 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.52 -22.08 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.505 -0.747 . . . . 0.0 110.928 169.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 m -84.11 0.18 49.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.485 1.514 . . . . 0.0 111.859 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.3 mt 52.73 49.74 19.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.427 1.891 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.33 159.95 26.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.358 1.463 . . . . 0.0 107.451 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.66 144.46 47.75 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.915 0.864 . . . . 0.0 111.026 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -142.11 151.39 42.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.619 2.368 . . . . 0.0 105.129 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 p -135.08 165.08 26.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -56.85 -37.53 71.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 174.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.88 67.59 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -78.95 -30.48 44.59 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.794 0.725 . . . . 0.0 111.259 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 48.6 mtt -72.03 -41.1 67.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.966 0.906 . . . . 0.0 110.887 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -54.3 146.06 16.38 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.238 1.015 . . . . 0.0 110.057 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.11 -21.15 12.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.937 1.256 . . . . 0.0 112.612 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -146.8 152.98 39.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.321 1.448 . . . . 0.0 108.443 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.77 141.14 17.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.4 m -135.02 146.8 49.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -172.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 90.1 mt -128.51 135.23 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.4 102.94 3.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.8 m -79.84 151.22 30.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.74 126.86 39.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.5 pt -137.84 147.75 57.99 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.742 0.417 . . . . 0.0 110.132 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.56 -34.41 7.34 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.187 1.925 . . . . 0.0 111.565 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -163.95 172.38 14.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.739 1.615 . . . . 0.0 109.179 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 pp -105.54 -9.36 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.77 1.228 . . . . 0.0 110.794 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -69.17 -34.57 75.17 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.651 -0.656 . . . . 0.0 110.282 169.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.36 146.82 52.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.478 1.511 . . . . 0.0 110.726 173.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.24 -3.25 52.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.223 0.916 . . . . 0.0 114.618 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.93 -22.72 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.966 1.307 . . . . 0.0 112.412 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 90.9 m -51.6 -65.07 0.62 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.872 1.269 . . . . 0.0 110.342 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.13 -33.05 50.68 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.054 0.541 . . . . 0.0 110.903 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.19 86.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.908 -0.568 . . . . 0.0 111.966 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -159.11 -39.16 0.06 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -64.78 -46.16 83.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.549 1.068 . . . . 0.0 112.567 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -69.92 -29.58 66.78 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.858 -1.151 . . . . 0.0 112.444 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -78.52 -45.27 22.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.274 0.943 . . . . 0.0 109.971 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.24 -44.96 96.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.175 -0.44 . . . . 0.0 111.376 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -63.04 -40.44 97.72 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.232 0.613 . . . . 0.0 110.417 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.37 -51.46 67.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.678 0.791 . . . . 0.0 109.851 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -64.16 -37.01 85.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.541 0.736 . . . . 0.0 110.973 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.87 76.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.468 1.507 . . . . 0.0 110.108 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -26.83 68.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.573 0.349 . . . . 0.0 111.932 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.13 -20.55 55.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.077 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.34 -36.54 84.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.267 1.394 . . . . 0.0 111.596 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.71 -170.91 43.48 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -74.22 21.62 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.26 150.56 2.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 O-C-N 120.7 -1.25 . . . . 0.0 110.786 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.17 143.41 47.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 125.01 43.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.57 156.37 45.87 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.601 0.76 . . . . 0.0 109.94 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.9 m -132.48 114.59 14.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -97.44 132.79 41.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 m -142.59 169.16 18.09 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.839 1.255 . . . . 0.0 109.305 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.13 169.48 10.18 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 110.738 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -80.86 -12.33 59.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.615 0.766 . . . . 0.0 112.007 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 28.4 tp -51.38 136.8 31.17 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.686 1.595 . . . . 0.0 110.075 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -51.94 -42.2 59.46 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.815 2.343 . . . . 0.0 113.202 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -66.55 3.06 1.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.912 1.285 . . . . 0.0 113.583 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.23 -2.93 3.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.93 2.092 . . . . 0.0 111.811 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -149.63 27.35 0.81 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.493 1.042 . . . . 0.0 112.728 -168.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.67 160.92 41.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.452 1.501 . . . . 0.0 107.292 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 47.22 41.81 12.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.288 1.035 . . . . 0.0 111.195 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -46.74 107.12 0.1 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.515 1.926 . . . . 0.0 112.378 -172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.6 p -72.23 -45.06 61.78 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.961 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.15 -10.3 59.1 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.578 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.9 -6.91 12.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.93 1.365 . . . . 0.0 112.352 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 109.84 2.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.381 0.537 . . . . 0.0 109.945 -170.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.24 -1.43 60.64 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.391 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.22 90.38 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.951 1.875 . . . . 0.0 109.313 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.35 -30.85 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.447 1.899 . . . . 0.0 114.547 -173.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.57 -30.21 71.36 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 t -76.98 144.78 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.01 131.26 28.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.592 0.71 . . . . 0.0 109.448 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.37 144.94 32.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.576 1.151 . . . . 0.0 109.304 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -132.6 155.36 48.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.332 1.453 . . . . 0.0 109.477 -170.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -112.94 138.26 50.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.388 1.075 . . . . 0.0 108.467 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.57 -17.93 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -61.79 -11.17 11.14 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.11 -0.994 . . . . 0.0 113.414 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -46.62 -45.31 18.98 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.529 1.532 . . . . 0.0 110.608 169.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.54 3.75 0.57 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 43.0 mmm 51.27 37.53 18.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.692 1.597 . . . . 0.0 112.127 -172.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -57.35 -59.77 4.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.423 1.089 . . . . 0.0 110.61 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -62.75 -36.5 83.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.072 0.949 . . . . 0.0 109.459 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.9 -60.56 3.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 126.195 1.855 . . . . 0.0 113.023 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.01 -35.26 57.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.194 0.497 . . . . 0.0 110.354 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.46 85.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.45 5.38 15.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.202 1.401 . . . . 0.0 110.782 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.45 64.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.282 -0.886 . . . . 0.0 112.834 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.95 0.2 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.483 1.113 . . . . 0.0 111.366 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -71.12 106.51 3.77 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.8 mt -65.62 121.19 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -65.45 -41.35 93.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.909 0.484 . . . . 0.0 110.553 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.78 -61.77 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.865 0.466 . . . . 0.0 110.156 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 21.9 tp -71.76 -19.27 62.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.646 0.778 . . . . 0.0 112.452 -172.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 54.11 41.52 31.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.148 1.379 . . . . 0.0 111.658 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.7 mt -128.07 179.01 5.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.775 1.23 . . . . 0.0 108.371 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.11 133.83 41.45 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.171 0.989 . . . . 0.0 108.831 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.78 152.67 38.76 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.58 1.152 . . . . 0.0 111.177 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.03 110.58 16.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 169.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -150.41 172.11 15.94 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -149.79 144.5 17.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.08 158.0 44.75 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.243 1.417 . . . . 0.0 108.781 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.86 144.36 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.03 126.57 20.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.219 1.008 . . . . 0.0 109.738 -168.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.01 161.51 24.17 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.465 1.506 . . . . 0.0 110.658 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -48.67 -33.93 10.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 112.686 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.5 5.23 36.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.157 1.383 . . . . 0.0 112.733 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.92 -5.72 83.16 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 120.885 -1.134 . . . . 0.0 112.74 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -72.76 121.27 19.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.006 1.403 . . . . 0.0 108.729 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.22 125.72 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.06 -10.89 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.462 1.105 . . . . 0.0 110.223 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -152.42 152.28 31.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.434 1.094 . . . . 0.0 108.268 170.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.21 137.46 14.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.86 1.664 . . . . 0.0 107.493 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -144.83 139.61 27.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -113.48 109.49 18.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.0 t -64.45 115.17 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.2 m -53.21 -25.66 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.994 1.318 . . . . 0.0 113.205 -170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.05 107.65 6.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.19 -25.37 68.04 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.333 1.853 . . . . 0.0 112.462 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.72 15.02 1.48 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.097 1.359 . . . . 0.0 111.695 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.53 175.94 9.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.767 2.827 . . . . 0.0 106.692 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -122.87 154.2 64.02 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.656 1.117 . . . . 0.0 112.135 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.67 177.05 2.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.397 3.398 . . . . 0.0 111.15 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -76.58 130.92 38.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -104.8 -3.98 22.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -33.97 69.97 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.59 -55.67 42.26 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.782 1.233 . . . . 0.0 112.588 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.97 -34.45 59.35 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.74 1.657 . . . . 0.0 111.963 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 mm -60.22 -46.39 94.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.824 1.193 . . . . 0.0 109.707 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.95 -31.86 71.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.716 1.143 . . . . 0.0 110.93 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.15 -39.46 94.73 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.052 0.387 . . . . 0.0 111.012 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.11 68.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.633 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -55.4 -38.61 69.14 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.274 0.943 . . . . 0.0 110.968 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.24 -28.39 64.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.562 0.745 . . . . 0.0 112.299 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.93 -48.3 7.08 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.553 . . . . 0.0 111.334 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.86 -45.46 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.362 1.065 . . . . 0.0 110.837 -171.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt . . . . . 0 C--O 1.25 1.113 0 C-N-CA 126.825 2.05 . . . . 0.0 110.793 179.371 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.9 28.65 0.49 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.397 -1.439 . . . . 0.0 112.971 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -164.93 173.3 11.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.043 2.937 . . . . 0.0 105.05 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 pt -136.98 173.33 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 123.478 1.609 . . . . 0.0 110.941 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 m -118.82 154.45 32.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -137.61 121.45 17.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.25 40.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.595 1.558 . . . . 0.0 113.641 -172.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.34 5.48 89.55 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.698 -0.626 . . . . 0.0 114.087 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.03 113.64 4.09 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.639 1.59 . . . . 0.0 109.541 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.1 139.59 71.25 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.942 2.428 . . . . 0.0 111.06 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.6 127.5 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.521 0.677 . . . . 0.0 109.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -69.48 151.73 45.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.998 1.319 . . . . 0.0 110.112 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.68 158.47 23.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.069 1.747 . . . . 0.0 108.694 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.71 -51.66 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.54 29.77 3.75 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.468 1.032 . . . . 0.0 111.92 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.84 164.51 1.51 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.595 1.158 . . . . 0.0 113.348 -172.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 103.64 20.64 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.321 3.048 . . . . 0.0 111.138 170.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.81 136.8 21.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -145.93 166.75 25.1 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.529 1.131 . . . . 0.0 108.131 -171.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.7 130.66 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.39 90.25 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.766 -1.019 . . . . 0.0 114.082 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.51 -8.15 58.95 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.548 1.674 . . . . 0.0 112.37 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 59.92 175.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.501 1.52 . . . . 0.0 112.097 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.22 115.5 13.98 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.89 1.676 . . . . 0.0 108.293 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.4 144.79 99.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.369 2.046 . . . . 0.0 112.699 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -82.07 62.1 5.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -94.09 173.4 7.67 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.4 m -118.55 151.32 38.09 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.718 0.77 . . . . 0.0 111.559 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.49 166.8 20.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.282 2.233 . . . . 0.0 106.996 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mp -109.56 154.49 22.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -83.46 178.81 7.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.053 0.941 . . . . 0.0 109.592 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.19 -26.88 68.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.728 -1.232 . . . . 0.0 110.938 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -80.62 1.49 29.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.313 1.445 . . . . 0.0 111.784 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.0 mt 55.12 35.82 25.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.857 2.063 . . . . 0.0 112.336 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.09 149.58 22.35 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.53 143.7 46.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.544 0.738 . . . . 0.0 110.095 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -144.9 102.19 3.74 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.6 m -70.97 154.24 41.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 27.2 tp -52.53 -39.65 61.62 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.671 -0.643 . . . . 0.0 111.05 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -18.85 40.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.7 -32.29 63.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.593 1.088 . . . . 0.0 110.886 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.4 mtt -73.41 -39.75 64.81 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.629 1.172 . . . . 0.0 110.229 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -55.81 150.48 12.91 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.814 0.816 . . . . 0.0 110.406 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.13 23.15 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.203 1.382 . . . . 0.0 112.216 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -149.14 153.86 38.33 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 108.749 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.22 138.5 16.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.4 m -134.82 148.4 50.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.068 0.947 . . . . 0.0 108.885 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.9 mt -132.81 132.84 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.99 105.99 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -84.46 149.65 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 168.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 t -134.0 128.99 53.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.5 pt -143.84 144.33 26.47 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.673 0.789 . . . . 0.0 109.374 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.75 -33.64 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.061 1.841 . . . . 0.0 111.709 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -154.01 173.15 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.594 1.958 . . . . 0.0 108.692 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.1 pt -132.91 -31.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.11 1.364 . . . . 0.0 110.94 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.64 -12.08 50.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.648 0.737 . . . . 0.0 110.979 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -64.11 -19.63 65.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.825 2.05 . . . . 0.0 112.762 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.71 65.56 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.852 0.739 . . . . 0.0 112.841 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.35 -19.61 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.0 1.4 . . . . 0.0 112.026 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.66 -58.09 9.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 170.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.11 -32.72 72.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.284 0.633 . . . . 0.0 111.131 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -47.86 84.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.005 -0.521 . . . . 0.0 111.383 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -165.86 -35.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -43.55 97.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 112.343 -169.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -62.49 -51.44 67.42 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.436 1.016 . . . . 0.0 109.763 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -62.65 -48.47 79.19 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.617 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -57.36 -51.3 69.96 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.494 0.588 . . . . 0.0 110.86 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -61.41 -40.08 93.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.964 0.906 . . . . 0.0 111.499 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.82 -46.73 71.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.518 0.727 . . . . 0.0 110.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.87 -36.24 81.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.184 0.902 . . . . 0.0 110.672 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.34 77.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.748 0.819 . . . . 0.0 110.292 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.4 -24.47 67.41 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -80.49 -19.12 46.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 112.539 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.59 -39.56 93.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.957 1.253 . . . . 0.0 111.86 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.71 -167.35 39.15 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.19 25.72 0.1 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.468 1.107 . . . . 0.0 112.912 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -57.24 142.32 13.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.206 1.402 . . . . 0.0 110.715 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -72.83 137.87 46.0 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 168.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.28 124.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -137.82 153.94 49.58 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.828 0.851 . . . . 0.0 110.323 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 m -126.16 103.94 7.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.7 mt -77.32 131.76 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.6 m -132.25 165.34 24.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.164 1.385 . . . . 0.0 109.314 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.69 169.6 6.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.798 0.808 . . . . 0.0 110.621 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -74.02 -22.11 59.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.727 0.811 . . . . 0.0 110.67 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.0 tp -52.43 129.2 42.99 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.448 1.499 . . . . 0.0 110.278 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.84 -39.4 68.16 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.096 2.531 . . . . 0.0 113.594 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -64.89 0.47 1.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.611 1.164 . . . . 0.0 113.898 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.99 -8.46 16.58 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.246 1.418 . . . . 0.0 113.001 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -143.1 -24.87 0.61 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.053 1.297 . . . . 0.0 114.354 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.85 -31.57 71.84 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.346 1.43 . . . . 0.0 113.496 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -87.89 -11.18 48.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.4 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.1 p90 32.23 48.39 0.11 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.338 2.655 . . . . 0.0 114.59 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.9 p -59.62 -28.57 67.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.15 -14.22 57.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.961 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.68 33.59 5.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.827 1.314 . . . . 0.0 110.395 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -141.24 135.58 30.82 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.46 -15.59 7.17 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.334 -0.704 . . . . 0.0 112.642 -170.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mt -128.83 76.93 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.2 -26.25 38.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -63.67 -27.66 69.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.502 1.121 . . . . 0.0 112.642 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.75 154.13 3.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.27 146.81 39.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.4 148.81 24.04 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.37 157.05 35.97 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.461 1.505 . . . . 0.0 108.554 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -128.82 49.25 2.24 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.193 2.197 . . . . 0.0 108.947 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -47.18 -41.82 18.68 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.567 0.747 . . . . 0.0 111.358 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -56.15 -19.89 15.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.166 0.986 . . . . 0.0 113.631 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -68.7 -22.33 64.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.048 -1.033 . . . . 0.0 111.618 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -133.72 -26.14 1.6 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.085 0.954 . . . . 0.0 112.999 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.79 -4.03 0.27 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.789 3.235 . . . . 0.0 115.731 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -57.25 -52.57 64.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.718 1.144 . . . . 0.0 110.965 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.67 -35.14 78.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.593 0.633 . . . . 0.0 111.129 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.24 -43.22 98.71 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.63 0.633 . . . . 0.0 112.119 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.66 -38.88 80.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.634 0.717 . . . . 0.0 110.31 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.82 84.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.644 0.778 . . . . 0.0 111.88 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.83 -6.19 58.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.72 0.808 . . . . 0.0 111.08 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.46 1.9 62.2 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.119 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.89 -19.74 26.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 124.638 1.175 . . . . 0.0 111.137 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.66 118.35 6.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.313 0.961 . . . . 0.0 108.651 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -81.61 105.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 126.197 1.799 . . . . 0.0 106.425 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.24 -40.59 61.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.752 1.221 . . . . 0.0 110.869 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -88.79 -4.74 58.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.34 0.656 . . . . 0.0 112.714 -170.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.6 tp -137.37 -5.8 1.8 Allowed 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.117 -0.989 . . . . 0.0 113.047 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 32.2 ptt-85 42.5 45.8 3.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.949 1.7 . . . . 0.0 112.767 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -134.87 176.59 8.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.119 1.768 . . . . 0.0 106.358 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.261 0.0 OUTLIER -106.49 147.5 29.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 121.884 2.129 . . . . 0.0 111.862 170.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.03 156.58 35.67 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.741 2.016 . . . . 0.0 112.785 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -82.54 116.34 21.92 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.2 m -150.79 167.06 28.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 108.96 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.93 142.96 19.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.22 151.83 42.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.775 1.23 . . . . 0.0 108.111 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.9 t -135.07 135.44 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -130.26 135.53 48.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.361 1.064 . . . . 0.0 109.239 -169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.48 167.25 5.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 109.502 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -51.13 -34.12 29.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.041 1.336 . . . . 0.0 112.711 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -80.24 -0.57 36.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.473 1.109 . . . . 0.0 112.547 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.66 79.33 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.896 1.236 . . . . 0.0 112.606 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.64 117.3 5.6 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.244 1.522 . . . . 0.0 109.469 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.84 115.67 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.848 0.859 . . . . 0.0 109.447 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.6 -12.21 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.657 1.183 . . . . 0.0 110.664 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -147.17 144.68 29.13 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.31 126.36 7.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.317 1.447 . . . . 0.0 107.283 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.82 145.56 29.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -114.47 111.08 20.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 t -61.95 125.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -172.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -59.42 -13.32 8.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.472 1.109 . . . . 0.0 113.663 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.6 128.13 21.42 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.98 63.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.065 . . . . 0.0 113.667 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.2 p -84.68 -4.49 59.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.083 1.31 . . . . 0.0 112.637 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -98.07 177.24 5.48 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.438 1.495 . . . . 0.0 109.974 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -133.51 151.57 77.57 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.015 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.0 -176.68 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.663 2.908 . . . . 0.0 109.249 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -76.85 119.47 20.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -91.29 -0.87 57.74 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.28 -36.05 40.33 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -51.21 -55.45 28.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.134 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.27 -33.88 47.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.584 1.601 . . . . 0.0 112.728 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.81 -45.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.185 1.357 . . . . 0.0 109.879 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.54 -36.84 85.0 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.376 0.989 . . . . 0.0 110.596 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.12 96.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.082 0.553 . . . . 0.0 111.178 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.15 -41.89 76.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.28 0.945 . . . . 0.0 110.302 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.29 -31.89 70.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.162 0.585 . . . . 0.0 112.012 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.59 -40.45 23.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.076 0.55 . . . . 0.0 111.807 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.55 -54.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.454 0.702 . . . . 0.0 109.483 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.1 pttt . . . . . 0 C--O 1.25 1.083 0 C-N-CA 127.722 2.409 . . . . 0.0 112.036 -178.231 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.11 11.19 0.76 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -146.14 143.79 29.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 169.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.6 pt -130.33 -178.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 122.172 0.987 . . . . 0.0 110.92 -169.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -127.1 146.35 50.41 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -143.68 133.25 23.56 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm 43.7 42.38 4.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.586 1.555 . . . . 0.0 112.138 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.18 28.5 70.04 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.161 -0.799 . . . . 0.0 114.54 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 139.6 10.52 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 169.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.39 145.33 42.73 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.592 2.195 . . . . 0.0 110.151 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.27 134.72 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.242 1.017 . . . . 0.0 110.28 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -75.29 152.81 38.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.156 1.782 . . . . 0.0 110.448 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.78 148.76 42.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.98 1.712 . . . . 0.0 108.08 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.15 -84.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.361 0.528 . . . . 0.0 110.935 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 40.48 2.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.296 1.427 . . . . 0.0 112.019 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -58.06 171.05 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.196 2.198 . . . . 0.0 114.593 -169.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 78.52 28.27 0.46 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.817 2.047 . . . . 0.0 114.032 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.6 138.88 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -148.4 164.08 35.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.451 1.1 . . . . 0.0 108.578 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.8 132.97 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 -0.52 89.65 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.219 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -76.55 -13.65 60.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.544 1.672 . . . . 0.0 112.657 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 60.95 157.15 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.813 2.045 . . . . 0.0 112.959 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.58 133.37 46.95 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.342 1.057 . . . . 0.0 109.049 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.3 -27.66 76.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.493 2.795 . . . . 0.0 114.772 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 62.43 98.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.381 2.272 . . . . 0.0 112.113 -170.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -129.49 170.47 13.68 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.901 1.68 . . . . 0.0 108.316 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.9 167.32 11.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.53 1.132 . . . . 0.0 109.279 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.9 -176.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 128.053 2.541 . . . . 0.0 104.215 168.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.05 139.16 35.87 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.6 p -87.64 171.08 10.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 118.821 0.737 . . . . 0.0 109.744 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.443 -0.785 . . . . 0.0 110.733 168.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m -79.35 1.58 24.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.717 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt 61.47 32.58 18.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.684 2.394 . . . . 0.0 112.201 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -91.89 140.33 29.78 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.91 55.83 2.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.085 1.754 . . . . 0.0 110.184 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.41 157.03 5.33 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.065 1.346 . . . . 0.0 108.394 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -133.5 163.8 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.03 -28.5 66.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.022 -0.424 . . . . 0.0 111.958 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.63 -19.71 51.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.085 -1.009 . . . . 0.0 113.647 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.2 -28.49 61.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.443 1.019 . . . . 0.0 110.941 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -74.01 -41.7 61.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.725 1.21 . . . . 0.0 110.039 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 133.48 49.49 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.54 -23.28 4.28 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.992 1.282 . . . . 0.0 112.426 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -154.99 157.38 37.58 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.663 1.185 . . . . 0.0 108.371 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -59.24 143.06 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -137.68 148.04 45.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.269 1.028 . . . . 0.0 108.243 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.2 mt -129.07 137.95 55.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.7 mt -132.17 124.13 51.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.2 t -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.99 131.37 64.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -139.78 136.99 17.86 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.591 0.757 . . . . 0.0 111.451 -170.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.8 -28.71 2.01 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.167 2.578 . . . . 0.0 112.146 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -163.42 170.69 17.06 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.072 1.749 . . . . 0.0 107.739 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -126.13 -18.91 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.109 1.364 . . . . 0.0 110.528 169.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.38 -13.39 58.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.866 0.867 . . . . 0.0 111.362 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 p -61.12 -22.22 64.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.08 1.752 . . . . 0.0 112.252 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.77 -10.24 65.76 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.017 0.817 . . . . 0.0 112.4 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.92 -29.11 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.663 1.231 . . . . 0.0 109.707 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.48 -55.4 35.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.933 0.333 . . . . 0.0 110.11 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -38.79 80.37 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.334 0.253 . . . . 0.0 111.038 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.63 -32.74 73.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.763 -0.636 . . . . 0.0 112.523 -175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -149.62 -46.36 0.13 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.361 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -60.51 -34.64 74.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.994 1.725 . . . . 0.0 111.531 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -50.69 -65.79 0.5 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.274 0.63 . . . . 0.0 109.844 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.89 -40.73 87.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.006 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -58.25 -54.91 41.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 122.502 0.321 . . . . 0.0 110.395 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -76.21 -27.77 56.96 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.918 -171.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.88 -53.08 62.08 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.658 1.183 . . . . 0.0 109.701 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.48 -39.68 88.92 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.324 0.511 . . . . 0.0 110.573 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.82 81.05 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.438 0.695 . . . . 0.0 110.828 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.13 -20.44 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -93.59 -14.86 26.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.413 1.006 . . . . 0.0 112.7 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.75 -31.88 73.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.666 1.121 . . . . 0.0 111.929 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.41 -158.69 31.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.89 26.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.286 1.434 . . . . 0.0 112.533 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.44 135.98 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.105 1.362 . . . . 0.0 108.022 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.95 146.57 52.65 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.72 127.19 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.11 151.34 51.34 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.615 0.766 . . . . 0.0 110.796 -173.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.8 m -133.72 100.34 4.74 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.34 128.71 39.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -125.64 150.18 47.79 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.58 174.1 10.77 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.402 0.62 . . . . 0.0 111.947 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.2 -17.91 62.5 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.166 1.386 . . . . 0.0 112.668 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.8 tp -51.85 133.98 37.85 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.732 1.613 . . . . 0.0 111.134 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -54.19 -27.98 49.58 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.269 2.646 . . . . 0.0 114.436 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -81.96 12.79 3.78 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.851 1.26 . . . . 0.0 112.633 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.08 168.1 15.07 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.028 1.731 . . . . 0.0 109.002 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 60.11 177.08 0.09 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.296 1.839 . . . . 0.0 113.481 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 60.61 -28.78 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.702 3.201 . . . . 0.0 117.123 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -129.26 20.64 5.75 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.721 1.608 . . . . 0.0 110.309 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -43.31 101.81 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.626 2.37 . . . . 0.0 111.157 171.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.4 -34.17 73.53 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.361 0.664 . . . . 0.0 111.608 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.57 13.52 62.18 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.814 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.11 26.42 5.18 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.875 1.337 . . . . 0.0 110.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.85 135.64 36.39 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.25 -13.72 43.78 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.879 -173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.43 76.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 125.822 1.649 . . . . 0.0 107.284 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.6 -21.55 10.75 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.489 1.916 . . . . 0.0 113.951 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.45 -27.3 67.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.435 1.094 . . . . 0.0 112.385 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.21 144.73 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.768 0.827 . . . . 0.0 109.227 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.3 129.2 48.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 p -97.67 141.74 30.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.458 1.103 . . . . 0.0 108.682 -172.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -125.47 156.62 38.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 110.077 -169.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -136.12 44.6 2.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.331 2.652 . . . . 0.0 109.11 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.07 -24.92 60.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.396 0.678 . . . . 0.0 112.311 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -51.12 -19.63 1.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.481 1.512 . . . . 0.0 114.387 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -59.52 -27.11 65.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.663 1.119 . . . . 0.0 112.457 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -135.77 -6.96 2.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.78 1.173 . . . . 0.0 113.251 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 86.6 mmm 52.83 26.9 4.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.632 1.573 . . . . 0.0 111.919 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -65.55 0.67 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.006 1.322 . . . . 0.0 111.298 -171.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.9 -36.7 79.92 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.151 0.58 . . . . 0.0 109.507 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.4 -51.56 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 124.249 0.928 . . . . 0.0 111.953 -172.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.39 -41.06 70.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.965 0.506 . . . . 0.0 109.938 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.02 79.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.472 0.709 . . . . 0.0 112.17 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -85.73 -4.84 59.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.762 0.825 . . . . 0.0 111.245 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.07 10.95 62.86 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.015 -0.881 . . . . 0.0 114.223 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.2 m -65.44 -16.98 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.465 1.133 . . . . 0.0 109.982 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.13 106.62 0.45 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.97 125.05 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.27 -37.19 86.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.41 0.684 . . . . 0.0 111.628 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -98.23 -50.71 4.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.284 0.634 . . . . 0.0 111.716 -169.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.7 -24.59 62.68 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.257 0.481 . . . . 0.0 111.306 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 97.3 mtt180 52.54 47.75 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.337 1.455 . . . . 0.0 111.393 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 71.6 mt -129.14 171.06 12.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.027 1.331 . . . . 0.0 107.854 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.62 117.56 22.08 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.42 141.8 40.85 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 111.0 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.86 108.6 1.81 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 m -144.31 164.38 30.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -150.09 139.77 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -142.5 156.11 45.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.554 1.141 . . . . 0.0 108.447 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.9 134.73 48.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -129.5 134.5 47.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.18 165.95 10.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.01 1.324 . . . . 0.0 109.565 169.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -50.24 -37.32 35.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.657 1.183 . . . . 0.0 112.679 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.46 2.91 46.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.76 61.6 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.516 1.055 . . . . 0.0 113.596 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -61.2 118.41 6.82 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.905 1.353 . . . . 0.0 109.166 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.53 113.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.73 0.812 . . . . 0.0 109.054 170.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.08 -26.48 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 0.0 109.459 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -153.38 152.2 30.79 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 107.063 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.68 127.58 5.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -147.08 149.66 33.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -121.59 113.55 19.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.77 119.43 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m -59.12 -19.21 42.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.457 1.503 . . . . 0.0 112.881 -171.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.69 95.72 3.11 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.05 -20.86 65.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.883 0.873 . . . . 0.0 112.599 -172.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 6.17 3.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.722 1.209 . . . . 0.0 112.222 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.98 162.26 30.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.999 2.12 . . . . 0.0 107.854 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -96.99 145.54 29.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.929 -0.482 . . . . 0.0 111.506 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.0 174.15 11.2 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.867 3.045 . . . . 0.0 111.333 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -82.12 129.6 34.86 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -84.03 -11.89 56.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -80.46 -34.57 35.86 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -55.74 -52.05 75.33 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.798 -1.096 . . . . 0.0 112.042 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.6 -37.2 17.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.107 1.431 . . . . 0.0 111.777 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.11 -44.51 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.027 0.831 . . . . 0.0 109.972 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.63 -38.61 91.61 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.156 0.889 . . . . 0.0 110.637 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.54 85.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.26 0.224 . . . . 0.0 111.241 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.28 -47.72 55.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.882 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.62 -39.74 65.18 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.34 0.973 . . . . 0.0 110.796 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.39 -29.66 58.92 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.899 . . . . 0.0 112.267 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.55 -40.42 8.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.488 0.715 . . . . 0.0 111.934 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.94 -39.68 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.362 1.065 . . . . 0.0 111.355 -169.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 C--O 1.248 0.986 0 C-N-CA 123.953 0.901 . . . . 0.0 109.49 179.262 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 119.047 -0.501 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.69 143.96 34.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.291 1.036 . . . . 0.0 111.481 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -146.18 171.86 14.31 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.356 2.663 . . . . 0.0 105.038 170.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 pt -134.15 -179.61 3.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -127.58 149.93 49.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -139.7 126.95 21.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 46.54 34.66 2.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.444 1.098 . . . . 0.0 112.303 -172.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.97 81.93 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.325 -0.86 . . . . 0.0 114.538 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.24 119.25 4.78 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.54 140.53 89.82 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.951 2.434 . . . . 0.0 111.331 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.1 152.93 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.389 1.076 . . . . 0.0 109.559 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -101.71 163.42 12.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.553 1.541 . . . . 0.0 110.307 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.3 mt -113.31 140.51 47.94 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.029 1.331 . . . . 0.0 108.319 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.4 t -75.35 -61.8 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.76 34.04 3.0 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.568 1.08 . . . . 0.0 113.371 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 52.76 -138.21 1.15 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.296 1.438 . . . . 0.0 110.132 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -135.79 132.23 36.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.479 1.112 . . . . 0.0 110.559 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.66 169.08 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 162.69 40.51 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -52.65 130.41 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.86 -3.76 83.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.745 -1.03 . . . . 0.0 114.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -84.31 -3.13 58.06 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.694 1.747 . . . . 0.0 112.726 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 61.65 171.2 0.12 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.4 1.88 . . . . 0.0 112.935 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -119.29 106.49 42.75 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.449 1.5 . . . . 0.0 108.56 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 144.86 99.08 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.393 2.062 . . . . 0.0 113.13 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.96 65.33 7.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.873 2.069 . . . . 0.0 110.937 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -97.47 158.12 15.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.448 170.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.91 163.77 27.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 112.983 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.29 134.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 168.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -76.26 155.18 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.5 p -123.1 174.05 7.47 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -46.49 -32.19 3.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.333 1.053 . . . . 0.0 112.127 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -113.82 15.89 18.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.111 1.364 . . . . 0.0 111.436 -171.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 53.03 45.01 29.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.773 2.029 . . . . 0.0 112.172 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.4 -12.4 58.97 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.311 12.8 pt-20 44.8 48.88 9.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.433 1.893 . . . . 0.0 111.714 -169.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -46.57 122.03 3.89 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.388 2.275 . . . . 0.0 108.646 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.37 146.35 40.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -39.58 57.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.012 0.824 . . . . 0.0 111.093 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.51 -18.84 21.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.35 -29.06 70.43 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.446 1.021 . . . . 0.0 111.241 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.6 mtt -70.62 -32.76 70.22 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.695 1.198 . . . . 0.0 111.701 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -64.39 133.98 53.68 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.64 -25.88 2.94 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.903 1.24 . . . . 0.0 112.168 -171.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -149.47 157.6 43.43 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.288 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.1 135.99 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.0 m -135.36 146.09 48.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.519 1.128 . . . . 0.0 108.165 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.87 135.84 54.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.02 135.8 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.8 p -115.02 151.27 34.5 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.4 t -134.77 133.01 54.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -137.09 146.42 54.46 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.555 1.142 . . . . 0.0 108.67 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.14 -34.14 23.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.527 2.151 . . . . 0.0 111.914 -176.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -143.29 154.23 43.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.758 1.623 . . . . 0.0 106.979 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 tp -90.64 -32.11 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.263 0.625 . . . . 0.0 111.471 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.77 -17.99 27.17 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.371 0.668 . . . . 0.0 112.232 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.3 p -65.74 163.96 15.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.1 1.36 . . . . 0.0 111.707 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.94 -24.2 33.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.937 1.256 . . . . 0.0 114.864 -171.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.45 -29.47 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.906 1.353 . . . . 0.0 112.203 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.6 t -51.74 -51.33 56.99 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.111 1.365 . . . . 0.0 110.762 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.42 -34.6 12.04 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.078 0.551 . . . . 0.0 111.523 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.24 70.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.752 0.821 . . . . 0.0 112.367 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.473 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.0 tm0? -152.62 -39.51 0.1 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-O 117.762 -1.114 . . . . 0.0 112.513 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -60.59 -42.67 97.18 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.177 1.353 . . . . 0.0 112.357 -169.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -56.45 -56.2 24.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.146 0.884 . . . . 0.0 110.469 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.65 -40.96 93.05 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.406 0.548 . . . . 0.0 111.05 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.473 ' CB ' HE21 ' A' ' 63' ' ' GLN . 25.5 t80 -56.48 -52.67 63.82 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.796 0.438 . . . . 0.0 110.785 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -67.52 -34.88 78.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.164 0.186 . . . . 0.0 111.259 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -64.61 -53.26 50.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.357 1.463 . . . . 0.0 109.763 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -63.53 -38.77 92.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.493 0.717 . . . . 0.0 109.456 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.84 78.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.521 0.728 . . . . 0.0 110.738 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.94 -27.09 67.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.083 0.553 . . . . 0.0 112.31 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -76.26 -24.17 54.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.185 175.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.9 mt -63.89 -40.84 97.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.678 1.126 . . . . 0.0 110.475 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.41 -169.43 42.55 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.35 19.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.155 1.382 . . . . 0.0 113.418 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.05 145.19 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.41 1.484 . . . . 0.0 110.923 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -70.43 144.82 51.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.27 132.69 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -145.54 156.75 43.9 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.885 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.5 m -136.1 116.72 13.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 173.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.95 142.22 14.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.711 1.605 . . . . 0.0 107.499 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -136.23 173.39 11.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 110.136 -170.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.59 -177.81 2.4 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.433 0.635 . . . . 0.0 109.944 169.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.3 -25.07 65.47 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.943 -0.473 . . . . 0.0 111.349 171.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.0 tp -49.08 110.35 1.5 Allowed Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 126.013 1.725 . . . . 0.0 111.479 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -88.79 -6.28 5.82 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.552 2.168 . . . . 0.0 113.673 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -38.05 -37.28 0.25 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.645 2.378 . . . . 0.0 116.524 -168.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.66 14.4 2.52 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.031 0.832 . . . . 0.0 112.759 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -68.12 -45.45 73.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.363 0.983 . . . . 0.0 108.717 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.15 -9.3 38.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.293 1.037 . . . . 0.0 113.182 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -110.09 8.5 23.93 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.955 1.302 . . . . 0.0 110.757 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 46.23 48.81 13.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.794 1.638 . . . . 0.0 112.767 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 131.47 50.41 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 173.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.6 73.25 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.158 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.88 3.08 1.39 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.028 1.331 . . . . 0.0 113.064 -169.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -85.0 144.53 28.23 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.47 -49.39 3.84 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.636 1.112 . . . . 0.0 110.856 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 pt -76.63 70.19 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 125.747 1.619 . . . . 0.0 109.435 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.61 -23.82 0.75 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.665 2.786 . . . . 0.0 114.961 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -62.37 -30.65 71.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.369 1.068 . . . . 0.0 111.997 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 t -74.57 156.89 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.98 0.912 . . . . 0.0 108.866 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.32 142.29 41.86 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -86.36 134.65 33.71 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -125.01 164.43 20.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.051 2.14 . . . . 0.0 106.724 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.51 169.9 17.45 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.161 0.984 . . . . 0.0 108.749 169.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -149.02 -17.77 0.3 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -58.77 -17.24 21.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.811 -1.181 . . . . 0.0 113.449 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -53.62 -30.04 40.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.452 1.101 . . . . 0.0 112.625 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -142.18 -6.9 0.93 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.549 1.068 . . . . 0.0 112.975 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.08 30.75 5.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.822 2.049 . . . . 0.0 112.714 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -65.29 0.68 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.785 1.634 . . . . 0.0 111.669 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.77 -34.5 75.97 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.684 0.794 . . . . 0.0 110.28 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.43 98.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 124.305 0.955 . . . . 0.0 112.783 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.38 -35.86 71.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.383 1.091 . . . . 0.0 109.946 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.21 74.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.26 2.46 11.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.468 1.507 . . . . 0.0 111.656 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.96 72.09 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 119.321 0.964 . . . . 0.0 112.399 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . 0.253 33.5 m -107.14 3.04 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.397 0.679 . . . . 0.0 111.429 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.65 105.67 12.07 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 80.4 mt -67.61 127.85 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -66.37 -48.51 69.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.939 0.896 . . . . 0.0 111.109 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -80.27 -49.55 11.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.603 0.239 . . . . 0.0 110.574 -170.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.4 tp -78.71 -18.16 54.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 112.084 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 45.14 52.02 8.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.384 1.474 . . . . 0.0 111.371 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.9 tp -139.25 168.93 18.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.04 138.14 47.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.463 0.574 . . . . 0.0 110.056 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.43 155.95 40.01 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.386 1.075 . . . . 0.0 110.737 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -84.66 109.96 18.39 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.0 m -149.88 168.18 24.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.722 0.409 . . . . 0.0 110.519 -173.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.13 147.1 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.599 1.16 . . . . 0.0 108.22 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -146.77 154.82 41.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.353 1.061 . . . . 0.0 109.036 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.92 140.37 40.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 171.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 mp -130.81 137.18 49.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.57 1.548 . . . . 0.0 107.337 -171.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.44 169.12 6.32 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.158 1.383 . . . . 0.0 109.855 169.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -49.58 -37.93 29.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.741 1.217 . . . . 0.0 112.174 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -75.29 -3.16 31.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.193 0.997 . . . . 0.0 112.677 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.1 -6.96 77.41 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.927 -1.108 . . . . 0.0 112.89 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 113.6 3.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 118.871 1.335 . . . . 0.0 108.365 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.4 129.73 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.27 -12.57 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.661 1.584 . . . . 0.0 109.925 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -151.47 150.15 30.07 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.434 1.093 . . . . 0.0 108.413 172.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.2 135.54 13.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.263 1.825 . . . . 0.0 107.168 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 150.28 30.99 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.451 0.7 . . . . 0.0 109.391 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -124.36 116.24 22.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.779 2.032 . . . . 0.0 105.637 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.24 128.68 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -60.05 -26.69 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.537 1.135 . . . . 0.0 113.268 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.01 105.66 6.46 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.7 66.29 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.124 1.37 . . . . 0.0 113.905 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.21 15.93 2.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.89 -175.63 3.84 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.005 2.122 . . . . 0.0 107.978 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -116.96 155.05 49.73 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.006 1.275 . . . . 0.0 112.689 -170.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.24 163.82 32.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -80.07 87.3 5.45 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 168.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -68.57 -5.72 21.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -71.3 -30.01 65.73 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.08 0.855 . . . . 0.0 109.302 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -63.9 -50.74 68.63 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.496 -1.24 . . . . 0.0 111.621 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.58 -32.46 48.29 Favored 'Trans proline' 0 C--N 1.35 0.622 0 CA-C-N 121.707 1.646 . . . . 0.0 112.111 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.5 mm -59.78 -44.82 94.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.998 1.272 . . . . 0.0 109.816 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.97 -37.15 86.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.262 0.937 . . . . 0.0 110.9 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.62 91.64 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.396 -0.19 . . . . 0.0 111.24 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.17 -46.49 70.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.59 173.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -53.78 -40.87 66.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.277 0.944 . . . . 0.0 110.545 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.0 65.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 112.204 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.9 mt -90.94 -41.81 10.93 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.954 0.502 . . . . 0.0 112.074 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.5 t -70.37 -42.43 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.952 0.901 . . . . 0.0 111.2 -171.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.035 0 C-N-CA 124.233 1.013 . . . . 0.0 109.594 179.319 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.14 144.81 56.98 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.149 0.58 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -154.76 149.16 26.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 169.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.11 174.45 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -112.19 151.57 29.39 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -133.52 116.55 16.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 172.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp 44.36 41.84 4.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.382 1.473 . . . . 0.0 111.69 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.32 5.0 80.23 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.59 116.74 4.13 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.319 174.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.61 84.37 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.291 2.66 . . . . 0.0 112.1 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.35 141.69 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.632 1.173 . . . . 0.0 110.402 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -82.01 162.11 22.74 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.208 1.803 . . . . 0.0 110.358 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.42 145.26 45.35 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.912 1.285 . . . . 0.0 108.118 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.3 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.182 0.593 . . . . 0.0 109.701 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.42 34.16 2.7 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.668 1.128 . . . . 0.0 113.677 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 52.27 -148.94 0.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.865 1.666 . . . . 0.0 112.435 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -123.96 116.3 22.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.029 1.732 . . . . 0.0 108.309 -169.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 m -72.43 171.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -144.08 164.01 31.88 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.79 138.16 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.56 -3.76 76.9 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.941 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.38 -15.54 61.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.145 1.472 . . . . 0.0 114.214 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.05 104.5 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.985 1.714 . . . . 0.0 111.159 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.24 131.79 90.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.651 0.78 . . . . 0.0 111.259 -175.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.59 149.51 81.86 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.764 2.309 . . . . 0.0 113.773 173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -77.31 67.93 3.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.321 1.848 . . . . 0.0 108.849 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.78 160.42 14.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.314 1.046 . . . . 0.0 109.134 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.8 163.89 27.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.997 1.319 . . . . 0.0 111.793 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.36 173.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 129.934 3.294 . . . . 0.0 105.02 168.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -131.53 139.51 49.28 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -86.68 176.02 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.555 0.616 . . . . 0.0 111.517 -172.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -60.91 -25.53 66.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.972 0.909 . . . . 0.0 110.331 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m -81.29 1.72 31.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.053 1.341 . . . . 0.0 111.646 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.8 mt 60.01 38.99 20.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 127.162 2.185 . . . . 0.0 111.893 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.08 160.75 27.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.756 0.823 . . . . 0.0 110.887 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.09 146.09 47.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.205 1.002 . . . . 0.0 110.576 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -147.42 157.79 43.72 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.442 2.697 . . . . 0.0 103.82 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -135.54 158.98 43.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.72 -25.91 63.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.81 66.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.396 1.453 . . . . 0.0 112.9 173.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.57 -27.09 58.46 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.868 0.758 . . . . 0.0 110.996 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.3 mtt -73.5 -34.98 65.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.214 1.006 . . . . 0.0 110.544 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -55.99 152.07 10.87 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.53 0.732 . . . . 0.0 110.413 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.44 33.22 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.134 1.35 . . . . 0.0 112.58 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -147.89 150.75 34.68 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.473 1.509 . . . . 0.0 108.022 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.37 142.27 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 m -135.69 147.58 48.57 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.328 1.051 . . . . 0.0 108.383 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.84 134.24 58.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -139.95 116.73 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -95.08 153.25 17.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -136.04 134.87 50.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.04 147.59 51.34 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.776 1.63 . . . . 0.0 108.299 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -38.73 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.519 2.146 . . . . 0.0 111.833 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -146.74 169.96 17.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.393 2.277 . . . . 0.0 105.916 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.263 0.0 OUTLIER -117.62 -15.58 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 122.673 0.389 . . . . 0.0 111.322 -175.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.36 -29.88 68.7 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.375 -0.828 . . . . 0.0 110.717 169.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.21 143.57 57.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.1 1.36 . . . . 0.0 110.764 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -17.34 50.81 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.535 1.064 . . . . 0.0 114.762 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -54.5 -25.24 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.788 1.294 . . . . 0.0 112.694 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.9 p -60.1 -32.93 71.45 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.939 0.79 . . . . 0.0 111.904 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.67 -28.21 6.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.752 0.821 . . . . 0.0 111.58 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.31 69.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.989 0.915 . . . . 0.0 112.428 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -152.6 -39.5 0.1 Allowed 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.749 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -57.84 -45.19 86.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.847 1.203 . . . . 0.0 111.897 -169.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -59.21 -52.32 66.19 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -60.48 -42.79 97.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.665 0.666 . . . . 0.0 111.076 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.6 -51.0 70.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.078 0.551 . . . . 0.0 110.661 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -66.48 -27.4 67.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.01 0.124 . . . . 0.0 111.078 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -65.67 -44.44 86.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.085 1.354 . . . . 0.0 110.082 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.8 -43.97 82.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.457 0.571 . . . . 0.0 110.206 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -45.62 77.62 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.93 -11.12 44.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.678 1.191 . . . . 0.0 113.237 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -118.68 -1.86 11.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.639 1.176 . . . . 0.0 113.828 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -60.18 -37.36 79.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.133 1.333 . . . . 0.0 109.493 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.98 -172.53 41.67 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 127.969 2.7 . . . . 0.0 106.942 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -75.82 27.66 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.362 1.081 . . . . 0.0 112.564 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.4 144.2 11.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 120.756 -1.215 . . . . 0.0 109.958 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.48 145.34 54.15 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.12 121.8 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -172.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -137.31 154.14 50.13 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.318 0.647 . . . . 0.0 111.327 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -130.62 105.69 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.72 131.56 33.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -129.2 173.17 10.73 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.266 1.827 . . . . 0.0 108.048 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.05 171.65 5.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.64 0.733 . . . . 0.0 110.363 169.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.99 -16.55 64.43 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.275 1.03 . . . . 0.0 111.604 171.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.2 mt -53.61 128.0 51.86 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.814 1.246 . . . . 0.0 109.999 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.23 -9.29 15.21 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.916 2.411 . . . . 0.0 113.419 -174.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -52.66 112.27 0.8 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.748 1.219 . . . . 0.0 111.11 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.85 5.65 0.24 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.73 2.412 . . . . 0.0 115.436 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -61.93 -35.51 78.64 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 120.044 1.293 . . . . 0.0 110.258 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.01 -9.22 9.27 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -112.46 -4.85 14.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.281 0.946 . . . . 0.0 111.618 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 3.3 p90 32.4 57.52 0.39 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.635 2.374 . . . . 0.0 113.816 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 p -54.94 -28.46 51.26 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.62 -12.18 55.7 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.593 1.088 . . . . 0.0 113.976 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.32 -10.37 4.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.049 1.74 . . . . 0.0 112.721 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -64.7 125.94 26.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.914 0.486 . . . . 0.0 111.358 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.76 -21.18 20.24 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.199 0.904 . . . . 0.0 112.46 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mt -84.85 -31.69 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.457 1.129 . . . . 0.0 110.514 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.41 -35.4 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 131.65 3.98 . . . . 0.0 116.341 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -66.78 -35.21 79.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.517 1.127 . . . . 0.0 111.571 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.86 150.8 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.632 1.173 . . . . 0.0 107.959 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.44 143.78 35.75 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 p -79.8 155.44 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.402 0.62 . . . . 0.0 109.523 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.1 mt -129.2 162.78 27.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.927 1.691 . . . . 0.0 107.312 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.5 m -137.17 44.58 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.572 1.549 . . . . 0.0 110.323 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -48.32 -36.03 13.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -169.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -50.82 -25.96 5.12 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.801 1.182 . . . . 0.0 114.182 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.7 ttt85 -60.19 -22.65 63.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.072 0.851 . . . . 0.0 112.376 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -127.79 -19.16 4.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.758 1.623 . . . . 0.0 111.955 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 58.25 11.54 1.62 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 129.928 3.291 . . . . 0.0 114.402 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.6 m -69.6 -42.81 73.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.456 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.25 -37.03 81.62 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.654 1.57 . . . . 0.0 109.379 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.35 -53.16 21.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.617 1.579 . . . . 0.0 112.865 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.11 -37.02 69.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.351 0.575 . . . . 0.0 110.477 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.84 -32.91 73.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.009 0.924 . . . . 0.0 112.911 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.35 1.04 13.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.648 1.179 . . . . 0.0 111.744 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.53 37.81 94.08 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 119.123 0.874 . . . . 0.0 112.047 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.37 -1.94 9.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.678 . . . . 0.0 110.91 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.87 106.1 5.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 168.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.9 mt -69.42 120.9 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -64.49 -43.13 95.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -89.07 -6.08 57.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -170.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -132.76 -13.23 2.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.582 0.753 . . . . 0.0 112.701 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.251 39.3 ptt180 41.65 43.44 2.37 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.711 1.604 . . . . 0.0 113.036 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 mt -124.98 172.54 9.33 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 170.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.85 140.02 45.46 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.885 0.874 . . . . 0.0 109.634 173.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.65 157.56 35.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.366 1.067 . . . . 0.0 110.793 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.16 112.12 19.96 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -153.76 167.05 30.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.78 147.18 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -143.61 155.27 44.22 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.305 1.442 . . . . 0.0 108.575 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.16 139.76 45.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -129.5 129.87 45.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.237 1.415 . . . . 0.0 108.334 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.28 166.71 9.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.015 0.926 . . . . 0.0 108.997 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -50.4 -31.03 13.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.754 174.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -81.84 -4.43 56.47 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.483 1.113 . . . . 0.0 113.217 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.86 62.9 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.209 -0.932 . . . . 0.0 111.596 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -86.55 118.09 25.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.56 114.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 170.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 p -97.44 -14.44 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.167 0.987 . . . . 0.0 109.886 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 152.32 32.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.274 1.029 . . . . 0.0 108.659 169.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.25 137.55 13.85 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.378 1.871 . . . . 0.0 107.251 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.21 149.97 31.85 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.187 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -123.71 114.52 20.05 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.39 135.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.3 m -58.64 -21.48 54.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.539 1.136 . . . . 0.0 113.509 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -140.08 129.6 24.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -53.83 -35.04 61.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -80.67 -6.93 59.07 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.516 1.053 . . . . 0.0 112.715 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.57 -173.67 4.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -137.89 156.33 74.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 110.104 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.38 168.29 16.67 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.836 2.357 . . . . 0.0 110.287 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -74.89 113.99 12.83 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -80.76 -6.71 58.86 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.11 -32.29 64.86 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 120.995 -1.065 . . . . 0.0 108.572 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -60.4 -51.32 80.9 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.147 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.14 -33.0 41.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.453 1.555 . . . . 0.0 112.747 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.2 mm -59.9 -47.47 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 120.455 1.479 . . . . 0.0 109.51 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.52 -38.88 92.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.027 0.83 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.78 92.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.324 0.249 . . . . 0.0 111.271 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.12 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.686 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -53.9 -41.64 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.069 0.849 . . . . 0.0 110.569 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.05 -30.45 64.27 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.571 0.749 . . . . 0.0 112.174 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 62.6 mt -90.43 -43.12 10.49 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.004 0.522 . . . . 0.0 111.68 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.6 t -71.49 -45.1 69.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.978 0.911 . . . . 0.0 111.331 -170.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.69 0.796 . . . . 0.0 109.642 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.94 14.71 1.47 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.593 1.957 . . . . 0.0 114.472 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -171.56 144.43 1.89 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 131.293 3.837 . . . . 0.0 102.412 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.8 pt -142.08 171.9 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 122.575 1.179 . . . . 0.0 110.366 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -109.96 157.41 19.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.51 113.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 45.51 43.95 9.4 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.66 1.584 . . . . 0.0 111.556 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 4.61 82.03 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.46 126.15 7.59 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 145.9 63.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.643 2.222 . . . . 0.0 110.148 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -136.39 179.48 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 108.778 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -127.54 158.98 35.98 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.5 mt -112.88 172.93 6.63 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.833 1.253 . . . . 0.0 109.35 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.74 149.82 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 56.99 19.09 29.02 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.925 1.726 . . . . 0.0 115.884 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -67.59 176.78 2.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.764 2.025 . . . . 0.0 114.976 -169.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.254 6.1 tt0 87.8 30.85 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.105 2.562 . . . . 0.0 113.325 169.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.16 143.44 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 168.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -149.45 165.19 32.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.872 1.269 . . . . 0.0 108.068 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 p -54.6 133.88 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.15 81.38 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.492 1.044 . . . . 0.0 113.806 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.71 -10.52 59.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.483 1.641 . . . . 0.0 114.177 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 71.37 127.71 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.463 1.905 . . . . 0.0 112.385 169.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.42 126.5 88.2 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.287 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -62.29 -30.31 81.03 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 114.147 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.6 t70 94.79 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 130.468 3.507 . . . . 0.0 106.838 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.04 174.2 10.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.821 2.049 . . . . 0.0 107.779 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 m -131.81 120.76 23.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -105.01 165.24 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.394 1.478 . . . . 0.0 107.506 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.07 143.32 38.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 p -76.58 179.29 6.06 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.087 0.955 . . . . 0.0 110.155 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.91 -24.46 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.162 -0.961 . . . . 0.0 111.114 168.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -89.93 3.79 52.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.784 2.034 . . . . 0.0 112.158 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 57.44 29.3 16.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.908 2.083 . . . . 0.0 113.188 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.24 144.48 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.61 142.23 42.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.469 0.708 . . . . 0.0 109.431 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -148.32 113.79 5.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 107.391 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 p -72.38 154.78 40.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.466 0.65 . . . . 0.0 109.321 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.52 -39.21 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.27 -25.69 15.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.101 0.961 . . . . 0.0 113.483 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.86 -28.5 55.45 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.791 1.178 . . . . 0.0 111.499 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.9 mtt -69.69 -30.93 68.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.045 0.938 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -57.76 152.61 15.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.526 0.679 . . . . 0.0 110.467 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.93 -8.23 38.94 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.482 1.039 . . . . 0.0 113.094 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -152.66 152.76 32.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.815 1.646 . . . . 0.0 107.861 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.21 144.93 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.8 m -136.01 148.15 48.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.399 1.08 . . . . 0.0 108.582 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.5 mt -130.62 137.74 55.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.5 mt -135.1 102.78 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -174.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -84.84 149.86 25.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -139.23 136.67 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -141.71 146.82 42.93 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.915 1.286 . . . . 0.0 109.316 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.48 -38.81 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.188 1.925 . . . . 0.0 111.496 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 p -162.77 148.66 12.34 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.26 1.424 . . . . 0.0 108.065 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.23 -19.33 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.652 0.781 . . . . 0.0 111.014 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.6 -26.17 68.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.342 1.057 . . . . 0.0 112.087 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 p -62.8 138.97 58.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.313 0.578 . . . . 0.0 110.686 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.63 -4.29 69.91 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.729 0.68 . . . . 0.0 113.392 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.86 -25.99 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.523 1.129 . . . . 0.0 111.968 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.78 -42.75 85.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.856 0.753 . . . . 0.0 111.83 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.35 -37.52 80.56 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.409 0.549 . . . . 0.0 110.134 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.21 72.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.404 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.7 tm0? -155.3 -53.6 0.09 Allowed 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -39.76 79.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.631 1.559 . . . . 0.0 114.486 -167.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -64.91 -48.91 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.536 1.517 . . . . 0.0 110.179 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -61.33 -49.16 78.11 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 118.846 0.748 . . . . 0.0 109.806 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CB ' HE21 ' A' ' 63' ' ' GLN . 61.1 t80 -56.98 -48.64 77.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.259 0.624 . . . . 0.0 110.797 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -61.98 -39.68 93.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.511 0.724 . . . . 0.0 110.856 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.84 -38.83 80.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.124 0.97 . . . . 0.0 111.075 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.94 -45.16 71.47 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.201 0.91 . . . . 0.0 110.309 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.86 69.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.929 1.291 . . . . 0.0 110.856 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.93 -21.35 61.01 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.949 0.9 . . . . 0.0 113.127 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -120.13 7.67 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.41 -30.79 68.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.851 1.205 . . . . 0.0 111.626 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.65 -74.25 0.06 OUTLIER Glycine 0 C--N 1.336 0.551 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -162.91 110.16 1.23 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.48 155.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.889 1.276 . . . . 0.0 107.987 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -76.45 144.26 40.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.66 129.66 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.56 157.69 45.38 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.27 1.028 . . . . 0.0 110.08 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 45.6 m -127.13 98.02 5.15 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 mt -76.69 128.61 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 m -139.32 170.03 16.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.617 1.567 . . . . 0.0 108.862 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.41 175.2 10.51 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.98 0.895 . . . . 0.0 111.612 176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -86.44 -14.36 43.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.663 1.585 . . . . 0.0 110.854 169.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 tp -50.28 142.21 14.86 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 127.065 2.146 . . . . 0.0 110.867 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -52.52 -34.01 60.34 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.858 2.372 . . . . 0.0 113.672 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -79.67 35.53 0.3 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.047 1.339 . . . . 0.0 111.595 175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.12 154.49 48.13 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.774 1.229 . . . . 0.0 109.139 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 62.45 -22.3 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.338 2.655 . . . . 0.0 117.202 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.1 -25.74 64.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.82 1.191 . . . . 0.0 114.056 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.12 39.93 3.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.481 1.512 . . . . 0.0 108.858 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -29.81 120.29 0.16 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.407 2.283 . . . . 0.0 113.601 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.3 m -77.78 46.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.659 1.583 . . . . 0.0 114.024 -169.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 97' ' ' ASN . . . 168.45 -34.33 0.19 Allowed Glycine 0 C--N 1.333 0.397 0 O-C-N 121.276 -0.89 . . . . 0.0 112.486 172.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 16.73 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.56 1.144 . . . . 0.0 114.071 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 95' ' ' GLY . 15.7 t-20 -136.1 65.85 1.52 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.871 1.668 . . . . 0.0 107.177 170.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.76 -37.57 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.805 1.193 . . . . 0.0 111.016 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.22 89.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.24 -23.55 9.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.494 1.918 . . . . 0.0 113.983 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.37 -32.26 72.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.858 0.863 . . . . 0.0 112.29 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.92 147.05 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -148.99 145.27 27.24 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 p -80.41 151.71 29.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.394 0.616 . . . . 0.0 109.586 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.44 156.64 29.79 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.171 1.388 . . . . 0.0 107.695 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 m -120.45 46.44 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.629 1.972 . . . . 0.0 110.326 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -55.52 -32.1 62.63 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.967 -1.083 . . . . 0.0 113.217 -170.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -55.87 -17.26 5.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -58.37 -27.38 64.16 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.305 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -141.88 -3.35 1.12 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.801 1.182 . . . . 0.0 113.808 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.86 28.66 6.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.5 2.32 . . . . 0.0 113.802 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 m -59.33 -58.9 6.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.923 0.889 . . . . 0.0 110.773 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.97 -33.92 75.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.803 0.841 . . . . 0.0 109.792 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.19 -57.77 8.65 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 125.141 1.353 . . . . 0.0 112.08 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.4 -39.77 58.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.149 0.474 . . . . 0.0 110.15 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.17 85.6 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.99 3.07 30.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.916 1.286 . . . . 0.0 110.672 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.62 29.06 71.56 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 121.553 -0.717 . . . . 0.0 113.625 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.06 -1.73 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.107 0.963 . . . . 0.0 110.612 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.44 105.73 1.24 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.638 1.108 . . . . 0.0 108.086 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.38 115.89 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -57.36 -43.42 83.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 111.028 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -92.9 -4.62 52.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -169.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.79 -14.75 2.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.648 0.779 . . . . 0.0 112.402 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 48.92 40.4 16.6 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.84 1.656 . . . . 0.0 112.144 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 mt -126.27 173.9 8.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.73 126.97 31.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.394 1.478 . . . . 0.0 108.972 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 137.32 58.24 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.749 1.219 . . . . 0.0 110.637 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.55 108.63 0.85 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.322 1.049 . . . . 0.0 108.318 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.2 p -156.58 170.16 23.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.012 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.03 147.37 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -144.18 153.01 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.05 136.07 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.9 mp -129.56 133.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.728 1.211 . . . . 0.0 107.801 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.44 161.08 14.94 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.659 1.183 . . . . 0.0 109.825 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -33.14 -41.82 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.428 2.691 . . . . 0.0 115.413 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -91.1 -8.15 49.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.51 3.38 43.76 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.202 0.906 . . . . 0.0 113.567 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -71.47 118.69 14.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.85 1.825 . . . . 0.0 108.691 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.96 116.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 170.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.52 -15.41 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.294 1.038 . . . . 0.0 109.967 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -149.87 150.08 31.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 108.081 171.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.72 127.02 5.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.126 1.77 . . . . 0.0 106.93 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -149.23 149.83 31.6 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.031 0.832 . . . . 0.0 110.076 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.28 113.82 20.96 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.69 126.87 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.6 m -63.98 -2.6 2.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.66 1.184 . . . . 0.0 114.168 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -141.52 124.39 16.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.08 -31.0 66.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.768 1.227 . . . . 0.0 113.501 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.5 p -86.73 15.81 5.37 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.004 0.82 . . . . 0.0 111.771 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -127.53 179.44 5.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.468 1.507 . . . . 0.0 110.085 -174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -137.81 159.16 69.88 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.772 1.229 . . . . 0.0 110.592 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -89.4 -178.64 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.436 2.758 . . . . 0.0 110.55 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -75.53 94.14 3.11 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -72.45 -6.3 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.708 0.803 . . . . 0.0 112.913 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.67 -28.59 61.84 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 119.658 1.117 . . . . 0.0 108.982 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -61.1 -49.96 86.42 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.11 -33.86 59.85 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.53 1.582 . . . . 0.0 112.732 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.92 -45.85 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.348 1.431 . . . . 0.0 109.639 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.67 -38.84 92.64 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.412 1.006 . . . . 0.0 110.53 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.43 91.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.53 0.332 . . . . 0.0 111.207 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.29 61.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.981 0.513 . . . . 0.0 110.761 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.21 -39.45 69.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.059 0.845 . . . . 0.0 110.957 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.01 65.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.463 0.705 . . . . 0.0 111.89 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 63.1 mt -91.87 -43.89 9.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.353 0.524 . . . . 0.0 111.452 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.51 -39.6 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 0.0 110.767 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 mttp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 126.488 1.915 . . . . 0.0 110.069 -174.016 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.04 156.01 42.34 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.151 0.98 . . . . 0.0 109.59 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -152.19 152.26 32.03 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.9 pt -133.62 179.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.655 0.74 . . . . 0.0 109.53 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -129.04 145.14 51.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -144.54 130.02 18.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 45.93 38.9 4.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.634 1.174 . . . . 0.0 112.175 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.44 26.32 73.54 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.274 -0.737 . . . . 0.0 114.374 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 139.91 11.33 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.22 144.74 42.34 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.369 2.046 . . . . 0.0 110.25 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.94 134.0 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.246 1.018 . . . . 0.0 109.767 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -81.2 166.22 20.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.618 1.967 . . . . 0.0 110.62 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.2 154.87 30.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.862 1.665 . . . . 0.0 109.539 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -85.65 -65.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.662 0.665 . . . . 0.0 110.24 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.63 4.22 86.38 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.68 0.657 . . . . 0.0 114.225 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 52.59 176.31 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.779 2.831 . . . . 0.0 116.45 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.93 113.51 3.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.591 1.956 . . . . 0.0 111.573 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.71 160.62 4.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -137.93 157.89 45.47 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.57 132.49 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.38 -2.1 87.43 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.667 -1.074 . . . . 0.0 114.279 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.57 -4.72 58.07 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.765 1.783 . . . . 0.0 112.596 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 59.16 177.2 0.08 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.561 1.544 . . . . 0.0 112.058 -169.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.09 135.29 21.08 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.287 1.835 . . . . 0.0 108.328 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -72.23 156.4 55.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.179 1.919 . . . . 0.0 109.453 172.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -74.59 66.02 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.676 1.99 . . . . 0.0 110.66 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -61.33 155.21 21.88 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.295 1.438 . . . . 0.0 109.561 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 m -94.86 155.1 16.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.37 171.66 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.161 2.184 . . . . 0.0 106.955 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.9 mt -132.93 130.2 39.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -72.85 -176.89 2.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.697 1.199 . . . . 0.0 111.981 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -57.37 -32.35 66.7 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 110.485 169.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -85.62 2.98 42.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.867 1.667 . . . . 0.0 112.047 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt 52.22 36.82 20.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.507 1.923 . . . . 0.0 112.315 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -91.75 149.53 21.56 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.3 144.81 49.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.159 0.981 . . . . 0.0 110.148 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -153.97 159.15 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.45 2.7 . . . . 0.0 104.838 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 m -142.53 166.45 24.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.9 tp -49.79 -42.03 45.86 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.683 0.393 . . . . 0.0 111.311 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.56 -21.9 63.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.38 -30.25 60.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.821 0.737 . . . . 0.0 111.06 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.8 mtt -72.45 -37.39 68.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.566 1.146 . . . . 0.0 110.662 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -55.98 152.77 9.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.008 0.908 . . . . 0.0 111.517 -173.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.53 11.59 66.05 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.977 1.275 . . . . 0.0 113.251 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -154.17 148.21 25.71 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.559 1.544 . . . . 0.0 107.699 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.17 141.49 16.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.8 m -133.19 143.09 48.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.1 mt -135.92 132.55 50.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -172.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -139.56 134.28 38.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -169.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.92 144.76 42.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 168.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 t -121.7 126.8 75.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.35 127.82 5.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -173.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.97 -41.98 71.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.261 1.974 . . . . 0.0 112.43 -169.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.7 t -157.5 145.98 19.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -17.82 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 122.438 0.295 . . . . 0.0 111.129 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.19 -21.37 63.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 112.672 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.5 p -59.15 -24.62 63.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.659 0.784 . . . . 0.0 112.431 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.54 -10.29 59.68 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.881 0.753 . . . . 0.0 112.144 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.93 -18.21 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 118.85 1.325 . . . . 0.0 110.069 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.6 p -51.77 -43.63 63.07 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.34 -41.13 63.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.849 0.749 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.23 -30.88 71.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 -173.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -146.76 -49.02 0.19 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.317 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 m -55.49 -45.32 77.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.643 1.11 . . . . 0.0 113.451 -167.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -48.8 80.22 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.703 0.683 . . . . 0.0 109.892 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.65 -45.94 73.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.843 0.747 . . . . 0.0 109.548 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.64 -53.49 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.432 0.693 . . . . 0.0 110.276 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -29.78 53.49 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -63.75 -55.32 24.11 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.334 1.054 . . . . 0.0 109.915 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.71 -37.35 87.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.6 0.76 . . . . 0.0 109.559 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.58 69.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.76 0.824 . . . . 0.0 110.799 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.79 68.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.467 0.307 . . . . 0.0 111.65 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -75.44 -22.74 57.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.007 -0.997 . . . . 0.0 112.641 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.57 -40.63 95.91 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.204 1.365 . . . . 0.0 110.944 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.47 -168.15 41.06 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -173.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -74.15 29.02 0.08 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.024 1.33 . . . . 0.0 113.311 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.9 m -62.08 154.6 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.482 -1.386 . . . . 0.0 110.832 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.62 149.71 29.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.58 123.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -133.91 149.02 51.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.097 0.559 . . . . 0.0 111.396 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -127.81 99.09 5.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -84.67 130.48 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 m -142.95 172.99 11.95 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.013 1.325 . . . . 0.0 110.639 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.74 172.01 8.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.895 0.878 . . . . 0.0 111.5 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.84 -4.6 58.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.297 1.039 . . . . 0.0 111.31 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.5 tp -46.73 126.07 8.19 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.706 1.602 . . . . 0.0 109.609 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -51.96 -27.44 28.24 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.622 2.881 . . . . 0.0 116.869 -169.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -75.53 -20.71 58.51 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.702 0.683 . . . . 0.0 112.261 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.42 172.29 9.73 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.494 0.718 . . . . 0.0 110.231 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.298 0.1 OUTLIER 42.93 20.06 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.926 2.491 . . . . 0.0 116.656 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.47 -7.37 56.1 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.514 1.126 . . . . 0.0 112.323 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.1 mtp85 55.69 30.84 16.26 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.033 1.733 . . . . 0.0 112.524 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -64.28 -25.83 68.23 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.981 -0.45 . . . . 0.0 111.421 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 p -158.78 171.87 19.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.018 1.727 . . . . 0.0 108.371 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.76 -84.41 1.11 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.94 36.9 0.64 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 -172.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -139.66 137.96 35.68 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.019 1.328 . . . . 0.0 108.197 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.99 -14.18 65.01 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.01 0.814 . . . . 0.0 112.024 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.91 93.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 126.335 1.854 . . . . 0.0 106.269 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.27 -25.63 48.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.501 1.52 . . . . 0.0 113.196 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -55.59 -36.67 67.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.987 1.315 . . . . 0.0 112.694 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.2 t -70.86 147.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -129.55 141.92 50.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.2 p -87.44 136.81 32.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.9 146.08 46.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 m -121.65 51.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.742 1.217 . . . . 0.0 109.687 -168.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.21 -31.48 43.32 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -56.66 -21.68 29.2 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.941 1.701 . . . . 0.0 114.05 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -76.49 -6.23 50.91 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.146 -0.971 . . . . 0.0 112.551 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.17 -39.88 0.6 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.028 1.331 . . . . 0.0 112.44 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.75 4.29 3.9 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 130.054 3.342 . . . . 0.0 114.815 170.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -58.81 -44.51 90.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.259 -1.353 . . . . 0.0 111.957 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.06 -41.58 90.6 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 121.064 1.756 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.61 -43.11 96.35 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 123.996 0.808 . . . . 0.0 111.772 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -72.76 -46.72 51.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.271 0.536 . . . . 0.0 109.994 173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.19 81.06 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.241 1.016 . . . . 0.0 112.532 -172.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.04 5.83 26.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.0 110.618 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.6 32.45 58.34 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.717 0.675 . . . . 0.0 113.563 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.35 -8.75 9.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 123.45 0.7 . . . . 0.0 110.097 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -68.96 111.32 4.91 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.32 128.13 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -66.87 -47.36 72.12 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 110.933 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -90.83 0.05 57.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 tp -129.82 -13.55 4.14 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.629 1.172 . . . . 0.0 111.591 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 47.15 47.91 16.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.922 1.689 . . . . 0.0 111.193 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.3 tp -139.88 156.88 46.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.468 1.107 . . . . 0.0 108.206 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.08 131.24 45.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.326 0.65 . . . . 0.0 109.519 173.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.85 164.32 25.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.993 1.317 . . . . 0.0 112.407 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -86.03 113.5 22.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.5 m -148.14 173.53 12.87 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.709 0.804 . . . . 0.0 109.681 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 144.7 17.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.886 1.274 . . . . 0.0 108.454 177.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -148.34 158.87 44.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.573 1.149 . . . . 0.0 109.998 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.04 140.65 40.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mp -131.75 135.73 47.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.235 1.414 . . . . 0.0 107.591 -173.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.35 166.67 7.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 110.04 169.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.32 -31.96 23.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.116 1.367 . . . . 0.0 113.012 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -80.91 -0.86 41.06 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.432 1.093 . . . . 0.0 112.67 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.12 -6.75 82.76 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.625 1.107 . . . . 0.0 112.608 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.2 124.9 22.37 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.719 1.259 . . . . 0.0 109.232 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.81 128.24 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.737 0.815 . . . . 0.0 110.112 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.79 -19.51 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 109.917 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -145.08 147.05 32.13 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.81 131.94 12.69 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.037 1.335 . . . . 0.0 108.237 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.26 149.66 31.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.606 0.762 . . . . 0.0 109.365 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -128.06 117.19 21.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.823 2.049 . . . . 0.0 105.55 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.5 125.32 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -59.09 -25.02 63.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.693 1.197 . . . . 0.0 112.86 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -134.58 100.77 4.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.09 66.64 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.563 1.145 . . . . 0.0 112.757 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.82 8.7 2.26 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.652 1.181 . . . . 0.0 112.422 170.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.68 162.48 30.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.252 1.821 . . . . 0.0 108.699 173.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -90.12 145.46 32.98 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.69 166.55 29.09 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.991 2.461 . . . . 0.0 111.579 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -85.44 139.39 31.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -104.07 -8.73 19.3 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.39 -39.29 59.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -51.36 -58.03 12.12 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.987 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.94 -34.41 23.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 121.493 1.569 . . . . 0.0 112.393 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 mm -59.58 -42.66 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.142 1.337 . . . . 0.0 109.998 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.39 -36.96 84.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.413 1.006 . . . . 0.0 110.716 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.45 87.24 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.376 -0.202 . . . . 0.0 110.884 175.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.59 -40.73 69.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.623 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.91 -40.65 76.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.92 1.236 . . . . 0.0 110.26 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.81 66.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.177 0.591 . . . . 0.0 112.317 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.09 -60.37 2.32 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.961 0.504 . . . . 0.0 110.46 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.39 -45.04 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.145 1.378 . . . . 0.0 111.905 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm . . . . . 0 C--O 1.25 1.094 0 C-N-CA 126.802 2.041 . . . . 0.0 110.936 -176.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.85 27.22 4.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.782 2.033 . . . . 0.0 114.959 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -83.51 171.84 12.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.483 0.713 . . . . 0.0 109.52 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 pt -131.43 171.82 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 123.18 1.467 . . . . 0.0 110.37 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -115.82 153.95 30.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -140.29 122.79 16.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.17 39.13 1.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.365 1.466 . . . . 0.0 113.492 -171.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.33 6.18 89.47 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.674 -0.641 . . . . 0.0 114.396 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.77 125.42 7.93 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.185 1.374 . . . . 0.0 109.863 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.76 141.17 48.68 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 CA-C-N 120.995 2.397 . . . . 0.0 110.062 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.57 138.96 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.777 0.831 . . . . 0.0 109.844 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -86.02 155.59 20.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.119 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mt -118.9 153.38 34.66 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.194 1.398 . . . . 0.0 107.94 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.87 -15.58 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.58 33.8 0.45 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.971 0.805 . . . . 0.0 111.79 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -51.74 151.15 3.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.401 0.681 . . . . 0.0 112.209 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.262 8.6 tt0 108.44 23.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 129.242 3.017 . . . . 0.0 112.727 169.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.68 141.21 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -148.7 165.47 31.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.101 0.96 . . . . 0.0 109.167 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 p -54.01 132.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.02 -0.2 89.93 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.081 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.66 -12.04 59.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.546 1.673 . . . . 0.0 112.545 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 59.68 167.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.449 1.9 . . . . 0.0 113.101 -171.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.04 128.25 31.31 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.351 1.46 . . . . 0.0 108.466 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.39 -25.06 63.92 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.304 2.669 . . . . 0.0 114.428 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 66.81 100.67 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.995 2.518 . . . . 0.0 112.441 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -142.46 172.34 12.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.522 1.529 . . . . 0.0 109.274 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -89.21 154.38 20.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.76 1.224 . . . . 0.0 111.427 -169.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.83 164.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 128.087 2.555 . . . . 0.0 104.995 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 tp -116.85 140.4 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.11 168.12 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.23 -24.65 66.51 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.736 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -80.33 0.65 32.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.976 1.71 . . . . 0.0 112.011 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.6 mt 64.83 44.32 3.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.097 2.159 . . . . 0.0 111.946 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -119.73 145.98 46.04 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.26 1.024 . . . . 0.0 108.886 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.42 139.4 45.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.674 0.79 . . . . 0.0 109.312 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -142.01 102.18 4.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 m -71.03 153.59 42.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -58.94 -30.85 68.18 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.169 -0.957 . . . . 0.0 110.863 170.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.07 8.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.397 1.479 . . . . 0.0 113.286 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.06 -28.12 35.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.991 0.916 . . . . 0.0 111.676 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.2 mtt -72.41 -48.56 40.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.129 0.971 . . . . 0.0 110.496 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.36 171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.966 0.888 . . . . 0.0 110.291 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 -15.2 48.19 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.451 1.5 . . . . 0.0 110.575 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -153.02 159.81 42.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.542 2.737 . . . . 0.0 106.29 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.4 144.29 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 m -132.74 149.37 52.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.207 1.003 . . . . 0.0 109.551 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.5 138.64 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.3 mt -139.49 113.68 7.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 m -89.32 144.95 25.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.31 134.81 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 pt -147.67 159.39 41.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 107.928 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.02 -52.24 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 N-CA-C 108.513 -1.38 . . . . 0.0 108.513 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 m -150.9 146.72 26.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.703 1.601 . . . . 0.0 108.643 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -20.7 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 111.047 171.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -60.1 -14.25 15.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.14 0.976 . . . . 0.0 113.319 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 p -56.65 -27.47 58.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.641 0.776 . . . . 0.0 111.866 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.43 4.67 84.79 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.167 0.889 . . . . 0.0 112.266 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.02 -13.88 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 119.065 1.433 . . . . 0.0 111.976 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.6 m -57.75 -47.47 82.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.118 0.967 . . . . 0.0 110.539 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.38 -28.83 64.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.318 0.647 . . . . 0.0 111.35 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.82 -59.5 5.05 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -161.51 -14.22 0.04 OUTLIER 'General case' 0 C--N 1.341 0.203 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -69.59 -31.01 68.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.283 1.401 . . . . 0.0 112.825 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -61.88 -50.57 71.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.269 0.941 . . . . 0.0 108.841 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -62.37 -48.05 81.45 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.587 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.15 -50.75 71.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.641 0.777 . . . . 0.0 110.562 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -68.46 -33.03 73.46 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.388 -0.195 . . . . 0.0 110.757 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.7 -42.03 78.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 111.426 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.33 -44.92 96.4 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.397 0.998 . . . . 0.0 109.678 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.02 -38.58 70.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.441 0.696 . . . . 0.0 111.402 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.89 -5.71 22.88 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -116.02 -12.3 11.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.689 1.596 . . . . 0.0 112.66 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -57.88 -32.47 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.643 1.11 . . . . 0.0 111.64 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.91 -159.69 32.88 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.61 22.21 0.14 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.469 -1.018 . . . . 0.0 112.386 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.82 134.83 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.979 1.712 . . . . 0.0 108.817 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.79 135.85 53.26 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -144.08 133.22 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -170.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.72 162.4 35.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.616 0.766 . . . . 0.0 110.926 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.8 m -133.03 124.46 27.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.22 133.27 53.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -141.12 169.09 18.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.152 0.981 . . . . 0.0 110.484 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.3 -179.06 1.49 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 112.003 174.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.13 -35.44 28.49 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -174.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.45 156.44 52.51 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 119.031 -0.509 . . . . 0.0 112.275 -169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.4 -38.59 63.44 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.545 2.83 . . . . 0.0 114.61 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -60.76 -8.78 3.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.0 1.32 . . . . 0.0 113.793 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.5 -6.86 10.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.552 1.941 . . . . 0.0 111.978 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -139.81 15.57 2.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.826 1.193 . . . . 0.0 113.664 -169.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.41 155.05 44.3 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.948 1.299 . . . . 0.0 108.724 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 48.01 38.71 9.88 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.532 1.133 . . . . 0.0 111.213 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -62.92 157.89 20.54 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.232 1.013 . . . . 0.0 111.404 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.93 -28.58 13.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.33 -65.52 1.85 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.95 34.29 0.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.365 1.066 . . . . 0.0 111.981 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -67.18 -5.37 13.34 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.991 1.316 . . . . 0.0 114.272 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.32 -17.81 1.89 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.132 1.825 . . . . 0.0 109.376 -169.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.22 91.8 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.4 -27.44 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -66.75 -22.16 66.05 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.073 0.949 . . . . 0.0 112.256 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 t -91.37 154.09 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.3 147.43 47.45 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.9 m -104.14 138.98 39.84 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.6 mp -118.44 160.97 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.108 1.763 . . . . 0.0 108.233 -170.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.7 54.31 1.88 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.231 1.412 . . . . 0.0 108.776 -168.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.13 -24.92 57.55 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -56.39 -19.73 16.2 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 120.299 1.409 . . . . 0.0 112.895 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -81.64 -4.3 55.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.857 1.263 . . . . 0.0 112.845 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -141.87 -41.98 0.35 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.032 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.44 -3.07 1.41 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 129.529 3.132 . . . . 0.0 114.83 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -64.91 -45.76 84.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.586 1.539 . . . . 0.0 110.691 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.25 -42.66 95.77 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.18 0.9 . . . . 0.0 110.51 174.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.87 96.28 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.82 -43.74 92.15 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.521 0.66 . . . . 0.0 109.707 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.78 -47.06 86.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.583 0.753 . . . . 0.0 112.188 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -83.8 -1.9 55.24 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.093 0.957 . . . . 0.0 111.504 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.31 38.04 95.32 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.402 -0.666 . . . . 0.0 111.936 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.2 -0.2 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.292 1.437 . . . . 0.0 110.584 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -76.82 114.88 16.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.28 113.0 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -59.15 -40.95 87.1 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.285 1.034 . . . . 0.0 110.595 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -91.72 -4.46 55.05 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 tp -140.51 -0.38 1.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.027 0.831 . . . . 0.0 113.178 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 43.28 41.51 3.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.697 1.999 . . . . 0.0 114.431 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -132.06 167.94 18.83 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.861 0.865 . . . . 0.0 108.847 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.72 134.48 47.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 162.78 15.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.332 1.453 . . . . 0.0 111.22 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -88.75 116.98 27.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -159.88 171.32 19.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.216 0.531 . . . . 0.0 110.096 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 t -143.5 142.15 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -141.18 155.33 46.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 109.442 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -137.42 135.67 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 42.8 mt -122.51 136.76 54.96 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.36 175.64 5.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.977 0.894 . . . . 0.0 110.208 169.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -56.88 -11.33 1.39 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.913 1.685 . . . . 0.0 114.897 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.96 14.83 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.487 1.494 . . . . 0.0 112.359 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.46 -1.87 67.12 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.418 1.009 . . . . 0.0 113.267 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -65.64 118.05 8.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.294 1.547 . . . . 0.0 108.114 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.06 110.95 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 p -91.73 -16.59 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 109.536 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -150.64 151.45 32.53 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.013 1.325 . . . . 0.0 107.504 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.96 132.94 9.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 107.149 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -142.02 150.01 40.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.636 0.653 . . . . 0.0 110.472 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -122.83 111.23 16.42 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 127.226 2.21 . . . . 0.0 105.041 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 t -72.5 140.04 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -58.94 -21.62 58.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.656 1.182 . . . . 0.0 113.892 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.42 134.07 30.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.3 -31.64 63.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.9 p -83.78 -6.73 59.5 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.317 0.962 . . . . 0.0 112.606 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -93.6 179.95 5.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.886 1.274 . . . . 0.0 109.921 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -133.92 157.36 77.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.256 1.422 . . . . 0.0 110.898 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.72 -176.87 3.1 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.166 2.578 . . . . 0.0 110.188 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -69.74 138.06 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -82.53 -9.32 59.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -107.22 -32.28 7.86 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.077 0.853 . . . . 0.0 110.887 -169.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -52.47 -49.14 87.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 -36.33 21.13 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 CA-C-N 121.631 1.618 . . . . 0.0 111.43 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.76 -45.36 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.476 0.71 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.83 -34.01 75.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 120.081 1.309 . . . . 0.0 110.498 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.61 91.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.482 0.313 . . . . 0.0 111.18 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.81 -47.34 59.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.075 174.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -55.91 -37.93 69.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.258 0.936 . . . . 0.0 110.901 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.8 -29.31 54.2 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.625 0.77 . . . . 0.0 112.005 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.6 mt -95.87 -43.84 7.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.681 0.792 . . . . 0.0 112.194 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.7 t -73.71 -43.82 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 111.57 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 C--O 1.249 1.074 0 C-N-CA 124.108 0.963 . . . . 0.0 109.676 179.875 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.25 142.21 52.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.807 0.843 . . . . 0.0 109.35 175.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -157.68 141.28 15.62 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 169.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 pt -140.37 179.09 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 122.012 0.91 . . . . 0.0 109.458 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -126.36 156.82 39.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.01 1.724 . . . . 0.0 106.632 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -147.45 128.33 14.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 43.31 40.92 2.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.827 1.251 . . . . 0.0 112.924 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 24.22 69.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.364 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 136.81 8.92 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.49 146.25 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.26 1.973 . . . . 0.0 109.904 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.67 150.17 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.272 1.029 . . . . 0.0 109.291 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.5 m -98.62 163.09 12.8 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.961 1.304 . . . . 0.0 108.902 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.18 170.44 8.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.936 1.295 . . . . 0.0 109.239 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.36 133.07 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.55 -13.75 66.57 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.858 0.742 . . . . 0.0 114.202 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 53.44 167.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.935 3.294 . . . . 0.0 117.71 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.43 137.08 43.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.925 2.89 . . . . 0.0 112.639 -168.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.53 153.1 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.81 170.55 18.5 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 121.16 -0.962 . . . . 0.0 109.781 -171.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -50.12 131.92 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.372 0.669 . . . . 0.0 110.769 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.87 79.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.595 1.093 . . . . 0.0 113.502 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -94.32 6.88 47.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.259 1.529 . . . . 0.0 113.516 -169.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 57.85 111.95 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.218 2.207 . . . . 0.0 114.915 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.33 89.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.876 169.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.03 -46.83 14.3 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.586 2.191 . . . . 0.0 113.49 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 121.57 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 1 C-N-CA 131.73 4.012 . . . . 0.0 105.451 -169.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.76 168.03 19.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.632 1.573 . . . . 0.0 109.067 -175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 m -122.27 146.15 47.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.751 1.22 . . . . 0.0 107.803 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.91 164.32 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.908 2.083 . . . . 0.0 107.731 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.3 mt -100.43 141.36 33.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -71.79 173.67 7.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.406 1.482 . . . . 0.0 110.941 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -67.49 -8.84 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.538 -0.726 . . . . 0.0 111.723 169.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.3 m -97.01 4.4 51.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.22 1.408 . . . . 0.0 111.835 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.97 51.98 13.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.388 1.875 . . . . 0.0 111.633 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.59 152.45 41.87 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -72.42 143.24 48.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.938 0.875 . . . . 0.0 110.301 -175.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -147.46 158.22 43.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.355 2.662 . . . . 0.0 105.73 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 p -137.25 166.64 23.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -55.47 -40.09 71.2 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 171.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -24.16 61.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.17 -33.08 50.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.924 0.784 . . . . 0.0 111.345 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.4 mtt -70.58 -36.35 73.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.426 1.09 . . . . 0.0 111.018 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -53.49 146.87 11.87 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.976 0.91 . . . . 0.0 110.784 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -17.79 11.43 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.106 1.336 . . . . 0.0 112.73 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -149.04 155.7 41.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.265 1.426 . . . . 0.0 108.87 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.2 136.94 19.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 76.8 m -133.19 145.0 50.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.22 134.31 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.0 mt -135.23 108.12 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 m -86.42 152.07 23.01 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 134.45 53.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 pt -144.06 154.88 58.62 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.001 1.72 . . . . 0.0 108.074 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.88 -44.04 6.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.906 1.737 . . . . 0.0 111.262 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 t -151.2 170.88 18.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.281 1.832 . . . . 0.0 107.344 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.0 pp -96.47 -20.16 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.482 1.113 . . . . 0.0 109.387 168.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -81.71 -25.89 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.91 -174.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -61.51 -17.6 55.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.057 1.343 . . . . 0.0 112.551 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.69 84.37 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.032 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.23 -18.42 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.096 1.448 . . . . 0.0 112.245 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 m -64.78 -16.42 63.02 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.548 1.139 . . . . 0.0 113.361 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.79 -20.49 57.09 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.503 1.121 . . . . 0.0 112.938 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.44 32.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.751 1.221 . . . . 0.0 108.72 171.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? 61.34 -65.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.686 2.394 . . . . 0.0 114.579 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.46 -48.36 81.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.351 1.432 . . . . 0.0 114.649 -167.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -64.81 -52.32 57.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.175 1.352 . . . . 0.0 109.537 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.87 -45.88 89.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 110.464 -173.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -56.4 -53.46 57.08 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.321 1.048 . . . . 0.0 110.988 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -72.19 -34.54 68.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.148 0.431 . . . . 0.0 111.033 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.74 -39.19 80.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.888 0.875 . . . . 0.0 109.63 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.62 -45.23 76.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.774 0.829 . . . . 0.0 109.925 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.17 80.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.434 1.093 . . . . 0.0 110.943 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.96 -15.4 43.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.039 0.936 . . . . 0.0 113.082 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -95.58 -16.08 22.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.91 0.884 . . . . 0.0 112.373 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.78 -37.71 87.76 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.757 1.162 . . . . 0.0 110.846 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.47 -172.26 44.81 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.463 1.982 . . . . 0.0 108.269 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -77.71 36.06 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.0 0.92 . . . . 0.0 112.809 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.8 m -56.82 146.38 6.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 120.759 -1.213 . . . . 0.0 110.824 -177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -76.93 138.63 39.81 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.58 121.65 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.24 157.14 47.53 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.693 0.797 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 m -134.3 108.01 7.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.1 mt -91.01 138.3 19.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.8 m -137.5 172.56 12.79 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.705 2.002 . . . . 0.0 109.947 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.35 -163.42 0.38 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -121.45 -41.23 2.51 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.402 -0.811 . . . . 0.0 111.836 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -26.12 2.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -90.44 44.19 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 CA-C-N 123.916 2.434 . . . . 0.0 111.871 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.5 t80 58.22 32.97 22.69 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.719 1.208 . . . . 0.0 111.756 -172.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.29 165.88 6.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.415 0.686 . . . . 0.0 111.667 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 61.09 -38.99 0.11 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 128.914 2.886 . . . . 0.0 115.136 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.96 -30.99 66.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.004 1.274 . . . . 0.0 114.117 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -127.55 42.49 3.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.927 1.691 . . . . 0.0 108.441 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -44.63 159.97 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.675 1.99 . . . . 0.0 114.53 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.9 m -130.32 146.65 51.94 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.097 1.359 . . . . 0.0 109.752 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.77 -45.59 1.92 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.618 1.58 . . . . 0.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.58 36.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.308 2.243 . . . . 0.0 112.616 172.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.88 23.52 2.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.95 2.1 . . . . 0.0 110.531 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.89 -20.34 0.19 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.236 0.922 . . . . 0.0 111.485 -171.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.45 84.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.53 -27.31 48.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.637 1.175 . . . . 0.0 113.606 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -62.88 -32.84 74.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.0 112.416 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.81 146.54 11.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.32 136.22 27.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 p -80.39 141.34 35.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -128.25 155.79 44.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.541 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -124.19 133.87 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.31 -16.85 12.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.596 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -63.17 -11.37 20.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -51.2 -37.32 46.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.422 169.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -148.28 -5.15 0.45 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.7 mmm 56.19 26.86 10.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.773 1.629 . . . . 0.0 112.671 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 m -58.91 -55.34 36.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.869 0.867 . . . . 0.0 111.021 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -63.41 -41.66 98.74 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.068 0.547 . . . . 0.0 109.735 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.94 -47.97 88.04 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 119.339 -0.7 . . . . 0.0 111.396 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.68 -45.31 68.6 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.832 0.816 . . . . 0.0 109.805 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.8 67.76 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.86 0.864 . . . . 0.0 113.097 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -112.39 3.2 16.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.942 1.297 . . . . 0.0 111.544 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.74 33.34 85.7 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 119.591 1.087 . . . . 0.0 112.92 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.8 m -115.13 -2.69 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.358 1.063 . . . . 0.0 111.021 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -69.63 108.74 3.98 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.22 128.78 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -65.77 -46.75 77.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.498 1.119 . . . . 0.0 111.245 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.47 -56.84 3.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.07 0.395 . . . . 0.0 110.391 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.62 -19.94 64.27 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.837 0.455 . . . . 0.0 112.078 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 53.83 38.92 29.66 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 110.967 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 mt -136.87 170.63 15.76 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.566 1.146 . . . . 0.0 108.649 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.14 133.67 41.44 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.15 154.54 41.88 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.612 0.765 . . . . 0.0 111.544 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.4 tpt85 -71.8 117.61 13.6 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -160.74 170.44 20.76 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.352 0.978 . . . . 0.0 108.488 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.49 146.41 17.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 118.741 0.701 . . . . 0.0 109.278 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -144.75 156.02 43.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.229 1.412 . . . . 0.0 109.21 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.7 t -136.32 140.91 42.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.1 mp -133.26 139.0 46.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.169 1.388 . . . . 0.0 108.79 -169.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.62 166.71 8.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.228 1.811 . . . . 0.0 109.941 169.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.28 -32.01 35.44 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 112.664 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -80.64 -2.99 48.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.582 1.153 . . . . 0.0 112.707 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.53 89.18 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.31 0.957 . . . . 0.0 112.724 -174.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -68.07 124.78 24.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.312 1.556 . . . . 0.0 108.285 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.84 132.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.99 -9.87 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.919 1.288 . . . . 0.0 110.956 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 150.94 30.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.175 0.99 . . . . 0.0 108.51 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.16 137.61 15.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.373 1.869 . . . . 0.0 107.457 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.0 143.93 30.76 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.32 105.47 7.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.546 -2.391 . . . . 0.0 104.546 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.6 144.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.158 -0.339 . . . . 0.0 110.416 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 m -62.22 -20.58 64.36 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.671 0.788 . . . . 0.0 112.007 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -144.48 122.88 12.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.77 65.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.965 1.306 . . . . 0.0 113.466 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.92 16.35 2.88 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.06 0.944 . . . . 0.0 111.55 173.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.73 161.3 35.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.025 2.53 . . . . 0.0 106.638 172.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -122.6 149.92 56.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 119.342 0.974 . . . . 0.0 112.468 -169.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.77 162.79 29.51 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.454 2.769 . . . . 0.0 112.247 -177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -70.94 112.85 7.43 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -75.39 -11.97 60.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.23 -32.91 69.34 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.923 1.238 . . . . 0.0 109.022 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -60.39 -53.36 65.45 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 117.533 -1.222 . . . . 0.0 112.063 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.37 -31.62 42.65 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-N 121.96 1.736 . . . . 0.0 112.256 172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.22 -42.73 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 120.169 1.35 . . . . 0.0 109.757 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.501 1.046 . . . . 0.0 110.937 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.15 93.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.68 0.218 . . . . 0.0 110.92 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.71 77.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.398 174.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -55.44 -43.73 75.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.069 0.85 . . . . 0.0 110.395 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.99 -31.48 66.97 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.081 0.552 . . . . 0.0 112.085 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.35 -46.95 11.22 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.767 0.427 . . . . 0.0 111.801 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.71 -50.0 47.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 123.971 0.908 . . . . 0.0 111.745 -169.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.65 -171.895 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.47 44.33 1.74 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.425 1.09 . . . . 0.0 110.274 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -65.15 171.93 3.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.427 0.691 . . . . 0.0 110.394 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.79 179.04 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.004 0.921 . . . . 0.0 109.677 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 148.6 45.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -141.88 127.62 19.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 44.88 35.84 1.66 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.444 1.098 . . . . 0.0 112.397 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.98 21.47 78.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 121.393 -0.817 . . . . 0.0 114.294 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.68 8.82 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.44 139.93 35.59 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.355 2.037 . . . . 0.0 110.083 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.35 154.59 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.479 1.112 . . . . 0.0 109.186 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -109.11 158.93 17.31 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.075 1.35 . . . . 0.0 107.841 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.29 158.46 22.34 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.093 0.86 . . . . 0.0 109.247 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.35 -18.33 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.59 33.57 0.63 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.816 0.735 . . . . 0.0 111.329 -174.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -50.79 151.31 2.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.7 1.2 . . . . 0.0 113.069 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.252 10.7 tt0 93.19 30.07 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.306 2.643 . . . . 0.0 112.26 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.14 144.24 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -148.88 160.61 43.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.83 131.46 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.395 0.678 . . . . 0.0 109.648 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.55 82.1 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.04 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.55 -6.5 59.47 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.554 1.677 . . . . 0.0 112.596 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.72 176.21 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.965 1.706 . . . . 0.0 112.451 -169.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.1 129.13 18.84 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 126.711 2.004 . . . . 0.0 107.723 -170.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.83 150.64 61.64 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.184 1.922 . . . . 0.0 112.133 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -75.8 68.66 2.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.288 1.835 . . . . 0.0 110.314 173.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -60.37 162.81 5.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.162 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -123.51 143.48 50.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.12 170.68 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.545 1.938 . . . . 0.0 108.703 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.4 119.49 22.8 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 125.47 1.508 . . . . 0.0 107.019 -170.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -73.97 173.25 10.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.543 1.137 . . . . 0.0 111.977 -171.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -21.88 66.16 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.086 -1.009 . . . . 0.0 111.226 170.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -80.76 0.19 35.78 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.727 1.611 . . . . 0.0 111.972 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.1 mt 55.27 52.84 10.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.955 2.102 . . . . 0.0 111.719 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.8 153.13 42.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 108.801 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.3 143.5 42.93 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.427 0.691 . . . . 0.0 109.325 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -150.26 160.26 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.252 2.221 . . . . 0.0 105.959 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 p -144.15 167.6 22.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.459 -0.775 . . . . 0.0 109.381 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 tp -53.98 -42.23 68.77 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.74 65.12 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.06 -30.7 55.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.886 0.766 . . . . 0.0 111.013 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.1 mtt -72.14 -40.31 68.17 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.446 1.098 . . . . 0.0 110.546 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -53.06 131.88 37.14 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.7 -23.29 4.0 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.009 1.29 . . . . 0.0 112.334 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -151.75 157.78 42.47 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.39 1.076 . . . . 0.0 109.415 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -56.83 140.86 14.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -134.75 146.79 49.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.899 0.88 . . . . 0.0 108.924 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.6 mt -136.46 135.71 49.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.7 mt -137.05 128.62 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -170.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -107.71 143.36 36.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.16 143.32 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.18 -0.95 . . . . 0.0 108.437 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 pt -144.5 161.36 44.38 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.781 2.032 . . . . 0.0 108.163 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -48.04 2.15 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.573 1.515 . . . . 0.0 110.631 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -162.55 156.72 21.21 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.074 1.35 . . . . 0.0 107.36 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.72 -30.72 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.981 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.81 -13.85 57.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 0.0 112.081 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.71 -20.47 64.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.276 0.631 . . . . 0.0 111.416 175.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 -25.57 3.8 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 124.31 0.957 . . . . 0.0 112.769 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.48 -17.03 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 119.019 1.409 . . . . 0.0 111.594 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.9 p -74.72 -30.07 61.4 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 120.768 -1.207 . . . . 0.0 111.558 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.5 -38.72 40.09 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.448 1.022 . . . . 0.0 109.839 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.63 67.17 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -136.28 -62.71 0.66 Allowed 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.676 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -57.76 -35.43 70.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.341 1.428 . . . . 0.0 113.159 -168.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -27.95 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 118.06 -0.972 . . . . 0.0 112.447 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -103.41 -48.93 3.84 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.842 1.201 . . . . 0.0 109.94 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -51.92 -49.17 63.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 119.497 1.044 . . . . 0.0 111.249 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -79.95 -23.89 41.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.189 -0.319 . . . . 0.0 111.223 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.7 -43.25 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.422 0.689 . . . . 0.0 110.12 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -64.3 -45.63 87.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.818 1.247 . . . . 0.0 108.919 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.87 68.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.556 1.142 . . . . 0.0 110.435 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -9.93 23.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.212 1.005 . . . . 0.0 113.092 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.2 -1.38 10.86 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.6 -34.13 77.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.227 1.376 . . . . 0.0 109.146 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.35 -169.83 40.33 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.494 1.997 . . . . 0.0 108.66 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.96 17.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 113.01 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.53 149.46 5.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.235 1.814 . . . . 0.0 111.272 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -68.75 144.14 54.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 123.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.59 152.8 48.47 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.054 0.542 . . . . 0.0 110.754 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -124.18 143.14 50.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.2 mt -127.4 135.99 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -135.49 168.19 19.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.325 1.45 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.23 172.61 4.57 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.834 0.826 . . . . 0.0 111.406 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.83 -7.34 59.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.166 0.986 . . . . 0.0 111.73 173.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.7 tp -52.31 136.08 40.97 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.257 1.423 . . . . 0.0 109.313 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -52.3 -25.28 23.5 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.566 2.844 . . . . 0.0 116.32 -174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -74.92 40.98 0.15 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.7 1.6 . . . . 0.0 112.113 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.24 177.27 10.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.106 1.363 . . . . 0.0 110.361 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.296 0.1 OUTLIER 41.54 35.35 0.45 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.816 2.446 . . . . 0.0 115.51 178.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.88 3.44 38.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.275 1.03 . . . . 0.0 112.546 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.262 32.7 ptt-85 44.99 34.01 1.16 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.714 2.006 . . . . 0.0 113.025 -169.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -78.64 -167.74 1.19 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.776 1.231 . . . . 0.0 109.214 171.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.1 p 30.04 -90.19 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.147 2.979 . . . . 0.0 114.149 174.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.25 -21.28 46.79 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.389 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.58 11.03 9.15 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.051 1.426 . . . . 0.0 111.754 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -60.12 -27.81 67.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.0 25.3 0.71 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -173.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.88 91.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.71 -28.93 58.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.462 1.505 . . . . 0.0 113.477 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.7 -17.56 64.7 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -75.99 155.82 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.163 0.892 . . . . 0.0 109.975 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.72 151.68 49.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.2 m -118.1 139.82 50.67 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.93 155.12 30.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.72 0.808 . . . . 0.0 110.094 -172.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -126.57 43.15 3.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.137 1.775 . . . . 0.0 109.139 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -46.13 -41.75 12.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 114.201 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -57.62 -17.58 15.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.275 1.03 . . . . 0.0 113.672 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -61.59 -24.84 66.95 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.004 -1.06 . . . . 0.0 111.832 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -128.39 -28.4 2.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.833 1.653 . . . . 0.0 112.034 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.0 tpt 75.04 10.8 3.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.403 2.681 . . . . 0.0 113.911 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.45 -53.14 61.54 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.846 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.4 -39.62 91.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.193 1.361 . . . . 0.0 109.906 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -50.06 -53.16 24.07 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 125.537 1.541 . . . . 0.0 112.478 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.76 -40.95 63.1 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.053 0.427 . . . . 0.0 110.309 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.23 98.18 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.156 0.982 . . . . 0.0 112.371 -169.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -102.09 -0.12 33.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.381 1.072 . . . . 0.0 110.62 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.53 94.23 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -114.72 0.11 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.98 1.312 . . . . 0.0 110.874 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -76.36 119.09 19.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.46 122.3 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.2 -44.5 97.19 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.94 1.296 . . . . 0.0 110.723 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -95.5 -50.9 4.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.971 0.35 . . . . 0.0 111.16 -172.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.95 -19.03 65.73 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.728 -0.608 . . . . 0.0 112.001 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 53.15 51.79 14.98 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.904 1.281 . . . . 0.0 109.6 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -145.2 162.8 36.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.665 1.586 . . . . 0.0 107.577 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 tp -78.77 132.41 36.9 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.43 -0.794 . . . . 0.0 109.038 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.87 174.92 6.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.045 0.938 . . . . 0.0 112.858 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.91 117.77 34.87 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 169.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -151.19 177.51 10.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.38 145.81 18.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -147.57 156.75 43.12 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.36 1.064 . . . . 0.0 110.051 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.54 139.2 43.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.6 mt -128.55 143.53 50.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.76 1.224 . . . . 0.0 108.619 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -71.51 175.52 5.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.116 0.967 . . . . 0.0 110.252 169.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.06 -23.89 36.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.326 1.451 . . . . 0.0 113.566 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.409 ' H ' ' CG ' ' A' ' 135' ' ' ASP . 32.0 m-80 -98.31 5.46 48.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.854 1.662 . . . . 0.0 111.411 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.64 -0.51 88.17 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.837 -0.98 . . . . 0.0 113.021 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.49 127.49 32.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.696 1.748 . . . . 0.0 108.198 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.85 125.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.47 0.708 . . . . 0.0 109.324 171.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.59 -21.04 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.803 2.041 . . . . 0.0 109.208 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -146.87 150.25 34.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.74 132.63 10.58 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.942 1.697 . . . . 0.0 106.873 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.19 145.48 28.31 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 169.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -115.12 116.41 28.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 t -68.49 126.43 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -57.78 -27.31 62.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.606 1.163 . . . . 0.0 112.617 -173.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.35 103.1 6.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.787 -2.671 . . . . 0.0 103.787 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.33 67.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.615 1.166 . . . . 0.0 112.471 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 p -87.44 19.95 3.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.229 1.012 . . . . 0.0 111.379 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.45 160.46 38.7 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.998 2.119 . . . . 0.0 107.665 175.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -86.66 147.29 43.41 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 121.755 -0.591 . . . . 0.0 112.076 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.03 167.6 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.398 2.732 . . . . 0.0 111.212 169.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -81.21 97.82 7.79 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 169.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -74.29 -4.55 36.85 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.81 -35.35 78.47 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.173 -0.954 . . . . 0.0 109.194 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -56.3 -57.36 23.28 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.34 1.456 . . . . 0.0 111.667 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.62 -33.18 46.25 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.486 1.566 . . . . 0.0 112.312 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 mm -59.05 -48.95 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.837 1.199 . . . . 0.0 109.613 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.54 -41.56 94.73 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.708 0.686 . . . . 0.0 110.537 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.14 87.72 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.686 0.395 . . . . 0.0 110.965 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.44 19.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.517 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -64.22 -26.65 68.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.048 1.294 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.71 70.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.647 1.112 . . . . 0.0 112.073 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.79 -43.87 35.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.646 0.657 . . . . 0.0 110.912 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.36 -48.94 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.38 0.672 . . . . 0.0 110.739 -173.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.057 0 C-N-CA 124.797 1.239 . . . . 0.0 109.969 178.829 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.91 67.76 1.7 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.999 1.32 . . . . 0.0 112.35 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.22 145.98 55.14 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 168.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.3 pt -137.1 -177.86 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 109.57 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -126.83 152.49 46.92 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -140.06 128.97 23.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt 43.95 36.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.267 1.427 . . . . 0.0 112.739 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.91 16.95 79.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.55 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.63 120.9 4.92 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 171.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.37 138.64 84.59 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.019 2.479 . . . . 0.0 111.357 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 m -143.41 162.06 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.36 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -118.78 161.83 19.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.463 1.505 . . . . 0.0 108.73 -169.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.96 163.06 14.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.659 1.584 . . . . 0.0 109.69 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.36 -62.39 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.524 0.602 . . . . 0.0 111.689 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.45 12.45 69.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -168.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 56.48 154.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.29 2.636 . . . . 0.0 114.602 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -71.78 139.77 49.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.856 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.93 165.74 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -152.11 162.09 41.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.347 -0.846 . . . . 0.0 109.174 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.43 130.44 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.04 0.44 90.29 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.928 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -5.73 59.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.664 . . . . 0.0 112.332 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 58.38 180.0 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 111.527 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.56 146.35 52.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.541 1.536 . . . . 0.0 110.015 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -56.41 -21.84 39.22 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.439 3.426 . . . . 0.0 116.114 174.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 73.49 66.63 0.1 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 108.621 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -69.69 169.12 13.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.401 1.88 . . . . 0.0 111.748 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.5 m -110.48 155.73 21.84 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.23 166.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 127.501 2.32 . . . . 0.0 106.387 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 tp -118.22 135.71 54.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.7 p -75.84 168.36 20.17 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.024 0.53 . . . . 0.0 110.195 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -62.94 -18.85 63.65 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.887 -0.508 . . . . 0.0 110.744 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -81.91 -0.64 44.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.61 1.564 . . . . 0.0 111.693 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.8 mt 62.1 47.12 5.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.277 2.231 . . . . 0.0 111.838 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.22 150.89 49.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.667 1.187 . . . . 0.0 108.971 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.93 145.23 44.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 109.588 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -152.75 163.34 39.89 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.208 2.203 . . . . 0.0 106.064 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 p -143.51 168.6 19.46 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.302 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.6 tp -55.38 -35.92 65.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.251 -0.281 . . . . 0.0 110.541 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.06 -23.71 48.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.83 -32.19 67.29 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.435 1.016 . . . . 0.0 110.795 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 29.7 mtt -80.26 -37.33 33.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.776 1.63 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -53.27 145.31 14.19 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.841 0.857 . . . . 0.0 110.288 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.86 -18.49 14.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.369 1.461 . . . . 0.0 112.588 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.65 153.28 35.34 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 108.06 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -58.37 145.16 10.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 m -138.44 149.15 45.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.578 0.751 . . . . 0.0 109.4 -169.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.42 136.68 54.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.28 112.71 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 m -93.8 155.12 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.74 139.21 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.62 158.52 75.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -48.93 5.9 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.326 1.351 . . . . 0.0 110.799 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 m -165.06 156.87 15.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.595 1.158 . . . . 0.0 109.224 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 tp -66.61 -21.42 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.07 -24.75 65.99 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.968 0.907 . . . . 0.0 111.895 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -72.12 151.29 43.13 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.039 -0.413 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.17 -24.9 75.81 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.731 -0.606 . . . . 0.0 113.374 -172.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 m -60.9 -21.63 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.515 1.157 . . . . 0.0 112.662 -174.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.0 p -60.75 -31.47 70.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.988 0.813 . . . . 0.0 111.929 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -115.29 -33.89 5.16 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.086 0.954 . . . . 0.0 110.773 -172.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -29.87 70.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.593 0.757 . . . . 0.0 112.083 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -148.37 -36.46 0.19 Allowed 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 113.296 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -64.62 -43.5 93.53 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.054 1.752 . . . . 0.0 111.031 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -54.9 -50.51 68.59 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.084 0.954 . . . . 0.0 111.083 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -61.21 -47.8 84.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 110.956 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.1 -46.43 90.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.106 0.412 . . . . 0.0 110.566 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -61.95 -39.13 91.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.758 0.823 . . . . 0.0 110.632 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.53 -49.27 77.37 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.617 0.767 . . . . 0.0 109.806 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -65.57 -39.9 92.18 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.963 0.505 . . . . 0.0 110.804 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.85 82.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 110.954 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.4 66.18 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -79.37 -25.39 42.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.206 0.912 . . . . 0.0 112.104 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.6 mt -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.192 0.906 . . . . 0.0 109.908 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.18 -170.02 43.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.53 37.99 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.671 0.788 . . . . 0.0 112.34 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -58.07 140.38 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 120.899 -1.125 . . . . 0.0 108.069 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.34 138.48 53.77 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 169.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.74 127.58 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.5 156.58 48.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.301 1.04 . . . . 0.0 109.362 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -140.18 119.86 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -100.75 141.71 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -145.19 167.42 22.84 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.177 0.991 . . . . 0.0 110.176 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.01 176.07 4.67 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.268 0.556 . . . . 0.0 109.965 169.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -124.84 30.88 5.8 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.642 1.177 . . . . 0.0 109.71 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.3 mt -66.36 168.7 9.02 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.209 1.404 . . . . 0.0 109.436 169.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.62 -17.37 4.69 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.949 3.099 . . . . 0.0 115.675 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -61.87 -10.8 10.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.092 1.357 . . . . 0.0 113.654 170.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.72 -177.5 0.21 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.267 2.227 . . . . 0.0 116.17 168.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -126.03 -14.52 6.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.847 2.459 . . . . 0.0 110.594 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.94 -35.34 58.5 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.035 2.134 . . . . 0.0 115.947 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.16 -25.13 65.11 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.21 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.2 p90 34.95 38.27 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.806 2.442 . . . . 0.0 115.015 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -40.33 71.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.14 0.976 . . . . 0.0 111.953 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.09 -14.8 54.81 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.73 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.38 13.96 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.362 1.465 . . . . 0.0 112.289 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -79.54 76.29 6.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.231 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.08 -18.23 0.54 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.26 1.409 . . . . 0.0 111.406 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.15 89.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.604 1.562 . . . . 0.0 107.438 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.61 -24.44 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.138 1.775 . . . . 0.0 113.607 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.65 -32.16 65.1 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.353 1.061 . . . . 0.0 112.892 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.55 137.89 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -121.67 124.82 45.19 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -80.52 141.88 34.72 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -129.52 148.63 51.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.727 1.611 . . . . 0.0 107.022 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -128.69 54.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.206 1.402 . . . . 0.0 108.494 -168.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -49.1 -34.5 14.01 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.788 1.235 . . . . 0.0 113.723 -169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -49.64 -25.06 2.54 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -62.69 -21.9 66.09 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.55 -21.64 2.8 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.461 1.504 . . . . 0.0 112.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 tpt 61.94 5.0 1.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.12 3.368 . . . . 0.0 114.725 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.3 m -66.59 -44.56 81.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.46 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.48 -40.31 96.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 121.298 1.863 . . . . 0.0 109.887 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.85 -46.44 92.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 123.918 0.77 . . . . 0.0 111.469 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.64 -41.78 65.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.672 0.736 . . . . 0.0 110.477 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.02 94.16 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.216 1.006 . . . . 0.0 111.986 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -95.15 4.67 53.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.83 0.852 . . . . 0.0 110.4 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.78 -10.27 14.06 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.306 176.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.75 -13.4 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.816 1.647 . . . . 0.0 112.79 -169.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.79 108.41 1.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.3 118.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.68 -45.31 85.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.952 1.701 . . . . 0.0 111.144 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -89.87 -1.56 58.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.292 0.637 . . . . 0.0 112.427 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -136.56 -6.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.772 0.829 . . . . 0.0 112.492 -171.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 40.96 42.6 1.55 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.892 2.077 . . . . 0.0 113.337 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.6 tp -132.67 153.84 50.72 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -169.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.73 123.34 22.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.36 137.61 56.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.115 0.566 . . . . 0.0 110.511 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.76 119.24 7.78 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.1 p -156.85 166.16 34.15 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.939 1.296 . . . . 0.0 107.555 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.29 146.31 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -144.65 154.93 43.31 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.786 1.234 . . . . 0.0 108.772 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.93 137.81 48.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -131.91 137.78 48.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.831 1.253 . . . . 0.0 108.201 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.94 164.71 14.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.631 1.572 . . . . 0.0 110.748 170.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -50.05 -35.58 25.62 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.691 1.596 . . . . 0.0 113.043 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 7.71 33.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.848 0.859 . . . . 0.0 113.002 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.95 -6.33 76.46 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.592 1.092 . . . . 0.0 113.278 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.31 128.83 37.86 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.029 1.414 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.74 123.44 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.137 0.975 . . . . 0.0 109.415 172.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.23 -12.55 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.354 1.462 . . . . 0.0 110.133 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -148.12 148.59 30.77 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.32 17.25 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.639 1.576 . . . . 0.0 107.709 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -145.3 148.0 32.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.789 0.836 . . . . 0.0 109.5 170.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -135.7 107.1 6.85 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.749 2.42 . . . . 0.0 105.496 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.28 136.26 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -169.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -62.13 -21.98 65.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.605 1.162 . . . . 0.0 112.993 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -136.97 94.87 3.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.03 -13.95 60.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.577 1.151 . . . . 0.0 113.818 -170.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -0.49 18.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.201 0.909 . . . . 0.0 112.143 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.65 170.44 13.8 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 108.588 175.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -115.01 158.49 40.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.698 0.799 . . . . 0.0 112.325 -169.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.27 -179.72 4.88 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.218 2.612 . . . . 0.0 110.866 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -73.51 140.36 46.32 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -100.42 -8.18 23.52 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -79.79 -36.1 37.55 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.032 -1.042 . . . . 0.0 108.378 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -51.42 -56.27 22.05 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.71 -1.138 . . . . 0.0 111.816 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -66.95 -32.5 35.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 CA-C-N 121.535 1.584 . . . . 0.0 112.846 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.6 mm -58.94 -44.24 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.43 1.468 . . . . 0.0 109.865 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.64 -37.62 87.07 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.454 1.025 . . . . 0.0 110.602 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.24 89.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.444 -0.16 . . . . 0.0 111.298 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.59 66.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.333 0.653 . . . . 0.0 110.869 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.75 -40.97 66.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.164 0.893 . . . . 0.0 110.58 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.16 63.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.629 0.772 . . . . 0.0 112.33 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 48.4 mt -97.55 -36.79 10.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.261 0.624 . . . . 0.0 112.279 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.84 -48.29 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.452 1.101 . . . . 0.0 110.417 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--O 1.249 1.034 0 C-N-CA 124.583 1.153 . . . . 0.0 109.745 178.297 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.13 62.15 0.64 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.03 1.732 . . . . 0.0 112.389 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.0 146.62 53.79 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 169.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.7 pt -135.78 -175.75 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.267 1.027 . . . . 0.0 108.938 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.91 154.72 50.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.17 126.13 17.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 43.07 45.45 4.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.109 1.364 . . . . 0.0 112.344 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.62 19.61 79.82 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.16 0.886 . . . . 0.0 114.925 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.17 120.29 4.03 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.53 140.48 89.67 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.918 2.412 . . . . 0.0 111.366 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.03 165.24 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.998 1.319 . . . . 0.0 108.684 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -126.65 154.92 43.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.107 0.963 . . . . 0.0 110.781 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.9 147.48 23.33 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.1 1.36 . . . . 0.0 110.964 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -77.13 -55.19 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 123.931 0.892 . . . . 0.0 109.887 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.45 32.68 7.19 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.197 0.903 . . . . 0.0 112.102 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 55.09 -146.79 0.55 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.023 0.929 . . . . 0.0 110.157 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.99 123.87 29.74 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.589 1.155 . . . . 0.0 110.755 -172.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -70.41 160.09 5.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.11 165.66 25.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -174.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -56.54 131.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.46 -5.67 72.36 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.786 1.184 . . . . 0.0 113.563 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.81 -5.9 57.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.525 1.662 . . . . 0.0 113.738 -170.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 66.7 112.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.381 1.872 . . . . 0.0 112.38 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.17 135.61 93.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.28 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.53 -46.74 13.43 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.579 2.186 . . . . 0.0 113.733 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 t70 122.51 126.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 131.471 3.908 . . . . 0.0 105.827 -169.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -138.84 165.74 26.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.691 1.596 . . . . 0.0 109.247 -175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.7 m -131.51 141.47 49.76 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.03 167.7 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.653 1.981 . . . . 0.0 108.41 -172.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.95 143.43 31.11 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 p -80.63 -179.64 7.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.29 1.436 . . . . 0.0 111.571 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -63.49 -24.52 67.86 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.425 -0.797 . . . . 0.0 110.836 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m -82.98 2.84 32.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.218 1.407 . . . . 0.0 111.768 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.2 mt 51.23 42.7 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.966 2.107 . . . . 0.0 112.774 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.82 160.55 21.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.182 0.993 . . . . 0.0 109.121 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.21 143.68 45.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.827 0.822 . . . . 0.0 110.691 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.463 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 42.0 tttp -148.81 153.83 38.67 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.765 2.426 . . . . 0.0 105.894 176.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 p -137.5 167.69 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.689 0.677 . . . . 0.0 110.124 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.64 -39.57 65.1 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.75 -25.75 60.88 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.18 -30.5 43.48 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.777 0.717 . . . . 0.0 111.436 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.2 mtt -71.76 -37.61 70.48 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.447 1.099 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.93 146.61 13.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.763 0.825 . . . . 0.0 110.27 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.99 2.77 48.92 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.548 1.071 . . . . 0.0 114.051 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -150.45 157.24 42.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.894 1.278 . . . . 0.0 108.814 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.56 139.59 19.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -136.77 146.19 45.47 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.28 135.51 62.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.1 mt -132.33 101.28 4.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -174.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -80.85 146.28 30.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.21 135.62 54.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.0 pt -145.82 159.06 48.22 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 125.001 1.321 . . . . 0.0 109.104 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.81 -53.03 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 N-CA-C 107.978 -1.586 . . . . 0.0 107.978 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -157.83 -177.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.413 2.285 . . . . 0.0 106.199 170.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 pt -86.94 -42.89 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.839 0.856 . . . . 0.0 109.724 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.36 -18.72 63.82 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.445 1.098 . . . . 0.0 111.095 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -20.15 61.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.572 1.149 . . . . 0.0 112.73 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.85 -15.42 3.08 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.29 0.95 . . . . 0.0 114.229 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.16 -7.26 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.929 1.364 . . . . 0.0 113.684 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.7 m -61.6 -33.75 74.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.442 1.019 . . . . 0.0 110.821 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.07 -18.75 45.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.934 0.894 . . . . 0.0 111.463 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.01 -173.9 2.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.331 1.053 . . . . 0.0 110.45 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -15.84 58.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.892 1.277 . . . . 0.0 113.688 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.91 64.75 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.324 1.449 . . . . 0.0 112.275 -169.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.8 tpt85 -57.94 -30.5 66.01 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.112 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 -42.93 7.53 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.833 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -59.36 -47.4 85.56 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.382 1.446 . . . . 0.0 111.914 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -67.3 -33.73 75.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.123 0.42 . . . . 0.0 110.377 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -65.12 -49.25 70.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.991 0.516 . . . . 0.0 109.678 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -61.32 -41.54 97.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.852 1.261 . . . . 0.0 110.195 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.52 -52.63 59.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.046 0.938 . . . . 0.0 110.62 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.91 67.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -83.1 -18.53 39.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.822 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.89 -38.43 91.06 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.324 1.42 . . . . 0.0 110.982 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.7 -169.27 42.33 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.35 23.84 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.017 0.909 . . . . 0.0 113.212 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -57.03 144.84 8.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.643 1.177 . . . . 0.0 109.72 -173.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.95 139.35 56.39 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.66 126.14 57.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.463 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 59.9 m-85 -128.1 150.77 49.82 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.615 0.766 . . . . 0.0 109.157 -177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.0 m -132.51 95.4 3.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -84.09 136.03 23.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.8 m -135.62 165.39 25.67 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.794 1.237 . . . . 0.0 110.905 -169.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.31 28.78 0.71 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.188 0.995 . . . . 0.0 113.63 -173.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 66.65 -5.03 0.67 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.216 2.206 . . . . 0.0 113.961 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.2 tp -53.1 121.42 24.07 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.185 1.394 . . . . 0.0 108.19 169.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -50.46 -36.4 48.59 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.482 2.788 . . . . 0.0 115.548 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -58.88 -29.42 66.98 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.878 0.471 . . . . 0.0 112.027 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.77 64.45 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -108.63 4.24 23.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.511 1.124 . . . . 0.0 111.68 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.15 -2.56 28.31 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.722 0.809 . . . . 0.0 112.721 170.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 57.45 26.26 12.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.858 1.663 . . . . 0.0 112.669 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -54.11 -37.22 64.08 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p -153.84 170.65 20.46 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.738 1.215 . . . . 0.0 108.728 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.55 -18.17 1.37 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.661 -1.077 . . . . 0.0 115.073 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 28.89 1.83 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.035 1.417 . . . . 0.0 111.787 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -136.94 146.84 45.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.97 -18.83 33.41 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.084 -0.842 . . . . 0.0 112.71 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.05 88.86 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 125.7 1.6 . . . . 0.0 107.839 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.58 -19.09 56.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.597 1.559 . . . . 0.0 114.049 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -60.43 -30.17 69.47 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.625 -0.672 . . . . 0.0 111.834 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 t -71.93 140.44 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -129.0 147.01 50.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 169.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 p -106.84 132.19 53.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.07 155.29 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -170.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.2 m -125.77 134.03 51.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -121.4 -34.24 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -56.68 -15.2 4.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.711 1.205 . . . . 0.0 113.399 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -56.3 -35.46 67.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.763 0.825 . . . . 0.0 112.003 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -140.78 -4.05 1.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.34 17.62 8.48 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.648 2.379 . . . . 0.0 114.493 173.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.5 m -60.51 -57.15 13.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.776 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.86 -40.9 97.64 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.541 0.61 . . . . 0.0 109.627 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.01 -43.68 99.15 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -74.58 -39.59 62.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.713 1.256 . . . . 0.0 110.461 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.06 -45.97 92.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.132 0.973 . . . . 0.0 111.932 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.27 -10.63 43.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.317 1.047 . . . . 0.0 110.538 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.42 -5.44 73.2 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.286 1.898 . . . . 0.0 113.874 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.55 -9.7 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.736 2.014 . . . . 0.0 112.954 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.88 112.97 2.26 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 168.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.419 HG23 ' H ' ' A' ' 124' ' ' LEU . 91.2 mt -76.02 133.18 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.53 -59.76 4.89 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.577 1.151 . . . . 0.0 110.585 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -74.66 -47.69 30.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.377 0.671 . . . . 0.0 111.579 -169.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.419 ' H ' HG23 ' A' ' 121' ' ' ILE . 14.4 tp -78.05 -15.24 59.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.325 0.65 . . . . 0.0 112.024 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 47.5 44.04 16.4 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.999 1.72 . . . . 0.0 111.993 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 tp -139.04 165.04 28.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.279 1.032 . . . . 0.0 108.245 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 127.18 32.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.36 150.43 48.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.054 0.454 . . . . 0.0 110.484 170.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 124.55 25.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.1 m -156.99 168.5 27.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.74 137.47 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -141.23 154.15 45.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.63 138.16 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.3 mp -130.64 135.95 48.36 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.032 0.933 . . . . 0.0 109.671 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.36 163.69 15.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.79 1.636 . . . . 0.0 109.313 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -52.21 -29.76 24.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.579 1.552 . . . . 0.0 113.265 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -71.56 -6.22 39.14 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.506 1.122 . . . . 0.0 113.09 177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.99 47.71 18.21 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -170.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.94 126.87 42.28 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.47 121.38 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.521 0.728 . . . . 0.0 109.439 -170.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.18 -7.68 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.05 1.34 . . . . 0.0 110.747 170.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -150.69 149.2 29.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.99 125.78 7.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.264 1.425 . . . . 0.0 108.177 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -140.84 149.78 42.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.453 0.569 . . . . 0.0 109.954 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.65 116.91 17.97 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.56 133.52 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -171.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -55.27 -28.33 52.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.398 1.079 . . . . 0.0 111.667 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.78 111.98 9.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.85 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.423 1.489 . . . . 0.0 113.152 -176.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 8.64 6.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.874 0.87 . . . . 0.0 112.438 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.39 -174.91 3.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.952 1.301 . . . . 0.0 110.258 172.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -103.87 147.36 34.15 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.21 -0.931 . . . . 0.0 113.426 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.04 178.8 6.07 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.693 2.929 . . . . 0.0 109.967 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.74 133.73 49.79 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -123.31 16.82 9.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 111.684 -170.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.43 -42.28 4.38 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -51.17 -46.35 88.95 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.341 -1.314 . . . . 0.0 112.851 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.87 -38.39 30.03 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 121.943 1.73 . . . . 0.0 111.644 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.7 mm -61.3 -42.37 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.34 -38.45 91.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.556 1.071 . . . . 0.0 111.088 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.09 99.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.56 0.344 . . . . 0.0 110.667 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.9 73.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.977 0.511 . . . . 0.0 110.823 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -55.09 -43.1 73.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.151 0.887 . . . . 0.0 110.285 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.255 0.622 . . . . 0.0 112.104 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.05 -41.9 18.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.871 0.469 . . . . 0.0 111.74 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.06 -52.54 32.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.975 0.91 . . . . 0.0 110.649 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 123.879 0.872 . . . . 0.0 110.004 177.361 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.28 63.99 1.59 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.034 1.734 . . . . 0.0 108.097 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -60.82 166.01 3.64 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.777 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 pt -129.86 172.75 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 123.225 1.488 . . . . 0.0 112.515 -175.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -118.56 156.67 28.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.597 2.759 . . . . 0.0 104.963 170.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.3 122.23 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? 48.1 36.69 6.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.927 1.291 . . . . 0.0 111.51 -175.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.93 85.47 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.39 -0.819 . . . . 0.0 114.694 176.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.47 118.1 5.07 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.41 143.42 77.2 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.808 2.339 . . . . 0.0 111.355 173.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.86 -175.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.958 1.303 . . . . 0.0 108.655 175.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -132.58 151.45 51.93 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.641 1.176 . . . . 0.0 108.154 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.12 155.59 17.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.71 1.604 . . . . 0.0 109.046 176.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -74.83 -25.36 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.65 17.29 1.11 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.247 -0.752 . . . . 0.0 112.91 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 47.65 -168.61 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.682 1.993 . . . . 0.0 113.838 178.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 145' ' ' TYR . 6.8 pm0 -80.76 128.76 34.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.705 -1.247 . . . . 0.0 113.414 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.3 170.31 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 165.01 34.01 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 120.998 -1.064 . . . . 0.0 109.514 -172.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.46 132.36 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 -2.21 87.56 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.836 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.05 -13.29 59.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.311 1.556 . . . . 0.0 112.4 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.51 176.64 0.06 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.208 1.803 . . . . 0.0 112.192 -169.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.99 137.75 30.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.163 1.385 . . . . 0.0 110.451 -171.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.17 -20.13 45.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.727 3.618 . . . . 0.0 117.122 176.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.33 72.37 0.13 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.63 1.972 . . . . 0.0 109.287 -169.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -72.82 175.89 6.11 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.65 1.58 . . . . 0.0 110.709 177.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.1 m -131.97 144.56 50.9 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.86 176.42 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 108.169 -177.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.9 mt -113.52 140.31 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.273 1.029 . . . . 0.0 109.474 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -72.59 176.23 5.65 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.383 1.473 . . . . 0.0 111.174 175.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -59.84 -22.58 62.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.154 0.582 . . . . 0.0 111.15 169.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.7 m -92.1 4.1 53.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.551 1.54 . . . . 0.0 112.212 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.6 mp 53.05 47.16 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.305 1.842 . . . . 0.0 112.164 -175.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -112.44 148.41 34.43 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.16 146.67 34.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.802 0.811 . . . . 0.0 111.1 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -150.41 114.98 5.21 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.79 1.636 . . . . 0.0 107.14 -172.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -79.93 161.89 25.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.209 0.603 . . . . 0.0 109.999 176.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.37 -36.5 73.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.68 44.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.924 0.89 . . . . 0.0 113.353 177.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -74.08 -32.64 63.35 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.444 1.02 . . . . 0.0 110.965 174.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.6 mtt -75.81 -34.61 60.16 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 111.371 177.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -54.67 158.29 2.65 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.607 1.163 . . . . 0.0 111.368 -177.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.85 67.01 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.335 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -146.33 159.67 43.05 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.038 2.135 . . . . 0.0 106.964 169.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.74 113.96 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 168.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.3 m -92.44 138.44 31.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.4 mt -132.84 133.05 59.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.19 139.93 41.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -172.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -123.04 152.51 40.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.61 124.92 35.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 pt -139.2 147.27 52.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.93 -47.87 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 120.723 0.948 . . . . 0.0 110.794 174.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.04 173.25 16.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -169.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.38 -42.96 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.616 1.566 . . . . 0.0 107.661 174.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.41 -28.16 68.41 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.625 1.17 . . . . 0.0 112.36 -175.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.37 -4.95 9.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 176.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.41 -29.75 2.84 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 121.082 -1.011 . . . . 0.0 114.174 169.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.79 -25.38 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.972 1.386 . . . . 0.0 112.599 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.47 -39.86 61.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.091 1.356 . . . . 0.0 111.769 169.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -107.13 -36.8 6.47 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.814 0.846 . . . . 0.0 111.172 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.54 68.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.811 0.844 . . . . 0.0 112.564 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -145.44 -41.27 0.23 Allowed 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.038 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -67.22 -44.41 79.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.654 1.116 . . . . 0.0 110.649 -169.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -59.35 -30.44 68.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 113.449 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -85.25 -43.62 13.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.948 0.794 . . . . 0.0 110.193 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.47 -50.67 72.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.428 0.691 . . . . 0.0 110.421 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -60.66 -38.38 84.7 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.991 0.516 . . . . 0.0 110.888 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.64 -33.18 75.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.166 0.986 . . . . 0.0 112.135 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.75 -46.29 15.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.169 0.895 . . . . 0.0 109.945 172.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -45.1 87.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.383 1.073 . . . . 0.0 111.017 -174.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.03 -15.06 55.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.082 0.953 . . . . 0.0 112.797 -173.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -117.14 3.99 12.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.14 -35.71 79.6 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.969 1.259 . . . . 0.0 110.719 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.03 -161.44 30.81 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.694 1.14 . . . . 0.0 110.278 -176.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -74.04 27.97 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.892 1.277 . . . . 0.0 112.42 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.06 144.83 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 108.362 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -84.04 155.31 22.78 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.44 124.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -172.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -139.35 157.73 45.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.057 0.543 . . . . 0.0 110.443 -176.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.6 m -136.29 103.98 5.48 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.97 150.16 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.624 1.17 . . . . 0.0 108.295 -174.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.3 m -127.27 158.41 37.25 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.195 1.798 . . . . 0.0 111.223 -169.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -108.44 -179.21 3.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.34 1.056 . . . . 0.0 111.933 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.71 -30.6 67.2 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -168.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.89 152.52 86.86 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 118.198 0.454 . . . . 0.0 111.958 -169.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -52.36 -40.33 71.0 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.883 3.055 . . . . 0.0 116.256 -169.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -78.81 30.98 0.2 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.669 1.188 . . . . 0.0 112.709 -172.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.44 178.42 4.62 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.077 -1.014 . . . . 0.0 112.075 178.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -68.98 162.93 25.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.049 1.74 . . . . 0.0 113.273 -169.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.58 62.87 0.6 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.235 2.214 . . . . 0.0 108.607 173.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 51.61 52.07 15.41 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.687 1.595 . . . . 0.0 112.399 -169.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -105.08 -164.94 1.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.397 1.079 . . . . 0.0 108.537 169.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 m 61.16 18.22 8.86 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.923 1.689 . . . . 0.0 114.808 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.12 -43.52 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.1 8.55 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.22 0.24 12.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.709 1.204 . . . . 0.0 112.144 176.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.68 -18.88 0.6 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.716 1.15 . . . . 0.0 112.38 177.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.93 95.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.13 -16.75 54.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.22 1.408 . . . . 0.0 114.049 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -60.23 -30.39 69.37 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.689 -0.632 . . . . 0.0 111.314 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.1 t -75.34 147.45 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.18 142.98 40.04 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.1 p -87.54 132.41 34.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.02 168.86 11.06 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.546 1.938 . . . . 0.0 107.547 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.3 m -136.63 147.66 47.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.126 0.97 . . . . 0.0 109.091 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -125.86 -19.09 4.95 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.523 0.729 . . . . 0.0 111.466 173.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -55.45 -24.62 31.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -173.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -73.1 -16.17 61.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.373 -0.822 . . . . 0.0 112.815 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -139.9 -21.99 0.87 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.546 1.066 . . . . 0.0 113.636 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.9 mmm 57.55 7.44 0.52 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.327 2.651 . . . . 0.0 115.816 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.2 m -62.39 -48.01 81.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.859 1.209 . . . . 0.0 111.846 -177.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -64.27 -40.33 95.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.445 1.475 . . . . 0.0 110.027 177.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.81 -57.28 9.93 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 125.749 1.642 . . . . 0.0 112.274 176.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.86 -42.58 81.1 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.134 0.467 . . . . 0.0 110.049 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.81 92.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.848 0.859 . . . . 0.0 112.2 -172.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.84 8.2 37.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.224 1.01 . . . . 0.0 110.896 -176.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.37 34.43 74.75 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.146 0.884 . . . . 0.0 111.704 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.3 m -108.87 -4.3 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.742 1.617 . . . . 0.0 110.316 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.63 113.52 8.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 168.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 84.3 mt -70.94 111.27 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 175.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -54.37 -40.91 68.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.442 1.497 . . . . 0.0 111.43 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.95 -4.02 55.18 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.69 -16.97 1.99 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.938 0.79 . . . . 0.0 112.763 -170.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.4 ttm105 47.46 42.41 14.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.82 1.648 . . . . 0.0 111.989 -173.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -122.09 163.03 20.17 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.04 131.52 36.3 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 138.8 56.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.162 1.385 . . . . 0.0 111.541 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -58.57 113.64 2.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.377 1.071 . . . . 0.0 108.78 171.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.3 p -156.23 173.63 16.56 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.927 0.394 . . . . 0.0 110.667 -176.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.93 149.12 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.439 1.496 . . . . 0.0 107.85 174.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -147.79 155.45 41.69 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.773 1.229 . . . . 0.0 110.119 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.59 142.87 33.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 mp -138.93 142.29 38.47 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -173.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.65 165.06 5.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.28 1.432 . . . . 0.0 110.038 169.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -51.13 -32.53 23.1 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.982 1.313 . . . . 0.0 112.848 176.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -79.5 0.41 29.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.835 1.254 . . . . 0.0 112.834 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.05 88.62 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.004 -1.06 . . . . 0.0 112.884 -175.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -67.75 121.88 16.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.068 1.434 . . . . 0.0 107.236 172.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.07 132.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.295 0.638 . . . . 0.0 109.446 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.53 -18.75 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.664 1.985 . . . . 0.0 109.662 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -147.27 149.45 32.89 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.04 138.84 17.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.105 1.762 . . . . 0.0 107.475 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -146.91 146.78 30.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.31 0.644 . . . . 0.0 109.796 170.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 17' ' ' GLU . 12.8 m-85 -139.13 93.42 2.69 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.6 2.76 . . . . 0.0 104.837 -173.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.7 m -62.52 147.37 11.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 O-C-N 121.769 -0.582 . . . . 0.0 110.415 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -66.45 -11.09 50.19 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -143.35 125.64 15.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.36 -24.13 58.91 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -176.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 38.3 p -89.78 -4.17 57.78 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.001 0.819 . . . . 0.0 112.298 176.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -84.62 176.49 8.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.248 1.419 . . . . 0.0 109.268 173.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -148.05 146.54 23.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.46 176.83 7.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.414 2.743 . . . . 0.0 110.451 177.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -76.8 119.53 20.7 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -67.82 -14.36 62.89 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -70.0 -30.02 67.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.015 1.279 . . . . 0.0 109.435 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -66.34 -49.78 52.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.357 -175.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -65.58 -35.79 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 121.366 1.524 . . . . 0.0 111.541 170.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.14 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 119.755 1.161 . . . . 0.0 110.154 179.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.84 -30.15 67.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.59 1.086 . . . . 0.0 110.741 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.09 97.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.004 0.366 . . . . 0.0 110.544 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.33 -45.05 85.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.944 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -56.7 -41.32 77.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.202 0.91 . . . . 0.0 110.498 176.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.22 71.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.65 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.85 -47.59 14.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.566 0.621 . . . . 0.0 111.89 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.05 -39.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 110.718 -172.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.2 mttm . . . . . 0 C--O 1.249 1.049 0 C-N-CA 126.039 1.735 . . . . 0.0 109.592 -175.829 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.5 pt -135.56 175.66 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 m -119.32 152.53 36.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -136.32 123.83 22.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 173.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.8 mttt 50.36 36.15 12.4 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.53 85.97 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 119.417 -1.373 . . . . 0.0 113.406 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.68 124.32 6.34 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.076 1.938 . . . . 0.0 108.364 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.05 144.5 99.47 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 CA-C-N 120.217 2.009 . . . . 0.0 109.994 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -145.47 145.27 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.175 0.99 . . . . 0.0 109.765 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -90.63 159.82 16.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.543 1.137 . . . . 0.0 109.93 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -111.81 153.27 26.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.338 1.455 . . . . 0.0 109.189 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -81.9 -56.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 121.96 -0.463 . . . . 0.0 110.427 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.42 12.72 33.33 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.034 -167.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 28.76 174.58 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 133.456 4.703 . . . . 0.0 120.657 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 12.82 62.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 129.786 3.234 . . . . 0.0 117.607 144.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 157.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 149.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -150.37 171.78 16.45 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 120.923 -1.111 . . . . 0.0 108.485 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.32 131.74 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.839 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.9 -10.01 72.11 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 116.922 -2.043 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.96 -13.0 61.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.537 1.668 . . . . 0.0 113.42 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 65.16 160.86 0.12 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.33 1.852 . . . . 0.0 110.544 -172.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.92 132.24 22.42 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.21 1.804 . . . . 0.0 109.013 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.5 -28.65 86.21 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.1 2.533 . . . . 0.0 118.459 -169.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 t70 75.12 99.8 0.07 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.169 -157.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' A' ' 112' ' ' SER . 2.2 p90 -125.87 -174.47 3.1 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 126.077 1.751 . . . . 0.0 106.702 169.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 m -115.94 153.89 30.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.746 2.018 . . . . 0.0 106.95 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.03 168.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.67 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 1.2 tp -112.07 147.02 36.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 172.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -79.17 172.53 13.67 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.37 -29.5 66.05 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.973 1.309 . . . . 0.0 110.933 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -80.52 -0.04 35.8 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.403 1.481 . . . . 0.0 112.968 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.1 mt 62.37 36.51 14.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.176 1.79 . . . . 0.0 112.526 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.54 144.28 28.82 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 171.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.92 132.4 45.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.113 0.959 . . . . 0.0 108.956 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 49.6 tttp -136.08 148.39 48.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.38 167.4 12.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.29 -37.29 67.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.626 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.43 63.64 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.894 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.12 -26.6 59.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.199 0.909 . . . . 0.0 111.625 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 mtt -78.21 -31.18 49.28 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.413 -0.804 . . . . 0.0 111.419 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -62.38 152.74 33.23 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.226 0.536 . . . . 0.0 110.0 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.16 -7.66 44.2 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -154.51 160.99 41.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.541 1.171 . . . . 0.0 109.15 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.16 137.59 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.5 m -132.28 147.23 52.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.351 1.46 . . . . 0.0 107.956 -173.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.65 137.44 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -137.46 117.62 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.3 m -93.09 150.74 20.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 163.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.05 133.95 55.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.23 151.73 62.42 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.31 -43.12 4.73 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.62 1.547 . . . . 0.0 110.747 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.2 m -150.75 171.5 17.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.583 2.353 . . . . 0.0 106.839 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 93' ' ' TRP . 1.1 pt -99.99 -20.45 5.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 123.147 0.579 . . . . 0.0 111.669 166.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.8 -22.4 66.89 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.215 -1.553 . . . . 0.0 112.122 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -65.57 1.82 1.12 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.107 1.763 . . . . 0.0 115.024 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.59 -18.64 3.58 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 121.363 1.892 . . . . 0.0 114.113 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.495 ' HB ' HH21 ' A' ' 129' ' ' ARG . 1.6 m -57.56 -23.09 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.59 1.695 . . . . 0.0 113.109 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . 0.265 61.2 m -36.82 -61.57 0.53 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.736 1.214 . . . . 0.0 110.259 165.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -75.35 -50.05 17.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 126.527 2.392 . . . . 0.0 105.866 -156.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.24 83.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.801 -166.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.53 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.1 tm0? -145.33 -47.37 0.22 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.675 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -63.26 -43.26 98.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.831 1.65 . . . . 0.0 111.65 -163.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -48.4 -56.26 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.702 2.001 . . . . 0.0 109.205 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -69.52 -45.64 68.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.813 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CB ' HE21 ' A' ' 63' ' ' GLN . 38.5 t80 -58.45 -45.64 88.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.005 0.522 . . . . 0.0 110.979 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.21 -39.87 93.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.117 0.967 . . . . 0.0 109.888 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.2 -46.29 84.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -63.22 -47.21 83.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.961 0.504 . . . . 0.0 110.538 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.24 -48.41 68.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.47 1.108 . . . . 0.0 110.508 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.52 -16.87 27.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.66 -15.59 17.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.874 1.27 . . . . 0.0 112.846 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.43 -33.09 72.03 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.332 0.514 . . . . 0.0 109.984 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.37 35.47 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.74 21.01 0.42 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.862 -0.787 . . . . 0.0 112.96 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 m -52.2 145.34 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.123 1.369 . . . . 0.0 110.589 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -70.35 143.6 51.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 134.29 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 52.8 m-85 -138.96 154.24 48.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.56 0.744 . . . . 0.0 109.523 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -129.74 115.64 17.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.85 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.1 m -135.46 166.88 22.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.17 0 O-C-N 122.105 -0.372 . . . . 0.0 110.216 164.552 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.516 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.217 -0.643 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -35.18 44.82 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.34 -28.21 70.24 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.197 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 93' ' ' TRP . . . -111.54 24.66 12.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.785 2.834 . . . . 0.0 111.96 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -115.08 106.68 14.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.65 -16.52 51.6 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.671 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.21 86.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.55 -22.68 13.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.7 -27.4 68.31 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.668 -1.27 . . . . 0.0 113.255 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.79 145.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -129.19 142.24 50.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.11 139.72 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.739 1.216 . . . . 0.0 109.021 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.5 mp -124.56 158.74 32.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.405 1.482 . . . . 0.0 108.999 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.81 73.22 1.51 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 127.05 2.14 . . . . 0.0 107.385 -169.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.71 -32.77 71.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.526 -1.359 . . . . 0.0 111.53 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -54.57 -17.31 3.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.195 1.798 . . . . 0.0 113.583 -167.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.67 ' HD3' ' CD2' ' A' ' 30' ' ' LEU . 5.3 ttt180 -65.27 -26.99 68.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -134.38 -17.15 2.06 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 124.914 1.384 . . . . 0.0 107.964 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' ' HA3' ' A' ' 114' ' ' GLY . 6.0 mmm 59.66 6.88 0.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.477 2.311 . . . . 0.0 111.513 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 27' ' ' PHE . 20.8 m -59.07 -49.18 78.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.742 1.61 . . . . 0.0 110.012 -170.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -62.57 -42.07 99.32 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.304 1.411 . . . . 0.0 109.916 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -51.21 -47.02 50.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 123.864 0.745 . . . . 0.0 113.237 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -73.85 -46.91 42.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.512 0.725 . . . . 0.0 109.247 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.7 78.49 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -104.09 7.13 36.29 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.844 1.258 . . . . 0.0 109.467 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.02 25.33 56.49 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 118.149 -1.361 . . . . 0.0 113.101 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.412 HG23 ' HA2' ' A' ' 114' ' ' GLY . 17.1 m -90.83 -9.1 10.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.688 1.744 . . . . 0.0 111.488 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -63.32 115.97 5.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.516 ' HA ' HD12 ' A' ' 13' ' ' LEU . 65.7 mt -75.14 120.92 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -61.17 -49.77 75.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.844 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.24 -31.2 43.51 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.432 0.457 . . . . 0.0 112.014 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' H ' HG22 ' A' ' 121' ' ' ILE . 21.8 tp -109.63 -18.21 13.53 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.116 0.966 . . . . 0.0 111.576 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 53.63 42.35 31.89 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.744 1.618 . . . . 0.0 114.507 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt -123.54 162.96 21.9 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.38 135.85 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.42 154.49 41.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.779 1.275 . . . . 0.0 110.091 167.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.495 HH21 ' HB ' ' A' ' 59' ' ' VAL . 17.1 tpt85 -77.38 112.0 13.65 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.683 166.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.06 173.38 14.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.98 140.07 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -142.27 155.88 45.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.056 1.342 . . . . 0.0 108.477 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.38 139.77 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -130.19 133.95 46.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -171.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.22 163.43 15.24 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 125.314 1.445 . . . . 0.0 110.877 164.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -48.61 -35.19 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.254 1.822 . . . . 0.0 113.998 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -2.66 39.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.659 1.572 . . . . 0.0 111.97 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.96 3.11 70.73 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.174 -1.579 . . . . 0.0 112.5 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -71.48 122.26 20.1 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.982 1.891 . . . . 0.0 109.36 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.41 126.49 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.38 -11.22 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 129.448 3.099 . . . . 0.0 107.767 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -152.61 152.48 31.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.227 1.411 . . . . 0.0 107.454 163.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.18 139.93 18.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -150.2 148.8 29.35 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.26 117.51 24.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.859 1.663 . . . . 0.0 106.906 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.71 129.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -57.56 -19.15 23.5 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.904 0.881 . . . . 0.0 113.165 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -138.54 124.23 19.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.12 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -84.12 6.4 22.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.419 1.487 . . . . 0.0 111.11 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.46 174.2 6.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.732 2.013 . . . . 0.0 107.235 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -128.53 152.87 79.13 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 120.716 -1.24 . . . . 0.0 110.861 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -80.96 170.35 15.38 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.591 2.194 . . . . 0.0 110.082 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -69.46 120.82 15.84 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 161.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -93.68 -8.09 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.698 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.12 -36.69 83.81 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.297 1.408 . . . . 0.0 108.847 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -63.12 -48.75 83.27 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 125.341 1.456 . . . . 0.0 112.254 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.71 -34.86 49.15 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 CA-C-N 119.59 0.889 . . . . 0.0 111.974 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 20.6 mm -60.02 -45.47 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 120.658 1.572 . . . . 0.0 110.507 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.86 -42.34 97.57 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 120.746 1.612 . . . . 0.0 109.263 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.04 95.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.882 0.473 . . . . 0.0 110.78 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.84 80.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.083 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -53.74 -49.65 67.69 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 117.077 -1.44 . . . . 0.0 108.368 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -52.82 -29.68 29.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.408 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.45 -49.18 7.38 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.1 t -60.6 -41.39 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.533 0.683 . . . . 0.0 111.827 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.439 -1.018 0 C-N-CA 130.64 3.576 . . . . 0.0 117.265 -161.116 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 120.672 0.272 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.94 -175.76 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.379 1.072 . . . . 0.0 108.834 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -118.5 152.15 36.5 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -136.04 109.42 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 42.89 41.83 2.77 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 111.825 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.23 -9.5 61.21 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.134 -0.814 . . . . 0.0 115.04 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.1 125.53 8.56 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.189 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.43 138.62 39.34 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 CA-C-N 120.859 2.33 . . . . 0.0 110.208 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.16 135.21 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.154 0.982 . . . . 0.0 110.453 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -75.91 155.17 35.42 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.834 1.653 . . . . 0.0 110.388 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.64 144.63 40.6 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.405 1.482 . . . . 0.0 107.877 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.24 -65.19 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 118.502 0.592 . . . . 0.0 111.299 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.09 35.17 4.85 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.627 1.108 . . . . 0.0 111.206 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -52.12 166.44 0.16 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.247 2.219 . . . . 0.0 116.075 -169.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 69.07 34.19 3.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.614 1.966 . . . . 0.0 113.379 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.54 144.78 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -150.12 162.93 39.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.802 0.841 . . . . 0.0 109.156 -169.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 p -52.89 132.82 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 109.541 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.19 -5.22 83.03 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.85 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.37 -11.28 59.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.457 1.628 . . . . 0.0 112.64 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 57.44 178.36 0.05 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.649 1.58 . . . . 0.0 111.952 -169.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.38 136.09 20.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.931 1.693 . . . . 0.0 109.016 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 95.5 Cg_endo -74.26 157.49 45.8 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.483 2.122 . . . . 0.0 109.77 172.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 27.6 t70 -77.47 67.91 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.02 1.728 . . . . 0.0 110.117 176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -59.27 162.3 4.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.442 170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.5 m -124.65 144.45 50.19 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.38 168.05 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.343 2.257 . . . . 0.0 107.528 -171.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.97 143.45 45.7 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.48 178.45 8.11 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.523 0.729 . . . . 0.0 109.949 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.98 -23.33 67.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.146 -0.971 . . . . 0.0 110.734 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 m -86.41 3.34 44.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.4 mt 55.62 33.1 20.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.82 2.048 . . . . 0.0 112.937 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.55 147.11 24.77 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.84 143.8 39.47 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 109.439 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -154.02 155.08 34.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.315 2.246 . . . . 0.0 105.547 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.2 m -139.58 166.57 24.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.119 0.872 . . . . 0.0 108.927 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 43.6 tp -50.15 -40.67 47.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.242 0.474 . . . . 0.0 111.026 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.1 62.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -77.4 -28.47 52.76 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.768 0.713 . . . . 0.0 111.133 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.8 mtt -80.36 -55.14 5.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.877 1.271 . . . . 0.0 110.513 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -59.74 134.01 56.62 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.06 -20.61 3.2 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.955 2.216 . . . . 0.0 110.512 -169.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -150.33 158.34 44.05 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.92 2.088 . . . . 0.0 107.219 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -56.65 144.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.4 m -137.09 145.82 44.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.2 mt -133.31 137.19 53.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mt -136.75 133.88 48.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m -114.98 147.44 40.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -136.5 133.32 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.25 150.35 51.69 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.55 1.14 . . . . 0.0 109.278 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.92 -50.13 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.558 1.505 . . . . 0.0 109.709 169.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -152.87 168.67 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.311 1.444 . . . . 0.0 108.108 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.85 -23.93 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.53 -27.06 62.93 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 0.0 111.839 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 32.2 0.08 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.12 2.168 . . . . 0.0 113.736 -174.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.68 -3.23 69.88 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 120.432 -1.418 . . . . 0.0 114.269 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.83 -12.28 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.498 1.149 . . . . 0.0 112.406 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.69 -0.04 2.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.458 1.503 . . . . 0.0 113.724 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -48.97 148.66 2.18 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 0.0 110.348 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.03 -28.69 10.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.914 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -50.06 -57.33 7.85 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.265 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -65.71 -42.86 90.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.493 1.497 . . . . 0.0 110.085 -170.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -63.81 -53.96 42.65 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 122.725 0.41 . . . . 0.0 110.169 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.27 -37.6 80.88 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.688 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -55.93 -51.93 65.92 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 119.438 1.017 . . . . 0.0 110.102 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -66.22 -33.61 76.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 0.0 110.572 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -64.25 -50.55 67.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.735 -0.603 . . . . 0.0 110.477 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -60.8 -41.73 96.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.167 0.894 . . . . 0.0 110.406 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.86 73.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.918 0.887 . . . . 0.0 110.316 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.1 -13.57 62.51 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -100.86 -17.31 16.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.859 1.264 . . . . 0.0 112.419 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -60.07 -37.87 81.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.051 1.296 . . . . 0.0 110.56 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.89 -173.09 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -74.0 22.69 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.89 0.876 . . . . 0.0 112.902 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.15 154.34 2.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.379 1.472 . . . . 0.0 110.733 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.82 143.75 52.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.45 130.45 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.36 153.05 46.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.136 0.574 . . . . 0.0 110.886 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 m -120.57 154.6 35.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.1 mt -136.55 134.85 49.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.2 m -131.71 160.79 34.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 109.86 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 121.205 0.526 . . . . 0.0 110.933 169.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m0 . . . . . 0 C--O 1.233 0.193 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 m 65.22 -48.13 0.36 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.571 2.748 . . . . 0.0 116.089 169.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.45 -48.67 8.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.99 38.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.742 1.617 . . . . 0.0 108.637 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -149.37 33.16 0.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.0 111.24 -170.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.74 -1.26 5.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.293 0.949 . . . . 0.0 113.103 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 mt -75.11 87.87 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -54.38 -30.22 51.28 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 114.013 -169.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.91 -25.17 67.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.585 0.754 . . . . 0.0 112.88 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -74.42 152.95 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.823 0.738 . . . . 0.0 109.87 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -137.44 151.2 48.25 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.1 m -121.95 96.57 5.11 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.82 160.98 31.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.945 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -127.8 37.43 4.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.025 2.13 . . . . 0.0 109.088 -169.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -47.65 -39.73 17.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.798 1.239 . . . . 0.0 114.098 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.96 -17.79 11.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.117 0.967 . . . . 0.0 113.487 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -62.82 -22.0 66.32 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.221 -0.925 . . . . 0.0 112.661 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.7 -26.15 1.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.718 1.607 . . . . 0.0 111.898 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 69.44 10.83 7.88 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.444 2.698 . . . . 0.0 113.741 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 m -61.69 -47.76 83.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.25 -38.15 88.16 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.509 1.504 . . . . 0.0 109.407 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.53 -59.02 4.39 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 126.386 1.946 . . . . 0.0 112.872 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.34 -42.32 65.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 25' ' ' PRO . . . -62.99 -39.68 95.46 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.0 0.92 . . . . 0.0 112.258 -169.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -107.11 5.13 27.61 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.716 1.206 . . . . 0.0 110.653 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.99 85.95 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.648 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.6 m -105.64 -1.79 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.531 1.132 . . . . 0.0 111.199 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.75 116.97 17.91 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 124' ' ' LEU . 66.5 mt -74.11 124.37 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.27 -46.82 78.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.307 0.643 . . . . 0.0 110.453 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -84.2 -51.92 6.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.365 0.266 . . . . 0.0 110.746 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -72.88 -22.93 60.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.276 0.63 . . . . 0.0 111.031 -178.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 49.97 57.59 6.38 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.432 1.093 . . . . 0.0 110.284 -171.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.99 173.45 11.7 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.045 1.338 . . . . 0.0 107.85 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.18 135.29 33.36 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.133 0.973 . . . . 0.0 108.381 172.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.79 165.32 18.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -83.21 113.22 20.51 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.8 m -155.19 166.49 33.4 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.661 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -147.05 142.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -144.06 158.12 43.91 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.293 1.037 . . . . 0.0 110.045 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.3 140.76 41.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -131.34 140.14 49.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.119 1.368 . . . . 0.0 108.122 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 166.0 17.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.924 1.289 . . . . 0.0 110.279 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -47.77 -38.43 15.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.436 1.495 . . . . 0.0 112.563 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.95 7.4 13.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.643 1.11 . . . . 0.0 113.663 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.52 -7.53 80.59 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 120.971 -1.08 . . . . 0.0 112.853 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -65.38 130.65 44.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 118.66 1.23 . . . . 0.0 108.937 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.9 OUTLIER -63.1 132.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.582 0.753 . . . . 0.0 109.84 171.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.15 -18.0 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.059 2.144 . . . . 0.0 109.811 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -148.57 150.19 32.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.63 133.31 11.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.764 1.626 . . . . 0.0 107.249 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -146.59 147.1 30.75 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.79 107.87 14.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.11 131.34 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -57.74 -20.58 35.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.845 1.258 . . . . 0.0 113.829 -169.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.13 130.81 25.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.22 12.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.725 1.61 . . . . 0.0 114.219 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -88.47 -1.9 58.3 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 118.542 0.61 . . . . 0.0 112.225 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -82.45 178.84 8.02 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.77 -1.206 . . . . 0.0 110.062 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -129.72 133.51 25.13 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.656 1.583 . . . . 0.0 109.077 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.6 173.59 11.26 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.508 2.805 . . . . 0.0 110.572 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -73.46 129.51 38.14 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 168.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -100.06 -4.66 29.4 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.96 -38.04 57.97 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -50.45 -58.24 10.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.52 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.35 -35.81 38.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 121.449 1.553 . . . . 0.0 112.133 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.97 -44.76 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.523 1.056 . . . . 0.0 110.302 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.65 -37.83 87.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 119.506 1.048 . . . . 0.0 110.247 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.9 96.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.359 0.264 . . . . 0.0 110.706 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.92 72.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.955 0.502 . . . . 0.0 111.414 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.81 -41.67 74.54 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.54 1.063 . . . . 0.0 110.214 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.15 67.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.27 0.628 . . . . 0.0 111.948 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.55 -46.43 14.47 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.365 0.666 . . . . 0.0 111.313 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.8 -44.73 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.801 0.84 . . . . 0.0 111.127 -169.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.357 1.063 . . . . 0.0 109.708 178.224 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.3 pt -119.35 174.06 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.226 1.013 . . . . 0.0 110.546 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -112.61 155.77 23.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -135.38 115.43 13.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? 37.53 53.87 1.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.89 1.676 . . . . 0.0 113.298 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.22 2.43 87.3 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.68 -0.511 . . . . 0.0 114.349 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.6 110.25 3.02 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.782 1.658 . . . . 0.0 109.888 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.75 137.59 74.82 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.13 2.553 . . . . 0.0 111.623 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -142.62 131.59 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.791 0.836 . . . . 0.0 109.759 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -82.29 147.07 29.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.474 1.51 . . . . 0.0 111.462 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.35 148.72 23.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.548 1.139 . . . . 0.0 109.222 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 t -78.15 -52.97 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 121.962 -0.461 . . . . 0.0 109.791 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.77 24.61 27.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.526 1.06 . . . . 0.0 112.096 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 52.5 -171.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.713 2.005 . . . . 0.0 113.38 -173.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -78.26 132.98 37.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.15 165.18 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -126.35 155.07 42.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.46 137.18 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.48 85.97 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 118.678 -1.068 . . . . 0.0 113.54 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.79 1.68 16.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.632 1.716 . . . . 0.0 113.907 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 54.39 65.62 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.287 1.035 . . . . 0.0 111.383 169.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.02 134.03 5.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.02 1.728 . . . . 0.0 112.651 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.04 154.63 26.86 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.491 2.794 . . . . 0.0 113.349 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 18.1 t0 -73.95 70.03 1.47 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.806 2.043 . . . . 0.0 109.676 169.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -62.95 167.24 4.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.418 1.487 . . . . 0.0 110.753 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -122.79 152.16 40.94 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.81 171.15 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.446 1.898 . . . . 0.0 107.38 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.4 mt -111.56 152.42 27.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -83.48 179.28 7.69 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.414 0.685 . . . . 0.0 109.608 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -51.01 -35.7 35.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.046 0.938 . . . . 0.0 110.454 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.9 m -101.55 16.15 26.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.549 1.54 . . . . 0.0 110.7 -170.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.2 mt 62.55 23.7 14.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.256 2.222 . . . . 0.0 113.628 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.35 142.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 169.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.22 142.19 47.31 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -147.73 155.4 41.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.5 p -139.69 168.3 20.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 47.0 tp -54.36 -42.52 70.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 169.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.33 -23.93 66.08 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.01 -31.67 64.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.836 0.743 . . . . 0.0 110.876 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 mtt -75.21 -35.9 61.44 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -53.67 151.45 6.09 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.902 0.858 . . . . 0.0 111.944 -171.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.7 57.23 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.005 1.288 . . . . 0.0 113.272 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -155.03 149.8 26.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.759 1.624 . . . . 0.0 107.27 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.5 t -58.23 136.69 21.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -130.68 145.58 51.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -140.96 137.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -138.97 133.09 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.2 m -119.98 150.77 39.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.84 136.96 53.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.3 pt -136.51 139.37 29.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.855 1.662 . . . . 0.0 107.911 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.27 -7.51 18.05 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.083 2.522 . . . . 0.0 112.888 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.0 m -160.87 177.33 10.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.601 2.36 . . . . 0.0 106.268 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.89 -14.3 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.36 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.52 -23.66 50.13 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.376 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -57.67 155.81 9.41 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.581 1.552 . . . . 0.0 111.887 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.97 -17.28 70.28 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.1 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.15 -24.33 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.603 1.702 . . . . 0.0 113.316 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 15.3 p -61.57 -29.17 69.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.269 0.94 . . . . 0.0 112.544 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.84 -34.61 30.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.034 -0.416 . . . . 0.0 110.137 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.05 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.602 0.761 . . . . 0.0 110.765 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -152.56 131.09 12.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.8 m 138.76 -56.75 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 1 C-N-CA 132.819 4.448 . . . . 0.0 105.52 169.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -60.25 -63.84 1.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.854 0.752 . . . . 0.0 110.993 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -65.06 -40.11 94.22 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.904 -0.497 . . . . 0.0 111.122 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -58.07 -50.34 73.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.07 0.548 . . . . 0.0 111.583 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.04 -37.51 87.69 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.276 0.63 . . . . 0.0 109.674 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.426 ' HA ' HG21 ' A' ' 99' ' ' ILE . 4.6 tt0 -58.36 -51.14 71.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.477 0.711 . . . . 0.0 110.166 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.35 -38.21 74.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.806 0.442 . . . . 0.0 110.635 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.38 88.87 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.58 -0.7 . . . . 0.0 111.139 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.77 -19.64 62.71 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.981 0.81 . . . . 0.0 112.62 173.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -76.7 -34.73 58.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 110.839 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.37 -40.62 91.47 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.407 0.683 . . . . 0.0 109.949 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.14 -170.64 43.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -75.57 38.22 0.15 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 111.861 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.91 144.45 14.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 O-C-N 120.853 -1.154 . . . . 0.0 109.806 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -73.15 141.26 47.43 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.05 128.7 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -136.8 155.19 50.14 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.662 0.664 . . . . 0.0 111.531 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -125.5 97.84 5.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.98 122.63 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -109.49 164.72 12.25 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.002 1.321 . . . . 0.0 109.206 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 110.295 169.591 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p -52.97 -37.47 61.21 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.549 -0.719 . . . . 0.0 112.681 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.96 -16.36 59.47 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.312 -0.715 . . . . 0.0 114.308 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.23 -15.91 15.85 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 112.412 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -75.05 94.49 2.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.652 0.66 . . . . 0.0 111.246 -169.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.73 -20.05 2.19 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.609 1.576 . . . . 0.0 111.105 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.426 HG21 ' HA ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -145.6 92.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.516 1.527 . . . . 0.0 107.973 -172.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.61 -33.89 7.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.299 1.84 . . . . 0.0 113.988 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.84 -20.06 65.86 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.479 1.111 . . . . 0.0 113.717 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.89 152.81 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.168 0.895 . . . . 0.0 108.945 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -129.34 146.24 51.25 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.0 m -97.26 135.11 39.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.98 162.98 16.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.988 1.715 . . . . 0.0 108.089 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -138.28 44.25 2.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.41 1.484 . . . . 0.0 109.573 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.12 -44.08 7.37 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.516 1.127 . . . . 0.0 112.848 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -59.97 -14.72 17.27 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -76.31 -6.71 52.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.077 -1.015 . . . . 0.0 112.416 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -139.07 -41.31 0.47 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.39 1.476 . . . . 0.0 111.294 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.4 tpt 78.34 2.1 2.69 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.149 2.98 . . . . 0.0 113.667 169.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 m -63.94 -46.51 84.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.852 1.66 . . . . 0.0 111.471 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.89 -39.56 89.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.227 1.376 . . . . 0.0 109.307 172.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.2 -53.69 18.31 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.41 1.957 . . . . 0.0 113.255 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.98 -34.89 50.69 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.989 0.516 . . . . 0.0 110.433 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.57 -39.54 93.93 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.217 0.607 . . . . 0.0 111.587 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -97.98 3.03 49.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.053 1.341 . . . . 0.0 110.31 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 60.79 8.4 10.12 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.348 1.452 . . . . 0.0 114.826 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 m -63.62 -23.04 32.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 C-N-CA 125.902 1.681 . . . . 0.0 110.94 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.38 118.51 4.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 124' ' ' LEU . 47.2 mm -87.47 124.12 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -61.35 -53.15 60.31 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.466 1.506 . . . . 0.0 110.718 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.97 -49.47 11.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.039 0.447 . . . . 0.0 110.5 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' H ' HG22 ' A' ' 121' ' ' ILE . 29.4 tp -72.83 -23.11 60.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.508 1.123 . . . . 0.0 112.779 -171.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 51.17 50.28 19.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 110.768 -169.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.5 mt -138.12 -173.25 3.47 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.7 pt? -113.24 146.69 38.91 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.199 1.0 . . . . 0.0 111.327 175.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.61 140.86 57.96 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.919 1.688 . . . . 0.0 113.805 -169.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -65.87 110.86 3.02 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 p -156.13 168.22 27.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.454 0.57 . . . . 0.0 111.166 -170.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.04 148.26 18.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.92 1.288 . . . . 0.0 108.129 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -145.7 154.5 42.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.503 1.121 . . . . 0.0 109.296 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.91 139.87 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -132.21 141.02 48.91 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.009 1.323 . . . . 0.0 108.233 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.39 162.43 20.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.351 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.5 -32.63 41.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.901 1.281 . . . . 0.0 113.228 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -80.25 -10.32 59.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.7 -2.71 49.08 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.388 0.994 . . . . 0.0 113.605 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.85 137.94 58.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.55 1.675 . . . . 0.0 108.753 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 129.46 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 80.6 t -113.26 -20.79 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.825 2.05 . . . . 0.0 109.541 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -143.84 148.34 35.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.351 1.06 . . . . 0.0 108.194 169.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.75 132.18 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.513 1.525 . . . . 0.0 107.701 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -149.77 147.59 28.19 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.662 1.185 . . . . 0.0 108.444 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.12 116.07 14.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.47 134.69 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 m -58.95 -18.68 35.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.154 0.982 . . . . 0.0 112.956 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -140.04 122.5 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.2 p -83.16 14.87 3.16 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.654 1.115 . . . . 0.0 111.983 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -125.77 -177.06 3.79 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.567 1.947 . . . . 0.0 108.91 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -137.78 151.5 70.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.244 1.418 . . . . 0.0 109.901 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.96 170.75 7.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.67 2.913 . . . . 0.0 111.606 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -77.33 87.1 3.73 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -68.32 1.12 3.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.3 1.44 . . . . 0.0 114.118 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -31.63 72.47 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -62.02 -53.07 62.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.324 1.049 . . . . 0.0 111.801 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -65.83 -31.26 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.742 1.658 . . . . 0.0 112.422 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.6 mm -58.3 -48.89 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.131 1.332 . . . . 0.0 109.35 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.17 -33.47 76.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.821 0.737 . . . . 0.0 110.81 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.28 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.734 0.414 . . . . 0.0 111.192 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.77 -49.51 65.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.895 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -63.64 -30.46 71.57 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.94 69.35 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.442 1.019 . . . . 0.0 111.835 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.19 -45.77 17.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.147 0.579 . . . . 0.0 111.478 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.74 -46.69 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.235 0.614 . . . . 0.0 111.024 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.5 tttm . . . . . 0 C--O 1.248 0.985 0 C-N-CA 124.401 1.081 . . . . 0.0 109.903 -179.706 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.443 -0.804 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.76 -178.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -115.19 147.67 40.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -134.18 120.67 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 43.83 39.69 2.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.053 1.341 . . . . 0.0 111.916 -173.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.57 12.6 79.96 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.74 117.44 3.95 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.174 -1.348 . . . . 0.0 109.846 173.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.21 139.34 89.74 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.342 2.695 . . . . 0.0 112.222 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.66 130.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.225 1.41 . . . . 0.0 109.889 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -75.63 161.67 28.91 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.351 1.86 . . . . 0.0 110.462 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.68 160.0 19.09 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.31 1.444 . . . . 0.0 110.173 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.78 -59.71 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.837 -0.539 . . . . 0.0 111.242 -169.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.2 32.61 6.94 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.397 0.998 . . . . 0.0 113.439 -169.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.43 -167.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.54 107.07 17.89 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.482 1.513 . . . . 0.0 109.748 -169.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.41 145.75 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -143.52 160.79 39.97 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.595 0.758 . . . . 0.0 109.028 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.75 134.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.31 3.37 89.81 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.796 -1.002 . . . . 0.0 113.988 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.03 -7.02 59.47 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.463 1.631 . . . . 0.0 112.298 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 58.07 178.18 0.06 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.369 1.467 . . . . 0.0 111.516 -169.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.09 24.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.792 1.637 . . . . 0.0 108.729 -171.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.18 158.04 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.708 2.272 . . . . 0.0 109.907 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 26.1 t70 -81.41 68.82 7.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.378 1.471 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -63.1 163.25 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.977 171.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.5 m -121.79 148.95 44.01 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -152.66 167.67 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.106 2.162 . . . . 0.0 105.76 -173.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.49 156.05 29.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 120.787 -1.195 . . . . 0.0 108.231 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.3 p -81.36 173.59 12.32 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.767 1.227 . . . . 0.0 110.016 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -63.77 -26.71 68.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.933 -1.104 . . . . 0.0 110.798 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 p -77.54 1.43 19.49 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.512 1.525 . . . . 0.0 111.94 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt 56.94 47.78 17.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.968 2.107 . . . . 0.0 111.986 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.01 141.96 47.43 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -64.52 144.09 57.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.464 1.105 . . . . 0.0 109.485 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -146.52 157.66 43.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.499 2.32 . . . . 0.0 105.477 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 p -146.62 167.82 22.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 67.5 tp -53.83 -43.78 69.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 170.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.37 66.52 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.85 -30.6 58.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.878 0.763 . . . . 0.0 111.114 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.3 mtt -73.88 -39.69 63.74 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.388 1.075 . . . . 0.0 110.945 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -53.56 140.91 27.13 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 109.862 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.6 -22.1 8.89 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.958 1.266 . . . . 0.0 112.738 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -148.36 152.83 37.71 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.888 1.275 . . . . 0.0 108.681 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.63 142.43 15.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.2 m -135.54 148.95 49.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.883 0.873 . . . . 0.0 109.036 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.4 mt -134.73 138.31 49.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.01 124.62 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 p -106.59 148.42 28.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 168.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.05 127.88 40.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.16 146.83 38.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 110.357 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.69 -39.69 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.072 1.848 . . . . 0.0 111.484 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.4 m -152.5 173.06 15.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 0.0 109.097 -169.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 pt -121.01 -29.8 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.51 1.124 . . . . 0.0 111.45 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.09 -11.64 31.75 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.537 0.735 . . . . 0.0 111.669 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -22.07 54.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.807 2.043 . . . . 0.0 112.532 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.23 -0.12 25.24 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.265 0.936 . . . . 0.0 112.942 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.55 -15.6 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 118.67 1.235 . . . . 0.0 112.856 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.3 m -54.95 -25.96 33.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.171 1.388 . . . . 0.0 113.289 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -124.58 32.24 5.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.142 1.377 . . . . 0.0 109.395 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.31 -166.98 2.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.414 1.486 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -43.57 -45.66 6.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.375 1.87 . . . . 0.0 113.938 -171.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 m -56.03 -42.36 76.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.279 1.4 . . . . 0.0 112.424 -169.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -65.94 -53.0 44.89 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.969 0.804 . . . . 0.0 110.398 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -64.69 -41.0 96.35 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.146 0.884 . . . . 0.0 111.146 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.2 -50.29 71.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.781 . . . . 0.0 110.269 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -62.56 -37.86 87.8 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.486 0.314 . . . . 0.0 110.692 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.76 -36.83 85.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.604 0.762 . . . . 0.0 110.695 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -74.82 -42.6 57.72 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.001 -1.062 . . . . 0.0 110.196 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.91 -49.35 66.11 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.82 1.248 . . . . 0.0 110.463 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.84 -12.56 25.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 0.0 113.563 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -108.36 -9.04 15.5 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 113.037 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.6 mt -64.96 -32.41 74.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.164 1.347 . . . . 0.0 110.584 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.08 -169.95 43.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.17 29.84 0.1 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.976 0.888 . . . . 0.0 112.451 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.72 149.76 3.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.68 -1.263 . . . . 0.0 110.34 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -71.78 141.18 49.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -142.55 131.55 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -139.01 156.67 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.841 0.856 . . . . 0.0 110.562 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.6 m -133.32 105.26 6.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.7 128.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 m -124.33 160.81 27.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.572 1.149 . . . . 0.0 109.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.037 169.339 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.41 -30.5 71.61 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.92 -10.88 73.49 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.622 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.15 32.47 5.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 110.293 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -137.56 132.06 32.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.8 -9.57 65.18 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.683 0.658 . . . . 0.0 111.544 -169.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mt -134.87 76.8 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -51.7 -31.69 27.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.3 1.44 . . . . 0.0 114.821 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -63.9 -27.96 69.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.04 151.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -133.37 143.97 49.3 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 m -93.07 143.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.84 158.72 25.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.073 1.349 . . . . 0.0 108.753 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 m -128.88 67.02 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.997 2.119 . . . . 0.0 108.449 -169.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.0 -35.9 48.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.257 0.623 . . . . 0.0 112.219 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -11.37 49.49 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.961 -1.087 . . . . 0.0 113.591 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -76.95 -29.75 55.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.887 1.221 . . . . 0.0 111.545 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -149.01 88.58 1.61 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 4.83 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.262 1.425 . . . . 0.0 113.581 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.3 m -55.92 -42.57 76.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.92 1.236 . . . . 0.0 110.722 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.68 -48.92 79.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.636 1.107 . . . . 0.0 110.84 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.5 98.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 123.66 0.648 . . . . 0.0 111.992 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.77 -42.01 67.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.454 0.627 . . . . 0.0 110.323 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.58 86.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.348 1.059 . . . . 0.0 111.913 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -92.01 3.53 55.03 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.925 0.89 . . . . 0.0 111.22 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.94 -4.84 8.97 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.625 1.107 . . . . 0.0 115.057 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.9 m -66.99 -8.94 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.986 2.114 . . . . 0.0 112.212 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.03 109.59 3.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 124' ' ' LEU . 67.7 mt -66.88 127.87 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -66.49 -49.76 65.52 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.298 1.039 . . . . 0.0 110.636 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -76.74 -49.56 15.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.524 ' H ' HG22 ' A' ' 121' ' ' ILE . 17.8 tp -80.26 -17.61 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 50.0 48.78 21.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.662 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.8 tp -137.84 161.67 35.99 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 108.426 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -72.91 129.76 38.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 110.722 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.41 168.07 18.23 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.864 1.266 . . . . 0.0 113.634 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -91.67 115.21 27.86 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.108 1.363 . . . . 0.0 108.191 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.7 m -154.48 166.84 32.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.105 0.562 . . . . 0.0 109.672 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.38 146.86 18.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -148.36 156.66 42.79 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.066 1.347 . . . . 0.0 109.105 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.96 144.97 30.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.2 mp -132.46 139.68 48.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.345 1.058 . . . . 0.0 108.661 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.95 166.62 13.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.223 1.409 . . . . 0.0 110.038 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -52.49 -31.38 34.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.149 1.38 . . . . 0.0 112.393 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.05 2.25 27.95 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.566 1.147 . . . . 0.0 112.7 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.4 -5.94 75.03 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 120.966 -1.084 . . . . 0.0 112.959 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.38 126.47 27.46 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.638 1.219 . . . . 0.0 108.964 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.77 128.94 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 109.625 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.5 t -116.83 -17.46 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.391 1.876 . . . . 0.0 109.851 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -145.38 147.68 32.53 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.26 135.58 15.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.161 1.385 . . . . 0.0 108.481 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.42 149.49 30.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.811 0.844 . . . . 0.0 109.299 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.05 106.44 9.28 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.434 2.294 . . . . 0.0 104.922 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 t -69.3 134.53 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -60.95 -19.5 60.96 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.945 1.298 . . . . 0.0 113.855 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -138.77 127.77 23.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.82 39.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.2 p -98.57 -5.79 31.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.431 1.092 . . . . 0.0 112.048 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -83.57 -174.47 5.3 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.373 1.469 . . . . 0.0 109.347 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -135.6 154.22 78.09 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.641 1.176 . . . . 0.0 109.905 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.55 172.71 10.08 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.938 2.426 . . . . 0.0 109.768 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -69.23 120.58 15.29 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 168.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -93.45 -2.49 54.47 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -76.02 -34.93 59.71 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.25 -54.36 55.58 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.766 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.65 -35.47 58.26 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.883 1.708 . . . . 0.0 111.885 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 mm -61.38 -50.39 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.465 1.029 . . . . 0.0 109.736 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.14 -36.95 84.49 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.986 0.812 . . . . 0.0 110.219 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.44 92.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.056 0.543 . . . . 0.0 111.068 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.43 -50.28 27.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.488 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.74 -27.24 69.07 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.235 1.38 . . . . 0.0 111.469 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.8 -31.68 68.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.668 1.122 . . . . 0.0 112.02 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.42 -44.21 36.91 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.193 0.597 . . . . 0.0 110.873 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.85 -48.42 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.365 0.666 . . . . 0.0 110.689 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 124.873 1.269 . . . . 0.0 110.031 179.742 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.46 179.58 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.723 0.809 . . . . 0.0 109.933 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.18 150.85 42.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -137.25 -84.26 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.455 1.025 . . . . 0.0 109.818 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.4 43.34 0.54 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.064 1.346 . . . . 0.0 110.97 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.78 70.52 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.261 0.934 . . . . 0.0 112.141 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 152.64 24.75 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.33 145.6 34.45 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.872 2.382 . . . . 0.0 110.65 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.97 139.04 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.53 1.132 . . . . 0.0 109.798 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -79.14 158.78 27.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.038 1.735 . . . . 0.0 110.038 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.93 149.77 43.82 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.05 1.74 . . . . 0.0 107.441 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.1 t -80.25 -83.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 118.364 0.529 . . . . 0.0 110.54 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 41.54 2.61 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.447 1.498 . . . . 0.0 111.908 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -60.84 171.66 1.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.648 1.979 . . . . 0.0 114.098 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 68.25 34.88 3.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.239 1.816 . . . . 0.0 113.82 169.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.91 142.99 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -151.11 162.09 41.51 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.428 0.691 . . . . 0.0 109.392 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.54 133.96 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.505 0.722 . . . . 0.0 109.76 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.67 1.74 90.57 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.156 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.11 -8.91 58.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.923 1.862 . . . . 0.0 112.297 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 57.35 174.39 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.755 1.622 . . . . 0.0 111.322 -169.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.43 139.98 26.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.111 1.364 . . . . 0.0 109.001 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.81 -27.91 80.12 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.205 2.604 . . . . 0.0 114.853 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 t70 84.39 116.25 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.284 2.634 . . . . 0.0 106.934 -169.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -131.22 161.74 31.55 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.856 1.263 . . . . 0.0 110.451 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -96.56 157.98 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.06 171.38 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.029 2.532 . . . . 0.0 106.641 172.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 tp -129.2 134.21 47.91 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.0 p -73.49 164.96 25.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -64.26 -13.83 51.94 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.758 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 m -83.25 1.07 42.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.452 1.501 . . . . 0.0 112.04 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp 57.31 53.12 7.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.797 2.039 . . . . 0.0 111.602 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.3 141.45 52.06 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.178 0.991 . . . . 0.0 108.433 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.22 143.53 40.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.16 0.981 . . . . 0.0 109.195 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -149.56 159.91 43.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.877 2.471 . . . . 0.0 105.039 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.0 m -142.32 163.78 31.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 tp -53.72 -38.11 63.97 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.321 -0.237 . . . . 0.0 110.659 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.66 -23.64 64.96 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.71 -32.23 57.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.937 0.789 . . . . 0.0 110.951 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.5 mtt -72.71 -38.31 67.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.378 1.071 . . . . 0.0 110.694 176.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -53.24 142.34 21.22 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.63 0.772 . . . . 0.0 109.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.32 -20.74 8.34 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.413 1.483 . . . . 0.0 112.293 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -150.16 154.69 38.45 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.197 1.399 . . . . 0.0 108.797 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.89 138.19 19.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 m -133.44 142.81 48.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.19 132.69 49.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -138.91 121.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.17 150.97 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.21 134.25 61.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.67 152.15 58.91 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.67 -46.94 4.47 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.446 1.431 . . . . 0.0 110.341 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.1 m -144.29 173.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 108.931 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.42 -26.27 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.13 -32.53 73.12 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 112.158 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -65.97 133.63 51.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.991 0.916 . . . . 0.0 109.888 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.0 -21.95 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.412 1.006 . . . . 0.0 114.476 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.85 -15.49 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.653 1.226 . . . . 0.0 112.262 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -26.84 57.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.332 0.969 . . . . 0.0 111.708 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -125.21 -34.93 2.68 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.775 1.23 . . . . 0.0 110.782 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.23 66.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.214 0.605 . . . . 0.0 112.081 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.97 -41.71 0.31 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.469 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . 0.252 3.4 m -65.54 -37.17 85.94 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -167.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -64.77 -53.7 42.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.014 1.279 . . . . 0.0 110.407 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -66.04 -42.27 89.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.368 0.531 . . . . 0.0 111.607 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.53 -50.43 73.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.719 0.808 . . . . 0.0 110.284 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -64.25 -38.19 90.17 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.833 0.288 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.15 -47.42 83.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.094 0.958 . . . . 0.0 110.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -70.04 -44.87 68.35 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.435 0.561 . . . . 0.0 110.525 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.29 79.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.725 0.693 . . . . 0.0 111.134 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.54 -14.57 43.54 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -102.92 -15.37 16.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.489 1.516 . . . . 0.0 112.02 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.67 -37.71 79.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.638 1.108 . . . . 0.0 110.718 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.57 -167.89 40.64 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.07 25.13 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.843 -0.798 . . . . 0.0 112.829 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -53.51 151.37 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.329 1.452 . . . . 0.0 111.449 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -77.08 139.62 40.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.13 123.3 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -139.47 156.48 46.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.181 0.592 . . . . 0.0 110.755 -175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -131.41 116.56 17.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.61 140.67 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.272 1.029 . . . . 0.0 108.27 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 m -140.99 175.38 9.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.313 1.445 . . . . 0.0 112.054 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 124.924 1.29 . . . . 0.0 113.646 -177.855 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.3 m -52.11 -34.89 46.27 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -171.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.41 -8.31 64.35 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.602 -1.11 . . . . 0.0 113.918 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.83 29.19 3.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.03 1.415 . . . . 0.0 111.546 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -135.88 69.21 1.43 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.593 1.157 . . . . 0.0 108.131 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.7 -27.04 0.26 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.357 0.98 . . . . 0.0 111.641 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 98.61 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.759 1.624 . . . . 0.0 106.867 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.83 -28.69 57.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.994 1.718 . . . . 0.0 114.267 -169.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -61.69 -32.12 72.29 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.12 0.568 . . . . 0.0 112.49 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.08 152.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.89 145.97 42.79 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -88.52 138.47 31.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.0 mp -128.64 167.63 16.92 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.085 2.154 . . . . 0.0 106.973 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.2 m -146.83 172.37 13.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.248 1.419 . . . . 0.0 107.585 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.81 2.6 3.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.429 0.633 . . . . 0.0 111.534 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -16.59 1.1 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -30.99 72.02 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.377 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -153.42 -7.48 0.17 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 tpt 56.45 27.6 12.39 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.182 1.393 . . . . 0.0 111.377 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.8 t -63.46 -62.36 1.72 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.542 1.537 . . . . 0.0 109.732 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -59.86 -38.93 83.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.9 0.48 . . . . 0.0 110.464 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.11 -56.66 13.51 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.619 2.057 . . . . 0.0 112.12 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.73 -36.73 62.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.686 0.743 . . . . 0.0 110.343 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.08 98.25 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.208 0.603 . . . . 0.0 111.773 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -102.23 3.84 38.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.297 1.039 . . . . 0.0 110.672 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.81 5.0 29.44 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 118.35 -1.25 . . . . 0.0 114.677 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.43 -13.68 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 119.139 1.47 . . . . 0.0 111.161 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.37 102.41 0.68 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 124' ' ' LEU . 81.3 mt -63.17 124.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -64.99 -45.37 85.88 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.958 0.903 . . . . 0.0 110.978 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.32 -49.45 12.42 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.917 0.326 . . . . 0.0 110.669 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.542 ' H ' HG22 ' A' ' 121' ' ' ILE . 15.0 tp -81.59 -14.21 57.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -170.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 47.84 48.38 17.71 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.06 1.344 . . . . 0.0 110.58 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.24 25.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.827 0.851 . . . . 0.0 108.843 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 129.22 37.34 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.08 160.68 26.15 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 111.646 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 104.63 16.61 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -145.74 163.17 35.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.596 0.759 . . . . 0.0 108.959 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.27 145.11 18.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -145.32 154.96 42.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 109.321 -169.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.82 136.54 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 171.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.31 139.63 51.7 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.868 1.267 . . . . 0.0 108.013 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 165.22 11.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.077 1.351 . . . . 0.0 110.245 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.6 -34.35 25.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.22 1.408 . . . . 0.0 112.816 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.8 12.1 20.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.059 0.943 . . . . 0.0 113.113 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.46 -6.17 82.8 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.451 1.024 . . . . 0.0 113.132 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 138.55 58.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.57 1.185 . . . . 0.0 109.518 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.89 133.18 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.17 -25.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.928 1.291 . . . . 0.0 109.91 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -150.59 151.8 33.11 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.51 138.41 16.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.578 1.551 . . . . 0.0 107.916 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -147.5 148.33 31.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.763 0.825 . . . . 0.0 108.824 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -127.43 112.54 15.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 t -66.88 133.11 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -60.58 -16.13 34.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.562 1.145 . . . . 0.0 112.66 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -139.33 111.67 7.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.36 -18.23 64.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -174.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.6 p -83.58 9.39 11.56 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.136 0.974 . . . . 0.0 110.976 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -132.68 174.02 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.231 2.612 . . . . 0.0 108.12 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -122.83 158.64 56.53 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.749 1.219 . . . . 0.0 111.553 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.75 179.34 3.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.206 2.604 . . . . 0.0 110.225 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -80.35 85.5 5.82 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -67.61 -0.46 3.94 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.438 1.495 . . . . 0.0 113.114 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.67 -25.8 49.82 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.169 -0.957 . . . . 0.0 109.364 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.53 -52.65 72.62 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.476 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.95 -33.73 73.62 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.585 1.602 . . . . 0.0 112.573 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 mm -59.79 -47.2 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.708 1.14 . . . . 0.0 109.525 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.66 -35.63 81.19 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.326 0.967 . . . . 0.0 110.931 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.76 -42.17 97.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.227 0.211 . . . . 0.0 110.801 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -40.23 80.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.321 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -57.53 -42.3 82.62 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.448 1.022 . . . . 0.0 110.242 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.31 -31.66 69.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.149 0.431 . . . . 0.0 111.965 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.75 -55.44 5.64 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.247 0.476 . . . . 0.0 110.745 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.19 -51.95 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 111.177 -169.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 21.1 pttm . . . . . 0 C--O 1.25 1.128 0 C-N-CA 127.792 2.437 . . . . 0.0 112.219 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.236 0.349 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.21 -175.22 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.161 1.384 . . . . 0.0 107.606 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -123.17 160.39 26.61 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -147.71 127.11 13.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 169.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 43.33 39.68 2.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.942 1.297 . . . . 0.0 112.908 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.24 15.27 74.76 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.167 0.889 . . . . 0.0 114.674 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.49 120.74 4.52 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.22 142.95 86.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.93 2.42 . . . . 0.0 111.259 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.43 135.02 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.231 1.013 . . . . 0.0 109.5 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -76.55 164.35 26.02 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.828 2.051 . . . . 0.0 109.261 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.83 165.15 23.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.869 0.868 . . . . 0.0 109.829 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.6 134.83 57.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.809 1.644 . . . . 0.0 107.207 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.2 -12.57 63.61 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.122 0.868 . . . . 0.0 114.002 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 53.26 164.92 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.354 3.061 . . . . 0.0 115.375 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -67.03 164.88 16.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.215 1.006 . . . . 0.0 113.319 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.69 166.26 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 126.607 1.963 . . . . 0.0 106.589 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -149.15 165.59 31.35 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.695 0.798 . . . . 0.0 109.061 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 141' ' ' VAL . 1.5 p -52.26 131.72 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 122.76 0.424 . . . . 0.0 109.893 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.84 71.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.654 1.121 . . . . 0.0 113.322 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.01 -10.78 59.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.329 1.565 . . . . 0.0 114.113 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 62.39 104.42 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.919 1.688 . . . . 0.0 112.5 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.13 134.57 68.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.523 1.129 . . . . 0.0 111.833 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.44 -27.01 83.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.541 2.827 . . . . 0.0 115.392 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.78 112.44 0.05 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.954 2.502 . . . . 0.0 111.34 -169.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -143.27 168.88 18.73 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.477 1.511 . . . . 0.0 109.73 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 159.58 33.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.089 1.755 . . . . 0.0 111.592 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.79 178.14 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 129.184 2.994 . . . . 0.0 105.833 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.85 133.54 53.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -79.81 -176.8 5.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.309 0.576 . . . . 0.0 110.413 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -46.94 -36.57 7.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.752 1.221 . . . . 0.0 111.722 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m -111.73 20.67 16.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.318 1.447 . . . . 0.0 110.556 -171.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.9 mt 56.24 32.59 20.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.96 2.104 . . . . 0.0 113.265 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.61 142.99 46.54 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.13 57.61 3.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.87 1.268 . . . . 0.0 110.136 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -59.54 158.21 10.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 108.107 169.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -137.57 166.76 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.89 -30.6 64.05 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.014 -0.429 . . . . 0.0 111.527 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.99 -20.99 64.47 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.626 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.06 -28.86 43.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.271 0.941 . . . . 0.0 110.754 172.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 mtt -71.38 -39.11 71.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.056 0.942 . . . . 0.0 110.497 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.47 135.39 39.8 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.86 -26.52 3.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.17 1.367 . . . . 0.0 112.169 -171.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -151.28 159.86 44.11 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.337 1.055 . . . . 0.0 109.722 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.9 t -58.48 136.67 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 170.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 45.8 m -136.96 148.74 47.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.952 1.301 . . . . 0.0 108.295 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 94.7 mt -133.63 135.45 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -136.96 104.79 3.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 149.6 25.5 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.5 t -136.85 141.25 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.99 154.51 54.9 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.299 1.04 . . . . 0.0 111.205 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -76.09 -50.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.775 1.65 . . . . 0.0 108.316 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -159.95 170.25 21.76 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.54 -7.13 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.991 1.717 . . . . 0.0 109.783 168.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -51.74 -26.13 8.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.394 1.877 . . . . 0.0 113.141 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 p -61.49 -9.57 5.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.813 2.045 . . . . 0.0 113.156 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.72 16.38 75.52 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.183 0.901 . . . . 0.0 112.124 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.17 -7.33 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.547 1.539 . . . . 0.0 113.165 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 91.9 m -47.99 -30.0 3.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.557 1.543 . . . . 0.0 114.405 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.91 -30.23 70.79 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.22 8.81 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.522 ' HG3' ' H ' ' A' ' 65' ' ' ARG . 4.6 pt20 -66.57 -169.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -42.96 -24.55 0.07 Allowed 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 127.392 2.277 . . . . 0.0 113.092 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 13.7 tpt180 -43.52 -50.93 7.03 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.934 1.294 . . . . 0.0 111.073 169.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -60.76 -50.11 74.78 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.06 0.846 . . . . 0.0 109.589 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -60.21 -47.02 87.74 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.3 -40.31 77.59 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.153 1.781 . . . . 0.0 110.255 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -69.23 -33.3 73.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.98 1.312 . . . . 0.0 110.817 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -72.34 -45.78 58.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.047 0.839 . . . . 0.0 109.675 169.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.66 -44.36 90.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.824 1.249 . . . . 0.0 111.882 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.52 -20.98 63.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 112.441 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -84.85 -16.73 40.3 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.314 0.961 . . . . 0.0 112.805 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.19 -29.95 69.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.629 1.104 . . . . 0.0 112.237 -169.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.26 -162.03 35.19 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.86 17.73 0.16 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.731 1.212 . . . . 0.0 112.509 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 m -55.42 145.38 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.601 1.561 . . . . 0.0 110.855 -172.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -71.38 138.88 49.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.45 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -127.44 153.22 46.55 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.889 0.875 . . . . 0.0 109.575 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -128.52 116.54 19.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.9 mt -99.72 140.17 19.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -140.25 173.18 11.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.124 0.97 . . . . 0.0 111.663 -171.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 167.52 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 118.612 -0.708 . . . . 0.0 112.074 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.0 m -146.2 -69.21 0.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.516 1.126 . . . . 0.0 111.223 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.3 -33.25 15.49 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 127.494 2.473 . . . . 0.0 115.6 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.49 18.97 5.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.156 1.382 . . . . 0.0 110.834 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -80.55 140.55 35.75 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.123 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -49.29 2.97 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.143 0.878 . . . . 0.0 112.184 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 pt -76.11 67.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 125.663 1.585 . . . . 0.0 109.859 169.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.79 -22.63 3.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.986 2.514 . . . . 0.0 114.319 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -59.58 -38.26 80.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.625 0.77 . . . . 0.0 111.547 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 t -69.42 141.26 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.41 144.78 47.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.7 m -98.95 135.45 40.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.47 164.48 21.81 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 128.194 2.598 . . . . 0.0 106.55 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.0 m -131.27 167.46 19.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -138.79 -26.51 0.86 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.459 -0.781 . . . . 0.0 112.506 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -51.81 -29.91 21.1 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -63.81 -24.64 67.84 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.53 -0.731 . . . . 0.0 112.919 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -122.56 -26.37 4.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.538 1.135 . . . . 0.0 111.688 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.1 tpt 65.67 2.66 2.16 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.566 3.146 . . . . 0.0 114.293 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -72.4 -39.47 67.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.562 -1.209 . . . . 0.0 112.433 -170.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.35 -39.5 94.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.683 1.583 . . . . 0.0 109.501 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.46 -48.24 77.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 124.253 0.93 . . . . 0.0 111.116 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.9 -46.05 76.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 117.876 0.838 . . . . 0.0 110.175 174.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.92 68.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.39 1.076 . . . . 0.0 113.355 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.84 3.69 22.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.372 1.069 . . . . 0.0 111.545 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.53 31.01 77.42 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 119.531 1.059 . . . . 0.0 112.767 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.63 -2.78 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -70.79 105.56 3.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.62 133.1 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -72.65 -50.45 24.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.253 0.621 . . . . 0.0 110.191 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.94 -56.32 4.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.929 0.492 . . . . 0.0 110.767 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.0 tp -68.8 -21.09 64.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.399 0.68 . . . . 0.0 111.912 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 52.79 42.57 31.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.559 1.543 . . . . 0.0 112.19 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.72 170.51 14.24 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.718 1.207 . . . . 0.0 108.234 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.7 134.94 46.62 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.37 41.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.333 0.653 . . . . 0.0 111.262 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -72.78 124.16 24.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.1 m -164.31 169.91 16.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.373 1.069 . . . . 0.0 108.221 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.38 147.95 18.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.75 156.74 45.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.562 1.545 . . . . 0.0 108.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.77 142.47 42.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 tp -137.27 127.65 26.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.726 1.211 . . . . 0.0 109.412 -168.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 168.38 17.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.466 1.106 . . . . 0.0 111.14 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -57.67 -26.17 61.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.858 1.663 . . . . 0.0 113.296 -173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.18 35.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.496 1.518 . . . . 0.0 111.418 -176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.62 10.01 53.89 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 121.258 -0.901 . . . . 0.0 112.847 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -75.43 114.6 14.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.706 1.753 . . . . 0.0 107.937 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.04 129.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.402 ' HA ' HG23 ' A' ' 20' ' ' VAL . 7.8 p -114.24 -11.53 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.319 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -150.6 151.0 31.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.0 133.99 13.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.187 1.795 . . . . 0.0 106.397 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -144.98 138.19 26.62 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.22 114.82 23.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.66 144.49 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.6 m -59.32 -23.27 62.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 111.759 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -145.77 126.31 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 5.61 1.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.294 1.438 . . . . 0.0 114.385 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -114.77 24.37 11.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.336 1.454 . . . . 0.0 109.693 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -138.25 162.74 33.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 129.317 3.047 . . . . 0.0 106.377 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -115.44 153.7 47.65 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 119.764 1.166 . . . . 0.0 113.022 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.07 179.18 6.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.065 3.177 . . . . 0.0 111.576 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -65.44 152.69 43.34 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.173 0.589 . . . . 0.0 110.101 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -109.78 -3.11 16.93 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.152 0.981 . . . . 0.0 112.149 -171.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -128.71 -40.81 1.53 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.803 0.729 . . . . 0.0 110.719 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -55.11 -46.19 99.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.136 -1.411 . . . . 0.0 112.159 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.69 -34.17 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.832 1.69 . . . . 0.0 112.515 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.07 -46.51 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.523 1.056 . . . . 0.0 109.742 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.95 -38.79 92.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.67 0.788 . . . . 0.0 110.011 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.17 96.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.1 66.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.912 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -55.85 -40.02 72.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.006 0.821 . . . . 0.0 110.692 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.65 67.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.235 0.614 . . . . 0.0 111.843 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.34 -48.79 9.34 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 122.951 0.5 . . . . 0.0 111.572 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.89 -49.68 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.818 . . . . 0.0 110.073 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 78.7 tttt . . . . . 0 C--O 1.249 1.065 0 C-N-CA 127.791 2.436 . . . . 0.0 111.04 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.0 pt -139.54 -177.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -115.83 153.55 31.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.13 110.69 9.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt 41.49 45.18 2.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.317 1.847 . . . . 0.0 111.974 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.75 -10.79 62.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.29 0.876 . . . . 0.0 115.29 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.47 120.38 6.45 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.031 -1.427 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.86 139.43 84.1 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.191 2.594 . . . . 0.0 112.113 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 m -145.94 159.62 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.18 1.392 . . . . 0.0 110.117 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.5 m -110.88 162.22 15.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.387 1.475 . . . . 0.0 109.461 -170.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.36 139.26 50.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 109.348 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.61 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.951 0.901 . . . . 0.0 110.784 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.47 71.37 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.984 0.802 . . . . 0.0 113.877 -171.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 52.89 -176.47 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.431 2.693 . . . . 0.0 116.907 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -68.01 111.25 4.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.528 1.931 . . . . 0.0 112.742 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -73.46 152.76 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 168.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -134.32 160.53 37.65 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -58.91 136.49 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.18 -4.17 85.99 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.81 1.195 . . . . 0.0 113.796 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.25 -9.35 59.18 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.72 1.76 . . . . 0.0 114.216 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 67.51 122.77 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.665 1.986 . . . . 0.0 111.838 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.01 127.77 91.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.702 -1.142 . . . . 0.0 108.069 173.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.62 -46.78 13.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.635 2.223 . . . . 0.0 113.846 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 t70 128.52 122.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 131.329 3.851 . . . . 0.0 105.554 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -146.96 169.18 19.71 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.273 1.429 . . . . 0.0 108.509 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.9 m -123.57 151.6 42.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 m -139.75 174.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 128.051 2.54 . . . . 0.0 106.548 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.91 153.16 40.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.4 p -80.49 176.9 9.37 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.495 1.118 . . . . 0.0 110.091 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.2 -26.49 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.022 -1.049 . . . . 0.0 110.891 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -79.14 0.57 27.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 111.863 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt 51.79 51.07 17.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.627 1.971 . . . . 0.0 111.985 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.16 141.94 47.96 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -70.08 148.1 49.18 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.612 1.165 . . . . 0.0 110.546 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -153.35 153.72 33.12 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.573 2.349 . . . . 0.0 105.488 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -137.54 164.83 27.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.926 0.785 . . . . 0.0 109.475 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.1 tp -49.89 -41.29 45.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 110.961 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.11 -18.61 65.45 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.53 -29.67 56.82 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.721 0.691 . . . . 0.0 110.949 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.5 mtt -74.84 -42.44 57.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.454 1.102 . . . . 0.0 110.364 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 144.62 24.33 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.432 0.693 . . . . 0.0 110.166 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.72 -17.55 22.95 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.766 1.175 . . . . 0.0 112.879 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -146.65 155.2 42.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.945 1.298 . . . . 0.0 108.874 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.42 141.23 16.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.5 m -134.7 146.74 49.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.088 0.955 . . . . 0.0 108.599 -174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.41 133.62 57.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.0 mt -138.82 131.0 37.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.98 143.35 46.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 169.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.72 137.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -141.9 156.8 65.36 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 108.032 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.54 -49.33 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 120.87 1.047 . . . . 0.0 109.448 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.0 m -162.53 144.93 10.89 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 120.931 -1.106 . . . . 0.0 109.967 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.67 -28.26 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 122.924 0.49 . . . . 0.0 111.251 170.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.22 -25.61 48.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.456 1.102 . . . . 0.0 113.55 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 79.7 p -64.09 -24.99 67.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.34 -4.12 74.06 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.772 -1.016 . . . . 0.0 112.712 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.86 -28.27 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.112 1.956 . . . . 0.0 110.008 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.5 p -57.89 -33.95 69.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.997 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.26 -33.56 24.01 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.92 0.782 . . . . 0.0 110.693 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.97 70.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.307 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.85 -49.06 0.19 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -54.38 -48.71 71.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -167.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -4.63 12.53 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.61 -39.88 2.82 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 123.861 0.864 . . . . 0.0 109.161 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.43 -47.47 72.8 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.712 0.805 . . . . 0.0 110.751 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -67.05 -31.21 71.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.797 0.439 . . . . 0.0 111.984 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -70.65 -51.46 27.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.4 -41.55 89.68 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.145 0.578 . . . . 0.0 110.181 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.02 75.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.164 0.986 . . . . 0.0 110.613 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.48 66.47 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -72.84 -27.81 62.16 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.802 1.183 . . . . 0.0 111.826 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 mt -63.91 -37.32 86.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.731 0.696 . . . . 0.0 111.17 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.2 -170.63 43.78 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.17 19.06 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.824 0.849 . . . . 0.0 113.273 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.1 m -55.42 153.84 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 111.464 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.48 143.04 44.79 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.89 126.78 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.49 151.55 50.48 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.412 0.551 . . . . 0.0 110.951 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.6 m -122.26 139.06 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.05 133.35 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -128.84 161.43 29.82 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.835 0.854 . . . . 0.0 110.67 -173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -169.794 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.1 p90 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 t 48.95 50.25 18.07 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.476 1.111 . . . . 0.0 110.227 -171.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.69 -139.8 4.66 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -169.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.0 69.47 1.45 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.23 1.412 . . . . 0.0 111.45 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.39 142.1 23.66 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 108.926 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.04 50.16 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.114 0.864 . . . . 0.0 112.897 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.26 94.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.32 -29.33 61.15 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.843 1.257 . . . . 0.0 114.117 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -64.37 -29.06 70.14 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.91 148.9 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.36 148.11 39.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.16 141.74 28.42 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.308 1.843 . . . . 0.0 108.28 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.63 155.2 36.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.749 1.619 . . . . 0.0 108.543 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.5 m -127.3 47.38 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.411 2.284 . . . . 0.0 109.204 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.41 -26.6 42.67 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.698 -0.626 . . . . 0.0 112.2 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -49.25 -26.44 2.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -70.15 -15.92 63.02 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.69 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -140.73 -22.07 0.8 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.827 1.194 . . . . 0.0 113.745 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 82.3 mmm 58.79 2.99 0.27 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.309 3.044 . . . . 0.0 116.021 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -62.89 -44.07 97.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.466 1.485 . . . . 0.0 111.994 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -64.87 -42.34 94.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.562 1.528 . . . . 0.0 109.756 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.27 -44.75 96.27 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 123.68 0.657 . . . . 0.0 111.773 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.44 -46.08 67.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.983 0.513 . . . . 0.0 109.843 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -38.92 78.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.082 0.953 . . . . 0.0 112.46 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -99.38 4.53 46.33 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.68 1.192 . . . . 0.0 111.824 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.22 37.5 64.82 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 118.454 0.57 . . . . 0.0 112.803 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.73 -7.55 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.358 1.063 . . . . 0.0 109.841 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.86 108.41 1.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.78 120.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.16 -43.81 98.0 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.618 1.167 . . . . 0.0 111.423 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -92.32 -4.78 53.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.466 0.707 . . . . 0.0 112.872 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.62 -11.59 2.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.919 . . . . 0.0 111.977 -170.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 41.6 ptt85 49.3 31.61 3.86 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.15 2.18 . . . . 0.0 114.599 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.3 mt -116.9 167.11 11.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.33 130.6 37.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 164.1 24.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.786 1.234 . . . . 0.0 112.809 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 99.25 11.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.8 m -144.06 162.69 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.885 0.874 . . . . 0.0 109.158 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.55 144.42 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -146.98 155.9 42.62 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.088 1.355 . . . . 0.0 109.068 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.8 t -139.5 143.77 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.88 136.15 36.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.841 0.856 . . . . 0.0 109.7 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.14 164.53 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.368 1.467 . . . . 0.0 109.133 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.4 -29.65 10.58 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.04 1.736 . . . . 0.0 113.253 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.35 1.79 12.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.688 1.195 . . . . 0.0 113.015 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.33 30.09 65.31 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 120.837 -1.165 . . . . 0.0 110.245 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -106.85 116.23 31.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.794 1.297 . . . . 0.0 108.494 -173.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.17 124.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.216 1.006 . . . . 0.0 110.679 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.07 -8.42 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.376 1.47 . . . . 0.0 111.131 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -147.99 147.45 29.65 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.81 15.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.456 1.502 . . . . 0.0 108.272 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.79 149.63 33.73 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.105 0.962 . . . . 0.0 109.216 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.16 104.93 7.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.761 2.424 . . . . 0.0 105.055 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.74 137.86 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.2 m -62.25 -11.95 17.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.149 1.38 . . . . 0.0 113.727 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -142.69 123.92 14.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -54.39 -27.02 33.72 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.863 1.265 . . . . 0.0 113.958 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.9 p -91.72 14.54 14.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.754 1.161 . . . . 0.0 112.368 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -123.66 170.84 10.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.632 1.573 . . . . 0.0 109.763 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -125.96 155.43 73.16 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.589 1.156 . . . . 0.0 110.953 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -91.65 179.93 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.082 3.188 . . . . 0.0 110.271 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -79.5 111.89 16.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -81.73 -0.68 44.03 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -76.57 -29.44 56.61 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.795 -1.191 . . . . 0.0 108.919 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -59.46 -50.66 86.1 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 117.663 -1.16 . . . . 0.0 111.456 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.65 -34.27 52.05 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.269 1.489 . . . . 0.0 112.44 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.57 -45.31 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.203 1.365 . . . . 0.0 109.933 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.87 -36.04 83.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.12 0.873 . . . . 0.0 110.797 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.386 -0.196 . . . . 0.0 111.068 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.4 77.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.985 0.514 . . . . 0.0 110.899 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -57.18 -40.47 77.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.168 0.894 . . . . 0.0 110.603 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.77 68.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.999 0.52 . . . . 0.0 111.912 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.51 -59.95 2.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.045 0.384 . . . . 0.0 110.921 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.53 -40.28 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.257 1.023 . . . . 0.0 112.14 -169.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? . . . . . 0 C--O 1.25 1.095 0 C-N-CA 127.217 2.207 . . . . 0.0 112.143 -176.386 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.9 pt -126.37 173.18 12.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.619 1.199 . . . . 0.0 111.217 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -116.16 138.3 51.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -90.72 -132.97 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.17 56.36 0.46 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.656 1.982 . . . . 0.0 111.317 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 22.63 45.02 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.341 0.972 . . . . 0.0 113.506 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.54 140.42 11.06 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.03 144.55 52.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.617 2.212 . . . . 0.0 109.572 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.85 126.73 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.412 0.685 . . . . 0.0 109.415 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -66.73 151.12 48.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.222 1.409 . . . . 0.0 110.509 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.66 145.73 47.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.0 1.72 . . . . 0.0 107.611 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.65 -23.06 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.85 31.31 0.51 Allowed Glycine 0 N--CA 1.464 0.549 0 CA-C-N 118.689 0.677 . . . . 0.0 111.648 -172.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.41 152.12 3.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 9.4 tt0 94.66 33.17 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.504 2.721 . . . . 0.0 113.997 169.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -64.0 152.99 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.47 167.88 25.84 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -169.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.54 129.87 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.209 0.604 . . . . 0.0 109.695 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -2.79 87.58 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.715 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.53 -11.4 59.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.485 1.642 . . . . 0.0 112.235 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 57.08 178.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.563 1.545 . . . . 0.0 112.291 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.85 138.82 33.39 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 127.001 2.12 . . . . 0.0 107.856 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -58.38 -44.39 38.46 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.813 2.342 . . . . 0.0 114.201 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 114.99 124.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 131.218 3.807 . . . . 0.0 105.439 -169.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -133.49 165.37 25.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 109.088 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -126.22 139.44 53.34 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.48 146.11 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.032 1.333 . . . . 0.0 108.276 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.44 166.15 22.31 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.6 p -130.62 -177.54 4.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.932 1.293 . . . . 0.0 108.419 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -47.27 -34.28 6.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.559 0.744 . . . . 0.0 111.537 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -112.77 14.53 19.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.819 1.248 . . . . 0.0 111.531 -170.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.6 mt 51.64 44.16 29.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.742 . . . . 0.0 112.123 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -73.29 -18.12 61.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 112.81 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.12 54.56 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 123.084 1.421 . . . . 0.0 108.604 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -58.76 161.0 5.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.066 1.746 . . . . 0.0 108.869 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.2 p -141.59 170.23 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 tp -54.55 -40.95 69.21 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.63 -20.66 63.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.64 -33.46 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.728 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 37.0 mtt -71.36 -39.73 71.08 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.301 1.041 . . . . 0.0 110.609 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -54.36 138.37 39.69 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 123.317 0.647 . . . . 0.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.24 7.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.01 1.29 . . . . 0.0 112.553 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -147.92 155.77 41.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.598 1.159 . . . . 0.0 109.258 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.41 139.67 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.1 m -135.36 147.83 49.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.231 1.012 . . . . 0.0 108.738 -172.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.09 136.78 54.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.3 mt -135.27 128.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.0 m -108.9 141.33 41.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -135.48 125.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.9 pt -150.06 159.6 35.12 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.201 1.8 . . . . 0.0 107.178 -170.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.71 -40.39 79.95 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.123 1.882 . . . . 0.0 112.234 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.07 165.53 15.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.812 1.645 . . . . 0.0 109.099 169.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pp -67.23 41.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 125.915 1.686 . . . . 0.0 112.861 169.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -158.18 -29.03 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.148 . . . . 0.0 113.208 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -72.57 32.51 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -168.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.82 -29.6 1.8 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.006 1.289 . . . . 0.0 114.591 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.3 -3.72 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.379 1.472 . . . . 0.0 113.202 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 29.2 m -74.45 33.36 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.975 -1.078 . . . . 0.0 110.65 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.38 179.84 1.18 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.099 1.36 . . . . 0.0 111.259 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.38 31.61 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.567 1.147 . . . . 0.0 113.235 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -62.94 -56.76 14.32 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.714 1.143 . . . . 0.0 109.437 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -62.16 -42.55 99.37 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 109.779 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -61.71 -53.95 49.14 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.829 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -64.11 -45.88 86.67 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.846 0.748 . . . . 0.0 110.268 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -54.09 -52.17 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.175 0.99 . . . . 0.0 110.853 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.18 -35.95 81.8 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.915 0.388 . . . . 0.0 110.823 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -69.98 -37.25 75.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.257 0.623 . . . . 0.0 111.838 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -74.49 -34.34 63.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.171 0.896 . . . . 0.0 110.919 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.32 -46.41 76.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.708 0.685 . . . . 0.0 110.794 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.97 -16.44 51.29 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.838 0.855 . . . . 0.0 113.293 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -83.21 -27.09 30.23 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.067 0.849 . . . . 0.0 111.847 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.0 -33.82 76.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.581 0.628 . . . . 0.0 110.987 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.36 -168.01 40.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -75.71 28.16 0.11 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.745 -0.856 . . . . 0.0 112.217 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -54.76 138.42 14.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.528 1.131 . . . . 0.0 109.059 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -66.13 137.97 57.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.07 119.53 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.61 149.62 52.18 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.915 0.486 . . . . 0.0 110.745 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 m -133.76 116.1 15.34 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mt -92.14 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -133.72 162.08 32.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.094 2.158 . . . . 0.0 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.204 1.402 . . . . 0.0 112.95 -178.055 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 62.9 m95 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.7 p -63.72 -15.05 57.51 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.675 -0.64 . . . . 0.0 112.393 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.36 -148.85 5.88 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 127.205 2.336 . . . . 0.0 107.738 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 54.69 41.43 31.94 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.702 1.201 . . . . 0.0 111.659 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -141.14 148.15 39.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.962 1.705 . . . . 0.0 107.278 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.04 -60.37 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 77.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 122.696 1.236 . . . . 0.0 108.898 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.88 -20.11 14.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.338 1.855 . . . . 0.0 113.974 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -58.38 -30.98 67.21 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.734 -0.604 . . . . 0.0 112.098 173.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.56 142.24 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.67 138.24 44.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.47 143.05 32.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.825 0.85 . . . . 0.0 108.817 -173.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -124.07 156.39 36.64 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.78 1.632 . . . . 0.0 108.247 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -136.41 144.44 44.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -134.26 -16.23 2.16 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -64.29 -14.32 55.21 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.717 -1.24 . . . . 0.0 114.143 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -65.55 -18.88 65.65 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.276 -0.89 . . . . 0.0 112.155 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -147.19 -15.64 0.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 35.6 mmm 50.15 37.33 14.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.245 1.818 . . . . 0.0 111.99 -169.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -56.94 15.43 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -63.3 -37.85 88.87 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.687 0.676 . . . . 0.0 109.812 175.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.77 -55.48 8.21 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.482 1.991 . . . . 0.0 113.216 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.47 -35.2 40.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.154 0.477 . . . . 0.0 110.506 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.47 79.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.186 0.595 . . . . 0.0 112.334 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.62 2.43 16.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.915 1.286 . . . . 0.0 110.684 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 8.08 62.55 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.289 -0.882 . . . . 0.0 114.276 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 m -79.47 -4.55 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.043 1.737 . . . . 0.0 112.175 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -67.0 115.76 7.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.5 mt -75.48 106.86 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -54.72 -40.63 69.45 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.805 0.842 . . . . 0.0 110.85 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -86.88 -5.1 59.21 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.02 -7.03 2.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.168 0.894 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 15.8 ptm180 40.2 43.33 1.36 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.89 2.076 . . . . 0.0 113.763 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt -131.74 175.83 8.85 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.04 129.55 34.78 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.758 0.823 . . . . 0.0 109.318 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 139.24 57.86 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.998 1.319 . . . . 0.0 111.1 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.49 113.14 3.1 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.4 p -154.15 164.13 39.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.284 0.564 . . . . 0.0 109.873 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 t -141.74 136.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -142.85 152.09 41.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.564 0.745 . . . . 0.0 109.229 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.65 136.25 52.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -130.85 136.74 48.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.86 1.264 . . . . 0.0 108.372 -169.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.06 165.46 15.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.22 1.408 . . . . 0.0 110.514 169.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.51 -33.22 20.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 113.182 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.32 5.74 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.172 0.897 . . . . 0.0 113.304 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.3 -7.59 75.49 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.607 1.099 . . . . 0.0 113.091 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.48 125.32 24.79 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.613 1.207 . . . . 0.0 109.034 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.86 128.75 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.94 -8.53 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.122 1.369 . . . . 0.0 111.04 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -153.86 150.48 28.45 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.7 133.74 11.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.522 1.529 . . . . 0.0 107.913 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -143.57 149.8 37.92 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.327 0.651 . . . . 0.0 110.138 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -128.09 112.74 14.92 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.09 133.47 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -57.9 -20.3 36.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.043 0.937 . . . . 0.0 112.633 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.43 124.47 13.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.49 -32.04 72.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.394 0.678 . . . . 0.0 112.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -79.41 17.28 0.87 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.483 1.113 . . . . 0.0 111.65 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -134.31 171.27 14.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 107.054 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.84 151.13 76.83 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 111.435 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -86.64 176.09 4.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.064 3.176 . . . . 0.0 110.421 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -71.52 133.37 45.77 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -110.7 3.07 18.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.0 0.52 . . . . 0.0 112.192 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.59 -40.27 42.75 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -54.65 -50.79 83.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.315 -1.326 . . . . 0.0 112.403 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.46 -36.64 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 CA-C-N 121.84 1.693 . . . . 0.0 112.431 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.5 mm -59.48 -46.75 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.315 0.961 . . . . 0.0 109.588 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.45 -35.85 82.15 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.304 -0.872 . . . . 0.0 110.845 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.87 98.46 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.356 0.262 . . . . 0.0 110.642 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.27 -47.04 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.919 0.488 . . . . 0.0 110.682 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.96 -42.5 72.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.211 0.914 . . . . 0.0 110.484 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.4 -31.12 67.39 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.346 0.658 . . . . 0.0 111.881 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -84.74 -44.01 13.74 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.763 0.425 . . . . 0.0 111.612 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.87 -51.35 24.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 123.774 0.83 . . . . 0.0 111.55 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.249 1.068 0 C-N-CA 123.948 0.899 . . . . 0.0 109.666 -178.455 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.57 172.81 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 122.397 1.094 . . . . 0.0 110.07 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 m -134.01 143.82 48.34 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.81 -2.292 . . . . 0.0 104.81 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -138.39 127.18 23.7 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 47.34 38.77 7.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.922 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.6 20.35 79.57 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.309 -0.717 . . . . 0.0 114.526 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.08 121.35 4.41 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 172.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.34 140.91 82.32 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.827 2.351 . . . . 0.0 110.715 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.25 135.81 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -74.78 157.7 34.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.597 1.559 . . . . 0.0 109.406 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 144.64 48.71 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.0 t -60.88 -52.18 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.495 0.718 . . . . 0.0 112.33 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.66 37.57 3.17 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.707 1.146 . . . . 0.0 112.41 -170.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.15 169.95 0.16 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.537 1.935 . . . . 0.0 115.018 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 77.18 28.21 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.769 2.028 . . . . 0.0 113.306 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -64.0 145.82 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -150.43 164.57 35.56 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.936 0.895 . . . . 0.0 109.555 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 p -53.0 133.04 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.305 0.642 . . . . 0.0 109.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.62 1.21 90.49 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.737 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.63 -12.93 60.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.439 1.619 . . . . 0.0 112.314 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.17 176.4 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.81 1.644 . . . . 0.0 112.025 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.72 147.58 63.33 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.647 1.579 . . . . 0.0 110.363 -173.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.02 -51.39 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.776 2.317 . . . . 0.0 112.277 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t70 118.11 127.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 1 C-N-CA 131.844 4.058 . . . . 0.0 105.88 -169.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.75 166.51 23.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.832 1.653 . . . . 0.0 108.844 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 m -132.13 138.2 47.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.52 174.47 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 127.778 2.431 . . . . 0.0 107.686 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.3 140.93 46.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.8 p -70.84 174.87 5.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.143 1.777 . . . . 0.0 110.846 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.52 -22.08 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.505 -0.747 . . . . 0.0 110.928 169.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 m -84.11 0.18 49.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.485 1.514 . . . . 0.0 111.859 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.3 mt 52.73 49.74 19.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.427 1.891 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.33 159.95 26.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.358 1.463 . . . . 0.0 107.451 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.66 144.46 47.75 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.915 0.864 . . . . 0.0 111.026 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -142.11 151.39 42.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.619 2.368 . . . . 0.0 105.129 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 p -135.08 165.08 26.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -56.85 -37.53 71.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 174.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.88 67.59 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -78.95 -30.48 44.59 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.794 0.725 . . . . 0.0 111.259 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 48.6 mtt -72.03 -41.1 67.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.966 0.906 . . . . 0.0 110.887 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -54.3 146.06 16.38 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.238 1.015 . . . . 0.0 110.057 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.11 -21.15 12.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.937 1.256 . . . . 0.0 112.612 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -146.8 152.98 39.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.321 1.448 . . . . 0.0 108.443 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.77 141.14 17.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.4 m -135.02 146.8 49.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -172.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 90.1 mt -128.51 135.23 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.4 102.94 3.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.8 m -79.84 151.22 30.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.74 126.86 39.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.5 pt -137.84 147.75 57.99 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.742 0.417 . . . . 0.0 110.132 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.56 -34.41 7.34 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.187 1.925 . . . . 0.0 111.565 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -163.95 172.38 14.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.739 1.615 . . . . 0.0 109.179 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 pp -105.54 -9.36 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.77 1.228 . . . . 0.0 110.794 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -69.17 -34.57 75.17 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.651 -0.656 . . . . 0.0 110.282 169.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.36 146.82 52.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.478 1.511 . . . . 0.0 110.726 173.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.24 -3.25 52.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.223 0.916 . . . . 0.0 114.618 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.93 -22.72 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.966 1.307 . . . . 0.0 112.412 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 90.9 m -51.6 -65.07 0.62 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.872 1.269 . . . . 0.0 110.342 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.13 -33.05 50.68 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.054 0.541 . . . . 0.0 110.903 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.19 86.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.908 -0.568 . . . . 0.0 111.966 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -159.11 -39.16 0.06 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -64.78 -46.16 83.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.549 1.068 . . . . 0.0 112.567 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -69.92 -29.58 66.78 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.858 -1.151 . . . . 0.0 112.444 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -78.52 -45.27 22.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.274 0.943 . . . . 0.0 109.971 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.24 -44.96 96.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.175 -0.44 . . . . 0.0 111.376 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -63.04 -40.44 97.72 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.232 0.613 . . . . 0.0 110.417 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.37 -51.46 67.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.678 0.791 . . . . 0.0 109.851 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -64.16 -37.01 85.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.541 0.736 . . . . 0.0 110.973 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.87 76.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.468 1.507 . . . . 0.0 110.108 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -26.83 68.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.573 0.349 . . . . 0.0 111.932 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.13 -20.55 55.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.077 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.34 -36.54 84.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.267 1.394 . . . . 0.0 111.596 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.71 -170.91 43.48 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -74.22 21.62 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.26 150.56 2.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 O-C-N 120.7 -1.25 . . . . 0.0 110.786 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.17 143.41 47.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 125.01 43.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.57 156.37 45.87 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.601 0.76 . . . . 0.0 109.94 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.9 m -132.48 114.59 14.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -97.44 132.79 41.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 m -142.59 169.16 18.09 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.839 1.255 . . . . 0.0 109.305 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 110.738 173.193 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.6 p -72.23 -45.06 61.78 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.961 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.15 -10.3 59.1 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.578 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.9 -6.91 12.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.93 1.365 . . . . 0.0 112.352 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 109.84 2.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.381 0.537 . . . . 0.0 109.945 -170.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.24 -1.43 60.64 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.391 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.22 90.38 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.951 1.875 . . . . 0.0 109.313 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.35 -30.85 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.447 1.899 . . . . 0.0 114.547 -173.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.57 -30.21 71.36 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 t -76.98 144.78 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.01 131.26 28.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.592 0.71 . . . . 0.0 109.448 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.37 144.94 32.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.576 1.151 . . . . 0.0 109.304 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -132.6 155.36 48.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.332 1.453 . . . . 0.0 109.477 -170.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -112.94 138.26 50.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.388 1.075 . . . . 0.0 108.467 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.57 -17.93 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -61.79 -11.17 11.14 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.11 -0.994 . . . . 0.0 113.414 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -46.62 -45.31 18.98 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.529 1.532 . . . . 0.0 110.608 169.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.54 3.75 0.57 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 43.0 mmm 51.27 37.53 18.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.692 1.597 . . . . 0.0 112.127 -172.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -57.35 -59.77 4.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.423 1.089 . . . . 0.0 110.61 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -62.75 -36.5 83.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.072 0.949 . . . . 0.0 109.459 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.9 -60.56 3.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 126.195 1.855 . . . . 0.0 113.023 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.01 -35.26 57.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.194 0.497 . . . . 0.0 110.354 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.46 85.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.45 5.38 15.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.202 1.401 . . . . 0.0 110.782 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.45 64.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.282 -0.886 . . . . 0.0 112.834 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.95 0.2 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.483 1.113 . . . . 0.0 111.366 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -71.12 106.51 3.77 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 124' ' ' LEU . 64.8 mt -65.62 121.19 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -65.45 -41.35 93.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.909 0.484 . . . . 0.0 110.553 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.78 -61.77 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.865 0.466 . . . . 0.0 110.156 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.418 ' H ' HG22 ' A' ' 121' ' ' ILE . 21.9 tp -71.76 -19.27 62.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.646 0.778 . . . . 0.0 112.452 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 54.11 41.52 31.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.148 1.379 . . . . 0.0 111.658 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.7 mt -128.07 179.01 5.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.775 1.23 . . . . 0.0 108.371 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.11 133.83 41.45 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.171 0.989 . . . . 0.0 108.831 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.78 152.67 38.76 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.58 1.152 . . . . 0.0 111.177 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.03 110.58 16.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 169.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -150.41 172.11 15.94 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -149.79 144.5 17.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.08 158.0 44.75 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.243 1.417 . . . . 0.0 108.781 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.86 144.36 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.03 126.57 20.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.219 1.008 . . . . 0.0 109.738 -168.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.01 161.51 24.17 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.465 1.506 . . . . 0.0 110.658 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -48.67 -33.93 10.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 112.686 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.5 5.23 36.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.157 1.383 . . . . 0.0 112.733 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.92 -5.72 83.16 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 120.885 -1.134 . . . . 0.0 112.74 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -72.76 121.27 19.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.006 1.403 . . . . 0.0 108.729 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.22 125.72 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.06 -10.89 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.462 1.105 . . . . 0.0 110.223 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -152.42 152.28 31.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.434 1.094 . . . . 0.0 108.268 170.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.21 137.46 14.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.86 1.664 . . . . 0.0 107.493 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -144.83 139.61 27.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -113.48 109.49 18.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.0 t -64.45 115.17 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.2 m -53.21 -25.66 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.994 1.318 . . . . 0.0 113.205 -170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.05 107.65 6.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.19 -25.37 68.04 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.333 1.853 . . . . 0.0 112.462 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.72 15.02 1.48 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.097 1.359 . . . . 0.0 111.695 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.53 175.94 9.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.767 2.827 . . . . 0.0 106.692 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -122.87 154.2 64.02 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.656 1.117 . . . . 0.0 112.135 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.67 177.05 2.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.397 3.398 . . . . 0.0 111.15 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -76.58 130.92 38.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -104.8 -3.98 22.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -33.97 69.97 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.59 -55.67 42.26 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.782 1.233 . . . . 0.0 112.588 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.97 -34.45 59.35 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.74 1.657 . . . . 0.0 111.963 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 mm -60.22 -46.39 94.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.824 1.193 . . . . 0.0 109.707 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.95 -31.86 71.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.716 1.143 . . . . 0.0 110.93 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.15 -39.46 94.73 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.052 0.387 . . . . 0.0 111.012 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.11 68.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.633 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -55.4 -38.61 69.14 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.274 0.943 . . . . 0.0 110.968 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.24 -28.39 64.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.562 0.745 . . . . 0.0 112.299 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.93 -48.3 7.08 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.553 . . . . 0.0 111.334 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.86 -45.46 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.362 1.065 . . . . 0.0 110.837 -171.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt . . . . . 0 C--O 1.25 1.113 0 C-N-CA 126.825 2.05 . . . . 0.0 110.793 179.371 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 pt -136.98 173.33 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 123.478 1.609 . . . . 0.0 110.941 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 m -118.82 154.45 32.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -137.61 121.45 17.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.25 40.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.595 1.558 . . . . 0.0 113.641 -172.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.34 5.48 89.55 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.698 -0.626 . . . . 0.0 114.087 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.03 113.64 4.09 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.639 1.59 . . . . 0.0 109.541 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.1 139.59 71.25 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.942 2.428 . . . . 0.0 111.06 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.6 127.5 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.521 0.677 . . . . 0.0 109.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -69.48 151.73 45.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.998 1.319 . . . . 0.0 110.112 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.68 158.47 23.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.069 1.747 . . . . 0.0 108.694 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.71 -51.66 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.54 29.77 3.75 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.468 1.032 . . . . 0.0 111.92 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.84 164.51 1.51 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.595 1.158 . . . . 0.0 113.348 -172.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 103.64 20.64 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.321 3.048 . . . . 0.0 111.138 170.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.81 136.8 21.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -145.93 166.75 25.1 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.529 1.131 . . . . 0.0 108.131 -171.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.7 130.66 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.39 90.25 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.766 -1.019 . . . . 0.0 114.082 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.51 -8.15 58.95 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.548 1.674 . . . . 0.0 112.37 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 59.92 175.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.501 1.52 . . . . 0.0 112.097 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.22 115.5 13.98 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.89 1.676 . . . . 0.0 108.293 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.4 144.79 99.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.369 2.046 . . . . 0.0 112.699 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -82.07 62.1 5.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -94.09 173.4 7.67 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.4 m -118.55 151.32 38.09 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.718 0.77 . . . . 0.0 111.559 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.49 166.8 20.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.282 2.233 . . . . 0.0 106.996 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mp -109.56 154.49 22.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -83.46 178.81 7.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.053 0.941 . . . . 0.0 109.592 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.19 -26.88 68.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.728 -1.232 . . . . 0.0 110.938 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -80.62 1.49 29.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.313 1.445 . . . . 0.0 111.784 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.0 mt 55.12 35.82 25.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.857 2.063 . . . . 0.0 112.336 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.09 149.58 22.35 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.53 143.7 46.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.544 0.738 . . . . 0.0 110.095 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -144.9 102.19 3.74 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.6 m -70.97 154.24 41.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 27.2 tp -52.53 -39.65 61.62 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.671 -0.643 . . . . 0.0 111.05 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -18.85 40.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.7 -32.29 63.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.593 1.088 . . . . 0.0 110.886 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.4 mtt -73.41 -39.75 64.81 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.629 1.172 . . . . 0.0 110.229 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -55.81 150.48 12.91 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.814 0.816 . . . . 0.0 110.406 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.13 23.15 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.203 1.382 . . . . 0.0 112.216 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -149.14 153.86 38.33 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 108.749 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.22 138.5 16.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.4 m -134.82 148.4 50.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.068 0.947 . . . . 0.0 108.885 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.9 mt -132.81 132.84 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.99 105.99 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -84.46 149.65 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 168.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 t -134.0 128.99 53.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.5 pt -143.84 144.33 26.47 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.673 0.789 . . . . 0.0 109.374 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.75 -33.64 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.061 1.841 . . . . 0.0 111.709 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -154.01 173.15 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.594 1.958 . . . . 0.0 108.692 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.1 pt -132.91 -31.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.11 1.364 . . . . 0.0 110.94 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.64 -12.08 50.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.648 0.737 . . . . 0.0 110.979 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -64.11 -19.63 65.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.825 2.05 . . . . 0.0 112.762 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.71 65.56 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.852 0.739 . . . . 0.0 112.841 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.35 -19.61 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.0 1.4 . . . . 0.0 112.026 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.66 -58.09 9.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 170.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.11 -32.72 72.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.284 0.633 . . . . 0.0 111.131 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -47.86 84.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.005 -0.521 . . . . 0.0 111.383 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -165.86 -35.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -43.55 97.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 112.343 -169.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -62.49 -51.44 67.42 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.436 1.016 . . . . 0.0 109.763 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -62.65 -48.47 79.19 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.617 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -57.36 -51.3 69.96 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.494 0.588 . . . . 0.0 110.86 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -61.41 -40.08 93.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.964 0.906 . . . . 0.0 111.499 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.82 -46.73 71.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.518 0.727 . . . . 0.0 110.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.87 -36.24 81.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.184 0.902 . . . . 0.0 110.672 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.34 77.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.748 0.819 . . . . 0.0 110.292 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.4 -24.47 67.41 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -80.49 -19.12 46.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 112.539 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.59 -39.56 93.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.957 1.253 . . . . 0.0 111.86 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.71 -167.35 39.15 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.19 25.72 0.1 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.468 1.107 . . . . 0.0 112.912 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -57.24 142.32 13.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.206 1.402 . . . . 0.0 110.715 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -72.83 137.87 46.0 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 168.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.28 124.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -137.82 153.94 49.58 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.828 0.851 . . . . 0.0 110.323 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 m -126.16 103.94 7.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.7 mt -77.32 131.76 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.6 m -132.25 165.34 24.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.164 1.385 . . . . 0.0 109.314 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.798 0.808 . . . . 0.0 110.621 169.727 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.9 p -59.62 -28.57 67.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.15 -14.22 57.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.961 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.68 33.59 5.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.827 1.314 . . . . 0.0 110.395 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -141.24 135.58 30.82 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.46 -15.59 7.17 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.334 -0.704 . . . . 0.0 112.642 -170.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mt -128.83 76.93 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.2 -26.25 38.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -63.67 -27.66 69.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.502 1.121 . . . . 0.0 112.642 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.75 154.13 3.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.27 146.81 39.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.4 148.81 24.04 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.37 157.05 35.97 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.461 1.505 . . . . 0.0 108.554 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -128.82 49.25 2.24 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.193 2.197 . . . . 0.0 108.947 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -47.18 -41.82 18.68 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.567 0.747 . . . . 0.0 111.358 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -56.15 -19.89 15.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.166 0.986 . . . . 0.0 113.631 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -68.7 -22.33 64.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.048 -1.033 . . . . 0.0 111.618 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -133.72 -26.14 1.6 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.085 0.954 . . . . 0.0 112.999 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.79 -4.03 0.27 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.789 3.235 . . . . 0.0 115.731 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -57.25 -52.57 64.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.718 1.144 . . . . 0.0 110.965 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.67 -35.14 78.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.593 0.633 . . . . 0.0 111.129 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.24 -43.22 98.71 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.63 0.633 . . . . 0.0 112.119 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.66 -38.88 80.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.634 0.717 . . . . 0.0 110.31 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.82 84.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.644 0.778 . . . . 0.0 111.88 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.83 -6.19 58.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.72 0.808 . . . . 0.0 111.08 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.46 1.9 62.2 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.119 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.89 -19.74 26.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 124.638 1.175 . . . . 0.0 111.137 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.66 118.35 6.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.313 0.961 . . . . 0.0 108.651 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -81.61 105.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 126.197 1.799 . . . . 0.0 106.425 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.24 -40.59 61.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.752 1.221 . . . . 0.0 110.869 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -88.79 -4.74 58.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.34 0.656 . . . . 0.0 112.714 -170.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.6 tp -137.37 -5.8 1.8 Allowed 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.117 -0.989 . . . . 0.0 113.047 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 32.2 ptt-85 42.5 45.8 3.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.949 1.7 . . . . 0.0 112.767 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -134.87 176.59 8.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.119 1.768 . . . . 0.0 106.358 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.261 0.0 OUTLIER -106.49 147.5 29.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 121.884 2.129 . . . . 0.0 111.862 170.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.03 156.58 35.67 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.741 2.016 . . . . 0.0 112.785 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -82.54 116.34 21.92 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.2 m -150.79 167.06 28.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 108.96 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.93 142.96 19.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.22 151.83 42.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.775 1.23 . . . . 0.0 108.111 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.9 t -135.07 135.44 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -130.26 135.53 48.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.361 1.064 . . . . 0.0 109.239 -169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.48 167.25 5.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 109.502 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -51.13 -34.12 29.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.041 1.336 . . . . 0.0 112.711 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -80.24 -0.57 36.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.473 1.109 . . . . 0.0 112.547 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.66 79.33 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.896 1.236 . . . . 0.0 112.606 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.64 117.3 5.6 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.244 1.522 . . . . 0.0 109.469 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.84 115.67 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.848 0.859 . . . . 0.0 109.447 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.6 -12.21 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.657 1.183 . . . . 0.0 110.664 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -147.17 144.68 29.13 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.31 126.36 7.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.317 1.447 . . . . 0.0 107.283 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.82 145.56 29.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -114.47 111.08 20.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 t -61.95 125.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -172.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -59.42 -13.32 8.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.472 1.109 . . . . 0.0 113.663 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.6 128.13 21.42 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.98 63.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.065 . . . . 0.0 113.667 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.2 p -84.68 -4.49 59.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.083 1.31 . . . . 0.0 112.637 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -98.07 177.24 5.48 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.438 1.495 . . . . 0.0 109.974 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -133.51 151.57 77.57 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.015 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.0 -176.68 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.663 2.908 . . . . 0.0 109.249 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -76.85 119.47 20.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -91.29 -0.87 57.74 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.28 -36.05 40.33 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -51.21 -55.45 28.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.134 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.27 -33.88 47.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.584 1.601 . . . . 0.0 112.728 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.81 -45.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.185 1.357 . . . . 0.0 109.879 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.54 -36.84 85.0 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.376 0.989 . . . . 0.0 110.596 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.12 96.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.082 0.553 . . . . 0.0 111.178 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.15 -41.89 76.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.28 0.945 . . . . 0.0 110.302 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.29 -31.89 70.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.162 0.585 . . . . 0.0 112.012 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.59 -40.45 23.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.076 0.55 . . . . 0.0 111.807 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.55 -54.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.454 0.702 . . . . 0.0 109.483 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.1 pttt . . . . . 0 C--O 1.25 1.083 0 C-N-CA 127.722 2.409 . . . . 0.0 112.036 -178.231 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.6 pt -130.33 -178.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 122.172 0.987 . . . . 0.0 110.92 -169.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -127.1 146.35 50.41 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -143.68 133.25 23.56 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm 43.7 42.38 4.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.586 1.555 . . . . 0.0 112.138 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.18 28.5 70.04 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.161 -0.799 . . . . 0.0 114.54 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 139.6 10.52 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 169.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.39 145.33 42.73 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.592 2.195 . . . . 0.0 110.151 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.27 134.72 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.242 1.017 . . . . 0.0 110.28 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -75.29 152.81 38.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.156 1.782 . . . . 0.0 110.448 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.78 148.76 42.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.98 1.712 . . . . 0.0 108.08 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.15 -84.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.361 0.528 . . . . 0.0 110.935 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 40.48 2.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.296 1.427 . . . . 0.0 112.019 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -58.06 171.05 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.196 2.198 . . . . 0.0 114.593 -169.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 78.52 28.27 0.46 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.817 2.047 . . . . 0.0 114.032 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.6 138.88 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -148.4 164.08 35.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.451 1.1 . . . . 0.0 108.578 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.8 132.97 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 -0.52 89.65 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.219 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -76.55 -13.65 60.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.544 1.672 . . . . 0.0 112.657 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 60.95 157.15 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.813 2.045 . . . . 0.0 112.959 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.58 133.37 46.95 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.342 1.057 . . . . 0.0 109.049 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.3 -27.66 76.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.493 2.795 . . . . 0.0 114.772 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 62.43 98.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.381 2.272 . . . . 0.0 112.113 -170.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -129.49 170.47 13.68 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.901 1.68 . . . . 0.0 108.316 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.9 167.32 11.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.53 1.132 . . . . 0.0 109.279 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.9 -176.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 128.053 2.541 . . . . 0.0 104.215 168.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.05 139.16 35.87 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.6 p -87.64 171.08 10.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 118.821 0.737 . . . . 0.0 109.744 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.443 -0.785 . . . . 0.0 110.733 168.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m -79.35 1.58 24.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.717 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt 61.47 32.58 18.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.684 2.394 . . . . 0.0 112.201 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -91.89 140.33 29.78 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.91 55.83 2.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.085 1.754 . . . . 0.0 110.184 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.41 157.03 5.33 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.065 1.346 . . . . 0.0 108.394 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -133.5 163.8 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.03 -28.5 66.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.022 -0.424 . . . . 0.0 111.958 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.63 -19.71 51.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.085 -1.009 . . . . 0.0 113.647 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.2 -28.49 61.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.443 1.019 . . . . 0.0 110.941 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -74.01 -41.7 61.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.725 1.21 . . . . 0.0 110.039 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 133.48 49.49 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.54 -23.28 4.28 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.992 1.282 . . . . 0.0 112.426 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -154.99 157.38 37.58 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.663 1.185 . . . . 0.0 108.371 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -59.24 143.06 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -137.68 148.04 45.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.269 1.028 . . . . 0.0 108.243 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.2 mt -129.07 137.95 55.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.7 mt -132.17 124.13 51.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.2 t -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.99 131.37 64.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -139.78 136.99 17.86 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.591 0.757 . . . . 0.0 111.451 -170.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.8 -28.71 2.01 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.167 2.578 . . . . 0.0 112.146 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -163.42 170.69 17.06 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.072 1.749 . . . . 0.0 107.739 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -126.13 -18.91 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.109 1.364 . . . . 0.0 110.528 169.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.38 -13.39 58.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.866 0.867 . . . . 0.0 111.362 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 p -61.12 -22.22 64.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.08 1.752 . . . . 0.0 112.252 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.77 -10.24 65.76 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.017 0.817 . . . . 0.0 112.4 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.92 -29.11 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.663 1.231 . . . . 0.0 109.707 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.48 -55.4 35.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.933 0.333 . . . . 0.0 110.11 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -38.79 80.37 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.334 0.253 . . . . 0.0 111.038 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.63 -32.74 73.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.763 -0.636 . . . . 0.0 112.523 -175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -149.62 -46.36 0.13 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.361 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -60.51 -34.64 74.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.994 1.725 . . . . 0.0 111.531 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -50.69 -65.79 0.5 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.274 0.63 . . . . 0.0 109.844 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.89 -40.73 87.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.006 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -58.25 -54.91 41.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 122.502 0.321 . . . . 0.0 110.395 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -76.21 -27.77 56.96 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.918 -171.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.88 -53.08 62.08 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.658 1.183 . . . . 0.0 109.701 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.48 -39.68 88.92 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.324 0.511 . . . . 0.0 110.573 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.82 81.05 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.438 0.695 . . . . 0.0 110.828 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.13 -20.44 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -93.59 -14.86 26.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.413 1.006 . . . . 0.0 112.7 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.75 -31.88 73.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.666 1.121 . . . . 0.0 111.929 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.41 -158.69 31.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.89 26.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.286 1.434 . . . . 0.0 112.533 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.44 135.98 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.105 1.362 . . . . 0.0 108.022 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.95 146.57 52.65 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.72 127.19 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.11 151.34 51.34 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.615 0.766 . . . . 0.0 110.796 -173.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.8 m -133.72 100.34 4.74 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.34 128.71 39.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -125.64 150.18 47.79 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 121.402 0.62 . . . . 0.0 111.947 176.133 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.4 -34.17 73.53 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.361 0.664 . . . . 0.0 111.608 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.57 13.52 62.18 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.814 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.11 26.42 5.18 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.875 1.337 . . . . 0.0 110.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.85 135.64 36.39 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.25 -13.72 43.78 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.879 -173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.43 76.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 125.822 1.649 . . . . 0.0 107.284 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.6 -21.55 10.75 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.489 1.916 . . . . 0.0 113.951 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.45 -27.3 67.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.435 1.094 . . . . 0.0 112.385 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.21 144.73 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.768 0.827 . . . . 0.0 109.227 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.3 129.2 48.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 p -97.67 141.74 30.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.458 1.103 . . . . 0.0 108.682 -172.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -125.47 156.62 38.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 110.077 -169.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -136.12 44.6 2.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.331 2.652 . . . . 0.0 109.11 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.07 -24.92 60.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.396 0.678 . . . . 0.0 112.311 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -51.12 -19.63 1.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.481 1.512 . . . . 0.0 114.387 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -59.52 -27.11 65.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.663 1.119 . . . . 0.0 112.457 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -135.77 -6.96 2.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.78 1.173 . . . . 0.0 113.251 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 86.6 mmm 52.83 26.9 4.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.632 1.573 . . . . 0.0 111.919 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -65.55 0.67 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.006 1.322 . . . . 0.0 111.298 -171.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.9 -36.7 79.92 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.151 0.58 . . . . 0.0 109.507 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.4 -51.56 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 124.249 0.928 . . . . 0.0 111.953 -172.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.39 -41.06 70.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.965 0.506 . . . . 0.0 109.938 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.02 79.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.472 0.709 . . . . 0.0 112.17 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -85.73 -4.84 59.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.762 0.825 . . . . 0.0 111.245 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.07 10.95 62.86 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.015 -0.881 . . . . 0.0 114.223 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.2 m -65.44 -16.98 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.465 1.133 . . . . 0.0 109.982 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.13 106.62 0.45 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.97 125.05 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.27 -37.19 86.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.41 0.684 . . . . 0.0 111.628 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -98.23 -50.71 4.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.284 0.634 . . . . 0.0 111.716 -169.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.7 -24.59 62.68 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.257 0.481 . . . . 0.0 111.306 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 97.3 mtt180 52.54 47.75 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.337 1.455 . . . . 0.0 111.393 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 71.6 mt -129.14 171.06 12.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.027 1.331 . . . . 0.0 107.854 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.62 117.56 22.08 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.42 141.8 40.85 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 111.0 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.86 108.6 1.81 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 m -144.31 164.38 30.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -150.09 139.77 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -142.5 156.11 45.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.554 1.141 . . . . 0.0 108.447 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.9 134.73 48.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -129.5 134.5 47.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.18 165.95 10.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.01 1.324 . . . . 0.0 109.565 169.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -50.24 -37.32 35.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.657 1.183 . . . . 0.0 112.679 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.46 2.91 46.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.76 61.6 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.516 1.055 . . . . 0.0 113.596 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -61.2 118.41 6.82 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.905 1.353 . . . . 0.0 109.166 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.53 113.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.73 0.812 . . . . 0.0 109.054 170.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.08 -26.48 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 0.0 109.459 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -153.38 152.2 30.79 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 107.063 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.68 127.58 5.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -147.08 149.66 33.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -121.59 113.55 19.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.77 119.43 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m -59.12 -19.21 42.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.457 1.503 . . . . 0.0 112.881 -171.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.69 95.72 3.11 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.05 -20.86 65.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.883 0.873 . . . . 0.0 112.599 -172.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 6.17 3.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.722 1.209 . . . . 0.0 112.222 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.98 162.26 30.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.999 2.12 . . . . 0.0 107.854 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -96.99 145.54 29.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.929 -0.482 . . . . 0.0 111.506 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.0 174.15 11.2 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.867 3.045 . . . . 0.0 111.333 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -82.12 129.6 34.86 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -84.03 -11.89 56.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -80.46 -34.57 35.86 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -55.74 -52.05 75.33 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.798 -1.096 . . . . 0.0 112.042 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.6 -37.2 17.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.107 1.431 . . . . 0.0 111.777 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.11 -44.51 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.027 0.831 . . . . 0.0 109.972 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.63 -38.61 91.61 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.156 0.889 . . . . 0.0 110.637 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.54 85.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.26 0.224 . . . . 0.0 111.241 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.28 -47.72 55.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.882 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.62 -39.74 65.18 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.34 0.973 . . . . 0.0 110.796 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.39 -29.66 58.92 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.899 . . . . 0.0 112.267 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.55 -40.42 8.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.488 0.715 . . . . 0.0 111.934 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.94 -39.68 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.362 1.065 . . . . 0.0 111.355 -169.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 C--O 1.248 0.986 0 C-N-CA 123.953 0.901 . . . . 0.0 109.49 179.262 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 C--O 1.238 0.46 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 pt -134.15 -179.61 3.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -127.58 149.93 49.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -139.7 126.95 21.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 46.54 34.66 2.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.444 1.098 . . . . 0.0 112.303 -172.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.97 81.93 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.325 -0.86 . . . . 0.0 114.538 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.24 119.25 4.78 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.54 140.53 89.82 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.951 2.434 . . . . 0.0 111.331 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.1 152.93 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.389 1.076 . . . . 0.0 109.559 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -101.71 163.42 12.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.553 1.541 . . . . 0.0 110.307 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.3 mt -113.31 140.51 47.94 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.029 1.331 . . . . 0.0 108.319 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.4 t -75.35 -61.8 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.76 34.04 3.0 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.568 1.08 . . . . 0.0 113.371 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 52.76 -138.21 1.15 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.296 1.438 . . . . 0.0 110.132 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -135.79 132.23 36.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.479 1.112 . . . . 0.0 110.559 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.66 169.08 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 162.69 40.51 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -52.65 130.41 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.86 -3.76 83.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.745 -1.03 . . . . 0.0 114.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -84.31 -3.13 58.06 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.694 1.747 . . . . 0.0 112.726 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 61.65 171.2 0.12 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.4 1.88 . . . . 0.0 112.935 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -119.29 106.49 42.75 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.449 1.5 . . . . 0.0 108.56 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 144.86 99.08 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.393 2.062 . . . . 0.0 113.13 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.96 65.33 7.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.873 2.069 . . . . 0.0 110.937 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -97.47 158.12 15.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.448 170.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.91 163.77 27.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 112.983 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.29 134.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 168.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -76.26 155.18 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.5 p -123.1 174.05 7.47 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -46.49 -32.19 3.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.333 1.053 . . . . 0.0 112.127 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -113.82 15.89 18.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.111 1.364 . . . . 0.0 111.436 -171.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 53.03 45.01 29.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.773 2.029 . . . . 0.0 112.172 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.4 -12.4 58.97 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.311 12.8 pt-20 44.8 48.88 9.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.433 1.893 . . . . 0.0 111.714 -169.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -46.57 122.03 3.89 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.388 2.275 . . . . 0.0 108.646 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.37 146.35 40.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -39.58 57.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.012 0.824 . . . . 0.0 111.093 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.51 -18.84 21.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.35 -29.06 70.43 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.446 1.021 . . . . 0.0 111.241 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.6 mtt -70.62 -32.76 70.22 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.695 1.198 . . . . 0.0 111.701 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -64.39 133.98 53.68 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.64 -25.88 2.94 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.903 1.24 . . . . 0.0 112.168 -171.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -149.47 157.6 43.43 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.288 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.1 135.99 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.0 m -135.36 146.09 48.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.519 1.128 . . . . 0.0 108.165 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.87 135.84 54.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.02 135.8 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.8 p -115.02 151.27 34.5 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.4 t -134.77 133.01 54.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -137.09 146.42 54.46 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.555 1.142 . . . . 0.0 108.67 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.14 -34.14 23.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.527 2.151 . . . . 0.0 111.914 -176.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -143.29 154.23 43.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.758 1.623 . . . . 0.0 106.979 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 tp -90.64 -32.11 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.263 0.625 . . . . 0.0 111.471 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.77 -17.99 27.17 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.371 0.668 . . . . 0.0 112.232 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.3 p -65.74 163.96 15.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.1 1.36 . . . . 0.0 111.707 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.94 -24.2 33.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.937 1.256 . . . . 0.0 114.864 -171.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.45 -29.47 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.906 1.353 . . . . 0.0 112.203 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.6 t -51.74 -51.33 56.99 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.111 1.365 . . . . 0.0 110.762 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.42 -34.6 12.04 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.078 0.551 . . . . 0.0 111.523 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.24 70.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.752 0.821 . . . . 0.0 112.367 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.471 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.0 tm0? -152.62 -39.51 0.1 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-O 117.762 -1.114 . . . . 0.0 112.513 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -60.59 -42.67 97.18 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.177 1.353 . . . . 0.0 112.357 -169.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -56.45 -56.2 24.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.146 0.884 . . . . 0.0 110.469 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.65 -40.96 93.05 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.406 0.548 . . . . 0.0 111.05 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.471 ' CB ' HE21 ' A' ' 63' ' ' GLN . 25.5 t80 -56.48 -52.67 63.82 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.796 0.438 . . . . 0.0 110.785 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -67.52 -34.88 78.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.164 0.186 . . . . 0.0 111.259 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -64.61 -53.26 50.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.357 1.463 . . . . 0.0 109.763 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -63.53 -38.77 92.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.493 0.717 . . . . 0.0 109.456 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.84 78.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.521 0.728 . . . . 0.0 110.738 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.94 -27.09 67.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.083 0.553 . . . . 0.0 112.31 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -76.26 -24.17 54.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.185 175.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.9 mt -63.89 -40.84 97.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.678 1.126 . . . . 0.0 110.475 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.41 -169.43 42.55 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.35 19.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.155 1.382 . . . . 0.0 113.418 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.05 145.19 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.41 1.484 . . . . 0.0 110.923 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -70.43 144.82 51.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.27 132.69 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -145.54 156.75 43.9 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.885 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.5 m -136.1 116.72 13.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 173.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.95 142.22 14.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.711 1.605 . . . . 0.0 107.499 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -136.23 173.39 11.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 110.136 -170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.433 0.635 . . . . 0.0 109.944 169.069 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 131.47 50.41 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 173.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.6 73.25 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.158 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.88 3.08 1.39 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.028 1.331 . . . . 0.0 113.064 -169.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -85.0 144.53 28.23 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.47 -49.39 3.84 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.636 1.112 . . . . 0.0 110.856 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 pt -76.63 70.19 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 125.747 1.619 . . . . 0.0 109.435 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.61 -23.82 0.75 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.665 2.786 . . . . 0.0 114.961 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -62.37 -30.65 71.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.369 1.068 . . . . 0.0 111.997 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 t -74.57 156.89 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.98 0.912 . . . . 0.0 108.866 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.32 142.29 41.86 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -86.36 134.65 33.71 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -125.01 164.43 20.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.051 2.14 . . . . 0.0 106.724 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.51 169.9 17.45 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.161 0.984 . . . . 0.0 108.749 169.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -149.02 -17.77 0.3 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -58.77 -17.24 21.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.811 -1.181 . . . . 0.0 113.449 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -53.62 -30.04 40.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.452 1.101 . . . . 0.0 112.625 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -142.18 -6.9 0.93 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.549 1.068 . . . . 0.0 112.975 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.08 30.75 5.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.822 2.049 . . . . 0.0 112.714 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -65.29 0.68 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.785 1.634 . . . . 0.0 111.669 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.77 -34.5 75.97 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.684 0.794 . . . . 0.0 110.28 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.43 98.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 124.305 0.955 . . . . 0.0 112.783 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.38 -35.86 71.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.383 1.091 . . . . 0.0 109.946 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.21 74.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.26 2.46 11.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.468 1.507 . . . . 0.0 111.656 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.96 72.09 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 119.321 0.964 . . . . 0.0 112.399 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . 0.253 33.5 m -107.14 3.04 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.397 0.679 . . . . 0.0 111.429 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.65 105.67 12.07 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 124' ' ' LEU . 80.4 mt -67.61 127.85 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -66.37 -48.51 69.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.939 0.896 . . . . 0.0 111.109 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -80.27 -49.55 11.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.603 0.239 . . . . 0.0 110.574 -170.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.448 ' H ' HG22 ' A' ' 121' ' ' ILE . 18.4 tp -78.71 -18.16 54.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 112.084 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 45.14 52.02 8.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.384 1.474 . . . . 0.0 111.371 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.9 tp -139.25 168.93 18.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.04 138.14 47.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.463 0.574 . . . . 0.0 110.056 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.43 155.95 40.01 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.386 1.075 . . . . 0.0 110.737 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -84.66 109.96 18.39 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.0 m -149.88 168.18 24.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.722 0.409 . . . . 0.0 110.519 -173.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.13 147.1 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.599 1.16 . . . . 0.0 108.22 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -146.77 154.82 41.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.353 1.061 . . . . 0.0 109.036 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.92 140.37 40.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 171.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 mp -130.81 137.18 49.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.57 1.548 . . . . 0.0 107.337 -171.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.44 169.12 6.32 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.158 1.383 . . . . 0.0 109.855 169.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -49.58 -37.93 29.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.741 1.217 . . . . 0.0 112.174 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -75.29 -3.16 31.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.193 0.997 . . . . 0.0 112.677 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.1 -6.96 77.41 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.927 -1.108 . . . . 0.0 112.89 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 113.6 3.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 118.871 1.335 . . . . 0.0 108.365 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.4 129.73 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.27 -12.57 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.661 1.584 . . . . 0.0 109.925 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -151.47 150.15 30.07 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.434 1.093 . . . . 0.0 108.413 172.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.2 135.54 13.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.263 1.825 . . . . 0.0 107.168 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 150.28 30.99 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.451 0.7 . . . . 0.0 109.391 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -124.36 116.24 22.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.779 2.032 . . . . 0.0 105.637 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.24 128.68 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -60.05 -26.69 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.537 1.135 . . . . 0.0 113.268 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.01 105.66 6.46 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.7 66.29 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.124 1.37 . . . . 0.0 113.905 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.21 15.93 2.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.89 -175.63 3.84 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.005 2.122 . . . . 0.0 107.978 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -116.96 155.05 49.73 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.006 1.275 . . . . 0.0 112.689 -170.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.24 163.82 32.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -80.07 87.3 5.45 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 168.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -68.57 -5.72 21.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -71.3 -30.01 65.73 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.08 0.855 . . . . 0.0 109.302 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -63.9 -50.74 68.63 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.496 -1.24 . . . . 0.0 111.621 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.58 -32.46 48.29 Favored 'Trans proline' 0 C--N 1.35 0.622 0 CA-C-N 121.707 1.646 . . . . 0.0 112.111 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.5 mm -59.78 -44.82 94.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.998 1.272 . . . . 0.0 109.816 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.97 -37.15 86.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.262 0.937 . . . . 0.0 110.9 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.62 91.64 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.396 -0.19 . . . . 0.0 111.24 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.17 -46.49 70.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.59 173.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -53.78 -40.87 66.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.277 0.944 . . . . 0.0 110.545 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.0 65.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 112.204 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.9 mt -90.94 -41.81 10.93 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.954 0.502 . . . . 0.0 112.074 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.5 t -70.37 -42.43 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.952 0.901 . . . . 0.0 111.2 -171.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.035 0 C-N-CA 124.233 1.013 . . . . 0.0 109.594 179.319 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.11 174.45 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -112.19 151.57 29.39 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -133.52 116.55 16.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 172.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp 44.36 41.84 4.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.382 1.473 . . . . 0.0 111.69 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.32 5.0 80.23 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.59 116.74 4.13 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.319 174.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.61 84.37 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.291 2.66 . . . . 0.0 112.1 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.35 141.69 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.632 1.173 . . . . 0.0 110.402 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -82.01 162.11 22.74 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.208 1.803 . . . . 0.0 110.358 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.42 145.26 45.35 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.912 1.285 . . . . 0.0 108.118 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.3 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.182 0.593 . . . . 0.0 109.701 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.42 34.16 2.7 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.668 1.128 . . . . 0.0 113.677 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 52.27 -148.94 0.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.865 1.666 . . . . 0.0 112.435 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -123.96 116.3 22.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.029 1.732 . . . . 0.0 108.309 -169.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 m -72.43 171.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -144.08 164.01 31.88 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.79 138.16 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.56 -3.76 76.9 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.941 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.38 -15.54 61.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.145 1.472 . . . . 0.0 114.214 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.05 104.5 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.985 1.714 . . . . 0.0 111.159 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.24 131.79 90.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.651 0.78 . . . . 0.0 111.259 -175.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.59 149.51 81.86 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.764 2.309 . . . . 0.0 113.773 173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -77.31 67.93 3.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.321 1.848 . . . . 0.0 108.849 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.78 160.42 14.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.314 1.046 . . . . 0.0 109.134 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.8 163.89 27.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.997 1.319 . . . . 0.0 111.793 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.36 173.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 129.934 3.294 . . . . 0.0 105.02 168.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -131.53 139.51 49.28 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -86.68 176.02 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.555 0.616 . . . . 0.0 111.517 -172.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -60.91 -25.53 66.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.972 0.909 . . . . 0.0 110.331 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m -81.29 1.72 31.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.053 1.341 . . . . 0.0 111.646 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.8 mt 60.01 38.99 20.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 127.162 2.185 . . . . 0.0 111.893 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.08 160.75 27.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.756 0.823 . . . . 0.0 110.887 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.09 146.09 47.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.205 1.002 . . . . 0.0 110.576 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -147.42 157.79 43.72 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.442 2.697 . . . . 0.0 103.82 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -135.54 158.98 43.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.72 -25.91 63.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.81 66.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.396 1.453 . . . . 0.0 112.9 173.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.57 -27.09 58.46 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.868 0.758 . . . . 0.0 110.996 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.3 mtt -73.5 -34.98 65.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.214 1.006 . . . . 0.0 110.544 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -55.99 152.07 10.87 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.53 0.732 . . . . 0.0 110.413 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.44 33.22 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.134 1.35 . . . . 0.0 112.58 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -147.89 150.75 34.68 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.473 1.509 . . . . 0.0 108.022 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.37 142.27 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 m -135.69 147.58 48.57 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.328 1.051 . . . . 0.0 108.383 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.84 134.24 58.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -139.95 116.73 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -95.08 153.25 17.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -136.04 134.87 50.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.04 147.59 51.34 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.776 1.63 . . . . 0.0 108.299 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -38.73 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.519 2.146 . . . . 0.0 111.833 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -146.74 169.96 17.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.393 2.277 . . . . 0.0 105.916 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.263 0.0 OUTLIER -117.62 -15.58 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 122.673 0.389 . . . . 0.0 111.322 -175.015 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.36 -29.88 68.7 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.375 -0.828 . . . . 0.0 110.717 169.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.21 143.57 57.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.1 1.36 . . . . 0.0 110.764 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -17.34 50.81 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.535 1.064 . . . . 0.0 114.762 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -54.5 -25.24 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.788 1.294 . . . . 0.0 112.694 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.9 p -60.1 -32.93 71.45 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.939 0.79 . . . . 0.0 111.904 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.67 -28.21 6.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.752 0.821 . . . . 0.0 111.58 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.31 69.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.989 0.915 . . . . 0.0 112.428 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -152.6 -39.5 0.1 Allowed 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.749 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -57.84 -45.19 86.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.847 1.203 . . . . 0.0 111.897 -169.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -59.21 -52.32 66.19 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -60.48 -42.79 97.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.665 0.666 . . . . 0.0 111.076 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.6 -51.0 70.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.078 0.551 . . . . 0.0 110.661 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -66.48 -27.4 67.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.01 0.124 . . . . 0.0 111.078 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -65.67 -44.44 86.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.085 1.354 . . . . 0.0 110.082 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.8 -43.97 82.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.457 0.571 . . . . 0.0 110.206 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -45.62 77.62 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.93 -11.12 44.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.678 1.191 . . . . 0.0 113.237 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -118.68 -1.86 11.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.639 1.176 . . . . 0.0 113.828 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -60.18 -37.36 79.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.133 1.333 . . . . 0.0 109.493 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.98 -172.53 41.67 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 127.969 2.7 . . . . 0.0 106.942 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -75.82 27.66 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.362 1.081 . . . . 0.0 112.564 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.4 144.2 11.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 120.756 -1.215 . . . . 0.0 109.958 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.48 145.34 54.15 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.12 121.8 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -172.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -137.31 154.14 50.13 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.318 0.647 . . . . 0.0 111.327 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -130.62 105.69 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.72 131.56 33.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -129.2 173.17 10.73 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.266 1.827 . . . . 0.0 108.048 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.64 0.733 . . . . 0.0 110.363 169.583 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 3.3 p90 . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 p -54.94 -28.46 51.26 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.62 -12.18 55.7 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.593 1.088 . . . . 0.0 113.976 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.32 -10.37 4.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.049 1.74 . . . . 0.0 112.721 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -64.7 125.94 26.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.914 0.486 . . . . 0.0 111.358 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.76 -21.18 20.24 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.199 0.904 . . . . 0.0 112.46 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mt -84.85 -31.69 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.457 1.129 . . . . 0.0 110.514 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.41 -35.4 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 131.65 3.98 . . . . 0.0 116.341 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -66.78 -35.21 79.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.517 1.127 . . . . 0.0 111.571 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.86 150.8 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.632 1.173 . . . . 0.0 107.959 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.44 143.78 35.75 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 p -79.8 155.44 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.402 0.62 . . . . 0.0 109.523 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.1 mt -129.2 162.78 27.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.927 1.691 . . . . 0.0 107.312 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.5 m -137.17 44.58 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.572 1.549 . . . . 0.0 110.323 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -48.32 -36.03 13.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -169.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -50.82 -25.96 5.12 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.801 1.182 . . . . 0.0 114.182 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.7 ttt85 -60.19 -22.65 63.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.072 0.851 . . . . 0.0 112.376 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -127.79 -19.16 4.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.758 1.623 . . . . 0.0 111.955 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 58.25 11.54 1.62 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 129.928 3.291 . . . . 0.0 114.402 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.6 m -69.6 -42.81 73.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.456 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.25 -37.03 81.62 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.654 1.57 . . . . 0.0 109.379 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.35 -53.16 21.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.617 1.579 . . . . 0.0 112.865 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.11 -37.02 69.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.351 0.575 . . . . 0.0 110.477 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.84 -32.91 73.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.009 0.924 . . . . 0.0 112.911 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.35 1.04 13.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.648 1.179 . . . . 0.0 111.744 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.53 37.81 94.08 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 119.123 0.874 . . . . 0.0 112.047 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.37 -1.94 9.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.678 . . . . 0.0 110.91 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.87 106.1 5.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 168.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.9 mt -69.42 120.9 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -64.49 -43.13 95.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -89.07 -6.08 57.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -170.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -132.76 -13.23 2.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.582 0.753 . . . . 0.0 112.701 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.251 39.3 ptt180 41.65 43.44 2.37 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.711 1.604 . . . . 0.0 113.036 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 mt -124.98 172.54 9.33 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 170.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.85 140.02 45.46 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.885 0.874 . . . . 0.0 109.634 173.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.65 157.56 35.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.366 1.067 . . . . 0.0 110.793 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.16 112.12 19.96 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -153.76 167.05 30.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.78 147.18 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -143.61 155.27 44.22 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.305 1.442 . . . . 0.0 108.575 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.16 139.76 45.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -129.5 129.87 45.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.237 1.415 . . . . 0.0 108.334 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.28 166.71 9.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.015 0.926 . . . . 0.0 108.997 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -50.4 -31.03 13.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.754 174.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -81.84 -4.43 56.47 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.483 1.113 . . . . 0.0 113.217 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.86 62.9 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.209 -0.932 . . . . 0.0 111.596 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -86.55 118.09 25.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.56 114.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 170.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 p -97.44 -14.44 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.167 0.987 . . . . 0.0 109.886 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 152.32 32.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.274 1.029 . . . . 0.0 108.659 169.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.25 137.55 13.85 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.378 1.871 . . . . 0.0 107.251 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.21 149.97 31.85 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.187 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -123.71 114.52 20.05 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.39 135.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.3 m -58.64 -21.48 54.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.539 1.136 . . . . 0.0 113.509 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -140.08 129.6 24.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -53.83 -35.04 61.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -80.67 -6.93 59.07 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.516 1.053 . . . . 0.0 112.715 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.57 -173.67 4.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -137.89 156.33 74.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 110.104 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.38 168.29 16.67 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.836 2.357 . . . . 0.0 110.287 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -74.89 113.99 12.83 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -80.76 -6.71 58.86 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.11 -32.29 64.86 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 120.995 -1.065 . . . . 0.0 108.572 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -60.4 -51.32 80.9 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.147 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.14 -33.0 41.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.453 1.555 . . . . 0.0 112.747 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.2 mm -59.9 -47.47 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 120.455 1.479 . . . . 0.0 109.51 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.52 -38.88 92.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.027 0.83 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.78 92.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.324 0.249 . . . . 0.0 111.271 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.12 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.686 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -53.9 -41.64 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.069 0.849 . . . . 0.0 110.569 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.05 -30.45 64.27 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.571 0.749 . . . . 0.0 112.174 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 62.6 mt -90.43 -43.12 10.49 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.004 0.522 . . . . 0.0 111.68 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.6 t -71.49 -45.1 69.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.978 0.911 . . . . 0.0 111.331 -170.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.69 0.796 . . . . 0.0 109.642 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.243 0.741 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.8 pt -142.08 171.9 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 122.575 1.179 . . . . 0.0 110.366 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -109.96 157.41 19.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.51 113.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 45.51 43.95 9.4 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.66 1.584 . . . . 0.0 111.556 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 4.61 82.03 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.46 126.15 7.59 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 145.9 63.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.643 2.222 . . . . 0.0 110.148 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -136.39 179.48 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 108.778 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -127.54 158.98 35.98 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.5 mt -112.88 172.93 6.63 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.833 1.253 . . . . 0.0 109.35 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.74 149.82 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 56.99 19.09 29.02 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.925 1.726 . . . . 0.0 115.884 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -67.59 176.78 2.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.764 2.025 . . . . 0.0 114.976 -169.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.254 6.1 tt0 87.8 30.85 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.105 2.562 . . . . 0.0 113.325 169.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.16 143.44 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 168.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -149.45 165.19 32.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.872 1.269 . . . . 0.0 108.068 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 p -54.6 133.88 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.15 81.38 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.492 1.044 . . . . 0.0 113.806 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.71 -10.52 59.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.483 1.641 . . . . 0.0 114.177 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 71.37 127.71 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.463 1.905 . . . . 0.0 112.385 169.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.42 126.5 88.2 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.287 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -62.29 -30.31 81.03 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 114.147 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.6 t70 94.79 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 130.468 3.507 . . . . 0.0 106.838 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.04 174.2 10.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.821 2.049 . . . . 0.0 107.779 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 m -131.81 120.76 23.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -105.01 165.24 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.394 1.478 . . . . 0.0 107.506 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.07 143.32 38.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 p -76.58 179.29 6.06 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.087 0.955 . . . . 0.0 110.155 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.91 -24.46 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.162 -0.961 . . . . 0.0 111.114 168.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -89.93 3.79 52.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.784 2.034 . . . . 0.0 112.158 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 57.44 29.3 16.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.908 2.083 . . . . 0.0 113.188 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.24 144.48 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.61 142.23 42.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.469 0.708 . . . . 0.0 109.431 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -148.32 113.79 5.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 107.391 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 p -72.38 154.78 40.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.466 0.65 . . . . 0.0 109.321 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.52 -39.21 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.27 -25.69 15.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.101 0.961 . . . . 0.0 113.483 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.86 -28.5 55.45 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.791 1.178 . . . . 0.0 111.499 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.9 mtt -69.69 -30.93 68.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.045 0.938 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -57.76 152.61 15.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.526 0.679 . . . . 0.0 110.467 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.93 -8.23 38.94 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.482 1.039 . . . . 0.0 113.094 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -152.66 152.76 32.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.815 1.646 . . . . 0.0 107.861 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.21 144.93 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.8 m -136.01 148.15 48.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.399 1.08 . . . . 0.0 108.582 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.5 mt -130.62 137.74 55.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.5 mt -135.1 102.78 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -174.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -84.84 149.86 25.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -139.23 136.67 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -141.71 146.82 42.93 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.915 1.286 . . . . 0.0 109.316 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.48 -38.81 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.188 1.925 . . . . 0.0 111.496 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 p -162.77 148.66 12.34 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.26 1.424 . . . . 0.0 108.065 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.23 -19.33 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.652 0.781 . . . . 0.0 111.014 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.6 -26.17 68.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.342 1.057 . . . . 0.0 112.087 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 p -62.8 138.97 58.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.313 0.578 . . . . 0.0 110.686 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.63 -4.29 69.91 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.729 0.68 . . . . 0.0 113.392 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.86 -25.99 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.523 1.129 . . . . 0.0 111.968 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.78 -42.75 85.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.856 0.753 . . . . 0.0 111.83 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.35 -37.52 80.56 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.409 0.549 . . . . 0.0 110.134 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.21 72.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.407 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.7 tm0? -155.3 -53.6 0.09 Allowed 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -39.76 79.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.631 1.559 . . . . 0.0 114.486 -167.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -64.91 -48.91 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.536 1.517 . . . . 0.0 110.179 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -61.33 -49.16 78.11 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 118.846 0.748 . . . . 0.0 109.806 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.407 ' CB ' HE21 ' A' ' 63' ' ' GLN . 61.1 t80 -56.98 -48.64 77.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.259 0.624 . . . . 0.0 110.797 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -61.98 -39.68 93.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.511 0.724 . . . . 0.0 110.856 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.84 -38.83 80.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.124 0.97 . . . . 0.0 111.075 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.94 -45.16 71.47 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.201 0.91 . . . . 0.0 110.309 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.86 69.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.929 1.291 . . . . 0.0 110.856 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.93 -21.35 61.01 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.949 0.9 . . . . 0.0 113.127 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -120.13 7.67 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.41 -30.79 68.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.851 1.205 . . . . 0.0 111.626 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.65 -74.25 0.06 OUTLIER Glycine 0 C--N 1.336 0.551 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -162.91 110.16 1.23 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.48 155.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.889 1.276 . . . . 0.0 107.987 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -76.45 144.26 40.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.66 129.66 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.56 157.69 45.38 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.27 1.028 . . . . 0.0 110.08 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 45.6 m -127.13 98.02 5.15 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 mt -76.69 128.61 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 m -139.32 170.03 16.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.617 1.567 . . . . 0.0 108.862 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.98 0.895 . . . . 0.0 111.612 176.024 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.3 m -77.78 46.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.659 1.583 . . . . 0.0 114.024 -169.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -34.33 0.19 Allowed Glycine 0 C--N 1.333 0.397 0 O-C-N 121.276 -0.89 . . . . 0.0 112.486 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 16.73 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.56 1.144 . . . . 0.0 114.071 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -136.1 65.85 1.52 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.871 1.668 . . . . 0.0 107.177 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.76 -37.57 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.805 1.193 . . . . 0.0 111.016 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.22 89.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.24 -23.55 9.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.494 1.918 . . . . 0.0 113.983 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.37 -32.26 72.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.858 0.863 . . . . 0.0 112.29 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.92 147.05 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -148.99 145.27 27.24 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 p -80.41 151.71 29.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.394 0.616 . . . . 0.0 109.586 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.44 156.64 29.79 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.171 1.388 . . . . 0.0 107.695 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 m -120.45 46.44 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.629 1.972 . . . . 0.0 110.326 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -55.52 -32.1 62.63 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.967 -1.083 . . . . 0.0 113.217 -170.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -55.87 -17.26 5.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -58.37 -27.38 64.16 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.305 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -141.88 -3.35 1.12 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.801 1.182 . . . . 0.0 113.808 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.86 28.66 6.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.5 2.32 . . . . 0.0 113.802 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 m -59.33 -58.9 6.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.923 0.889 . . . . 0.0 110.773 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.97 -33.92 75.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.803 0.841 . . . . 0.0 109.792 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.19 -57.77 8.65 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 125.141 1.353 . . . . 0.0 112.08 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.4 -39.77 58.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.149 0.474 . . . . 0.0 110.15 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.17 85.6 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.99 3.07 30.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.916 1.286 . . . . 0.0 110.672 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.62 29.06 71.56 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 121.553 -0.717 . . . . 0.0 113.625 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.06 -1.73 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.107 0.963 . . . . 0.0 110.612 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.44 105.73 1.24 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.638 1.108 . . . . 0.0 108.086 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.38 115.89 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -57.36 -43.42 83.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 111.028 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -92.9 -4.62 52.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -169.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.79 -14.75 2.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.648 0.779 . . . . 0.0 112.402 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 48.92 40.4 16.6 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.84 1.656 . . . . 0.0 112.144 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 mt -126.27 173.9 8.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.73 126.97 31.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.394 1.478 . . . . 0.0 108.972 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 137.32 58.24 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.749 1.219 . . . . 0.0 110.637 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.55 108.63 0.85 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.322 1.049 . . . . 0.0 108.318 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.2 p -156.58 170.16 23.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.012 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.03 147.37 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -144.18 153.01 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.05 136.07 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.9 mp -129.56 133.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.728 1.211 . . . . 0.0 107.801 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.44 161.08 14.94 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.659 1.183 . . . . 0.0 109.825 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -33.14 -41.82 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.428 2.691 . . . . 0.0 115.413 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -91.1 -8.15 49.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.51 3.38 43.76 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.202 0.906 . . . . 0.0 113.567 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -71.47 118.69 14.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.85 1.825 . . . . 0.0 108.691 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.96 116.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 170.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.52 -15.41 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.294 1.038 . . . . 0.0 109.967 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -149.87 150.08 31.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 108.081 171.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.72 127.02 5.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.126 1.77 . . . . 0.0 106.93 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -149.23 149.83 31.6 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.031 0.832 . . . . 0.0 110.076 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.28 113.82 20.96 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.69 126.87 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.6 m -63.98 -2.6 2.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.66 1.184 . . . . 0.0 114.168 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -141.52 124.39 16.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.08 -31.0 66.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.768 1.227 . . . . 0.0 113.501 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.5 p -86.73 15.81 5.37 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.004 0.82 . . . . 0.0 111.771 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -127.53 179.44 5.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.468 1.507 . . . . 0.0 110.085 -174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -137.81 159.16 69.88 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.772 1.229 . . . . 0.0 110.592 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -89.4 -178.64 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.436 2.758 . . . . 0.0 110.55 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -75.53 94.14 3.11 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -72.45 -6.3 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.708 0.803 . . . . 0.0 112.913 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.67 -28.59 61.84 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 119.658 1.117 . . . . 0.0 108.982 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -61.1 -49.96 86.42 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.11 -33.86 59.85 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.53 1.582 . . . . 0.0 112.732 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.92 -45.85 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.348 1.431 . . . . 0.0 109.639 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.67 -38.84 92.64 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.412 1.006 . . . . 0.0 110.53 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.43 91.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.53 0.332 . . . . 0.0 111.207 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.29 61.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.981 0.513 . . . . 0.0 110.761 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.21 -39.45 69.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.059 0.845 . . . . 0.0 110.957 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.01 65.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.463 0.705 . . . . 0.0 111.89 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 63.1 mt -91.87 -43.89 9.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.353 0.524 . . . . 0.0 111.452 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.51 -39.6 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 0.0 110.767 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 mttp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 126.488 1.915 . . . . 0.0 110.069 -174.016 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.9 pt -133.62 179.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.655 0.74 . . . . 0.0 109.53 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -129.04 145.14 51.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -144.54 130.02 18.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 45.93 38.9 4.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.634 1.174 . . . . 0.0 112.175 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.44 26.32 73.54 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.274 -0.737 . . . . 0.0 114.374 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 139.91 11.33 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.22 144.74 42.34 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.369 2.046 . . . . 0.0 110.25 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.94 134.0 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.246 1.018 . . . . 0.0 109.767 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -81.2 166.22 20.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.618 1.967 . . . . 0.0 110.62 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.2 154.87 30.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.862 1.665 . . . . 0.0 109.539 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -85.65 -65.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.662 0.665 . . . . 0.0 110.24 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.63 4.22 86.38 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.68 0.657 . . . . 0.0 114.225 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 52.59 176.31 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.779 2.831 . . . . 0.0 116.45 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.93 113.51 3.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.591 1.956 . . . . 0.0 111.573 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.71 160.62 4.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -137.93 157.89 45.47 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.57 132.49 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.38 -2.1 87.43 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.667 -1.074 . . . . 0.0 114.279 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.57 -4.72 58.07 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.765 1.783 . . . . 0.0 112.596 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 59.16 177.2 0.08 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.561 1.544 . . . . 0.0 112.058 -169.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.09 135.29 21.08 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.287 1.835 . . . . 0.0 108.328 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 87.1 Cg_endo -72.23 156.4 55.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.179 1.919 . . . . 0.0 109.453 172.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 25.3 t70 -74.59 66.02 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.676 1.99 . . . . 0.0 110.66 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -61.33 155.21 21.88 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.295 1.438 . . . . 0.0 109.561 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 m -94.86 155.1 16.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.37 171.66 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.161 2.184 . . . . 0.0 106.955 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.9 mt -132.93 130.2 39.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -72.85 -176.89 2.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.697 1.199 . . . . 0.0 111.981 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -57.37 -32.35 66.7 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 110.485 169.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -85.62 2.98 42.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.867 1.667 . . . . 0.0 112.047 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt 52.22 36.82 20.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.507 1.923 . . . . 0.0 112.315 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -91.75 149.53 21.56 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.3 144.81 49.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.159 0.981 . . . . 0.0 110.148 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -153.97 159.15 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.45 2.7 . . . . 0.0 104.838 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 m -142.53 166.45 24.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 53.9 tp -49.79 -42.03 45.86 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.683 0.393 . . . . 0.0 111.311 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.56 -21.9 63.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.38 -30.25 60.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.821 0.737 . . . . 0.0 111.06 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.8 mtt -72.45 -37.39 68.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.566 1.146 . . . . 0.0 110.662 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -55.98 152.77 9.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.008 0.908 . . . . 0.0 111.517 -173.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.53 11.59 66.05 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.977 1.275 . . . . 0.0 113.251 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -154.17 148.21 25.71 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.559 1.544 . . . . 0.0 107.699 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.17 141.49 16.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.8 m -133.19 143.09 48.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 77' ' ' VAL . 74.1 mt -135.92 132.55 50.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -172.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -139.56 134.28 38.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -169.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.92 144.76 42.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 168.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 t -121.7 126.8 75.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.35 127.82 5.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -173.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.97 -41.98 71.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.261 1.974 . . . . 0.0 112.43 -169.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.7 t -157.5 145.98 19.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -17.82 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 122.438 0.295 . . . . 0.0 111.129 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.19 -21.37 63.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 112.672 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.5 p -59.15 -24.62 63.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.659 0.784 . . . . 0.0 112.431 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.54 -10.29 59.68 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.881 0.753 . . . . 0.0 112.144 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.93 -18.21 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 118.85 1.325 . . . . 0.0 110.069 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.6 p -51.77 -43.63 63.07 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.34 -41.13 63.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.849 0.749 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.23 -30.88 71.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 -173.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -146.76 -49.02 0.19 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.317 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 m -55.49 -45.32 77.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.643 1.11 . . . . 0.0 113.451 -167.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -48.8 80.22 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.703 0.683 . . . . 0.0 109.892 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.65 -45.94 73.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.843 0.747 . . . . 0.0 109.548 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.64 -53.49 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.432 0.693 . . . . 0.0 110.276 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -29.78 53.49 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -63.75 -55.32 24.11 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.334 1.054 . . . . 0.0 109.915 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.71 -37.35 87.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.6 0.76 . . . . 0.0 109.559 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.58 69.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.76 0.824 . . . . 0.0 110.799 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.79 68.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.467 0.307 . . . . 0.0 111.65 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -75.44 -22.74 57.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.007 -0.997 . . . . 0.0 112.641 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.57 -40.63 95.91 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.204 1.365 . . . . 0.0 110.944 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.47 -168.15 41.06 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -173.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -74.15 29.02 0.08 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.024 1.33 . . . . 0.0 113.311 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 48' ' ' ILE . 23.9 m -62.08 154.6 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.482 -1.386 . . . . 0.0 110.832 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.62 149.71 29.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.58 123.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -133.91 149.02 51.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.097 0.559 . . . . 0.0 111.396 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -127.81 99.09 5.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -84.67 130.48 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 m -142.95 172.99 11.95 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.013 1.325 . . . . 0.0 110.639 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 123.895 0.878 . . . . 0.0 111.5 177.804 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m0 . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 p -158.78 171.87 19.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.018 1.727 . . . . 0.0 108.371 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.76 -84.41 1.11 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.94 36.9 0.64 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 -172.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -139.66 137.96 35.68 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.019 1.328 . . . . 0.0 108.197 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.99 -14.18 65.01 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.01 0.814 . . . . 0.0 112.024 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.91 93.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 126.335 1.854 . . . . 0.0 106.269 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.27 -25.63 48.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.501 1.52 . . . . 0.0 113.196 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -55.59 -36.67 67.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.987 1.315 . . . . 0.0 112.694 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.2 t -70.86 147.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -129.55 141.92 50.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.2 p -87.44 136.81 32.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.9 146.08 46.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 m -121.65 51.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.742 1.217 . . . . 0.0 109.687 -168.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.21 -31.48 43.32 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -56.66 -21.68 29.2 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.941 1.701 . . . . 0.0 114.05 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -76.49 -6.23 50.91 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.146 -0.971 . . . . 0.0 112.551 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.17 -39.88 0.6 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.028 1.331 . . . . 0.0 112.44 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.75 4.29 3.9 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 130.054 3.342 . . . . 0.0 114.815 170.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -58.81 -44.51 90.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.259 -1.353 . . . . 0.0 111.957 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.06 -41.58 90.6 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 121.064 1.756 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.61 -43.11 96.35 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 123.996 0.808 . . . . 0.0 111.772 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -72.76 -46.72 51.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.271 0.536 . . . . 0.0 109.994 173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 25' ' ' PRO . . . -58.99 -39.19 81.06 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.241 1.016 . . . . 0.0 112.532 -172.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.04 5.83 26.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.0 110.618 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.6 32.45 58.34 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.717 0.675 . . . . 0.0 113.563 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.35 -8.75 9.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 123.45 0.7 . . . . 0.0 110.097 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -68.96 111.32 4.91 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.32 128.13 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -66.87 -47.36 72.12 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 110.933 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -90.83 0.05 57.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 tp -129.82 -13.55 4.14 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.629 1.172 . . . . 0.0 111.591 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 47.15 47.91 16.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.922 1.689 . . . . 0.0 111.193 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.3 tp -139.88 156.88 46.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.468 1.107 . . . . 0.0 108.206 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.08 131.24 45.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.326 0.65 . . . . 0.0 109.519 173.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.85 164.32 25.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.993 1.317 . . . . 0.0 112.407 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -86.03 113.5 22.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.5 m -148.14 173.53 12.87 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.709 0.804 . . . . 0.0 109.681 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 144.7 17.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.886 1.274 . . . . 0.0 108.454 177.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -148.34 158.87 44.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.573 1.149 . . . . 0.0 109.998 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.04 140.65 40.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mp -131.75 135.73 47.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.235 1.414 . . . . 0.0 107.591 -173.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.35 166.67 7.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 110.04 169.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.32 -31.96 23.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.116 1.367 . . . . 0.0 113.012 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -80.91 -0.86 41.06 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.432 1.093 . . . . 0.0 112.67 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.12 -6.75 82.76 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.625 1.107 . . . . 0.0 112.608 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.2 124.9 22.37 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.719 1.259 . . . . 0.0 109.232 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.81 128.24 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.737 0.815 . . . . 0.0 110.112 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.79 -19.51 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 109.917 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -145.08 147.05 32.13 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.81 131.94 12.69 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.037 1.335 . . . . 0.0 108.237 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.26 149.66 31.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.606 0.762 . . . . 0.0 109.365 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -128.06 117.19 21.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.823 2.049 . . . . 0.0 105.55 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.5 125.32 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -59.09 -25.02 63.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.693 1.197 . . . . 0.0 112.86 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -134.58 100.77 4.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.09 66.64 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.563 1.145 . . . . 0.0 112.757 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.82 8.7 2.26 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.652 1.181 . . . . 0.0 112.422 170.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.68 162.48 30.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.252 1.821 . . . . 0.0 108.699 173.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -90.12 145.46 32.98 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.69 166.55 29.09 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.991 2.461 . . . . 0.0 111.579 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -85.44 139.39 31.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -104.07 -8.73 19.3 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.39 -39.29 59.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -51.36 -58.03 12.12 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.987 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.94 -34.41 23.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 121.493 1.569 . . . . 0.0 112.393 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 mm -59.58 -42.66 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.142 1.337 . . . . 0.0 109.998 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.39 -36.96 84.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.413 1.006 . . . . 0.0 110.716 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.45 87.24 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.376 -0.202 . . . . 0.0 110.884 175.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.59 -40.73 69.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.623 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.91 -40.65 76.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.92 1.236 . . . . 0.0 110.26 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.81 66.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.177 0.591 . . . . 0.0 112.317 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.09 -60.37 2.32 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.961 0.504 . . . . 0.0 110.46 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.39 -45.04 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.145 1.378 . . . . 0.0 111.905 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm . . . . . 0 C--O 1.25 1.094 0 C-N-CA 126.802 2.041 . . . . 0.0 110.936 -176.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 pt -131.43 171.82 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 123.18 1.467 . . . . 0.0 110.37 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -115.82 153.95 30.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -140.29 122.79 16.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.17 39.13 1.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.365 1.466 . . . . 0.0 113.492 -171.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.33 6.18 89.47 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.674 -0.641 . . . . 0.0 114.396 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.77 125.42 7.93 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.185 1.374 . . . . 0.0 109.863 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.76 141.17 48.68 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 CA-C-N 120.995 2.397 . . . . 0.0 110.062 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.57 138.96 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.777 0.831 . . . . 0.0 109.844 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -86.02 155.59 20.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.119 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mt -118.9 153.38 34.66 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.194 1.398 . . . . 0.0 107.94 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.87 -15.58 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.58 33.8 0.45 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.971 0.805 . . . . 0.0 111.79 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -51.74 151.15 3.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.401 0.681 . . . . 0.0 112.209 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.262 8.6 tt0 108.44 23.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 129.242 3.017 . . . . 0.0 112.727 169.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.68 141.21 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -148.7 165.47 31.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.101 0.96 . . . . 0.0 109.167 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 p -54.01 132.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.02 -0.2 89.93 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.081 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.66 -12.04 59.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.546 1.673 . . . . 0.0 112.545 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 59.68 167.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.449 1.9 . . . . 0.0 113.101 -171.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.04 128.25 31.31 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.351 1.46 . . . . 0.0 108.466 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.39 -25.06 63.92 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.304 2.669 . . . . 0.0 114.428 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 66.81 100.67 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.995 2.518 . . . . 0.0 112.441 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -142.46 172.34 12.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.522 1.529 . . . . 0.0 109.274 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -89.21 154.38 20.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.76 1.224 . . . . 0.0 111.427 -169.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.83 164.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 128.087 2.555 . . . . 0.0 104.995 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 tp -116.85 140.4 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.11 168.12 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.23 -24.65 66.51 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.736 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -80.33 0.65 32.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.976 1.71 . . . . 0.0 112.011 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.6 mt 64.83 44.32 3.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.097 2.159 . . . . 0.0 111.946 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -119.73 145.98 46.04 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.26 1.024 . . . . 0.0 108.886 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.42 139.4 45.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.674 0.79 . . . . 0.0 109.312 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -142.01 102.18 4.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 m -71.03 153.59 42.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -58.94 -30.85 68.18 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.169 -0.957 . . . . 0.0 110.863 170.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.07 8.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.397 1.479 . . . . 0.0 113.286 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.06 -28.12 35.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.991 0.916 . . . . 0.0 111.676 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.2 mtt -72.41 -48.56 40.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.129 0.971 . . . . 0.0 110.496 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.36 171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.966 0.888 . . . . 0.0 110.291 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 -15.2 48.19 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.451 1.5 . . . . 0.0 110.575 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -153.02 159.81 42.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.542 2.737 . . . . 0.0 106.29 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.4 144.29 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 m -132.74 149.37 52.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.207 1.003 . . . . 0.0 109.551 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.5 138.64 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.3 mt -139.49 113.68 7.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 m -89.32 144.95 25.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.31 134.81 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 pt -147.67 159.39 41.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 107.928 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.02 -52.24 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 N-CA-C 108.513 -1.38 . . . . 0.0 108.513 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 m -150.9 146.72 26.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.703 1.601 . . . . 0.0 108.643 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -20.7 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 111.047 171.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -60.1 -14.25 15.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.14 0.976 . . . . 0.0 113.319 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 p -56.65 -27.47 58.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.641 0.776 . . . . 0.0 111.866 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.43 4.67 84.79 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.167 0.889 . . . . 0.0 112.266 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.02 -13.88 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 119.065 1.433 . . . . 0.0 111.976 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.6 m -57.75 -47.47 82.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.118 0.967 . . . . 0.0 110.539 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.38 -28.83 64.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.318 0.647 . . . . 0.0 111.35 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.82 -59.5 5.05 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -161.51 -14.22 0.04 OUTLIER 'General case' 0 C--N 1.341 0.203 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -69.59 -31.01 68.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.283 1.401 . . . . 0.0 112.825 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -61.88 -50.57 71.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.269 0.941 . . . . 0.0 108.841 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -62.37 -48.05 81.45 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.587 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.15 -50.75 71.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.641 0.777 . . . . 0.0 110.562 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -68.46 -33.03 73.46 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.388 -0.195 . . . . 0.0 110.757 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.7 -42.03 78.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 111.426 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.33 -44.92 96.4 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.397 0.998 . . . . 0.0 109.678 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.02 -38.58 70.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.441 0.696 . . . . 0.0 111.402 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.89 -5.71 22.88 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -116.02 -12.3 11.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.689 1.596 . . . . 0.0 112.66 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -57.88 -32.47 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.643 1.11 . . . . 0.0 111.64 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.91 -159.69 32.88 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.61 22.21 0.14 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.469 -1.018 . . . . 0.0 112.386 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 77' ' ' VAL . 2.8 t -54.82 134.83 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.979 1.712 . . . . 0.0 108.817 -171.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.79 135.85 53.26 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -144.08 133.22 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -170.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.72 162.4 35.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.616 0.766 . . . . 0.0 110.926 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.8 m -133.03 124.46 27.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.22 133.27 53.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -141.12 169.09 18.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.152 0.981 . . . . 0.0 110.484 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 112.003 174.718 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.9 p90 . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.185 0.516 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.93 -28.58 13.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.33 -65.52 1.85 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.95 34.29 0.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.365 1.066 . . . . 0.0 111.981 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -67.18 -5.37 13.34 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.991 1.316 . . . . 0.0 114.272 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.32 -17.81 1.89 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.132 1.825 . . . . 0.0 109.376 -169.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.22 91.8 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.4 -27.44 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -66.75 -22.16 66.05 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.073 0.949 . . . . 0.0 112.256 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 t -91.37 154.09 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.3 147.43 47.45 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.9 m -104.14 138.98 39.84 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.6 mp -118.44 160.97 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.108 1.763 . . . . 0.0 108.233 -170.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.7 54.31 1.88 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.231 1.412 . . . . 0.0 108.776 -168.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.13 -24.92 57.55 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -56.39 -19.73 16.2 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 120.299 1.409 . . . . 0.0 112.895 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -81.64 -4.3 55.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.857 1.263 . . . . 0.0 112.845 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -141.87 -41.98 0.35 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.032 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.44 -3.07 1.41 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 129.529 3.132 . . . . 0.0 114.83 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -64.91 -45.76 84.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.586 1.539 . . . . 0.0 110.691 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.25 -42.66 95.77 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.18 0.9 . . . . 0.0 110.51 174.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.87 96.28 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.82 -43.74 92.15 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.521 0.66 . . . . 0.0 109.707 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.78 -47.06 86.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.583 0.753 . . . . 0.0 112.188 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -83.8 -1.9 55.24 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.093 0.957 . . . . 0.0 111.504 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.31 38.04 95.32 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.402 -0.666 . . . . 0.0 111.936 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.2 -0.2 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.292 1.437 . . . . 0.0 110.584 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -76.82 114.88 16.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.28 113.0 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -59.15 -40.95 87.1 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.285 1.034 . . . . 0.0 110.595 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -91.72 -4.46 55.05 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 tp -140.51 -0.38 1.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.027 0.831 . . . . 0.0 113.178 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 43.28 41.51 3.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.697 1.999 . . . . 0.0 114.431 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -132.06 167.94 18.83 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.861 0.865 . . . . 0.0 108.847 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.72 134.48 47.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 162.78 15.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.332 1.453 . . . . 0.0 111.22 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.406 ' CB ' ' HA ' ' A' ' 149' ' ' ALA . 16.9 tpt180 -88.75 116.98 27.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -159.88 171.32 19.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.216 0.531 . . . . 0.0 110.096 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 t -143.5 142.15 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -141.18 155.33 46.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 109.442 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -137.42 135.67 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 42.8 mt -122.51 136.76 54.96 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.36 175.64 5.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.977 0.894 . . . . 0.0 110.208 169.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -56.88 -11.33 1.39 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.913 1.685 . . . . 0.0 114.897 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.96 14.83 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.487 1.494 . . . . 0.0 112.359 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.46 -1.87 67.12 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.418 1.009 . . . . 0.0 113.267 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -65.64 118.05 8.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.294 1.547 . . . . 0.0 108.114 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.06 110.95 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 p -91.73 -16.59 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 109.536 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -150.64 151.45 32.53 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.013 1.325 . . . . 0.0 107.504 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.96 132.94 9.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 107.149 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -142.02 150.01 40.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.636 0.653 . . . . 0.0 110.472 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -122.83 111.23 16.42 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 127.226 2.21 . . . . 0.0 105.041 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 t -72.5 140.04 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -58.94 -21.62 58.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.656 1.182 . . . . 0.0 113.892 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.42 134.07 30.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.406 ' HA ' ' CB ' ' A' ' 129' ' ' ARG . . . -56.3 -31.64 63.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.9 p -83.78 -6.73 59.5 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.317 0.962 . . . . 0.0 112.606 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -93.6 179.95 5.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.886 1.274 . . . . 0.0 109.921 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -133.92 157.36 77.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.256 1.422 . . . . 0.0 110.898 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.72 -176.87 3.1 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.166 2.578 . . . . 0.0 110.188 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -69.74 138.06 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -82.53 -9.32 59.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -107.22 -32.28 7.86 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.077 0.853 . . . . 0.0 110.887 -169.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -52.47 -49.14 87.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 -36.33 21.13 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 CA-C-N 121.631 1.618 . . . . 0.0 111.43 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.76 -45.36 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.476 0.71 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.83 -34.01 75.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 120.081 1.309 . . . . 0.0 110.498 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.61 91.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.482 0.313 . . . . 0.0 111.18 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.81 -47.34 59.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.075 174.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -55.91 -37.93 69.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.258 0.936 . . . . 0.0 110.901 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.8 -29.31 54.2 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.625 0.77 . . . . 0.0 112.005 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.6 mt -95.87 -43.84 7.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.681 0.792 . . . . 0.0 112.194 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.7 t -73.71 -43.82 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 111.57 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 C--O 1.249 1.074 0 C-N-CA 124.108 0.963 . . . . 0.0 109.676 179.875 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--O 1.237 0.412 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 pt -140.37 179.09 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 122.012 0.91 . . . . 0.0 109.458 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -126.36 156.82 39.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.01 1.724 . . . . 0.0 106.632 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -147.45 128.33 14.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 43.31 40.92 2.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.827 1.251 . . . . 0.0 112.924 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 24.22 69.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.364 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 136.81 8.92 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.49 146.25 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.26 1.973 . . . . 0.0 109.904 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.67 150.17 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.272 1.029 . . . . 0.0 109.291 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.5 m -98.62 163.09 12.8 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.961 1.304 . . . . 0.0 108.902 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.18 170.44 8.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.936 1.295 . . . . 0.0 109.239 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.36 133.07 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.55 -13.75 66.57 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.858 0.742 . . . . 0.0 114.202 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 53.44 167.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.935 3.294 . . . . 0.0 117.71 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.43 137.08 43.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.925 2.89 . . . . 0.0 112.639 -168.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.53 153.1 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.81 170.55 18.5 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 121.16 -0.962 . . . . 0.0 109.781 -171.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -50.12 131.92 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.372 0.669 . . . . 0.0 110.769 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.87 79.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.595 1.093 . . . . 0.0 113.502 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -94.32 6.88 47.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.259 1.529 . . . . 0.0 113.516 -169.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 57.85 111.95 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.218 2.207 . . . . 0.0 114.915 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.33 89.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.876 169.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.03 -46.83 14.3 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.586 2.191 . . . . 0.0 113.49 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 121.57 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 1 C-N-CA 131.73 4.012 . . . . 0.0 105.451 -169.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.76 168.03 19.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.632 1.573 . . . . 0.0 109.067 -175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 m -122.27 146.15 47.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.751 1.22 . . . . 0.0 107.803 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.91 164.32 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.908 2.083 . . . . 0.0 107.731 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.3 mt -100.43 141.36 33.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -71.79 173.67 7.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.406 1.482 . . . . 0.0 110.941 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -67.49 -8.84 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.538 -0.726 . . . . 0.0 111.723 169.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.3 m -97.01 4.4 51.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.22 1.408 . . . . 0.0 111.835 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.97 51.98 13.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.388 1.875 . . . . 0.0 111.633 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.59 152.45 41.87 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -72.42 143.24 48.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.938 0.875 . . . . 0.0 110.301 -175.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -147.46 158.22 43.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.355 2.662 . . . . 0.0 105.73 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 p -137.25 166.64 23.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -55.47 -40.09 71.2 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 171.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -24.16 61.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.17 -33.08 50.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.924 0.784 . . . . 0.0 111.345 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.4 mtt -70.58 -36.35 73.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.426 1.09 . . . . 0.0 111.018 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -53.49 146.87 11.87 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.976 0.91 . . . . 0.0 110.784 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -17.79 11.43 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.106 1.336 . . . . 0.0 112.73 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -149.04 155.7 41.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.265 1.426 . . . . 0.0 108.87 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.2 136.94 19.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 76.8 m -133.19 145.0 50.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.22 134.31 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.0 mt -135.23 108.12 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 m -86.42 152.07 23.01 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 134.45 53.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 pt -144.06 154.88 58.62 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.001 1.72 . . . . 0.0 108.074 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.88 -44.04 6.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.906 1.737 . . . . 0.0 111.262 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 t -151.2 170.88 18.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.281 1.832 . . . . 0.0 107.344 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 56' ' ' ASP . 2.0 pp -96.47 -20.16 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.482 1.113 . . . . 0.0 109.387 168.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' N ' HD12 ' A' ' 55' ' ' ILE . 34.4 t70 -81.71 -25.89 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.91 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -61.51 -17.6 55.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.057 1.343 . . . . 0.0 112.551 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.69 84.37 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.032 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.23 -18.42 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.096 1.448 . . . . 0.0 112.245 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 m -64.78 -16.42 63.02 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.548 1.139 . . . . 0.0 113.361 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.79 -20.49 57.09 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.503 1.121 . . . . 0.0 112.938 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.44 32.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.751 1.221 . . . . 0.0 108.72 171.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? 61.34 -65.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.686 2.394 . . . . 0.0 114.579 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.46 -48.36 81.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.351 1.432 . . . . 0.0 114.649 -167.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -64.81 -52.32 57.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.175 1.352 . . . . 0.0 109.537 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.87 -45.88 89.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 110.464 -173.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -56.4 -53.46 57.08 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.321 1.048 . . . . 0.0 110.988 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -72.19 -34.54 68.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.148 0.431 . . . . 0.0 111.033 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.74 -39.19 80.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.888 0.875 . . . . 0.0 109.63 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.62 -45.23 76.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.774 0.829 . . . . 0.0 109.925 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.17 80.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.434 1.093 . . . . 0.0 110.943 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.96 -15.4 43.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.039 0.936 . . . . 0.0 113.082 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -95.58 -16.08 22.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.91 0.884 . . . . 0.0 112.373 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.78 -37.71 87.76 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.757 1.162 . . . . 0.0 110.846 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.47 -172.26 44.81 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.463 1.982 . . . . 0.0 108.269 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -77.71 36.06 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.0 0.92 . . . . 0.0 112.809 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.8 m -56.82 146.38 6.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 120.759 -1.213 . . . . 0.0 110.824 -177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -76.93 138.63 39.81 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.58 121.65 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.24 157.14 47.53 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.693 0.797 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 m -134.3 108.01 7.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.1 mt -91.01 138.3 19.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.8 m -137.5 172.56 12.79 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.705 2.002 . . . . 0.0 109.947 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.822 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.9 m -130.32 146.65 51.94 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.097 1.359 . . . . 0.0 109.752 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.77 -45.59 1.92 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.618 1.58 . . . . 0.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.58 36.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.308 2.243 . . . . 0.0 112.616 172.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.88 23.52 2.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.95 2.1 . . . . 0.0 110.531 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.89 -20.34 0.19 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.236 0.922 . . . . 0.0 111.485 -171.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.45 84.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.53 -27.31 48.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.637 1.175 . . . . 0.0 113.606 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -62.88 -32.84 74.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.0 112.416 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.81 146.54 11.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.32 136.22 27.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 p -80.39 141.34 35.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -128.25 155.79 44.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.541 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -124.19 133.87 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.31 -16.85 12.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.596 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -63.17 -11.37 20.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -51.2 -37.32 46.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.422 169.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -148.28 -5.15 0.45 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.7 mmm 56.19 26.86 10.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.773 1.629 . . . . 0.0 112.671 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 m -58.91 -55.34 36.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.869 0.867 . . . . 0.0 111.021 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -63.41 -41.66 98.74 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.068 0.547 . . . . 0.0 109.735 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.94 -47.97 88.04 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 119.339 -0.7 . . . . 0.0 111.396 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.68 -45.31 68.6 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.832 0.816 . . . . 0.0 109.805 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.8 67.76 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.86 0.864 . . . . 0.0 113.097 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -112.39 3.2 16.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.942 1.297 . . . . 0.0 111.544 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.74 33.34 85.7 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 119.591 1.087 . . . . 0.0 112.92 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.8 m -115.13 -2.69 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.358 1.063 . . . . 0.0 111.021 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -69.63 108.74 3.98 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.22 128.78 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -65.77 -46.75 77.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.498 1.119 . . . . 0.0 111.245 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.47 -56.84 3.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.07 0.395 . . . . 0.0 110.391 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.62 -19.94 64.27 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.837 0.455 . . . . 0.0 112.078 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 53.83 38.92 29.66 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 110.967 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 mt -136.87 170.63 15.76 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.566 1.146 . . . . 0.0 108.649 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.14 133.67 41.44 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.15 154.54 41.88 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.612 0.765 . . . . 0.0 111.544 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.4 tpt85 -71.8 117.61 13.6 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -160.74 170.44 20.76 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.352 0.978 . . . . 0.0 108.488 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.49 146.41 17.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 118.741 0.701 . . . . 0.0 109.278 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -144.75 156.02 43.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.229 1.412 . . . . 0.0 109.21 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.404 ' C ' HD12 ' A' ' 134' ' ' LEU . 60.7 t -136.32 140.91 42.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 133' ' ' VAL . 9.1 mp -133.26 139.0 46.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.169 1.388 . . . . 0.0 108.79 -169.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.62 166.71 8.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.228 1.811 . . . . 0.0 109.941 169.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.28 -32.01 35.44 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 112.664 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -80.64 -2.99 48.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.582 1.153 . . . . 0.0 112.707 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.53 89.18 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.31 0.957 . . . . 0.0 112.724 -174.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -68.07 124.78 24.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.312 1.556 . . . . 0.0 108.285 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.84 132.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.99 -9.87 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.919 1.288 . . . . 0.0 110.956 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 150.94 30.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.175 0.99 . . . . 0.0 108.51 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.16 137.61 15.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.373 1.869 . . . . 0.0 107.457 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.0 143.93 30.76 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.32 105.47 7.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.546 -2.391 . . . . 0.0 104.546 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.6 144.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.158 -0.339 . . . . 0.0 110.416 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 m -62.22 -20.58 64.36 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.671 0.788 . . . . 0.0 112.007 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -144.48 122.88 12.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.77 65.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.965 1.306 . . . . 0.0 113.466 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.92 16.35 2.88 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.06 0.944 . . . . 0.0 111.55 173.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.73 161.3 35.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.025 2.53 . . . . 0.0 106.638 172.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -122.6 149.92 56.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 119.342 0.974 . . . . 0.0 112.468 -169.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.77 162.79 29.51 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.454 2.769 . . . . 0.0 112.247 -177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -70.94 112.85 7.43 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -75.39 -11.97 60.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.23 -32.91 69.34 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.923 1.238 . . . . 0.0 109.022 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -60.39 -53.36 65.45 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 117.533 -1.222 . . . . 0.0 112.063 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.37 -31.62 42.65 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-N 121.96 1.736 . . . . 0.0 112.256 172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.22 -42.73 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 120.169 1.35 . . . . 0.0 109.757 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.501 1.046 . . . . 0.0 110.937 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.15 93.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.68 0.218 . . . . 0.0 110.92 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.71 77.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.398 174.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -55.44 -43.73 75.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.069 0.85 . . . . 0.0 110.395 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.99 -31.48 66.97 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.081 0.552 . . . . 0.0 112.085 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.35 -46.95 11.22 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.767 0.427 . . . . 0.0 111.801 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.71 -50.0 47.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 123.971 0.908 . . . . 0.0 111.745 -169.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.65 -171.895 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.756 0.312 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.79 179.04 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.004 0.921 . . . . 0.0 109.677 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 148.6 45.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -141.88 127.62 19.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 44.88 35.84 1.66 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.444 1.098 . . . . 0.0 112.397 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.98 21.47 78.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 121.393 -0.817 . . . . 0.0 114.294 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.68 8.82 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.44 139.93 35.59 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.355 2.037 . . . . 0.0 110.083 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.35 154.59 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.479 1.112 . . . . 0.0 109.186 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -109.11 158.93 17.31 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.075 1.35 . . . . 0.0 107.841 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.29 158.46 22.34 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.093 0.86 . . . . 0.0 109.247 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.35 -18.33 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.59 33.57 0.63 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.816 0.735 . . . . 0.0 111.329 -174.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -50.79 151.31 2.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.7 1.2 . . . . 0.0 113.069 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.252 10.7 tt0 93.19 30.07 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.306 2.643 . . . . 0.0 112.26 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.14 144.24 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -148.88 160.61 43.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.83 131.46 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.395 0.678 . . . . 0.0 109.648 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.55 82.1 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.04 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.55 -6.5 59.47 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.554 1.677 . . . . 0.0 112.596 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.72 176.21 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.965 1.706 . . . . 0.0 112.451 -169.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.1 129.13 18.84 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 126.711 2.004 . . . . 0.0 107.723 -170.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.83 150.64 61.64 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.184 1.922 . . . . 0.0 112.133 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 23.6 t0 -75.8 68.66 2.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.288 1.835 . . . . 0.0 110.314 173.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -60.37 162.81 5.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.162 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -123.51 143.48 50.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.12 170.68 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.545 1.938 . . . . 0.0 108.703 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.4 119.49 22.8 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 125.47 1.508 . . . . 0.0 107.019 -170.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -73.97 173.25 10.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.543 1.137 . . . . 0.0 111.977 -171.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -21.88 66.16 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.086 -1.009 . . . . 0.0 111.226 170.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -80.76 0.19 35.78 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.727 1.611 . . . . 0.0 111.972 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.1 mt 55.27 52.84 10.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.955 2.102 . . . . 0.0 111.719 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.8 153.13 42.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 108.801 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.3 143.5 42.93 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.427 0.691 . . . . 0.0 109.325 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -150.26 160.26 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.252 2.221 . . . . 0.0 105.959 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 p -144.15 167.6 22.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.459 -0.775 . . . . 0.0 109.381 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 57.4 tp -53.98 -42.23 68.77 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 172.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.74 65.12 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.06 -30.7 55.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.886 0.766 . . . . 0.0 111.013 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.1 mtt -72.14 -40.31 68.17 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.446 1.098 . . . . 0.0 110.546 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -53.06 131.88 37.14 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.7 -23.29 4.0 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.009 1.29 . . . . 0.0 112.334 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -151.75 157.78 42.47 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.39 1.076 . . . . 0.0 109.415 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -56.83 140.86 14.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -134.75 146.79 49.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.899 0.88 . . . . 0.0 108.924 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.6 mt -136.46 135.71 49.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.7 mt -137.05 128.62 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -170.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -107.71 143.36 36.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.16 143.32 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.18 -0.95 . . . . 0.0 108.437 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 pt -144.5 161.36 44.38 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.781 2.032 . . . . 0.0 108.163 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -48.04 2.15 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.573 1.515 . . . . 0.0 110.631 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -162.55 156.72 21.21 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.074 1.35 . . . . 0.0 107.36 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.72 -30.72 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.981 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.81 -13.85 57.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 0.0 112.081 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -62.71 -20.47 64.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.276 0.631 . . . . 0.0 111.416 175.157 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 -25.57 3.8 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 124.31 0.957 . . . . 0.0 112.769 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 57' ' ' THR . 4.6 t -64.48 -17.03 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 119.019 1.409 . . . . 0.0 111.594 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.9 p -74.72 -30.07 61.4 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 120.768 -1.207 . . . . 0.0 111.558 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.5 -38.72 40.09 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.448 1.022 . . . . 0.0 109.839 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.63 67.17 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -136.28 -62.71 0.66 Allowed 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.676 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -57.76 -35.43 70.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.341 1.428 . . . . 0.0 113.159 -168.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -27.95 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 118.06 -0.972 . . . . 0.0 112.447 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -103.41 -48.93 3.84 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.842 1.201 . . . . 0.0 109.94 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -51.92 -49.17 63.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 119.497 1.044 . . . . 0.0 111.249 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -79.95 -23.89 41.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.189 -0.319 . . . . 0.0 111.223 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.7 -43.25 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.422 0.689 . . . . 0.0 110.12 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -64.3 -45.63 87.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.818 1.247 . . . . 0.0 108.919 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.87 68.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.556 1.142 . . . . 0.0 110.435 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -9.93 23.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.212 1.005 . . . . 0.0 113.092 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.2 -1.38 10.86 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.6 -34.13 77.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.227 1.376 . . . . 0.0 109.146 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.35 -169.83 40.33 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.494 1.997 . . . . 0.0 108.66 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.96 17.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 113.01 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.53 149.46 5.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.235 1.814 . . . . 0.0 111.272 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -68.75 144.14 54.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 123.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.59 152.8 48.47 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.054 0.542 . . . . 0.0 110.754 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -124.18 143.14 50.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.2 mt -127.4 135.99 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -135.49 168.19 19.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.325 1.45 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.834 0.826 . . . . 0.0 111.406 172.948 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.8 t90 . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.1 p 30.04 -90.19 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.147 2.979 . . . . 0.0 114.149 174.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.25 -21.28 46.79 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.389 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.58 11.03 9.15 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.051 1.426 . . . . 0.0 111.754 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -60.12 -27.81 67.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.0 25.3 0.71 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -173.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.88 91.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.71 -28.93 58.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.462 1.505 . . . . 0.0 113.477 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.7 -17.56 64.7 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -75.99 155.82 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.163 0.892 . . . . 0.0 109.975 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.72 151.68 49.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.2 m -118.1 139.82 50.67 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.93 155.12 30.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.72 0.808 . . . . 0.0 110.094 -172.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -126.57 43.15 3.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.137 1.775 . . . . 0.0 109.139 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -46.13 -41.75 12.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 114.201 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -57.62 -17.58 15.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.275 1.03 . . . . 0.0 113.672 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -61.59 -24.84 66.95 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.004 -1.06 . . . . 0.0 111.832 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -128.39 -28.4 2.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.833 1.653 . . . . 0.0 112.034 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.0 tpt 75.04 10.8 3.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.403 2.681 . . . . 0.0 113.911 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.45 -53.14 61.54 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.846 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.4 -39.62 91.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.193 1.361 . . . . 0.0 109.906 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -50.06 -53.16 24.07 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 125.537 1.541 . . . . 0.0 112.478 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.76 -40.95 63.1 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.053 0.427 . . . . 0.0 110.309 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.23 98.18 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.156 0.982 . . . . 0.0 112.371 -169.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -102.09 -0.12 33.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.381 1.072 . . . . 0.0 110.62 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.53 94.23 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -114.72 0.11 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.98 1.312 . . . . 0.0 110.874 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -76.36 119.09 19.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.46 122.3 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.2 -44.5 97.19 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.94 1.296 . . . . 0.0 110.723 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -95.5 -50.9 4.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.971 0.35 . . . . 0.0 111.16 -172.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.95 -19.03 65.73 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.728 -0.608 . . . . 0.0 112.001 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 53.15 51.79 14.98 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.904 1.281 . . . . 0.0 109.6 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -145.2 162.8 36.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.665 1.586 . . . . 0.0 107.577 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 tp -78.77 132.41 36.9 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.43 -0.794 . . . . 0.0 109.038 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.87 174.92 6.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.045 0.938 . . . . 0.0 112.858 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.91 117.77 34.87 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 169.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -151.19 177.51 10.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.38 145.81 18.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -147.57 156.75 43.12 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.36 1.064 . . . . 0.0 110.051 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.54 139.2 43.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.6 mt -128.55 143.53 50.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.76 1.224 . . . . 0.0 108.619 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -71.51 175.52 5.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.116 0.967 . . . . 0.0 110.252 169.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.06 -23.89 36.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.326 1.451 . . . . 0.0 113.566 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.424 ' H ' ' CG ' ' A' ' 135' ' ' ASP . 32.0 m-80 -98.31 5.46 48.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.854 1.662 . . . . 0.0 111.411 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.64 -0.51 88.17 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.837 -0.98 . . . . 0.0 113.021 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.49 127.49 32.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.696 1.748 . . . . 0.0 108.198 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.85 125.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.47 0.708 . . . . 0.0 109.324 171.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.59 -21.04 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.803 2.041 . . . . 0.0 109.208 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -146.87 150.25 34.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.74 132.63 10.58 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.942 1.697 . . . . 0.0 106.873 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.19 145.48 28.31 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 169.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -115.12 116.41 28.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 t -68.49 126.43 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -57.78 -27.31 62.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.606 1.163 . . . . 0.0 112.617 -173.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.35 103.1 6.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.787 -2.671 . . . . 0.0 103.787 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.33 67.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.615 1.166 . . . . 0.0 112.471 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 p -87.44 19.95 3.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.229 1.012 . . . . 0.0 111.379 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.45 160.46 38.7 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.998 2.119 . . . . 0.0 107.665 175.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -86.66 147.29 43.41 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 121.755 -0.591 . . . . 0.0 112.076 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.03 167.6 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.398 2.732 . . . . 0.0 111.212 169.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -81.21 97.82 7.79 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 169.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -74.29 -4.55 36.85 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.81 -35.35 78.47 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.173 -0.954 . . . . 0.0 109.194 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -56.3 -57.36 23.28 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.34 1.456 . . . . 0.0 111.667 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.62 -33.18 46.25 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.486 1.566 . . . . 0.0 112.312 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 mm -59.05 -48.95 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.837 1.199 . . . . 0.0 109.613 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.54 -41.56 94.73 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.708 0.686 . . . . 0.0 110.537 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.14 87.72 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.686 0.395 . . . . 0.0 110.965 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.44 19.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.517 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -64.22 -26.65 68.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.048 1.294 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.71 70.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.647 1.112 . . . . 0.0 112.073 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.79 -43.87 35.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.646 0.657 . . . . 0.0 110.912 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.36 -48.94 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.38 0.672 . . . . 0.0 110.739 -173.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.057 0 C-N-CA 124.797 1.239 . . . . 0.0 109.969 178.829 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.3 pt -137.1 -177.86 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 109.57 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -126.83 152.49 46.92 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -140.06 128.97 23.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt 43.95 36.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.267 1.427 . . . . 0.0 112.739 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.91 16.95 79.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.55 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.63 120.9 4.92 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 171.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.37 138.64 84.59 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.019 2.479 . . . . 0.0 111.357 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 m -143.41 162.06 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.36 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -118.78 161.83 19.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.463 1.505 . . . . 0.0 108.73 -169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.96 163.06 14.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.659 1.584 . . . . 0.0 109.69 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.36 -62.39 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.524 0.602 . . . . 0.0 111.689 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.45 12.45 69.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -168.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 56.48 154.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.29 2.636 . . . . 0.0 114.602 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -71.78 139.77 49.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.856 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.93 165.74 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -152.11 162.09 41.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.347 -0.846 . . . . 0.0 109.174 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.43 130.44 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.04 0.44 90.29 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.928 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -5.73 59.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.664 . . . . 0.0 112.332 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 58.38 180.0 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 111.527 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.56 146.35 52.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.541 1.536 . . . . 0.0 110.015 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -56.41 -21.84 39.22 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.439 3.426 . . . . 0.0 116.114 174.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 73.49 66.63 0.1 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 108.621 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -69.69 169.12 13.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.401 1.88 . . . . 0.0 111.748 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.5 m -110.48 155.73 21.84 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.23 166.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 127.501 2.32 . . . . 0.0 106.387 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 tp -118.22 135.71 54.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.7 p -75.84 168.36 20.17 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.024 0.53 . . . . 0.0 110.195 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -62.94 -18.85 63.65 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.887 -0.508 . . . . 0.0 110.744 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -81.91 -0.64 44.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.61 1.564 . . . . 0.0 111.693 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.8 mt 62.1 47.12 5.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.277 2.231 . . . . 0.0 111.838 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.22 150.89 49.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.667 1.187 . . . . 0.0 108.971 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.93 145.23 44.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 109.588 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -152.75 163.34 39.89 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.208 2.203 . . . . 0.0 106.064 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 p -143.51 168.6 19.46 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.302 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.6 tp -55.38 -35.92 65.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.251 -0.281 . . . . 0.0 110.541 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.06 -23.71 48.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.83 -32.19 67.29 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.435 1.016 . . . . 0.0 110.795 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 29.7 mtt -80.26 -37.33 33.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.776 1.63 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -53.27 145.31 14.19 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.841 0.857 . . . . 0.0 110.288 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.86 -18.49 14.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.369 1.461 . . . . 0.0 112.588 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.65 153.28 35.34 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 108.06 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -58.37 145.16 10.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 m -138.44 149.15 45.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.578 0.751 . . . . 0.0 109.4 -169.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.42 136.68 54.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.28 112.71 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 m -93.8 155.12 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.74 139.21 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.62 158.52 75.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -48.93 5.9 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.326 1.351 . . . . 0.0 110.799 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 m -165.06 156.87 15.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.595 1.158 . . . . 0.0 109.224 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 tp -66.61 -21.42 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.07 -24.75 65.99 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.968 0.907 . . . . 0.0 111.895 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -72.12 151.29 43.13 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.039 -0.413 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.17 -24.9 75.81 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.731 -0.606 . . . . 0.0 113.374 -172.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 m -60.9 -21.63 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.515 1.157 . . . . 0.0 112.662 -174.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.0 p -60.75 -31.47 70.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.988 0.813 . . . . 0.0 111.929 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -115.29 -33.89 5.16 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.086 0.954 . . . . 0.0 110.773 -172.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -29.87 70.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.593 0.757 . . . . 0.0 112.083 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -148.37 -36.46 0.19 Allowed 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 113.296 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -64.62 -43.5 93.53 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.054 1.752 . . . . 0.0 111.031 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -54.9 -50.51 68.59 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.084 0.954 . . . . 0.0 111.083 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -61.21 -47.8 84.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 110.956 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.1 -46.43 90.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.106 0.412 . . . . 0.0 110.566 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -61.95 -39.13 91.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.758 0.823 . . . . 0.0 110.632 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.53 -49.27 77.37 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.617 0.767 . . . . 0.0 109.806 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -65.57 -39.9 92.18 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.963 0.505 . . . . 0.0 110.804 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.85 82.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 110.954 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.4 66.18 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -79.37 -25.39 42.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.206 0.912 . . . . 0.0 112.104 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.6 mt -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.192 0.906 . . . . 0.0 109.908 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.18 -170.02 43.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.53 37.99 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.671 0.788 . . . . 0.0 112.34 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 77' ' ' VAL . 3.3 t -58.07 140.38 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 120.899 -1.125 . . . . 0.0 108.069 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.34 138.48 53.77 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 169.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.74 127.58 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.5 156.58 48.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.301 1.04 . . . . 0.0 109.362 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -140.18 119.86 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -100.75 141.71 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -145.19 167.42 22.84 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.177 0.991 . . . . 0.0 110.176 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 CA-C-O 121.268 0.556 . . . . 0.0 109.965 169.278 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -40.33 71.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.14 0.976 . . . . 0.0 111.953 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.09 -14.8 54.81 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.73 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.38 13.96 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.362 1.465 . . . . 0.0 112.289 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -79.54 76.29 6.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.231 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.08 -18.23 0.54 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.26 1.409 . . . . 0.0 111.406 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.15 89.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.604 1.562 . . . . 0.0 107.438 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.61 -24.44 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.138 1.775 . . . . 0.0 113.607 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.65 -32.16 65.1 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.353 1.061 . . . . 0.0 112.892 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.55 137.89 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -121.67 124.82 45.19 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -80.52 141.88 34.72 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -129.52 148.63 51.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.727 1.611 . . . . 0.0 107.022 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -128.69 54.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.206 1.402 . . . . 0.0 108.494 -168.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -49.1 -34.5 14.01 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.788 1.235 . . . . 0.0 113.723 -169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -49.64 -25.06 2.54 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -62.69 -21.9 66.09 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.55 -21.64 2.8 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.461 1.504 . . . . 0.0 112.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 tpt 61.94 5.0 1.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.12 3.368 . . . . 0.0 114.725 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.3 m -66.59 -44.56 81.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.46 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.48 -40.31 96.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 121.298 1.863 . . . . 0.0 109.887 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.85 -46.44 92.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 123.918 0.77 . . . . 0.0 111.469 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.64 -41.78 65.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.672 0.736 . . . . 0.0 110.477 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.02 94.16 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.216 1.006 . . . . 0.0 111.986 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -95.15 4.67 53.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.83 0.852 . . . . 0.0 110.4 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.78 -10.27 14.06 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.306 176.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.75 -13.4 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.816 1.647 . . . . 0.0 112.79 -169.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.79 108.41 1.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.3 118.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.68 -45.31 85.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.952 1.701 . . . . 0.0 111.144 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -89.87 -1.56 58.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.292 0.637 . . . . 0.0 112.427 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -136.56 -6.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.772 0.829 . . . . 0.0 112.492 -171.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 40.96 42.6 1.55 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.892 2.077 . . . . 0.0 113.337 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.6 tp -132.67 153.84 50.72 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -169.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.73 123.34 22.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.36 137.61 56.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.115 0.566 . . . . 0.0 110.511 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.76 119.24 7.78 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.1 p -156.85 166.16 34.15 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.939 1.296 . . . . 0.0 107.555 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.29 146.31 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -144.65 154.93 43.31 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.786 1.234 . . . . 0.0 108.772 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.93 137.81 48.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -131.91 137.78 48.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.831 1.253 . . . . 0.0 108.201 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.94 164.71 14.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.631 1.572 . . . . 0.0 110.748 170.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -50.05 -35.58 25.62 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.691 1.596 . . . . 0.0 113.043 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 7.71 33.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.848 0.859 . . . . 0.0 113.002 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.95 -6.33 76.46 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.592 1.092 . . . . 0.0 113.278 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.31 128.83 37.86 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.029 1.414 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -61.74 123.44 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.137 0.975 . . . . 0.0 109.415 172.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.23 -12.55 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.354 1.462 . . . . 0.0 110.133 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -148.12 148.59 30.77 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.32 17.25 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.639 1.576 . . . . 0.0 107.709 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -145.3 148.0 32.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.789 0.836 . . . . 0.0 109.5 170.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -135.7 107.1 6.85 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.749 2.42 . . . . 0.0 105.496 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.28 136.26 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -169.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -62.13 -21.98 65.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.605 1.162 . . . . 0.0 112.993 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -136.97 94.87 3.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.03 -13.95 60.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.577 1.151 . . . . 0.0 113.818 -170.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -0.49 18.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.201 0.909 . . . . 0.0 112.143 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.65 170.44 13.8 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 108.588 175.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -115.01 158.49 40.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.698 0.799 . . . . 0.0 112.325 -169.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.27 -179.72 4.88 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.218 2.612 . . . . 0.0 110.866 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -73.51 140.36 46.32 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -100.42 -8.18 23.52 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -79.79 -36.1 37.55 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.032 -1.042 . . . . 0.0 108.378 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -51.42 -56.27 22.05 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.71 -1.138 . . . . 0.0 111.816 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -66.95 -32.5 35.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 CA-C-N 121.535 1.584 . . . . 0.0 112.846 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.6 mm -58.94 -44.24 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.43 1.468 . . . . 0.0 109.865 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.64 -37.62 87.07 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.454 1.025 . . . . 0.0 110.602 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.24 89.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.444 -0.16 . . . . 0.0 111.298 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.59 66.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.333 0.653 . . . . 0.0 110.869 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.75 -40.97 66.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.164 0.893 . . . . 0.0 110.58 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.16 63.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.629 0.772 . . . . 0.0 112.33 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 48.4 mt -97.55 -36.79 10.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.261 0.624 . . . . 0.0 112.279 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.84 -48.29 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.452 1.101 . . . . 0.0 110.417 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--O 1.249 1.034 0 C-N-CA 124.583 1.153 . . . . 0.0 109.745 178.297 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.7 pt -135.78 -175.75 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.267 1.027 . . . . 0.0 108.938 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.91 154.72 50.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.17 126.13 17.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 43.07 45.45 4.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.109 1.364 . . . . 0.0 112.344 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.62 19.61 79.82 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.16 0.886 . . . . 0.0 114.925 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.17 120.29 4.03 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.53 140.48 89.67 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.918 2.412 . . . . 0.0 111.366 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.03 165.24 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.998 1.319 . . . . 0.0 108.684 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -126.65 154.92 43.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.107 0.963 . . . . 0.0 110.781 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.9 147.48 23.33 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.1 1.36 . . . . 0.0 110.964 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -77.13 -55.19 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 123.931 0.892 . . . . 0.0 109.887 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.45 32.68 7.19 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.197 0.903 . . . . 0.0 112.102 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 55.09 -146.79 0.55 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.023 0.929 . . . . 0.0 110.157 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.99 123.87 29.74 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.589 1.155 . . . . 0.0 110.755 -172.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -70.41 160.09 5.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.11 165.66 25.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -174.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -56.54 131.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.46 -5.67 72.36 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.786 1.184 . . . . 0.0 113.563 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.81 -5.9 57.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.525 1.662 . . . . 0.0 113.738 -170.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 66.7 112.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.381 1.872 . . . . 0.0 112.38 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.17 135.61 93.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.28 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.53 -46.74 13.43 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.579 2.186 . . . . 0.0 113.733 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 t70 122.51 126.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 131.471 3.908 . . . . 0.0 105.827 -169.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -138.84 165.74 26.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.691 1.596 . . . . 0.0 109.247 -175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.7 m -131.51 141.47 49.76 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.03 167.7 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.653 1.981 . . . . 0.0 108.41 -172.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.95 143.43 31.11 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 p -80.63 -179.64 7.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.29 1.436 . . . . 0.0 111.571 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -63.49 -24.52 67.86 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.425 -0.797 . . . . 0.0 110.836 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m -82.98 2.84 32.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.218 1.407 . . . . 0.0 111.768 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.2 mt 51.23 42.7 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.966 2.107 . . . . 0.0 112.774 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.82 160.55 21.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.182 0.993 . . . . 0.0 109.121 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.21 143.68 45.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.827 0.822 . . . . 0.0 110.691 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 42.0 tttp -148.81 153.83 38.67 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.765 2.426 . . . . 0.0 105.894 176.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 p -137.5 167.69 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.689 0.677 . . . . 0.0 110.124 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.64 -39.57 65.1 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.75 -25.75 60.88 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.18 -30.5 43.48 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.777 0.717 . . . . 0.0 111.436 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.2 mtt -71.76 -37.61 70.48 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.447 1.099 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.93 146.61 13.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.763 0.825 . . . . 0.0 110.27 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.99 2.77 48.92 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.548 1.071 . . . . 0.0 114.051 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -150.45 157.24 42.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.894 1.278 . . . . 0.0 108.814 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.56 139.59 19.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -136.77 146.19 45.47 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.28 135.51 62.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.1 mt -132.33 101.28 4.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -174.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -80.85 146.28 30.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.21 135.62 54.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.0 pt -145.82 159.06 48.22 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 125.001 1.321 . . . . 0.0 109.104 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.81 -53.03 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 N-CA-C 107.978 -1.586 . . . . 0.0 107.978 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -157.83 -177.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.413 2.285 . . . . 0.0 106.199 170.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 pt -86.94 -42.89 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.839 0.856 . . . . 0.0 109.724 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.36 -18.72 63.82 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.445 1.098 . . . . 0.0 111.095 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -20.15 61.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.572 1.149 . . . . 0.0 112.73 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.85 -15.42 3.08 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.29 0.95 . . . . 0.0 114.229 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.16 -7.26 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.929 1.364 . . . . 0.0 113.684 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.7 m -61.6 -33.75 74.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.442 1.019 . . . . 0.0 110.821 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.07 -18.75 45.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.934 0.894 . . . . 0.0 111.463 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.01 -173.9 2.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.331 1.053 . . . . 0.0 110.45 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -15.84 58.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.892 1.277 . . . . 0.0 113.688 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.91 64.75 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.324 1.449 . . . . 0.0 112.275 -169.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.8 tpt85 -57.94 -30.5 66.01 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.112 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 -42.93 7.53 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.833 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -59.36 -47.4 85.56 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.382 1.446 . . . . 0.0 111.914 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -67.3 -33.73 75.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.123 0.42 . . . . 0.0 110.377 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -65.12 -49.25 70.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.991 0.516 . . . . 0.0 109.678 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -61.32 -41.54 97.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.852 1.261 . . . . 0.0 110.195 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.52 -52.63 59.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.046 0.938 . . . . 0.0 110.62 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.91 67.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -83.1 -18.53 39.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.822 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.89 -38.43 91.06 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.324 1.42 . . . . 0.0 110.982 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.7 -169.27 42.33 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.35 23.84 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.017 0.909 . . . . 0.0 113.212 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -57.03 144.84 8.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.643 1.177 . . . . 0.0 109.72 -173.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.95 139.35 56.39 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.66 126.14 57.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 59.9 m-85 -128.1 150.77 49.82 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.615 0.766 . . . . 0.0 109.157 -177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.0 m -132.51 95.4 3.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -84.09 136.03 23.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.8 m -135.62 165.39 25.67 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.794 1.237 . . . . 0.0 110.905 -169.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.188 0.995 . . . . 0.0 113.63 -173.376 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.2 m95 . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p -153.84 170.65 20.46 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.738 1.215 . . . . 0.0 108.728 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.55 -18.17 1.37 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.661 -1.077 . . . . 0.0 115.073 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 28.89 1.83 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.035 1.417 . . . . 0.0 111.787 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -136.94 146.84 45.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.97 -18.83 33.41 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.084 -0.842 . . . . 0.0 112.71 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.05 88.86 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 125.7 1.6 . . . . 0.0 107.839 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.58 -19.09 56.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.597 1.559 . . . . 0.0 114.049 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -60.43 -30.17 69.47 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.625 -0.672 . . . . 0.0 111.834 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 t -71.93 140.44 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -129.0 147.01 50.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 169.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 p -106.84 132.19 53.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.07 155.29 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -170.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.2 m -125.77 134.03 51.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -121.4 -34.24 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -56.68 -15.2 4.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.711 1.205 . . . . 0.0 113.399 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -56.3 -35.46 67.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.763 0.825 . . . . 0.0 112.003 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -140.78 -4.05 1.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.34 17.62 8.48 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.648 2.379 . . . . 0.0 114.493 173.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.5 m -60.51 -57.15 13.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.776 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.86 -40.9 97.64 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.541 0.61 . . . . 0.0 109.627 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.01 -43.68 99.15 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -74.58 -39.59 62.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.713 1.256 . . . . 0.0 110.461 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.06 -45.97 92.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.132 0.973 . . . . 0.0 111.932 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.27 -10.63 43.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.317 1.047 . . . . 0.0 110.538 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.42 -5.44 73.2 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.286 1.898 . . . . 0.0 113.874 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.55 -9.7 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.736 2.014 . . . . 0.0 112.954 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.88 112.97 2.26 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 168.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 124' ' ' LEU . 91.2 mt -76.02 133.18 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.53 -59.76 4.89 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.577 1.151 . . . . 0.0 110.585 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -74.66 -47.69 30.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.377 0.671 . . . . 0.0 111.579 -169.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.528 ' H ' HG22 ' A' ' 121' ' ' ILE . 14.4 tp -78.05 -15.24 59.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.325 0.65 . . . . 0.0 112.024 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 47.5 44.04 16.4 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.999 1.72 . . . . 0.0 111.993 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 tp -139.04 165.04 28.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.279 1.032 . . . . 0.0 108.245 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 127.18 32.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.36 150.43 48.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.054 0.454 . . . . 0.0 110.484 170.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 124.55 25.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.1 m -156.99 168.5 27.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.74 137.47 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -141.23 154.15 45.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.63 138.16 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.3 mp -130.64 135.95 48.36 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.032 0.933 . . . . 0.0 109.671 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.36 163.69 15.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.79 1.636 . . . . 0.0 109.313 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -52.21 -29.76 24.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.579 1.552 . . . . 0.0 113.265 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -71.56 -6.22 39.14 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.506 1.122 . . . . 0.0 113.09 177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.99 47.71 18.21 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -170.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.94 126.87 42.28 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -67.47 121.38 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.521 0.728 . . . . 0.0 109.439 -170.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.18 -7.68 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.05 1.34 . . . . 0.0 110.747 170.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -150.69 149.2 29.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.99 125.78 7.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.264 1.425 . . . . 0.0 108.177 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -140.84 149.78 42.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.453 0.569 . . . . 0.0 109.954 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.65 116.91 17.97 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.56 133.52 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -171.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -55.27 -28.33 52.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.398 1.079 . . . . 0.0 111.667 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.78 111.98 9.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.85 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.423 1.489 . . . . 0.0 113.152 -176.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 8.64 6.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.874 0.87 . . . . 0.0 112.438 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.39 -174.91 3.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.952 1.301 . . . . 0.0 110.258 172.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -103.87 147.36 34.15 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.21 -0.931 . . . . 0.0 113.426 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.04 178.8 6.07 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.693 2.929 . . . . 0.0 109.967 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.74 133.73 49.79 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -123.31 16.82 9.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 111.684 -170.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.43 -42.28 4.38 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -51.17 -46.35 88.95 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.341 -1.314 . . . . 0.0 112.851 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.87 -38.39 30.03 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 121.943 1.73 . . . . 0.0 111.644 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.7 mm -61.3 -42.37 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.34 -38.45 91.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.556 1.071 . . . . 0.0 111.088 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.09 99.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.56 0.344 . . . . 0.0 110.667 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.9 73.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.977 0.511 . . . . 0.0 110.823 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -55.09 -43.1 73.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.151 0.887 . . . . 0.0 110.285 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.255 0.622 . . . . 0.0 112.104 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.05 -41.9 18.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.871 0.469 . . . . 0.0 111.74 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.06 -52.54 32.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.975 0.91 . . . . 0.0 110.649 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 123.879 0.872 . . . . 0.0 110.004 177.361 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 CA--C 1.543 0.683 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 pt -129.86 172.75 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 123.225 1.488 . . . . 0.0 112.515 -175.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -118.56 156.67 28.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.597 2.759 . . . . 0.0 104.963 170.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.3 122.23 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? 48.1 36.69 6.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.927 1.291 . . . . 0.0 111.51 -175.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.93 85.47 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.39 -0.819 . . . . 0.0 114.694 176.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.47 118.1 5.07 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.41 143.42 77.2 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.808 2.339 . . . . 0.0 111.355 173.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.86 -175.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.958 1.303 . . . . 0.0 108.655 175.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -132.58 151.45 51.93 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.641 1.176 . . . . 0.0 108.154 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.12 155.59 17.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.71 1.604 . . . . 0.0 109.046 176.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -74.83 -25.36 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.65 17.29 1.11 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.247 -0.752 . . . . 0.0 112.91 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 47.65 -168.61 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.682 1.993 . . . . 0.0 113.838 178.062 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 145' ' ' TYR . 6.8 pm0 -80.76 128.76 34.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.705 -1.247 . . . . 0.0 113.414 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.3 170.31 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 165.01 34.01 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 120.998 -1.064 . . . . 0.0 109.514 -172.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.46 132.36 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 -2.21 87.56 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.836 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.05 -13.29 59.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.311 1.556 . . . . 0.0 112.4 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.51 176.64 0.06 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.208 1.803 . . . . 0.0 112.192 -169.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.99 137.75 30.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.163 1.385 . . . . 0.0 110.451 -171.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.17 -20.13 45.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.727 3.618 . . . . 0.0 117.122 176.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.33 72.37 0.13 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.63 1.972 . . . . 0.0 109.287 -169.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -72.82 175.89 6.11 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.65 1.58 . . . . 0.0 110.709 177.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.1 m -131.97 144.56 50.9 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.86 176.42 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 108.169 -177.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.9 mt -113.52 140.31 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.273 1.029 . . . . 0.0 109.474 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -72.59 176.23 5.65 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.383 1.473 . . . . 0.0 111.174 175.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -59.84 -22.58 62.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.154 0.582 . . . . 0.0 111.15 169.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.7 m -92.1 4.1 53.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.551 1.54 . . . . 0.0 112.212 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.6 mp 53.05 47.16 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.305 1.842 . . . . 0.0 112.164 -175.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -112.44 148.41 34.43 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.16 146.67 34.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.802 0.811 . . . . 0.0 111.1 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -150.41 114.98 5.21 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.79 1.636 . . . . 0.0 107.14 -172.075 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -79.93 161.89 25.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.209 0.603 . . . . 0.0 109.999 176.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.37 -36.5 73.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.68 44.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.924 0.89 . . . . 0.0 113.353 177.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -74.08 -32.64 63.35 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.444 1.02 . . . . 0.0 110.965 174.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.6 mtt -75.81 -34.61 60.16 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 111.371 177.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -54.67 158.29 2.65 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.607 1.163 . . . . 0.0 111.368 -177.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.85 67.01 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.335 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -146.33 159.67 43.05 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.038 2.135 . . . . 0.0 106.964 169.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 77' ' ' VAL . 74.9 t -65.74 113.96 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.3 m -92.44 138.44 31.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.4 mt -132.84 133.05 59.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.19 139.93 41.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -172.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -123.04 152.51 40.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.61 124.92 35.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 pt -139.2 147.27 52.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.93 -47.87 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 120.723 0.948 . . . . 0.0 110.794 174.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.04 173.25 16.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -169.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.38 -42.96 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.616 1.566 . . . . 0.0 107.661 174.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.41 -28.16 68.41 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.625 1.17 . . . . 0.0 112.36 -175.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.37 -4.95 9.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 176.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.41 -29.75 2.84 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 121.082 -1.011 . . . . 0.0 114.174 169.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.79 -25.38 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.972 1.386 . . . . 0.0 112.599 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.47 -39.86 61.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.091 1.356 . . . . 0.0 111.769 169.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -107.13 -36.8 6.47 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.814 0.846 . . . . 0.0 111.172 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.54 68.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.811 0.844 . . . . 0.0 112.564 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -145.44 -41.27 0.23 Allowed 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.038 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -67.22 -44.41 79.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.654 1.116 . . . . 0.0 110.649 -169.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -59.35 -30.44 68.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 113.449 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -85.25 -43.62 13.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.948 0.794 . . . . 0.0 110.193 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.47 -50.67 72.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.428 0.691 . . . . 0.0 110.421 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -60.66 -38.38 84.7 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.991 0.516 . . . . 0.0 110.888 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.64 -33.18 75.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.166 0.986 . . . . 0.0 112.135 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.75 -46.29 15.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.169 0.895 . . . . 0.0 109.945 172.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -45.1 87.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.383 1.073 . . . . 0.0 111.017 -174.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.03 -15.06 55.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.082 0.953 . . . . 0.0 112.797 -173.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -117.14 3.99 12.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.14 -35.71 79.6 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.969 1.259 . . . . 0.0 110.719 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.03 -161.44 30.81 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.694 1.14 . . . . 0.0 110.278 -176.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -74.04 27.97 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.892 1.277 . . . . 0.0 112.42 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 46' ' ' VAL . 15.9 m -65.06 144.83 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 108.362 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -84.04 155.31 22.78 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.44 124.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -172.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -139.35 157.73 45.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.057 0.543 . . . . 0.0 110.443 -176.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.6 m -136.29 103.98 5.48 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.97 150.16 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.624 1.17 . . . . 0.0 108.295 -174.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.3 m -127.27 158.41 37.25 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.195 1.798 . . . . 0.0 111.223 -169.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 124.34 1.056 . . . . 0.0 111.933 -178.442 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.6 m95 . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 m 61.16 18.22 8.86 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.923 1.689 . . . . 0.0 114.808 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.12 -43.52 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.1 8.55 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.22 0.24 12.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.709 1.204 . . . . 0.0 112.144 176.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.68 -18.88 0.6 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.716 1.15 . . . . 0.0 112.38 177.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.93 95.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.13 -16.75 54.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.22 1.408 . . . . 0.0 114.049 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -60.23 -30.39 69.37 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.689 -0.632 . . . . 0.0 111.314 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.1 t -75.34 147.45 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.18 142.98 40.04 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.1 p -87.54 132.41 34.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.02 168.86 11.06 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.546 1.938 . . . . 0.0 107.547 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.3 m -136.63 147.66 47.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.126 0.97 . . . . 0.0 109.091 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -125.86 -19.09 4.95 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.523 0.729 . . . . 0.0 111.466 173.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -55.45 -24.62 31.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -173.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -73.1 -16.17 61.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.373 -0.822 . . . . 0.0 112.815 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -139.9 -21.99 0.87 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.546 1.066 . . . . 0.0 113.636 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.9 mmm 57.55 7.44 0.52 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.327 2.651 . . . . 0.0 115.816 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.2 m -62.39 -48.01 81.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.859 1.209 . . . . 0.0 111.846 -177.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -64.27 -40.33 95.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.445 1.475 . . . . 0.0 110.027 177.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -49.81 -57.28 9.93 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 125.749 1.642 . . . . 0.0 112.274 176.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.86 -42.58 81.1 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.134 0.467 . . . . 0.0 110.049 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.81 92.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.848 0.859 . . . . 0.0 112.2 -172.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.84 8.2 37.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.224 1.01 . . . . 0.0 110.896 -176.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.37 34.43 74.75 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.146 0.884 . . . . 0.0 111.704 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.454 HG23 ' HA2' ' A' ' 114' ' ' GLY . 9.3 m -108.87 -4.3 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.742 1.617 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.63 113.52 8.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 168.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 84.3 mt -70.94 111.27 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 175.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -54.37 -40.91 68.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.442 1.497 . . . . 0.0 111.43 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.95 -4.02 55.18 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.69 -16.97 1.99 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.938 0.79 . . . . 0.0 112.763 -170.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.4 ttm105 47.46 42.41 14.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.82 1.648 . . . . 0.0 111.989 -173.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -122.09 163.03 20.17 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.04 131.52 36.3 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 138.8 56.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.162 1.385 . . . . 0.0 111.541 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -58.57 113.64 2.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.377 1.071 . . . . 0.0 108.78 171.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.3 p -156.23 173.63 16.56 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.927 0.394 . . . . 0.0 110.667 -176.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.93 149.12 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.439 1.496 . . . . 0.0 107.85 174.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -147.79 155.45 41.69 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.773 1.229 . . . . 0.0 110.119 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.59 142.87 33.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 mp -138.93 142.29 38.47 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -173.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.65 165.06 5.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.28 1.432 . . . . 0.0 110.038 169.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -51.13 -32.53 23.1 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.982 1.313 . . . . 0.0 112.848 176.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -79.5 0.41 29.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.835 1.254 . . . . 0.0 112.834 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.05 88.62 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.004 -1.06 . . . . 0.0 112.884 -175.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -67.75 121.88 16.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.068 1.434 . . . . 0.0 107.236 172.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.07 132.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.295 0.638 . . . . 0.0 109.446 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.53 -18.75 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.664 1.985 . . . . 0.0 109.662 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -147.27 149.45 32.89 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.04 138.84 17.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.105 1.762 . . . . 0.0 107.475 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -146.91 146.78 30.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.31 0.644 . . . . 0.0 109.796 170.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 17' ' ' GLU . 12.8 m-85 -139.13 93.42 2.69 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.6 2.76 . . . . 0.0 104.837 -173.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.7 m -62.52 147.37 11.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 O-C-N 121.769 -0.582 . . . . 0.0 110.415 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -66.45 -11.09 50.19 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.097 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -143.35 125.64 15.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.36 -24.13 58.91 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -176.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 38.3 p -89.78 -4.17 57.78 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.001 0.819 . . . . 0.0 112.298 176.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -84.62 176.49 8.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.248 1.419 . . . . 0.0 109.268 173.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -148.05 146.54 23.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.46 176.83 7.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.414 2.743 . . . . 0.0 110.451 177.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -76.8 119.53 20.7 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -67.82 -14.36 62.89 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -70.0 -30.02 67.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.015 1.279 . . . . 0.0 109.435 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -66.34 -49.78 52.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.357 -175.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -65.58 -35.79 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 121.366 1.524 . . . . 0.0 111.541 170.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.14 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 119.755 1.161 . . . . 0.0 110.154 179.079 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.84 -30.15 67.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.59 1.086 . . . . 0.0 110.741 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.09 97.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.004 0.366 . . . . 0.0 110.544 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.33 -45.05 85.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.944 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -56.7 -41.32 77.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.202 0.91 . . . . 0.0 110.498 176.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.22 71.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.65 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.85 -47.59 14.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.566 0.621 . . . . 0.0 111.89 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.05 -39.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 110.718 -172.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.2 mttm . . . . . 0 C--O 1.249 1.049 0 C-N-CA 126.039 1.735 . . . . 0.0 109.592 -175.829 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.512 ' HA ' ' OE1' ' A' ' 17' ' ' GLU 0.335 0.6 OUTLIER . . . . . 0 CA--C 1.496 -1.121 0 CA-C-O 122.72 1.248 . . . . 0.0 113.08 . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.43 74.34 1.11 Allowed 'General case' 0 N--CA 1.425 -1.678 1 N-CA-C 99.147 -4.39 . . . . 0.0 99.147 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.81 153.14 24.81 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 158.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.5 pt -135.56 175.66 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 m -119.32 152.53 36.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -136.32 123.83 22.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 173.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.8 mttt 50.36 36.15 12.4 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.53 85.97 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 119.417 -1.373 . . . . 0.0 113.406 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.68 124.32 6.34 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.076 1.938 . . . . 0.0 108.364 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.05 144.5 99.47 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 CA-C-N 120.217 2.009 . . . . 0.0 109.994 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -145.47 145.27 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.175 0.99 . . . . 0.0 109.765 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -90.63 159.82 16.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.543 1.137 . . . . 0.0 109.93 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -111.81 153.27 26.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.338 1.455 . . . . 0.0 109.189 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -81.9 -56.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 121.96 -0.463 . . . . 0.0 110.427 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.42 12.72 33.33 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.034 -167.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 28.76 174.58 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 133.456 4.703 . . . . 0.0 120.657 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 17.1 tt0 12.82 62.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 129.786 3.234 . . . . 0.0 117.607 144.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 157.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 149.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -150.37 171.78 16.45 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 120.923 -1.111 . . . . 0.0 108.485 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.32 131.74 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.839 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.9 -10.01 72.11 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 116.922 -2.043 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.96 -13.0 61.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.537 1.668 . . . . 0.0 113.42 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 65.16 160.86 0.12 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.33 1.852 . . . . 0.0 110.544 -172.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.92 132.24 22.42 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.21 1.804 . . . . 0.0 109.013 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.5 -28.65 86.21 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.1 2.533 . . . . 0.0 118.459 -169.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 t70 75.12 99.8 0.07 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.169 -157.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' A' ' 112' ' ' SER . 2.2 p90 -125.87 -174.47 3.1 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 126.077 1.751 . . . . 0.0 106.702 169.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 m -115.94 153.89 30.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.746 2.018 . . . . 0.0 106.95 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.03 168.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.67 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 1.2 tp -112.07 147.02 36.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 172.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -79.17 172.53 13.67 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.37 -29.5 66.05 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.973 1.309 . . . . 0.0 110.933 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -80.52 -0.04 35.8 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.403 1.481 . . . . 0.0 112.968 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.1 mt 62.37 36.51 14.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.176 1.79 . . . . 0.0 112.526 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.54 144.28 28.82 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 171.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.92 132.4 45.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.113 0.959 . . . . 0.0 108.956 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 49.6 tttp -136.08 148.39 48.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.38 167.4 12.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.29 -37.29 67.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.626 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.43 63.64 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.894 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.12 -26.6 59.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.199 0.909 . . . . 0.0 111.625 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 mtt -78.21 -31.18 49.28 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.413 -0.804 . . . . 0.0 111.419 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -62.38 152.74 33.23 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.226 0.536 . . . . 0.0 110.0 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.16 -7.66 44.2 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -154.51 160.99 41.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.541 1.171 . . . . 0.0 109.15 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.16 137.59 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.5 m -132.28 147.23 52.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.351 1.46 . . . . 0.0 107.956 -173.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.65 137.44 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -137.46 117.62 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.3 m -93.09 150.74 20.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 163.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.05 133.95 55.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.23 151.73 62.42 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.31 -43.12 4.73 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.62 1.547 . . . . 0.0 110.747 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.2 m -150.75 171.5 17.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.583 2.353 . . . . 0.0 106.839 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.513 ' H ' ' HA ' ' A' ' 89' ' ' ALA . 1.1 pt -99.99 -20.45 5.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 123.147 0.579 . . . . 0.0 111.669 166.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.8 -22.4 66.89 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.215 -1.553 . . . . 0.0 112.122 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -65.57 1.82 1.12 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.107 1.763 . . . . 0.0 115.024 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.59 -18.64 3.58 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 121.363 1.892 . . . . 0.0 114.113 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.495 ' HB ' HH21 ' A' ' 129' ' ' ARG . 1.6 m -57.56 -23.09 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.59 1.695 . . . . 0.0 113.109 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . 0.265 61.2 m -36.82 -61.57 0.53 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.736 1.214 . . . . 0.0 110.259 165.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -75.35 -50.05 17.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 126.527 2.392 . . . . 0.0 105.866 -156.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.24 83.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.801 -166.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.53 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.1 tm0? -145.33 -47.37 0.22 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.675 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -63.26 -43.26 98.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.831 1.65 . . . . 0.0 111.65 -163.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -48.4 -56.26 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.702 2.001 . . . . 0.0 109.205 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -69.52 -45.64 68.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.813 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CB ' HE21 ' A' ' 63' ' ' GLN . 38.5 t80 -58.45 -45.64 88.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.005 0.522 . . . . 0.0 110.979 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.21 -39.87 93.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.117 0.967 . . . . 0.0 109.888 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.2 -46.29 84.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -63.22 -47.21 83.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.961 0.504 . . . . 0.0 110.538 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.24 -48.41 68.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.47 1.108 . . . . 0.0 110.508 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.52 -16.87 27.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.66 -15.59 17.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.874 1.27 . . . . 0.0 112.846 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.43 -33.09 72.03 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.332 0.514 . . . . 0.0 109.984 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.37 35.47 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.74 21.01 0.42 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.862 -0.787 . . . . 0.0 112.96 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 m -52.2 145.34 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.123 1.369 . . . . 0.0 110.589 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -70.35 143.6 51.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 134.29 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 52.8 m-85 -138.96 154.24 48.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.56 0.744 . . . . 0.0 109.523 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -129.74 115.64 17.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.85 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.1 m -135.46 166.88 22.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.97 170.69 7.83 Favored 'General case' 0 CA--C 1.555 1.17 0 O-C-N 122.105 -0.372 . . . . 0.0 110.216 164.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -66.65 -35.82 81.08 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 126.428 1.891 . . . . 0.0 108.246 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 tp -29.96 122.98 0.3 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 130.138 3.375 . . . . 0.0 110.712 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.83 -30.69 30.71 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.322 2.681 . . . . 0.0 114.999 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -67.86 -4.3 12.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.024 1.329 . . . . 0.0 113.349 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HA ' ' H ' ' A' ' 55' ' ' ILE . . . -119.02 -14.79 9.33 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -150.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -128.43 -8.96 5.19 Favored 'General case' 0 CA--C 1.466 -2.288 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.511 ' O ' ' CH2' ' A' ' 93' ' ' TRP . . . -61.59 -30.3 70.58 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 115.824 -2.036 . . . . 0.0 107.022 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -155.79 8.81 0.25 Allowed 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 117.83 2.529 . . . . 0.0 117.83 -149.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.516 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 p90 57.81 37.01 26.97 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 115.205 -2.598 . . . . 0.0 108.74 123.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -35.18 44.82 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.34 -28.21 70.24 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.197 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 93' ' ' TRP . . . -111.54 24.66 12.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.785 2.834 . . . . 0.0 111.96 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -115.08 106.68 14.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.65 -16.52 51.6 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.671 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.21 86.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.55 -22.68 13.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.7 -27.4 68.31 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.668 -1.27 . . . . 0.0 113.255 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.79 145.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -129.19 142.24 50.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.11 139.72 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.739 1.216 . . . . 0.0 109.021 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.5 mp -124.56 158.74 32.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.405 1.482 . . . . 0.0 108.999 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.81 73.22 1.51 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 127.05 2.14 . . . . 0.0 107.385 -169.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.71 -32.77 71.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.526 -1.359 . . . . 0.0 111.53 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -54.57 -17.31 3.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.195 1.798 . . . . 0.0 113.583 -167.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.67 ' HD3' ' CD2' ' A' ' 30' ' ' LEU . 5.3 ttt180 -65.27 -26.99 68.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -134.38 -17.15 2.06 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 124.914 1.384 . . . . 0.0 107.964 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' ' HA3' ' A' ' 114' ' ' GLY . 6.0 mmm 59.66 6.88 0.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.477 2.311 . . . . 0.0 111.513 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 27' ' ' PHE . 20.8 m -59.07 -49.18 78.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.742 1.61 . . . . 0.0 110.012 -170.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -62.57 -42.07 99.32 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.304 1.411 . . . . 0.0 109.916 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -51.21 -47.02 50.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 123.864 0.745 . . . . 0.0 113.237 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -73.85 -46.91 42.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.512 0.725 . . . . 0.0 109.247 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.7 78.49 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -104.09 7.13 36.29 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.844 1.258 . . . . 0.0 109.467 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.02 25.33 56.49 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 118.149 -1.361 . . . . 0.0 113.101 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.412 HG23 ' HA2' ' A' ' 114' ' ' GLY . 17.1 m -90.83 -9.1 10.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.688 1.744 . . . . 0.0 111.488 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -63.32 115.97 5.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.516 ' HA ' HD12 ' A' ' 13' ' ' LEU . 65.7 mt -75.14 120.92 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -61.17 -49.77 75.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.844 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.24 -31.2 43.51 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.432 0.457 . . . . 0.0 112.014 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' H ' HG22 ' A' ' 121' ' ' ILE . 21.8 tp -109.63 -18.21 13.53 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.116 0.966 . . . . 0.0 111.576 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 53.63 42.35 31.89 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.744 1.618 . . . . 0.0 114.507 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt -123.54 162.96 21.9 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.38 135.85 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.42 154.49 41.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.779 1.275 . . . . 0.0 110.091 167.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.495 HH21 ' HB ' ' A' ' 59' ' ' VAL . 17.1 tpt85 -77.38 112.0 13.65 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.683 166.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.06 173.38 14.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.98 140.07 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -142.27 155.88 45.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.056 1.342 . . . . 0.0 108.477 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.38 139.77 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -130.19 133.95 46.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -171.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.22 163.43 15.24 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 125.314 1.445 . . . . 0.0 110.877 164.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -48.61 -35.19 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.254 1.822 . . . . 0.0 113.998 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -2.66 39.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.659 1.572 . . . . 0.0 111.97 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.96 3.11 70.73 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.174 -1.579 . . . . 0.0 112.5 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -71.48 122.26 20.1 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.982 1.891 . . . . 0.0 109.36 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.41 126.49 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.38 -11.22 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 129.448 3.099 . . . . 0.0 107.767 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -152.61 152.48 31.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.227 1.411 . . . . 0.0 107.454 163.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.18 139.93 18.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -150.2 148.8 29.35 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.26 117.51 24.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.859 1.663 . . . . 0.0 106.906 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.71 129.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -57.56 -19.15 23.5 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.904 0.881 . . . . 0.0 113.165 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -138.54 124.23 19.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.12 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -84.12 6.4 22.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.419 1.487 . . . . 0.0 111.11 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.46 174.2 6.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.732 2.013 . . . . 0.0 107.235 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -128.53 152.87 79.13 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 120.716 -1.24 . . . . 0.0 110.861 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -80.96 170.35 15.38 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.591 2.194 . . . . 0.0 110.082 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -69.46 120.82 15.84 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 161.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -93.68 -8.09 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.698 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.12 -36.69 83.81 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.297 1.408 . . . . 0.0 108.847 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -63.12 -48.75 83.27 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 125.341 1.456 . . . . 0.0 112.254 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.71 -34.86 49.15 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 CA-C-N 119.59 0.889 . . . . 0.0 111.974 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 20.6 mm -60.02 -45.47 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 120.658 1.572 . . . . 0.0 110.507 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.86 -42.34 97.57 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 120.746 1.612 . . . . 0.0 109.263 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.04 95.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.882 0.473 . . . . 0.0 110.78 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.84 80.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.083 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -53.74 -49.65 67.69 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 117.077 -1.44 . . . . 0.0 108.368 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -52.82 -29.68 29.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.408 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.45 -49.18 7.38 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.1 t -60.6 -41.39 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.533 0.683 . . . . 0.0 111.827 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.439 -1.018 0 C-N-CA 130.64 3.576 . . . . 0.0 117.265 -161.116 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.77 0.319 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.03 50.43 1.73 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.596 1.559 . . . . 0.0 109.621 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.39 170.23 5.06 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.474 169.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.94 -175.76 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.379 1.072 . . . . 0.0 108.834 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -118.5 152.15 36.5 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -136.04 109.42 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 42.89 41.83 2.77 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 111.825 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.23 -9.5 61.21 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.134 -0.814 . . . . 0.0 115.04 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.1 125.53 8.56 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.189 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.43 138.62 39.34 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 CA-C-N 120.859 2.33 . . . . 0.0 110.208 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.16 135.21 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.154 0.982 . . . . 0.0 110.453 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -75.91 155.17 35.42 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.834 1.653 . . . . 0.0 110.388 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.64 144.63 40.6 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.405 1.482 . . . . 0.0 107.877 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.24 -65.19 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 118.502 0.592 . . . . 0.0 111.299 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.09 35.17 4.85 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.627 1.108 . . . . 0.0 111.206 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -52.12 166.44 0.16 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.247 2.219 . . . . 0.0 116.075 -169.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 69.07 34.19 3.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.614 1.966 . . . . 0.0 113.379 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.54 144.78 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -150.12 162.93 39.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.802 0.841 . . . . 0.0 109.156 -169.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 p -52.89 132.82 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 109.541 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.19 -5.22 83.03 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.85 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.37 -11.28 59.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.457 1.628 . . . . 0.0 112.64 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 57.44 178.36 0.05 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.649 1.58 . . . . 0.0 111.952 -169.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.38 136.09 20.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.931 1.693 . . . . 0.0 109.016 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 95.5 Cg_endo -74.26 157.49 45.8 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.483 2.122 . . . . 0.0 109.77 172.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 27.6 t70 -77.47 67.91 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.02 1.728 . . . . 0.0 110.117 176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -59.27 162.3 4.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.442 170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.5 m -124.65 144.45 50.19 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.38 168.05 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.343 2.257 . . . . 0.0 107.528 -171.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.97 143.45 45.7 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.48 178.45 8.11 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.523 0.729 . . . . 0.0 109.949 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.98 -23.33 67.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.146 -0.971 . . . . 0.0 110.734 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 m -86.41 3.34 44.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.4 mt 55.62 33.1 20.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.82 2.048 . . . . 0.0 112.937 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.55 147.11 24.77 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.84 143.8 39.47 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 109.439 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -154.02 155.08 34.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.315 2.246 . . . . 0.0 105.547 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.2 m -139.58 166.57 24.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.119 0.872 . . . . 0.0 108.927 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 43.6 tp -50.15 -40.67 47.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.242 0.474 . . . . 0.0 111.026 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.1 62.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -77.4 -28.47 52.76 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.768 0.713 . . . . 0.0 111.133 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.8 mtt -80.36 -55.14 5.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.877 1.271 . . . . 0.0 110.513 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -59.74 134.01 56.62 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.06 -20.61 3.2 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.955 2.216 . . . . 0.0 110.512 -169.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -150.33 158.34 44.05 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.92 2.088 . . . . 0.0 107.219 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -56.65 144.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.4 m -137.09 145.82 44.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.2 mt -133.31 137.19 53.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mt -136.75 133.88 48.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m -114.98 147.44 40.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -136.5 133.32 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.25 150.35 51.69 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.55 1.14 . . . . 0.0 109.278 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.92 -50.13 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.558 1.505 . . . . 0.0 109.709 169.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -152.87 168.67 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.311 1.444 . . . . 0.0 108.108 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.85 -23.93 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.53 -27.06 62.93 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 0.0 111.839 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 32.2 0.08 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.12 2.168 . . . . 0.0 113.736 -174.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.68 -3.23 69.88 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 120.432 -1.418 . . . . 0.0 114.269 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.83 -12.28 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.498 1.149 . . . . 0.0 112.406 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.69 -0.04 2.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.458 1.503 . . . . 0.0 113.724 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -48.97 148.66 2.18 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 0.0 110.348 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.03 -28.69 10.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.914 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -50.06 -57.33 7.85 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.265 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -65.71 -42.86 90.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.493 1.497 . . . . 0.0 110.085 -170.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -63.81 -53.96 42.65 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 122.725 0.41 . . . . 0.0 110.169 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.27 -37.6 80.88 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.688 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -55.93 -51.93 65.92 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 119.438 1.017 . . . . 0.0 110.102 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -66.22 -33.61 76.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 0.0 110.572 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -64.25 -50.55 67.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.735 -0.603 . . . . 0.0 110.477 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -60.8 -41.73 96.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.167 0.894 . . . . 0.0 110.406 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.86 73.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.918 0.887 . . . . 0.0 110.316 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.1 -13.57 62.51 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -100.86 -17.31 16.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.859 1.264 . . . . 0.0 112.419 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -60.07 -37.87 81.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.051 1.296 . . . . 0.0 110.56 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.89 -173.09 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -74.0 22.69 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.89 0.876 . . . . 0.0 112.902 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.15 154.34 2.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.379 1.472 . . . . 0.0 110.733 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.82 143.75 52.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.45 130.45 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.36 153.05 46.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.136 0.574 . . . . 0.0 110.886 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 m -120.57 154.6 35.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.1 mt -136.55 134.85 49.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.2 m -131.71 160.79 34.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 109.86 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.68 170.86 5.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.205 0.526 . . . . 0.0 110.933 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -13.85 60.11 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.48 0.712 . . . . 0.0 112.18 175.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.0 tp -49.56 127.54 18.18 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.859 1.264 . . . . 0.0 109.602 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.58 -37.39 74.0 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.966 2.444 . . . . 0.0 114.531 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -68.16 -16.65 64.08 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.519 0.728 . . . . 0.0 112.856 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.72 -4.32 42.68 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -169.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -138.21 139.2 39.17 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.77 -179.69 7.01 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.231 1.812 . . . . 0.0 108.008 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -83.42 24.83 0.79 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.244 1.018 . . . . 0.0 110.127 169.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -134.97 160.64 37.65 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.868 1.267 . . . . 0.0 109.727 -170.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 m 65.22 -48.13 0.36 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.571 2.748 . . . . 0.0 116.089 169.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.45 -48.67 8.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.99 38.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.742 1.617 . . . . 0.0 108.637 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -149.37 33.16 0.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.0 111.24 -170.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.74 -1.26 5.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.293 0.949 . . . . 0.0 113.103 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 mt -75.11 87.87 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -54.38 -30.22 51.28 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 114.013 -169.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.91 -25.17 67.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.585 0.754 . . . . 0.0 112.88 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -74.42 152.95 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.823 0.738 . . . . 0.0 109.87 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -137.44 151.2 48.25 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.1 m -121.95 96.57 5.11 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.82 160.98 31.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.945 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -127.8 37.43 4.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.025 2.13 . . . . 0.0 109.088 -169.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -47.65 -39.73 17.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.798 1.239 . . . . 0.0 114.098 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.96 -17.79 11.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.117 0.967 . . . . 0.0 113.487 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -62.82 -22.0 66.32 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.221 -0.925 . . . . 0.0 112.661 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.7 -26.15 1.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.718 1.607 . . . . 0.0 111.898 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 69.44 10.83 7.88 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.444 2.698 . . . . 0.0 113.741 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 m -61.69 -47.76 83.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.25 -38.15 88.16 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.509 1.504 . . . . 0.0 109.407 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.53 -59.02 4.39 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 126.386 1.946 . . . . 0.0 112.872 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.34 -42.32 65.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 25' ' ' PRO . . . -62.99 -39.68 95.46 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.0 0.92 . . . . 0.0 112.258 -169.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -107.11 5.13 27.61 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.716 1.206 . . . . 0.0 110.653 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.99 85.95 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.648 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.6 m -105.64 -1.79 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.531 1.132 . . . . 0.0 111.199 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.75 116.97 17.91 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 124' ' ' LEU . 66.5 mt -74.11 124.37 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.27 -46.82 78.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.307 0.643 . . . . 0.0 110.453 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -84.2 -51.92 6.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.365 0.266 . . . . 0.0 110.746 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -72.88 -22.93 60.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.276 0.63 . . . . 0.0 111.031 -178.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 49.97 57.59 6.38 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.432 1.093 . . . . 0.0 110.284 -171.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.99 173.45 11.7 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.045 1.338 . . . . 0.0 107.85 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.18 135.29 33.36 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.133 0.973 . . . . 0.0 108.381 172.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.79 165.32 18.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -83.21 113.22 20.51 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.8 m -155.19 166.49 33.4 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.661 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -147.05 142.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -144.06 158.12 43.91 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.293 1.037 . . . . 0.0 110.045 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.3 140.76 41.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -131.34 140.14 49.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.119 1.368 . . . . 0.0 108.122 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 166.0 17.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.924 1.289 . . . . 0.0 110.279 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -47.77 -38.43 15.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.436 1.495 . . . . 0.0 112.563 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.95 7.4 13.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.643 1.11 . . . . 0.0 113.663 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.52 -7.53 80.59 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 120.971 -1.08 . . . . 0.0 112.853 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -65.38 130.65 44.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 118.66 1.23 . . . . 0.0 108.937 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.9 OUTLIER -63.1 132.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.582 0.753 . . . . 0.0 109.84 171.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.15 -18.0 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.059 2.144 . . . . 0.0 109.811 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -148.57 150.19 32.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.63 133.31 11.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.764 1.626 . . . . 0.0 107.249 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -146.59 147.1 30.75 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.79 107.87 14.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.11 131.34 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -57.74 -20.58 35.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.845 1.258 . . . . 0.0 113.829 -169.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.13 130.81 25.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.22 12.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.725 1.61 . . . . 0.0 114.219 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -88.47 -1.9 58.3 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 118.542 0.61 . . . . 0.0 112.225 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -82.45 178.84 8.02 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.77 -1.206 . . . . 0.0 110.062 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -129.72 133.51 25.13 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.656 1.583 . . . . 0.0 109.077 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.6 173.59 11.26 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.508 2.805 . . . . 0.0 110.572 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -73.46 129.51 38.14 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 168.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -100.06 -4.66 29.4 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.96 -38.04 57.97 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -50.45 -58.24 10.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.52 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.35 -35.81 38.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 121.449 1.553 . . . . 0.0 112.133 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.97 -44.76 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.523 1.056 . . . . 0.0 110.302 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.65 -37.83 87.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 119.506 1.048 . . . . 0.0 110.247 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.9 96.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.359 0.264 . . . . 0.0 110.706 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.92 72.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.955 0.502 . . . . 0.0 111.414 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.81 -41.67 74.54 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.54 1.063 . . . . 0.0 110.214 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.15 67.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.27 0.628 . . . . 0.0 111.948 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.55 -46.43 14.47 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.365 0.666 . . . . 0.0 111.313 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.8 -44.73 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.801 0.84 . . . . 0.0 111.127 -169.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.357 1.063 . . . . 0.0 109.708 178.224 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.48 67.27 1.53 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.01 0.924 . . . . 0.0 109.805 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.86 154.77 14.38 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.368 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.3 pt -119.35 174.06 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.226 1.013 . . . . 0.0 110.546 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -112.61 155.77 23.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -135.38 115.43 13.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? 37.53 53.87 1.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.89 1.676 . . . . 0.0 113.298 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.22 2.43 87.3 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.68 -0.511 . . . . 0.0 114.349 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.6 110.25 3.02 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.782 1.658 . . . . 0.0 109.888 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.75 137.59 74.82 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.13 2.553 . . . . 0.0 111.623 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -142.62 131.59 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.791 0.836 . . . . 0.0 109.759 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -82.29 147.07 29.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.474 1.51 . . . . 0.0 111.462 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.35 148.72 23.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.548 1.139 . . . . 0.0 109.222 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 t -78.15 -52.97 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 121.962 -0.461 . . . . 0.0 109.791 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.77 24.61 27.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.526 1.06 . . . . 0.0 112.096 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 52.5 -171.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.713 2.005 . . . . 0.0 113.38 -173.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -78.26 132.98 37.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.15 165.18 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -126.35 155.07 42.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.46 137.18 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.48 85.97 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 118.678 -1.068 . . . . 0.0 113.54 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.79 1.68 16.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.632 1.716 . . . . 0.0 113.907 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 54.39 65.62 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.287 1.035 . . . . 0.0 111.383 169.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.02 134.03 5.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.02 1.728 . . . . 0.0 112.651 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.04 154.63 26.86 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.491 2.794 . . . . 0.0 113.349 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 18.1 t0 -73.95 70.03 1.47 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.806 2.043 . . . . 0.0 109.676 169.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -62.95 167.24 4.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.418 1.487 . . . . 0.0 110.753 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -122.79 152.16 40.94 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.81 171.15 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.446 1.898 . . . . 0.0 107.38 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.4 mt -111.56 152.42 27.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -83.48 179.28 7.69 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.414 0.685 . . . . 0.0 109.608 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -51.01 -35.7 35.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.046 0.938 . . . . 0.0 110.454 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.9 m -101.55 16.15 26.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.549 1.54 . . . . 0.0 110.7 -170.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.2 mt 62.55 23.7 14.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.256 2.222 . . . . 0.0 113.628 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.35 142.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 169.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.22 142.19 47.31 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -147.73 155.4 41.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.5 p -139.69 168.3 20.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 47.0 tp -54.36 -42.52 70.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 169.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.33 -23.93 66.08 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.01 -31.67 64.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.836 0.743 . . . . 0.0 110.876 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 mtt -75.21 -35.9 61.44 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -53.67 151.45 6.09 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.902 0.858 . . . . 0.0 111.944 -171.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.7 57.23 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.005 1.288 . . . . 0.0 113.272 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -155.03 149.8 26.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.759 1.624 . . . . 0.0 107.27 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.5 t -58.23 136.69 21.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -130.68 145.58 51.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -140.96 137.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -138.97 133.09 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.2 m -119.98 150.77 39.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.84 136.96 53.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.3 pt -136.51 139.37 29.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.855 1.662 . . . . 0.0 107.911 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.27 -7.51 18.05 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.083 2.522 . . . . 0.0 112.888 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.0 m -160.87 177.33 10.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.601 2.36 . . . . 0.0 106.268 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.89 -14.3 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.36 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.52 -23.66 50.13 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.376 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -57.67 155.81 9.41 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.581 1.552 . . . . 0.0 111.887 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.97 -17.28 70.28 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.1 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.15 -24.33 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.603 1.702 . . . . 0.0 113.316 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 15.3 p -61.57 -29.17 69.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.269 0.94 . . . . 0.0 112.544 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.84 -34.61 30.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.034 -0.416 . . . . 0.0 110.137 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.05 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.602 0.761 . . . . 0.0 110.765 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -152.56 131.09 12.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.8 m 138.76 -56.75 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 1 C-N-CA 132.819 4.448 . . . . 0.0 105.52 169.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -60.25 -63.84 1.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.854 0.752 . . . . 0.0 110.993 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -65.06 -40.11 94.22 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.904 -0.497 . . . . 0.0 111.122 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -58.07 -50.34 73.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.07 0.548 . . . . 0.0 111.583 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.04 -37.51 87.69 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.276 0.63 . . . . 0.0 109.674 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.426 ' HA ' HG21 ' A' ' 99' ' ' ILE . 4.6 tt0 -58.36 -51.14 71.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.477 0.711 . . . . 0.0 110.166 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.35 -38.21 74.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.806 0.442 . . . . 0.0 110.635 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.38 88.87 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.58 -0.7 . . . . 0.0 111.139 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.77 -19.64 62.71 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.981 0.81 . . . . 0.0 112.62 173.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -76.7 -34.73 58.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 110.839 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.37 -40.62 91.47 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.407 0.683 . . . . 0.0 109.949 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.14 -170.64 43.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -75.57 38.22 0.15 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 111.861 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.91 144.45 14.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 O-C-N 120.853 -1.154 . . . . 0.0 109.806 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -73.15 141.26 47.43 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.05 128.7 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -136.8 155.19 50.14 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.662 0.664 . . . . 0.0 111.531 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -125.5 97.84 5.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.98 122.63 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -109.49 164.72 12.25 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.002 1.321 . . . . 0.0 109.206 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.16 176.04 3.49 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 110.295 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.21 -27.84 68.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.239 0.616 . . . . 0.0 111.734 171.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.6 mt -47.77 106.63 0.62 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.01 1.724 . . . . 0.0 110.398 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.1 1.52 7.27 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.094 2.529 . . . . 0.0 113.501 -169.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -43.7 -35.02 1.66 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.645 1.978 . . . . 0.0 115.588 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.1 31.38 0.93 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.767 -0.635 . . . . 0.0 110.917 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -61.65 -30.66 70.86 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 120.785 1.63 . . . . 0.0 111.997 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.87 -19.17 62.35 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.727 1.211 . . . . 0.0 113.994 172.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -67.54 -35.95 80.05 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 110.355 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER 30.84 52.89 0.15 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.045 2.138 . . . . 0.0 113.049 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p -52.97 -37.47 61.21 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.549 -0.719 . . . . 0.0 112.681 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.96 -16.36 59.47 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.312 -0.715 . . . . 0.0 114.308 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.23 -15.91 15.85 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 112.412 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -75.05 94.49 2.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.652 0.66 . . . . 0.0 111.246 -169.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.73 -20.05 2.19 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.609 1.576 . . . . 0.0 111.105 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.426 HG21 ' HA ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -145.6 92.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.516 1.527 . . . . 0.0 107.973 -172.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.61 -33.89 7.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.299 1.84 . . . . 0.0 113.988 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.84 -20.06 65.86 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.479 1.111 . . . . 0.0 113.717 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.89 152.81 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.168 0.895 . . . . 0.0 108.945 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -129.34 146.24 51.25 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.0 m -97.26 135.11 39.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.98 162.98 16.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.988 1.715 . . . . 0.0 108.089 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -138.28 44.25 2.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.41 1.484 . . . . 0.0 109.573 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.12 -44.08 7.37 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.516 1.127 . . . . 0.0 112.848 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -59.97 -14.72 17.27 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -76.31 -6.71 52.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.077 -1.015 . . . . 0.0 112.416 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -139.07 -41.31 0.47 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.39 1.476 . . . . 0.0 111.294 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.4 tpt 78.34 2.1 2.69 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.149 2.98 . . . . 0.0 113.667 169.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 m -63.94 -46.51 84.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.852 1.66 . . . . 0.0 111.471 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.89 -39.56 89.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.227 1.376 . . . . 0.0 109.307 172.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.2 -53.69 18.31 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.41 1.957 . . . . 0.0 113.255 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.98 -34.89 50.69 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.989 0.516 . . . . 0.0 110.433 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.57 -39.54 93.93 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.217 0.607 . . . . 0.0 111.587 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -97.98 3.03 49.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.053 1.341 . . . . 0.0 110.31 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 60.79 8.4 10.12 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.348 1.452 . . . . 0.0 114.826 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 m -63.62 -23.04 32.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 C-N-CA 125.902 1.681 . . . . 0.0 110.94 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.38 118.51 4.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 124' ' ' LEU . 47.2 mm -87.47 124.12 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -61.35 -53.15 60.31 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.466 1.506 . . . . 0.0 110.718 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.97 -49.47 11.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.039 0.447 . . . . 0.0 110.5 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' H ' HG22 ' A' ' 121' ' ' ILE . 29.4 tp -72.83 -23.11 60.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.508 1.123 . . . . 0.0 112.779 -171.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 51.17 50.28 19.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 110.768 -169.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.5 mt -138.12 -173.25 3.47 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.7 pt? -113.24 146.69 38.91 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.199 1.0 . . . . 0.0 111.327 175.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.61 140.86 57.96 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.919 1.688 . . . . 0.0 113.805 -169.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -65.87 110.86 3.02 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 p -156.13 168.22 27.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.454 0.57 . . . . 0.0 111.166 -170.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.04 148.26 18.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.92 1.288 . . . . 0.0 108.129 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -145.7 154.5 42.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.503 1.121 . . . . 0.0 109.296 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.91 139.87 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -132.21 141.02 48.91 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.009 1.323 . . . . 0.0 108.233 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.39 162.43 20.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.351 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.5 -32.63 41.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.901 1.281 . . . . 0.0 113.228 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -80.25 -10.32 59.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.7 -2.71 49.08 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.388 0.994 . . . . 0.0 113.605 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.85 137.94 58.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.55 1.675 . . . . 0.0 108.753 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 129.46 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 80.6 t -113.26 -20.79 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.825 2.05 . . . . 0.0 109.541 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -143.84 148.34 35.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.351 1.06 . . . . 0.0 108.194 169.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.75 132.18 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.513 1.525 . . . . 0.0 107.701 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -149.77 147.59 28.19 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.662 1.185 . . . . 0.0 108.444 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.12 116.07 14.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.47 134.69 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 m -58.95 -18.68 35.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.154 0.982 . . . . 0.0 112.956 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -140.04 122.5 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.2 p -83.16 14.87 3.16 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.654 1.115 . . . . 0.0 111.983 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -125.77 -177.06 3.79 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.567 1.947 . . . . 0.0 108.91 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -137.78 151.5 70.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.244 1.418 . . . . 0.0 109.901 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.96 170.75 7.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.67 2.913 . . . . 0.0 111.606 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -77.33 87.1 3.73 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -68.32 1.12 3.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.3 1.44 . . . . 0.0 114.118 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -31.63 72.47 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -62.02 -53.07 62.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.324 1.049 . . . . 0.0 111.801 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -65.83 -31.26 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.742 1.658 . . . . 0.0 112.422 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.6 mm -58.3 -48.89 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.131 1.332 . . . . 0.0 109.35 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.17 -33.47 76.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.821 0.737 . . . . 0.0 110.81 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.28 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.734 0.414 . . . . 0.0 111.192 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.77 -49.51 65.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.895 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -63.64 -30.46 71.57 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.94 69.35 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.442 1.019 . . . . 0.0 111.835 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.19 -45.77 17.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.147 0.579 . . . . 0.0 111.478 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.74 -46.69 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.235 0.614 . . . . 0.0 111.024 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.5 tttm . . . . . 0 C--O 1.248 0.985 0 C-N-CA 124.401 1.081 . . . . 0.0 109.903 -179.706 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.55 58.17 2.63 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.31 1.053 . . . . 0.0 109.961 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -148.41 140.64 24.14 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.76 -178.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -115.19 147.67 40.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -134.18 120.67 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 43.83 39.69 2.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.053 1.341 . . . . 0.0 111.916 -173.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.57 12.6 79.96 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.74 117.44 3.95 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.174 -1.348 . . . . 0.0 109.846 173.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.21 139.34 89.74 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.342 2.695 . . . . 0.0 112.222 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.66 130.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.225 1.41 . . . . 0.0 109.889 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -75.63 161.67 28.91 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.351 1.86 . . . . 0.0 110.462 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.68 160.0 19.09 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.31 1.444 . . . . 0.0 110.173 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.78 -59.71 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.837 -0.539 . . . . 0.0 111.242 -169.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.2 32.61 6.94 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.397 0.998 . . . . 0.0 113.439 -169.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.43 -167.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.54 107.07 17.89 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.482 1.513 . . . . 0.0 109.748 -169.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.41 145.75 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -143.52 160.79 39.97 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.595 0.758 . . . . 0.0 109.028 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.75 134.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.31 3.37 89.81 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.796 -1.002 . . . . 0.0 113.988 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.03 -7.02 59.47 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.463 1.631 . . . . 0.0 112.298 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 58.07 178.18 0.06 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.369 1.467 . . . . 0.0 111.516 -169.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.09 24.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.792 1.637 . . . . 0.0 108.729 -171.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.18 158.04 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.708 2.272 . . . . 0.0 109.907 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 26.1 t70 -81.41 68.82 7.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.378 1.471 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -63.1 163.25 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.977 171.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.5 m -121.79 148.95 44.01 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -152.66 167.67 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.106 2.162 . . . . 0.0 105.76 -173.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.49 156.05 29.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 120.787 -1.195 . . . . 0.0 108.231 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.3 p -81.36 173.59 12.32 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.767 1.227 . . . . 0.0 110.016 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -63.77 -26.71 68.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.933 -1.104 . . . . 0.0 110.798 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 p -77.54 1.43 19.49 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.512 1.525 . . . . 0.0 111.94 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt 56.94 47.78 17.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.968 2.107 . . . . 0.0 111.986 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.01 141.96 47.43 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -64.52 144.09 57.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.464 1.105 . . . . 0.0 109.485 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -146.52 157.66 43.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.499 2.32 . . . . 0.0 105.477 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 p -146.62 167.82 22.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 67.5 tp -53.83 -43.78 69.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 170.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.37 66.52 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.85 -30.6 58.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.878 0.763 . . . . 0.0 111.114 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.3 mtt -73.88 -39.69 63.74 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.388 1.075 . . . . 0.0 110.945 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -53.56 140.91 27.13 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 109.862 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.6 -22.1 8.89 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.958 1.266 . . . . 0.0 112.738 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -148.36 152.83 37.71 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.888 1.275 . . . . 0.0 108.681 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.63 142.43 15.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.2 m -135.54 148.95 49.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.883 0.873 . . . . 0.0 109.036 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.4 mt -134.73 138.31 49.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.01 124.62 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 p -106.59 148.42 28.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 168.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.05 127.88 40.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.16 146.83 38.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 110.357 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.69 -39.69 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.072 1.848 . . . . 0.0 111.484 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.4 m -152.5 173.06 15.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 0.0 109.097 -169.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 pt -121.01 -29.8 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.51 1.124 . . . . 0.0 111.45 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.09 -11.64 31.75 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.537 0.735 . . . . 0.0 111.669 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -22.07 54.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.807 2.043 . . . . 0.0 112.532 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.23 -0.12 25.24 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.265 0.936 . . . . 0.0 112.942 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.55 -15.6 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 118.67 1.235 . . . . 0.0 112.856 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.3 m -54.95 -25.96 33.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.171 1.388 . . . . 0.0 113.289 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -124.58 32.24 5.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.142 1.377 . . . . 0.0 109.395 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.31 -166.98 2.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.414 1.486 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -43.57 -45.66 6.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.375 1.87 . . . . 0.0 113.938 -171.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 m -56.03 -42.36 76.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.279 1.4 . . . . 0.0 112.424 -169.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -65.94 -53.0 44.89 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.969 0.804 . . . . 0.0 110.398 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -64.69 -41.0 96.35 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.146 0.884 . . . . 0.0 111.146 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.2 -50.29 71.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.781 . . . . 0.0 110.269 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -62.56 -37.86 87.8 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.486 0.314 . . . . 0.0 110.692 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.76 -36.83 85.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.604 0.762 . . . . 0.0 110.695 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -74.82 -42.6 57.72 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.001 -1.062 . . . . 0.0 110.196 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.91 -49.35 66.11 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.82 1.248 . . . . 0.0 110.463 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.84 -12.56 25.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 0.0 113.563 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -108.36 -9.04 15.5 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 113.037 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.6 mt -64.96 -32.41 74.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.164 1.347 . . . . 0.0 110.584 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.08 -169.95 43.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.17 29.84 0.1 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.976 0.888 . . . . 0.0 112.451 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.72 149.76 3.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.68 -1.263 . . . . 0.0 110.34 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -71.78 141.18 49.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -142.55 131.55 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -139.01 156.67 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.841 0.856 . . . . 0.0 110.562 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.6 m -133.32 105.26 6.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.7 128.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 m -124.33 160.81 27.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.572 1.149 . . . . 0.0 109.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.46 -163.73 0.13 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.037 169.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -124.37 21.65 8.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.52 1.128 . . . . 0.0 111.02 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.91 154.18 77.33 Favored Pre-proline 0 CA--C 1.537 0.481 0 O-C-N 121.282 -0.886 . . . . 0.0 108.888 169.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.72 -32.11 53.73 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.711 2.274 . . . . 0.0 112.886 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -75.63 -3.82 36.61 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.578 1.551 . . . . 0.0 113.241 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.28 146.43 44.31 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.947 1.299 . . . . 0.0 109.907 -170.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 45.38 -9.19 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 130.293 3.437 . . . . 0.0 119.765 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.2 60.55 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 121.32 1.873 . . . . 0.0 114.391 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -124.54 3.05 8.33 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.278 1.431 . . . . 0.0 111.337 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.6 p90 35.36 42.85 0.12 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.409 2.284 . . . . 0.0 113.784 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.41 -30.5 71.61 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.92 -10.88 73.49 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.622 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.15 32.47 5.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 110.293 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -137.56 132.06 32.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.8 -9.57 65.18 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.683 0.658 . . . . 0.0 111.544 -169.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mt -134.87 76.8 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -51.7 -31.69 27.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.3 1.44 . . . . 0.0 114.821 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -63.9 -27.96 69.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.04 151.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -133.37 143.97 49.3 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 m -93.07 143.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.84 158.72 25.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.073 1.349 . . . . 0.0 108.753 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 m -128.88 67.02 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.997 2.119 . . . . 0.0 108.449 -169.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.0 -35.9 48.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.257 0.623 . . . . 0.0 112.219 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -11.37 49.49 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.961 -1.087 . . . . 0.0 113.591 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -76.95 -29.75 55.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.887 1.221 . . . . 0.0 111.545 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -149.01 88.58 1.61 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 4.83 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.262 1.425 . . . . 0.0 113.581 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.3 m -55.92 -42.57 76.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.92 1.236 . . . . 0.0 110.722 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.68 -48.92 79.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.636 1.107 . . . . 0.0 110.84 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.5 98.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 123.66 0.648 . . . . 0.0 111.992 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.77 -42.01 67.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.454 0.627 . . . . 0.0 110.323 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.58 86.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.348 1.059 . . . . 0.0 111.913 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -92.01 3.53 55.03 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.925 0.89 . . . . 0.0 111.22 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.94 -4.84 8.97 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.625 1.107 . . . . 0.0 115.057 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.9 m -66.99 -8.94 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.986 2.114 . . . . 0.0 112.212 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.03 109.59 3.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 124' ' ' LEU . 67.7 mt -66.88 127.87 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -66.49 -49.76 65.52 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.298 1.039 . . . . 0.0 110.636 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -76.74 -49.56 15.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.524 ' H ' HG22 ' A' ' 121' ' ' ILE . 17.8 tp -80.26 -17.61 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 50.0 48.78 21.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.662 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.8 tp -137.84 161.67 35.99 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 108.426 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -72.91 129.76 38.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 110.722 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.41 168.07 18.23 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.864 1.266 . . . . 0.0 113.634 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -91.67 115.21 27.86 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.108 1.363 . . . . 0.0 108.191 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.7 m -154.48 166.84 32.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.105 0.562 . . . . 0.0 109.672 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.38 146.86 18.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -148.36 156.66 42.79 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.066 1.347 . . . . 0.0 109.105 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.96 144.97 30.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.2 mp -132.46 139.68 48.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.345 1.058 . . . . 0.0 108.661 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.95 166.62 13.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.223 1.409 . . . . 0.0 110.038 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -52.49 -31.38 34.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.149 1.38 . . . . 0.0 112.393 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.05 2.25 27.95 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.566 1.147 . . . . 0.0 112.7 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.4 -5.94 75.03 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 120.966 -1.084 . . . . 0.0 112.959 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.38 126.47 27.46 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.638 1.219 . . . . 0.0 108.964 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.77 128.94 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 109.625 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.5 t -116.83 -17.46 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.391 1.876 . . . . 0.0 109.851 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -145.38 147.68 32.53 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.26 135.58 15.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.161 1.385 . . . . 0.0 108.481 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.42 149.49 30.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.811 0.844 . . . . 0.0 109.299 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.05 106.44 9.28 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.434 2.294 . . . . 0.0 104.922 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 t -69.3 134.53 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -60.95 -19.5 60.96 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.945 1.298 . . . . 0.0 113.855 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -138.77 127.77 23.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.82 39.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.2 p -98.57 -5.79 31.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.431 1.092 . . . . 0.0 112.048 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -83.57 -174.47 5.3 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.373 1.469 . . . . 0.0 109.347 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -135.6 154.22 78.09 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.641 1.176 . . . . 0.0 109.905 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.55 172.71 10.08 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.938 2.426 . . . . 0.0 109.768 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -69.23 120.58 15.29 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 168.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -93.45 -2.49 54.47 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -76.02 -34.93 59.71 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.25 -54.36 55.58 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.766 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.65 -35.47 58.26 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.883 1.708 . . . . 0.0 111.885 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 mm -61.38 -50.39 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.465 1.029 . . . . 0.0 109.736 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.14 -36.95 84.49 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.986 0.812 . . . . 0.0 110.219 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.44 92.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.056 0.543 . . . . 0.0 111.068 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.43 -50.28 27.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.488 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.74 -27.24 69.07 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.235 1.38 . . . . 0.0 111.469 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.8 -31.68 68.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.668 1.122 . . . . 0.0 112.02 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.42 -44.21 36.91 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.193 0.597 . . . . 0.0 110.873 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.85 -48.42 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.365 0.666 . . . . 0.0 110.689 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 124.873 1.269 . . . . 0.0 110.031 179.742 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.867 0.365 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.7 44.6 2.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.075 1.75 . . . . 0.0 109.323 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -63.29 155.52 28.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.79 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.46 179.58 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.723 0.809 . . . . 0.0 109.933 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.18 150.85 42.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -137.25 -84.26 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.455 1.025 . . . . 0.0 109.818 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.4 43.34 0.54 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.064 1.346 . . . . 0.0 110.97 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.78 70.52 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.261 0.934 . . . . 0.0 112.141 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 152.64 24.75 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.33 145.6 34.45 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.872 2.382 . . . . 0.0 110.65 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.97 139.04 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.53 1.132 . . . . 0.0 109.798 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -79.14 158.78 27.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.038 1.735 . . . . 0.0 110.038 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.93 149.77 43.82 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.05 1.74 . . . . 0.0 107.441 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.1 t -80.25 -83.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 118.364 0.529 . . . . 0.0 110.54 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 41.54 2.61 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.447 1.498 . . . . 0.0 111.908 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -60.84 171.66 1.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.648 1.979 . . . . 0.0 114.098 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 68.25 34.88 3.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.239 1.816 . . . . 0.0 113.82 169.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.91 142.99 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -151.11 162.09 41.51 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.428 0.691 . . . . 0.0 109.392 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.54 133.96 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.505 0.722 . . . . 0.0 109.76 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.67 1.74 90.57 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.156 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.11 -8.91 58.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.923 1.862 . . . . 0.0 112.297 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 57.35 174.39 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.755 1.622 . . . . 0.0 111.322 -169.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.43 139.98 26.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.111 1.364 . . . . 0.0 109.001 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.81 -27.91 80.12 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.205 2.604 . . . . 0.0 114.853 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 t70 84.39 116.25 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.284 2.634 . . . . 0.0 106.934 -169.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -131.22 161.74 31.55 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.856 1.263 . . . . 0.0 110.451 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -96.56 157.98 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.06 171.38 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.029 2.532 . . . . 0.0 106.641 172.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 tp -129.2 134.21 47.91 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.0 p -73.49 164.96 25.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -64.26 -13.83 51.94 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.758 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 m -83.25 1.07 42.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.452 1.501 . . . . 0.0 112.04 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp 57.31 53.12 7.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.797 2.039 . . . . 0.0 111.602 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.3 141.45 52.06 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.178 0.991 . . . . 0.0 108.433 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.22 143.53 40.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.16 0.981 . . . . 0.0 109.195 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -149.56 159.91 43.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.877 2.471 . . . . 0.0 105.039 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.0 m -142.32 163.78 31.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 tp -53.72 -38.11 63.97 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.321 -0.237 . . . . 0.0 110.659 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.66 -23.64 64.96 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.71 -32.23 57.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.937 0.789 . . . . 0.0 110.951 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.5 mtt -72.71 -38.31 67.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.378 1.071 . . . . 0.0 110.694 176.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -53.24 142.34 21.22 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.63 0.772 . . . . 0.0 109.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.32 -20.74 8.34 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.413 1.483 . . . . 0.0 112.293 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -150.16 154.69 38.45 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.197 1.399 . . . . 0.0 108.797 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.89 138.19 19.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 m -133.44 142.81 48.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.19 132.69 49.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -138.91 121.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.17 150.97 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.21 134.25 61.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.67 152.15 58.91 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.67 -46.94 4.47 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.446 1.431 . . . . 0.0 110.341 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.1 m -144.29 173.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 108.931 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.42 -26.27 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.13 -32.53 73.12 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 112.158 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -65.97 133.63 51.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.991 0.916 . . . . 0.0 109.888 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.0 -21.95 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.412 1.006 . . . . 0.0 114.476 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.85 -15.49 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.653 1.226 . . . . 0.0 112.262 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -26.84 57.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.332 0.969 . . . . 0.0 111.708 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -125.21 -34.93 2.68 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.775 1.23 . . . . 0.0 110.782 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.23 66.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.214 0.605 . . . . 0.0 112.081 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.97 -41.71 0.31 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.469 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . 0.252 3.4 m -65.54 -37.17 85.94 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -167.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -64.77 -53.7 42.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.014 1.279 . . . . 0.0 110.407 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -66.04 -42.27 89.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.368 0.531 . . . . 0.0 111.607 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.53 -50.43 73.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.719 0.808 . . . . 0.0 110.284 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -64.25 -38.19 90.17 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.833 0.288 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.15 -47.42 83.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.094 0.958 . . . . 0.0 110.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -70.04 -44.87 68.35 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.435 0.561 . . . . 0.0 110.525 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.29 79.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.725 0.693 . . . . 0.0 111.134 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.54 -14.57 43.54 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -102.92 -15.37 16.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.489 1.516 . . . . 0.0 112.02 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.67 -37.71 79.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.638 1.108 . . . . 0.0 110.718 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.57 -167.89 40.64 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.07 25.13 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.843 -0.798 . . . . 0.0 112.829 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -53.51 151.37 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.329 1.452 . . . . 0.0 111.449 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -77.08 139.62 40.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.13 123.3 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -139.47 156.48 46.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.181 0.592 . . . . 0.0 110.755 -175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -131.41 116.56 17.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.61 140.67 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.272 1.029 . . . . 0.0 108.27 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 m -140.99 175.38 9.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.313 1.445 . . . . 0.0 112.054 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.26 -176.94 6.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.924 1.29 . . . . 0.0 113.646 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.31 -28.0 68.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.325 1.85 . . . . 0.0 113.711 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.5 148.93 63.47 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.928 0.891 . . . . 0.0 111.194 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.66 -36.04 65.96 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.745 1.63 . . . . 0.0 110.438 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -61.85 -5.93 2.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.968 1.707 . . . . 0.0 113.311 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.14 3.71 12.02 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.956 1.702 . . . . 0.0 111.44 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -138.83 21.41 2.66 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.405 1.002 . . . . 0.0 111.786 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.74 175.21 10.34 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.892 1.677 . . . . 0.0 108.437 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 73.56 -20.52 0.29 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.243 2.617 . . . . 0.0 113.488 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 36.05 47.6 0.45 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.014 2.526 . . . . 0.0 115.633 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.3 m -52.11 -34.89 46.27 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -171.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.41 -8.31 64.35 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.602 -1.11 . . . . 0.0 113.918 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.83 29.19 3.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.03 1.415 . . . . 0.0 111.546 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -135.88 69.21 1.43 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.593 1.157 . . . . 0.0 108.131 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.7 -27.04 0.26 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.357 0.98 . . . . 0.0 111.641 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 98.61 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.759 1.624 . . . . 0.0 106.867 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.83 -28.69 57.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.994 1.718 . . . . 0.0 114.267 -169.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -61.69 -32.12 72.29 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.12 0.568 . . . . 0.0 112.49 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.08 152.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.89 145.97 42.79 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -88.52 138.47 31.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.0 mp -128.64 167.63 16.92 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.085 2.154 . . . . 0.0 106.973 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.2 m -146.83 172.37 13.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.248 1.419 . . . . 0.0 107.585 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.81 2.6 3.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.429 0.633 . . . . 0.0 111.534 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -16.59 1.1 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -30.99 72.02 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.377 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -153.42 -7.48 0.17 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 tpt 56.45 27.6 12.39 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.182 1.393 . . . . 0.0 111.377 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.8 t -63.46 -62.36 1.72 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.542 1.537 . . . . 0.0 109.732 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -59.86 -38.93 83.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.9 0.48 . . . . 0.0 110.464 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.11 -56.66 13.51 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.619 2.057 . . . . 0.0 112.12 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.73 -36.73 62.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.686 0.743 . . . . 0.0 110.343 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.08 98.25 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.208 0.603 . . . . 0.0 111.773 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -102.23 3.84 38.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.297 1.039 . . . . 0.0 110.672 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.81 5.0 29.44 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 118.35 -1.25 . . . . 0.0 114.677 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.43 -13.68 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 119.139 1.47 . . . . 0.0 111.161 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.37 102.41 0.68 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 124' ' ' LEU . 81.3 mt -63.17 124.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -64.99 -45.37 85.88 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.958 0.903 . . . . 0.0 110.978 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.32 -49.45 12.42 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.917 0.326 . . . . 0.0 110.669 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.542 ' H ' HG22 ' A' ' 121' ' ' ILE . 15.0 tp -81.59 -14.21 57.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -170.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 47.84 48.38 17.71 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.06 1.344 . . . . 0.0 110.58 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.24 25.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.827 0.851 . . . . 0.0 108.843 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 129.22 37.34 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.08 160.68 26.15 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 111.646 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 104.63 16.61 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -145.74 163.17 35.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.596 0.759 . . . . 0.0 108.959 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.27 145.11 18.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -145.32 154.96 42.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 109.321 -169.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.82 136.54 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 171.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.31 139.63 51.7 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.868 1.267 . . . . 0.0 108.013 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 165.22 11.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.077 1.351 . . . . 0.0 110.245 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.6 -34.35 25.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.22 1.408 . . . . 0.0 112.816 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.8 12.1 20.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.059 0.943 . . . . 0.0 113.113 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.46 -6.17 82.8 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.451 1.024 . . . . 0.0 113.132 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 138.55 58.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.57 1.185 . . . . 0.0 109.518 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.89 133.18 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.17 -25.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.928 1.291 . . . . 0.0 109.91 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -150.59 151.8 33.11 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.51 138.41 16.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.578 1.551 . . . . 0.0 107.916 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -147.5 148.33 31.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.763 0.825 . . . . 0.0 108.824 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -127.43 112.54 15.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 t -66.88 133.11 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -60.58 -16.13 34.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.562 1.145 . . . . 0.0 112.66 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -139.33 111.67 7.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.36 -18.23 64.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -174.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.6 p -83.58 9.39 11.56 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.136 0.974 . . . . 0.0 110.976 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -132.68 174.02 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.231 2.612 . . . . 0.0 108.12 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -122.83 158.64 56.53 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.749 1.219 . . . . 0.0 111.553 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.75 179.34 3.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.206 2.604 . . . . 0.0 110.225 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -80.35 85.5 5.82 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -67.61 -0.46 3.94 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.438 1.495 . . . . 0.0 113.114 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.67 -25.8 49.82 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.169 -0.957 . . . . 0.0 109.364 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.53 -52.65 72.62 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.476 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.95 -33.73 73.62 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.585 1.602 . . . . 0.0 112.573 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 mm -59.79 -47.2 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.708 1.14 . . . . 0.0 109.525 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.66 -35.63 81.19 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.326 0.967 . . . . 0.0 110.931 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.76 -42.17 97.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.227 0.211 . . . . 0.0 110.801 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -40.23 80.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.321 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -57.53 -42.3 82.62 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.448 1.022 . . . . 0.0 110.242 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.31 -31.66 69.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.149 0.431 . . . . 0.0 111.965 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.75 -55.44 5.64 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.247 0.476 . . . . 0.0 110.745 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.19 -51.95 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 111.177 -169.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 21.1 pttm . . . . . 0 C--O 1.25 1.128 0 C-N-CA 127.792 2.437 . . . . 0.0 112.219 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.99 117.56 2.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.823 1.249 . . . . 0.0 110.009 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -154.94 140.81 18.21 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.21 -175.22 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.161 1.384 . . . . 0.0 107.606 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -123.17 160.39 26.61 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -147.71 127.11 13.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 169.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 43.33 39.68 2.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.942 1.297 . . . . 0.0 112.908 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.24 15.27 74.76 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.167 0.889 . . . . 0.0 114.674 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.49 120.74 4.52 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.22 142.95 86.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.93 2.42 . . . . 0.0 111.259 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.43 135.02 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.231 1.013 . . . . 0.0 109.5 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -76.55 164.35 26.02 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.828 2.051 . . . . 0.0 109.261 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.83 165.15 23.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.869 0.868 . . . . 0.0 109.829 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.6 134.83 57.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.809 1.644 . . . . 0.0 107.207 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.2 -12.57 63.61 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.122 0.868 . . . . 0.0 114.002 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 53.26 164.92 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.354 3.061 . . . . 0.0 115.375 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -67.03 164.88 16.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.215 1.006 . . . . 0.0 113.319 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.69 166.26 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 126.607 1.963 . . . . 0.0 106.589 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -149.15 165.59 31.35 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.695 0.798 . . . . 0.0 109.061 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 141' ' ' VAL . 1.5 p -52.26 131.72 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 122.76 0.424 . . . . 0.0 109.893 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.84 71.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.654 1.121 . . . . 0.0 113.322 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.01 -10.78 59.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.329 1.565 . . . . 0.0 114.113 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 62.39 104.42 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.919 1.688 . . . . 0.0 112.5 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.13 134.57 68.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.523 1.129 . . . . 0.0 111.833 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.44 -27.01 83.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.541 2.827 . . . . 0.0 115.392 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.78 112.44 0.05 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.954 2.502 . . . . 0.0 111.34 -169.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -143.27 168.88 18.73 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.477 1.511 . . . . 0.0 109.73 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 159.58 33.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.089 1.755 . . . . 0.0 111.592 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.79 178.14 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 129.184 2.994 . . . . 0.0 105.833 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.85 133.54 53.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -79.81 -176.8 5.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.309 0.576 . . . . 0.0 110.413 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -46.94 -36.57 7.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.752 1.221 . . . . 0.0 111.722 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m -111.73 20.67 16.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.318 1.447 . . . . 0.0 110.556 -171.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.9 mt 56.24 32.59 20.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.96 2.104 . . . . 0.0 113.265 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.61 142.99 46.54 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.13 57.61 3.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.87 1.268 . . . . 0.0 110.136 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -59.54 158.21 10.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 108.107 169.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -137.57 166.76 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.89 -30.6 64.05 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.014 -0.429 . . . . 0.0 111.527 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.99 -20.99 64.47 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.626 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.06 -28.86 43.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.271 0.941 . . . . 0.0 110.754 172.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 mtt -71.38 -39.11 71.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.056 0.942 . . . . 0.0 110.497 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.47 135.39 39.8 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.86 -26.52 3.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.17 1.367 . . . . 0.0 112.169 -171.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -151.28 159.86 44.11 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.337 1.055 . . . . 0.0 109.722 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.9 t -58.48 136.67 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 170.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 45.8 m -136.96 148.74 47.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.952 1.301 . . . . 0.0 108.295 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 94.7 mt -133.63 135.45 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -136.96 104.79 3.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 149.6 25.5 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.5 t -136.85 141.25 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.99 154.51 54.9 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.299 1.04 . . . . 0.0 111.205 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -76.09 -50.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.775 1.65 . . . . 0.0 108.316 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -159.95 170.25 21.76 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.54 -7.13 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.991 1.717 . . . . 0.0 109.783 168.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -51.74 -26.13 8.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.394 1.877 . . . . 0.0 113.141 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 p -61.49 -9.57 5.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.813 2.045 . . . . 0.0 113.156 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.72 16.38 75.52 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.183 0.901 . . . . 0.0 112.124 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.17 -7.33 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.547 1.539 . . . . 0.0 113.165 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 91.9 m -47.99 -30.0 3.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.557 1.543 . . . . 0.0 114.405 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.91 -30.23 70.79 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.22 8.81 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.522 ' HG3' ' H ' ' A' ' 65' ' ' ARG . 4.6 pt20 -66.57 -169.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -42.96 -24.55 0.07 Allowed 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 127.392 2.277 . . . . 0.0 113.092 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 13.7 tpt180 -43.52 -50.93 7.03 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.934 1.294 . . . . 0.0 111.073 169.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -60.76 -50.11 74.78 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.06 0.846 . . . . 0.0 109.589 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -60.21 -47.02 87.74 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.3 -40.31 77.59 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.153 1.781 . . . . 0.0 110.255 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -69.23 -33.3 73.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.98 1.312 . . . . 0.0 110.817 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -72.34 -45.78 58.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.047 0.839 . . . . 0.0 109.675 169.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.66 -44.36 90.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.824 1.249 . . . . 0.0 111.882 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.52 -20.98 63.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 112.441 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -84.85 -16.73 40.3 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.314 0.961 . . . . 0.0 112.805 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.19 -29.95 69.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.629 1.104 . . . . 0.0 112.237 -169.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.26 -162.03 35.19 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.86 17.73 0.16 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.731 1.212 . . . . 0.0 112.509 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 m -55.42 145.38 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.601 1.561 . . . . 0.0 110.855 -172.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -71.38 138.88 49.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.45 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -127.44 153.22 46.55 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.889 0.875 . . . . 0.0 109.575 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -128.52 116.54 19.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.9 mt -99.72 140.17 19.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -140.25 173.18 11.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.124 0.97 . . . . 0.0 111.663 -171.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.7 168.3 20.32 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 167.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -70.45 -10.51 59.34 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.452 -0.78 . . . . 0.0 112.923 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.4 tp -52.53 134.51 44.21 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.058 1.343 . . . . 0.0 110.709 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.8 -41.02 77.85 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.159 2.573 . . . . 0.0 112.464 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -82.86 26.81 0.57 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.732 1.213 . . . . 0.0 112.305 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.78 -3.62 5.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.822 1.649 . . . . 0.0 109.485 168.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -77.93 89.03 4.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.456 1.122 . . . . 0.0 108.358 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.04 -9.74 2.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.511 1.924 . . . . 0.0 115.148 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.0 ttm-85 -53.76 -23.09 10.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.727 1.603 . . . . 0.0 111.616 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 -27.96 66.09 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.773 0.715 . . . . 0.0 112.074 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.0 m -146.2 -69.21 0.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.516 1.126 . . . . 0.0 111.223 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.3 -33.25 15.49 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 127.494 2.473 . . . . 0.0 115.6 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.49 18.97 5.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.156 1.382 . . . . 0.0 110.834 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -80.55 140.55 35.75 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.123 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -49.29 2.97 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.143 0.878 . . . . 0.0 112.184 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 pt -76.11 67.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 125.663 1.585 . . . . 0.0 109.859 169.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.79 -22.63 3.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.986 2.514 . . . . 0.0 114.319 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -59.58 -38.26 80.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.625 0.77 . . . . 0.0 111.547 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 t -69.42 141.26 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.41 144.78 47.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.7 m -98.95 135.45 40.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.47 164.48 21.81 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 128.194 2.598 . . . . 0.0 106.55 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.0 m -131.27 167.46 19.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -138.79 -26.51 0.86 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.459 -0.781 . . . . 0.0 112.506 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -51.81 -29.91 21.1 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -63.81 -24.64 67.84 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.53 -0.731 . . . . 0.0 112.919 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -122.56 -26.37 4.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.538 1.135 . . . . 0.0 111.688 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.1 tpt 65.67 2.66 2.16 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.566 3.146 . . . . 0.0 114.293 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -72.4 -39.47 67.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.562 -1.209 . . . . 0.0 112.433 -170.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.35 -39.5 94.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.683 1.583 . . . . 0.0 109.501 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.46 -48.24 77.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 124.253 0.93 . . . . 0.0 111.116 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.9 -46.05 76.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 117.876 0.838 . . . . 0.0 110.175 174.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.92 68.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.39 1.076 . . . . 0.0 113.355 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.84 3.69 22.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.372 1.069 . . . . 0.0 111.545 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.53 31.01 77.42 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 119.531 1.059 . . . . 0.0 112.767 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.63 -2.78 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -70.79 105.56 3.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.62 133.1 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -72.65 -50.45 24.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.253 0.621 . . . . 0.0 110.191 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.94 -56.32 4.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.929 0.492 . . . . 0.0 110.767 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.0 tp -68.8 -21.09 64.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.399 0.68 . . . . 0.0 111.912 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 52.79 42.57 31.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.559 1.543 . . . . 0.0 112.19 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.72 170.51 14.24 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.718 1.207 . . . . 0.0 108.234 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.7 134.94 46.62 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.37 41.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.333 0.653 . . . . 0.0 111.262 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -72.78 124.16 24.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.1 m -164.31 169.91 16.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.373 1.069 . . . . 0.0 108.221 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.38 147.95 18.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.75 156.74 45.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.562 1.545 . . . . 0.0 108.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.77 142.47 42.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 tp -137.27 127.65 26.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.726 1.211 . . . . 0.0 109.412 -168.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 168.38 17.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.466 1.106 . . . . 0.0 111.14 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -57.67 -26.17 61.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.858 1.663 . . . . 0.0 113.296 -173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.18 35.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.496 1.518 . . . . 0.0 111.418 -176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.62 10.01 53.89 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 121.258 -0.901 . . . . 0.0 112.847 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -75.43 114.6 14.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.706 1.753 . . . . 0.0 107.937 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.04 129.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.402 ' HA ' HG23 ' A' ' 20' ' ' VAL . 7.8 p -114.24 -11.53 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.319 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -150.6 151.0 31.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.0 133.99 13.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.187 1.795 . . . . 0.0 106.397 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -144.98 138.19 26.62 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.22 114.82 23.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.66 144.49 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.6 m -59.32 -23.27 62.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 111.759 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -145.77 126.31 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 5.61 1.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.294 1.438 . . . . 0.0 114.385 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -114.77 24.37 11.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.336 1.454 . . . . 0.0 109.693 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -138.25 162.74 33.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 129.317 3.047 . . . . 0.0 106.377 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -115.44 153.7 47.65 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 119.764 1.166 . . . . 0.0 113.022 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.07 179.18 6.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.065 3.177 . . . . 0.0 111.576 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -65.44 152.69 43.34 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.173 0.589 . . . . 0.0 110.101 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -109.78 -3.11 16.93 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.152 0.981 . . . . 0.0 112.149 -171.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -128.71 -40.81 1.53 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.803 0.729 . . . . 0.0 110.719 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -55.11 -46.19 99.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.136 -1.411 . . . . 0.0 112.159 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.69 -34.17 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.832 1.69 . . . . 0.0 112.515 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.07 -46.51 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.523 1.056 . . . . 0.0 109.742 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.95 -38.79 92.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.67 0.788 . . . . 0.0 110.011 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.17 96.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.1 66.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.912 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -55.85 -40.02 72.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.006 0.821 . . . . 0.0 110.692 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.65 67.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.235 0.614 . . . . 0.0 111.843 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.34 -48.79 9.34 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 122.951 0.5 . . . . 0.0 111.572 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.89 -49.68 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.818 . . . . 0.0 110.073 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 78.7 tttt . . . . . 0 C--O 1.249 1.065 0 C-N-CA 127.791 2.436 . . . . 0.0 111.04 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 ttp . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.82 122.16 21.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.2 144.29 24.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.0 pt -139.54 -177.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -115.83 153.55 31.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.13 110.69 9.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt 41.49 45.18 2.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.317 1.847 . . . . 0.0 111.974 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.75 -10.79 62.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.29 0.876 . . . . 0.0 115.29 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.47 120.38 6.45 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.031 -1.427 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.86 139.43 84.1 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.191 2.594 . . . . 0.0 112.113 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 m -145.94 159.62 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.18 1.392 . . . . 0.0 110.117 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.5 m -110.88 162.22 15.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.387 1.475 . . . . 0.0 109.461 -170.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.36 139.26 50.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 109.348 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.61 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.951 0.901 . . . . 0.0 110.784 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.47 71.37 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.984 0.802 . . . . 0.0 113.877 -171.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 52.89 -176.47 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.431 2.693 . . . . 0.0 116.907 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -68.01 111.25 4.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.528 1.931 . . . . 0.0 112.742 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -73.46 152.76 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 168.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -134.32 160.53 37.65 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -58.91 136.49 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.18 -4.17 85.99 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.81 1.195 . . . . 0.0 113.796 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.25 -9.35 59.18 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.72 1.76 . . . . 0.0 114.216 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 67.51 122.77 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.665 1.986 . . . . 0.0 111.838 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.01 127.77 91.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.702 -1.142 . . . . 0.0 108.069 173.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.62 -46.78 13.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.635 2.223 . . . . 0.0 113.846 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 t70 128.52 122.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 131.329 3.851 . . . . 0.0 105.554 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -146.96 169.18 19.71 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.273 1.429 . . . . 0.0 108.509 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.9 m -123.57 151.6 42.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 m -139.75 174.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 128.051 2.54 . . . . 0.0 106.548 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.91 153.16 40.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.4 p -80.49 176.9 9.37 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.495 1.118 . . . . 0.0 110.091 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.2 -26.49 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.022 -1.049 . . . . 0.0 110.891 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -79.14 0.57 27.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 111.863 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt 51.79 51.07 17.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.627 1.971 . . . . 0.0 111.985 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.16 141.94 47.96 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -70.08 148.1 49.18 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.612 1.165 . . . . 0.0 110.546 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -153.35 153.72 33.12 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.573 2.349 . . . . 0.0 105.488 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -137.54 164.83 27.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.926 0.785 . . . . 0.0 109.475 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.1 tp -49.89 -41.29 45.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 110.961 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.11 -18.61 65.45 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.53 -29.67 56.82 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.721 0.691 . . . . 0.0 110.949 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.5 mtt -74.84 -42.44 57.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.454 1.102 . . . . 0.0 110.364 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 144.62 24.33 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.432 0.693 . . . . 0.0 110.166 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.72 -17.55 22.95 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.766 1.175 . . . . 0.0 112.879 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -146.65 155.2 42.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.945 1.298 . . . . 0.0 108.874 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.42 141.23 16.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.5 m -134.7 146.74 49.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.088 0.955 . . . . 0.0 108.599 -174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.41 133.62 57.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.0 mt -138.82 131.0 37.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.98 143.35 46.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 169.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.72 137.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -141.9 156.8 65.36 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 108.032 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.54 -49.33 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 120.87 1.047 . . . . 0.0 109.448 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.0 m -162.53 144.93 10.89 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 120.931 -1.106 . . . . 0.0 109.967 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.67 -28.26 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 122.924 0.49 . . . . 0.0 111.251 170.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.22 -25.61 48.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.456 1.102 . . . . 0.0 113.55 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 79.7 p -64.09 -24.99 67.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.34 -4.12 74.06 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.772 -1.016 . . . . 0.0 112.712 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.86 -28.27 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.112 1.956 . . . . 0.0 110.008 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.5 p -57.89 -33.95 69.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.997 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.26 -33.56 24.01 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.92 0.782 . . . . 0.0 110.693 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.97 70.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.307 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.85 -49.06 0.19 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -54.38 -48.71 71.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -167.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -4.63 12.53 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.61 -39.88 2.82 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 123.861 0.864 . . . . 0.0 109.161 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.43 -47.47 72.8 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.712 0.805 . . . . 0.0 110.751 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -67.05 -31.21 71.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.797 0.439 . . . . 0.0 111.984 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -70.65 -51.46 27.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.4 -41.55 89.68 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.145 0.578 . . . . 0.0 110.181 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.02 75.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.164 0.986 . . . . 0.0 110.613 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.48 66.47 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -72.84 -27.81 62.16 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.802 1.183 . . . . 0.0 111.826 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 mt -63.91 -37.32 86.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.731 0.696 . . . . 0.0 111.17 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.2 -170.63 43.78 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.17 19.06 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.824 0.849 . . . . 0.0 113.273 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.1 m -55.42 153.84 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 111.464 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.48 143.04 44.79 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.89 126.78 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.49 151.55 50.48 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.412 0.551 . . . . 0.0 110.951 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.6 m -122.26 139.06 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.05 133.35 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -128.84 161.43 29.82 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.835 0.854 . . . . 0.0 110.67 -173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.73 -166.16 1.43 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -80.59 -8.95 59.78 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.29 151.54 93.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 118.818 0.735 . . . . 0.0 110.946 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.35 -12.26 35.18 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.774 2.316 . . . . 0.0 113.448 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -110.42 17.19 21.07 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.027 1.331 . . . . 0.0 110.866 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.39 -33.5 75.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -171.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -139.61 156.14 47.03 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.531 1.132 . . . . 0.0 109.674 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.41 172.76 17.69 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.424 2.69 . . . . 0.0 105.101 169.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -92.63 37.03 1.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.413 -0.804 . . . . 0.0 109.225 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -151.43 165.94 32.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.054 1.342 . . . . 0.0 107.846 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 t 48.95 50.25 18.07 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.476 1.111 . . . . 0.0 110.227 -171.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.69 -139.8 4.66 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -169.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.0 69.47 1.45 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.23 1.412 . . . . 0.0 111.45 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.39 142.1 23.66 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 108.926 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.04 50.16 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.114 0.864 . . . . 0.0 112.897 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.26 94.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.32 -29.33 61.15 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.843 1.257 . . . . 0.0 114.117 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -64.37 -29.06 70.14 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.91 148.9 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.36 148.11 39.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.16 141.74 28.42 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.308 1.843 . . . . 0.0 108.28 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.63 155.2 36.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.749 1.619 . . . . 0.0 108.543 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.5 m -127.3 47.38 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.411 2.284 . . . . 0.0 109.204 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.41 -26.6 42.67 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.698 -0.626 . . . . 0.0 112.2 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -49.25 -26.44 2.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -70.15 -15.92 63.02 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.69 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -140.73 -22.07 0.8 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.827 1.194 . . . . 0.0 113.745 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 82.3 mmm 58.79 2.99 0.27 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.309 3.044 . . . . 0.0 116.021 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -62.89 -44.07 97.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.466 1.485 . . . . 0.0 111.994 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -64.87 -42.34 94.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.562 1.528 . . . . 0.0 109.756 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.27 -44.75 96.27 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 123.68 0.657 . . . . 0.0 111.773 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.44 -46.08 67.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.983 0.513 . . . . 0.0 109.843 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -38.92 78.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.082 0.953 . . . . 0.0 112.46 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -99.38 4.53 46.33 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.68 1.192 . . . . 0.0 111.824 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.22 37.5 64.82 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 118.454 0.57 . . . . 0.0 112.803 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.73 -7.55 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.358 1.063 . . . . 0.0 109.841 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.86 108.41 1.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.78 120.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.16 -43.81 98.0 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.618 1.167 . . . . 0.0 111.423 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -92.32 -4.78 53.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.466 0.707 . . . . 0.0 112.872 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.62 -11.59 2.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.919 . . . . 0.0 111.977 -170.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 41.6 ptt85 49.3 31.61 3.86 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.15 2.18 . . . . 0.0 114.599 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.3 mt -116.9 167.11 11.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.33 130.6 37.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 164.1 24.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.786 1.234 . . . . 0.0 112.809 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 99.25 11.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.8 m -144.06 162.69 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.885 0.874 . . . . 0.0 109.158 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.55 144.42 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -146.98 155.9 42.62 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.088 1.355 . . . . 0.0 109.068 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.8 t -139.5 143.77 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.88 136.15 36.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.841 0.856 . . . . 0.0 109.7 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.14 164.53 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.368 1.467 . . . . 0.0 109.133 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.4 -29.65 10.58 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.04 1.736 . . . . 0.0 113.253 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.35 1.79 12.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.688 1.195 . . . . 0.0 113.015 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.33 30.09 65.31 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 120.837 -1.165 . . . . 0.0 110.245 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -106.85 116.23 31.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.794 1.297 . . . . 0.0 108.494 -173.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.17 124.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.216 1.006 . . . . 0.0 110.679 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.07 -8.42 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.376 1.47 . . . . 0.0 111.131 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -147.99 147.45 29.65 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.81 15.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.456 1.502 . . . . 0.0 108.272 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.79 149.63 33.73 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.105 0.962 . . . . 0.0 109.216 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.16 104.93 7.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.761 2.424 . . . . 0.0 105.055 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.74 137.86 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.2 m -62.25 -11.95 17.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.149 1.38 . . . . 0.0 113.727 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -142.69 123.92 14.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -54.39 -27.02 33.72 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.863 1.265 . . . . 0.0 113.958 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.9 p -91.72 14.54 14.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.754 1.161 . . . . 0.0 112.368 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -123.66 170.84 10.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.632 1.573 . . . . 0.0 109.763 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -125.96 155.43 73.16 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.589 1.156 . . . . 0.0 110.953 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -91.65 179.93 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.082 3.188 . . . . 0.0 110.271 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -79.5 111.89 16.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -81.73 -0.68 44.03 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -76.57 -29.44 56.61 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.795 -1.191 . . . . 0.0 108.919 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -59.46 -50.66 86.1 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 117.663 -1.16 . . . . 0.0 111.456 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.65 -34.27 52.05 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.269 1.489 . . . . 0.0 112.44 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.57 -45.31 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.203 1.365 . . . . 0.0 109.933 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.87 -36.04 83.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.12 0.873 . . . . 0.0 110.797 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.386 -0.196 . . . . 0.0 111.068 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.4 77.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.985 0.514 . . . . 0.0 110.899 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -57.18 -40.47 77.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.168 0.894 . . . . 0.0 110.603 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.77 68.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.999 0.52 . . . . 0.0 111.912 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.51 -59.95 2.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.045 0.384 . . . . 0.0 110.921 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.53 -40.28 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.257 1.023 . . . . 0.0 112.14 -169.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? . . . . . 0 C--O 1.25 1.095 0 C-N-CA 127.217 2.207 . . . . 0.0 112.143 -176.386 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.859 0.362 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.13 41.34 3.49 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.032 1.733 . . . . 0.0 109.78 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -64.31 163.52 12.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.799 0.84 . . . . 0.0 109.707 169.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.9 pt -126.37 173.18 12.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.619 1.199 . . . . 0.0 111.217 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -116.16 138.3 51.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -90.72 -132.97 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.17 56.36 0.46 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.656 1.982 . . . . 0.0 111.317 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 22.63 45.02 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.341 0.972 . . . . 0.0 113.506 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.54 140.42 11.06 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.03 144.55 52.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.617 2.212 . . . . 0.0 109.572 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.85 126.73 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.412 0.685 . . . . 0.0 109.415 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -66.73 151.12 48.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.222 1.409 . . . . 0.0 110.509 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.66 145.73 47.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.0 1.72 . . . . 0.0 107.611 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.65 -23.06 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.85 31.31 0.51 Allowed Glycine 0 N--CA 1.464 0.549 0 CA-C-N 118.689 0.677 . . . . 0.0 111.648 -172.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.41 152.12 3.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 9.4 tt0 94.66 33.17 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.504 2.721 . . . . 0.0 113.997 169.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -64.0 152.99 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.47 167.88 25.84 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -169.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.54 129.87 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.209 0.604 . . . . 0.0 109.695 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -2.79 87.58 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.715 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.53 -11.4 59.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.485 1.642 . . . . 0.0 112.235 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 57.08 178.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.563 1.545 . . . . 0.0 112.291 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.85 138.82 33.39 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 127.001 2.12 . . . . 0.0 107.856 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -58.38 -44.39 38.46 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.813 2.342 . . . . 0.0 114.201 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 114.99 124.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 131.218 3.807 . . . . 0.0 105.439 -169.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -133.49 165.37 25.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 109.088 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -126.22 139.44 53.34 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.48 146.11 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.032 1.333 . . . . 0.0 108.276 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.44 166.15 22.31 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.6 p -130.62 -177.54 4.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.932 1.293 . . . . 0.0 108.419 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -47.27 -34.28 6.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.559 0.744 . . . . 0.0 111.537 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -112.77 14.53 19.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.819 1.248 . . . . 0.0 111.531 -170.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.6 mt 51.64 44.16 29.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.742 . . . . 0.0 112.123 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -73.29 -18.12 61.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 112.81 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.12 54.56 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 123.084 1.421 . . . . 0.0 108.604 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -58.76 161.0 5.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.066 1.746 . . . . 0.0 108.869 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.2 p -141.59 170.23 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 tp -54.55 -40.95 69.21 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.63 -20.66 63.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.64 -33.46 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.728 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 37.0 mtt -71.36 -39.73 71.08 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.301 1.041 . . . . 0.0 110.609 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -54.36 138.37 39.69 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 123.317 0.647 . . . . 0.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.24 7.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.01 1.29 . . . . 0.0 112.553 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -147.92 155.77 41.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.598 1.159 . . . . 0.0 109.258 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.41 139.67 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.1 m -135.36 147.83 49.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.231 1.012 . . . . 0.0 108.738 -172.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.09 136.78 54.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.3 mt -135.27 128.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.0 m -108.9 141.33 41.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -135.48 125.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.9 pt -150.06 159.6 35.12 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.201 1.8 . . . . 0.0 107.178 -170.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.71 -40.39 79.95 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.123 1.882 . . . . 0.0 112.234 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.07 165.53 15.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.812 1.645 . . . . 0.0 109.099 169.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pp -67.23 41.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 125.915 1.686 . . . . 0.0 112.861 169.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -158.18 -29.03 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.148 . . . . 0.0 113.208 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -72.57 32.51 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -168.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.82 -29.6 1.8 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.006 1.289 . . . . 0.0 114.591 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.3 -3.72 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.379 1.472 . . . . 0.0 113.202 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 29.2 m -74.45 33.36 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.975 -1.078 . . . . 0.0 110.65 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.38 179.84 1.18 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.099 1.36 . . . . 0.0 111.259 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.38 31.61 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.567 1.147 . . . . 0.0 113.235 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -62.94 -56.76 14.32 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.714 1.143 . . . . 0.0 109.437 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -62.16 -42.55 99.37 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 109.779 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -61.71 -53.95 49.14 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.829 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -64.11 -45.88 86.67 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.846 0.748 . . . . 0.0 110.268 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -54.09 -52.17 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.175 0.99 . . . . 0.0 110.853 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.18 -35.95 81.8 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.915 0.388 . . . . 0.0 110.823 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -69.98 -37.25 75.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.257 0.623 . . . . 0.0 111.838 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -74.49 -34.34 63.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.171 0.896 . . . . 0.0 110.919 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.32 -46.41 76.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.708 0.685 . . . . 0.0 110.794 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.97 -16.44 51.29 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.838 0.855 . . . . 0.0 113.293 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -83.21 -27.09 30.23 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.067 0.849 . . . . 0.0 111.847 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.0 -33.82 76.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.581 0.628 . . . . 0.0 110.987 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.36 -168.01 40.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -75.71 28.16 0.11 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.745 -0.856 . . . . 0.0 112.217 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -54.76 138.42 14.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.528 1.131 . . . . 0.0 109.059 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -66.13 137.97 57.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.07 119.53 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.61 149.62 52.18 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.915 0.486 . . . . 0.0 110.745 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 m -133.76 116.1 15.34 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mt -92.14 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -133.72 162.08 32.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.094 2.158 . . . . 0.0 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.06 -20.28 0.18 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.204 1.402 . . . . 0.0 112.95 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -80.39 70.85 7.15 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.6 mp -48.52 -35.1 8.12 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.59 -28.22 21.48 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.61 2.206 . . . . 0.0 114.834 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -117.38 -16.61 10.24 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.09 0.859 . . . . 0.0 112.26 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.73 148.22 20.87 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.582 0.753 . . . . 0.0 110.503 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 51.39 21.9 1.31 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.541 1.536 . . . . 0.0 113.778 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.02 -36.02 0.43 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -109.97 7.11 23.64 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.875 1.216 . . . . 0.0 114.173 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 62.9 m95 24.2 72.58 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.723 2.809 . . . . 0.0 116.309 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.7 p -63.72 -15.05 57.51 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.675 -0.64 . . . . 0.0 112.393 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.36 -148.85 5.88 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 127.205 2.336 . . . . 0.0 107.738 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 54.69 41.43 31.94 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.702 1.201 . . . . 0.0 111.659 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -141.14 148.15 39.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.962 1.705 . . . . 0.0 107.278 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.04 -60.37 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 77.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 122.696 1.236 . . . . 0.0 108.898 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.88 -20.11 14.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.338 1.855 . . . . 0.0 113.974 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -58.38 -30.98 67.21 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.734 -0.604 . . . . 0.0 112.098 173.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.56 142.24 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.67 138.24 44.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.47 143.05 32.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.825 0.85 . . . . 0.0 108.817 -173.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -124.07 156.39 36.64 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.78 1.632 . . . . 0.0 108.247 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -136.41 144.44 44.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -134.26 -16.23 2.16 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -64.29 -14.32 55.21 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.717 -1.24 . . . . 0.0 114.143 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -65.55 -18.88 65.65 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.276 -0.89 . . . . 0.0 112.155 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -147.19 -15.64 0.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 35.6 mmm 50.15 37.33 14.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.245 1.818 . . . . 0.0 111.99 -169.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -56.94 15.43 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -63.3 -37.85 88.87 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.687 0.676 . . . . 0.0 109.812 175.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.77 -55.48 8.21 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.482 1.991 . . . . 0.0 113.216 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.47 -35.2 40.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.154 0.477 . . . . 0.0 110.506 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.47 79.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.186 0.595 . . . . 0.0 112.334 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.62 2.43 16.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.915 1.286 . . . . 0.0 110.684 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 8.08 62.55 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.289 -0.882 . . . . 0.0 114.276 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 m -79.47 -4.55 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.043 1.737 . . . . 0.0 112.175 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -67.0 115.76 7.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.5 mt -75.48 106.86 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -54.72 -40.63 69.45 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.805 0.842 . . . . 0.0 110.85 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -86.88 -5.1 59.21 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.02 -7.03 2.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.168 0.894 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 15.8 ptm180 40.2 43.33 1.36 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.89 2.076 . . . . 0.0 113.763 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt -131.74 175.83 8.85 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.04 129.55 34.78 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.758 0.823 . . . . 0.0 109.318 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 139.24 57.86 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.998 1.319 . . . . 0.0 111.1 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.49 113.14 3.1 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.4 p -154.15 164.13 39.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.284 0.564 . . . . 0.0 109.873 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 t -141.74 136.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -142.85 152.09 41.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.564 0.745 . . . . 0.0 109.229 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.65 136.25 52.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -130.85 136.74 48.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.86 1.264 . . . . 0.0 108.372 -169.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.06 165.46 15.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.22 1.408 . . . . 0.0 110.514 169.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.51 -33.22 20.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 113.182 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.32 5.74 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.172 0.897 . . . . 0.0 113.304 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.3 -7.59 75.49 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.607 1.099 . . . . 0.0 113.091 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.48 125.32 24.79 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.613 1.207 . . . . 0.0 109.034 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.86 128.75 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.94 -8.53 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.122 1.369 . . . . 0.0 111.04 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -153.86 150.48 28.45 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.7 133.74 11.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.522 1.529 . . . . 0.0 107.913 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -143.57 149.8 37.92 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.327 0.651 . . . . 0.0 110.138 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -128.09 112.74 14.92 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.09 133.47 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -57.9 -20.3 36.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.043 0.937 . . . . 0.0 112.633 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.43 124.47 13.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.49 -32.04 72.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.394 0.678 . . . . 0.0 112.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -79.41 17.28 0.87 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.483 1.113 . . . . 0.0 111.65 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -134.31 171.27 14.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 107.054 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.84 151.13 76.83 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 111.435 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -86.64 176.09 4.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.064 3.176 . . . . 0.0 110.421 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -71.52 133.37 45.77 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -110.7 3.07 18.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.0 0.52 . . . . 0.0 112.192 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.59 -40.27 42.75 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -54.65 -50.79 83.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.315 -1.326 . . . . 0.0 112.403 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.46 -36.64 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 CA-C-N 121.84 1.693 . . . . 0.0 112.431 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.5 mm -59.48 -46.75 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.315 0.961 . . . . 0.0 109.588 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.45 -35.85 82.15 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.304 -0.872 . . . . 0.0 110.845 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.87 98.46 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.356 0.262 . . . . 0.0 110.642 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.27 -47.04 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.919 0.488 . . . . 0.0 110.682 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.96 -42.5 72.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.211 0.914 . . . . 0.0 110.484 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.4 -31.12 67.39 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.346 0.658 . . . . 0.0 111.881 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -84.74 -44.01 13.74 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.763 0.425 . . . . 0.0 111.612 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.87 -51.35 24.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 123.774 0.83 . . . . 0.0 111.55 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.249 1.068 0 C-N-CA 123.948 0.899 . . . . 0.0 109.666 -178.455 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 118.973 -0.536 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.46 11.94 4.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.442 1.097 . . . . 0.0 112.001 169.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.13 169.49 18.62 Favored 'General case' 0 N--CA 1.435 -1.218 1 C-N-CA 132.077 4.151 . . . . 0.0 106.275 178.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.57 172.81 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 122.397 1.094 . . . . 0.0 110.07 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 m -134.01 143.82 48.34 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.81 -2.292 . . . . 0.0 104.81 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -138.39 127.18 23.7 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 47.34 38.77 7.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.922 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.6 20.35 79.57 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.309 -0.717 . . . . 0.0 114.526 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.08 121.35 4.41 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 172.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.34 140.91 82.32 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.827 2.351 . . . . 0.0 110.715 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.25 135.81 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -74.78 157.7 34.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.597 1.559 . . . . 0.0 109.406 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 144.64 48.71 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.0 t -60.88 -52.18 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.495 0.718 . . . . 0.0 112.33 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.66 37.57 3.17 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.707 1.146 . . . . 0.0 112.41 -170.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.15 169.95 0.16 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.537 1.935 . . . . 0.0 115.018 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 77.18 28.21 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.769 2.028 . . . . 0.0 113.306 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -64.0 145.82 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -150.43 164.57 35.56 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.936 0.895 . . . . 0.0 109.555 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 p -53.0 133.04 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.305 0.642 . . . . 0.0 109.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.62 1.21 90.49 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.737 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.63 -12.93 60.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.439 1.619 . . . . 0.0 112.314 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.17 176.4 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.81 1.644 . . . . 0.0 112.025 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.72 147.58 63.33 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.647 1.579 . . . . 0.0 110.363 -173.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.02 -51.39 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.776 2.317 . . . . 0.0 112.277 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t70 118.11 127.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 1 C-N-CA 131.844 4.058 . . . . 0.0 105.88 -169.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.75 166.51 23.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.832 1.653 . . . . 0.0 108.844 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 m -132.13 138.2 47.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.52 174.47 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 127.778 2.431 . . . . 0.0 107.686 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.3 140.93 46.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.8 p -70.84 174.87 5.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.143 1.777 . . . . 0.0 110.846 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.52 -22.08 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.505 -0.747 . . . . 0.0 110.928 169.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 m -84.11 0.18 49.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.485 1.514 . . . . 0.0 111.859 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.3 mt 52.73 49.74 19.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.427 1.891 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.33 159.95 26.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.358 1.463 . . . . 0.0 107.451 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.66 144.46 47.75 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.915 0.864 . . . . 0.0 111.026 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -142.11 151.39 42.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.619 2.368 . . . . 0.0 105.129 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 p -135.08 165.08 26.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -56.85 -37.53 71.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 174.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.88 67.59 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -78.95 -30.48 44.59 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.794 0.725 . . . . 0.0 111.259 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 48.6 mtt -72.03 -41.1 67.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.966 0.906 . . . . 0.0 110.887 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -54.3 146.06 16.38 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.238 1.015 . . . . 0.0 110.057 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.11 -21.15 12.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.937 1.256 . . . . 0.0 112.612 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -146.8 152.98 39.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.321 1.448 . . . . 0.0 108.443 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.77 141.14 17.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.4 m -135.02 146.8 49.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -172.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 90.1 mt -128.51 135.23 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.4 102.94 3.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.8 m -79.84 151.22 30.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.74 126.86 39.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.5 pt -137.84 147.75 57.99 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.742 0.417 . . . . 0.0 110.132 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.56 -34.41 7.34 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.187 1.925 . . . . 0.0 111.565 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -163.95 172.38 14.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.739 1.615 . . . . 0.0 109.179 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 pp -105.54 -9.36 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.77 1.228 . . . . 0.0 110.794 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -69.17 -34.57 75.17 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.651 -0.656 . . . . 0.0 110.282 169.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.36 146.82 52.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.478 1.511 . . . . 0.0 110.726 173.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.24 -3.25 52.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.223 0.916 . . . . 0.0 114.618 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.93 -22.72 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.966 1.307 . . . . 0.0 112.412 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 90.9 m -51.6 -65.07 0.62 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.872 1.269 . . . . 0.0 110.342 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.13 -33.05 50.68 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.054 0.541 . . . . 0.0 110.903 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.19 86.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.908 -0.568 . . . . 0.0 111.966 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -159.11 -39.16 0.06 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -64.78 -46.16 83.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.549 1.068 . . . . 0.0 112.567 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -69.92 -29.58 66.78 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.858 -1.151 . . . . 0.0 112.444 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -78.52 -45.27 22.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.274 0.943 . . . . 0.0 109.971 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.24 -44.96 96.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.175 -0.44 . . . . 0.0 111.376 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -63.04 -40.44 97.72 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.232 0.613 . . . . 0.0 110.417 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.37 -51.46 67.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.678 0.791 . . . . 0.0 109.851 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -64.16 -37.01 85.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.541 0.736 . . . . 0.0 110.973 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.87 76.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.468 1.507 . . . . 0.0 110.108 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -26.83 68.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.573 0.349 . . . . 0.0 111.932 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.13 -20.55 55.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.077 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.34 -36.54 84.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.267 1.394 . . . . 0.0 111.596 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.71 -170.91 43.48 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -74.22 21.62 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.26 150.56 2.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 O-C-N 120.7 -1.25 . . . . 0.0 110.786 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.17 143.41 47.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 125.01 43.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.57 156.37 45.87 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.601 0.76 . . . . 0.0 109.94 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.9 m -132.48 114.59 14.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -97.44 132.79 41.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 m -142.59 169.16 18.09 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.839 1.255 . . . . 0.0 109.305 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.13 169.48 10.18 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 110.738 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -80.86 -12.33 59.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.615 0.766 . . . . 0.0 112.007 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 28.4 tp -51.38 136.8 31.17 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.686 1.595 . . . . 0.0 110.075 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -51.94 -42.2 59.46 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.815 2.343 . . . . 0.0 113.202 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -66.55 3.06 1.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.912 1.285 . . . . 0.0 113.583 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.23 -2.93 3.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.93 2.092 . . . . 0.0 111.811 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -149.63 27.35 0.81 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.493 1.042 . . . . 0.0 112.728 -168.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.67 160.92 41.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.452 1.501 . . . . 0.0 107.292 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 47.22 41.81 12.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.288 1.035 . . . . 0.0 111.195 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -46.74 107.12 0.1 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.515 1.926 . . . . 0.0 112.378 -172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.6 p -72.23 -45.06 61.78 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.961 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.15 -10.3 59.1 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.578 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.9 -6.91 12.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.93 1.365 . . . . 0.0 112.352 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 109.84 2.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.381 0.537 . . . . 0.0 109.945 -170.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.24 -1.43 60.64 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.391 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.22 90.38 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.951 1.875 . . . . 0.0 109.313 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.35 -30.85 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.447 1.899 . . . . 0.0 114.547 -173.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.57 -30.21 71.36 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 t -76.98 144.78 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.01 131.26 28.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.592 0.71 . . . . 0.0 109.448 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.37 144.94 32.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.576 1.151 . . . . 0.0 109.304 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -132.6 155.36 48.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.332 1.453 . . . . 0.0 109.477 -170.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -112.94 138.26 50.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.388 1.075 . . . . 0.0 108.467 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.57 -17.93 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -61.79 -11.17 11.14 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.11 -0.994 . . . . 0.0 113.414 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -46.62 -45.31 18.98 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.529 1.532 . . . . 0.0 110.608 169.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.54 3.75 0.57 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 43.0 mmm 51.27 37.53 18.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.692 1.597 . . . . 0.0 112.127 -172.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -57.35 -59.77 4.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.423 1.089 . . . . 0.0 110.61 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -62.75 -36.5 83.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.072 0.949 . . . . 0.0 109.459 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.9 -60.56 3.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 126.195 1.855 . . . . 0.0 113.023 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.01 -35.26 57.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.194 0.497 . . . . 0.0 110.354 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.46 85.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.45 5.38 15.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.202 1.401 . . . . 0.0 110.782 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.45 64.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.282 -0.886 . . . . 0.0 112.834 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.95 0.2 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.483 1.113 . . . . 0.0 111.366 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -71.12 106.51 3.77 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 124' ' ' LEU . 64.8 mt -65.62 121.19 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -65.45 -41.35 93.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.909 0.484 . . . . 0.0 110.553 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.78 -61.77 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.865 0.466 . . . . 0.0 110.156 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.418 ' H ' HG22 ' A' ' 121' ' ' ILE . 21.9 tp -71.76 -19.27 62.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.646 0.778 . . . . 0.0 112.452 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 54.11 41.52 31.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.148 1.379 . . . . 0.0 111.658 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.7 mt -128.07 179.01 5.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.775 1.23 . . . . 0.0 108.371 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.11 133.83 41.45 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.171 0.989 . . . . 0.0 108.831 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.78 152.67 38.76 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.58 1.152 . . . . 0.0 111.177 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.03 110.58 16.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 169.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -150.41 172.11 15.94 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -149.79 144.5 17.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.08 158.0 44.75 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.243 1.417 . . . . 0.0 108.781 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.86 144.36 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.03 126.57 20.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.219 1.008 . . . . 0.0 109.738 -168.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.01 161.51 24.17 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.465 1.506 . . . . 0.0 110.658 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -48.67 -33.93 10.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 112.686 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.5 5.23 36.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.157 1.383 . . . . 0.0 112.733 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.92 -5.72 83.16 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 120.885 -1.134 . . . . 0.0 112.74 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -72.76 121.27 19.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.006 1.403 . . . . 0.0 108.729 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.22 125.72 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.06 -10.89 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.462 1.105 . . . . 0.0 110.223 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -152.42 152.28 31.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.434 1.094 . . . . 0.0 108.268 170.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.21 137.46 14.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.86 1.664 . . . . 0.0 107.493 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -144.83 139.61 27.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -113.48 109.49 18.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.0 t -64.45 115.17 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.2 m -53.21 -25.66 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.994 1.318 . . . . 0.0 113.205 -170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.05 107.65 6.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.19 -25.37 68.04 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.333 1.853 . . . . 0.0 112.462 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.72 15.02 1.48 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.097 1.359 . . . . 0.0 111.695 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.53 175.94 9.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.767 2.827 . . . . 0.0 106.692 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -122.87 154.2 64.02 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.656 1.117 . . . . 0.0 112.135 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.67 177.05 2.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.397 3.398 . . . . 0.0 111.15 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -76.58 130.92 38.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -104.8 -3.98 22.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -33.97 69.97 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.59 -55.67 42.26 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.782 1.233 . . . . 0.0 112.588 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.97 -34.45 59.35 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.74 1.657 . . . . 0.0 111.963 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 mm -60.22 -46.39 94.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.824 1.193 . . . . 0.0 109.707 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.95 -31.86 71.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.716 1.143 . . . . 0.0 110.93 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.15 -39.46 94.73 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.052 0.387 . . . . 0.0 111.012 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.11 68.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.633 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -55.4 -38.61 69.14 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.274 0.943 . . . . 0.0 110.968 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.24 -28.39 64.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.562 0.745 . . . . 0.0 112.299 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.93 -48.3 7.08 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.553 . . . . 0.0 111.334 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.86 -45.46 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.362 1.065 . . . . 0.0 110.837 -171.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt . . . . . 0 C--O 1.25 1.113 0 C-N-CA 126.825 2.05 . . . . 0.0 110.793 179.371 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.9 28.65 0.49 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.397 -1.439 . . . . 0.0 112.971 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -164.93 173.3 11.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.043 2.937 . . . . 0.0 105.05 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 pt -136.98 173.33 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 123.478 1.609 . . . . 0.0 110.941 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 m -118.82 154.45 32.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -137.61 121.45 17.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.25 40.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.595 1.558 . . . . 0.0 113.641 -172.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.34 5.48 89.55 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.698 -0.626 . . . . 0.0 114.087 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.03 113.64 4.09 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.639 1.59 . . . . 0.0 109.541 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.1 139.59 71.25 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.942 2.428 . . . . 0.0 111.06 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.6 127.5 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.521 0.677 . . . . 0.0 109.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -69.48 151.73 45.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.998 1.319 . . . . 0.0 110.112 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.68 158.47 23.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.069 1.747 . . . . 0.0 108.694 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.71 -51.66 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.54 29.77 3.75 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.468 1.032 . . . . 0.0 111.92 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.84 164.51 1.51 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.595 1.158 . . . . 0.0 113.348 -172.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 103.64 20.64 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.321 3.048 . . . . 0.0 111.138 170.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.81 136.8 21.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -145.93 166.75 25.1 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.529 1.131 . . . . 0.0 108.131 -171.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.7 130.66 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.39 90.25 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.766 -1.019 . . . . 0.0 114.082 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.51 -8.15 58.95 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.548 1.674 . . . . 0.0 112.37 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 59.92 175.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.501 1.52 . . . . 0.0 112.097 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.22 115.5 13.98 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.89 1.676 . . . . 0.0 108.293 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.4 144.79 99.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.369 2.046 . . . . 0.0 112.699 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -82.07 62.1 5.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -94.09 173.4 7.67 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.4 m -118.55 151.32 38.09 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.718 0.77 . . . . 0.0 111.559 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.49 166.8 20.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.282 2.233 . . . . 0.0 106.996 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mp -109.56 154.49 22.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -83.46 178.81 7.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.053 0.941 . . . . 0.0 109.592 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.19 -26.88 68.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.728 -1.232 . . . . 0.0 110.938 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -80.62 1.49 29.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.313 1.445 . . . . 0.0 111.784 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.0 mt 55.12 35.82 25.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.857 2.063 . . . . 0.0 112.336 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.09 149.58 22.35 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.53 143.7 46.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.544 0.738 . . . . 0.0 110.095 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -144.9 102.19 3.74 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.6 m -70.97 154.24 41.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 27.2 tp -52.53 -39.65 61.62 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.671 -0.643 . . . . 0.0 111.05 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -18.85 40.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.7 -32.29 63.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.593 1.088 . . . . 0.0 110.886 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.4 mtt -73.41 -39.75 64.81 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.629 1.172 . . . . 0.0 110.229 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -55.81 150.48 12.91 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.814 0.816 . . . . 0.0 110.406 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.13 23.15 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.203 1.382 . . . . 0.0 112.216 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -149.14 153.86 38.33 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 108.749 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.22 138.5 16.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.4 m -134.82 148.4 50.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.068 0.947 . . . . 0.0 108.885 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.9 mt -132.81 132.84 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.99 105.99 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -84.46 149.65 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 168.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 t -134.0 128.99 53.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.5 pt -143.84 144.33 26.47 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.673 0.789 . . . . 0.0 109.374 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.75 -33.64 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.061 1.841 . . . . 0.0 111.709 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -154.01 173.15 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.594 1.958 . . . . 0.0 108.692 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.1 pt -132.91 -31.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.11 1.364 . . . . 0.0 110.94 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.64 -12.08 50.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.648 0.737 . . . . 0.0 110.979 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -64.11 -19.63 65.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.825 2.05 . . . . 0.0 112.762 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.71 65.56 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.852 0.739 . . . . 0.0 112.841 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.35 -19.61 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.0 1.4 . . . . 0.0 112.026 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.66 -58.09 9.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 170.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.11 -32.72 72.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.284 0.633 . . . . 0.0 111.131 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -47.86 84.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.005 -0.521 . . . . 0.0 111.383 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -165.86 -35.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -43.55 97.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 112.343 -169.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -62.49 -51.44 67.42 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.436 1.016 . . . . 0.0 109.763 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -62.65 -48.47 79.19 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.617 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -57.36 -51.3 69.96 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.494 0.588 . . . . 0.0 110.86 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -61.41 -40.08 93.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.964 0.906 . . . . 0.0 111.499 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.82 -46.73 71.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.518 0.727 . . . . 0.0 110.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.87 -36.24 81.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.184 0.902 . . . . 0.0 110.672 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.34 77.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.748 0.819 . . . . 0.0 110.292 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.4 -24.47 67.41 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -80.49 -19.12 46.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 112.539 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.59 -39.56 93.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.957 1.253 . . . . 0.0 111.86 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.71 -167.35 39.15 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.19 25.72 0.1 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.468 1.107 . . . . 0.0 112.912 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -57.24 142.32 13.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.206 1.402 . . . . 0.0 110.715 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -72.83 137.87 46.0 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 168.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.28 124.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -137.82 153.94 49.58 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.828 0.851 . . . . 0.0 110.323 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 m -126.16 103.94 7.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.7 mt -77.32 131.76 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.6 m -132.25 165.34 24.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.164 1.385 . . . . 0.0 109.314 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.69 169.6 6.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.798 0.808 . . . . 0.0 110.621 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -74.02 -22.11 59.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.727 0.811 . . . . 0.0 110.67 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.0 tp -52.43 129.2 42.99 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.448 1.499 . . . . 0.0 110.278 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.84 -39.4 68.16 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.096 2.531 . . . . 0.0 113.594 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -64.89 0.47 1.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.611 1.164 . . . . 0.0 113.898 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.99 -8.46 16.58 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.246 1.418 . . . . 0.0 113.001 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -143.1 -24.87 0.61 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.053 1.297 . . . . 0.0 114.354 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.85 -31.57 71.84 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.346 1.43 . . . . 0.0 113.496 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -87.89 -11.18 48.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.4 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.1 p90 32.23 48.39 0.11 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.338 2.655 . . . . 0.0 114.59 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.9 p -59.62 -28.57 67.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.15 -14.22 57.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.961 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.68 33.59 5.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.827 1.314 . . . . 0.0 110.395 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -141.24 135.58 30.82 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.46 -15.59 7.17 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.334 -0.704 . . . . 0.0 112.642 -170.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mt -128.83 76.93 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.2 -26.25 38.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -63.67 -27.66 69.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.502 1.121 . . . . 0.0 112.642 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.75 154.13 3.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.27 146.81 39.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.4 148.81 24.04 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.37 157.05 35.97 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.461 1.505 . . . . 0.0 108.554 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -128.82 49.25 2.24 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.193 2.197 . . . . 0.0 108.947 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -47.18 -41.82 18.68 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.567 0.747 . . . . 0.0 111.358 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -56.15 -19.89 15.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.166 0.986 . . . . 0.0 113.631 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -68.7 -22.33 64.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.048 -1.033 . . . . 0.0 111.618 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -133.72 -26.14 1.6 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.085 0.954 . . . . 0.0 112.999 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.79 -4.03 0.27 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.789 3.235 . . . . 0.0 115.731 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -57.25 -52.57 64.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.718 1.144 . . . . 0.0 110.965 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.67 -35.14 78.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.593 0.633 . . . . 0.0 111.129 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.24 -43.22 98.71 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.63 0.633 . . . . 0.0 112.119 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.66 -38.88 80.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.634 0.717 . . . . 0.0 110.31 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.82 84.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.644 0.778 . . . . 0.0 111.88 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.83 -6.19 58.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.72 0.808 . . . . 0.0 111.08 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.46 1.9 62.2 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.119 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.89 -19.74 26.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 124.638 1.175 . . . . 0.0 111.137 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.66 118.35 6.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.313 0.961 . . . . 0.0 108.651 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -81.61 105.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 126.197 1.799 . . . . 0.0 106.425 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.24 -40.59 61.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.752 1.221 . . . . 0.0 110.869 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -88.79 -4.74 58.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.34 0.656 . . . . 0.0 112.714 -170.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.6 tp -137.37 -5.8 1.8 Allowed 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.117 -0.989 . . . . 0.0 113.047 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 32.2 ptt-85 42.5 45.8 3.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.949 1.7 . . . . 0.0 112.767 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -134.87 176.59 8.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.119 1.768 . . . . 0.0 106.358 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.261 0.0 OUTLIER -106.49 147.5 29.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 121.884 2.129 . . . . 0.0 111.862 170.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.03 156.58 35.67 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.741 2.016 . . . . 0.0 112.785 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -82.54 116.34 21.92 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.2 m -150.79 167.06 28.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 108.96 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.93 142.96 19.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.22 151.83 42.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.775 1.23 . . . . 0.0 108.111 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.9 t -135.07 135.44 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -130.26 135.53 48.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.361 1.064 . . . . 0.0 109.239 -169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.48 167.25 5.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 109.502 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -51.13 -34.12 29.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.041 1.336 . . . . 0.0 112.711 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -80.24 -0.57 36.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.473 1.109 . . . . 0.0 112.547 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.66 79.33 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.896 1.236 . . . . 0.0 112.606 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.64 117.3 5.6 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.244 1.522 . . . . 0.0 109.469 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.84 115.67 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.848 0.859 . . . . 0.0 109.447 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.6 -12.21 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.657 1.183 . . . . 0.0 110.664 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -147.17 144.68 29.13 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.31 126.36 7.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.317 1.447 . . . . 0.0 107.283 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.82 145.56 29.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -114.47 111.08 20.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 t -61.95 125.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -172.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -59.42 -13.32 8.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.472 1.109 . . . . 0.0 113.663 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.6 128.13 21.42 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.98 63.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.065 . . . . 0.0 113.667 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.2 p -84.68 -4.49 59.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.083 1.31 . . . . 0.0 112.637 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -98.07 177.24 5.48 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.438 1.495 . . . . 0.0 109.974 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -133.51 151.57 77.57 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.015 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.0 -176.68 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.663 2.908 . . . . 0.0 109.249 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -76.85 119.47 20.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -91.29 -0.87 57.74 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.28 -36.05 40.33 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -51.21 -55.45 28.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.134 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.27 -33.88 47.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.584 1.601 . . . . 0.0 112.728 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.81 -45.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.185 1.357 . . . . 0.0 109.879 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.54 -36.84 85.0 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.376 0.989 . . . . 0.0 110.596 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.12 96.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.082 0.553 . . . . 0.0 111.178 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.15 -41.89 76.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.28 0.945 . . . . 0.0 110.302 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.29 -31.89 70.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.162 0.585 . . . . 0.0 112.012 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.59 -40.45 23.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.076 0.55 . . . . 0.0 111.807 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.55 -54.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.454 0.702 . . . . 0.0 109.483 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.1 pttt . . . . . 0 C--O 1.25 1.083 0 C-N-CA 127.722 2.409 . . . . 0.0 112.036 -178.231 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.11 11.19 0.76 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -146.14 143.79 29.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 169.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.6 pt -130.33 -178.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 122.172 0.987 . . . . 0.0 110.92 -169.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -127.1 146.35 50.41 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -143.68 133.25 23.56 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm 43.7 42.38 4.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.586 1.555 . . . . 0.0 112.138 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.18 28.5 70.04 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.161 -0.799 . . . . 0.0 114.54 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 139.6 10.52 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 169.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.39 145.33 42.73 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.592 2.195 . . . . 0.0 110.151 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.27 134.72 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.242 1.017 . . . . 0.0 110.28 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -75.29 152.81 38.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.156 1.782 . . . . 0.0 110.448 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.78 148.76 42.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.98 1.712 . . . . 0.0 108.08 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.15 -84.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.361 0.528 . . . . 0.0 110.935 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 40.48 2.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.296 1.427 . . . . 0.0 112.019 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -58.06 171.05 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.196 2.198 . . . . 0.0 114.593 -169.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 78.52 28.27 0.46 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.817 2.047 . . . . 0.0 114.032 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.6 138.88 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -148.4 164.08 35.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.451 1.1 . . . . 0.0 108.578 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.8 132.97 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 -0.52 89.65 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.219 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -76.55 -13.65 60.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.544 1.672 . . . . 0.0 112.657 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 60.95 157.15 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.813 2.045 . . . . 0.0 112.959 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.58 133.37 46.95 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.342 1.057 . . . . 0.0 109.049 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.3 -27.66 76.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.493 2.795 . . . . 0.0 114.772 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 62.43 98.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.381 2.272 . . . . 0.0 112.113 -170.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -129.49 170.47 13.68 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.901 1.68 . . . . 0.0 108.316 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.9 167.32 11.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.53 1.132 . . . . 0.0 109.279 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.9 -176.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 128.053 2.541 . . . . 0.0 104.215 168.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.05 139.16 35.87 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.6 p -87.64 171.08 10.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 118.821 0.737 . . . . 0.0 109.744 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.443 -0.785 . . . . 0.0 110.733 168.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m -79.35 1.58 24.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.717 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt 61.47 32.58 18.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.684 2.394 . . . . 0.0 112.201 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -91.89 140.33 29.78 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.91 55.83 2.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.085 1.754 . . . . 0.0 110.184 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.41 157.03 5.33 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.065 1.346 . . . . 0.0 108.394 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -133.5 163.8 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.03 -28.5 66.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.022 -0.424 . . . . 0.0 111.958 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.63 -19.71 51.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.085 -1.009 . . . . 0.0 113.647 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.2 -28.49 61.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.443 1.019 . . . . 0.0 110.941 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -74.01 -41.7 61.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.725 1.21 . . . . 0.0 110.039 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 133.48 49.49 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.54 -23.28 4.28 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.992 1.282 . . . . 0.0 112.426 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -154.99 157.38 37.58 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.663 1.185 . . . . 0.0 108.371 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -59.24 143.06 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -137.68 148.04 45.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.269 1.028 . . . . 0.0 108.243 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.2 mt -129.07 137.95 55.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.7 mt -132.17 124.13 51.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.2 t -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.99 131.37 64.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -139.78 136.99 17.86 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.591 0.757 . . . . 0.0 111.451 -170.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.8 -28.71 2.01 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.167 2.578 . . . . 0.0 112.146 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -163.42 170.69 17.06 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.072 1.749 . . . . 0.0 107.739 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -126.13 -18.91 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.109 1.364 . . . . 0.0 110.528 169.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.38 -13.39 58.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.866 0.867 . . . . 0.0 111.362 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 p -61.12 -22.22 64.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.08 1.752 . . . . 0.0 112.252 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.77 -10.24 65.76 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.017 0.817 . . . . 0.0 112.4 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.92 -29.11 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.663 1.231 . . . . 0.0 109.707 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.48 -55.4 35.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.933 0.333 . . . . 0.0 110.11 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -38.79 80.37 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.334 0.253 . . . . 0.0 111.038 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.63 -32.74 73.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.763 -0.636 . . . . 0.0 112.523 -175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -149.62 -46.36 0.13 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.361 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -60.51 -34.64 74.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.994 1.725 . . . . 0.0 111.531 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -50.69 -65.79 0.5 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.274 0.63 . . . . 0.0 109.844 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.89 -40.73 87.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.006 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -58.25 -54.91 41.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 122.502 0.321 . . . . 0.0 110.395 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -76.21 -27.77 56.96 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.918 -171.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.88 -53.08 62.08 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.658 1.183 . . . . 0.0 109.701 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.48 -39.68 88.92 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.324 0.511 . . . . 0.0 110.573 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.82 81.05 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.438 0.695 . . . . 0.0 110.828 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.13 -20.44 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -93.59 -14.86 26.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.413 1.006 . . . . 0.0 112.7 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.75 -31.88 73.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.666 1.121 . . . . 0.0 111.929 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.41 -158.69 31.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.89 26.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.286 1.434 . . . . 0.0 112.533 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.44 135.98 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.105 1.362 . . . . 0.0 108.022 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.95 146.57 52.65 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.72 127.19 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.11 151.34 51.34 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.615 0.766 . . . . 0.0 110.796 -173.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.8 m -133.72 100.34 4.74 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.34 128.71 39.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -125.64 150.18 47.79 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.58 174.1 10.77 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.402 0.62 . . . . 0.0 111.947 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.2 -17.91 62.5 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.166 1.386 . . . . 0.0 112.668 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.8 tp -51.85 133.98 37.85 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.732 1.613 . . . . 0.0 111.134 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -54.19 -27.98 49.58 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.269 2.646 . . . . 0.0 114.436 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -81.96 12.79 3.78 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.851 1.26 . . . . 0.0 112.633 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.08 168.1 15.07 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.028 1.731 . . . . 0.0 109.002 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 60.11 177.08 0.09 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.296 1.839 . . . . 0.0 113.481 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 60.61 -28.78 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.702 3.201 . . . . 0.0 117.123 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -129.26 20.64 5.75 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.721 1.608 . . . . 0.0 110.309 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -43.31 101.81 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.626 2.37 . . . . 0.0 111.157 171.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.4 -34.17 73.53 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.361 0.664 . . . . 0.0 111.608 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.57 13.52 62.18 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.814 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.11 26.42 5.18 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.875 1.337 . . . . 0.0 110.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.85 135.64 36.39 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.25 -13.72 43.78 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.879 -173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.43 76.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 125.822 1.649 . . . . 0.0 107.284 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.6 -21.55 10.75 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.489 1.916 . . . . 0.0 113.951 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.45 -27.3 67.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.435 1.094 . . . . 0.0 112.385 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.21 144.73 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.768 0.827 . . . . 0.0 109.227 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.3 129.2 48.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 p -97.67 141.74 30.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.458 1.103 . . . . 0.0 108.682 -172.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -125.47 156.62 38.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 110.077 -169.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -136.12 44.6 2.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.331 2.652 . . . . 0.0 109.11 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.07 -24.92 60.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.396 0.678 . . . . 0.0 112.311 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -51.12 -19.63 1.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.481 1.512 . . . . 0.0 114.387 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -59.52 -27.11 65.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.663 1.119 . . . . 0.0 112.457 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -135.77 -6.96 2.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.78 1.173 . . . . 0.0 113.251 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 86.6 mmm 52.83 26.9 4.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.632 1.573 . . . . 0.0 111.919 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -65.55 0.67 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.006 1.322 . . . . 0.0 111.298 -171.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.9 -36.7 79.92 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.151 0.58 . . . . 0.0 109.507 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.4 -51.56 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 124.249 0.928 . . . . 0.0 111.953 -172.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.39 -41.06 70.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.965 0.506 . . . . 0.0 109.938 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.02 79.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.472 0.709 . . . . 0.0 112.17 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -85.73 -4.84 59.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.762 0.825 . . . . 0.0 111.245 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.07 10.95 62.86 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.015 -0.881 . . . . 0.0 114.223 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.2 m -65.44 -16.98 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.465 1.133 . . . . 0.0 109.982 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.13 106.62 0.45 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.97 125.05 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.27 -37.19 86.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.41 0.684 . . . . 0.0 111.628 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -98.23 -50.71 4.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.284 0.634 . . . . 0.0 111.716 -169.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.7 -24.59 62.68 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.257 0.481 . . . . 0.0 111.306 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 97.3 mtt180 52.54 47.75 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.337 1.455 . . . . 0.0 111.393 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 71.6 mt -129.14 171.06 12.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.027 1.331 . . . . 0.0 107.854 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.62 117.56 22.08 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.42 141.8 40.85 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 111.0 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.86 108.6 1.81 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 m -144.31 164.38 30.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -150.09 139.77 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -142.5 156.11 45.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.554 1.141 . . . . 0.0 108.447 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.9 134.73 48.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -129.5 134.5 47.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.18 165.95 10.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.01 1.324 . . . . 0.0 109.565 169.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -50.24 -37.32 35.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.657 1.183 . . . . 0.0 112.679 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.46 2.91 46.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.76 61.6 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.516 1.055 . . . . 0.0 113.596 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -61.2 118.41 6.82 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.905 1.353 . . . . 0.0 109.166 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.53 113.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.73 0.812 . . . . 0.0 109.054 170.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.08 -26.48 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 0.0 109.459 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -153.38 152.2 30.79 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 107.063 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.68 127.58 5.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -147.08 149.66 33.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -121.59 113.55 19.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.77 119.43 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m -59.12 -19.21 42.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.457 1.503 . . . . 0.0 112.881 -171.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.69 95.72 3.11 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.05 -20.86 65.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.883 0.873 . . . . 0.0 112.599 -172.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 6.17 3.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.722 1.209 . . . . 0.0 112.222 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.98 162.26 30.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.999 2.12 . . . . 0.0 107.854 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -96.99 145.54 29.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.929 -0.482 . . . . 0.0 111.506 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.0 174.15 11.2 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.867 3.045 . . . . 0.0 111.333 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -82.12 129.6 34.86 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -84.03 -11.89 56.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -80.46 -34.57 35.86 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -55.74 -52.05 75.33 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.798 -1.096 . . . . 0.0 112.042 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.6 -37.2 17.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.107 1.431 . . . . 0.0 111.777 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.11 -44.51 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.027 0.831 . . . . 0.0 109.972 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.63 -38.61 91.61 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.156 0.889 . . . . 0.0 110.637 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.54 85.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.26 0.224 . . . . 0.0 111.241 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.28 -47.72 55.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.882 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.62 -39.74 65.18 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.34 0.973 . . . . 0.0 110.796 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.39 -29.66 58.92 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.899 . . . . 0.0 112.267 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.55 -40.42 8.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.488 0.715 . . . . 0.0 111.934 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.94 -39.68 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.362 1.065 . . . . 0.0 111.355 -169.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 C--O 1.248 0.986 0 C-N-CA 123.953 0.901 . . . . 0.0 109.49 179.262 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 119.047 -0.501 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.69 143.96 34.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.291 1.036 . . . . 0.0 111.481 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -146.18 171.86 14.31 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.356 2.663 . . . . 0.0 105.038 170.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 pt -134.15 -179.61 3.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -127.58 149.93 49.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -139.7 126.95 21.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 46.54 34.66 2.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.444 1.098 . . . . 0.0 112.303 -172.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.97 81.93 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.325 -0.86 . . . . 0.0 114.538 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.24 119.25 4.78 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.54 140.53 89.82 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.951 2.434 . . . . 0.0 111.331 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.1 152.93 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.389 1.076 . . . . 0.0 109.559 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -101.71 163.42 12.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.553 1.541 . . . . 0.0 110.307 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.3 mt -113.31 140.51 47.94 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.029 1.331 . . . . 0.0 108.319 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.4 t -75.35 -61.8 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.76 34.04 3.0 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.568 1.08 . . . . 0.0 113.371 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 52.76 -138.21 1.15 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.296 1.438 . . . . 0.0 110.132 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -135.79 132.23 36.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.479 1.112 . . . . 0.0 110.559 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.66 169.08 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 162.69 40.51 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -52.65 130.41 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.86 -3.76 83.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.745 -1.03 . . . . 0.0 114.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -84.31 -3.13 58.06 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.694 1.747 . . . . 0.0 112.726 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 61.65 171.2 0.12 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.4 1.88 . . . . 0.0 112.935 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -119.29 106.49 42.75 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.449 1.5 . . . . 0.0 108.56 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 144.86 99.08 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.393 2.062 . . . . 0.0 113.13 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.96 65.33 7.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.873 2.069 . . . . 0.0 110.937 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -97.47 158.12 15.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.448 170.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.91 163.77 27.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 112.983 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.29 134.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 168.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -76.26 155.18 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.5 p -123.1 174.05 7.47 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -46.49 -32.19 3.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.333 1.053 . . . . 0.0 112.127 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -113.82 15.89 18.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.111 1.364 . . . . 0.0 111.436 -171.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 53.03 45.01 29.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.773 2.029 . . . . 0.0 112.172 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.4 -12.4 58.97 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.311 12.8 pt-20 44.8 48.88 9.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.433 1.893 . . . . 0.0 111.714 -169.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -46.57 122.03 3.89 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.388 2.275 . . . . 0.0 108.646 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.37 146.35 40.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -39.58 57.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.012 0.824 . . . . 0.0 111.093 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.51 -18.84 21.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.35 -29.06 70.43 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.446 1.021 . . . . 0.0 111.241 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.6 mtt -70.62 -32.76 70.22 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.695 1.198 . . . . 0.0 111.701 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -64.39 133.98 53.68 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.64 -25.88 2.94 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.903 1.24 . . . . 0.0 112.168 -171.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -149.47 157.6 43.43 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.288 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.1 135.99 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.0 m -135.36 146.09 48.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.519 1.128 . . . . 0.0 108.165 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.87 135.84 54.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.02 135.8 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.8 p -115.02 151.27 34.5 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.4 t -134.77 133.01 54.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -137.09 146.42 54.46 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.555 1.142 . . . . 0.0 108.67 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.14 -34.14 23.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.527 2.151 . . . . 0.0 111.914 -176.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -143.29 154.23 43.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.758 1.623 . . . . 0.0 106.979 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 tp -90.64 -32.11 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.263 0.625 . . . . 0.0 111.471 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.77 -17.99 27.17 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.371 0.668 . . . . 0.0 112.232 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.3 p -65.74 163.96 15.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.1 1.36 . . . . 0.0 111.707 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.94 -24.2 33.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.937 1.256 . . . . 0.0 114.864 -171.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.45 -29.47 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.906 1.353 . . . . 0.0 112.203 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.6 t -51.74 -51.33 56.99 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.111 1.365 . . . . 0.0 110.762 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.42 -34.6 12.04 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.078 0.551 . . . . 0.0 111.523 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.24 70.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.752 0.821 . . . . 0.0 112.367 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.471 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.0 tm0? -152.62 -39.51 0.1 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-O 117.762 -1.114 . . . . 0.0 112.513 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -60.59 -42.67 97.18 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.177 1.353 . . . . 0.0 112.357 -169.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -56.45 -56.2 24.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.146 0.884 . . . . 0.0 110.469 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.65 -40.96 93.05 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.406 0.548 . . . . 0.0 111.05 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.471 ' CB ' HE21 ' A' ' 63' ' ' GLN . 25.5 t80 -56.48 -52.67 63.82 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.796 0.438 . . . . 0.0 110.785 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -67.52 -34.88 78.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.164 0.186 . . . . 0.0 111.259 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -64.61 -53.26 50.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.357 1.463 . . . . 0.0 109.763 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -63.53 -38.77 92.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.493 0.717 . . . . 0.0 109.456 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.84 78.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.521 0.728 . . . . 0.0 110.738 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.94 -27.09 67.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.083 0.553 . . . . 0.0 112.31 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -76.26 -24.17 54.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.185 175.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.9 mt -63.89 -40.84 97.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.678 1.126 . . . . 0.0 110.475 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.41 -169.43 42.55 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.35 19.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.155 1.382 . . . . 0.0 113.418 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.05 145.19 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.41 1.484 . . . . 0.0 110.923 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -70.43 144.82 51.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.27 132.69 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -145.54 156.75 43.9 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.885 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.5 m -136.1 116.72 13.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 173.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.95 142.22 14.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.711 1.605 . . . . 0.0 107.499 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -136.23 173.39 11.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 110.136 -170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.59 -177.81 2.4 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.433 0.635 . . . . 0.0 109.944 169.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.3 -25.07 65.47 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.943 -0.473 . . . . 0.0 111.349 171.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.0 tp -49.08 110.35 1.5 Allowed Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 126.013 1.725 . . . . 0.0 111.479 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -88.79 -6.28 5.82 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.552 2.168 . . . . 0.0 113.673 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -38.05 -37.28 0.25 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.645 2.378 . . . . 0.0 116.524 -168.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.66 14.4 2.52 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.031 0.832 . . . . 0.0 112.759 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -68.12 -45.45 73.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.363 0.983 . . . . 0.0 108.717 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.15 -9.3 38.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.293 1.037 . . . . 0.0 113.182 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -110.09 8.5 23.93 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.955 1.302 . . . . 0.0 110.757 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 46.23 48.81 13.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.794 1.638 . . . . 0.0 112.767 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 131.47 50.41 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 173.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.6 73.25 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.158 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.88 3.08 1.39 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.028 1.331 . . . . 0.0 113.064 -169.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -85.0 144.53 28.23 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.47 -49.39 3.84 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.636 1.112 . . . . 0.0 110.856 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 pt -76.63 70.19 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 125.747 1.619 . . . . 0.0 109.435 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.61 -23.82 0.75 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.665 2.786 . . . . 0.0 114.961 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -62.37 -30.65 71.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.369 1.068 . . . . 0.0 111.997 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 t -74.57 156.89 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.98 0.912 . . . . 0.0 108.866 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.32 142.29 41.86 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -86.36 134.65 33.71 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -125.01 164.43 20.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.051 2.14 . . . . 0.0 106.724 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.51 169.9 17.45 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.161 0.984 . . . . 0.0 108.749 169.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -149.02 -17.77 0.3 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -58.77 -17.24 21.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.811 -1.181 . . . . 0.0 113.449 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -53.62 -30.04 40.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.452 1.101 . . . . 0.0 112.625 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -142.18 -6.9 0.93 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.549 1.068 . . . . 0.0 112.975 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.08 30.75 5.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.822 2.049 . . . . 0.0 112.714 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -65.29 0.68 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.785 1.634 . . . . 0.0 111.669 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.77 -34.5 75.97 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.684 0.794 . . . . 0.0 110.28 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.43 98.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 124.305 0.955 . . . . 0.0 112.783 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.38 -35.86 71.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.383 1.091 . . . . 0.0 109.946 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.21 74.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.26 2.46 11.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.468 1.507 . . . . 0.0 111.656 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.96 72.09 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 119.321 0.964 . . . . 0.0 112.399 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . 0.253 33.5 m -107.14 3.04 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.397 0.679 . . . . 0.0 111.429 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.65 105.67 12.07 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 124' ' ' LEU . 80.4 mt -67.61 127.85 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -66.37 -48.51 69.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.939 0.896 . . . . 0.0 111.109 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -80.27 -49.55 11.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.603 0.239 . . . . 0.0 110.574 -170.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.448 ' H ' HG22 ' A' ' 121' ' ' ILE . 18.4 tp -78.71 -18.16 54.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 112.084 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 45.14 52.02 8.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.384 1.474 . . . . 0.0 111.371 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.9 tp -139.25 168.93 18.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.04 138.14 47.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.463 0.574 . . . . 0.0 110.056 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.43 155.95 40.01 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.386 1.075 . . . . 0.0 110.737 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -84.66 109.96 18.39 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.0 m -149.88 168.18 24.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.722 0.409 . . . . 0.0 110.519 -173.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.13 147.1 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.599 1.16 . . . . 0.0 108.22 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -146.77 154.82 41.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.353 1.061 . . . . 0.0 109.036 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.92 140.37 40.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 171.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 mp -130.81 137.18 49.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.57 1.548 . . . . 0.0 107.337 -171.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.44 169.12 6.32 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.158 1.383 . . . . 0.0 109.855 169.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -49.58 -37.93 29.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.741 1.217 . . . . 0.0 112.174 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -75.29 -3.16 31.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.193 0.997 . . . . 0.0 112.677 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.1 -6.96 77.41 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.927 -1.108 . . . . 0.0 112.89 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 113.6 3.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 118.871 1.335 . . . . 0.0 108.365 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.4 129.73 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.27 -12.57 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.661 1.584 . . . . 0.0 109.925 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -151.47 150.15 30.07 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.434 1.093 . . . . 0.0 108.413 172.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.2 135.54 13.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.263 1.825 . . . . 0.0 107.168 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 150.28 30.99 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.451 0.7 . . . . 0.0 109.391 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -124.36 116.24 22.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.779 2.032 . . . . 0.0 105.637 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.24 128.68 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -60.05 -26.69 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.537 1.135 . . . . 0.0 113.268 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.01 105.66 6.46 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.7 66.29 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.124 1.37 . . . . 0.0 113.905 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.21 15.93 2.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.89 -175.63 3.84 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.005 2.122 . . . . 0.0 107.978 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -116.96 155.05 49.73 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.006 1.275 . . . . 0.0 112.689 -170.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.24 163.82 32.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -80.07 87.3 5.45 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 168.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -68.57 -5.72 21.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -71.3 -30.01 65.73 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.08 0.855 . . . . 0.0 109.302 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -63.9 -50.74 68.63 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.496 -1.24 . . . . 0.0 111.621 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.58 -32.46 48.29 Favored 'Trans proline' 0 C--N 1.35 0.622 0 CA-C-N 121.707 1.646 . . . . 0.0 112.111 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.5 mm -59.78 -44.82 94.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.998 1.272 . . . . 0.0 109.816 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.97 -37.15 86.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.262 0.937 . . . . 0.0 110.9 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.62 91.64 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.396 -0.19 . . . . 0.0 111.24 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.17 -46.49 70.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.59 173.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -53.78 -40.87 66.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.277 0.944 . . . . 0.0 110.545 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.0 65.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 112.204 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.9 mt -90.94 -41.81 10.93 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.954 0.502 . . . . 0.0 112.074 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.5 t -70.37 -42.43 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.952 0.901 . . . . 0.0 111.2 -171.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.035 0 C-N-CA 124.233 1.013 . . . . 0.0 109.594 179.319 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.14 144.81 56.98 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.149 0.58 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -154.76 149.16 26.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 169.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.11 174.45 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -112.19 151.57 29.39 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -133.52 116.55 16.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 172.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp 44.36 41.84 4.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.382 1.473 . . . . 0.0 111.69 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.32 5.0 80.23 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.59 116.74 4.13 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.319 174.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.61 84.37 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.291 2.66 . . . . 0.0 112.1 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.35 141.69 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.632 1.173 . . . . 0.0 110.402 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -82.01 162.11 22.74 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.208 1.803 . . . . 0.0 110.358 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.42 145.26 45.35 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.912 1.285 . . . . 0.0 108.118 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.3 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.182 0.593 . . . . 0.0 109.701 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.42 34.16 2.7 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.668 1.128 . . . . 0.0 113.677 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 52.27 -148.94 0.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.865 1.666 . . . . 0.0 112.435 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -123.96 116.3 22.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.029 1.732 . . . . 0.0 108.309 -169.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 m -72.43 171.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -144.08 164.01 31.88 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.79 138.16 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.56 -3.76 76.9 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.941 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.38 -15.54 61.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.145 1.472 . . . . 0.0 114.214 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.05 104.5 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.985 1.714 . . . . 0.0 111.159 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.24 131.79 90.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.651 0.78 . . . . 0.0 111.259 -175.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.59 149.51 81.86 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.764 2.309 . . . . 0.0 113.773 173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -77.31 67.93 3.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.321 1.848 . . . . 0.0 108.849 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.78 160.42 14.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.314 1.046 . . . . 0.0 109.134 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.8 163.89 27.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.997 1.319 . . . . 0.0 111.793 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.36 173.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 129.934 3.294 . . . . 0.0 105.02 168.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -131.53 139.51 49.28 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -86.68 176.02 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.555 0.616 . . . . 0.0 111.517 -172.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -60.91 -25.53 66.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.972 0.909 . . . . 0.0 110.331 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m -81.29 1.72 31.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.053 1.341 . . . . 0.0 111.646 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.8 mt 60.01 38.99 20.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 127.162 2.185 . . . . 0.0 111.893 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.08 160.75 27.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.756 0.823 . . . . 0.0 110.887 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.09 146.09 47.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.205 1.002 . . . . 0.0 110.576 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -147.42 157.79 43.72 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.442 2.697 . . . . 0.0 103.82 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -135.54 158.98 43.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.72 -25.91 63.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.81 66.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.396 1.453 . . . . 0.0 112.9 173.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.57 -27.09 58.46 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.868 0.758 . . . . 0.0 110.996 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.3 mtt -73.5 -34.98 65.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.214 1.006 . . . . 0.0 110.544 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -55.99 152.07 10.87 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.53 0.732 . . . . 0.0 110.413 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.44 33.22 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.134 1.35 . . . . 0.0 112.58 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -147.89 150.75 34.68 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.473 1.509 . . . . 0.0 108.022 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.37 142.27 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 m -135.69 147.58 48.57 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.328 1.051 . . . . 0.0 108.383 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.84 134.24 58.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -139.95 116.73 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -95.08 153.25 17.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -136.04 134.87 50.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.04 147.59 51.34 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.776 1.63 . . . . 0.0 108.299 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -38.73 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.519 2.146 . . . . 0.0 111.833 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -146.74 169.96 17.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.393 2.277 . . . . 0.0 105.916 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.263 0.0 OUTLIER -117.62 -15.58 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 122.673 0.389 . . . . 0.0 111.322 -175.015 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.36 -29.88 68.7 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.375 -0.828 . . . . 0.0 110.717 169.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.21 143.57 57.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.1 1.36 . . . . 0.0 110.764 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -17.34 50.81 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.535 1.064 . . . . 0.0 114.762 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -54.5 -25.24 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.788 1.294 . . . . 0.0 112.694 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.9 p -60.1 -32.93 71.45 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.939 0.79 . . . . 0.0 111.904 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.67 -28.21 6.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.752 0.821 . . . . 0.0 111.58 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.31 69.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.989 0.915 . . . . 0.0 112.428 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -152.6 -39.5 0.1 Allowed 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.749 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -57.84 -45.19 86.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.847 1.203 . . . . 0.0 111.897 -169.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -59.21 -52.32 66.19 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -60.48 -42.79 97.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.665 0.666 . . . . 0.0 111.076 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.6 -51.0 70.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.078 0.551 . . . . 0.0 110.661 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -66.48 -27.4 67.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.01 0.124 . . . . 0.0 111.078 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -65.67 -44.44 86.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.085 1.354 . . . . 0.0 110.082 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.8 -43.97 82.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.457 0.571 . . . . 0.0 110.206 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -45.62 77.62 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.93 -11.12 44.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.678 1.191 . . . . 0.0 113.237 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -118.68 -1.86 11.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.639 1.176 . . . . 0.0 113.828 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -60.18 -37.36 79.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.133 1.333 . . . . 0.0 109.493 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.98 -172.53 41.67 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 127.969 2.7 . . . . 0.0 106.942 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -75.82 27.66 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.362 1.081 . . . . 0.0 112.564 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.4 144.2 11.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 120.756 -1.215 . . . . 0.0 109.958 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.48 145.34 54.15 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.12 121.8 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -172.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -137.31 154.14 50.13 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.318 0.647 . . . . 0.0 111.327 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -130.62 105.69 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.72 131.56 33.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -129.2 173.17 10.73 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.266 1.827 . . . . 0.0 108.048 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.05 171.65 5.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.64 0.733 . . . . 0.0 110.363 169.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.99 -16.55 64.43 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.275 1.03 . . . . 0.0 111.604 171.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.2 mt -53.61 128.0 51.86 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.814 1.246 . . . . 0.0 109.999 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.23 -9.29 15.21 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.916 2.411 . . . . 0.0 113.419 -174.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -52.66 112.27 0.8 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.748 1.219 . . . . 0.0 111.11 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.85 5.65 0.24 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.73 2.412 . . . . 0.0 115.436 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -61.93 -35.51 78.64 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 120.044 1.293 . . . . 0.0 110.258 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.01 -9.22 9.27 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -112.46 -4.85 14.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.281 0.946 . . . . 0.0 111.618 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 3.3 p90 32.4 57.52 0.39 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.635 2.374 . . . . 0.0 113.816 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 p -54.94 -28.46 51.26 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.62 -12.18 55.7 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.593 1.088 . . . . 0.0 113.976 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.32 -10.37 4.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.049 1.74 . . . . 0.0 112.721 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -64.7 125.94 26.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.914 0.486 . . . . 0.0 111.358 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.76 -21.18 20.24 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.199 0.904 . . . . 0.0 112.46 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mt -84.85 -31.69 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.457 1.129 . . . . 0.0 110.514 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.41 -35.4 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 131.65 3.98 . . . . 0.0 116.341 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -66.78 -35.21 79.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.517 1.127 . . . . 0.0 111.571 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.86 150.8 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.632 1.173 . . . . 0.0 107.959 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.44 143.78 35.75 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 p -79.8 155.44 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.402 0.62 . . . . 0.0 109.523 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.1 mt -129.2 162.78 27.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.927 1.691 . . . . 0.0 107.312 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.5 m -137.17 44.58 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.572 1.549 . . . . 0.0 110.323 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -48.32 -36.03 13.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -169.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -50.82 -25.96 5.12 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.801 1.182 . . . . 0.0 114.182 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.7 ttt85 -60.19 -22.65 63.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.072 0.851 . . . . 0.0 112.376 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -127.79 -19.16 4.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.758 1.623 . . . . 0.0 111.955 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 58.25 11.54 1.62 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 129.928 3.291 . . . . 0.0 114.402 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.6 m -69.6 -42.81 73.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.456 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.25 -37.03 81.62 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.654 1.57 . . . . 0.0 109.379 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.35 -53.16 21.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.617 1.579 . . . . 0.0 112.865 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.11 -37.02 69.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.351 0.575 . . . . 0.0 110.477 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.84 -32.91 73.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.009 0.924 . . . . 0.0 112.911 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.35 1.04 13.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.648 1.179 . . . . 0.0 111.744 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.53 37.81 94.08 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 119.123 0.874 . . . . 0.0 112.047 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.37 -1.94 9.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.678 . . . . 0.0 110.91 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.87 106.1 5.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 168.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.9 mt -69.42 120.9 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -64.49 -43.13 95.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -89.07 -6.08 57.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -170.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -132.76 -13.23 2.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.582 0.753 . . . . 0.0 112.701 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.251 39.3 ptt180 41.65 43.44 2.37 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.711 1.604 . . . . 0.0 113.036 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 mt -124.98 172.54 9.33 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 170.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.85 140.02 45.46 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.885 0.874 . . . . 0.0 109.634 173.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.65 157.56 35.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.366 1.067 . . . . 0.0 110.793 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.16 112.12 19.96 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -153.76 167.05 30.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.78 147.18 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -143.61 155.27 44.22 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.305 1.442 . . . . 0.0 108.575 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.16 139.76 45.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -129.5 129.87 45.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.237 1.415 . . . . 0.0 108.334 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.28 166.71 9.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.015 0.926 . . . . 0.0 108.997 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -50.4 -31.03 13.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.754 174.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -81.84 -4.43 56.47 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.483 1.113 . . . . 0.0 113.217 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.86 62.9 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.209 -0.932 . . . . 0.0 111.596 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -86.55 118.09 25.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.56 114.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 170.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 p -97.44 -14.44 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.167 0.987 . . . . 0.0 109.886 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 152.32 32.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.274 1.029 . . . . 0.0 108.659 169.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.25 137.55 13.85 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.378 1.871 . . . . 0.0 107.251 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.21 149.97 31.85 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.187 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -123.71 114.52 20.05 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.39 135.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.3 m -58.64 -21.48 54.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.539 1.136 . . . . 0.0 113.509 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -140.08 129.6 24.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -53.83 -35.04 61.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -80.67 -6.93 59.07 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.516 1.053 . . . . 0.0 112.715 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.57 -173.67 4.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -137.89 156.33 74.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 110.104 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.38 168.29 16.67 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.836 2.357 . . . . 0.0 110.287 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -74.89 113.99 12.83 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -80.76 -6.71 58.86 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.11 -32.29 64.86 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 120.995 -1.065 . . . . 0.0 108.572 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -60.4 -51.32 80.9 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.147 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.14 -33.0 41.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.453 1.555 . . . . 0.0 112.747 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.2 mm -59.9 -47.47 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 120.455 1.479 . . . . 0.0 109.51 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.52 -38.88 92.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.027 0.83 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.78 92.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.324 0.249 . . . . 0.0 111.271 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.12 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.686 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -53.9 -41.64 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.069 0.849 . . . . 0.0 110.569 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.05 -30.45 64.27 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.571 0.749 . . . . 0.0 112.174 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 62.6 mt -90.43 -43.12 10.49 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.004 0.522 . . . . 0.0 111.68 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.6 t -71.49 -45.1 69.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.978 0.911 . . . . 0.0 111.331 -170.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.69 0.796 . . . . 0.0 109.642 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.94 14.71 1.47 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.593 1.957 . . . . 0.0 114.472 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -171.56 144.43 1.89 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 131.293 3.837 . . . . 0.0 102.412 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.8 pt -142.08 171.9 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 122.575 1.179 . . . . 0.0 110.366 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -109.96 157.41 19.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.51 113.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 45.51 43.95 9.4 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.66 1.584 . . . . 0.0 111.556 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 4.61 82.03 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.46 126.15 7.59 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 145.9 63.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.643 2.222 . . . . 0.0 110.148 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -136.39 179.48 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 108.778 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -127.54 158.98 35.98 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.5 mt -112.88 172.93 6.63 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.833 1.253 . . . . 0.0 109.35 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.74 149.82 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 56.99 19.09 29.02 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.925 1.726 . . . . 0.0 115.884 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -67.59 176.78 2.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.764 2.025 . . . . 0.0 114.976 -169.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.254 6.1 tt0 87.8 30.85 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.105 2.562 . . . . 0.0 113.325 169.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.16 143.44 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 168.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -149.45 165.19 32.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.872 1.269 . . . . 0.0 108.068 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 p -54.6 133.88 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.15 81.38 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.492 1.044 . . . . 0.0 113.806 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.71 -10.52 59.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.483 1.641 . . . . 0.0 114.177 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 71.37 127.71 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.463 1.905 . . . . 0.0 112.385 169.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.42 126.5 88.2 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.287 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -62.29 -30.31 81.03 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 114.147 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.6 t70 94.79 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 130.468 3.507 . . . . 0.0 106.838 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.04 174.2 10.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.821 2.049 . . . . 0.0 107.779 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 m -131.81 120.76 23.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -105.01 165.24 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.394 1.478 . . . . 0.0 107.506 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.07 143.32 38.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 p -76.58 179.29 6.06 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.087 0.955 . . . . 0.0 110.155 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.91 -24.46 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.162 -0.961 . . . . 0.0 111.114 168.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -89.93 3.79 52.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.784 2.034 . . . . 0.0 112.158 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 57.44 29.3 16.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.908 2.083 . . . . 0.0 113.188 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.24 144.48 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.61 142.23 42.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.469 0.708 . . . . 0.0 109.431 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -148.32 113.79 5.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 107.391 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 p -72.38 154.78 40.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.466 0.65 . . . . 0.0 109.321 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.52 -39.21 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.27 -25.69 15.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.101 0.961 . . . . 0.0 113.483 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.86 -28.5 55.45 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.791 1.178 . . . . 0.0 111.499 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.9 mtt -69.69 -30.93 68.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.045 0.938 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -57.76 152.61 15.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.526 0.679 . . . . 0.0 110.467 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.93 -8.23 38.94 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.482 1.039 . . . . 0.0 113.094 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -152.66 152.76 32.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.815 1.646 . . . . 0.0 107.861 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.21 144.93 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.8 m -136.01 148.15 48.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.399 1.08 . . . . 0.0 108.582 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.5 mt -130.62 137.74 55.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.5 mt -135.1 102.78 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -174.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -84.84 149.86 25.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -139.23 136.67 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -141.71 146.82 42.93 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.915 1.286 . . . . 0.0 109.316 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.48 -38.81 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.188 1.925 . . . . 0.0 111.496 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 p -162.77 148.66 12.34 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.26 1.424 . . . . 0.0 108.065 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.23 -19.33 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.652 0.781 . . . . 0.0 111.014 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.6 -26.17 68.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.342 1.057 . . . . 0.0 112.087 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 p -62.8 138.97 58.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.313 0.578 . . . . 0.0 110.686 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.63 -4.29 69.91 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.729 0.68 . . . . 0.0 113.392 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.86 -25.99 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.523 1.129 . . . . 0.0 111.968 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.78 -42.75 85.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.856 0.753 . . . . 0.0 111.83 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.35 -37.52 80.56 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.409 0.549 . . . . 0.0 110.134 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.21 72.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.407 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.7 tm0? -155.3 -53.6 0.09 Allowed 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -39.76 79.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.631 1.559 . . . . 0.0 114.486 -167.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -64.91 -48.91 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.536 1.517 . . . . 0.0 110.179 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -61.33 -49.16 78.11 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 118.846 0.748 . . . . 0.0 109.806 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.407 ' CB ' HE21 ' A' ' 63' ' ' GLN . 61.1 t80 -56.98 -48.64 77.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.259 0.624 . . . . 0.0 110.797 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -61.98 -39.68 93.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.511 0.724 . . . . 0.0 110.856 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.84 -38.83 80.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.124 0.97 . . . . 0.0 111.075 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.94 -45.16 71.47 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.201 0.91 . . . . 0.0 110.309 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.86 69.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.929 1.291 . . . . 0.0 110.856 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.93 -21.35 61.01 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.949 0.9 . . . . 0.0 113.127 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -120.13 7.67 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.41 -30.79 68.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.851 1.205 . . . . 0.0 111.626 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.65 -74.25 0.06 OUTLIER Glycine 0 C--N 1.336 0.551 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -162.91 110.16 1.23 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.48 155.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.889 1.276 . . . . 0.0 107.987 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -76.45 144.26 40.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.66 129.66 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.56 157.69 45.38 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.27 1.028 . . . . 0.0 110.08 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 45.6 m -127.13 98.02 5.15 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 mt -76.69 128.61 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 m -139.32 170.03 16.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.617 1.567 . . . . 0.0 108.862 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.41 175.2 10.51 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.98 0.895 . . . . 0.0 111.612 176.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -86.44 -14.36 43.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.663 1.585 . . . . 0.0 110.854 169.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 tp -50.28 142.21 14.86 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 127.065 2.146 . . . . 0.0 110.867 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -52.52 -34.01 60.34 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.858 2.372 . . . . 0.0 113.672 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -79.67 35.53 0.3 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.047 1.339 . . . . 0.0 111.595 175.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.12 154.49 48.13 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.774 1.229 . . . . 0.0 109.139 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 62.45 -22.3 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.338 2.655 . . . . 0.0 117.202 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.1 -25.74 64.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.82 1.191 . . . . 0.0 114.056 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.12 39.93 3.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.481 1.512 . . . . 0.0 108.858 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -29.81 120.29 0.16 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.407 2.283 . . . . 0.0 113.601 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.3 m -77.78 46.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.659 1.583 . . . . 0.0 114.024 -169.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -34.33 0.19 Allowed Glycine 0 C--N 1.333 0.397 0 O-C-N 121.276 -0.89 . . . . 0.0 112.486 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 16.73 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.56 1.144 . . . . 0.0 114.071 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -136.1 65.85 1.52 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.871 1.668 . . . . 0.0 107.177 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.76 -37.57 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.805 1.193 . . . . 0.0 111.016 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.22 89.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.24 -23.55 9.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.494 1.918 . . . . 0.0 113.983 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.37 -32.26 72.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.858 0.863 . . . . 0.0 112.29 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.92 147.05 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -148.99 145.27 27.24 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 p -80.41 151.71 29.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.394 0.616 . . . . 0.0 109.586 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.44 156.64 29.79 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.171 1.388 . . . . 0.0 107.695 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 m -120.45 46.44 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.629 1.972 . . . . 0.0 110.326 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -55.52 -32.1 62.63 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.967 -1.083 . . . . 0.0 113.217 -170.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -55.87 -17.26 5.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -58.37 -27.38 64.16 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.305 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -141.88 -3.35 1.12 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.801 1.182 . . . . 0.0 113.808 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.86 28.66 6.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.5 2.32 . . . . 0.0 113.802 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 m -59.33 -58.9 6.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.923 0.889 . . . . 0.0 110.773 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.97 -33.92 75.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.803 0.841 . . . . 0.0 109.792 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.19 -57.77 8.65 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 125.141 1.353 . . . . 0.0 112.08 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.4 -39.77 58.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.149 0.474 . . . . 0.0 110.15 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.17 85.6 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.99 3.07 30.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.916 1.286 . . . . 0.0 110.672 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.62 29.06 71.56 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 121.553 -0.717 . . . . 0.0 113.625 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.06 -1.73 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.107 0.963 . . . . 0.0 110.612 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.44 105.73 1.24 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.638 1.108 . . . . 0.0 108.086 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.38 115.89 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -57.36 -43.42 83.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 111.028 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -92.9 -4.62 52.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -169.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.79 -14.75 2.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.648 0.779 . . . . 0.0 112.402 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 48.92 40.4 16.6 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.84 1.656 . . . . 0.0 112.144 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 mt -126.27 173.9 8.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.73 126.97 31.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.394 1.478 . . . . 0.0 108.972 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 137.32 58.24 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.749 1.219 . . . . 0.0 110.637 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.55 108.63 0.85 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.322 1.049 . . . . 0.0 108.318 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.2 p -156.58 170.16 23.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.012 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.03 147.37 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -144.18 153.01 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.05 136.07 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.9 mp -129.56 133.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.728 1.211 . . . . 0.0 107.801 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.44 161.08 14.94 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.659 1.183 . . . . 0.0 109.825 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -33.14 -41.82 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.428 2.691 . . . . 0.0 115.413 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -91.1 -8.15 49.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.51 3.38 43.76 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.202 0.906 . . . . 0.0 113.567 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -71.47 118.69 14.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.85 1.825 . . . . 0.0 108.691 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.96 116.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 170.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.52 -15.41 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.294 1.038 . . . . 0.0 109.967 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -149.87 150.08 31.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 108.081 171.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.72 127.02 5.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.126 1.77 . . . . 0.0 106.93 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -149.23 149.83 31.6 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.031 0.832 . . . . 0.0 110.076 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.28 113.82 20.96 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.69 126.87 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.6 m -63.98 -2.6 2.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.66 1.184 . . . . 0.0 114.168 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -141.52 124.39 16.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.08 -31.0 66.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.768 1.227 . . . . 0.0 113.501 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.5 p -86.73 15.81 5.37 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.004 0.82 . . . . 0.0 111.771 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -127.53 179.44 5.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.468 1.507 . . . . 0.0 110.085 -174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -137.81 159.16 69.88 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.772 1.229 . . . . 0.0 110.592 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -89.4 -178.64 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.436 2.758 . . . . 0.0 110.55 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -75.53 94.14 3.11 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -72.45 -6.3 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.708 0.803 . . . . 0.0 112.913 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.67 -28.59 61.84 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 119.658 1.117 . . . . 0.0 108.982 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -61.1 -49.96 86.42 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.11 -33.86 59.85 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.53 1.582 . . . . 0.0 112.732 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.92 -45.85 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.348 1.431 . . . . 0.0 109.639 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.67 -38.84 92.64 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.412 1.006 . . . . 0.0 110.53 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.43 91.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.53 0.332 . . . . 0.0 111.207 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.29 61.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.981 0.513 . . . . 0.0 110.761 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.21 -39.45 69.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.059 0.845 . . . . 0.0 110.957 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.01 65.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.463 0.705 . . . . 0.0 111.89 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 63.1 mt -91.87 -43.89 9.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.353 0.524 . . . . 0.0 111.452 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.51 -39.6 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 0.0 110.767 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 mttp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 126.488 1.915 . . . . 0.0 110.069 -174.016 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.04 156.01 42.34 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.151 0.98 . . . . 0.0 109.59 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -152.19 152.26 32.03 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.9 pt -133.62 179.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.655 0.74 . . . . 0.0 109.53 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -129.04 145.14 51.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -144.54 130.02 18.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 45.93 38.9 4.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.634 1.174 . . . . 0.0 112.175 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.44 26.32 73.54 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.274 -0.737 . . . . 0.0 114.374 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 139.91 11.33 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.22 144.74 42.34 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.369 2.046 . . . . 0.0 110.25 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.94 134.0 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.246 1.018 . . . . 0.0 109.767 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -81.2 166.22 20.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.618 1.967 . . . . 0.0 110.62 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.2 154.87 30.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.862 1.665 . . . . 0.0 109.539 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -85.65 -65.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.662 0.665 . . . . 0.0 110.24 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.63 4.22 86.38 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.68 0.657 . . . . 0.0 114.225 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 52.59 176.31 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.779 2.831 . . . . 0.0 116.45 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.93 113.51 3.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.591 1.956 . . . . 0.0 111.573 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.71 160.62 4.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -137.93 157.89 45.47 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.57 132.49 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.38 -2.1 87.43 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.667 -1.074 . . . . 0.0 114.279 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.57 -4.72 58.07 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.765 1.783 . . . . 0.0 112.596 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 59.16 177.2 0.08 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.561 1.544 . . . . 0.0 112.058 -169.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.09 135.29 21.08 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.287 1.835 . . . . 0.0 108.328 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 87.1 Cg_endo -72.23 156.4 55.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.179 1.919 . . . . 0.0 109.453 172.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 25.3 t70 -74.59 66.02 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.676 1.99 . . . . 0.0 110.66 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -61.33 155.21 21.88 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.295 1.438 . . . . 0.0 109.561 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 m -94.86 155.1 16.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.37 171.66 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.161 2.184 . . . . 0.0 106.955 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.9 mt -132.93 130.2 39.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -72.85 -176.89 2.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.697 1.199 . . . . 0.0 111.981 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -57.37 -32.35 66.7 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 110.485 169.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -85.62 2.98 42.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.867 1.667 . . . . 0.0 112.047 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt 52.22 36.82 20.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.507 1.923 . . . . 0.0 112.315 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -91.75 149.53 21.56 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.3 144.81 49.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.159 0.981 . . . . 0.0 110.148 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -153.97 159.15 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.45 2.7 . . . . 0.0 104.838 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 m -142.53 166.45 24.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 53.9 tp -49.79 -42.03 45.86 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.683 0.393 . . . . 0.0 111.311 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.56 -21.9 63.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.38 -30.25 60.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.821 0.737 . . . . 0.0 111.06 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.8 mtt -72.45 -37.39 68.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.566 1.146 . . . . 0.0 110.662 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -55.98 152.77 9.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.008 0.908 . . . . 0.0 111.517 -173.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.53 11.59 66.05 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.977 1.275 . . . . 0.0 113.251 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -154.17 148.21 25.71 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.559 1.544 . . . . 0.0 107.699 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.17 141.49 16.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.8 m -133.19 143.09 48.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 77' ' ' VAL . 74.1 mt -135.92 132.55 50.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -172.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -139.56 134.28 38.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -169.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.92 144.76 42.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 168.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 t -121.7 126.8 75.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.35 127.82 5.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -173.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.97 -41.98 71.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.261 1.974 . . . . 0.0 112.43 -169.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.7 t -157.5 145.98 19.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -17.82 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 122.438 0.295 . . . . 0.0 111.129 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.19 -21.37 63.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 112.672 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.5 p -59.15 -24.62 63.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.659 0.784 . . . . 0.0 112.431 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.54 -10.29 59.68 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.881 0.753 . . . . 0.0 112.144 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.93 -18.21 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 118.85 1.325 . . . . 0.0 110.069 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.6 p -51.77 -43.63 63.07 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.34 -41.13 63.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.849 0.749 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.23 -30.88 71.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 -173.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -146.76 -49.02 0.19 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.317 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 m -55.49 -45.32 77.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.643 1.11 . . . . 0.0 113.451 -167.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -48.8 80.22 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.703 0.683 . . . . 0.0 109.892 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.65 -45.94 73.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.843 0.747 . . . . 0.0 109.548 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.64 -53.49 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.432 0.693 . . . . 0.0 110.276 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -29.78 53.49 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -63.75 -55.32 24.11 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.334 1.054 . . . . 0.0 109.915 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.71 -37.35 87.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.6 0.76 . . . . 0.0 109.559 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.58 69.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.76 0.824 . . . . 0.0 110.799 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.79 68.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.467 0.307 . . . . 0.0 111.65 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -75.44 -22.74 57.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.007 -0.997 . . . . 0.0 112.641 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.57 -40.63 95.91 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.204 1.365 . . . . 0.0 110.944 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.47 -168.15 41.06 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -173.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -74.15 29.02 0.08 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.024 1.33 . . . . 0.0 113.311 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 48' ' ' ILE . 23.9 m -62.08 154.6 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.482 -1.386 . . . . 0.0 110.832 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.62 149.71 29.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.58 123.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -133.91 149.02 51.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.097 0.559 . . . . 0.0 111.396 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -127.81 99.09 5.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -84.67 130.48 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 m -142.95 172.99 11.95 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.013 1.325 . . . . 0.0 110.639 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.74 172.01 8.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.895 0.878 . . . . 0.0 111.5 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.84 -4.6 58.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.297 1.039 . . . . 0.0 111.31 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.5 tp -46.73 126.07 8.19 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.706 1.602 . . . . 0.0 109.609 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -51.96 -27.44 28.24 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.622 2.881 . . . . 0.0 116.869 -169.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -75.53 -20.71 58.51 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.702 0.683 . . . . 0.0 112.261 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.42 172.29 9.73 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.494 0.718 . . . . 0.0 110.231 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.298 0.1 OUTLIER 42.93 20.06 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.926 2.491 . . . . 0.0 116.656 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.47 -7.37 56.1 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.514 1.126 . . . . 0.0 112.323 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.1 mtp85 55.69 30.84 16.26 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.033 1.733 . . . . 0.0 112.524 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -64.28 -25.83 68.23 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.981 -0.45 . . . . 0.0 111.421 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 p -158.78 171.87 19.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.018 1.727 . . . . 0.0 108.371 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.76 -84.41 1.11 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.94 36.9 0.64 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 -172.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -139.66 137.96 35.68 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.019 1.328 . . . . 0.0 108.197 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.99 -14.18 65.01 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.01 0.814 . . . . 0.0 112.024 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.91 93.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 126.335 1.854 . . . . 0.0 106.269 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.27 -25.63 48.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.501 1.52 . . . . 0.0 113.196 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -55.59 -36.67 67.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.987 1.315 . . . . 0.0 112.694 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.2 t -70.86 147.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -129.55 141.92 50.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.2 p -87.44 136.81 32.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.9 146.08 46.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 m -121.65 51.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.742 1.217 . . . . 0.0 109.687 -168.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.21 -31.48 43.32 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -56.66 -21.68 29.2 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.941 1.701 . . . . 0.0 114.05 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -76.49 -6.23 50.91 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.146 -0.971 . . . . 0.0 112.551 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.17 -39.88 0.6 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.028 1.331 . . . . 0.0 112.44 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.75 4.29 3.9 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 130.054 3.342 . . . . 0.0 114.815 170.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -58.81 -44.51 90.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.259 -1.353 . . . . 0.0 111.957 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.06 -41.58 90.6 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 121.064 1.756 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.61 -43.11 96.35 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 123.996 0.808 . . . . 0.0 111.772 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -72.76 -46.72 51.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.271 0.536 . . . . 0.0 109.994 173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 25' ' ' PRO . . . -58.99 -39.19 81.06 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.241 1.016 . . . . 0.0 112.532 -172.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.04 5.83 26.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.0 110.618 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.6 32.45 58.34 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.717 0.675 . . . . 0.0 113.563 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.35 -8.75 9.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 123.45 0.7 . . . . 0.0 110.097 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -68.96 111.32 4.91 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.32 128.13 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -66.87 -47.36 72.12 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 110.933 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -90.83 0.05 57.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 tp -129.82 -13.55 4.14 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.629 1.172 . . . . 0.0 111.591 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 47.15 47.91 16.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.922 1.689 . . . . 0.0 111.193 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.3 tp -139.88 156.88 46.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.468 1.107 . . . . 0.0 108.206 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.08 131.24 45.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.326 0.65 . . . . 0.0 109.519 173.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.85 164.32 25.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.993 1.317 . . . . 0.0 112.407 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -86.03 113.5 22.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.5 m -148.14 173.53 12.87 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.709 0.804 . . . . 0.0 109.681 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 144.7 17.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.886 1.274 . . . . 0.0 108.454 177.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -148.34 158.87 44.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.573 1.149 . . . . 0.0 109.998 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.04 140.65 40.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mp -131.75 135.73 47.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.235 1.414 . . . . 0.0 107.591 -173.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.35 166.67 7.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 110.04 169.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.32 -31.96 23.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.116 1.367 . . . . 0.0 113.012 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -80.91 -0.86 41.06 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.432 1.093 . . . . 0.0 112.67 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.12 -6.75 82.76 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.625 1.107 . . . . 0.0 112.608 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.2 124.9 22.37 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.719 1.259 . . . . 0.0 109.232 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.81 128.24 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.737 0.815 . . . . 0.0 110.112 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.79 -19.51 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 109.917 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -145.08 147.05 32.13 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.81 131.94 12.69 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.037 1.335 . . . . 0.0 108.237 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.26 149.66 31.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.606 0.762 . . . . 0.0 109.365 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -128.06 117.19 21.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.823 2.049 . . . . 0.0 105.55 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.5 125.32 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -59.09 -25.02 63.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.693 1.197 . . . . 0.0 112.86 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -134.58 100.77 4.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.09 66.64 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.563 1.145 . . . . 0.0 112.757 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.82 8.7 2.26 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.652 1.181 . . . . 0.0 112.422 170.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.68 162.48 30.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.252 1.821 . . . . 0.0 108.699 173.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -90.12 145.46 32.98 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.69 166.55 29.09 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.991 2.461 . . . . 0.0 111.579 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -85.44 139.39 31.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -104.07 -8.73 19.3 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.39 -39.29 59.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -51.36 -58.03 12.12 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.987 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.94 -34.41 23.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 121.493 1.569 . . . . 0.0 112.393 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 mm -59.58 -42.66 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.142 1.337 . . . . 0.0 109.998 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.39 -36.96 84.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.413 1.006 . . . . 0.0 110.716 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.45 87.24 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.376 -0.202 . . . . 0.0 110.884 175.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.59 -40.73 69.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.623 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.91 -40.65 76.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.92 1.236 . . . . 0.0 110.26 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.81 66.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.177 0.591 . . . . 0.0 112.317 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.09 -60.37 2.32 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.961 0.504 . . . . 0.0 110.46 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.39 -45.04 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.145 1.378 . . . . 0.0 111.905 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm . . . . . 0 C--O 1.25 1.094 0 C-N-CA 126.802 2.041 . . . . 0.0 110.936 -176.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.85 27.22 4.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.782 2.033 . . . . 0.0 114.959 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -83.51 171.84 12.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.483 0.713 . . . . 0.0 109.52 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 pt -131.43 171.82 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 123.18 1.467 . . . . 0.0 110.37 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -115.82 153.95 30.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -140.29 122.79 16.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.17 39.13 1.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.365 1.466 . . . . 0.0 113.492 -171.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.33 6.18 89.47 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.674 -0.641 . . . . 0.0 114.396 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.77 125.42 7.93 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.185 1.374 . . . . 0.0 109.863 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.76 141.17 48.68 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 CA-C-N 120.995 2.397 . . . . 0.0 110.062 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.57 138.96 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.777 0.831 . . . . 0.0 109.844 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -86.02 155.59 20.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.119 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mt -118.9 153.38 34.66 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.194 1.398 . . . . 0.0 107.94 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.87 -15.58 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.58 33.8 0.45 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.971 0.805 . . . . 0.0 111.79 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -51.74 151.15 3.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.401 0.681 . . . . 0.0 112.209 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.262 8.6 tt0 108.44 23.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 129.242 3.017 . . . . 0.0 112.727 169.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.68 141.21 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -148.7 165.47 31.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.101 0.96 . . . . 0.0 109.167 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 p -54.01 132.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.02 -0.2 89.93 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.081 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.66 -12.04 59.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.546 1.673 . . . . 0.0 112.545 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 59.68 167.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.449 1.9 . . . . 0.0 113.101 -171.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.04 128.25 31.31 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.351 1.46 . . . . 0.0 108.466 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.39 -25.06 63.92 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.304 2.669 . . . . 0.0 114.428 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 66.81 100.67 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.995 2.518 . . . . 0.0 112.441 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -142.46 172.34 12.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.522 1.529 . . . . 0.0 109.274 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -89.21 154.38 20.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.76 1.224 . . . . 0.0 111.427 -169.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.83 164.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 128.087 2.555 . . . . 0.0 104.995 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 tp -116.85 140.4 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.11 168.12 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.23 -24.65 66.51 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.736 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -80.33 0.65 32.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.976 1.71 . . . . 0.0 112.011 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.6 mt 64.83 44.32 3.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.097 2.159 . . . . 0.0 111.946 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -119.73 145.98 46.04 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.26 1.024 . . . . 0.0 108.886 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.42 139.4 45.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.674 0.79 . . . . 0.0 109.312 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -142.01 102.18 4.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 m -71.03 153.59 42.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -58.94 -30.85 68.18 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.169 -0.957 . . . . 0.0 110.863 170.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.07 8.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.397 1.479 . . . . 0.0 113.286 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.06 -28.12 35.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.991 0.916 . . . . 0.0 111.676 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.2 mtt -72.41 -48.56 40.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.129 0.971 . . . . 0.0 110.496 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.36 171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.966 0.888 . . . . 0.0 110.291 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 -15.2 48.19 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.451 1.5 . . . . 0.0 110.575 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -153.02 159.81 42.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.542 2.737 . . . . 0.0 106.29 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.4 144.29 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 m -132.74 149.37 52.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.207 1.003 . . . . 0.0 109.551 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.5 138.64 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.3 mt -139.49 113.68 7.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 m -89.32 144.95 25.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.31 134.81 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 pt -147.67 159.39 41.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 107.928 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.02 -52.24 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 N-CA-C 108.513 -1.38 . . . . 0.0 108.513 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 m -150.9 146.72 26.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.703 1.601 . . . . 0.0 108.643 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -72.44 -20.7 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 111.047 171.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -60.1 -14.25 15.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.14 0.976 . . . . 0.0 113.319 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 p -56.65 -27.47 58.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.641 0.776 . . . . 0.0 111.866 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.43 4.67 84.79 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.167 0.889 . . . . 0.0 112.266 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.02 -13.88 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 119.065 1.433 . . . . 0.0 111.976 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.6 m -57.75 -47.47 82.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.118 0.967 . . . . 0.0 110.539 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.38 -28.83 64.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.318 0.647 . . . . 0.0 111.35 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.82 -59.5 5.05 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -161.51 -14.22 0.04 OUTLIER 'General case' 0 C--N 1.341 0.203 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -69.59 -31.01 68.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.283 1.401 . . . . 0.0 112.825 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -61.88 -50.57 71.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.269 0.941 . . . . 0.0 108.841 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -62.37 -48.05 81.45 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.587 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.15 -50.75 71.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.641 0.777 . . . . 0.0 110.562 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -68.46 -33.03 73.46 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.388 -0.195 . . . . 0.0 110.757 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.7 -42.03 78.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 111.426 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.33 -44.92 96.4 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.397 0.998 . . . . 0.0 109.678 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.02 -38.58 70.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.441 0.696 . . . . 0.0 111.402 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.89 -5.71 22.88 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -116.02 -12.3 11.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.689 1.596 . . . . 0.0 112.66 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -57.88 -32.47 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.643 1.11 . . . . 0.0 111.64 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.91 -159.69 32.88 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.61 22.21 0.14 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.469 -1.018 . . . . 0.0 112.386 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 77' ' ' VAL . 2.8 t -54.82 134.83 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.979 1.712 . . . . 0.0 108.817 -171.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.79 135.85 53.26 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -144.08 133.22 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -170.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.72 162.4 35.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.616 0.766 . . . . 0.0 110.926 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.8 m -133.03 124.46 27.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.22 133.27 53.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -141.12 169.09 18.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.152 0.981 . . . . 0.0 110.484 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.3 -179.06 1.49 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 112.003 174.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.13 -35.44 28.49 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -174.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.45 156.44 52.51 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 119.031 -0.509 . . . . 0.0 112.275 -169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.4 -38.59 63.44 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.545 2.83 . . . . 0.0 114.61 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -60.76 -8.78 3.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.0 1.32 . . . . 0.0 113.793 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HA ' HD13 ' A' ' 55' ' ' ILE . . . -118.5 -6.86 10.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.552 1.941 . . . . 0.0 111.978 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -139.81 15.57 2.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.826 1.193 . . . . 0.0 113.664 -169.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.41 155.05 44.3 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.948 1.299 . . . . 0.0 108.724 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 48.01 38.71 9.88 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.532 1.133 . . . . 0.0 111.213 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -62.92 157.89 20.54 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.232 1.013 . . . . 0.0 111.404 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.93 -28.58 13.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.33 -65.52 1.85 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.95 34.29 0.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.365 1.066 . . . . 0.0 111.981 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -67.18 -5.37 13.34 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.991 1.316 . . . . 0.0 114.272 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.32 -17.81 1.89 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.132 1.825 . . . . 0.0 109.376 -169.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.22 91.8 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.4 -27.44 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -66.75 -22.16 66.05 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.073 0.949 . . . . 0.0 112.256 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 t -91.37 154.09 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.3 147.43 47.45 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.9 m -104.14 138.98 39.84 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.6 mp -118.44 160.97 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.108 1.763 . . . . 0.0 108.233 -170.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.7 54.31 1.88 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.231 1.412 . . . . 0.0 108.776 -168.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.13 -24.92 57.55 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -56.39 -19.73 16.2 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 120.299 1.409 . . . . 0.0 112.895 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -81.64 -4.3 55.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.857 1.263 . . . . 0.0 112.845 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -141.87 -41.98 0.35 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.032 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.44 -3.07 1.41 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 129.529 3.132 . . . . 0.0 114.83 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -64.91 -45.76 84.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.586 1.539 . . . . 0.0 110.691 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.25 -42.66 95.77 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.18 0.9 . . . . 0.0 110.51 174.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.87 96.28 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.82 -43.74 92.15 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.521 0.66 . . . . 0.0 109.707 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.78 -47.06 86.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.583 0.753 . . . . 0.0 112.188 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -83.8 -1.9 55.24 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.093 0.957 . . . . 0.0 111.504 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.31 38.04 95.32 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.402 -0.666 . . . . 0.0 111.936 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.2 -0.2 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.292 1.437 . . . . 0.0 110.584 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -76.82 114.88 16.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.28 113.0 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -59.15 -40.95 87.1 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.285 1.034 . . . . 0.0 110.595 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -91.72 -4.46 55.05 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 tp -140.51 -0.38 1.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.027 0.831 . . . . 0.0 113.178 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 43.28 41.51 3.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.697 1.999 . . . . 0.0 114.431 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -132.06 167.94 18.83 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.861 0.865 . . . . 0.0 108.847 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.72 134.48 47.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 162.78 15.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.332 1.453 . . . . 0.0 111.22 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.406 ' CB ' ' HA ' ' A' ' 149' ' ' ALA . 16.9 tpt180 -88.75 116.98 27.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -159.88 171.32 19.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.216 0.531 . . . . 0.0 110.096 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 t -143.5 142.15 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -141.18 155.33 46.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 109.442 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -137.42 135.67 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 42.8 mt -122.51 136.76 54.96 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.36 175.64 5.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.977 0.894 . . . . 0.0 110.208 169.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -56.88 -11.33 1.39 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.913 1.685 . . . . 0.0 114.897 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.96 14.83 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.487 1.494 . . . . 0.0 112.359 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.46 -1.87 67.12 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.418 1.009 . . . . 0.0 113.267 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -65.64 118.05 8.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.294 1.547 . . . . 0.0 108.114 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.06 110.95 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 p -91.73 -16.59 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 109.536 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -150.64 151.45 32.53 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.013 1.325 . . . . 0.0 107.504 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.96 132.94 9.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 107.149 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -142.02 150.01 40.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.636 0.653 . . . . 0.0 110.472 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -122.83 111.23 16.42 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 127.226 2.21 . . . . 0.0 105.041 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 t -72.5 140.04 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -58.94 -21.62 58.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.656 1.182 . . . . 0.0 113.892 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.42 134.07 30.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.406 ' HA ' ' CB ' ' A' ' 129' ' ' ARG . . . -56.3 -31.64 63.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.9 p -83.78 -6.73 59.5 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.317 0.962 . . . . 0.0 112.606 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -93.6 179.95 5.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.886 1.274 . . . . 0.0 109.921 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -133.92 157.36 77.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.256 1.422 . . . . 0.0 110.898 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.72 -176.87 3.1 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.166 2.578 . . . . 0.0 110.188 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -69.74 138.06 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -82.53 -9.32 59.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -107.22 -32.28 7.86 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.077 0.853 . . . . 0.0 110.887 -169.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -52.47 -49.14 87.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 -36.33 21.13 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 CA-C-N 121.631 1.618 . . . . 0.0 111.43 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.76 -45.36 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.476 0.71 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.83 -34.01 75.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 120.081 1.309 . . . . 0.0 110.498 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.61 91.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.482 0.313 . . . . 0.0 111.18 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.81 -47.34 59.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.075 174.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -55.91 -37.93 69.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.258 0.936 . . . . 0.0 110.901 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.8 -29.31 54.2 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.625 0.77 . . . . 0.0 112.005 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.6 mt -95.87 -43.84 7.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.681 0.792 . . . . 0.0 112.194 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.7 t -73.71 -43.82 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 111.57 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 C--O 1.249 1.074 0 C-N-CA 124.108 0.963 . . . . 0.0 109.676 179.875 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.25 142.21 52.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.807 0.843 . . . . 0.0 109.35 175.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -157.68 141.28 15.62 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 169.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 pt -140.37 179.09 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 122.012 0.91 . . . . 0.0 109.458 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -126.36 156.82 39.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.01 1.724 . . . . 0.0 106.632 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -147.45 128.33 14.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 43.31 40.92 2.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.827 1.251 . . . . 0.0 112.924 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 24.22 69.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.364 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 136.81 8.92 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.49 146.25 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.26 1.973 . . . . 0.0 109.904 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.67 150.17 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.272 1.029 . . . . 0.0 109.291 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.5 m -98.62 163.09 12.8 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.961 1.304 . . . . 0.0 108.902 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.18 170.44 8.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.936 1.295 . . . . 0.0 109.239 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.36 133.07 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.55 -13.75 66.57 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.858 0.742 . . . . 0.0 114.202 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 53.44 167.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.935 3.294 . . . . 0.0 117.71 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.43 137.08 43.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.925 2.89 . . . . 0.0 112.639 -168.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.53 153.1 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.81 170.55 18.5 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 121.16 -0.962 . . . . 0.0 109.781 -171.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -50.12 131.92 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.372 0.669 . . . . 0.0 110.769 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.87 79.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.595 1.093 . . . . 0.0 113.502 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -94.32 6.88 47.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.259 1.529 . . . . 0.0 113.516 -169.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 57.85 111.95 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.218 2.207 . . . . 0.0 114.915 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.33 89.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.876 169.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.03 -46.83 14.3 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.586 2.191 . . . . 0.0 113.49 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 121.57 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 1 C-N-CA 131.73 4.012 . . . . 0.0 105.451 -169.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.76 168.03 19.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.632 1.573 . . . . 0.0 109.067 -175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 m -122.27 146.15 47.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.751 1.22 . . . . 0.0 107.803 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.91 164.32 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.908 2.083 . . . . 0.0 107.731 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.3 mt -100.43 141.36 33.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -71.79 173.67 7.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.406 1.482 . . . . 0.0 110.941 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -67.49 -8.84 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.538 -0.726 . . . . 0.0 111.723 169.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.3 m -97.01 4.4 51.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.22 1.408 . . . . 0.0 111.835 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.97 51.98 13.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.388 1.875 . . . . 0.0 111.633 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.59 152.45 41.87 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -72.42 143.24 48.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.938 0.875 . . . . 0.0 110.301 -175.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -147.46 158.22 43.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.355 2.662 . . . . 0.0 105.73 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 p -137.25 166.64 23.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -55.47 -40.09 71.2 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 171.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -24.16 61.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.17 -33.08 50.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.924 0.784 . . . . 0.0 111.345 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.4 mtt -70.58 -36.35 73.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.426 1.09 . . . . 0.0 111.018 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -53.49 146.87 11.87 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.976 0.91 . . . . 0.0 110.784 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -17.79 11.43 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.106 1.336 . . . . 0.0 112.73 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -149.04 155.7 41.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.265 1.426 . . . . 0.0 108.87 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.2 136.94 19.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 76.8 m -133.19 145.0 50.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.22 134.31 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.0 mt -135.23 108.12 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 m -86.42 152.07 23.01 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 134.45 53.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 pt -144.06 154.88 58.62 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.001 1.72 . . . . 0.0 108.074 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.88 -44.04 6.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.906 1.737 . . . . 0.0 111.262 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 t -151.2 170.88 18.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.281 1.832 . . . . 0.0 107.344 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 56' ' ' ASP . 2.0 pp -96.47 -20.16 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.482 1.113 . . . . 0.0 109.387 168.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' N ' HD12 ' A' ' 55' ' ' ILE . 34.4 t70 -81.71 -25.89 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.91 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -61.51 -17.6 55.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.057 1.343 . . . . 0.0 112.551 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.69 84.37 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.032 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.23 -18.42 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.096 1.448 . . . . 0.0 112.245 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 m -64.78 -16.42 63.02 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.548 1.139 . . . . 0.0 113.361 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.79 -20.49 57.09 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.503 1.121 . . . . 0.0 112.938 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.44 32.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.751 1.221 . . . . 0.0 108.72 171.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? 61.34 -65.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.686 2.394 . . . . 0.0 114.579 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.46 -48.36 81.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.351 1.432 . . . . 0.0 114.649 -167.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -64.81 -52.32 57.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.175 1.352 . . . . 0.0 109.537 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.87 -45.88 89.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 110.464 -173.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -56.4 -53.46 57.08 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.321 1.048 . . . . 0.0 110.988 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -72.19 -34.54 68.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.148 0.431 . . . . 0.0 111.033 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.74 -39.19 80.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.888 0.875 . . . . 0.0 109.63 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.62 -45.23 76.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.774 0.829 . . . . 0.0 109.925 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.17 80.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.434 1.093 . . . . 0.0 110.943 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.96 -15.4 43.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.039 0.936 . . . . 0.0 113.082 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -95.58 -16.08 22.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.91 0.884 . . . . 0.0 112.373 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.78 -37.71 87.76 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.757 1.162 . . . . 0.0 110.846 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.47 -172.26 44.81 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.463 1.982 . . . . 0.0 108.269 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -77.71 36.06 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.0 0.92 . . . . 0.0 112.809 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.8 m -56.82 146.38 6.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 120.759 -1.213 . . . . 0.0 110.824 -177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -76.93 138.63 39.81 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.58 121.65 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.24 157.14 47.53 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.693 0.797 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 m -134.3 108.01 7.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.1 mt -91.01 138.3 19.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.8 m -137.5 172.56 12.79 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.705 2.002 . . . . 0.0 109.947 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.35 -163.42 0.38 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -121.45 -41.23 2.51 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.402 -0.811 . . . . 0.0 111.836 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -26.12 2.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -90.44 44.19 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 CA-C-N 123.916 2.434 . . . . 0.0 111.871 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.5 t80 58.22 32.97 22.69 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.719 1.208 . . . . 0.0 111.756 -172.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.29 165.88 6.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.415 0.686 . . . . 0.0 111.667 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 61.09 -38.99 0.11 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 128.914 2.886 . . . . 0.0 115.136 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.96 -30.99 66.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.004 1.274 . . . . 0.0 114.117 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -127.55 42.49 3.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.927 1.691 . . . . 0.0 108.441 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -44.63 159.97 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.675 1.99 . . . . 0.0 114.53 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.9 m -130.32 146.65 51.94 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.097 1.359 . . . . 0.0 109.752 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.77 -45.59 1.92 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.618 1.58 . . . . 0.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.58 36.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.308 2.243 . . . . 0.0 112.616 172.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.88 23.52 2.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.95 2.1 . . . . 0.0 110.531 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.89 -20.34 0.19 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.236 0.922 . . . . 0.0 111.485 -171.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.45 84.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.53 -27.31 48.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.637 1.175 . . . . 0.0 113.606 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -62.88 -32.84 74.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.0 112.416 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.81 146.54 11.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.32 136.22 27.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 p -80.39 141.34 35.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -128.25 155.79 44.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.541 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -124.19 133.87 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.31 -16.85 12.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.596 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -63.17 -11.37 20.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -51.2 -37.32 46.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.422 169.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -148.28 -5.15 0.45 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.7 mmm 56.19 26.86 10.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.773 1.629 . . . . 0.0 112.671 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 m -58.91 -55.34 36.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.869 0.867 . . . . 0.0 111.021 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -63.41 -41.66 98.74 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.068 0.547 . . . . 0.0 109.735 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.94 -47.97 88.04 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 119.339 -0.7 . . . . 0.0 111.396 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.68 -45.31 68.6 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.832 0.816 . . . . 0.0 109.805 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.8 67.76 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.86 0.864 . . . . 0.0 113.097 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -112.39 3.2 16.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.942 1.297 . . . . 0.0 111.544 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.74 33.34 85.7 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 119.591 1.087 . . . . 0.0 112.92 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.8 m -115.13 -2.69 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.358 1.063 . . . . 0.0 111.021 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -69.63 108.74 3.98 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.22 128.78 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -65.77 -46.75 77.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.498 1.119 . . . . 0.0 111.245 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.47 -56.84 3.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.07 0.395 . . . . 0.0 110.391 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.62 -19.94 64.27 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.837 0.455 . . . . 0.0 112.078 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 53.83 38.92 29.66 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 110.967 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 mt -136.87 170.63 15.76 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.566 1.146 . . . . 0.0 108.649 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.14 133.67 41.44 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.15 154.54 41.88 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.612 0.765 . . . . 0.0 111.544 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.4 tpt85 -71.8 117.61 13.6 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -160.74 170.44 20.76 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.352 0.978 . . . . 0.0 108.488 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.49 146.41 17.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 118.741 0.701 . . . . 0.0 109.278 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -144.75 156.02 43.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.229 1.412 . . . . 0.0 109.21 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.404 ' C ' HD12 ' A' ' 134' ' ' LEU . 60.7 t -136.32 140.91 42.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 133' ' ' VAL . 9.1 mp -133.26 139.0 46.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.169 1.388 . . . . 0.0 108.79 -169.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.62 166.71 8.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.228 1.811 . . . . 0.0 109.941 169.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.28 -32.01 35.44 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 112.664 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -80.64 -2.99 48.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.582 1.153 . . . . 0.0 112.707 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.53 89.18 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.31 0.957 . . . . 0.0 112.724 -174.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -68.07 124.78 24.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.312 1.556 . . . . 0.0 108.285 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.84 132.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.99 -9.87 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.919 1.288 . . . . 0.0 110.956 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 150.94 30.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.175 0.99 . . . . 0.0 108.51 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.16 137.61 15.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.373 1.869 . . . . 0.0 107.457 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.0 143.93 30.76 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.32 105.47 7.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.546 -2.391 . . . . 0.0 104.546 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.6 144.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.158 -0.339 . . . . 0.0 110.416 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 m -62.22 -20.58 64.36 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.671 0.788 . . . . 0.0 112.007 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -144.48 122.88 12.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.77 65.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.965 1.306 . . . . 0.0 113.466 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.92 16.35 2.88 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.06 0.944 . . . . 0.0 111.55 173.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.73 161.3 35.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.025 2.53 . . . . 0.0 106.638 172.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -122.6 149.92 56.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 119.342 0.974 . . . . 0.0 112.468 -169.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.77 162.79 29.51 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.454 2.769 . . . . 0.0 112.247 -177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -70.94 112.85 7.43 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -75.39 -11.97 60.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.23 -32.91 69.34 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.923 1.238 . . . . 0.0 109.022 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -60.39 -53.36 65.45 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 117.533 -1.222 . . . . 0.0 112.063 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.37 -31.62 42.65 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-N 121.96 1.736 . . . . 0.0 112.256 172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.22 -42.73 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 120.169 1.35 . . . . 0.0 109.757 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.501 1.046 . . . . 0.0 110.937 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.15 93.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.68 0.218 . . . . 0.0 110.92 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.71 77.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.398 174.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -55.44 -43.73 75.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.069 0.85 . . . . 0.0 110.395 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.99 -31.48 66.97 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.081 0.552 . . . . 0.0 112.085 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.35 -46.95 11.22 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.767 0.427 . . . . 0.0 111.801 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.71 -50.0 47.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 123.971 0.908 . . . . 0.0 111.745 -169.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.65 -171.895 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.47 44.33 1.74 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.425 1.09 . . . . 0.0 110.274 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -65.15 171.93 3.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.427 0.691 . . . . 0.0 110.394 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.79 179.04 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.004 0.921 . . . . 0.0 109.677 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 148.6 45.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -141.88 127.62 19.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 44.88 35.84 1.66 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.444 1.098 . . . . 0.0 112.397 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.98 21.47 78.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 121.393 -0.817 . . . . 0.0 114.294 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.68 8.82 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.44 139.93 35.59 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.355 2.037 . . . . 0.0 110.083 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.35 154.59 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.479 1.112 . . . . 0.0 109.186 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -109.11 158.93 17.31 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.075 1.35 . . . . 0.0 107.841 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.29 158.46 22.34 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.093 0.86 . . . . 0.0 109.247 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.35 -18.33 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.59 33.57 0.63 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.816 0.735 . . . . 0.0 111.329 -174.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -50.79 151.31 2.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.7 1.2 . . . . 0.0 113.069 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.252 10.7 tt0 93.19 30.07 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.306 2.643 . . . . 0.0 112.26 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.14 144.24 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -148.88 160.61 43.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.83 131.46 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.395 0.678 . . . . 0.0 109.648 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.55 82.1 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.04 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.55 -6.5 59.47 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.554 1.677 . . . . 0.0 112.596 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.72 176.21 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.965 1.706 . . . . 0.0 112.451 -169.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.1 129.13 18.84 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 126.711 2.004 . . . . 0.0 107.723 -170.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.83 150.64 61.64 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.184 1.922 . . . . 0.0 112.133 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 23.6 t0 -75.8 68.66 2.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.288 1.835 . . . . 0.0 110.314 173.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -60.37 162.81 5.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.162 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -123.51 143.48 50.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.12 170.68 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.545 1.938 . . . . 0.0 108.703 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.4 119.49 22.8 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 125.47 1.508 . . . . 0.0 107.019 -170.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -73.97 173.25 10.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.543 1.137 . . . . 0.0 111.977 -171.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -21.88 66.16 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.086 -1.009 . . . . 0.0 111.226 170.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -80.76 0.19 35.78 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.727 1.611 . . . . 0.0 111.972 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.1 mt 55.27 52.84 10.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.955 2.102 . . . . 0.0 111.719 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.8 153.13 42.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 108.801 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.3 143.5 42.93 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.427 0.691 . . . . 0.0 109.325 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -150.26 160.26 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.252 2.221 . . . . 0.0 105.959 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 p -144.15 167.6 22.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.459 -0.775 . . . . 0.0 109.381 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 57.4 tp -53.98 -42.23 68.77 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 172.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.74 65.12 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.06 -30.7 55.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.886 0.766 . . . . 0.0 111.013 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.1 mtt -72.14 -40.31 68.17 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.446 1.098 . . . . 0.0 110.546 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -53.06 131.88 37.14 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.7 -23.29 4.0 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.009 1.29 . . . . 0.0 112.334 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -151.75 157.78 42.47 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.39 1.076 . . . . 0.0 109.415 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -56.83 140.86 14.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -134.75 146.79 49.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.899 0.88 . . . . 0.0 108.924 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.6 mt -136.46 135.71 49.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.7 mt -137.05 128.62 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -170.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -107.71 143.36 36.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.16 143.32 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.18 -0.95 . . . . 0.0 108.437 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 pt -144.5 161.36 44.38 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.781 2.032 . . . . 0.0 108.163 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -48.04 2.15 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.573 1.515 . . . . 0.0 110.631 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -162.55 156.72 21.21 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.074 1.35 . . . . 0.0 107.36 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.72 -30.72 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.981 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.81 -13.85 57.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 0.0 112.081 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -62.71 -20.47 64.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.276 0.631 . . . . 0.0 111.416 175.157 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 -25.57 3.8 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 124.31 0.957 . . . . 0.0 112.769 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 57' ' ' THR . 4.6 t -64.48 -17.03 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 119.019 1.409 . . . . 0.0 111.594 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.9 p -74.72 -30.07 61.4 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 120.768 -1.207 . . . . 0.0 111.558 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.5 -38.72 40.09 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.448 1.022 . . . . 0.0 109.839 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.63 67.17 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -136.28 -62.71 0.66 Allowed 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.676 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -57.76 -35.43 70.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.341 1.428 . . . . 0.0 113.159 -168.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -27.95 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 118.06 -0.972 . . . . 0.0 112.447 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -103.41 -48.93 3.84 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.842 1.201 . . . . 0.0 109.94 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -51.92 -49.17 63.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 119.497 1.044 . . . . 0.0 111.249 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -79.95 -23.89 41.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.189 -0.319 . . . . 0.0 111.223 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.7 -43.25 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.422 0.689 . . . . 0.0 110.12 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -64.3 -45.63 87.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.818 1.247 . . . . 0.0 108.919 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.87 68.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.556 1.142 . . . . 0.0 110.435 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -9.93 23.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.212 1.005 . . . . 0.0 113.092 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.2 -1.38 10.86 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.6 -34.13 77.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.227 1.376 . . . . 0.0 109.146 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.35 -169.83 40.33 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.494 1.997 . . . . 0.0 108.66 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.96 17.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 113.01 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.53 149.46 5.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.235 1.814 . . . . 0.0 111.272 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -68.75 144.14 54.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 123.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.59 152.8 48.47 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.054 0.542 . . . . 0.0 110.754 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -124.18 143.14 50.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.2 mt -127.4 135.99 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -135.49 168.19 19.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.325 1.45 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.23 172.61 4.57 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.834 0.826 . . . . 0.0 111.406 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.83 -7.34 59.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.166 0.986 . . . . 0.0 111.73 173.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.7 tp -52.31 136.08 40.97 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.257 1.423 . . . . 0.0 109.313 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -52.3 -25.28 23.5 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.566 2.844 . . . . 0.0 116.32 -174.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -74.92 40.98 0.15 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.7 1.6 . . . . 0.0 112.113 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.24 177.27 10.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.106 1.363 . . . . 0.0 110.361 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.296 0.1 OUTLIER 41.54 35.35 0.45 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.816 2.446 . . . . 0.0 115.51 178.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.88 3.44 38.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.275 1.03 . . . . 0.0 112.546 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.262 32.7 ptt-85 44.99 34.01 1.16 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.714 2.006 . . . . 0.0 113.025 -169.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -78.64 -167.74 1.19 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.776 1.231 . . . . 0.0 109.214 171.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.1 p 30.04 -90.19 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.147 2.979 . . . . 0.0 114.149 174.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.25 -21.28 46.79 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.389 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.58 11.03 9.15 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.051 1.426 . . . . 0.0 111.754 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -60.12 -27.81 67.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.0 25.3 0.71 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -173.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.88 91.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.71 -28.93 58.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.462 1.505 . . . . 0.0 113.477 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.7 -17.56 64.7 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -75.99 155.82 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.163 0.892 . . . . 0.0 109.975 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.72 151.68 49.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.2 m -118.1 139.82 50.67 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.93 155.12 30.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.72 0.808 . . . . 0.0 110.094 -172.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -126.57 43.15 3.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.137 1.775 . . . . 0.0 109.139 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -46.13 -41.75 12.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 114.201 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -57.62 -17.58 15.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.275 1.03 . . . . 0.0 113.672 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -61.59 -24.84 66.95 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.004 -1.06 . . . . 0.0 111.832 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -128.39 -28.4 2.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.833 1.653 . . . . 0.0 112.034 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.0 tpt 75.04 10.8 3.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.403 2.681 . . . . 0.0 113.911 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.45 -53.14 61.54 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.846 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.4 -39.62 91.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.193 1.361 . . . . 0.0 109.906 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -50.06 -53.16 24.07 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 125.537 1.541 . . . . 0.0 112.478 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.76 -40.95 63.1 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.053 0.427 . . . . 0.0 110.309 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.23 98.18 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.156 0.982 . . . . 0.0 112.371 -169.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -102.09 -0.12 33.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.381 1.072 . . . . 0.0 110.62 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.53 94.23 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -114.72 0.11 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.98 1.312 . . . . 0.0 110.874 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -76.36 119.09 19.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.46 122.3 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.2 -44.5 97.19 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.94 1.296 . . . . 0.0 110.723 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -95.5 -50.9 4.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.971 0.35 . . . . 0.0 111.16 -172.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.95 -19.03 65.73 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.728 -0.608 . . . . 0.0 112.001 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 53.15 51.79 14.98 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.904 1.281 . . . . 0.0 109.6 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -145.2 162.8 36.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.665 1.586 . . . . 0.0 107.577 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 tp -78.77 132.41 36.9 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.43 -0.794 . . . . 0.0 109.038 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.87 174.92 6.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.045 0.938 . . . . 0.0 112.858 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.91 117.77 34.87 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 169.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -151.19 177.51 10.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.38 145.81 18.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -147.57 156.75 43.12 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.36 1.064 . . . . 0.0 110.051 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.54 139.2 43.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.6 mt -128.55 143.53 50.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.76 1.224 . . . . 0.0 108.619 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -71.51 175.52 5.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.116 0.967 . . . . 0.0 110.252 169.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.06 -23.89 36.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.326 1.451 . . . . 0.0 113.566 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.424 ' H ' ' CG ' ' A' ' 135' ' ' ASP . 32.0 m-80 -98.31 5.46 48.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.854 1.662 . . . . 0.0 111.411 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.64 -0.51 88.17 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.837 -0.98 . . . . 0.0 113.021 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.49 127.49 32.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.696 1.748 . . . . 0.0 108.198 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.85 125.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.47 0.708 . . . . 0.0 109.324 171.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.59 -21.04 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.803 2.041 . . . . 0.0 109.208 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -146.87 150.25 34.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.74 132.63 10.58 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.942 1.697 . . . . 0.0 106.873 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.19 145.48 28.31 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 169.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -115.12 116.41 28.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 t -68.49 126.43 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -57.78 -27.31 62.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.606 1.163 . . . . 0.0 112.617 -173.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.35 103.1 6.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.787 -2.671 . . . . 0.0 103.787 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.33 67.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.615 1.166 . . . . 0.0 112.471 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 p -87.44 19.95 3.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.229 1.012 . . . . 0.0 111.379 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.45 160.46 38.7 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.998 2.119 . . . . 0.0 107.665 175.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -86.66 147.29 43.41 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 121.755 -0.591 . . . . 0.0 112.076 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.03 167.6 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.398 2.732 . . . . 0.0 111.212 169.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -81.21 97.82 7.79 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 169.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -74.29 -4.55 36.85 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.81 -35.35 78.47 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.173 -0.954 . . . . 0.0 109.194 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -56.3 -57.36 23.28 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.34 1.456 . . . . 0.0 111.667 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.62 -33.18 46.25 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.486 1.566 . . . . 0.0 112.312 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 mm -59.05 -48.95 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.837 1.199 . . . . 0.0 109.613 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.54 -41.56 94.73 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.708 0.686 . . . . 0.0 110.537 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.14 87.72 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.686 0.395 . . . . 0.0 110.965 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.44 19.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.517 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -64.22 -26.65 68.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.048 1.294 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.71 70.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.647 1.112 . . . . 0.0 112.073 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.79 -43.87 35.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.646 0.657 . . . . 0.0 110.912 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.36 -48.94 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.38 0.672 . . . . 0.0 110.739 -173.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.057 0 C-N-CA 124.797 1.239 . . . . 0.0 109.969 178.829 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.91 67.76 1.7 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.999 1.32 . . . . 0.0 112.35 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.22 145.98 55.14 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 168.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.3 pt -137.1 -177.86 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 109.57 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -126.83 152.49 46.92 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -140.06 128.97 23.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt 43.95 36.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.267 1.427 . . . . 0.0 112.739 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.91 16.95 79.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.55 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.63 120.9 4.92 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 171.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.37 138.64 84.59 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.019 2.479 . . . . 0.0 111.357 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 m -143.41 162.06 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.36 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -118.78 161.83 19.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.463 1.505 . . . . 0.0 108.73 -169.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.96 163.06 14.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.659 1.584 . . . . 0.0 109.69 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.36 -62.39 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.524 0.602 . . . . 0.0 111.689 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.45 12.45 69.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -168.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 56.48 154.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.29 2.636 . . . . 0.0 114.602 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -71.78 139.77 49.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.856 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.93 165.74 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -152.11 162.09 41.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.347 -0.846 . . . . 0.0 109.174 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.43 130.44 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.04 0.44 90.29 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.928 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -5.73 59.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.664 . . . . 0.0 112.332 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 58.38 180.0 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 111.527 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.56 146.35 52.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.541 1.536 . . . . 0.0 110.015 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -56.41 -21.84 39.22 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.439 3.426 . . . . 0.0 116.114 174.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 73.49 66.63 0.1 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 108.621 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -69.69 169.12 13.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.401 1.88 . . . . 0.0 111.748 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.5 m -110.48 155.73 21.84 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.23 166.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 127.501 2.32 . . . . 0.0 106.387 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 tp -118.22 135.71 54.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.7 p -75.84 168.36 20.17 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.024 0.53 . . . . 0.0 110.195 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -62.94 -18.85 63.65 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.887 -0.508 . . . . 0.0 110.744 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -81.91 -0.64 44.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.61 1.564 . . . . 0.0 111.693 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.8 mt 62.1 47.12 5.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.277 2.231 . . . . 0.0 111.838 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.22 150.89 49.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.667 1.187 . . . . 0.0 108.971 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.93 145.23 44.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 109.588 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -152.75 163.34 39.89 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.208 2.203 . . . . 0.0 106.064 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 p -143.51 168.6 19.46 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.302 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.6 tp -55.38 -35.92 65.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.251 -0.281 . . . . 0.0 110.541 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.06 -23.71 48.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.83 -32.19 67.29 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.435 1.016 . . . . 0.0 110.795 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 29.7 mtt -80.26 -37.33 33.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.776 1.63 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -53.27 145.31 14.19 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.841 0.857 . . . . 0.0 110.288 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.86 -18.49 14.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.369 1.461 . . . . 0.0 112.588 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.65 153.28 35.34 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 108.06 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -58.37 145.16 10.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 m -138.44 149.15 45.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.578 0.751 . . . . 0.0 109.4 -169.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.42 136.68 54.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.28 112.71 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 m -93.8 155.12 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.74 139.21 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.62 158.52 75.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -48.93 5.9 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.326 1.351 . . . . 0.0 110.799 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 m -165.06 156.87 15.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.595 1.158 . . . . 0.0 109.224 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 tp -66.61 -21.42 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.07 -24.75 65.99 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.968 0.907 . . . . 0.0 111.895 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -72.12 151.29 43.13 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.039 -0.413 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.17 -24.9 75.81 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.731 -0.606 . . . . 0.0 113.374 -172.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 m -60.9 -21.63 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.515 1.157 . . . . 0.0 112.662 -174.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.0 p -60.75 -31.47 70.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.988 0.813 . . . . 0.0 111.929 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -115.29 -33.89 5.16 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.086 0.954 . . . . 0.0 110.773 -172.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -29.87 70.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.593 0.757 . . . . 0.0 112.083 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -148.37 -36.46 0.19 Allowed 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 113.296 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -64.62 -43.5 93.53 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.054 1.752 . . . . 0.0 111.031 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -54.9 -50.51 68.59 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.084 0.954 . . . . 0.0 111.083 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -61.21 -47.8 84.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 110.956 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.1 -46.43 90.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.106 0.412 . . . . 0.0 110.566 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -61.95 -39.13 91.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.758 0.823 . . . . 0.0 110.632 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.53 -49.27 77.37 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.617 0.767 . . . . 0.0 109.806 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -65.57 -39.9 92.18 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.963 0.505 . . . . 0.0 110.804 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.85 82.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 110.954 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.4 66.18 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -79.37 -25.39 42.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.206 0.912 . . . . 0.0 112.104 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.6 mt -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.192 0.906 . . . . 0.0 109.908 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.18 -170.02 43.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.53 37.99 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.671 0.788 . . . . 0.0 112.34 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 77' ' ' VAL . 3.3 t -58.07 140.38 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 120.899 -1.125 . . . . 0.0 108.069 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.34 138.48 53.77 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 169.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.74 127.58 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.5 156.58 48.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.301 1.04 . . . . 0.0 109.362 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -140.18 119.86 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -100.75 141.71 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -145.19 167.42 22.84 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.177 0.991 . . . . 0.0 110.176 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.01 176.07 4.67 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.268 0.556 . . . . 0.0 109.965 169.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -124.84 30.88 5.8 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.642 1.177 . . . . 0.0 109.71 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.3 mt -66.36 168.7 9.02 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.209 1.404 . . . . 0.0 109.436 169.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.62 -17.37 4.69 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.949 3.099 . . . . 0.0 115.675 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -61.87 -10.8 10.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.092 1.357 . . . . 0.0 113.654 170.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.72 -177.5 0.21 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.267 2.227 . . . . 0.0 116.17 168.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -126.03 -14.52 6.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.847 2.459 . . . . 0.0 110.594 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.94 -35.34 58.5 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.035 2.134 . . . . 0.0 115.947 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.16 -25.13 65.11 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.21 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.2 p90 34.95 38.27 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.806 2.442 . . . . 0.0 115.015 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -40.33 71.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.14 0.976 . . . . 0.0 111.953 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.09 -14.8 54.81 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.73 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.38 13.96 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.362 1.465 . . . . 0.0 112.289 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -79.54 76.29 6.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.231 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.08 -18.23 0.54 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.26 1.409 . . . . 0.0 111.406 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.15 89.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.604 1.562 . . . . 0.0 107.438 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.61 -24.44 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.138 1.775 . . . . 0.0 113.607 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.65 -32.16 65.1 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.353 1.061 . . . . 0.0 112.892 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.55 137.89 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -121.67 124.82 45.19 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -80.52 141.88 34.72 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -129.52 148.63 51.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.727 1.611 . . . . 0.0 107.022 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -128.69 54.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.206 1.402 . . . . 0.0 108.494 -168.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -49.1 -34.5 14.01 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.788 1.235 . . . . 0.0 113.723 -169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -49.64 -25.06 2.54 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -62.69 -21.9 66.09 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.55 -21.64 2.8 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.461 1.504 . . . . 0.0 112.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 tpt 61.94 5.0 1.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.12 3.368 . . . . 0.0 114.725 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.3 m -66.59 -44.56 81.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.46 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.48 -40.31 96.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 121.298 1.863 . . . . 0.0 109.887 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.85 -46.44 92.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 123.918 0.77 . . . . 0.0 111.469 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.64 -41.78 65.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.672 0.736 . . . . 0.0 110.477 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.02 94.16 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.216 1.006 . . . . 0.0 111.986 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -95.15 4.67 53.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.83 0.852 . . . . 0.0 110.4 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.78 -10.27 14.06 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.306 176.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.75 -13.4 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.816 1.647 . . . . 0.0 112.79 -169.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.79 108.41 1.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.3 118.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.68 -45.31 85.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.952 1.701 . . . . 0.0 111.144 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -89.87 -1.56 58.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.292 0.637 . . . . 0.0 112.427 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -136.56 -6.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.772 0.829 . . . . 0.0 112.492 -171.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 40.96 42.6 1.55 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.892 2.077 . . . . 0.0 113.337 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.6 tp -132.67 153.84 50.72 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -169.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.73 123.34 22.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.36 137.61 56.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.115 0.566 . . . . 0.0 110.511 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.76 119.24 7.78 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.1 p -156.85 166.16 34.15 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.939 1.296 . . . . 0.0 107.555 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.29 146.31 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -144.65 154.93 43.31 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.786 1.234 . . . . 0.0 108.772 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.93 137.81 48.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -131.91 137.78 48.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.831 1.253 . . . . 0.0 108.201 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.94 164.71 14.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.631 1.572 . . . . 0.0 110.748 170.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -50.05 -35.58 25.62 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.691 1.596 . . . . 0.0 113.043 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 7.71 33.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.848 0.859 . . . . 0.0 113.002 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.95 -6.33 76.46 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.592 1.092 . . . . 0.0 113.278 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.31 128.83 37.86 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.029 1.414 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -61.74 123.44 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.137 0.975 . . . . 0.0 109.415 172.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.23 -12.55 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.354 1.462 . . . . 0.0 110.133 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -148.12 148.59 30.77 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.32 17.25 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.639 1.576 . . . . 0.0 107.709 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -145.3 148.0 32.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.789 0.836 . . . . 0.0 109.5 170.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -135.7 107.1 6.85 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.749 2.42 . . . . 0.0 105.496 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.28 136.26 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -169.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -62.13 -21.98 65.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.605 1.162 . . . . 0.0 112.993 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -136.97 94.87 3.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.03 -13.95 60.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.577 1.151 . . . . 0.0 113.818 -170.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -0.49 18.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.201 0.909 . . . . 0.0 112.143 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.65 170.44 13.8 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 108.588 175.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -115.01 158.49 40.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.698 0.799 . . . . 0.0 112.325 -169.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.27 -179.72 4.88 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.218 2.612 . . . . 0.0 110.866 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -73.51 140.36 46.32 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -100.42 -8.18 23.52 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -79.79 -36.1 37.55 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.032 -1.042 . . . . 0.0 108.378 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -51.42 -56.27 22.05 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.71 -1.138 . . . . 0.0 111.816 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -66.95 -32.5 35.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 CA-C-N 121.535 1.584 . . . . 0.0 112.846 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.6 mm -58.94 -44.24 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.43 1.468 . . . . 0.0 109.865 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.64 -37.62 87.07 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.454 1.025 . . . . 0.0 110.602 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.24 89.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.444 -0.16 . . . . 0.0 111.298 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.59 66.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.333 0.653 . . . . 0.0 110.869 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.75 -40.97 66.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.164 0.893 . . . . 0.0 110.58 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.16 63.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.629 0.772 . . . . 0.0 112.33 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 48.4 mt -97.55 -36.79 10.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.261 0.624 . . . . 0.0 112.279 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.84 -48.29 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.452 1.101 . . . . 0.0 110.417 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--O 1.249 1.034 0 C-N-CA 124.583 1.153 . . . . 0.0 109.745 178.297 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.13 62.15 0.64 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.03 1.732 . . . . 0.0 112.389 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.0 146.62 53.79 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 169.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.7 pt -135.78 -175.75 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.267 1.027 . . . . 0.0 108.938 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.91 154.72 50.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.17 126.13 17.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 43.07 45.45 4.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.109 1.364 . . . . 0.0 112.344 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.62 19.61 79.82 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.16 0.886 . . . . 0.0 114.925 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.17 120.29 4.03 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.53 140.48 89.67 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.918 2.412 . . . . 0.0 111.366 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.03 165.24 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.998 1.319 . . . . 0.0 108.684 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -126.65 154.92 43.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.107 0.963 . . . . 0.0 110.781 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.9 147.48 23.33 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.1 1.36 . . . . 0.0 110.964 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -77.13 -55.19 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 123.931 0.892 . . . . 0.0 109.887 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.45 32.68 7.19 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.197 0.903 . . . . 0.0 112.102 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 55.09 -146.79 0.55 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.023 0.929 . . . . 0.0 110.157 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.99 123.87 29.74 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.589 1.155 . . . . 0.0 110.755 -172.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -70.41 160.09 5.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.11 165.66 25.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -174.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -56.54 131.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.46 -5.67 72.36 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.786 1.184 . . . . 0.0 113.563 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.81 -5.9 57.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.525 1.662 . . . . 0.0 113.738 -170.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 66.7 112.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.381 1.872 . . . . 0.0 112.38 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.17 135.61 93.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.28 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.53 -46.74 13.43 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.579 2.186 . . . . 0.0 113.733 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 t70 122.51 126.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 131.471 3.908 . . . . 0.0 105.827 -169.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -138.84 165.74 26.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.691 1.596 . . . . 0.0 109.247 -175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.7 m -131.51 141.47 49.76 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.03 167.7 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.653 1.981 . . . . 0.0 108.41 -172.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.95 143.43 31.11 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 p -80.63 -179.64 7.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.29 1.436 . . . . 0.0 111.571 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -63.49 -24.52 67.86 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.425 -0.797 . . . . 0.0 110.836 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m -82.98 2.84 32.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.218 1.407 . . . . 0.0 111.768 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.2 mt 51.23 42.7 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.966 2.107 . . . . 0.0 112.774 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.82 160.55 21.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.182 0.993 . . . . 0.0 109.121 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.21 143.68 45.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.827 0.822 . . . . 0.0 110.691 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 42.0 tttp -148.81 153.83 38.67 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.765 2.426 . . . . 0.0 105.894 176.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 p -137.5 167.69 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.689 0.677 . . . . 0.0 110.124 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.64 -39.57 65.1 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.75 -25.75 60.88 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.18 -30.5 43.48 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.777 0.717 . . . . 0.0 111.436 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.2 mtt -71.76 -37.61 70.48 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.447 1.099 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.93 146.61 13.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.763 0.825 . . . . 0.0 110.27 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.99 2.77 48.92 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.548 1.071 . . . . 0.0 114.051 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -150.45 157.24 42.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.894 1.278 . . . . 0.0 108.814 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.56 139.59 19.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -136.77 146.19 45.47 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.28 135.51 62.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.1 mt -132.33 101.28 4.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -174.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -80.85 146.28 30.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.21 135.62 54.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.0 pt -145.82 159.06 48.22 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 125.001 1.321 . . . . 0.0 109.104 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.81 -53.03 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 N-CA-C 107.978 -1.586 . . . . 0.0 107.978 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -157.83 -177.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.413 2.285 . . . . 0.0 106.199 170.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 pt -86.94 -42.89 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.839 0.856 . . . . 0.0 109.724 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.36 -18.72 63.82 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.445 1.098 . . . . 0.0 111.095 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -20.15 61.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.572 1.149 . . . . 0.0 112.73 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.85 -15.42 3.08 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.29 0.95 . . . . 0.0 114.229 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.16 -7.26 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.929 1.364 . . . . 0.0 113.684 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.7 m -61.6 -33.75 74.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.442 1.019 . . . . 0.0 110.821 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.07 -18.75 45.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.934 0.894 . . . . 0.0 111.463 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.01 -173.9 2.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.331 1.053 . . . . 0.0 110.45 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -15.84 58.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.892 1.277 . . . . 0.0 113.688 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.91 64.75 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.324 1.449 . . . . 0.0 112.275 -169.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.8 tpt85 -57.94 -30.5 66.01 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.112 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 -42.93 7.53 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.833 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -59.36 -47.4 85.56 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.382 1.446 . . . . 0.0 111.914 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -67.3 -33.73 75.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.123 0.42 . . . . 0.0 110.377 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -65.12 -49.25 70.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.991 0.516 . . . . 0.0 109.678 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -61.32 -41.54 97.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.852 1.261 . . . . 0.0 110.195 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.52 -52.63 59.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.046 0.938 . . . . 0.0 110.62 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.91 67.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -83.1 -18.53 39.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.822 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.89 -38.43 91.06 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.324 1.42 . . . . 0.0 110.982 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.7 -169.27 42.33 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.35 23.84 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.017 0.909 . . . . 0.0 113.212 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -57.03 144.84 8.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.643 1.177 . . . . 0.0 109.72 -173.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.95 139.35 56.39 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.66 126.14 57.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 59.9 m-85 -128.1 150.77 49.82 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.615 0.766 . . . . 0.0 109.157 -177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.0 m -132.51 95.4 3.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -84.09 136.03 23.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.8 m -135.62 165.39 25.67 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.794 1.237 . . . . 0.0 110.905 -169.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.31 28.78 0.71 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.188 0.995 . . . . 0.0 113.63 -173.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 66.65 -5.03 0.67 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.216 2.206 . . . . 0.0 113.961 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.2 tp -53.1 121.42 24.07 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.185 1.394 . . . . 0.0 108.19 169.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -50.46 -36.4 48.59 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.482 2.788 . . . . 0.0 115.548 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -58.88 -29.42 66.98 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.878 0.471 . . . . 0.0 112.027 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.77 64.45 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -108.63 4.24 23.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.511 1.124 . . . . 0.0 111.68 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.15 -2.56 28.31 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.722 0.809 . . . . 0.0 112.721 170.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 57.45 26.26 12.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.858 1.663 . . . . 0.0 112.669 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -54.11 -37.22 64.08 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p -153.84 170.65 20.46 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.738 1.215 . . . . 0.0 108.728 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.55 -18.17 1.37 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.661 -1.077 . . . . 0.0 115.073 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 28.89 1.83 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.035 1.417 . . . . 0.0 111.787 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -136.94 146.84 45.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.97 -18.83 33.41 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.084 -0.842 . . . . 0.0 112.71 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.05 88.86 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 125.7 1.6 . . . . 0.0 107.839 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.58 -19.09 56.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.597 1.559 . . . . 0.0 114.049 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -60.43 -30.17 69.47 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.625 -0.672 . . . . 0.0 111.834 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 t -71.93 140.44 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -129.0 147.01 50.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 169.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 p -106.84 132.19 53.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.07 155.29 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -170.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.2 m -125.77 134.03 51.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -121.4 -34.24 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -56.68 -15.2 4.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.711 1.205 . . . . 0.0 113.399 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -56.3 -35.46 67.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.763 0.825 . . . . 0.0 112.003 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -140.78 -4.05 1.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.34 17.62 8.48 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.648 2.379 . . . . 0.0 114.493 173.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.5 m -60.51 -57.15 13.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.776 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.86 -40.9 97.64 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.541 0.61 . . . . 0.0 109.627 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.01 -43.68 99.15 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -74.58 -39.59 62.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.713 1.256 . . . . 0.0 110.461 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.06 -45.97 92.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.132 0.973 . . . . 0.0 111.932 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.27 -10.63 43.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.317 1.047 . . . . 0.0 110.538 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.42 -5.44 73.2 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.286 1.898 . . . . 0.0 113.874 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.55 -9.7 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.736 2.014 . . . . 0.0 112.954 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.88 112.97 2.26 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 168.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 124' ' ' LEU . 91.2 mt -76.02 133.18 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.53 -59.76 4.89 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.577 1.151 . . . . 0.0 110.585 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -74.66 -47.69 30.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.377 0.671 . . . . 0.0 111.579 -169.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.528 ' H ' HG22 ' A' ' 121' ' ' ILE . 14.4 tp -78.05 -15.24 59.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.325 0.65 . . . . 0.0 112.024 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 47.5 44.04 16.4 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.999 1.72 . . . . 0.0 111.993 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 tp -139.04 165.04 28.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.279 1.032 . . . . 0.0 108.245 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 127.18 32.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.36 150.43 48.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.054 0.454 . . . . 0.0 110.484 170.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 124.55 25.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.1 m -156.99 168.5 27.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.74 137.47 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -141.23 154.15 45.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.63 138.16 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.3 mp -130.64 135.95 48.36 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.032 0.933 . . . . 0.0 109.671 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.36 163.69 15.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.79 1.636 . . . . 0.0 109.313 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -52.21 -29.76 24.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.579 1.552 . . . . 0.0 113.265 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -71.56 -6.22 39.14 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.506 1.122 . . . . 0.0 113.09 177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.99 47.71 18.21 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -170.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.94 126.87 42.28 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -67.47 121.38 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.521 0.728 . . . . 0.0 109.439 -170.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.18 -7.68 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.05 1.34 . . . . 0.0 110.747 170.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -150.69 149.2 29.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.99 125.78 7.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.264 1.425 . . . . 0.0 108.177 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -140.84 149.78 42.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.453 0.569 . . . . 0.0 109.954 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.65 116.91 17.97 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.56 133.52 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -171.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -55.27 -28.33 52.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.398 1.079 . . . . 0.0 111.667 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.78 111.98 9.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.85 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.423 1.489 . . . . 0.0 113.152 -176.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 8.64 6.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.874 0.87 . . . . 0.0 112.438 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.39 -174.91 3.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.952 1.301 . . . . 0.0 110.258 172.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -103.87 147.36 34.15 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.21 -0.931 . . . . 0.0 113.426 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.04 178.8 6.07 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.693 2.929 . . . . 0.0 109.967 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.74 133.73 49.79 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -123.31 16.82 9.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 111.684 -170.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.43 -42.28 4.38 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -51.17 -46.35 88.95 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.341 -1.314 . . . . 0.0 112.851 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.87 -38.39 30.03 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 121.943 1.73 . . . . 0.0 111.644 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.7 mm -61.3 -42.37 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.34 -38.45 91.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.556 1.071 . . . . 0.0 111.088 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.09 99.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.56 0.344 . . . . 0.0 110.667 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.9 73.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.977 0.511 . . . . 0.0 110.823 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -55.09 -43.1 73.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.151 0.887 . . . . 0.0 110.285 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.255 0.622 . . . . 0.0 112.104 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.05 -41.9 18.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.871 0.469 . . . . 0.0 111.74 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.06 -52.54 32.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.975 0.91 . . . . 0.0 110.649 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 123.879 0.872 . . . . 0.0 110.004 177.361 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.28 63.99 1.59 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.034 1.734 . . . . 0.0 108.097 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -60.82 166.01 3.64 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.777 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 pt -129.86 172.75 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 123.225 1.488 . . . . 0.0 112.515 -175.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -118.56 156.67 28.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.597 2.759 . . . . 0.0 104.963 170.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.3 122.23 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? 48.1 36.69 6.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.927 1.291 . . . . 0.0 111.51 -175.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.93 85.47 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.39 -0.819 . . . . 0.0 114.694 176.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.47 118.1 5.07 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.41 143.42 77.2 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.808 2.339 . . . . 0.0 111.355 173.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.86 -175.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.958 1.303 . . . . 0.0 108.655 175.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -132.58 151.45 51.93 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.641 1.176 . . . . 0.0 108.154 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.12 155.59 17.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.71 1.604 . . . . 0.0 109.046 176.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -74.83 -25.36 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.65 17.29 1.11 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.247 -0.752 . . . . 0.0 112.91 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 47.65 -168.61 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.682 1.993 . . . . 0.0 113.838 178.062 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 145' ' ' TYR . 6.8 pm0 -80.76 128.76 34.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.705 -1.247 . . . . 0.0 113.414 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.3 170.31 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 165.01 34.01 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 120.998 -1.064 . . . . 0.0 109.514 -172.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.46 132.36 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 -2.21 87.56 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.836 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.05 -13.29 59.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.311 1.556 . . . . 0.0 112.4 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.51 176.64 0.06 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.208 1.803 . . . . 0.0 112.192 -169.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.99 137.75 30.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.163 1.385 . . . . 0.0 110.451 -171.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.17 -20.13 45.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.727 3.618 . . . . 0.0 117.122 176.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.33 72.37 0.13 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.63 1.972 . . . . 0.0 109.287 -169.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -72.82 175.89 6.11 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.65 1.58 . . . . 0.0 110.709 177.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.1 m -131.97 144.56 50.9 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.86 176.42 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 108.169 -177.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.9 mt -113.52 140.31 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.273 1.029 . . . . 0.0 109.474 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -72.59 176.23 5.65 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.383 1.473 . . . . 0.0 111.174 175.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -59.84 -22.58 62.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.154 0.582 . . . . 0.0 111.15 169.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.7 m -92.1 4.1 53.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.551 1.54 . . . . 0.0 112.212 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.6 mp 53.05 47.16 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.305 1.842 . . . . 0.0 112.164 -175.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -112.44 148.41 34.43 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.16 146.67 34.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.802 0.811 . . . . 0.0 111.1 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -150.41 114.98 5.21 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.79 1.636 . . . . 0.0 107.14 -172.075 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -79.93 161.89 25.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.209 0.603 . . . . 0.0 109.999 176.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.37 -36.5 73.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.68 44.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.924 0.89 . . . . 0.0 113.353 177.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -74.08 -32.64 63.35 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.444 1.02 . . . . 0.0 110.965 174.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.6 mtt -75.81 -34.61 60.16 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 111.371 177.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -54.67 158.29 2.65 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.607 1.163 . . . . 0.0 111.368 -177.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.85 67.01 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.335 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -146.33 159.67 43.05 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.038 2.135 . . . . 0.0 106.964 169.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 77' ' ' VAL . 74.9 t -65.74 113.96 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.3 m -92.44 138.44 31.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.4 mt -132.84 133.05 59.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.19 139.93 41.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -172.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -123.04 152.51 40.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.61 124.92 35.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 pt -139.2 147.27 52.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.93 -47.87 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 120.723 0.948 . . . . 0.0 110.794 174.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.04 173.25 16.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -169.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.38 -42.96 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.616 1.566 . . . . 0.0 107.661 174.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.41 -28.16 68.41 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.625 1.17 . . . . 0.0 112.36 -175.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.37 -4.95 9.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 176.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.41 -29.75 2.84 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 121.082 -1.011 . . . . 0.0 114.174 169.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.79 -25.38 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.972 1.386 . . . . 0.0 112.599 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.47 -39.86 61.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.091 1.356 . . . . 0.0 111.769 169.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -107.13 -36.8 6.47 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.814 0.846 . . . . 0.0 111.172 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.54 68.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.811 0.844 . . . . 0.0 112.564 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -145.44 -41.27 0.23 Allowed 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.038 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -67.22 -44.41 79.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.654 1.116 . . . . 0.0 110.649 -169.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -59.35 -30.44 68.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 113.449 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -85.25 -43.62 13.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.948 0.794 . . . . 0.0 110.193 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.47 -50.67 72.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.428 0.691 . . . . 0.0 110.421 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -60.66 -38.38 84.7 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.991 0.516 . . . . 0.0 110.888 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.64 -33.18 75.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.166 0.986 . . . . 0.0 112.135 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.75 -46.29 15.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.169 0.895 . . . . 0.0 109.945 172.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -45.1 87.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.383 1.073 . . . . 0.0 111.017 -174.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.03 -15.06 55.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.082 0.953 . . . . 0.0 112.797 -173.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -117.14 3.99 12.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.14 -35.71 79.6 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.969 1.259 . . . . 0.0 110.719 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.03 -161.44 30.81 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.694 1.14 . . . . 0.0 110.278 -176.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -74.04 27.97 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.892 1.277 . . . . 0.0 112.42 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 46' ' ' VAL . 15.9 m -65.06 144.83 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 108.362 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -84.04 155.31 22.78 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.44 124.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -172.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -139.35 157.73 45.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.057 0.543 . . . . 0.0 110.443 -176.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.6 m -136.29 103.98 5.48 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.97 150.16 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.624 1.17 . . . . 0.0 108.295 -174.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.3 m -127.27 158.41 37.25 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.195 1.798 . . . . 0.0 111.223 -169.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -108.44 -179.21 3.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.34 1.056 . . . . 0.0 111.933 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.71 -30.6 67.2 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -168.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.89 152.52 86.86 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 118.198 0.454 . . . . 0.0 111.958 -169.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -52.36 -40.33 71.0 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.883 3.055 . . . . 0.0 116.256 -169.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -78.81 30.98 0.2 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.669 1.188 . . . . 0.0 112.709 -172.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.44 178.42 4.62 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.077 -1.014 . . . . 0.0 112.075 178.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -68.98 162.93 25.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.049 1.74 . . . . 0.0 113.273 -169.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.58 62.87 0.6 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.235 2.214 . . . . 0.0 108.607 173.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 51.61 52.07 15.41 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.687 1.595 . . . . 0.0 112.399 -169.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -105.08 -164.94 1.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.397 1.079 . . . . 0.0 108.537 169.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 m 61.16 18.22 8.86 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.923 1.689 . . . . 0.0 114.808 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.12 -43.52 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.1 8.55 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.22 0.24 12.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.709 1.204 . . . . 0.0 112.144 176.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.68 -18.88 0.6 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.716 1.15 . . . . 0.0 112.38 177.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.93 95.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.13 -16.75 54.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.22 1.408 . . . . 0.0 114.049 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -60.23 -30.39 69.37 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.689 -0.632 . . . . 0.0 111.314 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.1 t -75.34 147.45 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.18 142.98 40.04 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.1 p -87.54 132.41 34.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.02 168.86 11.06 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.546 1.938 . . . . 0.0 107.547 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.3 m -136.63 147.66 47.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.126 0.97 . . . . 0.0 109.091 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -125.86 -19.09 4.95 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.523 0.729 . . . . 0.0 111.466 173.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -55.45 -24.62 31.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -173.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -73.1 -16.17 61.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.373 -0.822 . . . . 0.0 112.815 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -139.9 -21.99 0.87 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.546 1.066 . . . . 0.0 113.636 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.9 mmm 57.55 7.44 0.52 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.327 2.651 . . . . 0.0 115.816 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.2 m -62.39 -48.01 81.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.859 1.209 . . . . 0.0 111.846 -177.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -64.27 -40.33 95.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.445 1.475 . . . . 0.0 110.027 177.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -49.81 -57.28 9.93 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 125.749 1.642 . . . . 0.0 112.274 176.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.86 -42.58 81.1 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.134 0.467 . . . . 0.0 110.049 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.81 92.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.848 0.859 . . . . 0.0 112.2 -172.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.84 8.2 37.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.224 1.01 . . . . 0.0 110.896 -176.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.37 34.43 74.75 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.146 0.884 . . . . 0.0 111.704 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.454 HG23 ' HA2' ' A' ' 114' ' ' GLY . 9.3 m -108.87 -4.3 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.742 1.617 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.63 113.52 8.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 168.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 84.3 mt -70.94 111.27 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 175.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -54.37 -40.91 68.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.442 1.497 . . . . 0.0 111.43 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.95 -4.02 55.18 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.69 -16.97 1.99 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.938 0.79 . . . . 0.0 112.763 -170.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.4 ttm105 47.46 42.41 14.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.82 1.648 . . . . 0.0 111.989 -173.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -122.09 163.03 20.17 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.04 131.52 36.3 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 138.8 56.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.162 1.385 . . . . 0.0 111.541 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -58.57 113.64 2.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.377 1.071 . . . . 0.0 108.78 171.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.3 p -156.23 173.63 16.56 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.927 0.394 . . . . 0.0 110.667 -176.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.93 149.12 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.439 1.496 . . . . 0.0 107.85 174.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -147.79 155.45 41.69 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.773 1.229 . . . . 0.0 110.119 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.59 142.87 33.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 mp -138.93 142.29 38.47 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -173.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.65 165.06 5.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.28 1.432 . . . . 0.0 110.038 169.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -51.13 -32.53 23.1 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.982 1.313 . . . . 0.0 112.848 176.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -79.5 0.41 29.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.835 1.254 . . . . 0.0 112.834 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.05 88.62 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.004 -1.06 . . . . 0.0 112.884 -175.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -67.75 121.88 16.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.068 1.434 . . . . 0.0 107.236 172.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.07 132.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.295 0.638 . . . . 0.0 109.446 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.53 -18.75 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.664 1.985 . . . . 0.0 109.662 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -147.27 149.45 32.89 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.04 138.84 17.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.105 1.762 . . . . 0.0 107.475 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -146.91 146.78 30.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.31 0.644 . . . . 0.0 109.796 170.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 17' ' ' GLU . 12.8 m-85 -139.13 93.42 2.69 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.6 2.76 . . . . 0.0 104.837 -173.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.7 m -62.52 147.37 11.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 O-C-N 121.769 -0.582 . . . . 0.0 110.415 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -66.45 -11.09 50.19 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.097 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -143.35 125.64 15.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.36 -24.13 58.91 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -176.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 38.3 p -89.78 -4.17 57.78 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.001 0.819 . . . . 0.0 112.298 176.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -84.62 176.49 8.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.248 1.419 . . . . 0.0 109.268 173.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -148.05 146.54 23.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.46 176.83 7.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.414 2.743 . . . . 0.0 110.451 177.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -76.8 119.53 20.7 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -67.82 -14.36 62.89 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -70.0 -30.02 67.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.015 1.279 . . . . 0.0 109.435 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -66.34 -49.78 52.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.357 -175.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -65.58 -35.79 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 121.366 1.524 . . . . 0.0 111.541 170.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.14 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 119.755 1.161 . . . . 0.0 110.154 179.079 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.84 -30.15 67.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.59 1.086 . . . . 0.0 110.741 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.09 97.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.004 0.366 . . . . 0.0 110.544 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.33 -45.05 85.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.944 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -56.7 -41.32 77.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.202 0.91 . . . . 0.0 110.498 176.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.22 71.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.65 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.85 -47.59 14.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.566 0.621 . . . . 0.0 111.89 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.05 -39.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 110.718 -172.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.2 mttm . . . . . 0 C--O 1.249 1.049 0 C-N-CA 126.039 1.735 . . . . 0.0 109.592 -175.829 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.5 pt -135.56 175.66 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 m -119.32 152.53 36.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -136.32 123.83 22.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 173.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.8 mttt 50.36 36.15 12.4 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.53 85.97 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 119.417 -1.373 . . . . 0.0 113.406 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.68 124.32 6.34 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.076 1.938 . . . . 0.0 108.364 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.05 144.5 99.47 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 CA-C-N 120.217 2.009 . . . . 0.0 109.994 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -145.47 145.27 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.175 0.99 . . . . 0.0 109.765 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -90.63 159.82 16.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.543 1.137 . . . . 0.0 109.93 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -111.81 153.27 26.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.338 1.455 . . . . 0.0 109.189 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -81.9 -56.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 121.96 -0.463 . . . . 0.0 110.427 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.42 12.72 33.33 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.034 -167.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 28.76 174.58 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 133.456 4.703 . . . . 0.0 120.657 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 12.82 62.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 129.786 3.234 . . . . 0.0 117.607 144.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 157.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 149.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -150.37 171.78 16.45 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 120.923 -1.111 . . . . 0.0 108.485 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.32 131.74 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.839 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.9 -10.01 72.11 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 116.922 -2.043 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.96 -13.0 61.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.537 1.668 . . . . 0.0 113.42 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 65.16 160.86 0.12 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.33 1.852 . . . . 0.0 110.544 -172.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.92 132.24 22.42 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.21 1.804 . . . . 0.0 109.013 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.5 -28.65 86.21 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.1 2.533 . . . . 0.0 118.459 -169.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 t70 75.12 99.8 0.07 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.169 -157.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' A' ' 112' ' ' SER . 2.2 p90 -125.87 -174.47 3.1 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 126.077 1.751 . . . . 0.0 106.702 169.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 m -115.94 153.89 30.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.746 2.018 . . . . 0.0 106.95 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.03 168.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.67 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 1.2 tp -112.07 147.02 36.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 172.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -79.17 172.53 13.67 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.37 -29.5 66.05 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.973 1.309 . . . . 0.0 110.933 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -80.52 -0.04 35.8 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.403 1.481 . . . . 0.0 112.968 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.1 mt 62.37 36.51 14.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.176 1.79 . . . . 0.0 112.526 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.54 144.28 28.82 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 171.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.92 132.4 45.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.113 0.959 . . . . 0.0 108.956 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 49.6 tttp -136.08 148.39 48.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.38 167.4 12.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.29 -37.29 67.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.626 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.43 63.64 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.894 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.12 -26.6 59.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.199 0.909 . . . . 0.0 111.625 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 mtt -78.21 -31.18 49.28 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.413 -0.804 . . . . 0.0 111.419 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -62.38 152.74 33.23 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.226 0.536 . . . . 0.0 110.0 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.16 -7.66 44.2 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -154.51 160.99 41.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.541 1.171 . . . . 0.0 109.15 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.16 137.59 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.5 m -132.28 147.23 52.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.351 1.46 . . . . 0.0 107.956 -173.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.65 137.44 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -137.46 117.62 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.3 m -93.09 150.74 20.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 163.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.05 133.95 55.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.23 151.73 62.42 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.31 -43.12 4.73 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.62 1.547 . . . . 0.0 110.747 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.2 m -150.75 171.5 17.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.583 2.353 . . . . 0.0 106.839 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 93' ' ' TRP . 1.1 pt -99.99 -20.45 5.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 123.147 0.579 . . . . 0.0 111.669 166.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.8 -22.4 66.89 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.215 -1.553 . . . . 0.0 112.122 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -65.57 1.82 1.12 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.107 1.763 . . . . 0.0 115.024 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.59 -18.64 3.58 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 121.363 1.892 . . . . 0.0 114.113 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.495 ' HB ' HH21 ' A' ' 129' ' ' ARG . 1.6 m -57.56 -23.09 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.59 1.695 . . . . 0.0 113.109 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . 0.265 61.2 m -36.82 -61.57 0.53 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.736 1.214 . . . . 0.0 110.259 165.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -75.35 -50.05 17.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 126.527 2.392 . . . . 0.0 105.866 -156.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.24 83.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.801 -166.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.53 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.1 tm0? -145.33 -47.37 0.22 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.675 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -63.26 -43.26 98.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.831 1.65 . . . . 0.0 111.65 -163.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -48.4 -56.26 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.702 2.001 . . . . 0.0 109.205 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -69.52 -45.64 68.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.813 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CB ' HE21 ' A' ' 63' ' ' GLN . 38.5 t80 -58.45 -45.64 88.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.005 0.522 . . . . 0.0 110.979 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.21 -39.87 93.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.117 0.967 . . . . 0.0 109.888 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.2 -46.29 84.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -63.22 -47.21 83.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.961 0.504 . . . . 0.0 110.538 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.24 -48.41 68.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.47 1.108 . . . . 0.0 110.508 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.52 -16.87 27.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.66 -15.59 17.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.874 1.27 . . . . 0.0 112.846 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.43 -33.09 72.03 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.332 0.514 . . . . 0.0 109.984 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.37 35.47 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.74 21.01 0.42 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.862 -0.787 . . . . 0.0 112.96 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 m -52.2 145.34 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.123 1.369 . . . . 0.0 110.589 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -70.35 143.6 51.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 134.29 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 52.8 m-85 -138.96 154.24 48.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.56 0.744 . . . . 0.0 109.523 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -129.74 115.64 17.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.85 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.1 m -135.46 166.88 22.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.17 0 O-C-N 122.105 -0.372 . . . . 0.0 110.216 164.552 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.516 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 p90 . . . . . 0 C--O 1.217 -0.643 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -35.18 44.82 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.34 -28.21 70.24 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.197 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 93' ' ' TRP . . . -111.54 24.66 12.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.785 2.834 . . . . 0.0 111.96 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -115.08 106.68 14.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.65 -16.52 51.6 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.671 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.21 86.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.55 -22.68 13.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.7 -27.4 68.31 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.668 -1.27 . . . . 0.0 113.255 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.79 145.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -129.19 142.24 50.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.11 139.72 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.739 1.216 . . . . 0.0 109.021 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.5 mp -124.56 158.74 32.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.405 1.482 . . . . 0.0 108.999 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.81 73.22 1.51 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 127.05 2.14 . . . . 0.0 107.385 -169.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.71 -32.77 71.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.526 -1.359 . . . . 0.0 111.53 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -54.57 -17.31 3.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.195 1.798 . . . . 0.0 113.583 -167.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.67 ' HD3' ' CD2' ' A' ' 30' ' ' LEU . 5.3 ttt180 -65.27 -26.99 68.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -134.38 -17.15 2.06 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 124.914 1.384 . . . . 0.0 107.964 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' ' HA3' ' A' ' 114' ' ' GLY . 6.0 mmm 59.66 6.88 0.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.477 2.311 . . . . 0.0 111.513 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 27' ' ' PHE . 20.8 m -59.07 -49.18 78.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.742 1.61 . . . . 0.0 110.012 -170.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -62.57 -42.07 99.32 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.304 1.411 . . . . 0.0 109.916 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -51.21 -47.02 50.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 123.864 0.745 . . . . 0.0 113.237 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -73.85 -46.91 42.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.512 0.725 . . . . 0.0 109.247 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.7 78.49 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -104.09 7.13 36.29 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.844 1.258 . . . . 0.0 109.467 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.02 25.33 56.49 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 118.149 -1.361 . . . . 0.0 113.101 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.412 HG23 ' HA2' ' A' ' 114' ' ' GLY . 17.1 m -90.83 -9.1 10.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.688 1.744 . . . . 0.0 111.488 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -63.32 115.97 5.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.516 ' HA ' HD12 ' A' ' 13' ' ' LEU . 65.7 mt -75.14 120.92 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -61.17 -49.77 75.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.844 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.24 -31.2 43.51 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.432 0.457 . . . . 0.0 112.014 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' H ' HG22 ' A' ' 121' ' ' ILE . 21.8 tp -109.63 -18.21 13.53 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.116 0.966 . . . . 0.0 111.576 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 53.63 42.35 31.89 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.744 1.618 . . . . 0.0 114.507 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt -123.54 162.96 21.9 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.38 135.85 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.42 154.49 41.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.779 1.275 . . . . 0.0 110.091 167.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.495 HH21 ' HB ' ' A' ' 59' ' ' VAL . 17.1 tpt85 -77.38 112.0 13.65 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.683 166.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.06 173.38 14.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.98 140.07 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -142.27 155.88 45.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.056 1.342 . . . . 0.0 108.477 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.38 139.77 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -130.19 133.95 46.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -171.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.22 163.43 15.24 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 125.314 1.445 . . . . 0.0 110.877 164.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -48.61 -35.19 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.254 1.822 . . . . 0.0 113.998 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -2.66 39.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.659 1.572 . . . . 0.0 111.97 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.96 3.11 70.73 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.174 -1.579 . . . . 0.0 112.5 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -71.48 122.26 20.1 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.982 1.891 . . . . 0.0 109.36 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.41 126.49 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.38 -11.22 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 129.448 3.099 . . . . 0.0 107.767 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -152.61 152.48 31.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.227 1.411 . . . . 0.0 107.454 163.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.18 139.93 18.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -150.2 148.8 29.35 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.26 117.51 24.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.859 1.663 . . . . 0.0 106.906 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.71 129.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -57.56 -19.15 23.5 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.904 0.881 . . . . 0.0 113.165 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -138.54 124.23 19.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.12 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -84.12 6.4 22.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.419 1.487 . . . . 0.0 111.11 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.46 174.2 6.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.732 2.013 . . . . 0.0 107.235 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -128.53 152.87 79.13 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 120.716 -1.24 . . . . 0.0 110.861 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -80.96 170.35 15.38 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.591 2.194 . . . . 0.0 110.082 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -69.46 120.82 15.84 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 161.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -93.68 -8.09 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.698 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.12 -36.69 83.81 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.297 1.408 . . . . 0.0 108.847 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -63.12 -48.75 83.27 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 125.341 1.456 . . . . 0.0 112.254 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.71 -34.86 49.15 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 CA-C-N 119.59 0.889 . . . . 0.0 111.974 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 20.6 mm -60.02 -45.47 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 120.658 1.572 . . . . 0.0 110.507 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.86 -42.34 97.57 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 120.746 1.612 . . . . 0.0 109.263 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.04 95.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.882 0.473 . . . . 0.0 110.78 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.84 80.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.083 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -53.74 -49.65 67.69 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 117.077 -1.44 . . . . 0.0 108.368 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -52.82 -29.68 29.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.408 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.45 -49.18 7.38 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.1 t -60.6 -41.39 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.533 0.683 . . . . 0.0 111.827 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.439 -1.018 0 C-N-CA 130.64 3.576 . . . . 0.0 117.265 -161.116 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 120.672 0.272 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.94 -175.76 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.379 1.072 . . . . 0.0 108.834 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -118.5 152.15 36.5 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -136.04 109.42 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 42.89 41.83 2.77 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 111.825 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.23 -9.5 61.21 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.134 -0.814 . . . . 0.0 115.04 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.1 125.53 8.56 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.189 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.43 138.62 39.34 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 CA-C-N 120.859 2.33 . . . . 0.0 110.208 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.16 135.21 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.154 0.982 . . . . 0.0 110.453 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -75.91 155.17 35.42 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.834 1.653 . . . . 0.0 110.388 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.64 144.63 40.6 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.405 1.482 . . . . 0.0 107.877 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.24 -65.19 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 118.502 0.592 . . . . 0.0 111.299 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.09 35.17 4.85 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.627 1.108 . . . . 0.0 111.206 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -52.12 166.44 0.16 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.247 2.219 . . . . 0.0 116.075 -169.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 69.07 34.19 3.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.614 1.966 . . . . 0.0 113.379 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.54 144.78 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -150.12 162.93 39.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.802 0.841 . . . . 0.0 109.156 -169.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 p -52.89 132.82 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 109.541 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.19 -5.22 83.03 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.85 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.37 -11.28 59.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.457 1.628 . . . . 0.0 112.64 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 57.44 178.36 0.05 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.649 1.58 . . . . 0.0 111.952 -169.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.38 136.09 20.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.931 1.693 . . . . 0.0 109.016 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 95.5 Cg_endo -74.26 157.49 45.8 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.483 2.122 . . . . 0.0 109.77 172.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 27.6 t70 -77.47 67.91 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.02 1.728 . . . . 0.0 110.117 176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -59.27 162.3 4.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.442 170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.5 m -124.65 144.45 50.19 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.38 168.05 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.343 2.257 . . . . 0.0 107.528 -171.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.97 143.45 45.7 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.48 178.45 8.11 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.523 0.729 . . . . 0.0 109.949 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.98 -23.33 67.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.146 -0.971 . . . . 0.0 110.734 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 m -86.41 3.34 44.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.4 mt 55.62 33.1 20.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.82 2.048 . . . . 0.0 112.937 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.55 147.11 24.77 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.84 143.8 39.47 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 109.439 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -154.02 155.08 34.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.315 2.246 . . . . 0.0 105.547 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.2 m -139.58 166.57 24.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.119 0.872 . . . . 0.0 108.927 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 43.6 tp -50.15 -40.67 47.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.242 0.474 . . . . 0.0 111.026 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.1 62.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -77.4 -28.47 52.76 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.768 0.713 . . . . 0.0 111.133 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.8 mtt -80.36 -55.14 5.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.877 1.271 . . . . 0.0 110.513 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -59.74 134.01 56.62 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.06 -20.61 3.2 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.955 2.216 . . . . 0.0 110.512 -169.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -150.33 158.34 44.05 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.92 2.088 . . . . 0.0 107.219 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -56.65 144.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.4 m -137.09 145.82 44.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.2 mt -133.31 137.19 53.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mt -136.75 133.88 48.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m -114.98 147.44 40.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -136.5 133.32 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.25 150.35 51.69 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.55 1.14 . . . . 0.0 109.278 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.92 -50.13 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.558 1.505 . . . . 0.0 109.709 169.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -152.87 168.67 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.311 1.444 . . . . 0.0 108.108 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.85 -23.93 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.53 -27.06 62.93 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 0.0 111.839 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 32.2 0.08 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.12 2.168 . . . . 0.0 113.736 -174.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.68 -3.23 69.88 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 120.432 -1.418 . . . . 0.0 114.269 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.83 -12.28 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.498 1.149 . . . . 0.0 112.406 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.69 -0.04 2.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.458 1.503 . . . . 0.0 113.724 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -48.97 148.66 2.18 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 0.0 110.348 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.03 -28.69 10.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.914 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -50.06 -57.33 7.85 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.265 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -65.71 -42.86 90.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.493 1.497 . . . . 0.0 110.085 -170.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -63.81 -53.96 42.65 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 122.725 0.41 . . . . 0.0 110.169 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.27 -37.6 80.88 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.688 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -55.93 -51.93 65.92 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 119.438 1.017 . . . . 0.0 110.102 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -66.22 -33.61 76.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 0.0 110.572 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -64.25 -50.55 67.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.735 -0.603 . . . . 0.0 110.477 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -60.8 -41.73 96.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.167 0.894 . . . . 0.0 110.406 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.86 73.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.918 0.887 . . . . 0.0 110.316 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.1 -13.57 62.51 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -100.86 -17.31 16.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.859 1.264 . . . . 0.0 112.419 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -60.07 -37.87 81.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.051 1.296 . . . . 0.0 110.56 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.89 -173.09 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -74.0 22.69 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.89 0.876 . . . . 0.0 112.902 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.15 154.34 2.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.379 1.472 . . . . 0.0 110.733 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.82 143.75 52.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.45 130.45 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.36 153.05 46.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.136 0.574 . . . . 0.0 110.886 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 m -120.57 154.6 35.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.1 mt -136.55 134.85 49.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.2 m -131.71 160.79 34.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 109.86 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 121.205 0.526 . . . . 0.0 110.933 169.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m0 . . . . . 0 C--O 1.233 0.193 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 m 65.22 -48.13 0.36 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.571 2.748 . . . . 0.0 116.089 169.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.45 -48.67 8.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.99 38.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.742 1.617 . . . . 0.0 108.637 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -149.37 33.16 0.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.0 111.24 -170.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.74 -1.26 5.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.293 0.949 . . . . 0.0 113.103 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 mt -75.11 87.87 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -54.38 -30.22 51.28 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 114.013 -169.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.91 -25.17 67.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.585 0.754 . . . . 0.0 112.88 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -74.42 152.95 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.823 0.738 . . . . 0.0 109.87 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -137.44 151.2 48.25 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.1 m -121.95 96.57 5.11 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.82 160.98 31.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.945 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -127.8 37.43 4.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.025 2.13 . . . . 0.0 109.088 -169.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -47.65 -39.73 17.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.798 1.239 . . . . 0.0 114.098 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.96 -17.79 11.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.117 0.967 . . . . 0.0 113.487 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -62.82 -22.0 66.32 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.221 -0.925 . . . . 0.0 112.661 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.7 -26.15 1.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.718 1.607 . . . . 0.0 111.898 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 69.44 10.83 7.88 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.444 2.698 . . . . 0.0 113.741 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 m -61.69 -47.76 83.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.25 -38.15 88.16 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.509 1.504 . . . . 0.0 109.407 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.53 -59.02 4.39 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 126.386 1.946 . . . . 0.0 112.872 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.34 -42.32 65.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 25' ' ' PRO . . . -62.99 -39.68 95.46 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.0 0.92 . . . . 0.0 112.258 -169.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -107.11 5.13 27.61 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.716 1.206 . . . . 0.0 110.653 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.99 85.95 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.648 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.6 m -105.64 -1.79 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.531 1.132 . . . . 0.0 111.199 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.75 116.97 17.91 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 124' ' ' LEU . 66.5 mt -74.11 124.37 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.27 -46.82 78.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.307 0.643 . . . . 0.0 110.453 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -84.2 -51.92 6.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.365 0.266 . . . . 0.0 110.746 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -72.88 -22.93 60.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.276 0.63 . . . . 0.0 111.031 -178.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 49.97 57.59 6.38 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.432 1.093 . . . . 0.0 110.284 -171.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.99 173.45 11.7 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.045 1.338 . . . . 0.0 107.85 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.18 135.29 33.36 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.133 0.973 . . . . 0.0 108.381 172.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.79 165.32 18.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -83.21 113.22 20.51 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.8 m -155.19 166.49 33.4 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.661 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -147.05 142.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -144.06 158.12 43.91 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.293 1.037 . . . . 0.0 110.045 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.3 140.76 41.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -131.34 140.14 49.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.119 1.368 . . . . 0.0 108.122 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 166.0 17.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.924 1.289 . . . . 0.0 110.279 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -47.77 -38.43 15.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.436 1.495 . . . . 0.0 112.563 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.95 7.4 13.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.643 1.11 . . . . 0.0 113.663 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.52 -7.53 80.59 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 120.971 -1.08 . . . . 0.0 112.853 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -65.38 130.65 44.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 118.66 1.23 . . . . 0.0 108.937 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.9 OUTLIER -63.1 132.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.582 0.753 . . . . 0.0 109.84 171.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.15 -18.0 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.059 2.144 . . . . 0.0 109.811 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -148.57 150.19 32.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.63 133.31 11.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.764 1.626 . . . . 0.0 107.249 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -146.59 147.1 30.75 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.79 107.87 14.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.11 131.34 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -57.74 -20.58 35.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.845 1.258 . . . . 0.0 113.829 -169.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.13 130.81 25.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.22 12.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.725 1.61 . . . . 0.0 114.219 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -88.47 -1.9 58.3 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 118.542 0.61 . . . . 0.0 112.225 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -82.45 178.84 8.02 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.77 -1.206 . . . . 0.0 110.062 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -129.72 133.51 25.13 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.656 1.583 . . . . 0.0 109.077 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.6 173.59 11.26 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.508 2.805 . . . . 0.0 110.572 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -73.46 129.51 38.14 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 168.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -100.06 -4.66 29.4 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.96 -38.04 57.97 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -50.45 -58.24 10.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.52 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.35 -35.81 38.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 121.449 1.553 . . . . 0.0 112.133 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.97 -44.76 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.523 1.056 . . . . 0.0 110.302 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.65 -37.83 87.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 119.506 1.048 . . . . 0.0 110.247 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.9 96.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.359 0.264 . . . . 0.0 110.706 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.92 72.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.955 0.502 . . . . 0.0 111.414 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.81 -41.67 74.54 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.54 1.063 . . . . 0.0 110.214 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.15 67.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.27 0.628 . . . . 0.0 111.948 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.55 -46.43 14.47 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.365 0.666 . . . . 0.0 111.313 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.8 -44.73 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.801 0.84 . . . . 0.0 111.127 -169.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.357 1.063 . . . . 0.0 109.708 178.224 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.3 pt -119.35 174.06 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.226 1.013 . . . . 0.0 110.546 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -112.61 155.77 23.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -135.38 115.43 13.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? 37.53 53.87 1.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.89 1.676 . . . . 0.0 113.298 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.22 2.43 87.3 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.68 -0.511 . . . . 0.0 114.349 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.6 110.25 3.02 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.782 1.658 . . . . 0.0 109.888 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.75 137.59 74.82 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.13 2.553 . . . . 0.0 111.623 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -142.62 131.59 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.791 0.836 . . . . 0.0 109.759 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -82.29 147.07 29.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.474 1.51 . . . . 0.0 111.462 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.35 148.72 23.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.548 1.139 . . . . 0.0 109.222 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 t -78.15 -52.97 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 121.962 -0.461 . . . . 0.0 109.791 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.77 24.61 27.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.526 1.06 . . . . 0.0 112.096 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 52.5 -171.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.713 2.005 . . . . 0.0 113.38 -173.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -78.26 132.98 37.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.15 165.18 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -126.35 155.07 42.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.46 137.18 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.48 85.97 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 118.678 -1.068 . . . . 0.0 113.54 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.79 1.68 16.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.632 1.716 . . . . 0.0 113.907 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 54.39 65.62 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.287 1.035 . . . . 0.0 111.383 169.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.02 134.03 5.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.02 1.728 . . . . 0.0 112.651 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.04 154.63 26.86 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.491 2.794 . . . . 0.0 113.349 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 18.1 t0 -73.95 70.03 1.47 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.806 2.043 . . . . 0.0 109.676 169.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -62.95 167.24 4.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.418 1.487 . . . . 0.0 110.753 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -122.79 152.16 40.94 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.81 171.15 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.446 1.898 . . . . 0.0 107.38 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.4 mt -111.56 152.42 27.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -83.48 179.28 7.69 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.414 0.685 . . . . 0.0 109.608 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -51.01 -35.7 35.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.046 0.938 . . . . 0.0 110.454 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.9 m -101.55 16.15 26.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.549 1.54 . . . . 0.0 110.7 -170.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.2 mt 62.55 23.7 14.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.256 2.222 . . . . 0.0 113.628 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.35 142.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 169.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.22 142.19 47.31 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -147.73 155.4 41.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.5 p -139.69 168.3 20.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 47.0 tp -54.36 -42.52 70.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 169.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.33 -23.93 66.08 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.01 -31.67 64.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.836 0.743 . . . . 0.0 110.876 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 mtt -75.21 -35.9 61.44 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -53.67 151.45 6.09 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.902 0.858 . . . . 0.0 111.944 -171.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.7 57.23 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.005 1.288 . . . . 0.0 113.272 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -155.03 149.8 26.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.759 1.624 . . . . 0.0 107.27 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.5 t -58.23 136.69 21.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -130.68 145.58 51.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -140.96 137.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -138.97 133.09 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.2 m -119.98 150.77 39.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.84 136.96 53.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.3 pt -136.51 139.37 29.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.855 1.662 . . . . 0.0 107.911 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.27 -7.51 18.05 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.083 2.522 . . . . 0.0 112.888 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.0 m -160.87 177.33 10.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.601 2.36 . . . . 0.0 106.268 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.89 -14.3 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.36 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.52 -23.66 50.13 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.376 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -57.67 155.81 9.41 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.581 1.552 . . . . 0.0 111.887 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.97 -17.28 70.28 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.1 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.15 -24.33 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.603 1.702 . . . . 0.0 113.316 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 15.3 p -61.57 -29.17 69.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.269 0.94 . . . . 0.0 112.544 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.84 -34.61 30.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.034 -0.416 . . . . 0.0 110.137 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.05 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.602 0.761 . . . . 0.0 110.765 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -152.56 131.09 12.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.8 m 138.76 -56.75 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 1 C-N-CA 132.819 4.448 . . . . 0.0 105.52 169.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -60.25 -63.84 1.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.854 0.752 . . . . 0.0 110.993 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -65.06 -40.11 94.22 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.904 -0.497 . . . . 0.0 111.122 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -58.07 -50.34 73.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.07 0.548 . . . . 0.0 111.583 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.04 -37.51 87.69 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.276 0.63 . . . . 0.0 109.674 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.426 ' HA ' HG21 ' A' ' 99' ' ' ILE . 4.6 tt0 -58.36 -51.14 71.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.477 0.711 . . . . 0.0 110.166 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.35 -38.21 74.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.806 0.442 . . . . 0.0 110.635 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.38 88.87 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.58 -0.7 . . . . 0.0 111.139 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.77 -19.64 62.71 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.981 0.81 . . . . 0.0 112.62 173.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -76.7 -34.73 58.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 110.839 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.37 -40.62 91.47 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.407 0.683 . . . . 0.0 109.949 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.14 -170.64 43.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -75.57 38.22 0.15 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 111.861 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.91 144.45 14.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 O-C-N 120.853 -1.154 . . . . 0.0 109.806 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -73.15 141.26 47.43 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.05 128.7 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -136.8 155.19 50.14 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.662 0.664 . . . . 0.0 111.531 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -125.5 97.84 5.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.98 122.63 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -109.49 164.72 12.25 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.002 1.321 . . . . 0.0 109.206 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 110.295 169.591 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p -52.97 -37.47 61.21 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.549 -0.719 . . . . 0.0 112.681 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.96 -16.36 59.47 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.312 -0.715 . . . . 0.0 114.308 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.23 -15.91 15.85 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 112.412 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -75.05 94.49 2.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.652 0.66 . . . . 0.0 111.246 -169.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.73 -20.05 2.19 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.609 1.576 . . . . 0.0 111.105 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.426 HG21 ' HA ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -145.6 92.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.516 1.527 . . . . 0.0 107.973 -172.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.61 -33.89 7.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.299 1.84 . . . . 0.0 113.988 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.84 -20.06 65.86 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.479 1.111 . . . . 0.0 113.717 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.89 152.81 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.168 0.895 . . . . 0.0 108.945 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -129.34 146.24 51.25 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.0 m -97.26 135.11 39.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.98 162.98 16.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.988 1.715 . . . . 0.0 108.089 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -138.28 44.25 2.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.41 1.484 . . . . 0.0 109.573 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.12 -44.08 7.37 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.516 1.127 . . . . 0.0 112.848 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -59.97 -14.72 17.27 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -76.31 -6.71 52.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.077 -1.015 . . . . 0.0 112.416 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -139.07 -41.31 0.47 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.39 1.476 . . . . 0.0 111.294 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.4 tpt 78.34 2.1 2.69 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.149 2.98 . . . . 0.0 113.667 169.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 m -63.94 -46.51 84.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.852 1.66 . . . . 0.0 111.471 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.89 -39.56 89.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.227 1.376 . . . . 0.0 109.307 172.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.2 -53.69 18.31 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.41 1.957 . . . . 0.0 113.255 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.98 -34.89 50.69 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.989 0.516 . . . . 0.0 110.433 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.57 -39.54 93.93 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.217 0.607 . . . . 0.0 111.587 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -97.98 3.03 49.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.053 1.341 . . . . 0.0 110.31 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 60.79 8.4 10.12 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.348 1.452 . . . . 0.0 114.826 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 m -63.62 -23.04 32.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 C-N-CA 125.902 1.681 . . . . 0.0 110.94 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.38 118.51 4.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 124' ' ' LEU . 47.2 mm -87.47 124.12 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -61.35 -53.15 60.31 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.466 1.506 . . . . 0.0 110.718 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.97 -49.47 11.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.039 0.447 . . . . 0.0 110.5 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' H ' HG22 ' A' ' 121' ' ' ILE . 29.4 tp -72.83 -23.11 60.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.508 1.123 . . . . 0.0 112.779 -171.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 51.17 50.28 19.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 110.768 -169.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.5 mt -138.12 -173.25 3.47 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.7 pt? -113.24 146.69 38.91 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.199 1.0 . . . . 0.0 111.327 175.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.61 140.86 57.96 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.919 1.688 . . . . 0.0 113.805 -169.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -65.87 110.86 3.02 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 p -156.13 168.22 27.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.454 0.57 . . . . 0.0 111.166 -170.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.04 148.26 18.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.92 1.288 . . . . 0.0 108.129 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -145.7 154.5 42.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.503 1.121 . . . . 0.0 109.296 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.91 139.87 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -132.21 141.02 48.91 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.009 1.323 . . . . 0.0 108.233 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.39 162.43 20.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.351 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.5 -32.63 41.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.901 1.281 . . . . 0.0 113.228 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -80.25 -10.32 59.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.7 -2.71 49.08 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.388 0.994 . . . . 0.0 113.605 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.85 137.94 58.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.55 1.675 . . . . 0.0 108.753 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 129.46 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 80.6 t -113.26 -20.79 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.825 2.05 . . . . 0.0 109.541 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -143.84 148.34 35.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.351 1.06 . . . . 0.0 108.194 169.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.75 132.18 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.513 1.525 . . . . 0.0 107.701 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -149.77 147.59 28.19 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.662 1.185 . . . . 0.0 108.444 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.12 116.07 14.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.47 134.69 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 m -58.95 -18.68 35.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.154 0.982 . . . . 0.0 112.956 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -140.04 122.5 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.2 p -83.16 14.87 3.16 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.654 1.115 . . . . 0.0 111.983 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -125.77 -177.06 3.79 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.567 1.947 . . . . 0.0 108.91 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -137.78 151.5 70.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.244 1.418 . . . . 0.0 109.901 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.96 170.75 7.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.67 2.913 . . . . 0.0 111.606 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -77.33 87.1 3.73 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -68.32 1.12 3.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.3 1.44 . . . . 0.0 114.118 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -31.63 72.47 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -62.02 -53.07 62.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.324 1.049 . . . . 0.0 111.801 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -65.83 -31.26 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.742 1.658 . . . . 0.0 112.422 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.6 mm -58.3 -48.89 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.131 1.332 . . . . 0.0 109.35 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.17 -33.47 76.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.821 0.737 . . . . 0.0 110.81 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.28 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.734 0.414 . . . . 0.0 111.192 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.77 -49.51 65.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.895 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -63.64 -30.46 71.57 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.94 69.35 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.442 1.019 . . . . 0.0 111.835 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.19 -45.77 17.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.147 0.579 . . . . 0.0 111.478 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.74 -46.69 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.235 0.614 . . . . 0.0 111.024 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.5 tttm . . . . . 0 C--O 1.248 0.985 0 C-N-CA 124.401 1.081 . . . . 0.0 109.903 -179.706 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.443 -0.804 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.76 -178.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -115.19 147.67 40.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -134.18 120.67 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 43.83 39.69 2.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.053 1.341 . . . . 0.0 111.916 -173.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.57 12.6 79.96 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.74 117.44 3.95 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.174 -1.348 . . . . 0.0 109.846 173.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.21 139.34 89.74 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.342 2.695 . . . . 0.0 112.222 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.66 130.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.225 1.41 . . . . 0.0 109.889 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -75.63 161.67 28.91 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.351 1.86 . . . . 0.0 110.462 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.68 160.0 19.09 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.31 1.444 . . . . 0.0 110.173 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.78 -59.71 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.837 -0.539 . . . . 0.0 111.242 -169.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.2 32.61 6.94 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.397 0.998 . . . . 0.0 113.439 -169.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.43 -167.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.54 107.07 17.89 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.482 1.513 . . . . 0.0 109.748 -169.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.41 145.75 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -143.52 160.79 39.97 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.595 0.758 . . . . 0.0 109.028 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.75 134.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.31 3.37 89.81 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.796 -1.002 . . . . 0.0 113.988 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.03 -7.02 59.47 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.463 1.631 . . . . 0.0 112.298 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 58.07 178.18 0.06 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.369 1.467 . . . . 0.0 111.516 -169.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.09 24.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.792 1.637 . . . . 0.0 108.729 -171.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.18 158.04 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.708 2.272 . . . . 0.0 109.907 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 26.1 t70 -81.41 68.82 7.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.378 1.471 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -63.1 163.25 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.977 171.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.5 m -121.79 148.95 44.01 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -152.66 167.67 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.106 2.162 . . . . 0.0 105.76 -173.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.49 156.05 29.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 120.787 -1.195 . . . . 0.0 108.231 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.3 p -81.36 173.59 12.32 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.767 1.227 . . . . 0.0 110.016 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -63.77 -26.71 68.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.933 -1.104 . . . . 0.0 110.798 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 p -77.54 1.43 19.49 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.512 1.525 . . . . 0.0 111.94 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt 56.94 47.78 17.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.968 2.107 . . . . 0.0 111.986 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.01 141.96 47.43 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -64.52 144.09 57.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.464 1.105 . . . . 0.0 109.485 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -146.52 157.66 43.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.499 2.32 . . . . 0.0 105.477 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 p -146.62 167.82 22.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 67.5 tp -53.83 -43.78 69.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 170.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.37 66.52 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.85 -30.6 58.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.878 0.763 . . . . 0.0 111.114 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.3 mtt -73.88 -39.69 63.74 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.388 1.075 . . . . 0.0 110.945 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -53.56 140.91 27.13 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 109.862 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.6 -22.1 8.89 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.958 1.266 . . . . 0.0 112.738 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -148.36 152.83 37.71 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.888 1.275 . . . . 0.0 108.681 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.63 142.43 15.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.2 m -135.54 148.95 49.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.883 0.873 . . . . 0.0 109.036 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.4 mt -134.73 138.31 49.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.01 124.62 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 p -106.59 148.42 28.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 168.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.05 127.88 40.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.16 146.83 38.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 110.357 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.69 -39.69 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.072 1.848 . . . . 0.0 111.484 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.4 m -152.5 173.06 15.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 0.0 109.097 -169.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 pt -121.01 -29.8 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.51 1.124 . . . . 0.0 111.45 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.09 -11.64 31.75 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.537 0.735 . . . . 0.0 111.669 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -22.07 54.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.807 2.043 . . . . 0.0 112.532 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.23 -0.12 25.24 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.265 0.936 . . . . 0.0 112.942 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.55 -15.6 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 118.67 1.235 . . . . 0.0 112.856 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.3 m -54.95 -25.96 33.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.171 1.388 . . . . 0.0 113.289 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -124.58 32.24 5.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.142 1.377 . . . . 0.0 109.395 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.31 -166.98 2.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.414 1.486 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -43.57 -45.66 6.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.375 1.87 . . . . 0.0 113.938 -171.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 m -56.03 -42.36 76.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.279 1.4 . . . . 0.0 112.424 -169.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -65.94 -53.0 44.89 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.969 0.804 . . . . 0.0 110.398 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -64.69 -41.0 96.35 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.146 0.884 . . . . 0.0 111.146 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.2 -50.29 71.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.781 . . . . 0.0 110.269 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -62.56 -37.86 87.8 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.486 0.314 . . . . 0.0 110.692 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.76 -36.83 85.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.604 0.762 . . . . 0.0 110.695 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -74.82 -42.6 57.72 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.001 -1.062 . . . . 0.0 110.196 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.91 -49.35 66.11 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.82 1.248 . . . . 0.0 110.463 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.84 -12.56 25.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 0.0 113.563 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -108.36 -9.04 15.5 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 113.037 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.6 mt -64.96 -32.41 74.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.164 1.347 . . . . 0.0 110.584 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.08 -169.95 43.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.17 29.84 0.1 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.976 0.888 . . . . 0.0 112.451 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.72 149.76 3.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.68 -1.263 . . . . 0.0 110.34 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -71.78 141.18 49.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -142.55 131.55 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -139.01 156.67 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.841 0.856 . . . . 0.0 110.562 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.6 m -133.32 105.26 6.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.7 128.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 m -124.33 160.81 27.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.572 1.149 . . . . 0.0 109.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.037 169.339 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.41 -30.5 71.61 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.92 -10.88 73.49 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.622 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.15 32.47 5.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 110.293 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -137.56 132.06 32.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.8 -9.57 65.18 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.683 0.658 . . . . 0.0 111.544 -169.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mt -134.87 76.8 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -51.7 -31.69 27.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.3 1.44 . . . . 0.0 114.821 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -63.9 -27.96 69.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.04 151.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -133.37 143.97 49.3 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 m -93.07 143.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.84 158.72 25.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.073 1.349 . . . . 0.0 108.753 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 m -128.88 67.02 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.997 2.119 . . . . 0.0 108.449 -169.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.0 -35.9 48.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.257 0.623 . . . . 0.0 112.219 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -11.37 49.49 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.961 -1.087 . . . . 0.0 113.591 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -76.95 -29.75 55.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.887 1.221 . . . . 0.0 111.545 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -149.01 88.58 1.61 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 4.83 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.262 1.425 . . . . 0.0 113.581 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.3 m -55.92 -42.57 76.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.92 1.236 . . . . 0.0 110.722 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.68 -48.92 79.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.636 1.107 . . . . 0.0 110.84 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.5 98.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 123.66 0.648 . . . . 0.0 111.992 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.77 -42.01 67.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.454 0.627 . . . . 0.0 110.323 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.58 86.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.348 1.059 . . . . 0.0 111.913 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -92.01 3.53 55.03 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.925 0.89 . . . . 0.0 111.22 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.94 -4.84 8.97 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.625 1.107 . . . . 0.0 115.057 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.9 m -66.99 -8.94 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.986 2.114 . . . . 0.0 112.212 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.03 109.59 3.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 124' ' ' LEU . 67.7 mt -66.88 127.87 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -66.49 -49.76 65.52 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.298 1.039 . . . . 0.0 110.636 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -76.74 -49.56 15.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.524 ' H ' HG22 ' A' ' 121' ' ' ILE . 17.8 tp -80.26 -17.61 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 50.0 48.78 21.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.662 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.8 tp -137.84 161.67 35.99 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 108.426 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -72.91 129.76 38.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 110.722 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.41 168.07 18.23 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.864 1.266 . . . . 0.0 113.634 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -91.67 115.21 27.86 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.108 1.363 . . . . 0.0 108.191 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.7 m -154.48 166.84 32.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.105 0.562 . . . . 0.0 109.672 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.38 146.86 18.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -148.36 156.66 42.79 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.066 1.347 . . . . 0.0 109.105 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.96 144.97 30.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.2 mp -132.46 139.68 48.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.345 1.058 . . . . 0.0 108.661 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.95 166.62 13.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.223 1.409 . . . . 0.0 110.038 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -52.49 -31.38 34.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.149 1.38 . . . . 0.0 112.393 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.05 2.25 27.95 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.566 1.147 . . . . 0.0 112.7 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.4 -5.94 75.03 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 120.966 -1.084 . . . . 0.0 112.959 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.38 126.47 27.46 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.638 1.219 . . . . 0.0 108.964 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.77 128.94 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 109.625 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.5 t -116.83 -17.46 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.391 1.876 . . . . 0.0 109.851 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -145.38 147.68 32.53 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.26 135.58 15.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.161 1.385 . . . . 0.0 108.481 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.42 149.49 30.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.811 0.844 . . . . 0.0 109.299 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.05 106.44 9.28 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.434 2.294 . . . . 0.0 104.922 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 t -69.3 134.53 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -60.95 -19.5 60.96 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.945 1.298 . . . . 0.0 113.855 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -138.77 127.77 23.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.82 39.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.2 p -98.57 -5.79 31.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.431 1.092 . . . . 0.0 112.048 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -83.57 -174.47 5.3 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.373 1.469 . . . . 0.0 109.347 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -135.6 154.22 78.09 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.641 1.176 . . . . 0.0 109.905 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.55 172.71 10.08 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.938 2.426 . . . . 0.0 109.768 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -69.23 120.58 15.29 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 168.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -93.45 -2.49 54.47 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -76.02 -34.93 59.71 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.25 -54.36 55.58 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.766 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.65 -35.47 58.26 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.883 1.708 . . . . 0.0 111.885 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 mm -61.38 -50.39 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.465 1.029 . . . . 0.0 109.736 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.14 -36.95 84.49 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.986 0.812 . . . . 0.0 110.219 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.44 92.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.056 0.543 . . . . 0.0 111.068 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.43 -50.28 27.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.488 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.74 -27.24 69.07 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.235 1.38 . . . . 0.0 111.469 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.8 -31.68 68.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.668 1.122 . . . . 0.0 112.02 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.42 -44.21 36.91 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.193 0.597 . . . . 0.0 110.873 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.85 -48.42 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.365 0.666 . . . . 0.0 110.689 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 124.873 1.269 . . . . 0.0 110.031 179.742 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.46 179.58 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.723 0.809 . . . . 0.0 109.933 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.18 150.85 42.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -137.25 -84.26 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.455 1.025 . . . . 0.0 109.818 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.4 43.34 0.54 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.064 1.346 . . . . 0.0 110.97 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.78 70.52 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.261 0.934 . . . . 0.0 112.141 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 152.64 24.75 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.33 145.6 34.45 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.872 2.382 . . . . 0.0 110.65 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.97 139.04 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.53 1.132 . . . . 0.0 109.798 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -79.14 158.78 27.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.038 1.735 . . . . 0.0 110.038 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.93 149.77 43.82 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.05 1.74 . . . . 0.0 107.441 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.1 t -80.25 -83.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 118.364 0.529 . . . . 0.0 110.54 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 41.54 2.61 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.447 1.498 . . . . 0.0 111.908 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -60.84 171.66 1.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.648 1.979 . . . . 0.0 114.098 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 68.25 34.88 3.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.239 1.816 . . . . 0.0 113.82 169.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.91 142.99 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -151.11 162.09 41.51 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.428 0.691 . . . . 0.0 109.392 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.54 133.96 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.505 0.722 . . . . 0.0 109.76 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.67 1.74 90.57 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.156 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.11 -8.91 58.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.923 1.862 . . . . 0.0 112.297 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 57.35 174.39 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.755 1.622 . . . . 0.0 111.322 -169.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.43 139.98 26.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.111 1.364 . . . . 0.0 109.001 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.81 -27.91 80.12 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.205 2.604 . . . . 0.0 114.853 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 t70 84.39 116.25 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.284 2.634 . . . . 0.0 106.934 -169.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -131.22 161.74 31.55 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.856 1.263 . . . . 0.0 110.451 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -96.56 157.98 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.06 171.38 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.029 2.532 . . . . 0.0 106.641 172.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 tp -129.2 134.21 47.91 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.0 p -73.49 164.96 25.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -64.26 -13.83 51.94 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.758 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 m -83.25 1.07 42.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.452 1.501 . . . . 0.0 112.04 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp 57.31 53.12 7.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.797 2.039 . . . . 0.0 111.602 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.3 141.45 52.06 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.178 0.991 . . . . 0.0 108.433 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.22 143.53 40.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.16 0.981 . . . . 0.0 109.195 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -149.56 159.91 43.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.877 2.471 . . . . 0.0 105.039 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.0 m -142.32 163.78 31.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 tp -53.72 -38.11 63.97 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.321 -0.237 . . . . 0.0 110.659 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.66 -23.64 64.96 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.71 -32.23 57.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.937 0.789 . . . . 0.0 110.951 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.5 mtt -72.71 -38.31 67.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.378 1.071 . . . . 0.0 110.694 176.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -53.24 142.34 21.22 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.63 0.772 . . . . 0.0 109.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.32 -20.74 8.34 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.413 1.483 . . . . 0.0 112.293 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -150.16 154.69 38.45 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.197 1.399 . . . . 0.0 108.797 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.89 138.19 19.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 m -133.44 142.81 48.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.19 132.69 49.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -138.91 121.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.17 150.97 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.21 134.25 61.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.67 152.15 58.91 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.67 -46.94 4.47 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.446 1.431 . . . . 0.0 110.341 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.1 m -144.29 173.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 108.931 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.42 -26.27 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.13 -32.53 73.12 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 112.158 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -65.97 133.63 51.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.991 0.916 . . . . 0.0 109.888 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.0 -21.95 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.412 1.006 . . . . 0.0 114.476 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.85 -15.49 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.653 1.226 . . . . 0.0 112.262 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -26.84 57.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.332 0.969 . . . . 0.0 111.708 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -125.21 -34.93 2.68 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.775 1.23 . . . . 0.0 110.782 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.23 66.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.214 0.605 . . . . 0.0 112.081 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.97 -41.71 0.31 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.469 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . 0.252 3.4 m -65.54 -37.17 85.94 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -167.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -64.77 -53.7 42.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.014 1.279 . . . . 0.0 110.407 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -66.04 -42.27 89.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.368 0.531 . . . . 0.0 111.607 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.53 -50.43 73.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.719 0.808 . . . . 0.0 110.284 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -64.25 -38.19 90.17 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.833 0.288 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.15 -47.42 83.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.094 0.958 . . . . 0.0 110.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -70.04 -44.87 68.35 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.435 0.561 . . . . 0.0 110.525 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.29 79.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.725 0.693 . . . . 0.0 111.134 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.54 -14.57 43.54 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -102.92 -15.37 16.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.489 1.516 . . . . 0.0 112.02 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.67 -37.71 79.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.638 1.108 . . . . 0.0 110.718 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.57 -167.89 40.64 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.07 25.13 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.843 -0.798 . . . . 0.0 112.829 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -53.51 151.37 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.329 1.452 . . . . 0.0 111.449 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -77.08 139.62 40.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.13 123.3 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -139.47 156.48 46.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.181 0.592 . . . . 0.0 110.755 -175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -131.41 116.56 17.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.61 140.67 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.272 1.029 . . . . 0.0 108.27 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 m -140.99 175.38 9.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.313 1.445 . . . . 0.0 112.054 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 124.924 1.29 . . . . 0.0 113.646 -177.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.3 m -52.11 -34.89 46.27 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -171.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.41 -8.31 64.35 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.602 -1.11 . . . . 0.0 113.918 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.83 29.19 3.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.03 1.415 . . . . 0.0 111.546 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -135.88 69.21 1.43 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.593 1.157 . . . . 0.0 108.131 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.7 -27.04 0.26 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.357 0.98 . . . . 0.0 111.641 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 98.61 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.759 1.624 . . . . 0.0 106.867 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.83 -28.69 57.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.994 1.718 . . . . 0.0 114.267 -169.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -61.69 -32.12 72.29 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.12 0.568 . . . . 0.0 112.49 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.08 152.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.89 145.97 42.79 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -88.52 138.47 31.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.0 mp -128.64 167.63 16.92 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.085 2.154 . . . . 0.0 106.973 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.2 m -146.83 172.37 13.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.248 1.419 . . . . 0.0 107.585 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.81 2.6 3.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.429 0.633 . . . . 0.0 111.534 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -16.59 1.1 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -30.99 72.02 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.377 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -153.42 -7.48 0.17 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 tpt 56.45 27.6 12.39 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.182 1.393 . . . . 0.0 111.377 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.8 t -63.46 -62.36 1.72 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.542 1.537 . . . . 0.0 109.732 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -59.86 -38.93 83.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.9 0.48 . . . . 0.0 110.464 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.11 -56.66 13.51 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.619 2.057 . . . . 0.0 112.12 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.73 -36.73 62.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.686 0.743 . . . . 0.0 110.343 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.08 98.25 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.208 0.603 . . . . 0.0 111.773 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -102.23 3.84 38.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.297 1.039 . . . . 0.0 110.672 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.81 5.0 29.44 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 118.35 -1.25 . . . . 0.0 114.677 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.43 -13.68 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 119.139 1.47 . . . . 0.0 111.161 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.37 102.41 0.68 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 124' ' ' LEU . 81.3 mt -63.17 124.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -64.99 -45.37 85.88 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.958 0.903 . . . . 0.0 110.978 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.32 -49.45 12.42 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.917 0.326 . . . . 0.0 110.669 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.542 ' H ' HG22 ' A' ' 121' ' ' ILE . 15.0 tp -81.59 -14.21 57.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -170.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 47.84 48.38 17.71 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.06 1.344 . . . . 0.0 110.58 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.24 25.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.827 0.851 . . . . 0.0 108.843 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 129.22 37.34 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.08 160.68 26.15 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 111.646 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 104.63 16.61 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -145.74 163.17 35.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.596 0.759 . . . . 0.0 108.959 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.27 145.11 18.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -145.32 154.96 42.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 109.321 -169.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.82 136.54 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 171.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.31 139.63 51.7 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.868 1.267 . . . . 0.0 108.013 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 165.22 11.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.077 1.351 . . . . 0.0 110.245 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.6 -34.35 25.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.22 1.408 . . . . 0.0 112.816 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.8 12.1 20.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.059 0.943 . . . . 0.0 113.113 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.46 -6.17 82.8 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.451 1.024 . . . . 0.0 113.132 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 138.55 58.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.57 1.185 . . . . 0.0 109.518 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.89 133.18 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.17 -25.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.928 1.291 . . . . 0.0 109.91 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -150.59 151.8 33.11 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.51 138.41 16.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.578 1.551 . . . . 0.0 107.916 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -147.5 148.33 31.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.763 0.825 . . . . 0.0 108.824 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -127.43 112.54 15.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 t -66.88 133.11 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -60.58 -16.13 34.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.562 1.145 . . . . 0.0 112.66 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -139.33 111.67 7.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.36 -18.23 64.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -174.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.6 p -83.58 9.39 11.56 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.136 0.974 . . . . 0.0 110.976 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -132.68 174.02 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.231 2.612 . . . . 0.0 108.12 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -122.83 158.64 56.53 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.749 1.219 . . . . 0.0 111.553 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.75 179.34 3.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.206 2.604 . . . . 0.0 110.225 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -80.35 85.5 5.82 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -67.61 -0.46 3.94 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.438 1.495 . . . . 0.0 113.114 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.67 -25.8 49.82 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.169 -0.957 . . . . 0.0 109.364 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.53 -52.65 72.62 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.476 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.95 -33.73 73.62 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.585 1.602 . . . . 0.0 112.573 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 mm -59.79 -47.2 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.708 1.14 . . . . 0.0 109.525 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.66 -35.63 81.19 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.326 0.967 . . . . 0.0 110.931 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.76 -42.17 97.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.227 0.211 . . . . 0.0 110.801 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -40.23 80.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.321 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -57.53 -42.3 82.62 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.448 1.022 . . . . 0.0 110.242 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.31 -31.66 69.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.149 0.431 . . . . 0.0 111.965 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.75 -55.44 5.64 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.247 0.476 . . . . 0.0 110.745 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.19 -51.95 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 111.177 -169.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 21.1 pttm . . . . . 0 C--O 1.25 1.128 0 C-N-CA 127.792 2.437 . . . . 0.0 112.219 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.236 0.349 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.21 -175.22 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.161 1.384 . . . . 0.0 107.606 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -123.17 160.39 26.61 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -147.71 127.11 13.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 169.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 43.33 39.68 2.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.942 1.297 . . . . 0.0 112.908 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.24 15.27 74.76 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.167 0.889 . . . . 0.0 114.674 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.49 120.74 4.52 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.22 142.95 86.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.93 2.42 . . . . 0.0 111.259 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.43 135.02 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.231 1.013 . . . . 0.0 109.5 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -76.55 164.35 26.02 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.828 2.051 . . . . 0.0 109.261 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.83 165.15 23.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.869 0.868 . . . . 0.0 109.829 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.6 134.83 57.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.809 1.644 . . . . 0.0 107.207 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.2 -12.57 63.61 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.122 0.868 . . . . 0.0 114.002 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 53.26 164.92 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.354 3.061 . . . . 0.0 115.375 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -67.03 164.88 16.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.215 1.006 . . . . 0.0 113.319 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.69 166.26 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 126.607 1.963 . . . . 0.0 106.589 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -149.15 165.59 31.35 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.695 0.798 . . . . 0.0 109.061 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 141' ' ' VAL . 1.5 p -52.26 131.72 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 122.76 0.424 . . . . 0.0 109.893 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.84 71.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.654 1.121 . . . . 0.0 113.322 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.01 -10.78 59.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.329 1.565 . . . . 0.0 114.113 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 62.39 104.42 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.919 1.688 . . . . 0.0 112.5 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.13 134.57 68.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.523 1.129 . . . . 0.0 111.833 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.44 -27.01 83.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.541 2.827 . . . . 0.0 115.392 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.78 112.44 0.05 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.954 2.502 . . . . 0.0 111.34 -169.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -143.27 168.88 18.73 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.477 1.511 . . . . 0.0 109.73 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 159.58 33.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.089 1.755 . . . . 0.0 111.592 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.79 178.14 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 129.184 2.994 . . . . 0.0 105.833 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.85 133.54 53.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -79.81 -176.8 5.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.309 0.576 . . . . 0.0 110.413 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -46.94 -36.57 7.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.752 1.221 . . . . 0.0 111.722 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m -111.73 20.67 16.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.318 1.447 . . . . 0.0 110.556 -171.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.9 mt 56.24 32.59 20.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.96 2.104 . . . . 0.0 113.265 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.61 142.99 46.54 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.13 57.61 3.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.87 1.268 . . . . 0.0 110.136 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -59.54 158.21 10.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 108.107 169.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -137.57 166.76 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.89 -30.6 64.05 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.014 -0.429 . . . . 0.0 111.527 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.99 -20.99 64.47 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.626 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.06 -28.86 43.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.271 0.941 . . . . 0.0 110.754 172.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 mtt -71.38 -39.11 71.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.056 0.942 . . . . 0.0 110.497 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.47 135.39 39.8 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.86 -26.52 3.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.17 1.367 . . . . 0.0 112.169 -171.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -151.28 159.86 44.11 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.337 1.055 . . . . 0.0 109.722 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.9 t -58.48 136.67 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 170.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 45.8 m -136.96 148.74 47.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.952 1.301 . . . . 0.0 108.295 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 94.7 mt -133.63 135.45 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -136.96 104.79 3.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 149.6 25.5 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.5 t -136.85 141.25 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.99 154.51 54.9 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.299 1.04 . . . . 0.0 111.205 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -76.09 -50.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.775 1.65 . . . . 0.0 108.316 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -159.95 170.25 21.76 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.54 -7.13 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.991 1.717 . . . . 0.0 109.783 168.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -51.74 -26.13 8.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.394 1.877 . . . . 0.0 113.141 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 p -61.49 -9.57 5.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.813 2.045 . . . . 0.0 113.156 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.72 16.38 75.52 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.183 0.901 . . . . 0.0 112.124 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.17 -7.33 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.547 1.539 . . . . 0.0 113.165 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 91.9 m -47.99 -30.0 3.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.557 1.543 . . . . 0.0 114.405 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.91 -30.23 70.79 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.22 8.81 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.522 ' HG3' ' H ' ' A' ' 65' ' ' ARG . 4.6 pt20 -66.57 -169.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -42.96 -24.55 0.07 Allowed 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 127.392 2.277 . . . . 0.0 113.092 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 13.7 tpt180 -43.52 -50.93 7.03 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.934 1.294 . . . . 0.0 111.073 169.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -60.76 -50.11 74.78 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.06 0.846 . . . . 0.0 109.589 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -60.21 -47.02 87.74 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.3 -40.31 77.59 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.153 1.781 . . . . 0.0 110.255 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -69.23 -33.3 73.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.98 1.312 . . . . 0.0 110.817 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -72.34 -45.78 58.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.047 0.839 . . . . 0.0 109.675 169.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.66 -44.36 90.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.824 1.249 . . . . 0.0 111.882 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.52 -20.98 63.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 112.441 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -84.85 -16.73 40.3 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.314 0.961 . . . . 0.0 112.805 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.19 -29.95 69.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.629 1.104 . . . . 0.0 112.237 -169.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.26 -162.03 35.19 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.86 17.73 0.16 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.731 1.212 . . . . 0.0 112.509 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 m -55.42 145.38 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.601 1.561 . . . . 0.0 110.855 -172.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -71.38 138.88 49.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.45 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -127.44 153.22 46.55 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.889 0.875 . . . . 0.0 109.575 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -128.52 116.54 19.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.9 mt -99.72 140.17 19.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -140.25 173.18 11.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.124 0.97 . . . . 0.0 111.663 -171.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 167.52 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.64 0 CA-C-O 118.612 -0.708 . . . . 0.0 112.074 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.0 m -146.2 -69.21 0.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.516 1.126 . . . . 0.0 111.223 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.3 -33.25 15.49 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 127.494 2.473 . . . . 0.0 115.6 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.49 18.97 5.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.156 1.382 . . . . 0.0 110.834 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -80.55 140.55 35.75 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.123 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -49.29 2.97 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.143 0.878 . . . . 0.0 112.184 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 pt -76.11 67.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 125.663 1.585 . . . . 0.0 109.859 169.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.79 -22.63 3.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.986 2.514 . . . . 0.0 114.319 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -59.58 -38.26 80.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.625 0.77 . . . . 0.0 111.547 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 t -69.42 141.26 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.41 144.78 47.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.7 m -98.95 135.45 40.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.47 164.48 21.81 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 128.194 2.598 . . . . 0.0 106.55 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.0 m -131.27 167.46 19.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -138.79 -26.51 0.86 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.459 -0.781 . . . . 0.0 112.506 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -51.81 -29.91 21.1 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -63.81 -24.64 67.84 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.53 -0.731 . . . . 0.0 112.919 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -122.56 -26.37 4.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.538 1.135 . . . . 0.0 111.688 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.1 tpt 65.67 2.66 2.16 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.566 3.146 . . . . 0.0 114.293 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -72.4 -39.47 67.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.562 -1.209 . . . . 0.0 112.433 -170.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.35 -39.5 94.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.683 1.583 . . . . 0.0 109.501 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.46 -48.24 77.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 124.253 0.93 . . . . 0.0 111.116 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.9 -46.05 76.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 117.876 0.838 . . . . 0.0 110.175 174.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.92 68.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.39 1.076 . . . . 0.0 113.355 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.84 3.69 22.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.372 1.069 . . . . 0.0 111.545 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.53 31.01 77.42 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 119.531 1.059 . . . . 0.0 112.767 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.63 -2.78 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -70.79 105.56 3.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.62 133.1 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -72.65 -50.45 24.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.253 0.621 . . . . 0.0 110.191 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.94 -56.32 4.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.929 0.492 . . . . 0.0 110.767 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.0 tp -68.8 -21.09 64.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.399 0.68 . . . . 0.0 111.912 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 52.79 42.57 31.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.559 1.543 . . . . 0.0 112.19 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.72 170.51 14.24 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.718 1.207 . . . . 0.0 108.234 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.7 134.94 46.62 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.37 41.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.333 0.653 . . . . 0.0 111.262 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -72.78 124.16 24.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.1 m -164.31 169.91 16.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.373 1.069 . . . . 0.0 108.221 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.38 147.95 18.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.75 156.74 45.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.562 1.545 . . . . 0.0 108.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.77 142.47 42.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 tp -137.27 127.65 26.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.726 1.211 . . . . 0.0 109.412 -168.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 168.38 17.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.466 1.106 . . . . 0.0 111.14 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -57.67 -26.17 61.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.858 1.663 . . . . 0.0 113.296 -173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.18 35.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.496 1.518 . . . . 0.0 111.418 -176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.62 10.01 53.89 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 121.258 -0.901 . . . . 0.0 112.847 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -75.43 114.6 14.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.706 1.753 . . . . 0.0 107.937 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.04 129.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.402 ' HA ' HG23 ' A' ' 20' ' ' VAL . 7.8 p -114.24 -11.53 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.319 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -150.6 151.0 31.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.0 133.99 13.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.187 1.795 . . . . 0.0 106.397 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -144.98 138.19 26.62 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.22 114.82 23.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.66 144.49 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.6 m -59.32 -23.27 62.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 111.759 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -145.77 126.31 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 5.61 1.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.294 1.438 . . . . 0.0 114.385 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -114.77 24.37 11.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.336 1.454 . . . . 0.0 109.693 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -138.25 162.74 33.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 129.317 3.047 . . . . 0.0 106.377 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -115.44 153.7 47.65 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 119.764 1.166 . . . . 0.0 113.022 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.07 179.18 6.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.065 3.177 . . . . 0.0 111.576 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -65.44 152.69 43.34 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.173 0.589 . . . . 0.0 110.101 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -109.78 -3.11 16.93 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.152 0.981 . . . . 0.0 112.149 -171.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -128.71 -40.81 1.53 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.803 0.729 . . . . 0.0 110.719 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -55.11 -46.19 99.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.136 -1.411 . . . . 0.0 112.159 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.69 -34.17 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.832 1.69 . . . . 0.0 112.515 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.07 -46.51 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.523 1.056 . . . . 0.0 109.742 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.95 -38.79 92.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.67 0.788 . . . . 0.0 110.011 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.17 96.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.1 66.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.912 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -55.85 -40.02 72.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.006 0.821 . . . . 0.0 110.692 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.65 67.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.235 0.614 . . . . 0.0 111.843 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.34 -48.79 9.34 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 122.951 0.5 . . . . 0.0 111.572 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.89 -49.68 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.818 . . . . 0.0 110.073 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 78.7 tttt . . . . . 0 C--O 1.249 1.065 0 C-N-CA 127.791 2.436 . . . . 0.0 111.04 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.0 pt -139.54 -177.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -115.83 153.55 31.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.13 110.69 9.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt 41.49 45.18 2.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.317 1.847 . . . . 0.0 111.974 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.75 -10.79 62.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.29 0.876 . . . . 0.0 115.29 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.47 120.38 6.45 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.031 -1.427 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.86 139.43 84.1 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.191 2.594 . . . . 0.0 112.113 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 m -145.94 159.62 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.18 1.392 . . . . 0.0 110.117 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.5 m -110.88 162.22 15.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.387 1.475 . . . . 0.0 109.461 -170.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.36 139.26 50.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 109.348 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.61 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.951 0.901 . . . . 0.0 110.784 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.47 71.37 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.984 0.802 . . . . 0.0 113.877 -171.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 52.89 -176.47 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.431 2.693 . . . . 0.0 116.907 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -68.01 111.25 4.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.528 1.931 . . . . 0.0 112.742 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -73.46 152.76 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 168.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -134.32 160.53 37.65 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -58.91 136.49 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.18 -4.17 85.99 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.81 1.195 . . . . 0.0 113.796 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.25 -9.35 59.18 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.72 1.76 . . . . 0.0 114.216 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 67.51 122.77 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.665 1.986 . . . . 0.0 111.838 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.01 127.77 91.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.702 -1.142 . . . . 0.0 108.069 173.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.62 -46.78 13.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.635 2.223 . . . . 0.0 113.846 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 t70 128.52 122.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 131.329 3.851 . . . . 0.0 105.554 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -146.96 169.18 19.71 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.273 1.429 . . . . 0.0 108.509 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.9 m -123.57 151.6 42.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 m -139.75 174.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 128.051 2.54 . . . . 0.0 106.548 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.91 153.16 40.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.4 p -80.49 176.9 9.37 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.495 1.118 . . . . 0.0 110.091 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.2 -26.49 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.022 -1.049 . . . . 0.0 110.891 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -79.14 0.57 27.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 111.863 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt 51.79 51.07 17.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.627 1.971 . . . . 0.0 111.985 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.16 141.94 47.96 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -70.08 148.1 49.18 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.612 1.165 . . . . 0.0 110.546 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -153.35 153.72 33.12 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.573 2.349 . . . . 0.0 105.488 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -137.54 164.83 27.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.926 0.785 . . . . 0.0 109.475 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.1 tp -49.89 -41.29 45.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 110.961 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.11 -18.61 65.45 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.53 -29.67 56.82 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.721 0.691 . . . . 0.0 110.949 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.5 mtt -74.84 -42.44 57.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.454 1.102 . . . . 0.0 110.364 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 144.62 24.33 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.432 0.693 . . . . 0.0 110.166 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.72 -17.55 22.95 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.766 1.175 . . . . 0.0 112.879 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -146.65 155.2 42.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.945 1.298 . . . . 0.0 108.874 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.42 141.23 16.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.5 m -134.7 146.74 49.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.088 0.955 . . . . 0.0 108.599 -174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.41 133.62 57.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.0 mt -138.82 131.0 37.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.98 143.35 46.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 169.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.72 137.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -141.9 156.8 65.36 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 108.032 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.54 -49.33 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 120.87 1.047 . . . . 0.0 109.448 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.0 m -162.53 144.93 10.89 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 120.931 -1.106 . . . . 0.0 109.967 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.67 -28.26 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 122.924 0.49 . . . . 0.0 111.251 170.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.22 -25.61 48.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.456 1.102 . . . . 0.0 113.55 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 79.7 p -64.09 -24.99 67.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.34 -4.12 74.06 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.772 -1.016 . . . . 0.0 112.712 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.86 -28.27 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.112 1.956 . . . . 0.0 110.008 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.5 p -57.89 -33.95 69.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.997 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.26 -33.56 24.01 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.92 0.782 . . . . 0.0 110.693 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.97 70.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.307 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.85 -49.06 0.19 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -54.38 -48.71 71.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -167.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -4.63 12.53 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.61 -39.88 2.82 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 123.861 0.864 . . . . 0.0 109.161 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.43 -47.47 72.8 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.712 0.805 . . . . 0.0 110.751 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -67.05 -31.21 71.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.797 0.439 . . . . 0.0 111.984 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -70.65 -51.46 27.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.4 -41.55 89.68 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.145 0.578 . . . . 0.0 110.181 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.02 75.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.164 0.986 . . . . 0.0 110.613 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.48 66.47 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -72.84 -27.81 62.16 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.802 1.183 . . . . 0.0 111.826 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 mt -63.91 -37.32 86.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.731 0.696 . . . . 0.0 111.17 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.2 -170.63 43.78 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.17 19.06 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.824 0.849 . . . . 0.0 113.273 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.1 m -55.42 153.84 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 111.464 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.48 143.04 44.79 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.89 126.78 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.49 151.55 50.48 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.412 0.551 . . . . 0.0 110.951 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.6 m -122.26 139.06 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.05 133.35 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -128.84 161.43 29.82 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.835 0.854 . . . . 0.0 110.67 -173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -169.794 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.1 p90 . . . . . 0 C--O 1.234 0.275 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 t 48.95 50.25 18.07 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.476 1.111 . . . . 0.0 110.227 -171.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.69 -139.8 4.66 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -169.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.0 69.47 1.45 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.23 1.412 . . . . 0.0 111.45 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.39 142.1 23.66 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 108.926 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.04 50.16 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.114 0.864 . . . . 0.0 112.897 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.26 94.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.32 -29.33 61.15 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.843 1.257 . . . . 0.0 114.117 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -64.37 -29.06 70.14 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.91 148.9 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.36 148.11 39.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.16 141.74 28.42 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.308 1.843 . . . . 0.0 108.28 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.63 155.2 36.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.749 1.619 . . . . 0.0 108.543 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.5 m -127.3 47.38 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.411 2.284 . . . . 0.0 109.204 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.41 -26.6 42.67 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.698 -0.626 . . . . 0.0 112.2 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -49.25 -26.44 2.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -70.15 -15.92 63.02 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.69 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -140.73 -22.07 0.8 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.827 1.194 . . . . 0.0 113.745 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 82.3 mmm 58.79 2.99 0.27 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.309 3.044 . . . . 0.0 116.021 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -62.89 -44.07 97.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.466 1.485 . . . . 0.0 111.994 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -64.87 -42.34 94.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.562 1.528 . . . . 0.0 109.756 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.27 -44.75 96.27 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 123.68 0.657 . . . . 0.0 111.773 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.44 -46.08 67.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.983 0.513 . . . . 0.0 109.843 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -38.92 78.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.082 0.953 . . . . 0.0 112.46 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -99.38 4.53 46.33 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.68 1.192 . . . . 0.0 111.824 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.22 37.5 64.82 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 118.454 0.57 . . . . 0.0 112.803 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.73 -7.55 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.358 1.063 . . . . 0.0 109.841 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.86 108.41 1.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.78 120.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.16 -43.81 98.0 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.618 1.167 . . . . 0.0 111.423 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -92.32 -4.78 53.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.466 0.707 . . . . 0.0 112.872 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.62 -11.59 2.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.919 . . . . 0.0 111.977 -170.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 41.6 ptt85 49.3 31.61 3.86 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.15 2.18 . . . . 0.0 114.599 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.3 mt -116.9 167.11 11.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.33 130.6 37.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 164.1 24.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.786 1.234 . . . . 0.0 112.809 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 99.25 11.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.8 m -144.06 162.69 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.885 0.874 . . . . 0.0 109.158 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.55 144.42 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -146.98 155.9 42.62 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.088 1.355 . . . . 0.0 109.068 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.8 t -139.5 143.77 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.88 136.15 36.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.841 0.856 . . . . 0.0 109.7 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.14 164.53 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.368 1.467 . . . . 0.0 109.133 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.4 -29.65 10.58 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.04 1.736 . . . . 0.0 113.253 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.35 1.79 12.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.688 1.195 . . . . 0.0 113.015 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.33 30.09 65.31 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 120.837 -1.165 . . . . 0.0 110.245 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -106.85 116.23 31.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.794 1.297 . . . . 0.0 108.494 -173.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.17 124.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.216 1.006 . . . . 0.0 110.679 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.07 -8.42 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.376 1.47 . . . . 0.0 111.131 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -147.99 147.45 29.65 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.81 15.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.456 1.502 . . . . 0.0 108.272 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.79 149.63 33.73 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.105 0.962 . . . . 0.0 109.216 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.16 104.93 7.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.761 2.424 . . . . 0.0 105.055 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.74 137.86 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.2 m -62.25 -11.95 17.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.149 1.38 . . . . 0.0 113.727 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -142.69 123.92 14.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -54.39 -27.02 33.72 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.863 1.265 . . . . 0.0 113.958 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.9 p -91.72 14.54 14.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.754 1.161 . . . . 0.0 112.368 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -123.66 170.84 10.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.632 1.573 . . . . 0.0 109.763 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -125.96 155.43 73.16 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.589 1.156 . . . . 0.0 110.953 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -91.65 179.93 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.082 3.188 . . . . 0.0 110.271 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -79.5 111.89 16.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -81.73 -0.68 44.03 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -76.57 -29.44 56.61 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.795 -1.191 . . . . 0.0 108.919 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -59.46 -50.66 86.1 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 117.663 -1.16 . . . . 0.0 111.456 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.65 -34.27 52.05 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.269 1.489 . . . . 0.0 112.44 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.57 -45.31 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.203 1.365 . . . . 0.0 109.933 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.87 -36.04 83.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.12 0.873 . . . . 0.0 110.797 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.386 -0.196 . . . . 0.0 111.068 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.4 77.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.985 0.514 . . . . 0.0 110.899 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -57.18 -40.47 77.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.168 0.894 . . . . 0.0 110.603 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.77 68.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.999 0.52 . . . . 0.0 111.912 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.51 -59.95 2.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.045 0.384 . . . . 0.0 110.921 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.53 -40.28 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.257 1.023 . . . . 0.0 112.14 -169.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? . . . . . 0 C--O 1.25 1.095 0 C-N-CA 127.217 2.207 . . . . 0.0 112.143 -176.386 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.9 pt -126.37 173.18 12.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.619 1.199 . . . . 0.0 111.217 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -116.16 138.3 51.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -90.72 -132.97 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.17 56.36 0.46 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.656 1.982 . . . . 0.0 111.317 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 22.63 45.02 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.341 0.972 . . . . 0.0 113.506 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.54 140.42 11.06 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.03 144.55 52.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.617 2.212 . . . . 0.0 109.572 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.85 126.73 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.412 0.685 . . . . 0.0 109.415 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -66.73 151.12 48.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.222 1.409 . . . . 0.0 110.509 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.66 145.73 47.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.0 1.72 . . . . 0.0 107.611 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.65 -23.06 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.85 31.31 0.51 Allowed Glycine 0 N--CA 1.464 0.549 0 CA-C-N 118.689 0.677 . . . . 0.0 111.648 -172.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.41 152.12 3.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 9.4 tt0 94.66 33.17 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.504 2.721 . . . . 0.0 113.997 169.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -64.0 152.99 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.47 167.88 25.84 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -169.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.54 129.87 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.209 0.604 . . . . 0.0 109.695 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -2.79 87.58 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.715 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.53 -11.4 59.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.485 1.642 . . . . 0.0 112.235 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 57.08 178.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.563 1.545 . . . . 0.0 112.291 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.85 138.82 33.39 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 127.001 2.12 . . . . 0.0 107.856 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -58.38 -44.39 38.46 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.813 2.342 . . . . 0.0 114.201 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 114.99 124.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 131.218 3.807 . . . . 0.0 105.439 -169.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -133.49 165.37 25.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 109.088 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -126.22 139.44 53.34 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.48 146.11 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.032 1.333 . . . . 0.0 108.276 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.44 166.15 22.31 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.6 p -130.62 -177.54 4.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.932 1.293 . . . . 0.0 108.419 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -47.27 -34.28 6.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.559 0.744 . . . . 0.0 111.537 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -112.77 14.53 19.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.819 1.248 . . . . 0.0 111.531 -170.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.6 mt 51.64 44.16 29.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.742 . . . . 0.0 112.123 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -73.29 -18.12 61.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 112.81 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.12 54.56 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 123.084 1.421 . . . . 0.0 108.604 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -58.76 161.0 5.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.066 1.746 . . . . 0.0 108.869 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.2 p -141.59 170.23 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 tp -54.55 -40.95 69.21 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.63 -20.66 63.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.64 -33.46 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.728 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 37.0 mtt -71.36 -39.73 71.08 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.301 1.041 . . . . 0.0 110.609 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -54.36 138.37 39.69 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 123.317 0.647 . . . . 0.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.24 7.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.01 1.29 . . . . 0.0 112.553 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -147.92 155.77 41.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.598 1.159 . . . . 0.0 109.258 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.41 139.67 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.1 m -135.36 147.83 49.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.231 1.012 . . . . 0.0 108.738 -172.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.09 136.78 54.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.3 mt -135.27 128.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.0 m -108.9 141.33 41.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -135.48 125.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.9 pt -150.06 159.6 35.12 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.201 1.8 . . . . 0.0 107.178 -170.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.71 -40.39 79.95 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.123 1.882 . . . . 0.0 112.234 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.07 165.53 15.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.812 1.645 . . . . 0.0 109.099 169.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pp -67.23 41.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 125.915 1.686 . . . . 0.0 112.861 169.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -158.18 -29.03 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.148 . . . . 0.0 113.208 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -72.57 32.51 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -168.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.82 -29.6 1.8 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.006 1.289 . . . . 0.0 114.591 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.3 -3.72 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.379 1.472 . . . . 0.0 113.202 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 29.2 m -74.45 33.36 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.975 -1.078 . . . . 0.0 110.65 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.38 179.84 1.18 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.099 1.36 . . . . 0.0 111.259 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.38 31.61 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.567 1.147 . . . . 0.0 113.235 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -62.94 -56.76 14.32 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.714 1.143 . . . . 0.0 109.437 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -62.16 -42.55 99.37 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 109.779 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -61.71 -53.95 49.14 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.829 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -64.11 -45.88 86.67 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.846 0.748 . . . . 0.0 110.268 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -54.09 -52.17 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.175 0.99 . . . . 0.0 110.853 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.18 -35.95 81.8 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.915 0.388 . . . . 0.0 110.823 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -69.98 -37.25 75.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.257 0.623 . . . . 0.0 111.838 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -74.49 -34.34 63.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.171 0.896 . . . . 0.0 110.919 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.32 -46.41 76.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.708 0.685 . . . . 0.0 110.794 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.97 -16.44 51.29 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.838 0.855 . . . . 0.0 113.293 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -83.21 -27.09 30.23 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.067 0.849 . . . . 0.0 111.847 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.0 -33.82 76.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.581 0.628 . . . . 0.0 110.987 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.36 -168.01 40.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -75.71 28.16 0.11 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.745 -0.856 . . . . 0.0 112.217 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -54.76 138.42 14.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.528 1.131 . . . . 0.0 109.059 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -66.13 137.97 57.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.07 119.53 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.61 149.62 52.18 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.915 0.486 . . . . 0.0 110.745 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 m -133.76 116.1 15.34 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mt -92.14 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -133.72 162.08 32.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.094 2.158 . . . . 0.0 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.204 1.402 . . . . 0.0 112.95 -178.055 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 62.9 m95 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.7 p -63.72 -15.05 57.51 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.675 -0.64 . . . . 0.0 112.393 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.36 -148.85 5.88 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 127.205 2.336 . . . . 0.0 107.738 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 54.69 41.43 31.94 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.702 1.201 . . . . 0.0 111.659 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -141.14 148.15 39.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.962 1.705 . . . . 0.0 107.278 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.04 -60.37 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 77.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 122.696 1.236 . . . . 0.0 108.898 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.88 -20.11 14.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.338 1.855 . . . . 0.0 113.974 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -58.38 -30.98 67.21 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.734 -0.604 . . . . 0.0 112.098 173.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.56 142.24 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.67 138.24 44.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.47 143.05 32.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.825 0.85 . . . . 0.0 108.817 -173.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -124.07 156.39 36.64 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.78 1.632 . . . . 0.0 108.247 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -136.41 144.44 44.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -134.26 -16.23 2.16 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -64.29 -14.32 55.21 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.717 -1.24 . . . . 0.0 114.143 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -65.55 -18.88 65.65 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.276 -0.89 . . . . 0.0 112.155 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -147.19 -15.64 0.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 35.6 mmm 50.15 37.33 14.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.245 1.818 . . . . 0.0 111.99 -169.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -56.94 15.43 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -63.3 -37.85 88.87 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.687 0.676 . . . . 0.0 109.812 175.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.77 -55.48 8.21 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.482 1.991 . . . . 0.0 113.216 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.47 -35.2 40.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.154 0.477 . . . . 0.0 110.506 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.47 79.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.186 0.595 . . . . 0.0 112.334 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.62 2.43 16.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.915 1.286 . . . . 0.0 110.684 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 8.08 62.55 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.289 -0.882 . . . . 0.0 114.276 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 m -79.47 -4.55 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.043 1.737 . . . . 0.0 112.175 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -67.0 115.76 7.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.5 mt -75.48 106.86 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -54.72 -40.63 69.45 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.805 0.842 . . . . 0.0 110.85 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -86.88 -5.1 59.21 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.02 -7.03 2.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.168 0.894 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 15.8 ptm180 40.2 43.33 1.36 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.89 2.076 . . . . 0.0 113.763 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt -131.74 175.83 8.85 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.04 129.55 34.78 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.758 0.823 . . . . 0.0 109.318 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 139.24 57.86 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.998 1.319 . . . . 0.0 111.1 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.49 113.14 3.1 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.4 p -154.15 164.13 39.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.284 0.564 . . . . 0.0 109.873 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 t -141.74 136.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -142.85 152.09 41.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.564 0.745 . . . . 0.0 109.229 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.65 136.25 52.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -130.85 136.74 48.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.86 1.264 . . . . 0.0 108.372 -169.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.06 165.46 15.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.22 1.408 . . . . 0.0 110.514 169.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.51 -33.22 20.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 113.182 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.32 5.74 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.172 0.897 . . . . 0.0 113.304 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.3 -7.59 75.49 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.607 1.099 . . . . 0.0 113.091 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.48 125.32 24.79 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.613 1.207 . . . . 0.0 109.034 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.86 128.75 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.94 -8.53 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.122 1.369 . . . . 0.0 111.04 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -153.86 150.48 28.45 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.7 133.74 11.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.522 1.529 . . . . 0.0 107.913 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -143.57 149.8 37.92 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.327 0.651 . . . . 0.0 110.138 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -128.09 112.74 14.92 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.09 133.47 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -57.9 -20.3 36.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.043 0.937 . . . . 0.0 112.633 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.43 124.47 13.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.49 -32.04 72.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.394 0.678 . . . . 0.0 112.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -79.41 17.28 0.87 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.483 1.113 . . . . 0.0 111.65 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -134.31 171.27 14.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 107.054 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.84 151.13 76.83 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 111.435 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -86.64 176.09 4.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.064 3.176 . . . . 0.0 110.421 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -71.52 133.37 45.77 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -110.7 3.07 18.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.0 0.52 . . . . 0.0 112.192 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.59 -40.27 42.75 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -54.65 -50.79 83.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.315 -1.326 . . . . 0.0 112.403 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.46 -36.64 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 CA-C-N 121.84 1.693 . . . . 0.0 112.431 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.5 mm -59.48 -46.75 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.315 0.961 . . . . 0.0 109.588 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.45 -35.85 82.15 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.304 -0.872 . . . . 0.0 110.845 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.87 98.46 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.356 0.262 . . . . 0.0 110.642 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.27 -47.04 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.919 0.488 . . . . 0.0 110.682 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.96 -42.5 72.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.211 0.914 . . . . 0.0 110.484 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.4 -31.12 67.39 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.346 0.658 . . . . 0.0 111.881 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -84.74 -44.01 13.74 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.763 0.425 . . . . 0.0 111.612 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.87 -51.35 24.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 123.774 0.83 . . . . 0.0 111.55 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.249 1.068 0 C-N-CA 123.948 0.899 . . . . 0.0 109.666 -178.455 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.218 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.57 172.81 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 122.397 1.094 . . . . 0.0 110.07 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 m -134.01 143.82 48.34 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.81 -2.292 . . . . 0.0 104.81 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -138.39 127.18 23.7 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 47.34 38.77 7.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.922 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.6 20.35 79.57 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.309 -0.717 . . . . 0.0 114.526 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.08 121.35 4.41 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 172.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.34 140.91 82.32 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.827 2.351 . . . . 0.0 110.715 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.25 135.81 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -74.78 157.7 34.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.597 1.559 . . . . 0.0 109.406 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 144.64 48.71 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.0 t -60.88 -52.18 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.495 0.718 . . . . 0.0 112.33 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.66 37.57 3.17 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.707 1.146 . . . . 0.0 112.41 -170.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.15 169.95 0.16 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.537 1.935 . . . . 0.0 115.018 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 77.18 28.21 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.769 2.028 . . . . 0.0 113.306 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -64.0 145.82 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -150.43 164.57 35.56 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.936 0.895 . . . . 0.0 109.555 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 p -53.0 133.04 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.305 0.642 . . . . 0.0 109.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.62 1.21 90.49 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.737 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.63 -12.93 60.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.439 1.619 . . . . 0.0 112.314 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.17 176.4 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.81 1.644 . . . . 0.0 112.025 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.72 147.58 63.33 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.647 1.579 . . . . 0.0 110.363 -173.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.02 -51.39 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.776 2.317 . . . . 0.0 112.277 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t70 118.11 127.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 1 C-N-CA 131.844 4.058 . . . . 0.0 105.88 -169.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.75 166.51 23.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.832 1.653 . . . . 0.0 108.844 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 m -132.13 138.2 47.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.52 174.47 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 127.778 2.431 . . . . 0.0 107.686 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.3 140.93 46.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.8 p -70.84 174.87 5.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.143 1.777 . . . . 0.0 110.846 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.52 -22.08 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.505 -0.747 . . . . 0.0 110.928 169.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 m -84.11 0.18 49.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.485 1.514 . . . . 0.0 111.859 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.3 mt 52.73 49.74 19.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.427 1.891 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.33 159.95 26.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.358 1.463 . . . . 0.0 107.451 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.66 144.46 47.75 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.915 0.864 . . . . 0.0 111.026 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -142.11 151.39 42.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.619 2.368 . . . . 0.0 105.129 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 p -135.08 165.08 26.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -56.85 -37.53 71.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 174.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.88 67.59 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -78.95 -30.48 44.59 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.794 0.725 . . . . 0.0 111.259 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 48.6 mtt -72.03 -41.1 67.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.966 0.906 . . . . 0.0 110.887 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -54.3 146.06 16.38 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.238 1.015 . . . . 0.0 110.057 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.11 -21.15 12.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.937 1.256 . . . . 0.0 112.612 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -146.8 152.98 39.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.321 1.448 . . . . 0.0 108.443 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.77 141.14 17.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.4 m -135.02 146.8 49.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -172.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 90.1 mt -128.51 135.23 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.4 102.94 3.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.8 m -79.84 151.22 30.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.74 126.86 39.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.5 pt -137.84 147.75 57.99 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.742 0.417 . . . . 0.0 110.132 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.56 -34.41 7.34 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.187 1.925 . . . . 0.0 111.565 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -163.95 172.38 14.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.739 1.615 . . . . 0.0 109.179 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 pp -105.54 -9.36 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.77 1.228 . . . . 0.0 110.794 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -69.17 -34.57 75.17 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.651 -0.656 . . . . 0.0 110.282 169.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.36 146.82 52.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.478 1.511 . . . . 0.0 110.726 173.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.24 -3.25 52.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.223 0.916 . . . . 0.0 114.618 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.93 -22.72 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.966 1.307 . . . . 0.0 112.412 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 90.9 m -51.6 -65.07 0.62 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.872 1.269 . . . . 0.0 110.342 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.13 -33.05 50.68 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.054 0.541 . . . . 0.0 110.903 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.19 86.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.908 -0.568 . . . . 0.0 111.966 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -159.11 -39.16 0.06 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -64.78 -46.16 83.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.549 1.068 . . . . 0.0 112.567 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -69.92 -29.58 66.78 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.858 -1.151 . . . . 0.0 112.444 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -78.52 -45.27 22.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.274 0.943 . . . . 0.0 109.971 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.24 -44.96 96.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.175 -0.44 . . . . 0.0 111.376 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -63.04 -40.44 97.72 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.232 0.613 . . . . 0.0 110.417 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.37 -51.46 67.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.678 0.791 . . . . 0.0 109.851 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -64.16 -37.01 85.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.541 0.736 . . . . 0.0 110.973 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.87 76.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.468 1.507 . . . . 0.0 110.108 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -26.83 68.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.573 0.349 . . . . 0.0 111.932 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.13 -20.55 55.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.077 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.34 -36.54 84.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.267 1.394 . . . . 0.0 111.596 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.71 -170.91 43.48 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -74.22 21.62 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.26 150.56 2.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 O-C-N 120.7 -1.25 . . . . 0.0 110.786 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.17 143.41 47.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 125.01 43.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.57 156.37 45.87 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.601 0.76 . . . . 0.0 109.94 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.9 m -132.48 114.59 14.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -97.44 132.79 41.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 m -142.59 169.16 18.09 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.839 1.255 . . . . 0.0 109.305 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 110.738 173.193 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.6 p -72.23 -45.06 61.78 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.961 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.15 -10.3 59.1 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.578 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.9 -6.91 12.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.93 1.365 . . . . 0.0 112.352 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 109.84 2.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.381 0.537 . . . . 0.0 109.945 -170.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.24 -1.43 60.64 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.391 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.22 90.38 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.951 1.875 . . . . 0.0 109.313 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.35 -30.85 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.447 1.899 . . . . 0.0 114.547 -173.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.57 -30.21 71.36 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 t -76.98 144.78 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.01 131.26 28.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.592 0.71 . . . . 0.0 109.448 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.37 144.94 32.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.576 1.151 . . . . 0.0 109.304 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -132.6 155.36 48.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.332 1.453 . . . . 0.0 109.477 -170.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -112.94 138.26 50.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.388 1.075 . . . . 0.0 108.467 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.57 -17.93 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -61.79 -11.17 11.14 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.11 -0.994 . . . . 0.0 113.414 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -46.62 -45.31 18.98 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.529 1.532 . . . . 0.0 110.608 169.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.54 3.75 0.57 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 43.0 mmm 51.27 37.53 18.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.692 1.597 . . . . 0.0 112.127 -172.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -57.35 -59.77 4.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.423 1.089 . . . . 0.0 110.61 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -62.75 -36.5 83.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.072 0.949 . . . . 0.0 109.459 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.9 -60.56 3.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 126.195 1.855 . . . . 0.0 113.023 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.01 -35.26 57.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.194 0.497 . . . . 0.0 110.354 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.46 85.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.45 5.38 15.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.202 1.401 . . . . 0.0 110.782 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.45 64.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.282 -0.886 . . . . 0.0 112.834 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.95 0.2 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.483 1.113 . . . . 0.0 111.366 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -71.12 106.51 3.77 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 124' ' ' LEU . 64.8 mt -65.62 121.19 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -65.45 -41.35 93.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.909 0.484 . . . . 0.0 110.553 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.78 -61.77 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.865 0.466 . . . . 0.0 110.156 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.418 ' H ' HG22 ' A' ' 121' ' ' ILE . 21.9 tp -71.76 -19.27 62.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.646 0.778 . . . . 0.0 112.452 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 54.11 41.52 31.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.148 1.379 . . . . 0.0 111.658 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.7 mt -128.07 179.01 5.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.775 1.23 . . . . 0.0 108.371 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.11 133.83 41.45 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.171 0.989 . . . . 0.0 108.831 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.78 152.67 38.76 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.58 1.152 . . . . 0.0 111.177 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.03 110.58 16.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 169.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -150.41 172.11 15.94 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -149.79 144.5 17.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.08 158.0 44.75 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.243 1.417 . . . . 0.0 108.781 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.86 144.36 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.03 126.57 20.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.219 1.008 . . . . 0.0 109.738 -168.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.01 161.51 24.17 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.465 1.506 . . . . 0.0 110.658 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -48.67 -33.93 10.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 112.686 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.5 5.23 36.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.157 1.383 . . . . 0.0 112.733 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.92 -5.72 83.16 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 120.885 -1.134 . . . . 0.0 112.74 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -72.76 121.27 19.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.006 1.403 . . . . 0.0 108.729 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.22 125.72 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.06 -10.89 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.462 1.105 . . . . 0.0 110.223 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -152.42 152.28 31.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.434 1.094 . . . . 0.0 108.268 170.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.21 137.46 14.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.86 1.664 . . . . 0.0 107.493 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -144.83 139.61 27.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -113.48 109.49 18.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.0 t -64.45 115.17 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.2 m -53.21 -25.66 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.994 1.318 . . . . 0.0 113.205 -170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.05 107.65 6.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.19 -25.37 68.04 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.333 1.853 . . . . 0.0 112.462 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.72 15.02 1.48 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.097 1.359 . . . . 0.0 111.695 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.53 175.94 9.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.767 2.827 . . . . 0.0 106.692 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -122.87 154.2 64.02 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.656 1.117 . . . . 0.0 112.135 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.67 177.05 2.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.397 3.398 . . . . 0.0 111.15 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -76.58 130.92 38.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -104.8 -3.98 22.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -33.97 69.97 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.59 -55.67 42.26 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.782 1.233 . . . . 0.0 112.588 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.97 -34.45 59.35 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.74 1.657 . . . . 0.0 111.963 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 mm -60.22 -46.39 94.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.824 1.193 . . . . 0.0 109.707 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.95 -31.86 71.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.716 1.143 . . . . 0.0 110.93 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.15 -39.46 94.73 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.052 0.387 . . . . 0.0 111.012 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.11 68.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.633 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -55.4 -38.61 69.14 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.274 0.943 . . . . 0.0 110.968 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.24 -28.39 64.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.562 0.745 . . . . 0.0 112.299 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.93 -48.3 7.08 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.553 . . . . 0.0 111.334 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.86 -45.46 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.362 1.065 . . . . 0.0 110.837 -171.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt . . . . . 0 C--O 1.25 1.113 0 C-N-CA 126.825 2.05 . . . . 0.0 110.793 179.371 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 pt -136.98 173.33 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 123.478 1.609 . . . . 0.0 110.941 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 m -118.82 154.45 32.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -137.61 121.45 17.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.25 40.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.595 1.558 . . . . 0.0 113.641 -172.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.34 5.48 89.55 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.698 -0.626 . . . . 0.0 114.087 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.03 113.64 4.09 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.639 1.59 . . . . 0.0 109.541 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.1 139.59 71.25 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.942 2.428 . . . . 0.0 111.06 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.6 127.5 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.521 0.677 . . . . 0.0 109.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -69.48 151.73 45.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.998 1.319 . . . . 0.0 110.112 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.68 158.47 23.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.069 1.747 . . . . 0.0 108.694 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.71 -51.66 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.54 29.77 3.75 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.468 1.032 . . . . 0.0 111.92 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.84 164.51 1.51 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.595 1.158 . . . . 0.0 113.348 -172.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 103.64 20.64 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.321 3.048 . . . . 0.0 111.138 170.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.81 136.8 21.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -145.93 166.75 25.1 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.529 1.131 . . . . 0.0 108.131 -171.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.7 130.66 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.39 90.25 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.766 -1.019 . . . . 0.0 114.082 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.51 -8.15 58.95 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.548 1.674 . . . . 0.0 112.37 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 59.92 175.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.501 1.52 . . . . 0.0 112.097 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.22 115.5 13.98 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.89 1.676 . . . . 0.0 108.293 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.4 144.79 99.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.369 2.046 . . . . 0.0 112.699 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -82.07 62.1 5.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -94.09 173.4 7.67 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.4 m -118.55 151.32 38.09 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.718 0.77 . . . . 0.0 111.559 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.49 166.8 20.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.282 2.233 . . . . 0.0 106.996 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mp -109.56 154.49 22.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -83.46 178.81 7.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.053 0.941 . . . . 0.0 109.592 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.19 -26.88 68.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.728 -1.232 . . . . 0.0 110.938 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -80.62 1.49 29.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.313 1.445 . . . . 0.0 111.784 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.0 mt 55.12 35.82 25.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.857 2.063 . . . . 0.0 112.336 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.09 149.58 22.35 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.53 143.7 46.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.544 0.738 . . . . 0.0 110.095 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -144.9 102.19 3.74 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.6 m -70.97 154.24 41.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 27.2 tp -52.53 -39.65 61.62 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.671 -0.643 . . . . 0.0 111.05 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -18.85 40.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.7 -32.29 63.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.593 1.088 . . . . 0.0 110.886 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.4 mtt -73.41 -39.75 64.81 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.629 1.172 . . . . 0.0 110.229 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -55.81 150.48 12.91 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.814 0.816 . . . . 0.0 110.406 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.13 23.15 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.203 1.382 . . . . 0.0 112.216 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -149.14 153.86 38.33 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 108.749 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.22 138.5 16.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.4 m -134.82 148.4 50.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.068 0.947 . . . . 0.0 108.885 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.9 mt -132.81 132.84 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.99 105.99 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -84.46 149.65 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 168.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 t -134.0 128.99 53.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.5 pt -143.84 144.33 26.47 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.673 0.789 . . . . 0.0 109.374 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.75 -33.64 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.061 1.841 . . . . 0.0 111.709 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -154.01 173.15 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.594 1.958 . . . . 0.0 108.692 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.1 pt -132.91 -31.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.11 1.364 . . . . 0.0 110.94 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.64 -12.08 50.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.648 0.737 . . . . 0.0 110.979 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -64.11 -19.63 65.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.825 2.05 . . . . 0.0 112.762 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.71 65.56 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.852 0.739 . . . . 0.0 112.841 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.35 -19.61 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.0 1.4 . . . . 0.0 112.026 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.66 -58.09 9.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 170.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.11 -32.72 72.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.284 0.633 . . . . 0.0 111.131 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -47.86 84.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.005 -0.521 . . . . 0.0 111.383 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -165.86 -35.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -43.55 97.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 112.343 -169.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -62.49 -51.44 67.42 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.436 1.016 . . . . 0.0 109.763 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -62.65 -48.47 79.19 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.617 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -57.36 -51.3 69.96 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.494 0.588 . . . . 0.0 110.86 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -61.41 -40.08 93.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.964 0.906 . . . . 0.0 111.499 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.82 -46.73 71.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.518 0.727 . . . . 0.0 110.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.87 -36.24 81.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.184 0.902 . . . . 0.0 110.672 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.34 77.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.748 0.819 . . . . 0.0 110.292 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.4 -24.47 67.41 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -80.49 -19.12 46.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 112.539 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.59 -39.56 93.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.957 1.253 . . . . 0.0 111.86 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.71 -167.35 39.15 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.19 25.72 0.1 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.468 1.107 . . . . 0.0 112.912 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -57.24 142.32 13.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.206 1.402 . . . . 0.0 110.715 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -72.83 137.87 46.0 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 168.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.28 124.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -137.82 153.94 49.58 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.828 0.851 . . . . 0.0 110.323 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 m -126.16 103.94 7.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.7 mt -77.32 131.76 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.6 m -132.25 165.34 24.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.164 1.385 . . . . 0.0 109.314 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.798 0.808 . . . . 0.0 110.621 169.727 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.9 p -59.62 -28.57 67.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.15 -14.22 57.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.961 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.68 33.59 5.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.827 1.314 . . . . 0.0 110.395 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -141.24 135.58 30.82 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.46 -15.59 7.17 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.334 -0.704 . . . . 0.0 112.642 -170.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mt -128.83 76.93 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.2 -26.25 38.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -63.67 -27.66 69.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.502 1.121 . . . . 0.0 112.642 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.75 154.13 3.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.27 146.81 39.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.4 148.81 24.04 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.37 157.05 35.97 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.461 1.505 . . . . 0.0 108.554 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -128.82 49.25 2.24 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.193 2.197 . . . . 0.0 108.947 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -47.18 -41.82 18.68 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.567 0.747 . . . . 0.0 111.358 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -56.15 -19.89 15.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.166 0.986 . . . . 0.0 113.631 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -68.7 -22.33 64.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.048 -1.033 . . . . 0.0 111.618 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -133.72 -26.14 1.6 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.085 0.954 . . . . 0.0 112.999 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.79 -4.03 0.27 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.789 3.235 . . . . 0.0 115.731 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -57.25 -52.57 64.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.718 1.144 . . . . 0.0 110.965 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.67 -35.14 78.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.593 0.633 . . . . 0.0 111.129 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.24 -43.22 98.71 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.63 0.633 . . . . 0.0 112.119 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.66 -38.88 80.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.634 0.717 . . . . 0.0 110.31 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.82 84.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.644 0.778 . . . . 0.0 111.88 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.83 -6.19 58.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.72 0.808 . . . . 0.0 111.08 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.46 1.9 62.2 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.119 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.89 -19.74 26.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 124.638 1.175 . . . . 0.0 111.137 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.66 118.35 6.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.313 0.961 . . . . 0.0 108.651 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -81.61 105.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 126.197 1.799 . . . . 0.0 106.425 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.24 -40.59 61.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.752 1.221 . . . . 0.0 110.869 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -88.79 -4.74 58.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.34 0.656 . . . . 0.0 112.714 -170.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.6 tp -137.37 -5.8 1.8 Allowed 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.117 -0.989 . . . . 0.0 113.047 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 32.2 ptt-85 42.5 45.8 3.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.949 1.7 . . . . 0.0 112.767 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -134.87 176.59 8.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.119 1.768 . . . . 0.0 106.358 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.261 0.0 OUTLIER -106.49 147.5 29.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 121.884 2.129 . . . . 0.0 111.862 170.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.03 156.58 35.67 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.741 2.016 . . . . 0.0 112.785 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -82.54 116.34 21.92 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.2 m -150.79 167.06 28.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 108.96 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.93 142.96 19.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.22 151.83 42.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.775 1.23 . . . . 0.0 108.111 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.9 t -135.07 135.44 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -130.26 135.53 48.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.361 1.064 . . . . 0.0 109.239 -169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.48 167.25 5.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 109.502 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -51.13 -34.12 29.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.041 1.336 . . . . 0.0 112.711 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -80.24 -0.57 36.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.473 1.109 . . . . 0.0 112.547 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.66 79.33 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.896 1.236 . . . . 0.0 112.606 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.64 117.3 5.6 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.244 1.522 . . . . 0.0 109.469 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.84 115.67 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.848 0.859 . . . . 0.0 109.447 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.6 -12.21 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.657 1.183 . . . . 0.0 110.664 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -147.17 144.68 29.13 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.31 126.36 7.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.317 1.447 . . . . 0.0 107.283 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.82 145.56 29.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -114.47 111.08 20.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 t -61.95 125.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -172.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -59.42 -13.32 8.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.472 1.109 . . . . 0.0 113.663 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.6 128.13 21.42 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.98 63.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.065 . . . . 0.0 113.667 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.2 p -84.68 -4.49 59.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.083 1.31 . . . . 0.0 112.637 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -98.07 177.24 5.48 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.438 1.495 . . . . 0.0 109.974 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -133.51 151.57 77.57 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.015 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.0 -176.68 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.663 2.908 . . . . 0.0 109.249 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -76.85 119.47 20.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -91.29 -0.87 57.74 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.28 -36.05 40.33 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -51.21 -55.45 28.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.134 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.27 -33.88 47.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.584 1.601 . . . . 0.0 112.728 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.81 -45.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.185 1.357 . . . . 0.0 109.879 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.54 -36.84 85.0 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.376 0.989 . . . . 0.0 110.596 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.12 96.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.082 0.553 . . . . 0.0 111.178 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.15 -41.89 76.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.28 0.945 . . . . 0.0 110.302 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.29 -31.89 70.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.162 0.585 . . . . 0.0 112.012 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.59 -40.45 23.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.076 0.55 . . . . 0.0 111.807 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.55 -54.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.454 0.702 . . . . 0.0 109.483 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.1 pttt . . . . . 0 C--O 1.25 1.083 0 C-N-CA 127.722 2.409 . . . . 0.0 112.036 -178.231 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.6 pt -130.33 -178.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 122.172 0.987 . . . . 0.0 110.92 -169.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -127.1 146.35 50.41 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -143.68 133.25 23.56 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm 43.7 42.38 4.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.586 1.555 . . . . 0.0 112.138 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.18 28.5 70.04 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.161 -0.799 . . . . 0.0 114.54 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 139.6 10.52 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 169.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.39 145.33 42.73 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.592 2.195 . . . . 0.0 110.151 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.27 134.72 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.242 1.017 . . . . 0.0 110.28 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -75.29 152.81 38.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.156 1.782 . . . . 0.0 110.448 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.78 148.76 42.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.98 1.712 . . . . 0.0 108.08 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.15 -84.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.361 0.528 . . . . 0.0 110.935 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 40.48 2.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.296 1.427 . . . . 0.0 112.019 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -58.06 171.05 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.196 2.198 . . . . 0.0 114.593 -169.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 78.52 28.27 0.46 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.817 2.047 . . . . 0.0 114.032 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.6 138.88 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -148.4 164.08 35.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.451 1.1 . . . . 0.0 108.578 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.8 132.97 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 -0.52 89.65 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.219 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -76.55 -13.65 60.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.544 1.672 . . . . 0.0 112.657 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 60.95 157.15 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.813 2.045 . . . . 0.0 112.959 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.58 133.37 46.95 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.342 1.057 . . . . 0.0 109.049 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.3 -27.66 76.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.493 2.795 . . . . 0.0 114.772 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 62.43 98.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.381 2.272 . . . . 0.0 112.113 -170.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -129.49 170.47 13.68 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.901 1.68 . . . . 0.0 108.316 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.9 167.32 11.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.53 1.132 . . . . 0.0 109.279 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.9 -176.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 128.053 2.541 . . . . 0.0 104.215 168.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.05 139.16 35.87 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.6 p -87.64 171.08 10.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 118.821 0.737 . . . . 0.0 109.744 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.443 -0.785 . . . . 0.0 110.733 168.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m -79.35 1.58 24.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.717 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt 61.47 32.58 18.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.684 2.394 . . . . 0.0 112.201 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -91.89 140.33 29.78 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.91 55.83 2.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.085 1.754 . . . . 0.0 110.184 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.41 157.03 5.33 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.065 1.346 . . . . 0.0 108.394 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -133.5 163.8 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.03 -28.5 66.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.022 -0.424 . . . . 0.0 111.958 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.63 -19.71 51.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.085 -1.009 . . . . 0.0 113.647 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.2 -28.49 61.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.443 1.019 . . . . 0.0 110.941 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -74.01 -41.7 61.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.725 1.21 . . . . 0.0 110.039 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 133.48 49.49 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.54 -23.28 4.28 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.992 1.282 . . . . 0.0 112.426 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -154.99 157.38 37.58 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.663 1.185 . . . . 0.0 108.371 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -59.24 143.06 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -137.68 148.04 45.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.269 1.028 . . . . 0.0 108.243 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.2 mt -129.07 137.95 55.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.7 mt -132.17 124.13 51.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.2 t -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.99 131.37 64.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -139.78 136.99 17.86 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.591 0.757 . . . . 0.0 111.451 -170.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.8 -28.71 2.01 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.167 2.578 . . . . 0.0 112.146 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -163.42 170.69 17.06 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.072 1.749 . . . . 0.0 107.739 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -126.13 -18.91 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.109 1.364 . . . . 0.0 110.528 169.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.38 -13.39 58.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.866 0.867 . . . . 0.0 111.362 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 p -61.12 -22.22 64.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.08 1.752 . . . . 0.0 112.252 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.77 -10.24 65.76 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.017 0.817 . . . . 0.0 112.4 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.92 -29.11 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.663 1.231 . . . . 0.0 109.707 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.48 -55.4 35.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.933 0.333 . . . . 0.0 110.11 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -38.79 80.37 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.334 0.253 . . . . 0.0 111.038 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.63 -32.74 73.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.763 -0.636 . . . . 0.0 112.523 -175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -149.62 -46.36 0.13 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.361 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -60.51 -34.64 74.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.994 1.725 . . . . 0.0 111.531 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -50.69 -65.79 0.5 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.274 0.63 . . . . 0.0 109.844 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.89 -40.73 87.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.006 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -58.25 -54.91 41.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 122.502 0.321 . . . . 0.0 110.395 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -76.21 -27.77 56.96 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.918 -171.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.88 -53.08 62.08 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.658 1.183 . . . . 0.0 109.701 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.48 -39.68 88.92 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.324 0.511 . . . . 0.0 110.573 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.82 81.05 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.438 0.695 . . . . 0.0 110.828 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.13 -20.44 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -93.59 -14.86 26.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.413 1.006 . . . . 0.0 112.7 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.75 -31.88 73.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.666 1.121 . . . . 0.0 111.929 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.41 -158.69 31.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.89 26.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.286 1.434 . . . . 0.0 112.533 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.44 135.98 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.105 1.362 . . . . 0.0 108.022 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.95 146.57 52.65 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.72 127.19 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.11 151.34 51.34 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.615 0.766 . . . . 0.0 110.796 -173.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.8 m -133.72 100.34 4.74 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.34 128.71 39.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -125.64 150.18 47.79 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 121.402 0.62 . . . . 0.0 111.947 176.133 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.4 -34.17 73.53 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.361 0.664 . . . . 0.0 111.608 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.57 13.52 62.18 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.814 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.11 26.42 5.18 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.875 1.337 . . . . 0.0 110.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.85 135.64 36.39 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.25 -13.72 43.78 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.879 -173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.43 76.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 125.822 1.649 . . . . 0.0 107.284 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.6 -21.55 10.75 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.489 1.916 . . . . 0.0 113.951 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.45 -27.3 67.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.435 1.094 . . . . 0.0 112.385 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.21 144.73 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.768 0.827 . . . . 0.0 109.227 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.3 129.2 48.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 p -97.67 141.74 30.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.458 1.103 . . . . 0.0 108.682 -172.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -125.47 156.62 38.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 110.077 -169.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -136.12 44.6 2.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.331 2.652 . . . . 0.0 109.11 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.07 -24.92 60.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.396 0.678 . . . . 0.0 112.311 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -51.12 -19.63 1.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.481 1.512 . . . . 0.0 114.387 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -59.52 -27.11 65.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.663 1.119 . . . . 0.0 112.457 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -135.77 -6.96 2.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.78 1.173 . . . . 0.0 113.251 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 86.6 mmm 52.83 26.9 4.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.632 1.573 . . . . 0.0 111.919 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -65.55 0.67 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.006 1.322 . . . . 0.0 111.298 -171.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.9 -36.7 79.92 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.151 0.58 . . . . 0.0 109.507 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.4 -51.56 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 124.249 0.928 . . . . 0.0 111.953 -172.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.39 -41.06 70.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.965 0.506 . . . . 0.0 109.938 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.02 79.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.472 0.709 . . . . 0.0 112.17 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -85.73 -4.84 59.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.762 0.825 . . . . 0.0 111.245 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.07 10.95 62.86 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.015 -0.881 . . . . 0.0 114.223 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.2 m -65.44 -16.98 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.465 1.133 . . . . 0.0 109.982 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.13 106.62 0.45 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.97 125.05 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.27 -37.19 86.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.41 0.684 . . . . 0.0 111.628 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -98.23 -50.71 4.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.284 0.634 . . . . 0.0 111.716 -169.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.7 -24.59 62.68 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.257 0.481 . . . . 0.0 111.306 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 97.3 mtt180 52.54 47.75 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.337 1.455 . . . . 0.0 111.393 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 71.6 mt -129.14 171.06 12.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.027 1.331 . . . . 0.0 107.854 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.62 117.56 22.08 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.42 141.8 40.85 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 111.0 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.86 108.6 1.81 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 m -144.31 164.38 30.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -150.09 139.77 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -142.5 156.11 45.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.554 1.141 . . . . 0.0 108.447 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.9 134.73 48.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -129.5 134.5 47.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.18 165.95 10.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.01 1.324 . . . . 0.0 109.565 169.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -50.24 -37.32 35.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.657 1.183 . . . . 0.0 112.679 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.46 2.91 46.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.76 61.6 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.516 1.055 . . . . 0.0 113.596 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -61.2 118.41 6.82 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.905 1.353 . . . . 0.0 109.166 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.53 113.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.73 0.812 . . . . 0.0 109.054 170.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.08 -26.48 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 0.0 109.459 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -153.38 152.2 30.79 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 107.063 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.68 127.58 5.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -147.08 149.66 33.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -121.59 113.55 19.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.77 119.43 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m -59.12 -19.21 42.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.457 1.503 . . . . 0.0 112.881 -171.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.69 95.72 3.11 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.05 -20.86 65.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.883 0.873 . . . . 0.0 112.599 -172.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 6.17 3.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.722 1.209 . . . . 0.0 112.222 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.98 162.26 30.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.999 2.12 . . . . 0.0 107.854 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -96.99 145.54 29.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.929 -0.482 . . . . 0.0 111.506 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.0 174.15 11.2 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.867 3.045 . . . . 0.0 111.333 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -82.12 129.6 34.86 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -84.03 -11.89 56.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -80.46 -34.57 35.86 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -55.74 -52.05 75.33 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.798 -1.096 . . . . 0.0 112.042 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.6 -37.2 17.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.107 1.431 . . . . 0.0 111.777 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.11 -44.51 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.027 0.831 . . . . 0.0 109.972 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.63 -38.61 91.61 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.156 0.889 . . . . 0.0 110.637 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.54 85.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.26 0.224 . . . . 0.0 111.241 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.28 -47.72 55.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.882 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.62 -39.74 65.18 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.34 0.973 . . . . 0.0 110.796 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.39 -29.66 58.92 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.899 . . . . 0.0 112.267 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.55 -40.42 8.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.488 0.715 . . . . 0.0 111.934 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.94 -39.68 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.362 1.065 . . . . 0.0 111.355 -169.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 C--O 1.248 0.986 0 C-N-CA 123.953 0.901 . . . . 0.0 109.49 179.262 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 C--O 1.238 0.46 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 pt -134.15 -179.61 3.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -127.58 149.93 49.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -139.7 126.95 21.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 46.54 34.66 2.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.444 1.098 . . . . 0.0 112.303 -172.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.97 81.93 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.325 -0.86 . . . . 0.0 114.538 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.24 119.25 4.78 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.54 140.53 89.82 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.951 2.434 . . . . 0.0 111.331 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.1 152.93 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.389 1.076 . . . . 0.0 109.559 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -101.71 163.42 12.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.553 1.541 . . . . 0.0 110.307 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.3 mt -113.31 140.51 47.94 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.029 1.331 . . . . 0.0 108.319 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.4 t -75.35 -61.8 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.76 34.04 3.0 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.568 1.08 . . . . 0.0 113.371 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 52.76 -138.21 1.15 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.296 1.438 . . . . 0.0 110.132 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -135.79 132.23 36.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.479 1.112 . . . . 0.0 110.559 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.66 169.08 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 162.69 40.51 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -52.65 130.41 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.86 -3.76 83.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.745 -1.03 . . . . 0.0 114.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -84.31 -3.13 58.06 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.694 1.747 . . . . 0.0 112.726 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 61.65 171.2 0.12 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.4 1.88 . . . . 0.0 112.935 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -119.29 106.49 42.75 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.449 1.5 . . . . 0.0 108.56 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 144.86 99.08 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.393 2.062 . . . . 0.0 113.13 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.96 65.33 7.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.873 2.069 . . . . 0.0 110.937 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -97.47 158.12 15.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.448 170.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.91 163.77 27.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 112.983 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.29 134.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 168.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -76.26 155.18 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.5 p -123.1 174.05 7.47 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -46.49 -32.19 3.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.333 1.053 . . . . 0.0 112.127 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -113.82 15.89 18.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.111 1.364 . . . . 0.0 111.436 -171.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 53.03 45.01 29.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.773 2.029 . . . . 0.0 112.172 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.4 -12.4 58.97 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.311 12.8 pt-20 44.8 48.88 9.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.433 1.893 . . . . 0.0 111.714 -169.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -46.57 122.03 3.89 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.388 2.275 . . . . 0.0 108.646 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.37 146.35 40.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -39.58 57.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.012 0.824 . . . . 0.0 111.093 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.51 -18.84 21.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.35 -29.06 70.43 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.446 1.021 . . . . 0.0 111.241 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.6 mtt -70.62 -32.76 70.22 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.695 1.198 . . . . 0.0 111.701 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -64.39 133.98 53.68 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.64 -25.88 2.94 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.903 1.24 . . . . 0.0 112.168 -171.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -149.47 157.6 43.43 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.288 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.1 135.99 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.0 m -135.36 146.09 48.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.519 1.128 . . . . 0.0 108.165 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.87 135.84 54.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.02 135.8 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.8 p -115.02 151.27 34.5 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.4 t -134.77 133.01 54.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -137.09 146.42 54.46 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.555 1.142 . . . . 0.0 108.67 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.14 -34.14 23.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.527 2.151 . . . . 0.0 111.914 -176.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -143.29 154.23 43.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.758 1.623 . . . . 0.0 106.979 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 tp -90.64 -32.11 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.263 0.625 . . . . 0.0 111.471 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.77 -17.99 27.17 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.371 0.668 . . . . 0.0 112.232 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.3 p -65.74 163.96 15.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.1 1.36 . . . . 0.0 111.707 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.94 -24.2 33.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.937 1.256 . . . . 0.0 114.864 -171.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.45 -29.47 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.906 1.353 . . . . 0.0 112.203 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.6 t -51.74 -51.33 56.99 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.111 1.365 . . . . 0.0 110.762 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.42 -34.6 12.04 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.078 0.551 . . . . 0.0 111.523 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.24 70.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.752 0.821 . . . . 0.0 112.367 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.471 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.0 tm0? -152.62 -39.51 0.1 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-O 117.762 -1.114 . . . . 0.0 112.513 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -60.59 -42.67 97.18 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.177 1.353 . . . . 0.0 112.357 -169.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -56.45 -56.2 24.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.146 0.884 . . . . 0.0 110.469 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.65 -40.96 93.05 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.406 0.548 . . . . 0.0 111.05 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.471 ' CB ' HE21 ' A' ' 63' ' ' GLN . 25.5 t80 -56.48 -52.67 63.82 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.796 0.438 . . . . 0.0 110.785 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -67.52 -34.88 78.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.164 0.186 . . . . 0.0 111.259 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -64.61 -53.26 50.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.357 1.463 . . . . 0.0 109.763 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -63.53 -38.77 92.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.493 0.717 . . . . 0.0 109.456 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.84 78.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.521 0.728 . . . . 0.0 110.738 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.94 -27.09 67.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.083 0.553 . . . . 0.0 112.31 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -76.26 -24.17 54.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.185 175.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.9 mt -63.89 -40.84 97.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.678 1.126 . . . . 0.0 110.475 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.41 -169.43 42.55 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.35 19.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.155 1.382 . . . . 0.0 113.418 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.05 145.19 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.41 1.484 . . . . 0.0 110.923 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -70.43 144.82 51.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.27 132.69 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -145.54 156.75 43.9 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.885 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.5 m -136.1 116.72 13.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 173.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.95 142.22 14.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.711 1.605 . . . . 0.0 107.499 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -136.23 173.39 11.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 110.136 -170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.433 0.635 . . . . 0.0 109.944 169.069 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 131.47 50.41 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 173.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.6 73.25 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.158 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.88 3.08 1.39 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.028 1.331 . . . . 0.0 113.064 -169.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -85.0 144.53 28.23 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.47 -49.39 3.84 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.636 1.112 . . . . 0.0 110.856 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 pt -76.63 70.19 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 125.747 1.619 . . . . 0.0 109.435 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.61 -23.82 0.75 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.665 2.786 . . . . 0.0 114.961 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -62.37 -30.65 71.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.369 1.068 . . . . 0.0 111.997 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 t -74.57 156.89 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.98 0.912 . . . . 0.0 108.866 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.32 142.29 41.86 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -86.36 134.65 33.71 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -125.01 164.43 20.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.051 2.14 . . . . 0.0 106.724 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.51 169.9 17.45 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.161 0.984 . . . . 0.0 108.749 169.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -149.02 -17.77 0.3 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -58.77 -17.24 21.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.811 -1.181 . . . . 0.0 113.449 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -53.62 -30.04 40.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.452 1.101 . . . . 0.0 112.625 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -142.18 -6.9 0.93 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.549 1.068 . . . . 0.0 112.975 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.08 30.75 5.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.822 2.049 . . . . 0.0 112.714 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -65.29 0.68 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.785 1.634 . . . . 0.0 111.669 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.77 -34.5 75.97 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.684 0.794 . . . . 0.0 110.28 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.43 98.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 124.305 0.955 . . . . 0.0 112.783 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.38 -35.86 71.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.383 1.091 . . . . 0.0 109.946 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.21 74.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.26 2.46 11.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.468 1.507 . . . . 0.0 111.656 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.96 72.09 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 119.321 0.964 . . . . 0.0 112.399 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . 0.253 33.5 m -107.14 3.04 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.397 0.679 . . . . 0.0 111.429 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.65 105.67 12.07 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 124' ' ' LEU . 80.4 mt -67.61 127.85 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -66.37 -48.51 69.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.939 0.896 . . . . 0.0 111.109 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -80.27 -49.55 11.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.603 0.239 . . . . 0.0 110.574 -170.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.448 ' H ' HG22 ' A' ' 121' ' ' ILE . 18.4 tp -78.71 -18.16 54.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 112.084 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 45.14 52.02 8.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.384 1.474 . . . . 0.0 111.371 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.9 tp -139.25 168.93 18.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.04 138.14 47.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.463 0.574 . . . . 0.0 110.056 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.43 155.95 40.01 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.386 1.075 . . . . 0.0 110.737 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -84.66 109.96 18.39 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.0 m -149.88 168.18 24.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.722 0.409 . . . . 0.0 110.519 -173.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.13 147.1 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.599 1.16 . . . . 0.0 108.22 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -146.77 154.82 41.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.353 1.061 . . . . 0.0 109.036 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.92 140.37 40.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 171.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 mp -130.81 137.18 49.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.57 1.548 . . . . 0.0 107.337 -171.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.44 169.12 6.32 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.158 1.383 . . . . 0.0 109.855 169.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -49.58 -37.93 29.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.741 1.217 . . . . 0.0 112.174 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -75.29 -3.16 31.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.193 0.997 . . . . 0.0 112.677 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.1 -6.96 77.41 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.927 -1.108 . . . . 0.0 112.89 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 113.6 3.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 118.871 1.335 . . . . 0.0 108.365 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.4 129.73 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.27 -12.57 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.661 1.584 . . . . 0.0 109.925 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -151.47 150.15 30.07 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.434 1.093 . . . . 0.0 108.413 172.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.2 135.54 13.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.263 1.825 . . . . 0.0 107.168 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 150.28 30.99 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.451 0.7 . . . . 0.0 109.391 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -124.36 116.24 22.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.779 2.032 . . . . 0.0 105.637 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.24 128.68 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -60.05 -26.69 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.537 1.135 . . . . 0.0 113.268 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.01 105.66 6.46 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.7 66.29 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.124 1.37 . . . . 0.0 113.905 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.21 15.93 2.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.89 -175.63 3.84 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.005 2.122 . . . . 0.0 107.978 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -116.96 155.05 49.73 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.006 1.275 . . . . 0.0 112.689 -170.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.24 163.82 32.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -80.07 87.3 5.45 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 168.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -68.57 -5.72 21.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -71.3 -30.01 65.73 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.08 0.855 . . . . 0.0 109.302 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -63.9 -50.74 68.63 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.496 -1.24 . . . . 0.0 111.621 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.58 -32.46 48.29 Favored 'Trans proline' 0 C--N 1.35 0.622 0 CA-C-N 121.707 1.646 . . . . 0.0 112.111 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.5 mm -59.78 -44.82 94.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.998 1.272 . . . . 0.0 109.816 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.97 -37.15 86.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.262 0.937 . . . . 0.0 110.9 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.62 91.64 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.396 -0.19 . . . . 0.0 111.24 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.17 -46.49 70.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.59 173.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -53.78 -40.87 66.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.277 0.944 . . . . 0.0 110.545 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.0 65.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 112.204 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.9 mt -90.94 -41.81 10.93 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.954 0.502 . . . . 0.0 112.074 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.5 t -70.37 -42.43 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.952 0.901 . . . . 0.0 111.2 -171.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.035 0 C-N-CA 124.233 1.013 . . . . 0.0 109.594 179.319 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.11 174.45 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -112.19 151.57 29.39 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -133.52 116.55 16.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 172.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp 44.36 41.84 4.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.382 1.473 . . . . 0.0 111.69 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.32 5.0 80.23 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.59 116.74 4.13 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.319 174.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.61 84.37 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.291 2.66 . . . . 0.0 112.1 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.35 141.69 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.632 1.173 . . . . 0.0 110.402 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -82.01 162.11 22.74 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.208 1.803 . . . . 0.0 110.358 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.42 145.26 45.35 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.912 1.285 . . . . 0.0 108.118 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.3 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.182 0.593 . . . . 0.0 109.701 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.42 34.16 2.7 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.668 1.128 . . . . 0.0 113.677 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 52.27 -148.94 0.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.865 1.666 . . . . 0.0 112.435 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -123.96 116.3 22.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.029 1.732 . . . . 0.0 108.309 -169.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 m -72.43 171.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -144.08 164.01 31.88 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.79 138.16 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.56 -3.76 76.9 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.941 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.38 -15.54 61.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.145 1.472 . . . . 0.0 114.214 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.05 104.5 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.985 1.714 . . . . 0.0 111.159 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.24 131.79 90.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.651 0.78 . . . . 0.0 111.259 -175.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.59 149.51 81.86 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.764 2.309 . . . . 0.0 113.773 173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -77.31 67.93 3.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.321 1.848 . . . . 0.0 108.849 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.78 160.42 14.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.314 1.046 . . . . 0.0 109.134 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.8 163.89 27.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.997 1.319 . . . . 0.0 111.793 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.36 173.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 129.934 3.294 . . . . 0.0 105.02 168.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -131.53 139.51 49.28 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -86.68 176.02 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.555 0.616 . . . . 0.0 111.517 -172.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -60.91 -25.53 66.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.972 0.909 . . . . 0.0 110.331 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m -81.29 1.72 31.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.053 1.341 . . . . 0.0 111.646 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.8 mt 60.01 38.99 20.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 127.162 2.185 . . . . 0.0 111.893 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.08 160.75 27.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.756 0.823 . . . . 0.0 110.887 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.09 146.09 47.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.205 1.002 . . . . 0.0 110.576 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -147.42 157.79 43.72 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.442 2.697 . . . . 0.0 103.82 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -135.54 158.98 43.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.72 -25.91 63.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.81 66.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.396 1.453 . . . . 0.0 112.9 173.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.57 -27.09 58.46 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.868 0.758 . . . . 0.0 110.996 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.3 mtt -73.5 -34.98 65.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.214 1.006 . . . . 0.0 110.544 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -55.99 152.07 10.87 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.53 0.732 . . . . 0.0 110.413 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.44 33.22 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.134 1.35 . . . . 0.0 112.58 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -147.89 150.75 34.68 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.473 1.509 . . . . 0.0 108.022 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.37 142.27 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 m -135.69 147.58 48.57 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.328 1.051 . . . . 0.0 108.383 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.84 134.24 58.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -139.95 116.73 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -95.08 153.25 17.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -136.04 134.87 50.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.04 147.59 51.34 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.776 1.63 . . . . 0.0 108.299 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -38.73 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.519 2.146 . . . . 0.0 111.833 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -146.74 169.96 17.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.393 2.277 . . . . 0.0 105.916 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.263 0.0 OUTLIER -117.62 -15.58 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 122.673 0.389 . . . . 0.0 111.322 -175.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.36 -29.88 68.7 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.375 -0.828 . . . . 0.0 110.717 169.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.21 143.57 57.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.1 1.36 . . . . 0.0 110.764 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -17.34 50.81 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.535 1.064 . . . . 0.0 114.762 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -54.5 -25.24 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.788 1.294 . . . . 0.0 112.694 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.9 p -60.1 -32.93 71.45 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.939 0.79 . . . . 0.0 111.904 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.67 -28.21 6.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.752 0.821 . . . . 0.0 111.58 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.31 69.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.989 0.915 . . . . 0.0 112.428 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -152.6 -39.5 0.1 Allowed 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.749 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -57.84 -45.19 86.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.847 1.203 . . . . 0.0 111.897 -169.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -59.21 -52.32 66.19 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -60.48 -42.79 97.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.665 0.666 . . . . 0.0 111.076 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.6 -51.0 70.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.078 0.551 . . . . 0.0 110.661 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -66.48 -27.4 67.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.01 0.124 . . . . 0.0 111.078 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -65.67 -44.44 86.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.085 1.354 . . . . 0.0 110.082 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.8 -43.97 82.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.457 0.571 . . . . 0.0 110.206 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -45.62 77.62 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.93 -11.12 44.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.678 1.191 . . . . 0.0 113.237 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -118.68 -1.86 11.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.639 1.176 . . . . 0.0 113.828 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -60.18 -37.36 79.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.133 1.333 . . . . 0.0 109.493 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.98 -172.53 41.67 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 127.969 2.7 . . . . 0.0 106.942 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -75.82 27.66 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.362 1.081 . . . . 0.0 112.564 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.4 144.2 11.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 120.756 -1.215 . . . . 0.0 109.958 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.48 145.34 54.15 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.12 121.8 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -172.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -137.31 154.14 50.13 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.318 0.647 . . . . 0.0 111.327 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -130.62 105.69 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.72 131.56 33.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -129.2 173.17 10.73 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.266 1.827 . . . . 0.0 108.048 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.64 0.733 . . . . 0.0 110.363 169.583 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 3.3 p90 . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 p -54.94 -28.46 51.26 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.62 -12.18 55.7 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.593 1.088 . . . . 0.0 113.976 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.32 -10.37 4.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.049 1.74 . . . . 0.0 112.721 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -64.7 125.94 26.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.914 0.486 . . . . 0.0 111.358 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.76 -21.18 20.24 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.199 0.904 . . . . 0.0 112.46 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mt -84.85 -31.69 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.457 1.129 . . . . 0.0 110.514 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.41 -35.4 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 131.65 3.98 . . . . 0.0 116.341 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -66.78 -35.21 79.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.517 1.127 . . . . 0.0 111.571 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.86 150.8 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.632 1.173 . . . . 0.0 107.959 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.44 143.78 35.75 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 p -79.8 155.44 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.402 0.62 . . . . 0.0 109.523 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.1 mt -129.2 162.78 27.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.927 1.691 . . . . 0.0 107.312 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.5 m -137.17 44.58 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.572 1.549 . . . . 0.0 110.323 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -48.32 -36.03 13.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -169.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -50.82 -25.96 5.12 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.801 1.182 . . . . 0.0 114.182 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.7 ttt85 -60.19 -22.65 63.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.072 0.851 . . . . 0.0 112.376 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -127.79 -19.16 4.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.758 1.623 . . . . 0.0 111.955 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 58.25 11.54 1.62 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 129.928 3.291 . . . . 0.0 114.402 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.6 m -69.6 -42.81 73.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.456 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.25 -37.03 81.62 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.654 1.57 . . . . 0.0 109.379 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.35 -53.16 21.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.617 1.579 . . . . 0.0 112.865 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.11 -37.02 69.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.351 0.575 . . . . 0.0 110.477 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.84 -32.91 73.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.009 0.924 . . . . 0.0 112.911 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.35 1.04 13.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.648 1.179 . . . . 0.0 111.744 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.53 37.81 94.08 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 119.123 0.874 . . . . 0.0 112.047 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.37 -1.94 9.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.678 . . . . 0.0 110.91 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.87 106.1 5.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 168.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.9 mt -69.42 120.9 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -64.49 -43.13 95.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -89.07 -6.08 57.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -170.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -132.76 -13.23 2.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.582 0.753 . . . . 0.0 112.701 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.251 39.3 ptt180 41.65 43.44 2.37 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.711 1.604 . . . . 0.0 113.036 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 mt -124.98 172.54 9.33 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 170.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.85 140.02 45.46 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.885 0.874 . . . . 0.0 109.634 173.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.65 157.56 35.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.366 1.067 . . . . 0.0 110.793 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.16 112.12 19.96 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -153.76 167.05 30.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.78 147.18 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -143.61 155.27 44.22 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.305 1.442 . . . . 0.0 108.575 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.16 139.76 45.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -129.5 129.87 45.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.237 1.415 . . . . 0.0 108.334 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.28 166.71 9.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.015 0.926 . . . . 0.0 108.997 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -50.4 -31.03 13.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.754 174.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -81.84 -4.43 56.47 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.483 1.113 . . . . 0.0 113.217 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.86 62.9 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.209 -0.932 . . . . 0.0 111.596 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -86.55 118.09 25.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.56 114.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 170.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 p -97.44 -14.44 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.167 0.987 . . . . 0.0 109.886 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 152.32 32.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.274 1.029 . . . . 0.0 108.659 169.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.25 137.55 13.85 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.378 1.871 . . . . 0.0 107.251 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.21 149.97 31.85 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.187 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -123.71 114.52 20.05 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.39 135.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.3 m -58.64 -21.48 54.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.539 1.136 . . . . 0.0 113.509 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -140.08 129.6 24.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -53.83 -35.04 61.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -80.67 -6.93 59.07 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.516 1.053 . . . . 0.0 112.715 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.57 -173.67 4.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -137.89 156.33 74.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 110.104 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.38 168.29 16.67 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.836 2.357 . . . . 0.0 110.287 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -74.89 113.99 12.83 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -80.76 -6.71 58.86 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.11 -32.29 64.86 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 120.995 -1.065 . . . . 0.0 108.572 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -60.4 -51.32 80.9 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.147 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.14 -33.0 41.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.453 1.555 . . . . 0.0 112.747 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.2 mm -59.9 -47.47 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 120.455 1.479 . . . . 0.0 109.51 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.52 -38.88 92.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.027 0.83 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.78 92.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.324 0.249 . . . . 0.0 111.271 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.12 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.686 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -53.9 -41.64 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.069 0.849 . . . . 0.0 110.569 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.05 -30.45 64.27 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.571 0.749 . . . . 0.0 112.174 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 62.6 mt -90.43 -43.12 10.49 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.004 0.522 . . . . 0.0 111.68 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.6 t -71.49 -45.1 69.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.978 0.911 . . . . 0.0 111.331 -170.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.69 0.796 . . . . 0.0 109.642 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.243 0.741 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.8 pt -142.08 171.9 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 122.575 1.179 . . . . 0.0 110.366 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -109.96 157.41 19.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.51 113.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 45.51 43.95 9.4 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.66 1.584 . . . . 0.0 111.556 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 4.61 82.03 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.46 126.15 7.59 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 145.9 63.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.643 2.222 . . . . 0.0 110.148 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -136.39 179.48 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 108.778 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -127.54 158.98 35.98 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.5 mt -112.88 172.93 6.63 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.833 1.253 . . . . 0.0 109.35 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.74 149.82 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 56.99 19.09 29.02 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.925 1.726 . . . . 0.0 115.884 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -67.59 176.78 2.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.764 2.025 . . . . 0.0 114.976 -169.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.254 6.1 tt0 87.8 30.85 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.105 2.562 . . . . 0.0 113.325 169.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.16 143.44 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 168.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -149.45 165.19 32.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.872 1.269 . . . . 0.0 108.068 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 p -54.6 133.88 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.15 81.38 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.492 1.044 . . . . 0.0 113.806 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.71 -10.52 59.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.483 1.641 . . . . 0.0 114.177 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 71.37 127.71 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.463 1.905 . . . . 0.0 112.385 169.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.42 126.5 88.2 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.287 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -62.29 -30.31 81.03 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 114.147 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.6 t70 94.79 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 130.468 3.507 . . . . 0.0 106.838 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.04 174.2 10.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.821 2.049 . . . . 0.0 107.779 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 m -131.81 120.76 23.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -105.01 165.24 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.394 1.478 . . . . 0.0 107.506 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.07 143.32 38.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 p -76.58 179.29 6.06 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.087 0.955 . . . . 0.0 110.155 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.91 -24.46 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.162 -0.961 . . . . 0.0 111.114 168.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -89.93 3.79 52.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.784 2.034 . . . . 0.0 112.158 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 57.44 29.3 16.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.908 2.083 . . . . 0.0 113.188 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.24 144.48 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.61 142.23 42.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.469 0.708 . . . . 0.0 109.431 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -148.32 113.79 5.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 107.391 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 p -72.38 154.78 40.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.466 0.65 . . . . 0.0 109.321 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.52 -39.21 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.27 -25.69 15.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.101 0.961 . . . . 0.0 113.483 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.86 -28.5 55.45 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.791 1.178 . . . . 0.0 111.499 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.9 mtt -69.69 -30.93 68.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.045 0.938 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -57.76 152.61 15.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.526 0.679 . . . . 0.0 110.467 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.93 -8.23 38.94 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.482 1.039 . . . . 0.0 113.094 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -152.66 152.76 32.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.815 1.646 . . . . 0.0 107.861 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.21 144.93 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.8 m -136.01 148.15 48.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.399 1.08 . . . . 0.0 108.582 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.5 mt -130.62 137.74 55.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.5 mt -135.1 102.78 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -174.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -84.84 149.86 25.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -139.23 136.67 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -141.71 146.82 42.93 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.915 1.286 . . . . 0.0 109.316 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.48 -38.81 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.188 1.925 . . . . 0.0 111.496 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 p -162.77 148.66 12.34 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.26 1.424 . . . . 0.0 108.065 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.23 -19.33 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.652 0.781 . . . . 0.0 111.014 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.6 -26.17 68.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.342 1.057 . . . . 0.0 112.087 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 p -62.8 138.97 58.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.313 0.578 . . . . 0.0 110.686 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.63 -4.29 69.91 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.729 0.68 . . . . 0.0 113.392 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.86 -25.99 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.523 1.129 . . . . 0.0 111.968 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.78 -42.75 85.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.856 0.753 . . . . 0.0 111.83 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.35 -37.52 80.56 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.409 0.549 . . . . 0.0 110.134 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.21 72.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.407 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.7 tm0? -155.3 -53.6 0.09 Allowed 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -39.76 79.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.631 1.559 . . . . 0.0 114.486 -167.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -64.91 -48.91 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.536 1.517 . . . . 0.0 110.179 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -61.33 -49.16 78.11 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 118.846 0.748 . . . . 0.0 109.806 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.407 ' CB ' HE21 ' A' ' 63' ' ' GLN . 61.1 t80 -56.98 -48.64 77.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.259 0.624 . . . . 0.0 110.797 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -61.98 -39.68 93.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.511 0.724 . . . . 0.0 110.856 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.84 -38.83 80.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.124 0.97 . . . . 0.0 111.075 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.94 -45.16 71.47 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.201 0.91 . . . . 0.0 110.309 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.86 69.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.929 1.291 . . . . 0.0 110.856 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.93 -21.35 61.01 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.949 0.9 . . . . 0.0 113.127 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -120.13 7.67 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.41 -30.79 68.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.851 1.205 . . . . 0.0 111.626 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.65 -74.25 0.06 OUTLIER Glycine 0 C--N 1.336 0.551 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -162.91 110.16 1.23 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.48 155.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.889 1.276 . . . . 0.0 107.987 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -76.45 144.26 40.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.66 129.66 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.56 157.69 45.38 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.27 1.028 . . . . 0.0 110.08 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 45.6 m -127.13 98.02 5.15 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 mt -76.69 128.61 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 m -139.32 170.03 16.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.617 1.567 . . . . 0.0 108.862 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.98 0.895 . . . . 0.0 111.612 176.024 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.3 m -77.78 46.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.659 1.583 . . . . 0.0 114.024 -169.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -34.33 0.19 Allowed Glycine 0 C--N 1.333 0.397 0 O-C-N 121.276 -0.89 . . . . 0.0 112.486 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 16.73 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.56 1.144 . . . . 0.0 114.071 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -136.1 65.85 1.52 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.871 1.668 . . . . 0.0 107.177 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.76 -37.57 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.805 1.193 . . . . 0.0 111.016 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.22 89.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.24 -23.55 9.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.494 1.918 . . . . 0.0 113.983 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.37 -32.26 72.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.858 0.863 . . . . 0.0 112.29 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.92 147.05 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -148.99 145.27 27.24 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 p -80.41 151.71 29.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.394 0.616 . . . . 0.0 109.586 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.44 156.64 29.79 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.171 1.388 . . . . 0.0 107.695 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 m -120.45 46.44 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.629 1.972 . . . . 0.0 110.326 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -55.52 -32.1 62.63 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.967 -1.083 . . . . 0.0 113.217 -170.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -55.87 -17.26 5.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -58.37 -27.38 64.16 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.305 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -141.88 -3.35 1.12 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.801 1.182 . . . . 0.0 113.808 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.86 28.66 6.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.5 2.32 . . . . 0.0 113.802 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 m -59.33 -58.9 6.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.923 0.889 . . . . 0.0 110.773 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.97 -33.92 75.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.803 0.841 . . . . 0.0 109.792 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.19 -57.77 8.65 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 125.141 1.353 . . . . 0.0 112.08 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.4 -39.77 58.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.149 0.474 . . . . 0.0 110.15 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.17 85.6 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.99 3.07 30.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.916 1.286 . . . . 0.0 110.672 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.62 29.06 71.56 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 121.553 -0.717 . . . . 0.0 113.625 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.06 -1.73 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.107 0.963 . . . . 0.0 110.612 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.44 105.73 1.24 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.638 1.108 . . . . 0.0 108.086 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.38 115.89 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -57.36 -43.42 83.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 111.028 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -92.9 -4.62 52.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -169.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.79 -14.75 2.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.648 0.779 . . . . 0.0 112.402 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 48.92 40.4 16.6 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.84 1.656 . . . . 0.0 112.144 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 mt -126.27 173.9 8.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.73 126.97 31.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.394 1.478 . . . . 0.0 108.972 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 137.32 58.24 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.749 1.219 . . . . 0.0 110.637 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.55 108.63 0.85 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.322 1.049 . . . . 0.0 108.318 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.2 p -156.58 170.16 23.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.012 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.03 147.37 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -144.18 153.01 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.05 136.07 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.9 mp -129.56 133.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.728 1.211 . . . . 0.0 107.801 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.44 161.08 14.94 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.659 1.183 . . . . 0.0 109.825 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -33.14 -41.82 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.428 2.691 . . . . 0.0 115.413 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -91.1 -8.15 49.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.51 3.38 43.76 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.202 0.906 . . . . 0.0 113.567 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -71.47 118.69 14.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.85 1.825 . . . . 0.0 108.691 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.96 116.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 170.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.52 -15.41 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.294 1.038 . . . . 0.0 109.967 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -149.87 150.08 31.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 108.081 171.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.72 127.02 5.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.126 1.77 . . . . 0.0 106.93 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -149.23 149.83 31.6 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.031 0.832 . . . . 0.0 110.076 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.28 113.82 20.96 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.69 126.87 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.6 m -63.98 -2.6 2.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.66 1.184 . . . . 0.0 114.168 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -141.52 124.39 16.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.08 -31.0 66.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.768 1.227 . . . . 0.0 113.501 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.5 p -86.73 15.81 5.37 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.004 0.82 . . . . 0.0 111.771 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -127.53 179.44 5.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.468 1.507 . . . . 0.0 110.085 -174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -137.81 159.16 69.88 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.772 1.229 . . . . 0.0 110.592 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -89.4 -178.64 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.436 2.758 . . . . 0.0 110.55 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -75.53 94.14 3.11 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -72.45 -6.3 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.708 0.803 . . . . 0.0 112.913 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.67 -28.59 61.84 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 119.658 1.117 . . . . 0.0 108.982 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -61.1 -49.96 86.42 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.11 -33.86 59.85 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.53 1.582 . . . . 0.0 112.732 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.92 -45.85 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.348 1.431 . . . . 0.0 109.639 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.67 -38.84 92.64 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.412 1.006 . . . . 0.0 110.53 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.43 91.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.53 0.332 . . . . 0.0 111.207 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.29 61.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.981 0.513 . . . . 0.0 110.761 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.21 -39.45 69.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.059 0.845 . . . . 0.0 110.957 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.01 65.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.463 0.705 . . . . 0.0 111.89 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 63.1 mt -91.87 -43.89 9.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.353 0.524 . . . . 0.0 111.452 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.51 -39.6 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 0.0 110.767 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 mttp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 126.488 1.915 . . . . 0.0 110.069 -174.016 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.9 pt -133.62 179.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.655 0.74 . . . . 0.0 109.53 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -129.04 145.14 51.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -144.54 130.02 18.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 45.93 38.9 4.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.634 1.174 . . . . 0.0 112.175 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.44 26.32 73.54 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.274 -0.737 . . . . 0.0 114.374 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 139.91 11.33 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.22 144.74 42.34 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.369 2.046 . . . . 0.0 110.25 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.94 134.0 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.246 1.018 . . . . 0.0 109.767 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -81.2 166.22 20.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.618 1.967 . . . . 0.0 110.62 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.2 154.87 30.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.862 1.665 . . . . 0.0 109.539 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -85.65 -65.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.662 0.665 . . . . 0.0 110.24 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.63 4.22 86.38 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.68 0.657 . . . . 0.0 114.225 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 52.59 176.31 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.779 2.831 . . . . 0.0 116.45 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.93 113.51 3.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.591 1.956 . . . . 0.0 111.573 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.71 160.62 4.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -137.93 157.89 45.47 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.57 132.49 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.38 -2.1 87.43 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.667 -1.074 . . . . 0.0 114.279 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.57 -4.72 58.07 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.765 1.783 . . . . 0.0 112.596 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 59.16 177.2 0.08 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.561 1.544 . . . . 0.0 112.058 -169.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.09 135.29 21.08 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.287 1.835 . . . . 0.0 108.328 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 87.1 Cg_endo -72.23 156.4 55.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.179 1.919 . . . . 0.0 109.453 172.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 25.3 t70 -74.59 66.02 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.676 1.99 . . . . 0.0 110.66 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -61.33 155.21 21.88 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.295 1.438 . . . . 0.0 109.561 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 m -94.86 155.1 16.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.37 171.66 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.161 2.184 . . . . 0.0 106.955 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.9 mt -132.93 130.2 39.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -72.85 -176.89 2.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.697 1.199 . . . . 0.0 111.981 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -57.37 -32.35 66.7 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 110.485 169.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -85.62 2.98 42.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.867 1.667 . . . . 0.0 112.047 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt 52.22 36.82 20.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.507 1.923 . . . . 0.0 112.315 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -91.75 149.53 21.56 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.3 144.81 49.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.159 0.981 . . . . 0.0 110.148 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -153.97 159.15 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.45 2.7 . . . . 0.0 104.838 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 m -142.53 166.45 24.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 53.9 tp -49.79 -42.03 45.86 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.683 0.393 . . . . 0.0 111.311 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.56 -21.9 63.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.38 -30.25 60.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.821 0.737 . . . . 0.0 111.06 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.8 mtt -72.45 -37.39 68.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.566 1.146 . . . . 0.0 110.662 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -55.98 152.77 9.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.008 0.908 . . . . 0.0 111.517 -173.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.53 11.59 66.05 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.977 1.275 . . . . 0.0 113.251 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -154.17 148.21 25.71 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.559 1.544 . . . . 0.0 107.699 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.17 141.49 16.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.8 m -133.19 143.09 48.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 77' ' ' VAL . 74.1 mt -135.92 132.55 50.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -172.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -139.56 134.28 38.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -169.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.92 144.76 42.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 168.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 t -121.7 126.8 75.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.35 127.82 5.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -173.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.97 -41.98 71.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.261 1.974 . . . . 0.0 112.43 -169.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.7 t -157.5 145.98 19.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -17.82 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 122.438 0.295 . . . . 0.0 111.129 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.19 -21.37 63.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 112.672 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.5 p -59.15 -24.62 63.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.659 0.784 . . . . 0.0 112.431 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.54 -10.29 59.68 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.881 0.753 . . . . 0.0 112.144 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.93 -18.21 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 118.85 1.325 . . . . 0.0 110.069 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.6 p -51.77 -43.63 63.07 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.34 -41.13 63.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.849 0.749 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.23 -30.88 71.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 -173.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -146.76 -49.02 0.19 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.317 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 m -55.49 -45.32 77.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.643 1.11 . . . . 0.0 113.451 -167.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -48.8 80.22 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.703 0.683 . . . . 0.0 109.892 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.65 -45.94 73.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.843 0.747 . . . . 0.0 109.548 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.64 -53.49 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.432 0.693 . . . . 0.0 110.276 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -29.78 53.49 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -63.75 -55.32 24.11 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.334 1.054 . . . . 0.0 109.915 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.71 -37.35 87.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.6 0.76 . . . . 0.0 109.559 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.58 69.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.76 0.824 . . . . 0.0 110.799 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.79 68.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.467 0.307 . . . . 0.0 111.65 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -75.44 -22.74 57.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.007 -0.997 . . . . 0.0 112.641 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.57 -40.63 95.91 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.204 1.365 . . . . 0.0 110.944 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.47 -168.15 41.06 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -173.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -74.15 29.02 0.08 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.024 1.33 . . . . 0.0 113.311 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 48' ' ' ILE . 23.9 m -62.08 154.6 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.482 -1.386 . . . . 0.0 110.832 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.62 149.71 29.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.58 123.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -133.91 149.02 51.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.097 0.559 . . . . 0.0 111.396 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -127.81 99.09 5.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -84.67 130.48 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 m -142.95 172.99 11.95 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.013 1.325 . . . . 0.0 110.639 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 123.895 0.878 . . . . 0.0 111.5 177.804 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m0 . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 p -158.78 171.87 19.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.018 1.727 . . . . 0.0 108.371 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.76 -84.41 1.11 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.94 36.9 0.64 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 -172.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -139.66 137.96 35.68 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.019 1.328 . . . . 0.0 108.197 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.99 -14.18 65.01 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.01 0.814 . . . . 0.0 112.024 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.91 93.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 126.335 1.854 . . . . 0.0 106.269 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.27 -25.63 48.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.501 1.52 . . . . 0.0 113.196 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -55.59 -36.67 67.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.987 1.315 . . . . 0.0 112.694 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.2 t -70.86 147.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -129.55 141.92 50.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.2 p -87.44 136.81 32.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.9 146.08 46.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 m -121.65 51.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.742 1.217 . . . . 0.0 109.687 -168.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.21 -31.48 43.32 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -56.66 -21.68 29.2 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.941 1.701 . . . . 0.0 114.05 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -76.49 -6.23 50.91 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.146 -0.971 . . . . 0.0 112.551 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.17 -39.88 0.6 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.028 1.331 . . . . 0.0 112.44 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.75 4.29 3.9 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 130.054 3.342 . . . . 0.0 114.815 170.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -58.81 -44.51 90.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.259 -1.353 . . . . 0.0 111.957 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.06 -41.58 90.6 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 121.064 1.756 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.61 -43.11 96.35 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 123.996 0.808 . . . . 0.0 111.772 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -72.76 -46.72 51.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.271 0.536 . . . . 0.0 109.994 173.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 25' ' ' PRO . . . -58.99 -39.19 81.06 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.241 1.016 . . . . 0.0 112.532 -172.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.04 5.83 26.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.0 110.618 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.6 32.45 58.34 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.717 0.675 . . . . 0.0 113.563 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.35 -8.75 9.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 123.45 0.7 . . . . 0.0 110.097 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -68.96 111.32 4.91 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.32 128.13 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -66.87 -47.36 72.12 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 110.933 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -90.83 0.05 57.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 tp -129.82 -13.55 4.14 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.629 1.172 . . . . 0.0 111.591 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 47.15 47.91 16.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.922 1.689 . . . . 0.0 111.193 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.3 tp -139.88 156.88 46.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.468 1.107 . . . . 0.0 108.206 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.08 131.24 45.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.326 0.65 . . . . 0.0 109.519 173.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.85 164.32 25.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.993 1.317 . . . . 0.0 112.407 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -86.03 113.5 22.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.5 m -148.14 173.53 12.87 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.709 0.804 . . . . 0.0 109.681 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 144.7 17.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.886 1.274 . . . . 0.0 108.454 177.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -148.34 158.87 44.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.573 1.149 . . . . 0.0 109.998 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.04 140.65 40.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mp -131.75 135.73 47.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.235 1.414 . . . . 0.0 107.591 -173.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.35 166.67 7.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 110.04 169.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.32 -31.96 23.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.116 1.367 . . . . 0.0 113.012 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -80.91 -0.86 41.06 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.432 1.093 . . . . 0.0 112.67 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.12 -6.75 82.76 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.625 1.107 . . . . 0.0 112.608 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.2 124.9 22.37 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.719 1.259 . . . . 0.0 109.232 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.81 128.24 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.737 0.815 . . . . 0.0 110.112 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.79 -19.51 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 109.917 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -145.08 147.05 32.13 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.81 131.94 12.69 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.037 1.335 . . . . 0.0 108.237 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.26 149.66 31.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.606 0.762 . . . . 0.0 109.365 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -128.06 117.19 21.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.823 2.049 . . . . 0.0 105.55 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.5 125.32 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -59.09 -25.02 63.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.693 1.197 . . . . 0.0 112.86 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -134.58 100.77 4.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.09 66.64 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.563 1.145 . . . . 0.0 112.757 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.82 8.7 2.26 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.652 1.181 . . . . 0.0 112.422 170.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.68 162.48 30.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.252 1.821 . . . . 0.0 108.699 173.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -90.12 145.46 32.98 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.69 166.55 29.09 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.991 2.461 . . . . 0.0 111.579 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -85.44 139.39 31.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -104.07 -8.73 19.3 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.39 -39.29 59.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -51.36 -58.03 12.12 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.987 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.94 -34.41 23.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 121.493 1.569 . . . . 0.0 112.393 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 mm -59.58 -42.66 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.142 1.337 . . . . 0.0 109.998 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.39 -36.96 84.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.413 1.006 . . . . 0.0 110.716 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.45 87.24 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.376 -0.202 . . . . 0.0 110.884 175.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.59 -40.73 69.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.623 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.91 -40.65 76.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.92 1.236 . . . . 0.0 110.26 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.81 66.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.177 0.591 . . . . 0.0 112.317 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.09 -60.37 2.32 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.961 0.504 . . . . 0.0 110.46 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.39 -45.04 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.145 1.378 . . . . 0.0 111.905 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm . . . . . 0 C--O 1.25 1.094 0 C-N-CA 126.802 2.041 . . . . 0.0 110.936 -176.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 pt -131.43 171.82 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 123.18 1.467 . . . . 0.0 110.37 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -115.82 153.95 30.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -140.29 122.79 16.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.17 39.13 1.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.365 1.466 . . . . 0.0 113.492 -171.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.33 6.18 89.47 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.674 -0.641 . . . . 0.0 114.396 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.77 125.42 7.93 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.185 1.374 . . . . 0.0 109.863 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.76 141.17 48.68 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 CA-C-N 120.995 2.397 . . . . 0.0 110.062 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.57 138.96 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.777 0.831 . . . . 0.0 109.844 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -86.02 155.59 20.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.119 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mt -118.9 153.38 34.66 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.194 1.398 . . . . 0.0 107.94 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.87 -15.58 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.58 33.8 0.45 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.971 0.805 . . . . 0.0 111.79 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -51.74 151.15 3.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.401 0.681 . . . . 0.0 112.209 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.262 8.6 tt0 108.44 23.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 129.242 3.017 . . . . 0.0 112.727 169.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.68 141.21 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -148.7 165.47 31.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.101 0.96 . . . . 0.0 109.167 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 p -54.01 132.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.02 -0.2 89.93 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.081 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.66 -12.04 59.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.546 1.673 . . . . 0.0 112.545 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 59.68 167.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.449 1.9 . . . . 0.0 113.101 -171.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.04 128.25 31.31 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.351 1.46 . . . . 0.0 108.466 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.39 -25.06 63.92 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.304 2.669 . . . . 0.0 114.428 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 66.81 100.67 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.995 2.518 . . . . 0.0 112.441 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -142.46 172.34 12.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.522 1.529 . . . . 0.0 109.274 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -89.21 154.38 20.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.76 1.224 . . . . 0.0 111.427 -169.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.83 164.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 128.087 2.555 . . . . 0.0 104.995 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 tp -116.85 140.4 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.11 168.12 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.23 -24.65 66.51 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.736 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -80.33 0.65 32.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.976 1.71 . . . . 0.0 112.011 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.6 mt 64.83 44.32 3.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.097 2.159 . . . . 0.0 111.946 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -119.73 145.98 46.04 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.26 1.024 . . . . 0.0 108.886 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.42 139.4 45.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.674 0.79 . . . . 0.0 109.312 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -142.01 102.18 4.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 m -71.03 153.59 42.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -58.94 -30.85 68.18 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.169 -0.957 . . . . 0.0 110.863 170.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.07 8.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.397 1.479 . . . . 0.0 113.286 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.06 -28.12 35.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.991 0.916 . . . . 0.0 111.676 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.2 mtt -72.41 -48.56 40.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.129 0.971 . . . . 0.0 110.496 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.36 171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.966 0.888 . . . . 0.0 110.291 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 -15.2 48.19 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.451 1.5 . . . . 0.0 110.575 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -153.02 159.81 42.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.542 2.737 . . . . 0.0 106.29 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.4 144.29 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 m -132.74 149.37 52.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.207 1.003 . . . . 0.0 109.551 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.5 138.64 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.3 mt -139.49 113.68 7.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 m -89.32 144.95 25.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.31 134.81 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 pt -147.67 159.39 41.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 107.928 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.02 -52.24 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 N-CA-C 108.513 -1.38 . . . . 0.0 108.513 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 m -150.9 146.72 26.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.703 1.601 . . . . 0.0 108.643 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -20.7 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 111.047 171.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -60.1 -14.25 15.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.14 0.976 . . . . 0.0 113.319 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 p -56.65 -27.47 58.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.641 0.776 . . . . 0.0 111.866 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.43 4.67 84.79 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.167 0.889 . . . . 0.0 112.266 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.02 -13.88 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 119.065 1.433 . . . . 0.0 111.976 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.6 m -57.75 -47.47 82.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.118 0.967 . . . . 0.0 110.539 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.38 -28.83 64.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.318 0.647 . . . . 0.0 111.35 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.82 -59.5 5.05 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -161.51 -14.22 0.04 OUTLIER 'General case' 0 C--N 1.341 0.203 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -69.59 -31.01 68.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.283 1.401 . . . . 0.0 112.825 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -61.88 -50.57 71.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.269 0.941 . . . . 0.0 108.841 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -62.37 -48.05 81.45 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.587 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.15 -50.75 71.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.641 0.777 . . . . 0.0 110.562 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -68.46 -33.03 73.46 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.388 -0.195 . . . . 0.0 110.757 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.7 -42.03 78.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 111.426 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.33 -44.92 96.4 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.397 0.998 . . . . 0.0 109.678 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.02 -38.58 70.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.441 0.696 . . . . 0.0 111.402 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.89 -5.71 22.88 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -116.02 -12.3 11.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.689 1.596 . . . . 0.0 112.66 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -57.88 -32.47 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.643 1.11 . . . . 0.0 111.64 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.91 -159.69 32.88 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.61 22.21 0.14 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.469 -1.018 . . . . 0.0 112.386 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 77' ' ' VAL . 2.8 t -54.82 134.83 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.979 1.712 . . . . 0.0 108.817 -171.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.79 135.85 53.26 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -144.08 133.22 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -170.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.72 162.4 35.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.616 0.766 . . . . 0.0 110.926 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.8 m -133.03 124.46 27.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.22 133.27 53.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -141.12 169.09 18.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.152 0.981 . . . . 0.0 110.484 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 112.003 174.718 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.9 p90 . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.185 0.516 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.93 -28.58 13.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.33 -65.52 1.85 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.95 34.29 0.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.365 1.066 . . . . 0.0 111.981 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -67.18 -5.37 13.34 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.991 1.316 . . . . 0.0 114.272 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.32 -17.81 1.89 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.132 1.825 . . . . 0.0 109.376 -169.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.22 91.8 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.4 -27.44 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -66.75 -22.16 66.05 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.073 0.949 . . . . 0.0 112.256 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 t -91.37 154.09 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.3 147.43 47.45 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.9 m -104.14 138.98 39.84 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.6 mp -118.44 160.97 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.108 1.763 . . . . 0.0 108.233 -170.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.7 54.31 1.88 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.231 1.412 . . . . 0.0 108.776 -168.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.13 -24.92 57.55 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -56.39 -19.73 16.2 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 120.299 1.409 . . . . 0.0 112.895 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -81.64 -4.3 55.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.857 1.263 . . . . 0.0 112.845 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -141.87 -41.98 0.35 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.032 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.44 -3.07 1.41 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 129.529 3.132 . . . . 0.0 114.83 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -64.91 -45.76 84.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.586 1.539 . . . . 0.0 110.691 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.25 -42.66 95.77 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.18 0.9 . . . . 0.0 110.51 174.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.87 96.28 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.82 -43.74 92.15 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.521 0.66 . . . . 0.0 109.707 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.78 -47.06 86.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.583 0.753 . . . . 0.0 112.188 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -83.8 -1.9 55.24 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.093 0.957 . . . . 0.0 111.504 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.31 38.04 95.32 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.402 -0.666 . . . . 0.0 111.936 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.2 -0.2 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.292 1.437 . . . . 0.0 110.584 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -76.82 114.88 16.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.28 113.0 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -59.15 -40.95 87.1 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.285 1.034 . . . . 0.0 110.595 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -91.72 -4.46 55.05 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 tp -140.51 -0.38 1.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.027 0.831 . . . . 0.0 113.178 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 43.28 41.51 3.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.697 1.999 . . . . 0.0 114.431 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -132.06 167.94 18.83 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.861 0.865 . . . . 0.0 108.847 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.72 134.48 47.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 162.78 15.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.332 1.453 . . . . 0.0 111.22 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.406 ' CB ' ' HA ' ' A' ' 149' ' ' ALA . 16.9 tpt180 -88.75 116.98 27.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -159.88 171.32 19.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.216 0.531 . . . . 0.0 110.096 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 t -143.5 142.15 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -141.18 155.33 46.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 109.442 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -137.42 135.67 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 42.8 mt -122.51 136.76 54.96 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.36 175.64 5.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.977 0.894 . . . . 0.0 110.208 169.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -56.88 -11.33 1.39 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.913 1.685 . . . . 0.0 114.897 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.96 14.83 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.487 1.494 . . . . 0.0 112.359 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.46 -1.87 67.12 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.418 1.009 . . . . 0.0 113.267 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -65.64 118.05 8.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.294 1.547 . . . . 0.0 108.114 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.06 110.95 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 p -91.73 -16.59 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 109.536 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -150.64 151.45 32.53 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.013 1.325 . . . . 0.0 107.504 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.96 132.94 9.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 107.149 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -142.02 150.01 40.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.636 0.653 . . . . 0.0 110.472 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -122.83 111.23 16.42 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 127.226 2.21 . . . . 0.0 105.041 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 t -72.5 140.04 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -58.94 -21.62 58.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.656 1.182 . . . . 0.0 113.892 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.42 134.07 30.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.406 ' HA ' ' CB ' ' A' ' 129' ' ' ARG . . . -56.3 -31.64 63.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.9 p -83.78 -6.73 59.5 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.317 0.962 . . . . 0.0 112.606 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -93.6 179.95 5.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.886 1.274 . . . . 0.0 109.921 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -133.92 157.36 77.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.256 1.422 . . . . 0.0 110.898 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.72 -176.87 3.1 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.166 2.578 . . . . 0.0 110.188 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -69.74 138.06 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -82.53 -9.32 59.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -107.22 -32.28 7.86 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.077 0.853 . . . . 0.0 110.887 -169.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -52.47 -49.14 87.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 -36.33 21.13 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 CA-C-N 121.631 1.618 . . . . 0.0 111.43 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.76 -45.36 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.476 0.71 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.83 -34.01 75.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 120.081 1.309 . . . . 0.0 110.498 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.61 91.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.482 0.313 . . . . 0.0 111.18 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.81 -47.34 59.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.075 174.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -55.91 -37.93 69.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.258 0.936 . . . . 0.0 110.901 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.8 -29.31 54.2 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.625 0.77 . . . . 0.0 112.005 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.6 mt -95.87 -43.84 7.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.681 0.792 . . . . 0.0 112.194 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.7 t -73.71 -43.82 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 111.57 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 C--O 1.249 1.074 0 C-N-CA 124.108 0.963 . . . . 0.0 109.676 179.875 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--O 1.237 0.412 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 pt -140.37 179.09 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 122.012 0.91 . . . . 0.0 109.458 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -126.36 156.82 39.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.01 1.724 . . . . 0.0 106.632 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -147.45 128.33 14.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 43.31 40.92 2.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.827 1.251 . . . . 0.0 112.924 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 24.22 69.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.364 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 136.81 8.92 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.49 146.25 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.26 1.973 . . . . 0.0 109.904 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.67 150.17 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.272 1.029 . . . . 0.0 109.291 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.5 m -98.62 163.09 12.8 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.961 1.304 . . . . 0.0 108.902 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.18 170.44 8.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.936 1.295 . . . . 0.0 109.239 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.36 133.07 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.55 -13.75 66.57 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.858 0.742 . . . . 0.0 114.202 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 53.44 167.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.935 3.294 . . . . 0.0 117.71 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.43 137.08 43.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.925 2.89 . . . . 0.0 112.639 -168.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.53 153.1 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.81 170.55 18.5 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 121.16 -0.962 . . . . 0.0 109.781 -171.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -50.12 131.92 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.372 0.669 . . . . 0.0 110.769 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.87 79.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.595 1.093 . . . . 0.0 113.502 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -94.32 6.88 47.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.259 1.529 . . . . 0.0 113.516 -169.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 57.85 111.95 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.218 2.207 . . . . 0.0 114.915 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.33 89.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.876 169.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.03 -46.83 14.3 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.586 2.191 . . . . 0.0 113.49 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 121.57 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 1 C-N-CA 131.73 4.012 . . . . 0.0 105.451 -169.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.76 168.03 19.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.632 1.573 . . . . 0.0 109.067 -175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 m -122.27 146.15 47.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.751 1.22 . . . . 0.0 107.803 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.91 164.32 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.908 2.083 . . . . 0.0 107.731 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.3 mt -100.43 141.36 33.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -71.79 173.67 7.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.406 1.482 . . . . 0.0 110.941 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -67.49 -8.84 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.538 -0.726 . . . . 0.0 111.723 169.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.3 m -97.01 4.4 51.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.22 1.408 . . . . 0.0 111.835 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.97 51.98 13.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.388 1.875 . . . . 0.0 111.633 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.59 152.45 41.87 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -72.42 143.24 48.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.938 0.875 . . . . 0.0 110.301 -175.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -147.46 158.22 43.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.355 2.662 . . . . 0.0 105.73 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 p -137.25 166.64 23.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -55.47 -40.09 71.2 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 171.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -24.16 61.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.17 -33.08 50.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.924 0.784 . . . . 0.0 111.345 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.4 mtt -70.58 -36.35 73.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.426 1.09 . . . . 0.0 111.018 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -53.49 146.87 11.87 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.976 0.91 . . . . 0.0 110.784 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -17.79 11.43 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.106 1.336 . . . . 0.0 112.73 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -149.04 155.7 41.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.265 1.426 . . . . 0.0 108.87 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.2 136.94 19.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 76.8 m -133.19 145.0 50.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.22 134.31 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.0 mt -135.23 108.12 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 m -86.42 152.07 23.01 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 134.45 53.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 pt -144.06 154.88 58.62 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.001 1.72 . . . . 0.0 108.074 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.88 -44.04 6.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.906 1.737 . . . . 0.0 111.262 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 t -151.2 170.88 18.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.281 1.832 . . . . 0.0 107.344 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 56' ' ' ASP . 2.0 pp -96.47 -20.16 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.482 1.113 . . . . 0.0 109.387 168.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' N ' HD12 ' A' ' 55' ' ' ILE . 34.4 t70 -81.71 -25.89 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.91 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -61.51 -17.6 55.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.057 1.343 . . . . 0.0 112.551 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.69 84.37 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.032 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.23 -18.42 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.096 1.448 . . . . 0.0 112.245 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 m -64.78 -16.42 63.02 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.548 1.139 . . . . 0.0 113.361 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.79 -20.49 57.09 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.503 1.121 . . . . 0.0 112.938 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.44 32.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.751 1.221 . . . . 0.0 108.72 171.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? 61.34 -65.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.686 2.394 . . . . 0.0 114.579 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.46 -48.36 81.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.351 1.432 . . . . 0.0 114.649 -167.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -64.81 -52.32 57.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.175 1.352 . . . . 0.0 109.537 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.87 -45.88 89.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 110.464 -173.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -56.4 -53.46 57.08 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.321 1.048 . . . . 0.0 110.988 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -72.19 -34.54 68.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.148 0.431 . . . . 0.0 111.033 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.74 -39.19 80.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.888 0.875 . . . . 0.0 109.63 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.62 -45.23 76.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.774 0.829 . . . . 0.0 109.925 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.17 80.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.434 1.093 . . . . 0.0 110.943 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.96 -15.4 43.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.039 0.936 . . . . 0.0 113.082 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -95.58 -16.08 22.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.91 0.884 . . . . 0.0 112.373 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.78 -37.71 87.76 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.757 1.162 . . . . 0.0 110.846 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.47 -172.26 44.81 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.463 1.982 . . . . 0.0 108.269 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -77.71 36.06 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.0 0.92 . . . . 0.0 112.809 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.8 m -56.82 146.38 6.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 120.759 -1.213 . . . . 0.0 110.824 -177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -76.93 138.63 39.81 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.58 121.65 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.24 157.14 47.53 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.693 0.797 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 m -134.3 108.01 7.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.1 mt -91.01 138.3 19.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.8 m -137.5 172.56 12.79 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.705 2.002 . . . . 0.0 109.947 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.822 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.9 m -130.32 146.65 51.94 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.097 1.359 . . . . 0.0 109.752 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.77 -45.59 1.92 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.618 1.58 . . . . 0.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.58 36.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.308 2.243 . . . . 0.0 112.616 172.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.88 23.52 2.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.95 2.1 . . . . 0.0 110.531 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.89 -20.34 0.19 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.236 0.922 . . . . 0.0 111.485 -171.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.45 84.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.53 -27.31 48.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.637 1.175 . . . . 0.0 113.606 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -62.88 -32.84 74.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.0 112.416 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.81 146.54 11.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.32 136.22 27.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 p -80.39 141.34 35.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -128.25 155.79 44.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.541 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -124.19 133.87 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.31 -16.85 12.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.596 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -63.17 -11.37 20.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -51.2 -37.32 46.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.422 169.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -148.28 -5.15 0.45 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.7 mmm 56.19 26.86 10.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.773 1.629 . . . . 0.0 112.671 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 m -58.91 -55.34 36.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.869 0.867 . . . . 0.0 111.021 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -63.41 -41.66 98.74 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.068 0.547 . . . . 0.0 109.735 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.94 -47.97 88.04 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 119.339 -0.7 . . . . 0.0 111.396 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.68 -45.31 68.6 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.832 0.816 . . . . 0.0 109.805 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.8 67.76 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.86 0.864 . . . . 0.0 113.097 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -112.39 3.2 16.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.942 1.297 . . . . 0.0 111.544 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.74 33.34 85.7 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 119.591 1.087 . . . . 0.0 112.92 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.8 m -115.13 -2.69 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.358 1.063 . . . . 0.0 111.021 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -69.63 108.74 3.98 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.22 128.78 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -65.77 -46.75 77.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.498 1.119 . . . . 0.0 111.245 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.47 -56.84 3.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.07 0.395 . . . . 0.0 110.391 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.62 -19.94 64.27 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.837 0.455 . . . . 0.0 112.078 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 53.83 38.92 29.66 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 110.967 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 mt -136.87 170.63 15.76 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.566 1.146 . . . . 0.0 108.649 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.14 133.67 41.44 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.15 154.54 41.88 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.612 0.765 . . . . 0.0 111.544 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.4 tpt85 -71.8 117.61 13.6 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -160.74 170.44 20.76 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.352 0.978 . . . . 0.0 108.488 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.49 146.41 17.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 118.741 0.701 . . . . 0.0 109.278 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -144.75 156.02 43.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.229 1.412 . . . . 0.0 109.21 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.404 ' C ' HD12 ' A' ' 134' ' ' LEU . 60.7 t -136.32 140.91 42.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 133' ' ' VAL . 9.1 mp -133.26 139.0 46.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.169 1.388 . . . . 0.0 108.79 -169.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.62 166.71 8.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.228 1.811 . . . . 0.0 109.941 169.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.28 -32.01 35.44 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 112.664 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -80.64 -2.99 48.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.582 1.153 . . . . 0.0 112.707 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.53 89.18 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.31 0.957 . . . . 0.0 112.724 -174.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -68.07 124.78 24.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.312 1.556 . . . . 0.0 108.285 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.84 132.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.99 -9.87 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.919 1.288 . . . . 0.0 110.956 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 150.94 30.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.175 0.99 . . . . 0.0 108.51 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.16 137.61 15.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.373 1.869 . . . . 0.0 107.457 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.0 143.93 30.76 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.32 105.47 7.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.546 -2.391 . . . . 0.0 104.546 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.6 144.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.158 -0.339 . . . . 0.0 110.416 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 m -62.22 -20.58 64.36 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.671 0.788 . . . . 0.0 112.007 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -144.48 122.88 12.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.77 65.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.965 1.306 . . . . 0.0 113.466 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.92 16.35 2.88 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.06 0.944 . . . . 0.0 111.55 173.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.73 161.3 35.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.025 2.53 . . . . 0.0 106.638 172.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -122.6 149.92 56.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 119.342 0.974 . . . . 0.0 112.468 -169.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.77 162.79 29.51 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.454 2.769 . . . . 0.0 112.247 -177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -70.94 112.85 7.43 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -75.39 -11.97 60.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.23 -32.91 69.34 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.923 1.238 . . . . 0.0 109.022 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -60.39 -53.36 65.45 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 117.533 -1.222 . . . . 0.0 112.063 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.37 -31.62 42.65 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-N 121.96 1.736 . . . . 0.0 112.256 172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.22 -42.73 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 120.169 1.35 . . . . 0.0 109.757 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.501 1.046 . . . . 0.0 110.937 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.15 93.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.68 0.218 . . . . 0.0 110.92 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.71 77.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.398 174.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -55.44 -43.73 75.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.069 0.85 . . . . 0.0 110.395 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.99 -31.48 66.97 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.081 0.552 . . . . 0.0 112.085 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.35 -46.95 11.22 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.767 0.427 . . . . 0.0 111.801 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.71 -50.0 47.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 123.971 0.908 . . . . 0.0 111.745 -169.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.65 -171.895 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.756 0.312 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.79 179.04 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.004 0.921 . . . . 0.0 109.677 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 148.6 45.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -141.88 127.62 19.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 44.88 35.84 1.66 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.444 1.098 . . . . 0.0 112.397 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.98 21.47 78.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 121.393 -0.817 . . . . 0.0 114.294 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.68 8.82 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.44 139.93 35.59 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.355 2.037 . . . . 0.0 110.083 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.35 154.59 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.479 1.112 . . . . 0.0 109.186 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -109.11 158.93 17.31 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.075 1.35 . . . . 0.0 107.841 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.29 158.46 22.34 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.093 0.86 . . . . 0.0 109.247 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.35 -18.33 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.59 33.57 0.63 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.816 0.735 . . . . 0.0 111.329 -174.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -50.79 151.31 2.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.7 1.2 . . . . 0.0 113.069 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.252 10.7 tt0 93.19 30.07 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.306 2.643 . . . . 0.0 112.26 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.14 144.24 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -148.88 160.61 43.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.83 131.46 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.395 0.678 . . . . 0.0 109.648 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.55 82.1 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.04 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.55 -6.5 59.47 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.554 1.677 . . . . 0.0 112.596 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.72 176.21 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.965 1.706 . . . . 0.0 112.451 -169.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.1 129.13 18.84 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 126.711 2.004 . . . . 0.0 107.723 -170.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.83 150.64 61.64 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.184 1.922 . . . . 0.0 112.133 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 23.6 t0 -75.8 68.66 2.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.288 1.835 . . . . 0.0 110.314 173.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -60.37 162.81 5.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.162 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -123.51 143.48 50.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.12 170.68 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.545 1.938 . . . . 0.0 108.703 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.4 119.49 22.8 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 125.47 1.508 . . . . 0.0 107.019 -170.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -73.97 173.25 10.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.543 1.137 . . . . 0.0 111.977 -171.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -21.88 66.16 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.086 -1.009 . . . . 0.0 111.226 170.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -80.76 0.19 35.78 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.727 1.611 . . . . 0.0 111.972 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.1 mt 55.27 52.84 10.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.955 2.102 . . . . 0.0 111.719 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.8 153.13 42.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 108.801 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.3 143.5 42.93 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.427 0.691 . . . . 0.0 109.325 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -150.26 160.26 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.252 2.221 . . . . 0.0 105.959 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 p -144.15 167.6 22.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.459 -0.775 . . . . 0.0 109.381 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 57.4 tp -53.98 -42.23 68.77 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 172.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.74 65.12 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.06 -30.7 55.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.886 0.766 . . . . 0.0 111.013 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.1 mtt -72.14 -40.31 68.17 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.446 1.098 . . . . 0.0 110.546 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -53.06 131.88 37.14 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.7 -23.29 4.0 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.009 1.29 . . . . 0.0 112.334 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -151.75 157.78 42.47 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.39 1.076 . . . . 0.0 109.415 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -56.83 140.86 14.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -134.75 146.79 49.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.899 0.88 . . . . 0.0 108.924 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.6 mt -136.46 135.71 49.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.7 mt -137.05 128.62 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -170.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -107.71 143.36 36.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.16 143.32 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.18 -0.95 . . . . 0.0 108.437 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 pt -144.5 161.36 44.38 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.781 2.032 . . . . 0.0 108.163 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -48.04 2.15 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.573 1.515 . . . . 0.0 110.631 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -162.55 156.72 21.21 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.074 1.35 . . . . 0.0 107.36 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.72 -30.72 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.981 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.81 -13.85 57.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 0.0 112.081 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -62.71 -20.47 64.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.276 0.631 . . . . 0.0 111.416 175.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 -25.57 3.8 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 124.31 0.957 . . . . 0.0 112.769 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 57' ' ' THR . 4.6 t -64.48 -17.03 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 119.019 1.409 . . . . 0.0 111.594 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.9 p -74.72 -30.07 61.4 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 120.768 -1.207 . . . . 0.0 111.558 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.5 -38.72 40.09 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.448 1.022 . . . . 0.0 109.839 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.63 67.17 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -136.28 -62.71 0.66 Allowed 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.676 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -57.76 -35.43 70.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.341 1.428 . . . . 0.0 113.159 -168.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -27.95 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 118.06 -0.972 . . . . 0.0 112.447 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -103.41 -48.93 3.84 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.842 1.201 . . . . 0.0 109.94 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -51.92 -49.17 63.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 119.497 1.044 . . . . 0.0 111.249 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -79.95 -23.89 41.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.189 -0.319 . . . . 0.0 111.223 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.7 -43.25 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.422 0.689 . . . . 0.0 110.12 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -64.3 -45.63 87.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.818 1.247 . . . . 0.0 108.919 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.87 68.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.556 1.142 . . . . 0.0 110.435 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -9.93 23.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.212 1.005 . . . . 0.0 113.092 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.2 -1.38 10.86 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.6 -34.13 77.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.227 1.376 . . . . 0.0 109.146 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.35 -169.83 40.33 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.494 1.997 . . . . 0.0 108.66 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.96 17.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 113.01 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.53 149.46 5.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.235 1.814 . . . . 0.0 111.272 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -68.75 144.14 54.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 123.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.59 152.8 48.47 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.054 0.542 . . . . 0.0 110.754 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -124.18 143.14 50.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.2 mt -127.4 135.99 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -135.49 168.19 19.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.325 1.45 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 121.834 0.826 . . . . 0.0 111.406 172.948 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.8 t90 . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.1 p 30.04 -90.19 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.147 2.979 . . . . 0.0 114.149 174.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.25 -21.28 46.79 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.389 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.58 11.03 9.15 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.051 1.426 . . . . 0.0 111.754 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -60.12 -27.81 67.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.0 25.3 0.71 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -173.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.88 91.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.71 -28.93 58.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.462 1.505 . . . . 0.0 113.477 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.7 -17.56 64.7 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -75.99 155.82 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.163 0.892 . . . . 0.0 109.975 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.72 151.68 49.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.2 m -118.1 139.82 50.67 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.93 155.12 30.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.72 0.808 . . . . 0.0 110.094 -172.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -126.57 43.15 3.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.137 1.775 . . . . 0.0 109.139 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -46.13 -41.75 12.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 114.201 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -57.62 -17.58 15.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.275 1.03 . . . . 0.0 113.672 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -61.59 -24.84 66.95 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.004 -1.06 . . . . 0.0 111.832 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -128.39 -28.4 2.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.833 1.653 . . . . 0.0 112.034 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.0 tpt 75.04 10.8 3.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.403 2.681 . . . . 0.0 113.911 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.45 -53.14 61.54 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.846 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.4 -39.62 91.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.193 1.361 . . . . 0.0 109.906 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -50.06 -53.16 24.07 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 125.537 1.541 . . . . 0.0 112.478 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.76 -40.95 63.1 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.053 0.427 . . . . 0.0 110.309 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.23 98.18 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.156 0.982 . . . . 0.0 112.371 -169.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -102.09 -0.12 33.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.381 1.072 . . . . 0.0 110.62 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.53 94.23 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -114.72 0.11 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.98 1.312 . . . . 0.0 110.874 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -76.36 119.09 19.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.46 122.3 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.2 -44.5 97.19 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.94 1.296 . . . . 0.0 110.723 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -95.5 -50.9 4.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.971 0.35 . . . . 0.0 111.16 -172.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.95 -19.03 65.73 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.728 -0.608 . . . . 0.0 112.001 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 53.15 51.79 14.98 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.904 1.281 . . . . 0.0 109.6 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -145.2 162.8 36.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.665 1.586 . . . . 0.0 107.577 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 tp -78.77 132.41 36.9 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.43 -0.794 . . . . 0.0 109.038 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.87 174.92 6.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.045 0.938 . . . . 0.0 112.858 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.91 117.77 34.87 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 169.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -151.19 177.51 10.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.38 145.81 18.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -147.57 156.75 43.12 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.36 1.064 . . . . 0.0 110.051 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.54 139.2 43.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.6 mt -128.55 143.53 50.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.76 1.224 . . . . 0.0 108.619 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -71.51 175.52 5.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.116 0.967 . . . . 0.0 110.252 169.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.06 -23.89 36.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.326 1.451 . . . . 0.0 113.566 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.424 ' H ' ' CG ' ' A' ' 135' ' ' ASP . 32.0 m-80 -98.31 5.46 48.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.854 1.662 . . . . 0.0 111.411 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.64 -0.51 88.17 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.837 -0.98 . . . . 0.0 113.021 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.49 127.49 32.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.696 1.748 . . . . 0.0 108.198 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.85 125.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.47 0.708 . . . . 0.0 109.324 171.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.59 -21.04 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.803 2.041 . . . . 0.0 109.208 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -146.87 150.25 34.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.74 132.63 10.58 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.942 1.697 . . . . 0.0 106.873 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.19 145.48 28.31 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 169.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -115.12 116.41 28.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 t -68.49 126.43 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -57.78 -27.31 62.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.606 1.163 . . . . 0.0 112.617 -173.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.35 103.1 6.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.787 -2.671 . . . . 0.0 103.787 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.33 67.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.615 1.166 . . . . 0.0 112.471 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 p -87.44 19.95 3.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.229 1.012 . . . . 0.0 111.379 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.45 160.46 38.7 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.998 2.119 . . . . 0.0 107.665 175.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -86.66 147.29 43.41 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 121.755 -0.591 . . . . 0.0 112.076 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.03 167.6 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.398 2.732 . . . . 0.0 111.212 169.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -81.21 97.82 7.79 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 169.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -74.29 -4.55 36.85 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.81 -35.35 78.47 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.173 -0.954 . . . . 0.0 109.194 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -56.3 -57.36 23.28 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.34 1.456 . . . . 0.0 111.667 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.62 -33.18 46.25 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.486 1.566 . . . . 0.0 112.312 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 mm -59.05 -48.95 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.837 1.199 . . . . 0.0 109.613 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.54 -41.56 94.73 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.708 0.686 . . . . 0.0 110.537 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.14 87.72 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.686 0.395 . . . . 0.0 110.965 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.44 19.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.517 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -64.22 -26.65 68.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.048 1.294 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.71 70.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.647 1.112 . . . . 0.0 112.073 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.79 -43.87 35.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.646 0.657 . . . . 0.0 110.912 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.36 -48.94 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.38 0.672 . . . . 0.0 110.739 -173.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.057 0 C-N-CA 124.797 1.239 . . . . 0.0 109.969 178.829 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.3 pt -137.1 -177.86 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 109.57 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -126.83 152.49 46.92 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -140.06 128.97 23.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt 43.95 36.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.267 1.427 . . . . 0.0 112.739 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.91 16.95 79.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.55 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.63 120.9 4.92 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 171.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.37 138.64 84.59 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.019 2.479 . . . . 0.0 111.357 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 m -143.41 162.06 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.36 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -118.78 161.83 19.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.463 1.505 . . . . 0.0 108.73 -169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.96 163.06 14.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.659 1.584 . . . . 0.0 109.69 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.36 -62.39 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.524 0.602 . . . . 0.0 111.689 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.45 12.45 69.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -168.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 56.48 154.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.29 2.636 . . . . 0.0 114.602 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -71.78 139.77 49.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.856 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.93 165.74 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -152.11 162.09 41.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.347 -0.846 . . . . 0.0 109.174 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.43 130.44 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.04 0.44 90.29 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.928 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -5.73 59.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.664 . . . . 0.0 112.332 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 58.38 180.0 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 111.527 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.56 146.35 52.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.541 1.536 . . . . 0.0 110.015 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -56.41 -21.84 39.22 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.439 3.426 . . . . 0.0 116.114 174.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 73.49 66.63 0.1 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 108.621 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -69.69 169.12 13.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.401 1.88 . . . . 0.0 111.748 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.5 m -110.48 155.73 21.84 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.23 166.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 127.501 2.32 . . . . 0.0 106.387 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 tp -118.22 135.71 54.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.7 p -75.84 168.36 20.17 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.024 0.53 . . . . 0.0 110.195 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -62.94 -18.85 63.65 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.887 -0.508 . . . . 0.0 110.744 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -81.91 -0.64 44.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.61 1.564 . . . . 0.0 111.693 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.8 mt 62.1 47.12 5.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.277 2.231 . . . . 0.0 111.838 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.22 150.89 49.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.667 1.187 . . . . 0.0 108.971 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.93 145.23 44.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 109.588 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -152.75 163.34 39.89 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.208 2.203 . . . . 0.0 106.064 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 p -143.51 168.6 19.46 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.302 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.6 tp -55.38 -35.92 65.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.251 -0.281 . . . . 0.0 110.541 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.06 -23.71 48.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.83 -32.19 67.29 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.435 1.016 . . . . 0.0 110.795 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 29.7 mtt -80.26 -37.33 33.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.776 1.63 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -53.27 145.31 14.19 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.841 0.857 . . . . 0.0 110.288 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.86 -18.49 14.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.369 1.461 . . . . 0.0 112.588 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.65 153.28 35.34 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 108.06 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -58.37 145.16 10.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 m -138.44 149.15 45.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.578 0.751 . . . . 0.0 109.4 -169.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.42 136.68 54.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.28 112.71 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 m -93.8 155.12 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.74 139.21 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.62 158.52 75.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -48.93 5.9 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.326 1.351 . . . . 0.0 110.799 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 m -165.06 156.87 15.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.595 1.158 . . . . 0.0 109.224 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 tp -66.61 -21.42 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.07 -24.75 65.99 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.968 0.907 . . . . 0.0 111.895 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -72.12 151.29 43.13 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.039 -0.413 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.17 -24.9 75.81 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.731 -0.606 . . . . 0.0 113.374 -172.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 m -60.9 -21.63 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.515 1.157 . . . . 0.0 112.662 -174.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.0 p -60.75 -31.47 70.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.988 0.813 . . . . 0.0 111.929 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -115.29 -33.89 5.16 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.086 0.954 . . . . 0.0 110.773 -172.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -29.87 70.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.593 0.757 . . . . 0.0 112.083 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -148.37 -36.46 0.19 Allowed 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 113.296 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -64.62 -43.5 93.53 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.054 1.752 . . . . 0.0 111.031 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -54.9 -50.51 68.59 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.084 0.954 . . . . 0.0 111.083 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -61.21 -47.8 84.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 110.956 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.1 -46.43 90.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.106 0.412 . . . . 0.0 110.566 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -61.95 -39.13 91.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.758 0.823 . . . . 0.0 110.632 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.53 -49.27 77.37 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.617 0.767 . . . . 0.0 109.806 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -65.57 -39.9 92.18 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.963 0.505 . . . . 0.0 110.804 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.85 82.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 110.954 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.4 66.18 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -79.37 -25.39 42.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.206 0.912 . . . . 0.0 112.104 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.6 mt -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.192 0.906 . . . . 0.0 109.908 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.18 -170.02 43.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.53 37.99 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.671 0.788 . . . . 0.0 112.34 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 77' ' ' VAL . 3.3 t -58.07 140.38 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 120.899 -1.125 . . . . 0.0 108.069 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.34 138.48 53.77 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 169.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.74 127.58 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.5 156.58 48.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.301 1.04 . . . . 0.0 109.362 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -140.18 119.86 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -100.75 141.71 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -145.19 167.42 22.84 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.177 0.991 . . . . 0.0 110.176 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 CA-C-O 121.268 0.556 . . . . 0.0 109.965 169.278 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -40.33 71.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.14 0.976 . . . . 0.0 111.953 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.09 -14.8 54.81 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.73 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.38 13.96 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.362 1.465 . . . . 0.0 112.289 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -79.54 76.29 6.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.231 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.08 -18.23 0.54 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.26 1.409 . . . . 0.0 111.406 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.15 89.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.604 1.562 . . . . 0.0 107.438 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.61 -24.44 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.138 1.775 . . . . 0.0 113.607 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.65 -32.16 65.1 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.353 1.061 . . . . 0.0 112.892 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.55 137.89 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -121.67 124.82 45.19 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -80.52 141.88 34.72 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -129.52 148.63 51.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.727 1.611 . . . . 0.0 107.022 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -128.69 54.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.206 1.402 . . . . 0.0 108.494 -168.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -49.1 -34.5 14.01 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.788 1.235 . . . . 0.0 113.723 -169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -49.64 -25.06 2.54 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -62.69 -21.9 66.09 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.55 -21.64 2.8 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.461 1.504 . . . . 0.0 112.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 tpt 61.94 5.0 1.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.12 3.368 . . . . 0.0 114.725 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.3 m -66.59 -44.56 81.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.46 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.48 -40.31 96.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 121.298 1.863 . . . . 0.0 109.887 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.85 -46.44 92.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 123.918 0.77 . . . . 0.0 111.469 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.64 -41.78 65.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.672 0.736 . . . . 0.0 110.477 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.02 94.16 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.216 1.006 . . . . 0.0 111.986 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -95.15 4.67 53.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.83 0.852 . . . . 0.0 110.4 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.78 -10.27 14.06 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.306 176.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.75 -13.4 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.816 1.647 . . . . 0.0 112.79 -169.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.79 108.41 1.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.3 118.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.68 -45.31 85.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.952 1.701 . . . . 0.0 111.144 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -89.87 -1.56 58.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.292 0.637 . . . . 0.0 112.427 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -136.56 -6.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.772 0.829 . . . . 0.0 112.492 -171.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 40.96 42.6 1.55 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.892 2.077 . . . . 0.0 113.337 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.6 tp -132.67 153.84 50.72 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -169.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.73 123.34 22.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.36 137.61 56.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.115 0.566 . . . . 0.0 110.511 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.76 119.24 7.78 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.1 p -156.85 166.16 34.15 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.939 1.296 . . . . 0.0 107.555 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.29 146.31 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -144.65 154.93 43.31 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.786 1.234 . . . . 0.0 108.772 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.93 137.81 48.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -131.91 137.78 48.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.831 1.253 . . . . 0.0 108.201 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.94 164.71 14.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.631 1.572 . . . . 0.0 110.748 170.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -50.05 -35.58 25.62 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.691 1.596 . . . . 0.0 113.043 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 7.71 33.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.848 0.859 . . . . 0.0 113.002 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.95 -6.33 76.46 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.592 1.092 . . . . 0.0 113.278 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.31 128.83 37.86 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.029 1.414 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -61.74 123.44 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.137 0.975 . . . . 0.0 109.415 172.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.23 -12.55 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.354 1.462 . . . . 0.0 110.133 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -148.12 148.59 30.77 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.32 17.25 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.639 1.576 . . . . 0.0 107.709 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -145.3 148.0 32.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.789 0.836 . . . . 0.0 109.5 170.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -135.7 107.1 6.85 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.749 2.42 . . . . 0.0 105.496 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.28 136.26 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -169.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -62.13 -21.98 65.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.605 1.162 . . . . 0.0 112.993 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -136.97 94.87 3.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.03 -13.95 60.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.577 1.151 . . . . 0.0 113.818 -170.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -0.49 18.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.201 0.909 . . . . 0.0 112.143 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.65 170.44 13.8 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 108.588 175.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -115.01 158.49 40.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.698 0.799 . . . . 0.0 112.325 -169.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.27 -179.72 4.88 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.218 2.612 . . . . 0.0 110.866 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -73.51 140.36 46.32 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -100.42 -8.18 23.52 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -79.79 -36.1 37.55 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.032 -1.042 . . . . 0.0 108.378 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -51.42 -56.27 22.05 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.71 -1.138 . . . . 0.0 111.816 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -66.95 -32.5 35.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 CA-C-N 121.535 1.584 . . . . 0.0 112.846 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.6 mm -58.94 -44.24 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.43 1.468 . . . . 0.0 109.865 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.64 -37.62 87.07 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.454 1.025 . . . . 0.0 110.602 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.24 89.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.444 -0.16 . . . . 0.0 111.298 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.59 66.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.333 0.653 . . . . 0.0 110.869 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.75 -40.97 66.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.164 0.893 . . . . 0.0 110.58 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.16 63.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.629 0.772 . . . . 0.0 112.33 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 48.4 mt -97.55 -36.79 10.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.261 0.624 . . . . 0.0 112.279 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.84 -48.29 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.452 1.101 . . . . 0.0 110.417 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--O 1.249 1.034 0 C-N-CA 124.583 1.153 . . . . 0.0 109.745 178.297 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.7 pt -135.78 -175.75 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.267 1.027 . . . . 0.0 108.938 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.91 154.72 50.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.17 126.13 17.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 43.07 45.45 4.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.109 1.364 . . . . 0.0 112.344 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.62 19.61 79.82 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.16 0.886 . . . . 0.0 114.925 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.17 120.29 4.03 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.53 140.48 89.67 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.918 2.412 . . . . 0.0 111.366 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.03 165.24 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.998 1.319 . . . . 0.0 108.684 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -126.65 154.92 43.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.107 0.963 . . . . 0.0 110.781 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.9 147.48 23.33 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.1 1.36 . . . . 0.0 110.964 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -77.13 -55.19 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 123.931 0.892 . . . . 0.0 109.887 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.45 32.68 7.19 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.197 0.903 . . . . 0.0 112.102 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 55.09 -146.79 0.55 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.023 0.929 . . . . 0.0 110.157 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.99 123.87 29.74 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.589 1.155 . . . . 0.0 110.755 -172.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -70.41 160.09 5.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.11 165.66 25.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -174.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -56.54 131.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.46 -5.67 72.36 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.786 1.184 . . . . 0.0 113.563 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.81 -5.9 57.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.525 1.662 . . . . 0.0 113.738 -170.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 66.7 112.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.381 1.872 . . . . 0.0 112.38 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.17 135.61 93.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.28 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.53 -46.74 13.43 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.579 2.186 . . . . 0.0 113.733 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 t70 122.51 126.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 131.471 3.908 . . . . 0.0 105.827 -169.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -138.84 165.74 26.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.691 1.596 . . . . 0.0 109.247 -175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.7 m -131.51 141.47 49.76 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.03 167.7 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.653 1.981 . . . . 0.0 108.41 -172.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.95 143.43 31.11 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 p -80.63 -179.64 7.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.29 1.436 . . . . 0.0 111.571 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -63.49 -24.52 67.86 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.425 -0.797 . . . . 0.0 110.836 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m -82.98 2.84 32.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.218 1.407 . . . . 0.0 111.768 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.2 mt 51.23 42.7 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.966 2.107 . . . . 0.0 112.774 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.82 160.55 21.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.182 0.993 . . . . 0.0 109.121 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.21 143.68 45.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.827 0.822 . . . . 0.0 110.691 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 42.0 tttp -148.81 153.83 38.67 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.765 2.426 . . . . 0.0 105.894 176.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 p -137.5 167.69 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.689 0.677 . . . . 0.0 110.124 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.64 -39.57 65.1 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.75 -25.75 60.88 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.18 -30.5 43.48 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.777 0.717 . . . . 0.0 111.436 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.2 mtt -71.76 -37.61 70.48 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.447 1.099 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.93 146.61 13.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.763 0.825 . . . . 0.0 110.27 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.99 2.77 48.92 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.548 1.071 . . . . 0.0 114.051 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -150.45 157.24 42.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.894 1.278 . . . . 0.0 108.814 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.56 139.59 19.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -136.77 146.19 45.47 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.28 135.51 62.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.1 mt -132.33 101.28 4.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -174.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -80.85 146.28 30.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.21 135.62 54.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.0 pt -145.82 159.06 48.22 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 125.001 1.321 . . . . 0.0 109.104 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.81 -53.03 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 N-CA-C 107.978 -1.586 . . . . 0.0 107.978 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -157.83 -177.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.413 2.285 . . . . 0.0 106.199 170.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 pt -86.94 -42.89 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.839 0.856 . . . . 0.0 109.724 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.36 -18.72 63.82 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.445 1.098 . . . . 0.0 111.095 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -20.15 61.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.572 1.149 . . . . 0.0 112.73 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.85 -15.42 3.08 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.29 0.95 . . . . 0.0 114.229 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.16 -7.26 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.929 1.364 . . . . 0.0 113.684 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.7 m -61.6 -33.75 74.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.442 1.019 . . . . 0.0 110.821 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.07 -18.75 45.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.934 0.894 . . . . 0.0 111.463 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.01 -173.9 2.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.331 1.053 . . . . 0.0 110.45 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -15.84 58.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.892 1.277 . . . . 0.0 113.688 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.91 64.75 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.324 1.449 . . . . 0.0 112.275 -169.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.8 tpt85 -57.94 -30.5 66.01 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.112 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 -42.93 7.53 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.833 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -59.36 -47.4 85.56 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.382 1.446 . . . . 0.0 111.914 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -67.3 -33.73 75.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.123 0.42 . . . . 0.0 110.377 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -65.12 -49.25 70.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.991 0.516 . . . . 0.0 109.678 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -61.32 -41.54 97.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.852 1.261 . . . . 0.0 110.195 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.52 -52.63 59.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.046 0.938 . . . . 0.0 110.62 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.91 67.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -83.1 -18.53 39.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.822 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.89 -38.43 91.06 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.324 1.42 . . . . 0.0 110.982 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.7 -169.27 42.33 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.35 23.84 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.017 0.909 . . . . 0.0 113.212 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -57.03 144.84 8.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.643 1.177 . . . . 0.0 109.72 -173.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.95 139.35 56.39 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.66 126.14 57.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 59.9 m-85 -128.1 150.77 49.82 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.615 0.766 . . . . 0.0 109.157 -177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.0 m -132.51 95.4 3.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -84.09 136.03 23.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.8 m -135.62 165.39 25.67 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.794 1.237 . . . . 0.0 110.905 -169.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.188 0.995 . . . . 0.0 113.63 -173.376 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.2 m95 . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p -153.84 170.65 20.46 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.738 1.215 . . . . 0.0 108.728 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.55 -18.17 1.37 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.661 -1.077 . . . . 0.0 115.073 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 28.89 1.83 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.035 1.417 . . . . 0.0 111.787 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -136.94 146.84 45.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.97 -18.83 33.41 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.084 -0.842 . . . . 0.0 112.71 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.05 88.86 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 125.7 1.6 . . . . 0.0 107.839 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.58 -19.09 56.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.597 1.559 . . . . 0.0 114.049 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -60.43 -30.17 69.47 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.625 -0.672 . . . . 0.0 111.834 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 t -71.93 140.44 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -129.0 147.01 50.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 169.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 p -106.84 132.19 53.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.07 155.29 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -170.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.2 m -125.77 134.03 51.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -121.4 -34.24 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -56.68 -15.2 4.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.711 1.205 . . . . 0.0 113.399 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -56.3 -35.46 67.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.763 0.825 . . . . 0.0 112.003 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -140.78 -4.05 1.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.34 17.62 8.48 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.648 2.379 . . . . 0.0 114.493 173.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.5 m -60.51 -57.15 13.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.776 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.86 -40.9 97.64 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.541 0.61 . . . . 0.0 109.627 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.01 -43.68 99.15 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -74.58 -39.59 62.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.713 1.256 . . . . 0.0 110.461 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.06 -45.97 92.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.132 0.973 . . . . 0.0 111.932 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.27 -10.63 43.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.317 1.047 . . . . 0.0 110.538 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.42 -5.44 73.2 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.286 1.898 . . . . 0.0 113.874 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.55 -9.7 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.736 2.014 . . . . 0.0 112.954 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.88 112.97 2.26 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 168.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 124' ' ' LEU . 91.2 mt -76.02 133.18 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.53 -59.76 4.89 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.577 1.151 . . . . 0.0 110.585 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -74.66 -47.69 30.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.377 0.671 . . . . 0.0 111.579 -169.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.528 ' H ' HG22 ' A' ' 121' ' ' ILE . 14.4 tp -78.05 -15.24 59.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.325 0.65 . . . . 0.0 112.024 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 47.5 44.04 16.4 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.999 1.72 . . . . 0.0 111.993 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 tp -139.04 165.04 28.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.279 1.032 . . . . 0.0 108.245 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 127.18 32.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.36 150.43 48.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.054 0.454 . . . . 0.0 110.484 170.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 124.55 25.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.1 m -156.99 168.5 27.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.74 137.47 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -141.23 154.15 45.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.63 138.16 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.3 mp -130.64 135.95 48.36 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.032 0.933 . . . . 0.0 109.671 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.36 163.69 15.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.79 1.636 . . . . 0.0 109.313 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -52.21 -29.76 24.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.579 1.552 . . . . 0.0 113.265 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -71.56 -6.22 39.14 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.506 1.122 . . . . 0.0 113.09 177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.99 47.71 18.21 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -170.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.94 126.87 42.28 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -67.47 121.38 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.521 0.728 . . . . 0.0 109.439 -170.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.18 -7.68 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.05 1.34 . . . . 0.0 110.747 170.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -150.69 149.2 29.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.99 125.78 7.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.264 1.425 . . . . 0.0 108.177 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -140.84 149.78 42.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.453 0.569 . . . . 0.0 109.954 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.65 116.91 17.97 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.56 133.52 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -171.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -55.27 -28.33 52.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.398 1.079 . . . . 0.0 111.667 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.78 111.98 9.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.85 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.423 1.489 . . . . 0.0 113.152 -176.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 8.64 6.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.874 0.87 . . . . 0.0 112.438 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.39 -174.91 3.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.952 1.301 . . . . 0.0 110.258 172.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -103.87 147.36 34.15 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.21 -0.931 . . . . 0.0 113.426 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.04 178.8 6.07 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.693 2.929 . . . . 0.0 109.967 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.74 133.73 49.79 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -123.31 16.82 9.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 111.684 -170.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.43 -42.28 4.38 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -51.17 -46.35 88.95 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.341 -1.314 . . . . 0.0 112.851 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.87 -38.39 30.03 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 121.943 1.73 . . . . 0.0 111.644 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.7 mm -61.3 -42.37 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.34 -38.45 91.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.556 1.071 . . . . 0.0 111.088 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.09 99.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.56 0.344 . . . . 0.0 110.667 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.9 73.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.977 0.511 . . . . 0.0 110.823 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -55.09 -43.1 73.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.151 0.887 . . . . 0.0 110.285 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.255 0.622 . . . . 0.0 112.104 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.05 -41.9 18.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.871 0.469 . . . . 0.0 111.74 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.06 -52.54 32.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.975 0.91 . . . . 0.0 110.649 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 123.879 0.872 . . . . 0.0 110.004 177.361 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 CA--C 1.543 0.683 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 pt -129.86 172.75 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 123.225 1.488 . . . . 0.0 112.515 -175.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -118.56 156.67 28.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.597 2.759 . . . . 0.0 104.963 170.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.3 122.23 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? 48.1 36.69 6.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.927 1.291 . . . . 0.0 111.51 -175.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.93 85.47 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.39 -0.819 . . . . 0.0 114.694 176.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.47 118.1 5.07 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.41 143.42 77.2 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.808 2.339 . . . . 0.0 111.355 173.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.86 -175.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.958 1.303 . . . . 0.0 108.655 175.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -132.58 151.45 51.93 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.641 1.176 . . . . 0.0 108.154 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.12 155.59 17.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.71 1.604 . . . . 0.0 109.046 176.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -74.83 -25.36 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.65 17.29 1.11 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.247 -0.752 . . . . 0.0 112.91 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 47.65 -168.61 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.682 1.993 . . . . 0.0 113.838 178.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 145' ' ' TYR . 6.8 pm0 -80.76 128.76 34.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.705 -1.247 . . . . 0.0 113.414 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.3 170.31 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 165.01 34.01 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 120.998 -1.064 . . . . 0.0 109.514 -172.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.46 132.36 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 -2.21 87.56 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.836 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.05 -13.29 59.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.311 1.556 . . . . 0.0 112.4 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.51 176.64 0.06 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.208 1.803 . . . . 0.0 112.192 -169.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.99 137.75 30.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.163 1.385 . . . . 0.0 110.451 -171.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.17 -20.13 45.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.727 3.618 . . . . 0.0 117.122 176.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.33 72.37 0.13 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.63 1.972 . . . . 0.0 109.287 -169.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -72.82 175.89 6.11 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.65 1.58 . . . . 0.0 110.709 177.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.1 m -131.97 144.56 50.9 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.86 176.42 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 108.169 -177.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.9 mt -113.52 140.31 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.273 1.029 . . . . 0.0 109.474 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -72.59 176.23 5.65 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.383 1.473 . . . . 0.0 111.174 175.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -59.84 -22.58 62.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.154 0.582 . . . . 0.0 111.15 169.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.7 m -92.1 4.1 53.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.551 1.54 . . . . 0.0 112.212 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.6 mp 53.05 47.16 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.305 1.842 . . . . 0.0 112.164 -175.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -112.44 148.41 34.43 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.16 146.67 34.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.802 0.811 . . . . 0.0 111.1 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -150.41 114.98 5.21 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.79 1.636 . . . . 0.0 107.14 -172.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -79.93 161.89 25.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.209 0.603 . . . . 0.0 109.999 176.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.37 -36.5 73.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.68 44.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.924 0.89 . . . . 0.0 113.353 177.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -74.08 -32.64 63.35 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.444 1.02 . . . . 0.0 110.965 174.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.6 mtt -75.81 -34.61 60.16 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 111.371 177.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -54.67 158.29 2.65 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.607 1.163 . . . . 0.0 111.368 -177.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.85 67.01 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.335 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -146.33 159.67 43.05 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.038 2.135 . . . . 0.0 106.964 169.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 77' ' ' VAL . 74.9 t -65.74 113.96 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.3 m -92.44 138.44 31.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.4 mt -132.84 133.05 59.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.19 139.93 41.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -172.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -123.04 152.51 40.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.61 124.92 35.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 pt -139.2 147.27 52.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.93 -47.87 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 120.723 0.948 . . . . 0.0 110.794 174.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.04 173.25 16.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -169.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.38 -42.96 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.616 1.566 . . . . 0.0 107.661 174.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.41 -28.16 68.41 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.625 1.17 . . . . 0.0 112.36 -175.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.37 -4.95 9.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 176.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.41 -29.75 2.84 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 121.082 -1.011 . . . . 0.0 114.174 169.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.79 -25.38 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.972 1.386 . . . . 0.0 112.599 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.47 -39.86 61.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.091 1.356 . . . . 0.0 111.769 169.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -107.13 -36.8 6.47 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.814 0.846 . . . . 0.0 111.172 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.54 68.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.811 0.844 . . . . 0.0 112.564 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -145.44 -41.27 0.23 Allowed 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.038 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -67.22 -44.41 79.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.654 1.116 . . . . 0.0 110.649 -169.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -59.35 -30.44 68.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 113.449 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -85.25 -43.62 13.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.948 0.794 . . . . 0.0 110.193 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.47 -50.67 72.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.428 0.691 . . . . 0.0 110.421 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -60.66 -38.38 84.7 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.991 0.516 . . . . 0.0 110.888 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.64 -33.18 75.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.166 0.986 . . . . 0.0 112.135 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.75 -46.29 15.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.169 0.895 . . . . 0.0 109.945 172.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -45.1 87.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.383 1.073 . . . . 0.0 111.017 -174.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.03 -15.06 55.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.082 0.953 . . . . 0.0 112.797 -173.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -117.14 3.99 12.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.14 -35.71 79.6 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.969 1.259 . . . . 0.0 110.719 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.03 -161.44 30.81 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.694 1.14 . . . . 0.0 110.278 -176.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -74.04 27.97 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.892 1.277 . . . . 0.0 112.42 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 46' ' ' VAL . 15.9 m -65.06 144.83 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 108.362 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -84.04 155.31 22.78 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.44 124.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -172.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -139.35 157.73 45.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.057 0.543 . . . . 0.0 110.443 -176.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.6 m -136.29 103.98 5.48 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.97 150.16 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.624 1.17 . . . . 0.0 108.295 -174.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.3 m -127.27 158.41 37.25 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.195 1.798 . . . . 0.0 111.223 -169.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 124.34 1.056 . . . . 0.0 111.933 -178.442 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.6 m95 . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 m 61.16 18.22 8.86 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.923 1.689 . . . . 0.0 114.808 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.12 -43.52 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.1 8.55 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.22 0.24 12.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.709 1.204 . . . . 0.0 112.144 176.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.68 -18.88 0.6 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.716 1.15 . . . . 0.0 112.38 177.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.93 95.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.13 -16.75 54.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.22 1.408 . . . . 0.0 114.049 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -60.23 -30.39 69.37 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.689 -0.632 . . . . 0.0 111.314 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.1 t -75.34 147.45 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.18 142.98 40.04 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.1 p -87.54 132.41 34.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.02 168.86 11.06 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.546 1.938 . . . . 0.0 107.547 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.3 m -136.63 147.66 47.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.126 0.97 . . . . 0.0 109.091 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -125.86 -19.09 4.95 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.523 0.729 . . . . 0.0 111.466 173.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -55.45 -24.62 31.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -173.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -73.1 -16.17 61.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.373 -0.822 . . . . 0.0 112.815 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -139.9 -21.99 0.87 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.546 1.066 . . . . 0.0 113.636 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.9 mmm 57.55 7.44 0.52 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.327 2.651 . . . . 0.0 115.816 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.2 m -62.39 -48.01 81.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.859 1.209 . . . . 0.0 111.846 -177.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -64.27 -40.33 95.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.445 1.475 . . . . 0.0 110.027 177.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -49.81 -57.28 9.93 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 125.749 1.642 . . . . 0.0 112.274 176.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.86 -42.58 81.1 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.134 0.467 . . . . 0.0 110.049 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.81 92.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.848 0.859 . . . . 0.0 112.2 -172.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.84 8.2 37.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.224 1.01 . . . . 0.0 110.896 -176.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.37 34.43 74.75 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.146 0.884 . . . . 0.0 111.704 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.454 HG23 ' HA2' ' A' ' 114' ' ' GLY . 9.3 m -108.87 -4.3 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.742 1.617 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.63 113.52 8.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 168.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 84.3 mt -70.94 111.27 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 175.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -54.37 -40.91 68.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.442 1.497 . . . . 0.0 111.43 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.95 -4.02 55.18 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.69 -16.97 1.99 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.938 0.79 . . . . 0.0 112.763 -170.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.4 ttm105 47.46 42.41 14.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.82 1.648 . . . . 0.0 111.989 -173.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -122.09 163.03 20.17 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.04 131.52 36.3 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 138.8 56.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.162 1.385 . . . . 0.0 111.541 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -58.57 113.64 2.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.377 1.071 . . . . 0.0 108.78 171.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.3 p -156.23 173.63 16.56 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.927 0.394 . . . . 0.0 110.667 -176.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.93 149.12 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.439 1.496 . . . . 0.0 107.85 174.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -147.79 155.45 41.69 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.773 1.229 . . . . 0.0 110.119 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.59 142.87 33.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 mp -138.93 142.29 38.47 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -173.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.65 165.06 5.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.28 1.432 . . . . 0.0 110.038 169.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -51.13 -32.53 23.1 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.982 1.313 . . . . 0.0 112.848 176.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -79.5 0.41 29.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.835 1.254 . . . . 0.0 112.834 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.05 88.62 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.004 -1.06 . . . . 0.0 112.884 -175.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -67.75 121.88 16.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.068 1.434 . . . . 0.0 107.236 172.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.07 132.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.295 0.638 . . . . 0.0 109.446 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.53 -18.75 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.664 1.985 . . . . 0.0 109.662 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -147.27 149.45 32.89 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.04 138.84 17.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.105 1.762 . . . . 0.0 107.475 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -146.91 146.78 30.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.31 0.644 . . . . 0.0 109.796 170.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 17' ' ' GLU . 12.8 m-85 -139.13 93.42 2.69 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.6 2.76 . . . . 0.0 104.837 -173.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.7 m -62.52 147.37 11.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 O-C-N 121.769 -0.582 . . . . 0.0 110.415 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -66.45 -11.09 50.19 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -143.35 125.64 15.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.36 -24.13 58.91 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -176.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 38.3 p -89.78 -4.17 57.78 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.001 0.819 . . . . 0.0 112.298 176.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -84.62 176.49 8.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.248 1.419 . . . . 0.0 109.268 173.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -148.05 146.54 23.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.46 176.83 7.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.414 2.743 . . . . 0.0 110.451 177.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -76.8 119.53 20.7 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -67.82 -14.36 62.89 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -70.0 -30.02 67.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.015 1.279 . . . . 0.0 109.435 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -66.34 -49.78 52.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.357 -175.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -65.58 -35.79 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 121.366 1.524 . . . . 0.0 111.541 170.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.14 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 119.755 1.161 . . . . 0.0 110.154 179.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.84 -30.15 67.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.59 1.086 . . . . 0.0 110.741 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.09 97.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.004 0.366 . . . . 0.0 110.544 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.33 -45.05 85.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.944 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -56.7 -41.32 77.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.202 0.91 . . . . 0.0 110.498 176.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.22 71.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.65 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.85 -47.59 14.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.566 0.621 . . . . 0.0 111.89 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.05 -39.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 110.718 -172.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.2 mttm . . . . . 0 C--O 1.249 1.049 0 C-N-CA 126.039 1.735 . . . . 0.0 109.592 -175.829 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.512 ' HA ' ' OE1' ' A' ' 17' ' ' GLU 0.335 0.6 OUTLIER . . . . . 0 CA--C 1.496 -1.121 0 CA-C-O 122.72 1.248 . . . . 0.0 113.08 . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.43 74.34 1.11 Allowed 'General case' 0 N--CA 1.425 -1.678 1 N-CA-C 99.147 -4.39 . . . . 0.0 99.147 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.81 153.14 24.81 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 158.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.5 pt -135.56 175.66 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 m -119.32 152.53 36.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 170.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -136.32 123.83 22.17 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 103.706 -2.702 . . . . 0.0 103.706 173.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.8 mttt 50.36 36.15 12.4 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.53 85.97 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 119.417 -1.373 . . . . 0.0 113.406 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.68 124.32 6.34 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.076 1.938 . . . . 0.0 108.364 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.05 144.5 99.47 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 CA-C-N 120.217 2.009 . . . . 0.0 109.994 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -145.47 145.27 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.175 0.99 . . . . 0.0 109.765 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -90.63 159.82 16.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.543 1.137 . . . . 0.0 109.93 -171.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -111.81 153.27 26.82 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.338 1.455 . . . . 0.0 109.189 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.3 t -81.9 -56.73 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 121.96 -0.463 . . . . 0.0 110.427 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.42 12.72 33.33 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.034 -167.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 28.76 174.58 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 1 C-N-CA 133.456 4.703 . . . . 0.0 120.657 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 17.1 tt0 12.82 62.36 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 129.786 3.234 . . . . 0.0 117.607 144.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.96 157.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 149.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -150.37 171.78 16.45 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 120.923 -1.111 . . . . 0.0 108.485 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.32 131.74 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.839 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.9 -10.01 72.11 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 116.922 -2.043 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.96 -13.0 61.51 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.537 1.668 . . . . 0.0 113.42 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 65.16 160.86 0.12 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.33 1.852 . . . . 0.0 110.544 -172.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.92 132.24 22.42 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.21 1.804 . . . . 0.0 109.013 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -58.5 -28.65 86.21 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.1 2.533 . . . . 0.0 118.459 -169.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 t70 75.12 99.8 0.07 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.169 -157.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' A' ' 112' ' ' SER . 2.2 p90 -125.87 -174.47 3.1 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 126.077 1.751 . . . . 0.0 106.702 169.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 m -115.94 153.89 30.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.746 2.018 . . . . 0.0 106.95 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.03 168.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.67 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 1.2 tp -112.07 147.02 36.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 172.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -79.17 172.53 13.67 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.37 -29.5 66.05 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.973 1.309 . . . . 0.0 110.933 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -80.52 -0.04 35.8 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.403 1.481 . . . . 0.0 112.968 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.1 mt 62.37 36.51 14.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.176 1.79 . . . . 0.0 112.526 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.54 144.28 28.82 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 171.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.92 132.4 45.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.113 0.959 . . . . 0.0 108.956 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 49.6 tttp -136.08 148.39 48.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.38 167.4 12.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.29 -37.29 67.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.626 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.59 -26.43 63.64 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 117.561 -1.209 . . . . 0.0 112.894 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.12 -26.6 59.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.199 0.909 . . . . 0.0 111.625 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.5 mtt -78.21 -31.18 49.28 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.413 -0.804 . . . . 0.0 111.419 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -62.38 152.74 33.23 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.226 0.536 . . . . 0.0 110.0 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.16 -7.66 44.2 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -154.51 160.99 41.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.541 1.171 . . . . 0.0 109.15 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.16 137.59 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.5 m -132.28 147.23 52.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.351 1.46 . . . . 0.0 107.956 -173.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.65 137.44 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.0 mt -137.46 117.62 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.3 m -93.09 150.74 20.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 163.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.05 133.95 55.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.23 151.73 62.42 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.31 -43.12 4.73 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.62 1.547 . . . . 0.0 110.747 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.2 m -150.75 171.5 17.07 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.583 2.353 . . . . 0.0 106.839 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.513 ' H ' ' HA ' ' A' ' 89' ' ' ALA . 1.1 pt -99.99 -20.45 5.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 C-N-CA 123.147 0.579 . . . . 0.0 111.669 166.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.8 -22.4 66.89 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.215 -1.553 . . . . 0.0 112.122 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 p -65.57 1.82 1.12 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.107 1.763 . . . . 0.0 115.024 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.59 -18.64 3.58 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 121.363 1.892 . . . . 0.0 114.113 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.495 ' HB ' HH21 ' A' ' 129' ' ' ARG . 1.6 m -57.56 -23.09 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.59 1.695 . . . . 0.0 113.109 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . 0.265 61.2 m -36.82 -61.57 0.53 Allowed 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.736 1.214 . . . . 0.0 110.259 165.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -75.35 -50.05 17.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 126.527 2.392 . . . . 0.0 105.866 -156.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.24 83.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.801 -166.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.53 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.1 tm0? -145.33 -47.37 0.22 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 117.579 -1.201 . . . . 0.0 112.675 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -63.26 -43.26 98.47 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.831 1.65 . . . . 0.0 111.65 -163.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -48.4 -56.26 8.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.702 2.001 . . . . 0.0 109.205 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -69.52 -45.64 68.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.813 -172.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CB ' HE21 ' A' ' 63' ' ' GLN . 38.5 t80 -58.45 -45.64 88.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.005 0.522 . . . . 0.0 110.979 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.21 -39.87 93.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.117 0.967 . . . . 0.0 109.888 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.2 -46.29 84.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -63.22 -47.21 83.46 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.961 0.504 . . . . 0.0 110.538 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.24 -48.41 68.22 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.47 1.108 . . . . 0.0 110.508 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.52 -16.87 27.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -100.66 -15.59 17.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.874 1.27 . . . . 0.0 112.846 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.43 -33.09 72.03 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.332 0.514 . . . . 0.0 109.984 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.37 35.47 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.74 21.01 0.42 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.862 -0.787 . . . . 0.0 112.96 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 m -52.2 145.34 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.123 1.369 . . . . 0.0 110.589 -174.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -70.35 143.6 51.9 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.74 134.29 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 52.8 m-85 -138.96 154.24 48.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.56 0.744 . . . . 0.0 109.523 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -129.74 115.64 17.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 170.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.85 140.23 16.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.1 m -135.46 166.88 22.15 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.97 170.69 7.83 Favored 'General case' 0 CA--C 1.555 1.17 0 O-C-N 122.105 -0.372 . . . . 0.0 110.216 164.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -66.65 -35.82 81.08 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 126.428 1.891 . . . . 0.0 108.246 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 tp -29.96 122.98 0.3 Allowed Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 130.138 3.375 . . . . 0.0 110.712 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.83 -30.69 30.71 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.322 2.681 . . . . 0.0 114.999 -167.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -67.86 -4.3 12.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.024 1.329 . . . . 0.0 113.349 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HA ' ' H ' ' A' ' 55' ' ' ILE . . . -119.02 -14.79 9.33 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -150.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.543 HE22 ' CB ' ' A' ' 106' ' ' SER . 20.7 mt-30 -128.43 -8.96 5.19 Favored 'General case' 0 CA--C 1.466 -2.288 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.511 ' O ' ' CH2' ' A' ' 93' ' ' TRP . . . -61.59 -30.3 70.58 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 115.824 -2.036 . . . . 0.0 107.022 -175.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -155.79 8.81 0.25 Allowed 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 117.83 2.529 . . . . 0.0 117.83 -149.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.516 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 p90 57.81 37.01 26.97 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 115.205 -2.598 . . . . 0.0 108.74 123.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -35.18 44.82 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.34 -28.21 70.24 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.197 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 93' ' ' TRP . . . -111.54 24.66 12.51 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.785 2.834 . . . . 0.0 111.96 -171.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -115.08 106.68 14.39 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 103.65 -16.52 51.6 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.671 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.21 86.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -54.55 -22.68 13.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.7 -27.4 68.31 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.668 -1.27 . . . . 0.0 113.255 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.79 145.69 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -129.19 142.24 50.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 172.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.11 139.72 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.739 1.216 . . . . 0.0 109.021 174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.5 mp -124.56 158.74 32.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.405 1.482 . . . . 0.0 108.999 -173.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.543 ' CB ' HE22 ' A' ' 90' ' ' GLN . 0.8 OUTLIER -132.81 73.22 1.51 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 127.05 2.14 . . . . 0.0 107.385 -169.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -69.71 -32.77 71.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.526 -1.359 . . . . 0.0 111.53 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -54.57 -17.31 3.11 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.195 1.798 . . . . 0.0 113.583 -167.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.67 ' HD3' ' CD2' ' A' ' 30' ' ' LEU . 5.3 ttt180 -65.27 -26.99 68.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -134.38 -17.15 2.06 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 124.914 1.384 . . . . 0.0 107.964 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' ' HA3' ' A' ' 114' ' ' GLY . 6.0 mmm 59.66 6.88 0.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.477 2.311 . . . . 0.0 111.513 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 27' ' ' PHE . 20.8 m -59.07 -49.18 78.87 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.742 1.61 . . . . 0.0 110.012 -170.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -62.57 -42.07 99.32 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 120.304 1.411 . . . . 0.0 109.916 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -51.21 -47.02 50.93 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 123.864 0.745 . . . . 0.0 113.237 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -73.85 -46.91 42.02 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.512 0.725 . . . . 0.0 109.247 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.7 78.49 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -104.09 7.13 36.29 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.844 1.258 . . . . 0.0 109.467 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.02 25.33 56.49 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 118.149 -1.361 . . . . 0.0 113.101 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.412 HG23 ' HA2' ' A' ' 114' ' ' GLY . 17.1 m -90.83 -9.1 10.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.688 1.744 . . . . 0.0 111.488 176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -63.32 115.97 5.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.516 ' HA ' HD12 ' A' ' 13' ' ' LEU . 65.7 mt -75.14 120.92 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -61.17 -49.77 75.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.844 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -79.24 -31.2 43.51 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.432 0.457 . . . . 0.0 112.014 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' H ' HG22 ' A' ' 121' ' ' ILE . 21.8 tp -109.63 -18.21 13.53 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.116 0.966 . . . . 0.0 111.576 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 53.63 42.35 31.89 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.744 1.618 . . . . 0.0 114.507 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt -123.54 162.96 21.9 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.38 135.85 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.42 154.49 41.71 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.779 1.275 . . . . 0.0 110.091 167.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.495 HH21 ' HB ' ' A' ' 59' ' ' VAL . 17.1 tpt85 -77.38 112.0 13.65 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.667 -1.606 . . . . 0.0 107.683 166.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.06 173.38 14.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.98 140.07 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -142.27 155.88 45.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.056 1.342 . . . . 0.0 108.477 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.38 139.77 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.5 mp -130.19 133.95 46.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -171.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.22 163.43 15.24 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 125.314 1.445 . . . . 0.0 110.877 164.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -48.61 -35.19 13.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.254 1.822 . . . . 0.0 113.998 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -2.66 39.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 120.659 1.572 . . . . 0.0 111.97 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.96 3.11 70.73 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.174 -1.579 . . . . 0.0 112.5 -171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -71.48 122.26 20.1 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 119.982 1.891 . . . . 0.0 109.36 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.41 126.49 15.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 172.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -119.38 -11.22 10.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 129.448 3.099 . . . . 0.0 107.767 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -152.61 152.48 31.85 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.227 1.411 . . . . 0.0 107.454 163.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.18 139.93 18.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 169.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -150.2 148.8 29.35 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 168.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -124.26 117.51 24.71 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.859 1.663 . . . . 0.0 106.906 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.71 129.35 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -170.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 m -57.56 -19.15 23.5 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.904 0.881 . . . . 0.0 113.165 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -138.54 124.23 19.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.82 -25.12 65.41 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -84.12 6.4 22.49 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.419 1.487 . . . . 0.0 111.11 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.46 174.2 6.69 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.732 2.013 . . . . 0.0 107.235 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -128.53 152.87 79.13 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 120.716 -1.24 . . . . 0.0 110.861 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -80.96 170.35 15.38 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.591 2.194 . . . . 0.0 110.082 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -69.46 120.82 15.84 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 161.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -93.68 -8.09 41.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.698 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -66.12 -36.69 83.81 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.297 1.408 . . . . 0.0 108.847 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -63.12 -48.75 83.27 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 125.341 1.456 . . . . 0.0 112.254 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.71 -34.86 49.15 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 CA-C-N 119.59 0.889 . . . . 0.0 111.974 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 20.6 mm -60.02 -45.47 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 120.658 1.572 . . . . 0.0 110.507 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.86 -42.34 97.57 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 120.746 1.612 . . . . 0.0 109.263 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.04 95.45 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.882 0.473 . . . . 0.0 110.78 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.84 80.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.083 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -53.74 -49.65 67.69 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 117.077 -1.44 . . . . 0.0 108.368 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -52.82 -29.68 29.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.408 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.45 -49.18 7.38 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.1 t -60.6 -41.39 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.533 0.683 . . . . 0.0 111.827 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.439 -1.018 0 C-N-CA 130.64 3.576 . . . . 0.0 117.265 -161.116 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.77 0.319 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.03 50.43 1.73 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.596 1.559 . . . . 0.0 109.621 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.39 170.23 5.06 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.474 169.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.94 -175.76 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.379 1.072 . . . . 0.0 108.834 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -118.5 152.15 36.5 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -136.04 109.42 7.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt 42.89 41.83 2.77 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 111.825 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 99.23 -9.5 61.21 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.134 -0.814 . . . . 0.0 115.04 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.1 125.53 8.56 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.948 -1.473 . . . . 0.0 110.189 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.43 138.62 39.34 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 CA-C-N 120.859 2.33 . . . . 0.0 110.208 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.8 m -145.16 135.21 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.154 0.982 . . . . 0.0 110.453 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -75.91 155.17 35.42 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.834 1.653 . . . . 0.0 110.388 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.64 144.63 40.6 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.405 1.482 . . . . 0.0 107.877 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.4 t -71.24 -65.19 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 118.502 0.592 . . . . 0.0 111.299 -171.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.09 35.17 4.85 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.627 1.108 . . . . 0.0 111.206 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -52.12 166.44 0.16 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.247 2.219 . . . . 0.0 116.075 -169.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 69.07 34.19 3.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.614 1.966 . . . . 0.0 113.379 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.54 144.78 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -150.12 162.93 39.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.802 0.841 . . . . 0.0 109.156 -169.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 p -52.89 132.82 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.283 0.633 . . . . 0.0 109.541 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.19 -5.22 83.03 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.85 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.37 -11.28 59.93 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.457 1.628 . . . . 0.0 112.64 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 57.44 178.36 0.05 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.649 1.58 . . . . 0.0 111.952 -169.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -137.38 136.09 20.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.931 1.693 . . . . 0.0 109.016 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 95.5 Cg_endo -74.26 157.49 45.8 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.483 2.122 . . . . 0.0 109.77 172.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 27.6 t70 -77.47 67.91 3.48 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.02 1.728 . . . . 0.0 110.117 176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -59.27 162.3 4.74 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.442 170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 84.5 m -124.65 144.45 50.19 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.38 168.05 21.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.343 2.257 . . . . 0.0 107.528 -171.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.97 143.45 45.7 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.436 -1.691 . . . . 0.0 106.436 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.48 178.45 8.11 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.523 0.729 . . . . 0.0 109.949 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -62.98 -23.33 67.38 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.146 -0.971 . . . . 0.0 110.734 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 m -86.41 3.34 44.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.596 1.558 . . . . 0.0 111.589 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 75.4 mt 55.62 33.1 20.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.82 2.048 . . . . 0.0 112.937 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -88.55 147.11 24.77 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.84 143.8 39.47 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.847 0.859 . . . . 0.0 109.439 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -154.02 155.08 34.86 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.315 2.246 . . . . 0.0 105.547 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.2 m -139.58 166.57 24.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.119 0.872 . . . . 0.0 108.927 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 43.6 tp -50.15 -40.67 47.19 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.242 0.474 . . . . 0.0 111.026 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.1 62.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -77.4 -28.47 52.76 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.768 0.713 . . . . 0.0 111.133 173.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.8 mtt -80.36 -55.14 5.1 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.877 1.271 . . . . 0.0 110.513 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -59.74 134.01 56.62 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.06 -20.61 3.2 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.955 2.216 . . . . 0.0 110.512 -169.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -150.33 158.34 44.05 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.92 2.088 . . . . 0.0 107.219 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -56.65 144.73 8.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.4 m -137.09 145.82 44.36 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.2 mt -133.31 137.19 53.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mt -136.75 133.88 48.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m -114.98 147.44 40.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.7 t -136.5 133.32 49.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -174.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.25 150.35 51.69 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.55 1.14 . . . . 0.0 109.278 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.92 -50.13 1.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.558 1.505 . . . . 0.0 109.709 169.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -152.87 168.67 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.311 1.444 . . . . 0.0 108.108 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.85 -23.93 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.53 -27.06 62.93 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.905 0.882 . . . . 0.0 111.839 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 32.2 0.08 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.12 2.168 . . . . 0.0 113.736 -174.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.68 -3.23 69.88 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 120.432 -1.418 . . . . 0.0 114.269 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.83 -12.28 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 118.498 1.149 . . . . 0.0 112.406 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.69 -0.04 2.65 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.458 1.503 . . . . 0.0 113.724 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -48.97 148.66 2.18 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.906 0.882 . . . . 0.0 110.348 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.03 -28.69 10.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.914 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -50.06 -57.33 7.85 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.265 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -65.71 -42.86 90.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.493 1.497 . . . . 0.0 110.085 -170.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -63.81 -53.96 42.65 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 122.725 0.41 . . . . 0.0 110.169 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.27 -37.6 80.88 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.688 -175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -55.93 -51.93 65.92 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 119.438 1.017 . . . . 0.0 110.102 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -66.22 -33.61 76.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.657 0.265 . . . . 0.0 110.572 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -64.25 -50.55 67.52 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.735 -0.603 . . . . 0.0 110.477 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -60.8 -41.73 96.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.167 0.894 . . . . 0.0 110.406 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.86 73.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.918 0.887 . . . . 0.0 110.316 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.1 -13.57 62.51 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -100.86 -17.31 16.92 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.859 1.264 . . . . 0.0 112.419 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 mt -60.07 -37.87 81.16 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.051 1.296 . . . . 0.0 110.56 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.89 -173.09 44.74 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -74.0 22.69 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.89 0.876 . . . . 0.0 112.902 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 m -57.15 154.34 2.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.379 1.472 . . . . 0.0 110.733 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -69.82 143.75 52.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.45 130.45 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.36 153.05 46.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.136 0.574 . . . . 0.0 110.886 -174.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.8 m -120.57 154.6 35.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.1 mt -136.55 134.85 49.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 72.2 m -131.71 160.79 34.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.419 1.488 . . . . 0.0 109.86 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.68 170.86 5.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.205 0.526 . . . . 0.0 110.933 169.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.38 -13.85 60.11 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.48 0.712 . . . . 0.0 112.18 175.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.0 tp -49.56 127.54 18.18 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.859 1.264 . . . . 0.0 109.602 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -52.58 -37.39 74.0 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.966 2.444 . . . . 0.0 114.531 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -68.16 -16.65 64.08 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.519 0.728 . . . . 0.0 112.856 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.72 -4.32 42.68 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -169.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -138.21 139.2 39.17 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.77 -179.69 7.01 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.231 1.812 . . . . 0.0 108.008 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -83.42 24.83 0.79 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.244 1.018 . . . . 0.0 110.127 169.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -134.97 160.64 37.65 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.868 1.267 . . . . 0.0 109.727 -170.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 m 65.22 -48.13 0.36 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.571 2.748 . . . . 0.0 116.089 169.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -76.45 -48.67 8.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.99 38.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.742 1.617 . . . . 0.0 108.637 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -149.37 33.16 0.72 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.822 0.849 . . . . 0.0 111.24 -170.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.74 -1.26 5.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.293 0.949 . . . . 0.0 113.103 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 mt -75.11 87.87 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -54.38 -30.22 51.28 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 114.013 -169.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -64.91 -25.17 67.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.585 0.754 . . . . 0.0 112.88 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -74.42 152.95 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.823 0.738 . . . . 0.0 109.87 -171.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -137.44 151.2 48.25 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.1 m -121.95 96.57 5.11 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -171.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.82 160.98 31.31 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.945 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 m -127.8 37.43 4.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.025 2.13 . . . . 0.0 109.088 -169.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -47.65 -39.73 17.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.798 1.239 . . . . 0.0 114.098 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.96 -17.79 11.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.117 0.967 . . . . 0.0 113.487 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 mtp85 -62.82 -22.0 66.32 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.221 -0.925 . . . . 0.0 112.661 172.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -133.7 -26.15 1.61 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.718 1.607 . . . . 0.0 111.898 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 69.44 10.83 7.88 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 128.444 2.698 . . . . 0.0 113.741 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.8 m -61.69 -47.76 83.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.82 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.25 -38.15 88.16 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.509 1.504 . . . . 0.0 109.407 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.53 -59.02 4.39 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 126.386 1.946 . . . . 0.0 112.872 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.34 -42.32 65.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 25' ' ' PRO . . . -62.99 -39.68 95.46 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.0 0.92 . . . . 0.0 112.258 -169.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -107.11 5.13 27.61 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.716 1.206 . . . . 0.0 110.653 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.99 85.95 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.648 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.6 m -105.64 -1.79 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.531 1.132 . . . . 0.0 111.199 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.75 116.97 17.91 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 124' ' ' LEU . 66.5 mt -74.11 124.37 31.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.27 -46.82 78.96 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.307 0.643 . . . . 0.0 110.453 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -84.2 -51.92 6.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.365 0.266 . . . . 0.0 110.746 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' H ' HG22 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -72.88 -22.93 60.68 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.276 0.63 . . . . 0.0 111.031 -178.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 49.97 57.59 6.38 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.432 1.093 . . . . 0.0 110.284 -171.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.99 173.45 11.7 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.045 1.338 . . . . 0.0 107.85 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 52.1 tp -87.18 135.29 33.36 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.133 0.973 . . . . 0.0 108.381 172.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.79 165.32 18.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -83.21 113.22 20.51 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.8 m -155.19 166.49 33.4 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.439 -0.788 . . . . 0.0 109.661 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -147.05 142.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -144.06 158.12 43.91 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.293 1.037 . . . . 0.0 110.045 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.3 140.76 41.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.9 mp -131.34 140.14 49.67 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.119 1.368 . . . . 0.0 108.122 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.12 166.0 17.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.924 1.289 . . . . 0.0 110.279 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -47.77 -38.43 15.56 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.436 1.495 . . . . 0.0 112.563 172.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.95 7.4 13.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.643 1.11 . . . . 0.0 113.663 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.52 -7.53 80.59 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 120.971 -1.08 . . . . 0.0 112.853 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -65.38 130.65 44.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 118.66 1.23 . . . . 0.0 108.937 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.9 OUTLIER -63.1 132.72 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 123.582 0.753 . . . . 0.0 109.84 171.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.15 -18.0 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.059 2.144 . . . . 0.0 109.811 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -148.57 150.19 32.88 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.63 133.31 11.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.764 1.626 . . . . 0.0 107.249 174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -146.59 147.1 30.75 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 169.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -117.79 107.87 14.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.5 t -66.11 131.34 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -57.74 -20.58 35.69 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.845 1.258 . . . . 0.0 113.829 -169.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -140.13 130.81 25.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.22 12.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.725 1.61 . . . . 0.0 114.219 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -88.47 -1.9 58.3 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 118.542 0.61 . . . . 0.0 112.225 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -82.45 178.84 8.02 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.77 -1.206 . . . . 0.0 110.062 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -129.72 133.51 25.13 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.656 1.583 . . . . 0.0 109.077 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.6 173.59 11.26 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.508 2.805 . . . . 0.0 110.572 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -73.46 129.51 38.14 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 168.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -100.06 -4.66 29.4 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.96 -38.04 57.97 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -50.45 -58.24 10.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.52 175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.35 -35.81 38.28 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 121.449 1.553 . . . . 0.0 112.133 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.3 mm -60.97 -44.76 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.523 1.056 . . . . 0.0 110.302 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.65 -37.83 87.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 119.506 1.048 . . . . 0.0 110.247 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.9 96.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.359 0.264 . . . . 0.0 110.706 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.53 -43.92 72.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.955 0.502 . . . . 0.0 111.414 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -55.81 -41.67 74.54 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.54 1.063 . . . . 0.0 110.214 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.15 67.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.27 0.628 . . . . 0.0 111.948 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.55 -46.43 14.47 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.365 0.666 . . . . 0.0 111.313 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.8 -44.73 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.801 0.84 . . . . 0.0 111.127 -169.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.357 1.063 . . . . 0.0 109.708 178.224 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.48 67.27 1.53 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.01 0.924 . . . . 0.0 109.805 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.86 154.77 14.38 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.368 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.3 pt -119.35 174.06 5.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.226 1.013 . . . . 0.0 110.546 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -112.61 155.77 23.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -135.38 115.43 13.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? 37.53 53.87 1.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.89 1.676 . . . . 0.0 113.298 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.22 2.43 87.3 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 119.68 -0.511 . . . . 0.0 114.349 174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.6 110.25 3.02 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.782 1.658 . . . . 0.0 109.888 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.75 137.59 74.82 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.13 2.553 . . . . 0.0 111.623 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -142.62 131.59 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.791 0.836 . . . . 0.0 109.759 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -82.29 147.07 29.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.474 1.51 . . . . 0.0 111.462 -169.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.35 148.72 23.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.548 1.139 . . . . 0.0 109.222 174.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.3 t -78.15 -52.97 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 O-C-N 121.962 -0.461 . . . . 0.0 109.791 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.77 24.61 27.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.526 1.06 . . . . 0.0 112.096 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 52.5 -171.55 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.713 2.005 . . . . 0.0 113.38 -173.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -78.26 132.98 37.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -66.15 165.18 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -126.35 155.07 42.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 121.268 -0.895 . . . . 0.0 109.121 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.46 137.18 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.48 85.97 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-O 118.678 -1.068 . . . . 0.0 113.54 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.79 1.68 16.63 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.632 1.716 . . . . 0.0 113.907 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 54.39 65.62 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.287 1.035 . . . . 0.0 111.383 169.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.02 134.03 5.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.02 1.728 . . . . 0.0 112.651 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.04 154.63 26.86 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.491 2.794 . . . . 0.0 113.349 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 18.1 t0 -73.95 70.03 1.47 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.806 2.043 . . . . 0.0 109.676 169.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -62.95 167.24 4.9 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.418 1.487 . . . . 0.0 110.753 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 m -122.79 152.16 40.94 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.81 171.15 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.446 1.898 . . . . 0.0 107.38 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.4 mt -111.56 152.42 27.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.3 p -83.48 179.28 7.69 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.414 0.685 . . . . 0.0 109.608 173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -51.01 -35.7 35.44 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.046 0.938 . . . . 0.0 110.454 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.9 m -101.55 16.15 26.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.549 1.54 . . . . 0.0 110.7 -170.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.2 mt 62.55 23.7 14.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.256 2.222 . . . . 0.0 113.628 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.35 142.86 35.66 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 169.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.22 142.19 47.31 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -147.73 155.4 41.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.5 p -139.69 168.3 20.14 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 47.0 tp -54.36 -42.52 70.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 169.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.33 -23.93 66.08 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.01 -31.67 64.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.836 0.743 . . . . 0.0 110.876 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.3 mtt -75.21 -35.9 61.44 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.628 1.171 . . . . 0.0 111.339 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -53.67 151.45 6.09 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.902 0.858 . . . . 0.0 111.944 -171.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.7 57.23 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.005 1.288 . . . . 0.0 113.272 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -155.03 149.8 26.61 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.759 1.624 . . . . 0.0 107.27 172.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.5 t -58.23 136.69 21.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 170.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -130.68 145.58 51.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -140.96 137.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -138.97 133.09 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.2 m -119.98 150.77 39.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.7 t -133.84 136.96 53.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.3 pt -136.51 139.37 29.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.855 1.662 . . . . 0.0 107.911 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.27 -7.51 18.05 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.083 2.522 . . . . 0.0 112.888 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.0 m -160.87 177.33 10.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.601 2.36 . . . . 0.0 106.268 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.89 -14.3 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.36 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.52 -23.66 50.13 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.058 -1.026 . . . . 0.0 111.376 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 t -57.67 155.81 9.41 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.581 1.552 . . . . 0.0 111.887 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.97 -17.28 70.28 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.892 -0.949 . . . . 0.0 113.1 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -62.15 -24.33 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.603 1.702 . . . . 0.0 113.316 -169.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 15.3 p -61.57 -29.17 69.85 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.269 0.94 . . . . 0.0 112.544 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.84 -34.61 30.06 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.034 -0.416 . . . . 0.0 110.137 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.05 95.53 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.602 0.761 . . . . 0.0 110.765 175.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -152.56 131.09 12.22 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.8 m 138.76 -56.75 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 1 C-N-CA 132.819 4.448 . . . . 0.0 105.52 169.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -60.25 -63.84 1.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.854 0.752 . . . . 0.0 110.993 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -65.06 -40.11 94.22 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.904 -0.497 . . . . 0.0 111.122 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -58.07 -50.34 73.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.07 0.548 . . . . 0.0 111.583 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -64.04 -37.51 87.69 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.276 0.63 . . . . 0.0 109.674 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.426 ' HA ' HG21 ' A' ' 99' ' ' ILE . 4.6 tt0 -58.36 -51.14 71.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.477 0.711 . . . . 0.0 110.166 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.35 -38.21 74.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.806 0.442 . . . . 0.0 110.635 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.38 88.87 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.58 -0.7 . . . . 0.0 111.139 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.77 -19.64 62.71 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.981 0.81 . . . . 0.0 112.62 173.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -76.7 -34.73 58.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.484 1.038 . . . . 0.0 110.839 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.37 -40.62 91.47 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.407 0.683 . . . . 0.0 109.949 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.14 -170.64 43.56 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -75.57 38.22 0.15 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 111.861 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.91 144.45 14.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 O-C-N 120.853 -1.154 . . . . 0.0 109.806 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -73.15 141.26 47.43 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.05 128.7 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -136.8 155.19 50.14 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.662 0.664 . . . . 0.0 111.531 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -125.5 97.84 5.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.98 122.63 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -109.49 164.72 12.25 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.002 1.321 . . . . 0.0 109.206 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.16 176.04 3.49 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 110.295 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.21 -27.84 68.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.239 0.616 . . . . 0.0 111.734 171.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.6 mt -47.77 106.63 0.62 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.01 1.724 . . . . 0.0 110.398 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.1 1.52 7.27 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.094 2.529 . . . . 0.0 113.501 -169.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -43.7 -35.02 1.66 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.645 1.978 . . . . 0.0 115.588 -169.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.1 31.38 0.93 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.767 -0.635 . . . . 0.0 110.917 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -61.65 -30.66 70.86 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 120.785 1.63 . . . . 0.0 111.997 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.87 -19.17 62.35 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.727 1.211 . . . . 0.0 113.994 172.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -67.54 -35.95 80.05 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.815 0.846 . . . . 0.0 110.355 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER 30.84 52.89 0.15 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.045 2.138 . . . . 0.0 113.049 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p -52.97 -37.47 61.21 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.549 -0.719 . . . . 0.0 112.681 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.96 -16.36 59.47 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.312 -0.715 . . . . 0.0 114.308 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.23 -15.91 15.85 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.196 1.398 . . . . 0.0 112.412 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -75.05 94.49 2.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.652 0.66 . . . . 0.0 111.246 -169.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.73 -20.05 2.19 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.609 1.576 . . . . 0.0 111.105 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.426 HG21 ' HA ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -145.6 92.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.516 1.527 . . . . 0.0 107.973 -172.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -47.61 -33.89 7.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.299 1.84 . . . . 0.0 113.988 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.84 -20.06 65.86 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.479 1.111 . . . . 0.0 113.717 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.89 152.81 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.168 0.895 . . . . 0.0 108.945 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -129.34 146.24 51.25 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 90.0 m -97.26 135.11 39.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.98 162.98 16.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.988 1.715 . . . . 0.0 108.089 -173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -138.28 44.25 2.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.41 1.484 . . . . 0.0 109.573 -169.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -44.12 -44.08 7.37 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.516 1.127 . . . . 0.0 112.848 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -59.97 -14.72 17.27 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -76.31 -6.71 52.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.077 -1.015 . . . . 0.0 112.416 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -139.07 -41.31 0.47 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.39 1.476 . . . . 0.0 111.294 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.4 tpt 78.34 2.1 2.69 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 129.149 2.98 . . . . 0.0 113.667 169.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.8 m -63.94 -46.51 84.42 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.852 1.66 . . . . 0.0 111.471 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.89 -39.56 89.72 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.227 1.376 . . . . 0.0 109.307 172.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.2 -53.69 18.31 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 126.41 1.957 . . . . 0.0 113.255 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.98 -34.89 50.69 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 122.989 0.516 . . . . 0.0 110.433 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.57 -39.54 93.93 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.217 0.607 . . . . 0.0 111.587 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -97.98 3.03 49.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.053 1.341 . . . . 0.0 110.31 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 60.79 8.4 10.12 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.348 1.452 . . . . 0.0 114.826 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 m -63.62 -23.04 32.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 C-N-CA 125.902 1.681 . . . . 0.0 110.94 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.38 118.51 4.18 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 124' ' ' LEU . 47.2 mm -87.47 124.12 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -61.35 -53.15 60.31 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.466 1.506 . . . . 0.0 110.718 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -79.97 -49.47 11.81 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.039 0.447 . . . . 0.0 110.5 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' H ' HG22 ' A' ' 121' ' ' ILE . 29.4 tp -72.83 -23.11 60.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.508 1.123 . . . . 0.0 112.779 -171.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 51.17 50.28 19.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.287 1.035 . . . . 0.0 110.768 -169.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.5 mt -138.12 -173.25 3.47 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.7 pt? -113.24 146.69 38.91 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.199 1.0 . . . . 0.0 111.327 175.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.61 140.86 57.96 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.919 1.688 . . . . 0.0 113.805 -169.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -65.87 110.86 3.02 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 p -156.13 168.22 27.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.454 0.57 . . . . 0.0 111.166 -170.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.04 148.26 18.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.92 1.288 . . . . 0.0 108.129 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -145.7 154.5 42.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.503 1.121 . . . . 0.0 109.296 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.5 t -135.91 139.87 45.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -132.21 141.02 48.91 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.009 1.323 . . . . 0.0 108.233 -169.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.39 162.43 20.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.716 1.206 . . . . 0.0 109.351 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.5 -32.63 41.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.901 1.281 . . . . 0.0 113.228 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -80.25 -10.32 59.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.7 -2.71 49.08 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.388 0.994 . . . . 0.0 113.605 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.85 137.94 58.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.55 1.675 . . . . 0.0 108.753 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.25 129.46 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 80.6 t -113.26 -20.79 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.825 2.05 . . . . 0.0 109.541 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -143.84 148.34 35.38 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.351 1.06 . . . . 0.0 108.194 169.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.75 132.18 12.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.513 1.525 . . . . 0.0 107.701 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -149.77 147.59 28.19 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.662 1.185 . . . . 0.0 108.444 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.12 116.07 14.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.47 134.69 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 m -58.95 -18.68 35.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.154 0.982 . . . . 0.0 112.956 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -140.04 122.5 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -57.69 -30.07 65.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.2 p -83.16 14.87 3.16 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.654 1.115 . . . . 0.0 111.983 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -125.77 -177.06 3.79 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.567 1.947 . . . . 0.0 108.91 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -137.78 151.5 70.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.244 1.418 . . . . 0.0 109.901 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.96 170.75 7.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.67 2.913 . . . . 0.0 111.606 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -77.33 87.1 3.73 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -68.32 1.12 3.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.3 1.44 . . . . 0.0 114.118 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -31.63 72.47 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 170.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -62.02 -53.07 62.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.324 1.049 . . . . 0.0 111.801 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -65.83 -31.26 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-N 121.742 1.658 . . . . 0.0 112.422 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.6 mm -58.3 -48.89 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.131 1.332 . . . . 0.0 109.35 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.17 -33.47 76.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.821 0.737 . . . . 0.0 110.81 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.59 -40.28 92.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.734 0.414 . . . . 0.0 111.192 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.77 -49.51 65.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.95 -0.548 . . . . 0.0 110.895 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -63.64 -30.46 71.57 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.739 1.154 . . . . 0.0 111.385 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.94 69.35 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.442 1.019 . . . . 0.0 111.835 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.19 -45.77 17.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.147 0.579 . . . . 0.0 111.478 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.0 t -68.74 -46.69 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.235 0.614 . . . . 0.0 111.024 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.5 tttm . . . . . 0 C--O 1.248 0.985 0 C-N-CA 124.401 1.081 . . . . 0.0 109.903 -179.706 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.55 58.17 2.63 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.31 1.053 . . . . 0.0 109.961 172.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -148.41 140.64 24.14 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.1 pt -131.76 -178.27 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 m -115.19 147.67 40.01 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -134.18 120.67 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.9 mttt 43.83 39.69 2.73 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.053 1.341 . . . . 0.0 111.916 -173.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.57 12.6 79.96 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.74 117.44 3.95 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.174 -1.348 . . . . 0.0 109.846 173.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.21 139.34 89.74 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.342 2.695 . . . . 0.0 112.222 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.6 m -145.66 130.17 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.225 1.41 . . . . 0.0 109.889 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -75.63 161.67 28.91 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.351 1.86 . . . . 0.0 110.462 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -113.68 160.0 19.09 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.31 1.444 . . . . 0.0 110.173 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.78 -59.71 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.837 -0.539 . . . . 0.0 111.242 -169.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.2 32.61 6.94 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.397 0.998 . . . . 0.0 113.439 -169.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.43 -167.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.54 107.07 17.89 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.482 1.513 . . . . 0.0 109.748 -169.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.41 145.75 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 168.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -143.52 160.79 39.97 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.595 0.758 . . . . 0.0 109.028 -174.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.75 134.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.31 3.37 89.81 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.796 -1.002 . . . . 0.0 113.988 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.03 -7.02 59.47 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.463 1.631 . . . . 0.0 112.298 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 58.07 178.18 0.06 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.369 1.467 . . . . 0.0 111.516 -169.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.09 24.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.792 1.637 . . . . 0.0 108.729 -171.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.18 158.04 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.708 2.272 . . . . 0.0 109.907 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 26.1 t70 -81.41 68.82 7.88 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.378 1.471 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -63.1 163.25 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.977 171.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.5 m -121.79 148.95 44.01 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -152.66 167.67 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.106 2.162 . . . . 0.0 105.76 -173.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -118.49 156.05 29.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 120.787 -1.195 . . . . 0.0 108.231 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.3 p -81.36 173.59 12.32 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.767 1.227 . . . . 0.0 110.016 172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -63.77 -26.71 68.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.933 -1.104 . . . . 0.0 110.798 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 p -77.54 1.43 19.49 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.512 1.525 . . . . 0.0 111.94 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.1 mt 56.94 47.78 17.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.968 2.107 . . . . 0.0 111.986 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -116.01 141.96 47.43 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 -64.52 144.09 57.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.464 1.105 . . . . 0.0 109.485 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -146.52 157.66 43.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 127.499 2.32 . . . . 0.0 105.477 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.6 p -146.62 167.82 22.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 67.5 tp -53.83 -43.78 69.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 170.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.37 66.52 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.85 -30.6 58.99 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.878 0.763 . . . . 0.0 111.114 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.3 mtt -73.88 -39.69 63.74 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.388 1.075 . . . . 0.0 110.945 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -53.56 140.91 27.13 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 123.492 0.717 . . . . 0.0 109.862 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.6 -22.1 8.89 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.958 1.266 . . . . 0.0 112.738 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -148.36 152.83 37.71 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.888 1.275 . . . . 0.0 108.681 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.63 142.43 15.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.2 m -135.54 148.95 49.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.883 0.873 . . . . 0.0 109.036 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.4 mt -134.73 138.31 49.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.01 124.62 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -171.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 p -106.59 148.42 28.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 168.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.6 t -137.05 127.88 40.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 pt -143.16 146.83 38.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 110.357 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.69 -39.69 2.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.072 1.848 . . . . 0.0 111.484 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.4 m -152.5 173.06 15.61 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.973 1.709 . . . . 0.0 109.097 -169.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 pt -121.01 -29.8 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.51 1.124 . . . . 0.0 111.45 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -64.09 -11.64 31.75 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.537 0.735 . . . . 0.0 111.669 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.55 -22.07 54.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.807 2.043 . . . . 0.0 112.532 169.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.23 -0.12 25.24 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.265 0.936 . . . . 0.0 112.942 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.55 -15.6 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 118.67 1.235 . . . . 0.0 112.856 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 60.3 m -54.95 -25.96 33.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.171 1.388 . . . . 0.0 113.289 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -124.58 32.24 5.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.142 1.377 . . . . 0.0 109.395 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.31 -166.98 2.37 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.414 1.486 . . . . 0.0 109.277 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -43.57 -45.66 6.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.375 1.87 . . . . 0.0 113.938 -171.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.6 m -56.03 -42.36 76.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.279 1.4 . . . . 0.0 112.424 -169.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -65.94 -53.0 44.89 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.969 0.804 . . . . 0.0 110.398 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -64.69 -41.0 96.35 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.146 0.884 . . . . 0.0 111.146 -175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -56.2 -50.29 71.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.781 . . . . 0.0 110.269 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -62.56 -37.86 87.8 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.486 0.314 . . . . 0.0 110.692 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.76 -36.83 85.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.604 0.762 . . . . 0.0 110.695 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -74.82 -42.6 57.72 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.001 -1.062 . . . . 0.0 110.196 175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -52.91 -49.35 66.11 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.82 1.248 . . . . 0.0 110.463 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.84 -12.56 25.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.598 1.159 . . . . 0.0 113.563 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -108.36 -9.04 15.5 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 113.037 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.6 mt -64.96 -32.41 74.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.164 1.347 . . . . 0.0 110.584 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.08 -169.95 43.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.17 29.84 0.1 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.976 0.888 . . . . 0.0 112.451 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.8 m -56.72 149.76 3.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 O-C-N 120.68 -1.263 . . . . 0.0 110.34 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -71.78 141.18 49.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 168.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -142.55 131.55 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -139.01 156.67 47.03 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.841 0.856 . . . . 0.0 110.562 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.6 m -133.32 105.26 6.86 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 mt -84.7 128.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.7 m -124.33 160.81 27.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.572 1.149 . . . . 0.0 109.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.46 -163.73 0.13 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.037 169.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -124.37 21.65 8.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.52 1.128 . . . . 0.0 111.02 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.91 154.18 77.33 Favored Pre-proline 0 CA--C 1.537 0.481 0 O-C-N 121.282 -0.886 . . . . 0.0 108.888 169.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.72 -32.11 53.73 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.711 2.274 . . . . 0.0 112.886 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -75.63 -3.82 36.61 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.578 1.551 . . . . 0.0 113.241 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.28 146.43 44.31 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.947 1.299 . . . . 0.0 109.907 -170.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 45.38 -9.19 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 130.293 3.437 . . . . 0.0 119.765 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.2 60.55 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 121.32 1.873 . . . . 0.0 114.391 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -124.54 3.05 8.33 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.278 1.431 . . . . 0.0 111.337 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.6 p90 35.36 42.85 0.12 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.409 2.284 . . . . 0.0 113.784 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.41 -30.5 71.61 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.92 -10.88 73.49 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.338 -0.701 . . . . 0.0 112.622 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -126.15 32.47 5.22 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 110.293 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -137.56 132.06 32.6 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.8 -9.57 65.18 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.683 0.658 . . . . 0.0 111.544 -169.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mt -134.87 76.8 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -51.7 -31.69 27.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.3 1.44 . . . . 0.0 114.821 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -63.9 -27.96 69.51 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.04 151.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -133.37 143.97 49.3 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 m -93.07 143.97 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.1 mp -118.84 158.72 25.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.073 1.349 . . . . 0.0 108.753 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 m -128.88 67.02 1.41 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.997 2.119 . . . . 0.0 108.449 -169.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.0 -35.9 48.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 123.257 0.623 . . . . 0.0 112.219 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -11.37 49.49 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.961 -1.087 . . . . 0.0 113.591 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -76.95 -29.75 55.73 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.887 1.221 . . . . 0.0 111.545 169.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -149.01 88.58 1.61 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 4.83 0.06 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.262 1.425 . . . . 0.0 113.581 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.3 m -55.92 -42.57 76.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.92 1.236 . . . . 0.0 110.722 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.68 -48.92 79.65 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.636 1.107 . . . . 0.0 110.84 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.91 -42.5 98.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 123.66 0.648 . . . . 0.0 111.992 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.77 -42.01 67.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.454 0.627 . . . . 0.0 110.323 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.58 86.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.348 1.059 . . . . 0.0 111.913 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -92.01 3.53 55.03 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.925 0.89 . . . . 0.0 111.22 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.94 -4.84 8.97 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.625 1.107 . . . . 0.0 115.057 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.9 m -66.99 -8.94 8.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.986 2.114 . . . . 0.0 112.212 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.03 109.59 3.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.524 HG22 ' H ' ' A' ' 124' ' ' LEU . 67.7 mt -66.88 127.87 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -66.49 -49.76 65.52 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 124.298 1.039 . . . . 0.0 110.636 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -76.74 -49.56 15.7 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.524 ' H ' HG22 ' A' ' 121' ' ' ILE . 17.8 tp -80.26 -17.61 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 50.0 48.78 21.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.599 1.16 . . . . 0.0 110.662 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.8 tp -137.84 161.67 35.99 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 108.426 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.5 tp -72.91 129.76 38.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 110.722 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.41 168.07 18.23 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.864 1.266 . . . . 0.0 113.634 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -91.67 115.21 27.86 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.108 1.363 . . . . 0.0 108.191 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.7 m -154.48 166.84 32.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.105 0.562 . . . . 0.0 109.672 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.38 146.86 18.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -148.36 156.66 42.79 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.066 1.347 . . . . 0.0 109.105 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.96 144.97 30.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.2 mp -132.46 139.68 48.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.345 1.058 . . . . 0.0 108.661 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.95 166.62 13.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.223 1.409 . . . . 0.0 110.038 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -52.49 -31.38 34.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.149 1.38 . . . . 0.0 112.393 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -81.05 2.25 27.95 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.566 1.147 . . . . 0.0 112.7 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.4 -5.94 75.03 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 120.966 -1.084 . . . . 0.0 112.959 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.38 126.47 27.46 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 118.638 1.219 . . . . 0.0 108.964 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.77 128.94 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.863 0.865 . . . . 0.0 109.625 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.5 t -116.83 -17.46 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.391 1.876 . . . . 0.0 109.851 -176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -145.38 147.68 32.53 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.26 135.58 15.91 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.161 1.385 . . . . 0.0 108.481 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.42 149.49 30.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.811 0.844 . . . . 0.0 109.299 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -127.05 106.44 9.28 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.434 2.294 . . . . 0.0 104.922 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 t -69.3 134.53 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -60.95 -19.5 60.96 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.945 1.298 . . . . 0.0 113.855 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -138.77 127.77 23.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.82 39.13 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.2 p -98.57 -5.79 31.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.431 1.092 . . . . 0.0 112.048 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -83.57 -174.47 5.3 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.373 1.469 . . . . 0.0 109.347 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -135.6 154.22 78.09 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.641 1.176 . . . . 0.0 109.905 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.55 172.71 10.08 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.938 2.426 . . . . 0.0 109.768 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -69.23 120.58 15.29 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 168.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -93.45 -2.49 54.47 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -76.02 -34.93 59.71 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.25 -54.36 55.58 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.766 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.65 -35.47 58.26 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.883 1.708 . . . . 0.0 111.885 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 mm -61.38 -50.39 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.465 1.029 . . . . 0.0 109.736 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.14 -36.95 84.49 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.986 0.812 . . . . 0.0 110.219 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.44 92.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.056 0.543 . . . . 0.0 111.068 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.43 -50.28 27.47 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.488 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.74 -27.24 69.07 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.235 1.38 . . . . 0.0 111.469 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.8 -31.68 68.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.668 1.122 . . . . 0.0 112.02 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.42 -44.21 36.91 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.193 0.597 . . . . 0.0 110.873 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.85 -48.42 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.365 0.666 . . . . 0.0 110.689 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 124.873 1.269 . . . . 0.0 110.031 179.742 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.867 0.365 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.7 44.6 2.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.075 1.75 . . . . 0.0 109.323 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -63.29 155.52 28.33 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.79 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.5 pt -131.46 179.58 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.723 0.809 . . . . 0.0 109.933 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -123.18 150.85 42.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -137.25 -84.26 0.33 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.455 1.025 . . . . 0.0 109.818 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.4 43.34 0.54 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.064 1.346 . . . . 0.0 110.97 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.59 29.78 70.52 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.261 0.934 . . . . 0.0 112.141 -170.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.67 152.64 24.75 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.33 145.6 34.45 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.872 2.382 . . . . 0.0 110.65 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.97 139.04 30.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.53 1.132 . . . . 0.0 109.798 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -79.14 158.78 27.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.038 1.735 . . . . 0.0 110.038 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -122.93 149.77 43.82 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.05 1.74 . . . . 0.0 107.441 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.1 t -80.25 -83.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 118.364 0.529 . . . . 0.0 110.54 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.95 41.54 2.61 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.447 1.498 . . . . 0.0 111.908 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -60.84 171.66 1.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.648 1.979 . . . . 0.0 114.098 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 68.25 34.88 3.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.239 1.816 . . . . 0.0 113.82 169.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.91 142.99 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 168.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -151.11 162.09 41.51 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.428 0.691 . . . . 0.0 109.392 -172.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.54 133.96 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.505 0.722 . . . . 0.0 109.76 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.67 1.74 90.57 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.156 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -85.11 -8.91 58.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.923 1.862 . . . . 0.0 112.297 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 57.35 174.39 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.755 1.622 . . . . 0.0 111.322 -169.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.43 139.98 26.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.111 1.364 . . . . 0.0 109.001 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.81 -27.91 80.12 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.205 2.604 . . . . 0.0 114.853 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 t70 84.39 116.25 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.284 2.634 . . . . 0.0 106.934 -169.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -131.22 161.74 31.55 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.856 1.263 . . . . 0.0 110.451 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -96.56 157.98 15.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.06 171.38 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 128.029 2.532 . . . . 0.0 106.641 172.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 tp -129.2 134.21 47.91 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.0 p -73.49 164.96 25.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -64.26 -13.83 51.94 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.758 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 m -83.25 1.07 42.69 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.452 1.501 . . . . 0.0 112.04 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp 57.31 53.12 7.94 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.797 2.039 . . . . 0.0 111.602 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -124.3 141.45 52.06 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.178 0.991 . . . . 0.0 108.433 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -76.22 143.53 40.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.16 0.981 . . . . 0.0 109.195 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -149.56 159.91 43.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.877 2.471 . . . . 0.0 105.039 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.0 m -142.32 163.78 31.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.2 tp -53.72 -38.11 63.97 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 122.321 -0.237 . . . . 0.0 110.659 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.66 -23.64 64.96 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.71 -32.23 57.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.937 0.789 . . . . 0.0 110.951 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.5 mtt -72.71 -38.31 67.54 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.378 1.071 . . . . 0.0 110.694 176.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -53.24 142.34 21.22 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.63 0.772 . . . . 0.0 109.889 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.32 -20.74 8.34 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.413 1.483 . . . . 0.0 112.293 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -150.16 154.69 38.45 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.197 1.399 . . . . 0.0 108.797 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.4 t -57.89 138.19 19.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.8 m -133.44 142.81 48.48 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.0 mt -136.19 132.69 49.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.3 mt -138.91 121.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.17 150.97 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 t -131.21 134.25 61.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 pt -142.67 152.15 58.91 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.67 -46.94 4.47 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.446 1.431 . . . . 0.0 110.341 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.1 m -144.29 173.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 108.931 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.42 -26.27 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 171.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.13 -32.53 73.12 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 112.158 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -65.97 133.63 51.25 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.991 0.916 . . . . 0.0 109.888 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.0 -21.95 54.04 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.412 1.006 . . . . 0.0 114.476 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.85 -15.49 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.653 1.226 . . . . 0.0 112.262 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -56.7 -26.84 57.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.332 0.969 . . . . 0.0 111.708 169.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -125.21 -34.93 2.68 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.775 1.23 . . . . 0.0 110.782 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.33 -24.23 66.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.214 0.605 . . . . 0.0 112.081 176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.97 -41.71 0.31 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 118.637 -0.697 . . . . 0.0 112.469 169.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . 0.252 3.4 m -65.54 -37.17 85.94 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -167.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -64.77 -53.7 42.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 120.014 1.279 . . . . 0.0 110.407 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -66.04 -42.27 89.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 118.368 0.531 . . . . 0.0 111.607 -172.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.53 -50.43 73.57 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.719 0.808 . . . . 0.0 110.284 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -64.25 -38.19 90.17 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.833 0.288 . . . . 0.0 111.0 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.15 -47.42 83.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.094 0.958 . . . . 0.0 110.24 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -70.04 -44.87 68.35 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 118.435 0.561 . . . . 0.0 110.525 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.76 -42.29 79.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.725 0.693 . . . . 0.0 111.134 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.54 -14.57 43.54 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -102.92 -15.37 16.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.489 1.516 . . . . 0.0 112.02 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 mp -59.67 -37.71 79.51 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.638 1.108 . . . . 0.0 110.718 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.57 -167.89 40.64 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -76.07 25.13 0.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.843 -0.798 . . . . 0.0 112.829 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -53.51 151.37 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.329 1.452 . . . . 0.0 111.449 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -77.08 139.62 40.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.13 123.3 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -139.47 156.48 46.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.181 0.592 . . . . 0.0 110.755 -175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.2 m -131.41 116.56 17.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.3 mt -100.61 140.67 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.272 1.029 . . . . 0.0 108.27 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.8 m -140.99 175.38 9.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.313 1.445 . . . . 0.0 112.054 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.26 -176.94 6.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.924 1.29 . . . . 0.0 113.646 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -66.31 -28.0 68.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.325 1.85 . . . . 0.0 113.711 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.5 148.93 63.47 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.928 0.891 . . . . 0.0 111.194 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.66 -36.04 65.96 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.745 1.63 . . . . 0.0 110.438 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -61.85 -5.93 2.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.968 1.707 . . . . 0.0 113.311 171.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -118.14 3.71 12.02 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.956 1.702 . . . . 0.0 111.44 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -138.83 21.41 2.66 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.405 1.002 . . . . 0.0 111.786 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.74 175.21 10.34 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.892 1.677 . . . . 0.0 108.437 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 73.56 -20.52 0.29 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.243 2.617 . . . . 0.0 113.488 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 36.05 47.6 0.45 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.014 2.526 . . . . 0.0 115.633 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.3 m -52.11 -34.89 46.27 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -171.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.41 -8.31 64.35 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.602 -1.11 . . . . 0.0 113.918 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.83 29.19 3.83 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.03 1.415 . . . . 0.0 111.546 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -135.88 69.21 1.43 Allowed 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.593 1.157 . . . . 0.0 108.131 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.7 -27.04 0.26 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.357 0.98 . . . . 0.0 111.641 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.17 98.61 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.759 1.624 . . . . 0.0 106.867 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.83 -28.69 57.58 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.994 1.718 . . . . 0.0 114.267 -169.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -61.69 -32.12 72.29 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.12 0.568 . . . . 0.0 112.49 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.08 152.67 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.89 145.97 42.79 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.6 m -88.52 138.47 31.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.0 mp -128.64 167.63 16.92 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.085 2.154 . . . . 0.0 106.973 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.2 m -146.83 172.37 13.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.248 1.419 . . . . 0.0 107.585 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.81 2.6 3.16 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.429 0.633 . . . . 0.0 111.534 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.01 -16.59 1.1 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -30.99 72.02 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.365 -0.826 . . . . 0.0 111.377 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -153.42 -7.48 0.17 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 tpt 56.45 27.6 12.39 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.182 1.393 . . . . 0.0 111.377 -169.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.8 t -63.46 -62.36 1.72 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.542 1.537 . . . . 0.0 109.732 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -59.86 -38.93 83.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.9 0.48 . . . . 0.0 110.464 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.11 -56.66 13.51 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.619 2.057 . . . . 0.0 112.12 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.73 -36.73 62.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.686 0.743 . . . . 0.0 110.343 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.08 98.25 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.208 0.603 . . . . 0.0 111.773 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -102.23 3.84 38.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.297 1.039 . . . . 0.0 110.672 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.81 5.0 29.44 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 118.35 -1.25 . . . . 0.0 114.677 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.43 -13.68 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 119.139 1.47 . . . . 0.0 111.161 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -65.37 102.41 0.68 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.542 HG22 ' H ' ' A' ' 124' ' ' LEU . 81.3 mt -63.17 124.81 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -64.99 -45.37 85.88 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.958 0.903 . . . . 0.0 110.978 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.32 -49.45 12.42 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 117.917 0.326 . . . . 0.0 110.669 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.542 ' H ' HG22 ' A' ' 121' ' ' ILE . 15.0 tp -81.59 -14.21 57.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -170.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 47.84 48.38 17.71 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.06 1.344 . . . . 0.0 110.58 -172.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.84 165.24 25.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.827 0.851 . . . . 0.0 108.843 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 129.22 37.34 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.08 160.68 26.15 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.763 1.225 . . . . 0.0 111.646 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 104.63 16.61 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -145.74 163.17 35.79 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.596 0.759 . . . . 0.0 108.959 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.27 145.11 18.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -145.32 154.96 42.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 109.321 -169.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.82 136.54 50.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 171.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.31 139.63 51.7 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.868 1.267 . . . . 0.0 108.013 -172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 165.22 11.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.077 1.351 . . . . 0.0 110.245 170.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.6 -34.35 25.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.22 1.408 . . . . 0.0 112.816 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.8 12.1 20.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.059 0.943 . . . . 0.0 113.113 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.46 -6.17 82.8 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.451 1.024 . . . . 0.0 113.132 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.29 138.55 58.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.57 1.185 . . . . 0.0 109.518 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.89 133.18 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.17 -25.03 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.928 1.291 . . . . 0.0 109.91 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -150.59 151.8 33.11 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 169.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.51 138.41 16.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.578 1.551 . . . . 0.0 107.916 173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -147.5 148.33 31.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.763 0.825 . . . . 0.0 108.824 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -127.43 112.54 15.1 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 t -66.88 133.11 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -60.58 -16.13 34.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.562 1.145 . . . . 0.0 112.66 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -139.33 111.67 7.58 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.36 -18.23 64.43 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -174.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.6 p -83.58 9.39 11.56 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.136 0.974 . . . . 0.0 110.976 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -132.68 174.02 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.231 2.612 . . . . 0.0 108.12 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -122.83 158.64 56.53 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.749 1.219 . . . . 0.0 111.553 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.75 179.34 3.88 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.206 2.604 . . . . 0.0 110.225 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -80.35 85.5 5.82 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -67.61 -0.46 3.94 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.438 1.495 . . . . 0.0 113.114 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.67 -25.8 49.82 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 121.169 -0.957 . . . . 0.0 109.364 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -59.53 -52.65 72.62 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.476 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -62.95 -33.73 73.62 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.585 1.602 . . . . 0.0 112.573 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 mm -59.79 -47.2 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.708 1.14 . . . . 0.0 109.525 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.66 -35.63 81.19 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.326 0.967 . . . . 0.0 110.931 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.76 -42.17 97.87 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.227 0.211 . . . . 0.0 110.801 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.7 -40.23 80.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 119.08 -0.486 . . . . 0.0 111.321 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -57.53 -42.3 82.62 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.448 1.022 . . . . 0.0 110.242 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.31 -31.66 69.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.149 0.431 . . . . 0.0 111.965 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.75 -55.44 5.64 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.247 0.476 . . . . 0.0 110.745 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.19 -51.95 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 111.177 -169.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 21.1 pttm . . . . . 0 C--O 1.25 1.128 0 C-N-CA 127.792 2.437 . . . . 0.0 112.219 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.99 117.56 2.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.823 1.249 . . . . 0.0 110.009 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -154.94 140.81 18.21 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.21 -175.22 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 125.161 1.384 . . . . 0.0 107.606 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -123.17 160.39 26.61 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -147.71 127.11 13.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 169.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 43.33 39.68 2.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.942 1.297 . . . . 0.0 112.908 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.24 15.27 74.76 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.167 0.889 . . . . 0.0 114.674 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.49 120.74 4.52 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.22 142.95 86.69 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.93 2.42 . . . . 0.0 111.259 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.43 135.02 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.231 1.013 . . . . 0.0 109.5 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -76.55 164.35 26.02 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.828 2.051 . . . . 0.0 109.261 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.83 165.15 23.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.869 0.868 . . . . 0.0 109.829 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.6 134.83 57.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.809 1.644 . . . . 0.0 107.207 -171.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.2 -12.57 63.61 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.122 0.868 . . . . 0.0 114.002 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 53.26 164.92 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.354 3.061 . . . . 0.0 115.375 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -67.03 164.88 16.83 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.215 1.006 . . . . 0.0 113.319 -169.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.69 166.26 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 126.607 1.963 . . . . 0.0 106.589 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -149.15 165.59 31.35 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.695 0.798 . . . . 0.0 109.061 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 141' ' ' VAL . 1.5 p -52.26 131.72 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 122.76 0.424 . . . . 0.0 109.893 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.19 -10.84 71.51 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.654 1.121 . . . . 0.0 113.322 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.01 -10.78 59.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.329 1.565 . . . . 0.0 114.113 -171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 62.39 104.42 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.919 1.688 . . . . 0.0 112.5 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.13 134.57 68.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.523 1.129 . . . . 0.0 111.833 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.44 -27.01 83.9 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.541 2.827 . . . . 0.0 115.392 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t70 70.78 112.44 0.05 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.954 2.502 . . . . 0.0 111.34 -169.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -143.27 168.88 18.73 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.477 1.511 . . . . 0.0 109.73 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 159.58 33.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.089 1.755 . . . . 0.0 111.592 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.1 m -141.79 178.14 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 129.184 2.994 . . . . 0.0 105.833 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -124.85 133.54 53.06 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -79.81 -176.8 5.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.309 0.576 . . . . 0.0 110.413 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -46.94 -36.57 7.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.752 1.221 . . . . 0.0 111.722 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 m -111.73 20.67 16.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.318 1.447 . . . . 0.0 110.556 -171.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.9 mt 56.24 32.59 20.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.96 2.104 . . . . 0.0 113.265 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.61 142.99 46.54 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.13 57.61 3.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.87 1.268 . . . . 0.0 110.136 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.6 tttp -59.54 158.21 10.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 108.107 169.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -137.57 166.76 23.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.89 -30.6 64.05 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 122.014 -0.429 . . . . 0.0 111.527 174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.99 -20.99 64.47 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.008 -1.057 . . . . 0.0 113.626 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.06 -28.86 43.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.271 0.941 . . . . 0.0 110.754 172.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 38.6 mtt -71.38 -39.11 71.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.056 0.942 . . . . 0.0 110.497 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -53.47 135.39 39.8 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.86 -26.52 3.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.17 1.367 . . . . 0.0 112.169 -171.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -151.28 159.86 44.11 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.337 1.055 . . . . 0.0 109.722 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.9 t -58.48 136.67 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 170.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 45.8 m -136.96 148.74 47.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.952 1.301 . . . . 0.0 108.295 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 94.7 mt -133.63 135.45 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.0 mt -136.96 104.79 3.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 149.6 25.5 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 168.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.5 t -136.85 141.25 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.99 154.51 54.9 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.299 1.04 . . . . 0.0 111.205 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -76.09 -50.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.775 1.65 . . . . 0.0 108.316 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -159.95 170.25 21.76 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 -169.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.54 -7.13 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.991 1.717 . . . . 0.0 109.783 168.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -51.74 -26.13 8.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.394 1.877 . . . . 0.0 113.141 170.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 p -61.49 -9.57 5.98 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.813 2.045 . . . . 0.0 113.156 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.72 16.38 75.52 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.183 0.901 . . . . 0.0 112.124 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 m -71.17 -7.33 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.547 1.539 . . . . 0.0 113.165 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 91.9 m -47.99 -30.0 3.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.557 1.543 . . . . 0.0 114.405 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.91 -30.23 70.79 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.22 8.81 0.94 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.522 ' HG3' ' H ' ' A' ' 65' ' ' ARG . 4.6 pt20 -66.57 -169.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -174.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -42.96 -24.55 0.07 Allowed 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 127.392 2.277 . . . . 0.0 113.092 169.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' H ' ' HG3' ' A' ' 63' ' ' GLN . 13.7 tpt180 -43.52 -50.93 7.03 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.934 1.294 . . . . 0.0 111.073 169.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -60.76 -50.11 74.78 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 119.06 0.846 . . . . 0.0 109.589 -177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -60.21 -47.02 87.74 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.3 -40.31 77.59 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.153 1.781 . . . . 0.0 110.255 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -69.23 -33.3 73.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.98 1.312 . . . . 0.0 110.817 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -72.34 -45.78 58.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.047 0.839 . . . . 0.0 109.675 169.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.66 -44.36 90.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.824 1.249 . . . . 0.0 111.882 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.52 -20.98 63.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 112.441 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -84.85 -16.73 40.3 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.314 0.961 . . . . 0.0 112.805 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.19 -29.95 69.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.629 1.104 . . . . 0.0 112.237 -169.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.26 -162.03 35.19 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.86 17.73 0.16 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.731 1.212 . . . . 0.0 112.509 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 m -55.42 145.38 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.601 1.561 . . . . 0.0 110.855 -172.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -71.38 138.88 49.53 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.45 119.29 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -127.44 153.22 46.55 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.889 0.875 . . . . 0.0 109.575 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -128.52 116.54 19.83 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.9 mt -99.72 140.17 19.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -140.25 173.18 11.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.124 0.97 . . . . 0.0 111.663 -171.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.7 168.3 20.32 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 167.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -70.45 -10.51 59.34 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.452 -0.78 . . . . 0.0 112.923 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.4 tp -52.53 134.51 44.21 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.058 1.343 . . . . 0.0 110.709 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.8 -41.02 77.85 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.159 2.573 . . . . 0.0 112.464 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -82.86 26.81 0.57 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.732 1.213 . . . . 0.0 112.305 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.78 -3.62 5.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.822 1.649 . . . . 0.0 109.485 168.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -77.93 89.03 4.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.456 1.122 . . . . 0.0 108.358 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.04 -9.74 2.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.511 1.924 . . . . 0.0 115.148 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.0 ttm-85 -53.76 -23.09 10.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.727 1.603 . . . . 0.0 111.616 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 -27.96 66.09 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.773 0.715 . . . . 0.0 112.074 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 91.0 m -146.2 -69.21 0.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.516 1.126 . . . . 0.0 111.223 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.3 -33.25 15.49 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 127.494 2.473 . . . . 0.0 115.6 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.49 18.97 5.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.156 1.382 . . . . 0.0 110.834 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -80.55 140.55 35.75 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.918 -0.489 . . . . 0.0 110.123 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.38 -49.29 2.97 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.143 0.878 . . . . 0.0 112.184 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 pt -76.11 67.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 C-N-CA 125.663 1.585 . . . . 0.0 109.859 169.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.79 -22.63 3.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.986 2.514 . . . . 0.0 114.319 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -59.58 -38.26 80.7 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.625 0.77 . . . . 0.0 111.547 172.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.5 t -69.42 141.26 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.41 144.78 47.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.7 m -98.95 135.45 40.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.47 164.48 21.81 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 128.194 2.598 . . . . 0.0 106.55 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 67.0 m -131.27 167.46 19.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 169.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -138.79 -26.51 0.86 Allowed 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 118.459 -0.781 . . . . 0.0 112.506 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -51.81 -29.91 21.1 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -63.81 -24.64 67.84 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.53 -0.731 . . . . 0.0 112.919 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -122.56 -26.37 4.57 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.538 1.135 . . . . 0.0 111.688 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.1 tpt 65.67 2.66 2.16 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.566 3.146 . . . . 0.0 114.293 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.6 m -72.4 -39.47 67.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.562 -1.209 . . . . 0.0 112.433 -170.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.35 -39.5 94.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.683 1.583 . . . . 0.0 109.501 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.46 -48.24 77.56 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 124.253 0.93 . . . . 0.0 111.116 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.9 -46.05 76.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 117.876 0.838 . . . . 0.0 110.175 174.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.92 68.63 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.39 1.076 . . . . 0.0 113.355 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -108.84 3.69 22.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.372 1.069 . . . . 0.0 111.545 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.53 31.01 77.42 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 119.531 1.059 . . . . 0.0 112.767 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.63 -2.78 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -70.79 105.56 3.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.62 133.1 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -72.65 -50.45 24.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.253 0.621 . . . . 0.0 110.191 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.94 -56.32 4.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.929 0.492 . . . . 0.0 110.767 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.0 tp -68.8 -21.09 64.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.399 0.68 . . . . 0.0 111.912 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 52.79 42.57 31.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.559 1.543 . . . . 0.0 112.19 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.72 170.51 14.24 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.718 1.207 . . . . 0.0 108.234 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.7 134.94 46.62 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.05 152.37 41.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.333 0.653 . . . . 0.0 111.262 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -72.78 124.16 24.8 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.1 m -164.31 169.91 16.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.373 1.069 . . . . 0.0 108.221 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.38 147.95 18.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -142.75 156.74 45.04 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.562 1.545 . . . . 0.0 108.473 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.77 142.47 42.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 tp -137.27 127.65 26.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.726 1.211 . . . . 0.0 109.412 -168.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.27 168.38 17.45 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.466 1.106 . . . . 0.0 111.14 172.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -57.67 -26.17 61.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.858 1.663 . . . . 0.0 113.296 -173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.1 1.18 35.96 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.496 1.518 . . . . 0.0 111.418 -176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.62 10.01 53.89 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 121.258 -0.901 . . . . 0.0 112.847 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -75.43 114.6 14.16 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.706 1.753 . . . . 0.0 107.937 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.04 129.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.402 ' HA ' HG23 ' A' ' 20' ' ' VAL . 7.8 p -114.24 -11.53 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.391 1.076 . . . . 0.0 110.319 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -150.6 151.0 31.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.0 133.99 13.15 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.187 1.795 . . . . 0.0 106.397 172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -144.98 138.19 26.62 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.22 114.82 23.02 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.66 144.49 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.6 m -59.32 -23.27 62.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 111.759 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -145.77 126.31 14.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.03 5.61 1.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.294 1.438 . . . . 0.0 114.385 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 p -114.77 24.37 11.84 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.336 1.454 . . . . 0.0 109.693 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -138.25 162.74 33.54 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 129.317 3.047 . . . . 0.0 106.377 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -115.44 153.7 47.65 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 119.764 1.166 . . . . 0.0 113.022 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.07 179.18 6.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 124.065 3.177 . . . . 0.0 111.576 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -65.44 152.69 43.34 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.173 0.589 . . . . 0.0 110.101 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -109.78 -3.11 16.93 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.152 0.981 . . . . 0.0 112.149 -171.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -128.71 -40.81 1.53 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 118.803 0.729 . . . . 0.0 110.719 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -55.11 -46.19 99.71 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.136 -1.411 . . . . 0.0 112.159 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.69 -34.17 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 CA-C-N 121.832 1.69 . . . . 0.0 112.515 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.7 mm -64.07 -46.51 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.523 1.056 . . . . 0.0 109.742 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.95 -38.79 92.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.67 0.788 . . . . 0.0 110.011 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.17 96.56 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.8 -46.1 66.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.912 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -55.85 -40.02 72.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.006 0.821 . . . . 0.0 110.692 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.65 67.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.235 0.614 . . . . 0.0 111.843 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.34 -48.79 9.34 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 122.951 0.5 . . . . 0.0 111.572 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.89 -49.68 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.746 0.818 . . . . 0.0 110.073 -173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 78.7 tttt . . . . . 0 C--O 1.249 1.065 0 C-N-CA 127.791 2.436 . . . . 0.0 111.04 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 ttp . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.82 122.16 21.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.2 144.29 24.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.0 pt -139.54 -177.02 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -115.83 153.55 31.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.13 110.69 9.76 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt 41.49 45.18 2.71 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.317 1.847 . . . . 0.0 111.974 -175.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.75 -10.79 62.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.29 0.876 . . . . 0.0 115.29 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.47 120.38 6.45 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.031 -1.427 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.86 139.43 84.1 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.191 2.594 . . . . 0.0 112.113 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 m -145.94 159.62 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.18 1.392 . . . . 0.0 110.117 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.5 m -110.88 162.22 15.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.387 1.475 . . . . 0.0 109.461 -170.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.36 139.26 50.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.992 1.317 . . . . 0.0 109.348 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.61 -62.32 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.951 0.901 . . . . 0.0 110.784 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.39 10.47 71.37 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.984 0.802 . . . . 0.0 113.877 -171.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 52.89 -176.47 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.431 2.693 . . . . 0.0 116.907 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -68.01 111.25 4.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.528 1.931 . . . . 0.0 112.742 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.0 t -73.46 152.76 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 168.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -134.32 160.53 37.65 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -58.91 136.49 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.18 -4.17 85.99 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.81 1.195 . . . . 0.0 113.796 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.25 -9.35 59.18 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.72 1.76 . . . . 0.0 114.216 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 67.51 122.77 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.665 1.986 . . . . 0.0 111.838 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.01 127.77 91.28 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.702 -1.142 . . . . 0.0 108.069 173.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -61.62 -46.78 13.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.635 2.223 . . . . 0.0 113.846 -173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 t70 128.52 122.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 131.329 3.851 . . . . 0.0 105.554 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -146.96 169.18 19.71 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.273 1.429 . . . . 0.0 108.509 -175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.9 m -123.57 151.6 42.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 m -139.75 174.01 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 128.051 2.54 . . . . 0.0 106.548 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.91 153.16 40.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.4 p -80.49 176.9 9.37 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.495 1.118 . . . . 0.0 110.091 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.2 -26.49 67.76 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.022 -1.049 . . . . 0.0 110.891 169.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -79.14 0.57 27.66 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.481 1.512 . . . . 0.0 111.863 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt 51.79 51.07 17.34 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.627 1.971 . . . . 0.0 111.985 -173.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.16 141.94 47.96 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -70.08 148.1 49.18 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.612 1.165 . . . . 0.0 110.546 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -153.35 153.72 33.12 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.573 2.349 . . . . 0.0 105.488 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -137.54 164.83 27.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.926 0.785 . . . . 0.0 109.475 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.1 tp -49.89 -41.29 45.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.425 0.69 . . . . 0.0 110.961 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.11 -18.61 65.45 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -76.53 -29.67 56.82 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.721 0.691 . . . . 0.0 110.949 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.5 mtt -74.84 -42.44 57.96 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.454 1.102 . . . . 0.0 110.364 174.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 144.62 24.33 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.432 0.693 . . . . 0.0 110.166 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.72 -17.55 22.95 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.766 1.175 . . . . 0.0 112.879 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -146.65 155.2 42.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.945 1.298 . . . . 0.0 108.874 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.9 t -59.42 141.23 16.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.5 m -134.7 146.74 49.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.088 0.955 . . . . 0.0 108.599 -174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.41 133.62 57.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.0 mt -138.82 131.0 37.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.98 143.35 46.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 169.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.72 137.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -141.9 156.8 65.36 Favored Pre-proline 0 C--N 1.326 -0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 108.032 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.54 -49.33 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 120.87 1.047 . . . . 0.0 109.448 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.0 m -162.53 144.93 10.89 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 120.931 -1.106 . . . . 0.0 109.967 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.67 -28.26 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 122.924 0.49 . . . . 0.0 111.251 170.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -56.22 -25.61 48.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.456 1.102 . . . . 0.0 113.55 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 79.7 p -64.09 -24.99 67.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.34 -4.12 74.06 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.772 -1.016 . . . . 0.0 112.712 -169.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.0 t -61.86 -28.27 43.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.112 1.956 . . . . 0.0 110.008 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 28.5 p -57.89 -33.95 69.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.997 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.26 -33.56 24.01 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.92 0.782 . . . . 0.0 110.693 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.97 70.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.307 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.85 -49.06 0.19 Allowed 'General case' 0 C--N 1.344 0.346 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -54.38 -48.71 71.22 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -167.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -4.63 12.53 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.61 -39.88 2.82 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 123.861 0.864 . . . . 0.0 109.161 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.43 -47.47 72.8 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.712 0.805 . . . . 0.0 110.751 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -67.05 -31.21 71.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.797 0.439 . . . . 0.0 111.984 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -70.65 -51.46 27.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.4 -41.55 89.68 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.145 0.578 . . . . 0.0 110.181 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.02 75.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.164 0.986 . . . . 0.0 110.613 177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.48 66.47 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -72.84 -27.81 62.16 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.802 1.183 . . . . 0.0 111.826 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.8 mt -63.91 -37.32 86.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.731 0.696 . . . . 0.0 111.17 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.2 -170.63 43.78 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -73.17 19.06 0.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.824 0.849 . . . . 0.0 113.273 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.1 m -55.42 153.84 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 111.464 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.48 143.04 44.79 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.89 126.78 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.49 151.55 50.48 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.412 0.551 . . . . 0.0 110.951 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.6 m -122.26 139.06 54.23 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 170.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.05 133.35 68.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -128.84 161.43 29.82 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.835 0.854 . . . . 0.0 110.67 -173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.73 -166.16 1.43 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -80.59 -8.95 59.78 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.29 151.54 93.78 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 118.818 0.735 . . . . 0.0 110.946 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.35 -12.26 35.18 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.774 2.316 . . . . 0.0 113.448 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -110.42 17.19 21.07 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.027 1.331 . . . . 0.0 110.866 179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.39 -33.5 75.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -171.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -139.61 156.14 47.03 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.531 1.132 . . . . 0.0 109.674 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.41 172.76 17.69 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.424 2.69 . . . . 0.0 105.101 169.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -92.63 37.03 1.0 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.413 -0.804 . . . . 0.0 109.225 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -151.43 165.94 32.58 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.054 1.342 . . . . 0.0 107.846 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 t 48.95 50.25 18.07 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.476 1.111 . . . . 0.0 110.227 -171.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.69 -139.8 4.66 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -169.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.0 69.47 1.45 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.23 1.412 . . . . 0.0 111.45 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -150.39 142.1 23.66 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 108.926 173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.1 -16.04 50.16 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.114 0.864 . . . . 0.0 112.897 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.26 94.04 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -56.32 -29.33 61.15 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.843 1.257 . . . . 0.0 114.117 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -64.37 -29.06 70.14 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.91 148.9 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -141.36 148.11 39.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -95.16 141.74 28.42 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.308 1.843 . . . . 0.0 108.28 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.63 155.2 36.83 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.749 1.619 . . . . 0.0 108.543 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.5 m -127.3 47.38 2.37 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 127.411 2.284 . . . . 0.0 109.204 -169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -55.41 -26.6 42.67 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.698 -0.626 . . . . 0.0 112.2 -174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -49.25 -26.44 2.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -70.15 -15.92 63.02 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.69 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -140.73 -22.07 0.8 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.827 1.194 . . . . 0.0 113.745 -173.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 82.3 mmm 58.79 2.99 0.27 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 129.309 3.044 . . . . 0.0 116.021 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -62.89 -44.07 97.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 120.466 1.485 . . . . 0.0 111.994 -175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -64.87 -42.34 94.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.562 1.528 . . . . 0.0 109.756 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -59.27 -44.75 96.27 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 123.68 0.657 . . . . 0.0 111.773 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.44 -46.08 67.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.983 0.513 . . . . 0.0 109.843 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -38.92 78.89 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.082 0.953 . . . . 0.0 112.46 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -99.38 4.53 46.33 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.68 1.192 . . . . 0.0 111.824 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.22 37.5 64.82 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 118.454 0.57 . . . . 0.0 112.803 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.73 -7.55 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.358 1.063 . . . . 0.0 109.841 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.86 108.41 1.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 169.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.78 120.33 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -62.16 -43.81 98.0 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.618 1.167 . . . . 0.0 111.423 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -92.32 -4.78 53.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.466 0.707 . . . . 0.0 112.872 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.62 -11.59 2.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.919 . . . . 0.0 111.977 -170.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 41.6 ptt85 49.3 31.61 3.86 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.15 2.18 . . . . 0.0 114.599 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.3 mt -116.9 167.11 11.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.33 130.6 37.37 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.18 164.1 24.95 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.786 1.234 . . . . 0.0 112.809 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 99.25 11.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 175.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.8 m -144.06 162.69 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.885 0.874 . . . . 0.0 109.158 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.55 144.42 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -146.98 155.9 42.62 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.088 1.355 . . . . 0.0 109.068 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.8 t -139.5 143.77 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mp -137.88 136.15 36.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.841 0.856 . . . . 0.0 109.7 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.14 164.53 15.4 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.368 1.467 . . . . 0.0 109.133 168.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -50.4 -29.65 10.58 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.04 1.736 . . . . 0.0 113.253 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -75.35 1.79 12.89 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.688 1.195 . . . . 0.0 113.015 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.33 30.09 65.31 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 120.837 -1.165 . . . . 0.0 110.245 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -106.85 116.23 31.57 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 118.794 1.297 . . . . 0.0 108.494 -173.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.17 124.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.216 1.006 . . . . 0.0 110.679 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.07 -8.42 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.376 1.47 . . . . 0.0 111.131 171.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -147.99 147.45 29.65 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.47 134.81 15.12 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.456 1.502 . . . . 0.0 108.272 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.79 149.63 33.73 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.105 0.962 . . . . 0.0 109.216 169.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.16 104.93 7.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.761 2.424 . . . . 0.0 105.055 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.74 137.86 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.2 m -62.25 -11.95 17.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.149 1.38 . . . . 0.0 113.727 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -142.69 123.92 14.62 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -54.39 -27.02 33.72 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.863 1.265 . . . . 0.0 113.958 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.9 p -91.72 14.54 14.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 119.754 1.161 . . . . 0.0 112.368 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -123.66 170.84 10.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.632 1.573 . . . . 0.0 109.763 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -125.96 155.43 73.16 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.589 1.156 . . . . 0.0 110.953 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -91.65 179.93 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.082 3.188 . . . . 0.0 110.271 172.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -79.5 111.89 16.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -81.73 -0.68 44.03 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -76.57 -29.44 56.61 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.795 -1.191 . . . . 0.0 108.919 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -59.46 -50.66 86.1 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 117.663 -1.16 . . . . 0.0 111.456 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.65 -34.27 52.05 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 121.269 1.489 . . . . 0.0 112.44 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 mm -59.57 -45.31 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.203 1.365 . . . . 0.0 109.933 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.87 -36.04 83.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 119.12 0.873 . . . . 0.0 110.797 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.07 96.43 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.386 -0.196 . . . . 0.0 111.068 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.4 -43.4 77.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.985 0.514 . . . . 0.0 110.899 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -57.18 -40.47 77.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.168 0.894 . . . . 0.0 110.603 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.77 68.23 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.999 0.52 . . . . 0.0 111.912 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.51 -59.95 2.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.045 0.384 . . . . 0.0 110.921 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 59.7 t -63.53 -40.28 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.257 1.023 . . . . 0.0 112.14 -169.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? . . . . . 0 C--O 1.25 1.095 0 C-N-CA 127.217 2.207 . . . . 0.0 112.143 -176.386 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.859 0.362 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.13 41.34 3.49 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.032 1.733 . . . . 0.0 109.78 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -64.31 163.52 12.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.799 0.84 . . . . 0.0 109.707 169.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.9 pt -126.37 173.18 12.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 122.619 1.199 . . . . 0.0 111.217 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -116.16 138.3 51.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -90.72 -132.97 0.11 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.17 56.36 0.46 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.656 1.982 . . . . 0.0 111.317 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 22.63 45.02 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.341 0.972 . . . . 0.0 113.506 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.54 140.42 11.06 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.03 144.55 52.93 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.617 2.212 . . . . 0.0 109.572 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.85 126.73 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.412 0.685 . . . . 0.0 109.415 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -66.73 151.12 48.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.222 1.409 . . . . 0.0 110.509 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.66 145.73 47.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.0 1.72 . . . . 0.0 107.611 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.65 -23.06 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.85 31.31 0.51 Allowed Glycine 0 N--CA 1.464 0.549 0 CA-C-N 118.689 0.677 . . . . 0.0 111.648 -172.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.41 152.12 3.68 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.276 9.4 tt0 94.66 33.17 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 128.504 2.721 . . . . 0.0 113.997 169.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.4 m -64.0 152.99 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -150.47 167.88 25.84 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.372 -0.83 . . . . 0.0 110.545 -169.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.54 129.87 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.209 0.604 . . . . 0.0 109.695 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -2.79 87.58 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.715 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.53 -11.4 59.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.485 1.642 . . . . 0.0 112.235 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 57.08 178.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.563 1.545 . . . . 0.0 112.291 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.85 138.82 33.39 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 127.001 2.12 . . . . 0.0 107.856 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -58.38 -44.39 38.46 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.813 2.342 . . . . 0.0 114.201 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 114.99 124.16 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 131.218 3.807 . . . . 0.0 105.439 -169.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -133.49 165.37 25.04 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 109.088 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -126.22 139.44 53.34 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.48 146.11 22.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.032 1.333 . . . . 0.0 108.276 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.44 166.15 22.31 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.6 p -130.62 -177.54 4.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.932 1.293 . . . . 0.0 108.419 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -47.27 -34.28 6.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.559 0.744 . . . . 0.0 111.537 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.3 m -112.77 14.53 19.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.819 1.248 . . . . 0.0 111.531 -170.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.6 mt 51.64 44.16 29.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.742 . . . . 0.0 112.123 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -73.29 -18.12 61.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 112.81 -172.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 57.12 54.56 6.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 123.084 1.421 . . . . 0.0 108.604 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -58.76 161.0 5.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.066 1.746 . . . . 0.0 108.869 170.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.2 p -141.59 170.23 16.1 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.115 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 tp -54.55 -40.95 69.21 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.63 -20.66 63.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.64 -33.46 60.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.728 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 37.0 mtt -71.36 -39.73 71.08 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.301 1.041 . . . . 0.0 110.609 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -54.36 138.37 39.69 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 123.317 0.647 . . . . 0.0 109.366 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.24 7.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.01 1.29 . . . . 0.0 112.553 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -147.92 155.77 41.95 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.598 1.159 . . . . 0.0 109.258 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.41 139.67 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.1 m -135.36 147.83 49.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.231 1.012 . . . . 0.0 108.738 -172.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.4 mt -133.09 136.78 54.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.3 mt -135.27 128.56 48.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.0 m -108.9 141.33 41.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.9 t -135.48 125.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.9 pt -150.06 159.6 35.12 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.201 1.8 . . . . 0.0 107.178 -170.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.71 -40.39 79.95 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.123 1.882 . . . . 0.0 112.234 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.07 165.53 15.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.812 1.645 . . . . 0.0 109.099 169.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 pp -67.23 41.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 125.915 1.686 . . . . 0.0 112.861 169.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -158.18 -29.03 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.569 1.148 . . . . 0.0 113.208 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 p -72.57 32.51 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -168.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.82 -29.6 1.8 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.006 1.289 . . . . 0.0 114.591 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 m -66.3 -3.72 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.379 1.472 . . . . 0.0 113.202 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 29.2 m -74.45 33.36 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.975 -1.078 . . . . 0.0 110.65 169.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.38 179.84 1.18 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.099 1.36 . . . . 0.0 111.259 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.38 31.61 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.567 1.147 . . . . 0.0 113.235 -172.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -62.94 -56.76 14.32 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.714 1.143 . . . . 0.0 109.437 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 m -62.16 -42.55 99.37 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.68 0.673 . . . . 0.0 109.779 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -61.71 -53.95 49.14 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.829 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -64.11 -45.88 86.67 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 118.846 0.748 . . . . 0.0 110.268 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -54.09 -52.17 61.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.175 0.99 . . . . 0.0 110.853 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -66.18 -35.95 81.8 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.915 0.388 . . . . 0.0 110.823 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -69.98 -37.25 75.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.257 0.623 . . . . 0.0 111.838 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -74.49 -34.34 63.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.171 0.896 . . . . 0.0 110.919 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.32 -46.41 76.3 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.708 0.685 . . . . 0.0 110.794 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.97 -16.44 51.29 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.838 0.855 . . . . 0.0 113.293 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -83.21 -27.09 30.23 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.067 0.849 . . . . 0.0 111.847 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.0 -33.82 76.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.581 0.628 . . . . 0.0 110.987 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.36 -168.01 40.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -75.71 28.16 0.11 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.745 -0.856 . . . . 0.0 112.217 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -54.76 138.42 14.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.528 1.131 . . . . 0.0 109.059 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -66.13 137.97 57.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.07 119.53 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -130.61 149.62 52.18 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.915 0.486 . . . . 0.0 110.745 -172.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.1 m -133.76 116.1 15.34 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.0 mt -92.14 150.31 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.9 m -133.72 162.08 32.93 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.094 2.158 . . . . 0.0 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.06 -20.28 0.18 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.204 1.402 . . . . 0.0 112.95 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -80.39 70.85 7.15 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 169.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.6 mp -48.52 -35.1 8.12 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -50.59 -28.22 21.48 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.61 2.206 . . . . 0.0 114.834 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -117.38 -16.61 10.24 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.09 0.859 . . . . 0.0 112.26 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.73 148.22 20.87 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.582 0.753 . . . . 0.0 110.503 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 51.39 21.9 1.31 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.541 1.536 . . . . 0.0 113.778 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.02 -36.02 0.43 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -109.97 7.11 23.64 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.875 1.216 . . . . 0.0 114.173 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 62.9 m95 24.2 72.58 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.723 2.809 . . . . 0.0 116.309 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.7 p -63.72 -15.05 57.51 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.675 -0.64 . . . . 0.0 112.393 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.36 -148.85 5.88 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 127.205 2.336 . . . . 0.0 107.738 -173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 54.69 41.43 31.94 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.702 1.201 . . . . 0.0 111.659 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -141.14 148.15 39.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.962 1.705 . . . . 0.0 107.278 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.04 -60.37 4.45 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.37 77.02 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 122.696 1.236 . . . . 0.0 108.898 169.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.88 -20.11 14.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.338 1.855 . . . . 0.0 113.974 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -58.38 -30.98 67.21 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.734 -0.604 . . . . 0.0 112.098 173.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.56 142.24 17.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -134.67 138.24 44.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -102.47 143.05 32.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.825 0.85 . . . . 0.0 108.817 -173.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -124.07 156.39 36.64 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.78 1.632 . . . . 0.0 108.247 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -136.41 144.44 44.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -134.26 -16.23 2.16 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -64.29 -14.32 55.21 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.717 -1.24 . . . . 0.0 114.143 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -65.55 -18.88 65.65 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.276 -0.89 . . . . 0.0 112.155 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -147.19 -15.64 0.4 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 35.6 mmm 50.15 37.33 14.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.245 1.818 . . . . 0.0 111.99 -169.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -56.94 15.43 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -63.3 -37.85 88.87 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.687 0.676 . . . . 0.0 109.812 175.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -46.77 -55.48 8.21 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.482 1.991 . . . . 0.0 113.216 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -79.47 -35.2 40.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.154 0.477 . . . . 0.0 110.506 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.47 79.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.186 0.595 . . . . 0.0 112.334 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -112.62 2.43 16.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.915 1.286 . . . . 0.0 110.684 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 8.08 62.55 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.289 -0.882 . . . . 0.0 114.276 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 m -79.47 -4.55 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.043 1.737 . . . . 0.0 112.175 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -67.0 115.76 7.08 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.5 mt -75.48 106.86 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -54.72 -40.63 69.45 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.805 0.842 . . . . 0.0 110.85 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -86.88 -5.1 59.21 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.02 -7.03 2.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.168 0.894 . . . . 0.0 112.322 -171.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 15.8 ptm180 40.2 43.33 1.36 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.89 2.076 . . . . 0.0 113.763 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt -131.74 175.83 8.85 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.04 129.55 34.78 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.758 0.823 . . . . 0.0 109.318 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.55 139.24 57.86 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.998 1.319 . . . . 0.0 111.1 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.49 113.14 3.1 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.4 p -154.15 164.13 39.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.284 0.564 . . . . 0.0 109.873 -173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.3 t -141.74 136.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -169.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -142.85 152.09 41.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.564 0.745 . . . . 0.0 109.229 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.65 136.25 52.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -130.85 136.74 48.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.86 1.264 . . . . 0.0 108.372 -169.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.06 165.46 15.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.22 1.408 . . . . 0.0 110.514 169.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.51 -33.22 20.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 113.182 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.32 5.74 40.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.172 0.897 . . . . 0.0 113.304 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.3 -7.59 75.49 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.607 1.099 . . . . 0.0 113.091 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.48 125.32 24.79 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 118.613 1.207 . . . . 0.0 109.034 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -58.86 128.75 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 169.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.7 m -109.94 -8.53 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.122 1.369 . . . . 0.0 111.04 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -153.86 150.48 28.45 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.7 133.74 11.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.522 1.529 . . . . 0.0 107.913 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -143.57 149.8 37.92 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.327 0.651 . . . . 0.0 110.138 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -128.09 112.74 14.92 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.09 133.47 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -57.9 -20.3 36.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.043 0.937 . . . . 0.0 112.633 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -144.43 124.47 13.6 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.49 -32.04 72.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.394 0.678 . . . . 0.0 112.624 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -79.41 17.28 0.87 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.483 1.113 . . . . 0.0 111.65 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -134.31 171.27 14.51 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 107.054 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.84 151.13 76.83 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 111.435 -175.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -86.64 176.09 4.91 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 124.064 3.176 . . . . 0.0 110.421 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -71.52 133.37 45.77 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 168.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -110.7 3.07 18.89 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.0 0.52 . . . . 0.0 112.192 -175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.59 -40.27 42.75 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -54.65 -50.79 83.6 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.315 -1.326 . . . . 0.0 112.403 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.46 -36.64 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 CA-C-N 121.84 1.693 . . . . 0.0 112.431 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.5 mm -59.48 -46.75 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.315 0.961 . . . . 0.0 109.588 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.45 -35.85 82.15 Favored 'General case' 0 C--N 1.333 -0.123 0 O-C-N 121.304 -0.872 . . . . 0.0 110.845 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.87 98.46 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.356 0.262 . . . . 0.0 110.642 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.27 -47.04 71.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.919 0.488 . . . . 0.0 110.682 173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -54.96 -42.5 72.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.211 0.914 . . . . 0.0 110.484 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.4 -31.12 67.39 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.346 0.658 . . . . 0.0 111.881 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.1 mt -84.74 -44.01 13.74 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.763 0.425 . . . . 0.0 111.612 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.87 -51.35 24.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 123.774 0.83 . . . . 0.0 111.55 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 C--O 1.249 1.068 0 C-N-CA 123.948 0.899 . . . . 0.0 109.666 -178.455 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 118.973 -0.536 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.46 11.94 4.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.442 1.097 . . . . 0.0 112.001 169.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.13 169.49 18.62 Favored 'General case' 0 N--CA 1.435 -1.218 1 C-N-CA 132.077 4.151 . . . . 0.0 106.275 178.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.6 pt -137.57 172.81 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 122.397 1.094 . . . . 0.0 110.07 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 m -134.01 143.82 48.34 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.81 -2.292 . . . . 0.0 104.81 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -138.39 127.18 23.7 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 47.34 38.77 7.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.525 1.13 . . . . 0.0 111.922 -174.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.6 20.35 79.57 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.309 -0.717 . . . . 0.0 114.526 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.08 121.35 4.41 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 172.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.34 140.91 82.32 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.827 2.351 . . . . 0.0 110.715 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.25 135.81 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -74.78 157.7 34.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.597 1.559 . . . . 0.0 109.406 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 144.64 48.71 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.0 t -60.88 -52.18 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.495 0.718 . . . . 0.0 112.33 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.66 37.57 3.17 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.707 1.146 . . . . 0.0 112.41 -170.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.15 169.95 0.16 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.537 1.935 . . . . 0.0 115.018 -170.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 77.18 28.21 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.769 2.028 . . . . 0.0 113.306 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -64.0 145.82 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -150.43 164.57 35.56 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.936 0.895 . . . . 0.0 109.555 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 p -53.0 133.04 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.305 0.642 . . . . 0.0 109.562 175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.62 1.21 90.49 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.737 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.63 -12.93 60.08 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.439 1.619 . . . . 0.0 112.314 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.17 176.4 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.81 1.644 . . . . 0.0 112.025 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.72 147.58 63.33 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.647 1.579 . . . . 0.0 110.363 -173.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -73.02 -51.39 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.776 2.317 . . . . 0.0 112.277 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t70 118.11 127.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 1 C-N-CA 131.844 4.058 . . . . 0.0 105.88 -169.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -135.75 166.51 23.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.832 1.653 . . . . 0.0 108.844 -177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 m -132.13 138.2 47.99 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.52 174.47 6.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 127.778 2.431 . . . . 0.0 107.686 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.3 140.93 46.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.8 p -70.84 174.87 5.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.143 1.777 . . . . 0.0 110.846 175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.52 -22.08 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.505 -0.747 . . . . 0.0 110.928 169.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 m -84.11 0.18 49.46 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.485 1.514 . . . . 0.0 111.859 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.3 mt 52.73 49.74 19.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.427 1.891 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.33 159.95 26.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.358 1.463 . . . . 0.0 107.451 169.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -72.66 144.46 47.75 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.915 0.864 . . . . 0.0 111.026 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -142.11 151.39 42.27 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.619 2.368 . . . . 0.0 105.129 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.2 p -135.08 165.08 26.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -56.85 -37.53 71.41 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 174.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.92 -23.88 67.59 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -78.95 -30.48 44.59 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.794 0.725 . . . . 0.0 111.259 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 48.6 mtt -72.03 -41.1 67.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.966 0.906 . . . . 0.0 110.887 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -54.3 146.06 16.38 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.238 1.015 . . . . 0.0 110.057 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.11 -21.15 12.3 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.937 1.256 . . . . 0.0 112.612 -174.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -146.8 152.98 39.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.321 1.448 . . . . 0.0 108.443 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.77 141.14 17.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.4 m -135.02 146.8 49.35 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -172.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 90.1 mt -128.51 135.23 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.1 mt -135.4 102.94 3.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.8 m -79.84 151.22 30.36 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.74 126.86 39.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.5 pt -137.84 147.75 57.99 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 122.742 0.417 . . . . 0.0 110.132 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.56 -34.41 7.34 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.187 1.925 . . . . 0.0 111.565 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -163.95 172.38 14.01 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.739 1.615 . . . . 0.0 109.179 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 pp -105.54 -9.36 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 124.77 1.228 . . . . 0.0 110.794 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -69.17 -34.57 75.17 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.651 -0.656 . . . . 0.0 110.282 169.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.36 146.82 52.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.478 1.511 . . . . 0.0 110.726 173.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.24 -3.25 52.23 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.223 0.916 . . . . 0.0 114.618 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.93 -22.72 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.966 1.307 . . . . 0.0 112.412 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 90.9 m -51.6 -65.07 0.62 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.872 1.269 . . . . 0.0 110.342 170.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.13 -33.05 50.68 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.054 0.541 . . . . 0.0 110.903 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.19 86.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.908 -0.568 . . . . 0.0 111.966 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -159.11 -39.16 0.06 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -64.78 -46.16 83.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.549 1.068 . . . . 0.0 112.567 -168.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -69.92 -29.58 66.78 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.858 -1.151 . . . . 0.0 112.444 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -78.52 -45.27 22.32 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.274 0.943 . . . . 0.0 109.971 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.24 -44.96 96.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.175 -0.44 . . . . 0.0 111.376 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -63.04 -40.44 97.72 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.232 0.613 . . . . 0.0 110.417 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.37 -51.46 67.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.678 0.791 . . . . 0.0 109.851 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -64.16 -37.01 85.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.541 0.736 . . . . 0.0 110.973 -176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.87 76.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.468 1.507 . . . . 0.0 110.108 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.44 -26.83 68.71 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.573 0.349 . . . . 0.0 111.932 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -77.13 -20.55 55.45 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.013 -0.994 . . . . 0.0 113.077 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.8 mt -64.34 -36.54 84.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.267 1.394 . . . . 0.0 111.596 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.71 -170.91 43.48 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -74.22 21.62 0.1 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.26 150.56 2.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 O-C-N 120.7 -1.25 . . . . 0.0 110.786 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -73.17 143.41 47.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 169.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 125.01 43.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.57 156.37 45.87 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.601 0.76 . . . . 0.0 109.94 -177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.9 m -132.48 114.59 14.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.3 mt -97.44 132.79 41.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 m -142.59 169.16 18.09 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.839 1.255 . . . . 0.0 109.305 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.13 169.48 10.18 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.076 0.465 . . . . 0.0 110.738 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -80.86 -12.33 59.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.615 0.766 . . . . 0.0 112.007 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 28.4 tp -51.38 136.8 31.17 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.686 1.595 . . . . 0.0 110.075 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -51.94 -42.2 59.46 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.815 2.343 . . . . 0.0 113.202 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -66.55 3.06 1.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.912 1.285 . . . . 0.0 113.583 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.23 -2.93 3.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.93 2.092 . . . . 0.0 111.811 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -149.63 27.35 0.81 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.493 1.042 . . . . 0.0 112.728 -168.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.67 160.92 41.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.452 1.501 . . . . 0.0 107.292 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 47.22 41.81 12.44 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.288 1.035 . . . . 0.0 111.195 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -46.74 107.12 0.1 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.515 1.926 . . . . 0.0 112.378 -172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.6 p -72.23 -45.06 61.78 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.751 0.421 . . . . 0.0 111.961 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.15 -10.3 59.1 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.208 -1.329 . . . . 0.0 115.578 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -114.9 -6.91 12.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.93 1.365 . . . . 0.0 112.352 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.95 109.84 2.25 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.381 0.537 . . . . 0.0 109.945 -170.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.24 -1.43 60.64 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.391 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.22 90.38 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.951 1.875 . . . . 0.0 109.313 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.35 -30.85 30.74 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.447 1.899 . . . . 0.0 114.547 -173.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.57 -30.21 71.36 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.5 t -76.98 144.78 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -139.01 131.26 28.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.592 0.71 . . . . 0.0 109.448 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.37 144.94 32.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.576 1.151 . . . . 0.0 109.304 169.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -132.6 155.36 48.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.332 1.453 . . . . 0.0 109.477 -170.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -112.94 138.26 50.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.388 1.075 . . . . 0.0 108.467 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -128.57 -17.93 4.03 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -61.79 -11.17 11.14 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.11 -0.994 . . . . 0.0 113.414 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -46.62 -45.31 18.98 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.529 1.532 . . . . 0.0 110.608 169.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.54 3.75 0.57 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 43.0 mmm 51.27 37.53 18.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.692 1.597 . . . . 0.0 112.127 -172.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -57.35 -59.77 4.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.423 1.089 . . . . 0.0 110.61 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -62.75 -36.5 83.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.072 0.949 . . . . 0.0 109.459 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -44.9 -60.56 3.83 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 126.195 1.855 . . . . 0.0 113.023 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.01 -35.26 57.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.194 0.497 . . . . 0.0 110.354 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.46 85.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.45 5.38 15.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.202 1.401 . . . . 0.0 110.782 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.51 32.45 64.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 121.282 -0.886 . . . . 0.0 112.834 171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.5 m -111.95 0.2 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.483 1.113 . . . . 0.0 111.366 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -71.12 106.51 3.77 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 124' ' ' LEU . 64.8 mt -65.62 121.19 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -65.45 -41.35 93.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.909 0.484 . . . . 0.0 110.553 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.78 -61.77 1.87 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.865 0.466 . . . . 0.0 110.156 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.418 ' H ' HG22 ' A' ' 121' ' ' ILE . 21.9 tp -71.76 -19.27 62.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.646 0.778 . . . . 0.0 112.452 -172.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 54.11 41.52 31.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.148 1.379 . . . . 0.0 111.658 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.7 mt -128.07 179.01 5.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.775 1.23 . . . . 0.0 108.371 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.11 133.83 41.45 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.171 0.989 . . . . 0.0 108.831 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.78 152.67 38.76 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.58 1.152 . . . . 0.0 111.177 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.03 110.58 16.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 169.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -150.41 172.11 15.94 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.0 p -149.79 144.5 17.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.08 158.0 44.75 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.243 1.417 . . . . 0.0 108.781 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.6 t -132.86 144.36 36.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.03 126.57 20.31 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.219 1.008 . . . . 0.0 109.738 -168.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.01 161.51 24.17 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.465 1.506 . . . . 0.0 110.658 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -48.67 -33.93 10.94 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 112.686 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.5 5.23 36.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.157 1.383 . . . . 0.0 112.733 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.92 -5.72 83.16 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 120.885 -1.134 . . . . 0.0 112.74 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -72.76 121.27 19.61 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.006 1.403 . . . . 0.0 108.729 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.22 125.72 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.06 -10.89 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.462 1.105 . . . . 0.0 110.223 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -152.42 152.28 31.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.434 1.094 . . . . 0.0 108.268 170.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.21 137.46 14.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.86 1.664 . . . . 0.0 107.493 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -144.83 139.61 27.85 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -113.48 109.49 18.75 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.0 t -64.45 115.17 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -169.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.2 m -53.21 -25.66 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.994 1.318 . . . . 0.0 113.205 -170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.05 107.65 6.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.19 -25.37 68.04 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 126.333 1.853 . . . . 0.0 112.462 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.72 15.02 1.48 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.097 1.359 . . . . 0.0 111.695 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.53 175.94 9.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.767 2.827 . . . . 0.0 106.692 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -122.87 154.2 64.02 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.656 1.117 . . . . 0.0 112.135 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -89.67 177.05 2.75 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.397 3.398 . . . . 0.0 111.15 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -76.58 130.92 38.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 168.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -104.8 -3.98 22.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -33.97 69.97 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -57.59 -55.67 42.26 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.782 1.233 . . . . 0.0 112.588 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.97 -34.45 59.35 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.74 1.657 . . . . 0.0 111.963 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 mm -60.22 -46.39 94.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.824 1.193 . . . . 0.0 109.707 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -68.95 -31.86 71.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.716 1.143 . . . . 0.0 110.93 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.15 -39.46 94.73 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.052 0.387 . . . . 0.0 111.012 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.24 -46.11 68.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.633 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -55.4 -38.61 69.14 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.274 0.943 . . . . 0.0 110.968 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.24 -28.39 64.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.562 0.745 . . . . 0.0 112.299 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.93 -48.3 7.08 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.553 . . . . 0.0 111.334 174.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.86 -45.46 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.362 1.065 . . . . 0.0 110.837 -171.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt . . . . . 0 C--O 1.25 1.113 0 C-N-CA 126.825 2.05 . . . . 0.0 110.793 179.371 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.9 28.65 0.49 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.397 -1.439 . . . . 0.0 112.971 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -164.93 173.3 11.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.043 2.937 . . . . 0.0 105.05 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 pt -136.98 173.33 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 123.478 1.609 . . . . 0.0 110.941 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 m -118.82 154.45 32.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -137.61 121.45 17.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.25 40.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.595 1.558 . . . . 0.0 113.641 -172.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.34 5.48 89.55 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.698 -0.626 . . . . 0.0 114.087 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.03 113.64 4.09 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.639 1.59 . . . . 0.0 109.541 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.1 139.59 71.25 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.942 2.428 . . . . 0.0 111.06 173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.6 127.5 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.521 0.677 . . . . 0.0 109.315 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -69.48 151.73 45.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.998 1.319 . . . . 0.0 110.112 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.68 158.47 23.75 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.069 1.747 . . . . 0.0 108.694 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.71 -51.66 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.54 29.77 3.75 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.468 1.032 . . . . 0.0 111.92 -169.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.84 164.51 1.51 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.595 1.158 . . . . 0.0 113.348 -172.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 103.64 20.64 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.321 3.048 . . . . 0.0 111.138 170.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.81 136.8 21.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -145.93 166.75 25.1 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.529 1.131 . . . . 0.0 108.131 -171.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.7 130.66 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.13 4.39 90.25 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.766 -1.019 . . . . 0.0 114.082 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.51 -8.15 58.95 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.548 1.674 . . . . 0.0 112.37 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 59.92 175.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.501 1.52 . . . . 0.0 112.097 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.22 115.5 13.98 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 125.89 1.676 . . . . 0.0 108.293 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.4 144.79 99.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.369 2.046 . . . . 0.0 112.699 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -82.07 62.1 5.66 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.38 1.872 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -94.09 173.4 7.67 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 89.4 m -118.55 151.32 38.09 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.718 0.77 . . . . 0.0 111.559 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.49 166.8 20.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 127.282 2.233 . . . . 0.0 106.996 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mp -109.56 154.49 22.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.9 p -83.46 178.81 7.86 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.053 0.941 . . . . 0.0 109.592 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.19 -26.88 68.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.728 -1.232 . . . . 0.0 110.938 169.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -80.62 1.49 29.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.313 1.445 . . . . 0.0 111.784 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.0 mt 55.12 35.82 25.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.857 2.063 . . . . 0.0 112.336 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -98.09 149.58 22.35 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.53 143.7 46.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.544 0.738 . . . . 0.0 110.095 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -144.9 102.19 3.74 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.6 m -70.97 154.24 41.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 27.2 tp -52.53 -39.65 61.62 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.671 -0.643 . . . . 0.0 111.05 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -18.85 40.46 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.7 -32.29 63.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.593 1.088 . . . . 0.0 110.886 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.4 mtt -73.41 -39.75 64.81 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.629 1.172 . . . . 0.0 110.229 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -55.81 150.48 12.91 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.814 0.816 . . . . 0.0 110.406 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.09 -19.13 23.15 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.203 1.382 . . . . 0.0 112.216 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -149.14 153.86 38.33 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 108.749 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.22 138.5 16.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.4 m -134.82 148.4 50.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.068 0.947 . . . . 0.0 108.885 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.9 mt -132.81 132.84 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.99 105.99 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -84.46 149.65 25.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 168.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 t -134.0 128.99 53.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.5 pt -143.84 144.33 26.47 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.673 0.789 . . . . 0.0 109.374 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.75 -33.64 6.25 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.061 1.841 . . . . 0.0 111.709 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -154.01 173.15 16.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.594 1.958 . . . . 0.0 108.692 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.1 pt -132.91 -31.03 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.11 1.364 . . . . 0.0 110.94 171.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.64 -12.08 50.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.648 0.737 . . . . 0.0 110.979 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -64.11 -19.63 65.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.825 2.05 . . . . 0.0 112.762 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.13 5.71 65.56 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.852 0.739 . . . . 0.0 112.841 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.35 -19.61 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.0 1.4 . . . . 0.0 112.026 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.66 -58.09 9.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.999 0.92 . . . . 0.0 109.306 170.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.11 -32.72 72.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.284 0.633 . . . . 0.0 111.131 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -47.86 84.04 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.005 -0.521 . . . . 0.0 111.383 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -165.86 -35.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -43.55 97.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.285 0.948 . . . . 0.0 112.343 -169.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -62.49 -51.44 67.42 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.436 1.016 . . . . 0.0 109.763 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -62.65 -48.47 79.19 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.617 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -57.36 -51.3 69.96 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.494 0.588 . . . . 0.0 110.86 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -61.41 -40.08 93.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.964 0.906 . . . . 0.0 111.499 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.82 -46.73 71.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.518 0.727 . . . . 0.0 110.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.87 -36.24 81.86 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.184 0.902 . . . . 0.0 110.672 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.34 77.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.748 0.819 . . . . 0.0 110.292 176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.4 -24.47 67.41 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -80.49 -19.12 46.63 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 112.539 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.59 -39.56 93.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.957 1.253 . . . . 0.0 111.86 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.71 -167.35 39.15 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.19 25.72 0.1 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.468 1.107 . . . . 0.0 112.912 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -57.24 142.32 13.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 125.206 1.402 . . . . 0.0 110.715 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -72.83 137.87 46.0 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 168.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.28 124.06 7.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -137.82 153.94 49.58 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.828 0.851 . . . . 0.0 110.323 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 m -126.16 103.94 7.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.7 mt -77.32 131.76 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.6 m -132.25 165.34 24.36 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.164 1.385 . . . . 0.0 109.314 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.69 169.6 6.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.798 0.808 . . . . 0.0 110.621 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -74.02 -22.11 59.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.727 0.811 . . . . 0.0 110.67 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.0 tp -52.43 129.2 42.99 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.448 1.499 . . . . 0.0 110.278 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.84 -39.4 68.16 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.096 2.531 . . . . 0.0 113.594 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -64.89 0.47 1.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.611 1.164 . . . . 0.0 113.898 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.99 -8.46 16.58 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.246 1.418 . . . . 0.0 113.001 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -143.1 -24.87 0.61 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.053 1.297 . . . . 0.0 114.354 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.85 -31.57 71.84 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.346 1.43 . . . . 0.0 113.496 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -87.89 -11.18 48.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.083 -0.96 . . . . 0.0 112.4 177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.1 p90 32.23 48.39 0.11 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.338 2.655 . . . . 0.0 114.59 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.9 p -59.62 -28.57 67.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.15 -14.22 57.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.961 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -119.68 33.59 5.56 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.827 1.314 . . . . 0.0 110.395 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -141.24 135.58 30.82 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.46 -15.59 7.17 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.334 -0.704 . . . . 0.0 112.642 -170.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.1 mt -128.83 76.93 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.2 -26.25 38.12 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.742 1.217 . . . . 0.0 113.282 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -63.67 -27.66 69.37 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.502 1.121 . . . . 0.0 112.642 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.75 154.13 3.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.27 146.81 39.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.4 148.81 24.04 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.37 157.05 35.97 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.461 1.505 . . . . 0.0 108.554 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -128.82 49.25 2.24 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.193 2.197 . . . . 0.0 108.947 -169.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -47.18 -41.82 18.68 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.567 0.747 . . . . 0.0 111.358 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -56.15 -19.89 15.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.166 0.986 . . . . 0.0 113.631 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -68.7 -22.33 64.36 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.048 -1.033 . . . . 0.0 111.618 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -133.72 -26.14 1.6 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.085 0.954 . . . . 0.0 112.999 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.79 -4.03 0.27 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.789 3.235 . . . . 0.0 115.731 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -57.25 -52.57 64.8 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.718 1.144 . . . . 0.0 110.965 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.67 -35.14 78.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.593 0.633 . . . . 0.0 111.129 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.24 -43.22 98.71 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.63 0.633 . . . . 0.0 112.119 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.66 -38.88 80.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.634 0.717 . . . . 0.0 110.31 173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.82 84.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.644 0.778 . . . . 0.0 111.88 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -81.83 -6.19 58.87 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.72 0.808 . . . . 0.0 111.08 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.46 1.9 62.2 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.834 -0.981 . . . . 0.0 114.119 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.89 -19.74 26.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 124.638 1.175 . . . . 0.0 111.137 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.66 118.35 6.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.313 0.961 . . . . 0.0 108.651 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -81.61 105.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 C-N-CA 126.197 1.799 . . . . 0.0 106.425 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.24 -40.59 61.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.752 1.221 . . . . 0.0 110.869 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -88.79 -4.74 58.43 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.34 0.656 . . . . 0.0 112.714 -170.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.6 tp -137.37 -5.8 1.8 Allowed 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.117 -0.989 . . . . 0.0 113.047 -171.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.25 32.2 ptt-85 42.5 45.8 3.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.949 1.7 . . . . 0.0 112.767 -173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -134.87 176.59 8.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.119 1.768 . . . . 0.0 106.358 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.261 0.0 OUTLIER -106.49 147.5 29.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 121.884 2.129 . . . . 0.0 111.862 170.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.03 156.58 35.67 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.741 2.016 . . . . 0.0 112.785 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -82.54 116.34 21.92 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 168.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.2 m -150.79 167.06 28.58 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 108.96 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.93 142.96 19.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.22 151.83 42.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.775 1.23 . . . . 0.0 108.111 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.9 t -135.07 135.44 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -130.26 135.53 48.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.361 1.064 . . . . 0.0 109.239 -169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.48 167.25 5.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.562 1.545 . . . . 0.0 109.502 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -51.13 -34.12 29.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.041 1.336 . . . . 0.0 112.711 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -80.24 -0.57 36.92 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.473 1.109 . . . . 0.0 112.547 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.66 79.33 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.896 1.236 . . . . 0.0 112.606 -174.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.64 117.3 5.6 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.244 1.522 . . . . 0.0 109.469 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.84 115.67 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.848 0.859 . . . . 0.0 109.447 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.3 m -95.6 -12.21 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.657 1.183 . . . . 0.0 110.664 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -147.17 144.68 29.13 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.31 126.36 7.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.317 1.447 . . . . 0.0 107.283 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -146.82 145.56 29.93 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -114.47 111.08 20.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 t -61.95 125.43 18.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -172.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.5 m -59.42 -13.32 8.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.472 1.109 . . . . 0.0 113.663 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -140.6 128.13 21.42 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 169.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.73 -29.98 63.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.361 1.065 . . . . 0.0 113.667 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.2 p -84.68 -4.49 59.05 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.083 1.31 . . . . 0.0 112.637 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -98.07 177.24 5.48 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.438 1.495 . . . . 0.0 109.974 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -133.51 151.57 77.57 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.473 1.109 . . . . 0.0 111.015 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -85.0 -176.68 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.663 2.908 . . . . 0.0 109.249 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -76.85 119.47 20.66 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -91.29 -0.87 57.74 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.28 -36.05 40.33 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -51.21 -55.45 28.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.134 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.27 -33.88 47.0 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 121.584 1.601 . . . . 0.0 112.728 175.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.6 mm -59.81 -45.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 120.185 1.357 . . . . 0.0 109.879 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.54 -36.84 85.0 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.376 0.989 . . . . 0.0 110.596 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.12 96.4 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.307 0.243 . . . . 0.0 110.798 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.14 -43.67 73.87 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.082 0.553 . . . . 0.0 111.178 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.15 -41.89 76.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.28 0.945 . . . . 0.0 110.302 176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.29 -31.89 70.69 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.162 0.585 . . . . 0.0 112.012 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.59 -40.45 23.01 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 123.076 0.55 . . . . 0.0 111.807 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.55 -54.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.454 0.702 . . . . 0.0 109.483 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.1 pttt . . . . . 0 C--O 1.25 1.083 0 C-N-CA 127.722 2.409 . . . . 0.0 112.036 -178.231 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.11 11.19 0.76 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -146.14 143.79 29.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 169.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.6 pt -130.33 -178.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 122.172 0.987 . . . . 0.0 110.92 -169.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -127.1 146.35 50.41 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -143.68 133.25 23.56 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm 43.7 42.38 4.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.586 1.555 . . . . 0.0 112.138 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.18 28.5 70.04 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.161 -0.799 . . . . 0.0 114.54 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 139.6 10.52 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 169.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.39 145.33 42.73 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.592 2.195 . . . . 0.0 110.151 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.27 134.72 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.242 1.017 . . . . 0.0 110.28 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -75.29 152.81 38.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.156 1.782 . . . . 0.0 110.448 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.78 148.76 42.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.98 1.712 . . . . 0.0 108.08 176.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.15 -84.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 118.361 0.528 . . . . 0.0 110.935 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 40.48 2.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.296 1.427 . . . . 0.0 112.019 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -58.06 171.05 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.196 2.198 . . . . 0.0 114.593 -169.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 78.52 28.27 0.46 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.817 2.047 . . . . 0.0 114.032 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.6 138.88 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -148.4 164.08 35.2 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.451 1.1 . . . . 0.0 108.578 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.2 p -54.8 132.97 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.92 -0.52 89.65 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.883 -0.954 . . . . 0.0 114.219 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t70 -76.55 -13.65 60.07 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.544 1.672 . . . . 0.0 112.657 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 60.95 157.15 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.813 2.045 . . . . 0.0 112.959 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.58 133.37 46.95 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.342 1.057 . . . . 0.0 109.049 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.3 -27.66 76.31 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.493 2.795 . . . . 0.0 114.772 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t70 62.43 98.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.381 2.272 . . . . 0.0 112.113 -170.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -129.49 170.47 13.68 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.901 1.68 . . . . 0.0 108.316 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.9 167.32 11.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.53 1.132 . . . . 0.0 109.279 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.9 -176.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 128.053 2.541 . . . . 0.0 104.215 168.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.05 139.16 35.87 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.6 p -87.64 171.08 10.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 118.821 0.737 . . . . 0.0 109.744 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.443 -0.785 . . . . 0.0 110.733 168.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m -79.35 1.58 24.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.156 1.383 . . . . 0.0 111.717 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.1 mt 61.47 32.58 18.85 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.684 2.394 . . . . 0.0 112.201 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -91.89 140.33 29.78 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.91 55.83 2.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.085 1.754 . . . . 0.0 110.184 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.3 tttp -56.41 157.03 5.33 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.065 1.346 . . . . 0.0 108.394 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.9 m -133.5 163.8 28.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.03 -28.5 66.48 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.022 -0.424 . . . . 0.0 111.958 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.63 -19.71 51.02 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.085 -1.009 . . . . 0.0 113.647 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.2 -28.49 61.3 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.443 1.019 . . . . 0.0 110.941 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -74.01 -41.7 61.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.725 1.21 . . . . 0.0 110.039 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -55.3 133.48 49.49 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.54 -23.28 4.28 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.992 1.282 . . . . 0.0 112.426 -171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tppm? -154.99 157.38 37.58 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.663 1.185 . . . . 0.0 108.371 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -59.24 143.06 14.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -137.68 148.04 45.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.269 1.028 . . . . 0.0 108.243 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.2 mt -129.07 137.95 55.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.7 mt -132.17 124.13 51.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.2 t -101.65 142.05 33.58 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.99 131.37 64.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.1 pt -139.78 136.99 17.86 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.591 0.757 . . . . 0.0 111.451 -170.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.8 -28.71 2.01 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.167 2.578 . . . . 0.0 112.146 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.3 t -163.42 170.69 17.06 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.072 1.749 . . . . 0.0 107.739 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -126.13 -18.91 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.109 1.364 . . . . 0.0 110.528 169.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.38 -13.39 58.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.866 0.867 . . . . 0.0 111.362 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 p -61.12 -22.22 64.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.08 1.752 . . . . 0.0 112.252 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.77 -10.24 65.76 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.017 0.817 . . . . 0.0 112.4 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.4 t -60.92 -29.11 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.663 1.231 . . . . 0.0 109.707 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.48 -55.4 35.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.933 0.333 . . . . 0.0 110.11 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.75 -38.79 80.37 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.334 0.253 . . . . 0.0 111.038 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.63 -32.74 73.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.763 -0.636 . . . . 0.0 112.523 -175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -149.62 -46.36 0.13 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-O 117.235 -1.364 . . . . 0.0 113.361 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 m -60.51 -34.64 74.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.994 1.725 . . . . 0.0 111.531 -172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -50.69 -65.79 0.5 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.274 0.63 . . . . 0.0 109.844 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -66.89 -40.73 87.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.006 -169.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -58.25 -54.91 41.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 122.502 0.321 . . . . 0.0 110.395 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -76.21 -27.77 56.96 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.918 -171.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -59.88 -53.08 62.08 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.658 1.183 . . . . 0.0 109.701 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.48 -39.68 88.92 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.324 0.511 . . . . 0.0 110.573 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.82 81.05 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.438 0.695 . . . . 0.0 110.828 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.13 -20.44 65.77 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -93.59 -14.86 26.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.413 1.006 . . . . 0.0 112.7 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.0 mt -63.75 -31.88 73.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.666 1.121 . . . . 0.0 111.929 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.41 -158.69 31.64 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -174.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.89 26.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.286 1.434 . . . . 0.0 112.533 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.44 135.98 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 125.105 1.362 . . . . 0.0 108.022 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.95 146.57 52.65 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.72 127.19 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -134.11 151.34 51.34 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.615 0.766 . . . . 0.0 110.796 -173.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.8 m -133.72 100.34 4.74 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 mt -86.34 128.71 39.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.7 m -125.64 150.18 47.79 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.58 174.1 10.77 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.402 0.62 . . . . 0.0 111.947 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.2 -17.91 62.5 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.166 1.386 . . . . 0.0 112.668 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.8 tp -51.85 133.98 37.85 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.732 1.613 . . . . 0.0 111.134 -172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -54.19 -27.98 49.58 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.269 2.646 . . . . 0.0 114.436 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -81.96 12.79 3.78 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.851 1.26 . . . . 0.0 112.633 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.08 168.1 15.07 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.028 1.731 . . . . 0.0 109.002 173.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 60.11 177.08 0.09 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.296 1.839 . . . . 0.0 113.481 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 60.61 -28.78 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.702 3.201 . . . . 0.0 117.123 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -129.26 20.64 5.75 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.721 1.608 . . . . 0.0 110.309 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -43.31 101.81 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.626 2.37 . . . . 0.0 111.157 171.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.2 p -60.4 -34.17 73.53 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.361 0.664 . . . . 0.0 111.608 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.57 13.52 62.18 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.814 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.11 26.42 5.18 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.875 1.337 . . . . 0.0 110.621 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.85 135.64 36.39 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.25 -13.72 43.78 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.216 -0.769 . . . . 0.0 112.879 -173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.43 76.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.144 0 C-N-CA 125.822 1.649 . . . . 0.0 107.284 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -54.6 -21.55 10.75 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.489 1.916 . . . . 0.0 113.951 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.45 -27.3 67.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.435 1.094 . . . . 0.0 112.385 175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.21 144.73 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.768 0.827 . . . . 0.0 109.227 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -126.3 129.2 48.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 p -97.67 141.74 30.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.458 1.103 . . . . 0.0 108.682 -172.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.3 mp -125.47 156.62 38.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.505 1.122 . . . . 0.0 110.077 -169.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.1 m -136.12 44.6 2.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.331 2.652 . . . . 0.0 109.11 -169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.07 -24.92 60.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.396 0.678 . . . . 0.0 112.311 -170.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -51.12 -19.63 1.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.481 1.512 . . . . 0.0 114.387 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -59.52 -27.11 65.88 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.663 1.119 . . . . 0.0 112.457 171.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -135.77 -6.96 2.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.78 1.173 . . . . 0.0 113.251 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 86.6 mmm 52.83 26.9 4.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.632 1.573 . . . . 0.0 111.919 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -65.55 0.67 Allowed 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.006 1.322 . . . . 0.0 111.298 -171.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -60.9 -36.7 79.92 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.151 0.58 . . . . 0.0 109.507 172.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.4 -51.56 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 124.249 0.928 . . . . 0.0 111.953 -172.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.39 -41.06 70.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.965 0.506 . . . . 0.0 109.938 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.29 -49.02 79.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.472 0.709 . . . . 0.0 112.17 -175.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -85.73 -4.84 59.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.762 0.825 . . . . 0.0 111.245 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.07 10.95 62.86 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.015 -0.881 . . . . 0.0 114.223 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.2 m -65.44 -16.98 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 118.465 1.133 . . . . 0.0 109.982 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.13 106.62 0.45 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.2 mt -70.97 125.05 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.27 -37.19 86.44 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.41 0.684 . . . . 0.0 111.628 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -98.23 -50.71 4.25 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.284 0.634 . . . . 0.0 111.716 -169.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.3 tp -70.7 -24.59 62.68 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.257 0.481 . . . . 0.0 111.306 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.254 97.3 mtt180 52.54 47.75 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.337 1.455 . . . . 0.0 111.393 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 71.6 mt -129.14 171.06 12.78 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.027 1.331 . . . . 0.0 107.854 169.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.62 117.56 22.08 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.42 141.8 40.85 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 111.0 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.86 108.6 1.81 Allowed 'General case' 0 C--N 1.342 0.278 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 m -144.31 164.38 30.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -150.09 139.77 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -142.5 156.11 45.11 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.554 1.141 . . . . 0.0 108.447 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.9 134.73 48.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.7 mp -129.5 134.5 47.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.18 165.95 10.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.01 1.324 . . . . 0.0 109.565 169.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -50.24 -37.32 35.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.657 1.183 . . . . 0.0 112.679 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.46 2.91 46.09 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.76 61.6 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.516 1.055 . . . . 0.0 113.596 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -61.2 118.41 6.82 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.905 1.353 . . . . 0.0 109.166 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.53 113.95 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.73 0.812 . . . . 0.0 109.054 170.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.08 -26.48 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 0.0 109.459 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -153.38 152.2 30.79 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 107.063 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.68 127.58 5.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -147.08 149.66 33.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -121.59 113.55 19.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.77 119.43 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.5 m -59.12 -19.21 42.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.457 1.503 . . . . 0.0 112.881 -171.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -137.69 95.72 3.11 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.05 -20.86 65.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.883 0.873 . . . . 0.0 112.599 -172.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 6.17 3.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.722 1.209 . . . . 0.0 112.222 169.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.98 162.26 30.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.999 2.12 . . . . 0.0 107.854 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -96.99 145.54 29.76 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 121.929 -0.482 . . . . 0.0 111.506 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.0 174.15 11.2 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.867 3.045 . . . . 0.0 111.333 171.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -82.12 129.6 34.86 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -84.03 -11.89 56.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -80.46 -34.57 35.86 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.37 -0.831 . . . . 0.0 109.45 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -55.74 -52.05 75.33 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.798 -1.096 . . . . 0.0 112.042 -176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.6 -37.2 17.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.107 1.431 . . . . 0.0 111.777 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.11 -44.51 95.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.027 0.831 . . . . 0.0 109.972 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.63 -38.61 91.61 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 119.156 0.889 . . . . 0.0 110.637 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.54 85.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.26 0.224 . . . . 0.0 111.241 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.28 -47.72 55.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.882 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -53.62 -39.74 65.18 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.34 0.973 . . . . 0.0 110.796 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -55.39 -29.66 58.92 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.899 . . . . 0.0 112.267 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.55 -40.42 8.65 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.488 0.715 . . . . 0.0 111.934 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.94 -39.68 45.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.362 1.065 . . . . 0.0 111.355 -169.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 C--O 1.248 0.986 0 C-N-CA 123.953 0.901 . . . . 0.0 109.49 179.262 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 119.047 -0.501 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.69 143.96 34.29 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.291 1.036 . . . . 0.0 111.481 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -146.18 171.86 14.31 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 128.356 2.663 . . . . 0.0 105.038 170.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 pt -134.15 -179.61 3.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -127.58 149.93 49.94 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -139.7 126.95 21.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.6 mttm 46.54 34.66 2.5 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.444 1.098 . . . . 0.0 112.303 -172.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.97 81.93 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 121.325 -0.86 . . . . 0.0 114.538 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.24 119.25 4.78 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.54 140.53 89.82 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.951 2.434 . . . . 0.0 111.331 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.1 152.93 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.389 1.076 . . . . 0.0 109.559 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -101.71 163.42 12.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.553 1.541 . . . . 0.0 110.307 -169.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.3 mt -113.31 140.51 47.94 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.029 1.331 . . . . 0.0 108.319 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.4 t -75.35 -61.8 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.76 34.04 3.0 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.568 1.08 . . . . 0.0 113.371 -171.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 52.76 -138.21 1.15 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.296 1.438 . . . . 0.0 110.132 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -135.79 132.23 36.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.479 1.112 . . . . 0.0 110.559 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -84.66 169.08 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 168.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.46 162.69 40.51 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -52.65 130.41 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.86 -3.76 83.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.745 -1.03 . . . . 0.0 114.358 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -84.31 -3.13 58.06 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.694 1.747 . . . . 0.0 112.726 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 61.65 171.2 0.12 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.4 1.88 . . . . 0.0 112.935 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -119.29 106.49 42.75 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 125.449 1.5 . . . . 0.0 108.56 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 144.86 99.08 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.393 2.062 . . . . 0.0 113.13 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.96 65.33 7.05 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.873 2.069 . . . . 0.0 110.937 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -97.47 158.12 15.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.448 170.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.91 163.77 27.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.868 0.842 . . . . 0.0 112.983 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.29 134.71 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 168.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -76.26 155.18 34.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.5 p -123.1 174.05 7.47 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -46.49 -32.19 3.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.333 1.053 . . . . 0.0 112.127 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.7 m -113.82 15.89 18.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.111 1.364 . . . . 0.0 111.436 -171.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 53.03 45.01 29.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.773 2.029 . . . . 0.0 112.172 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.4 -12.4 58.97 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.265 1.026 . . . . 0.0 112.265 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.311 12.8 pt-20 44.8 48.88 9.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.433 1.893 . . . . 0.0 111.714 -169.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -46.57 122.03 3.89 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 127.388 2.275 . . . . 0.0 108.646 169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.37 146.35 40.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 169.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -39.58 57.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.012 0.824 . . . . 0.0 111.093 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.51 -18.84 21.03 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.35 -29.06 70.43 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.446 1.021 . . . . 0.0 111.241 175.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.6 mtt -70.62 -32.76 70.22 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.695 1.198 . . . . 0.0 111.701 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -64.39 133.98 53.68 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.64 -25.88 2.94 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.903 1.24 . . . . 0.0 112.168 -171.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -149.47 157.6 43.43 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.288 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.2 t -58.1 135.99 21.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.0 m -135.36 146.09 48.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.519 1.128 . . . . 0.0 108.165 -170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.87 135.84 54.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.6 mt -138.02 135.8 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.8 p -115.02 151.27 34.5 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.4 t -134.77 133.01 54.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.3 pt -137.09 146.42 54.46 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.555 1.142 . . . . 0.0 108.67 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.14 -34.14 23.06 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.527 2.151 . . . . 0.0 111.914 -176.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -143.29 154.23 43.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.758 1.623 . . . . 0.0 106.979 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 tp -90.64 -32.11 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.263 0.625 . . . . 0.0 111.471 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.77 -17.99 27.17 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.371 0.668 . . . . 0.0 112.232 -170.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.3 p -65.74 163.96 15.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.1 1.36 . . . . 0.0 111.707 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.94 -24.2 33.6 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.937 1.256 . . . . 0.0 114.864 -171.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.45 -29.47 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 118.906 1.353 . . . . 0.0 112.203 176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.6 t -51.74 -51.33 56.99 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.111 1.365 . . . . 0.0 110.762 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.42 -34.6 12.04 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.078 0.551 . . . . 0.0 111.523 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.24 70.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.752 0.821 . . . . 0.0 112.367 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.471 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.0 tm0? -152.62 -39.51 0.1 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-O 117.762 -1.114 . . . . 0.0 112.513 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -60.59 -42.67 97.18 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.177 1.353 . . . . 0.0 112.357 -169.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -56.45 -56.2 24.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.146 0.884 . . . . 0.0 110.469 173.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.65 -40.96 93.05 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.406 0.548 . . . . 0.0 111.05 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.471 ' CB ' HE21 ' A' ' 63' ' ' GLN . 25.5 t80 -56.48 -52.67 63.82 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 122.796 0.438 . . . . 0.0 110.785 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -67.52 -34.88 78.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.164 0.186 . . . . 0.0 111.259 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -64.61 -53.26 50.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.357 1.463 . . . . 0.0 109.763 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -63.53 -38.77 92.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.493 0.717 . . . . 0.0 109.456 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.84 78.27 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.521 0.728 . . . . 0.0 110.738 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.94 -27.09 67.98 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.083 0.553 . . . . 0.0 112.31 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -76.26 -24.17 54.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.333 -0.842 . . . . 0.0 112.185 175.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.9 mt -63.89 -40.84 97.45 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.678 1.126 . . . . 0.0 110.475 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.41 -169.43 42.55 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.35 19.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.155 1.382 . . . . 0.0 113.418 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 m -56.05 145.19 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.41 1.484 . . . . 0.0 110.923 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -70.43 144.82 51.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.27 132.69 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -145.54 156.75 43.9 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.885 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.5 m -136.1 116.72 13.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 173.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -95.95 142.22 14.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.711 1.605 . . . . 0.0 107.499 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -136.23 173.39 11.77 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 110.136 -170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.59 -177.81 2.4 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.433 0.635 . . . . 0.0 109.944 169.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.3 -25.07 65.47 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.943 -0.473 . . . . 0.0 111.349 171.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.0 tp -49.08 110.35 1.5 Allowed Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 126.013 1.725 . . . . 0.0 111.479 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -88.79 -6.28 5.82 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.552 2.168 . . . . 0.0 113.673 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -38.05 -37.28 0.25 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.645 2.378 . . . . 0.0 116.524 -168.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.66 14.4 2.52 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.031 0.832 . . . . 0.0 112.759 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -68.12 -45.45 73.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.363 0.983 . . . . 0.0 108.717 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.15 -9.3 38.5 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.293 1.037 . . . . 0.0 113.182 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -110.09 8.5 23.93 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.955 1.302 . . . . 0.0 110.757 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 46.23 48.81 13.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.794 1.638 . . . . 0.0 112.767 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.74 131.47 50.41 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 173.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.83 1.6 73.25 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.158 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.88 3.08 1.39 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.028 1.331 . . . . 0.0 113.064 -169.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -85.0 144.53 28.23 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.278 -0.889 . . . . 0.0 110.222 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.47 -49.39 3.84 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.636 1.112 . . . . 0.0 110.856 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 pt -76.63 70.19 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 125.747 1.619 . . . . 0.0 109.435 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.61 -23.82 0.75 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.665 2.786 . . . . 0.0 114.961 -177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -62.37 -30.65 71.34 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.369 1.068 . . . . 0.0 111.997 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.4 t -74.57 156.89 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.98 0.912 . . . . 0.0 108.866 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.32 142.29 41.86 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -86.36 134.65 33.71 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.4 mp -125.01 164.43 20.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.051 2.14 . . . . 0.0 106.724 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.51 169.9 17.45 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.161 0.984 . . . . 0.0 108.749 169.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -149.02 -17.77 0.3 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -58.77 -17.24 21.49 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.811 -1.181 . . . . 0.0 113.449 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -53.62 -30.04 40.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.452 1.101 . . . . 0.0 112.625 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -142.18 -6.9 0.93 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.549 1.068 . . . . 0.0 112.975 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.08 30.75 5.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.822 2.049 . . . . 0.0 112.714 -170.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -65.29 0.68 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.785 1.634 . . . . 0.0 111.669 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -61.77 -34.5 75.97 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.684 0.794 . . . . 0.0 110.28 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -43.43 98.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 124.305 0.955 . . . . 0.0 112.783 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.38 -35.86 71.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.383 1.091 . . . . 0.0 109.946 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.21 74.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -118.26 2.46 11.94 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.468 1.507 . . . . 0.0 111.656 -173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.24 31.96 72.09 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 119.321 0.964 . . . . 0.0 112.399 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . 0.253 33.5 m -107.14 3.04 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.397 0.679 . . . . 0.0 111.429 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.65 105.67 12.07 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 104.308 -2.479 . . . . 0.0 104.308 168.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 124' ' ' LEU . 80.4 mt -67.61 127.85 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -66.37 -48.51 69.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.939 0.896 . . . . 0.0 111.109 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -80.27 -49.55 11.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.603 0.239 . . . . 0.0 110.574 -170.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.448 ' H ' HG22 ' A' ' 121' ' ' ILE . 18.4 tp -78.71 -18.16 54.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.683 0.793 . . . . 0.0 112.084 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 45.14 52.02 8.74 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.384 1.474 . . . . 0.0 111.371 -170.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.9 tp -139.25 168.93 18.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -72.04 138.14 47.67 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.463 0.574 . . . . 0.0 110.056 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.43 155.95 40.01 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.386 1.075 . . . . 0.0 110.737 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -84.66 109.96 18.39 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.0 m -149.88 168.18 24.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.722 0.409 . . . . 0.0 110.519 -173.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.13 147.1 19.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.599 1.16 . . . . 0.0 108.22 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -146.77 154.82 41.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.353 1.061 . . . . 0.0 109.036 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.92 140.37 40.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 171.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.0 mp -130.81 137.18 49.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.57 1.548 . . . . 0.0 107.337 -171.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.44 169.12 6.32 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.158 1.383 . . . . 0.0 109.855 169.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -49.58 -37.93 29.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.741 1.217 . . . . 0.0 112.174 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -75.29 -3.16 31.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.193 0.997 . . . . 0.0 112.677 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.1 -6.96 77.41 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.927 -1.108 . . . . 0.0 112.89 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 113.6 3.02 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 118.871 1.335 . . . . 0.0 108.365 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.4 129.73 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.27 -12.57 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.661 1.584 . . . . 0.0 109.925 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -151.47 150.15 30.07 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.434 1.093 . . . . 0.0 108.413 172.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.2 135.54 13.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.263 1.825 . . . . 0.0 107.168 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -150.6 150.28 30.99 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.451 0.7 . . . . 0.0 109.391 171.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -124.36 116.24 22.27 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.779 2.032 . . . . 0.0 105.637 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.24 128.68 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -60.05 -26.69 66.35 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.537 1.135 . . . . 0.0 113.268 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.01 105.66 6.46 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.51 -25.7 66.29 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.124 1.37 . . . . 0.0 113.905 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.21 15.93 2.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.89 -175.63 3.84 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 127.005 2.122 . . . . 0.0 107.978 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -116.96 155.05 49.73 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 120.006 1.275 . . . . 0.0 112.689 -170.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.24 163.82 32.04 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.164 2.576 . . . . 0.0 111.13 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -80.07 87.3 5.45 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 168.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -68.57 -5.72 21.39 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -71.3 -30.01 65.73 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.08 0.855 . . . . 0.0 109.302 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -63.9 -50.74 68.63 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.496 -1.24 . . . . 0.0 111.621 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.58 -32.46 48.29 Favored 'Trans proline' 0 C--N 1.35 0.622 0 CA-C-N 121.707 1.646 . . . . 0.0 112.111 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.5 mm -59.78 -44.82 94.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.998 1.272 . . . . 0.0 109.816 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.97 -37.15 86.69 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 119.262 0.937 . . . . 0.0 110.9 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.62 91.64 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.396 -0.19 . . . . 0.0 111.24 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.17 -46.49 70.58 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.59 173.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -53.78 -40.87 66.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.277 0.944 . . . . 0.0 110.545 177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.0 65.12 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.27 0.628 . . . . 0.0 112.204 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.9 mt -90.94 -41.81 10.93 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.954 0.502 . . . . 0.0 112.074 176.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.5 t -70.37 -42.43 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.952 0.901 . . . . 0.0 111.2 -171.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.3 tptp . . . . . 0 C--O 1.249 1.035 0 C-N-CA 124.233 1.013 . . . . 0.0 109.594 179.319 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.14 144.81 56.98 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.149 0.58 . . . . 0.0 109.708 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -154.76 149.16 26.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 169.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.11 174.45 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 170.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -112.19 151.57 29.39 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -133.52 116.55 16.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 172.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp 44.36 41.84 4.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.382 1.473 . . . . 0.0 111.69 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.32 5.0 80.23 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -112.59 116.74 4.13 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.097 -1.39 . . . . 0.0 110.319 174.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.68 140.61 84.37 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.291 2.66 . . . . 0.0 112.1 173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.35 141.69 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.632 1.173 . . . . 0.0 110.402 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -82.01 162.11 22.74 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.208 1.803 . . . . 0.0 110.358 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.42 145.26 45.35 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.912 1.285 . . . . 0.0 108.118 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.3 t -74.3 -61.71 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.182 0.593 . . . . 0.0 109.701 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.42 34.16 2.7 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.668 1.128 . . . . 0.0 113.677 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 52.27 -148.94 0.39 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.865 1.666 . . . . 0.0 112.435 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -123.96 116.3 22.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.029 1.732 . . . . 0.0 108.309 -169.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.2 m -72.43 171.65 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -144.08 164.01 31.88 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.79 138.16 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.56 -3.76 76.9 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 119.025 -0.875 . . . . 0.0 113.941 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -73.38 -15.54 61.36 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.145 1.472 . . . . 0.0 114.214 -170.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.05 104.5 0.07 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.985 1.714 . . . . 0.0 111.159 172.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.24 131.79 90.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.651 0.78 . . . . 0.0 111.259 -175.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.59 149.51 81.86 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.764 2.309 . . . . 0.0 113.773 173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -77.31 67.93 3.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.321 1.848 . . . . 0.0 108.849 169.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.78 160.42 14.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.314 1.046 . . . . 0.0 109.134 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.8 163.89 27.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.997 1.319 . . . . 0.0 111.793 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.36 173.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 129.934 3.294 . . . . 0.0 105.02 168.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -131.53 139.51 49.28 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.3 p -86.68 176.02 7.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.555 0.616 . . . . 0.0 111.517 -172.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -60.91 -25.53 66.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.972 0.909 . . . . 0.0 110.331 168.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 m -81.29 1.72 31.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.053 1.341 . . . . 0.0 111.646 174.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.8 mt 60.01 38.99 20.48 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 127.162 2.185 . . . . 0.0 111.893 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.08 160.75 27.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.756 0.823 . . . . 0.0 110.887 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.09 146.09 47.76 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.205 1.002 . . . . 0.0 110.576 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -147.42 157.79 43.72 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.442 2.697 . . . . 0.0 103.82 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -135.54 158.98 43.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 tt -58.72 -25.91 63.41 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.81 66.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.396 1.453 . . . . 0.0 112.9 173.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -75.57 -27.09 58.46 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.868 0.758 . . . . 0.0 110.996 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.3 mtt -73.5 -34.98 65.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.214 1.006 . . . . 0.0 110.544 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -55.99 152.07 10.87 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.53 0.732 . . . . 0.0 110.413 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.78 -19.44 33.22 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.134 1.35 . . . . 0.0 112.58 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -147.89 150.75 34.68 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.473 1.509 . . . . 0.0 108.022 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.37 142.27 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 m -135.69 147.58 48.57 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.328 1.051 . . . . 0.0 108.383 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.5 mt -132.84 134.24 58.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.9 mt -139.95 116.73 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -95.08 153.25 17.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -136.04 134.87 50.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.04 147.59 51.34 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.776 1.63 . . . . 0.0 108.299 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -38.73 16.63 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.519 2.146 . . . . 0.0 111.833 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -146.74 169.96 17.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.393 2.277 . . . . 0.0 105.916 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.263 0.0 OUTLIER -117.62 -15.58 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 122.673 0.389 . . . . 0.0 111.322 -175.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.36 -29.88 68.7 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.375 -0.828 . . . . 0.0 110.717 169.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.21 143.57 57.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.1 1.36 . . . . 0.0 110.764 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.93 -17.34 50.81 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.535 1.064 . . . . 0.0 114.762 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -54.5 -25.24 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 118.788 1.294 . . . . 0.0 112.694 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.9 p -60.1 -32.93 71.45 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.939 0.79 . . . . 0.0 111.904 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -117.67 -28.21 6.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.752 0.821 . . . . 0.0 111.58 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.27 -30.31 69.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.989 0.915 . . . . 0.0 112.428 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -152.6 -39.5 0.1 Allowed 'General case' 0 C--N 1.34 0.181 0 CA-C-O 117.928 -1.034 . . . . 0.0 111.749 174.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.4 m -57.84 -45.19 86.59 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.847 1.203 . . . . 0.0 111.897 -169.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -59.21 -52.32 66.19 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 123.838 0.855 . . . . 0.0 110.883 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -60.48 -42.79 97.01 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.665 0.666 . . . . 0.0 111.076 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.6 -51.0 70.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.078 0.551 . . . . 0.0 110.661 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -66.48 -27.4 67.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.01 0.124 . . . . 0.0 111.078 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -65.67 -44.44 86.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.085 1.354 . . . . 0.0 110.082 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -66.8 -43.97 82.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.457 0.571 . . . . 0.0 110.206 173.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -45.62 77.62 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.068 0.947 . . . . 0.0 111.226 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.93 -11.12 44.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.678 1.191 . . . . 0.0 113.237 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -118.68 -1.86 11.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.639 1.176 . . . . 0.0 113.828 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.3 mt -60.18 -37.36 79.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.133 1.333 . . . . 0.0 109.493 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.98 -172.53 41.67 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 127.969 2.7 . . . . 0.0 106.942 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -75.82 27.66 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.362 1.081 . . . . 0.0 112.564 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.4 144.2 11.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 120.756 -1.215 . . . . 0.0 109.958 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -68.48 145.34 54.15 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.12 121.8 10.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -172.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -137.31 154.14 50.13 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.318 0.647 . . . . 0.0 111.327 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -130.62 105.69 7.99 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.5 mt -81.72 131.56 33.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -129.2 173.17 10.73 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.266 1.827 . . . . 0.0 108.048 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.05 171.65 5.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.64 0.733 . . . . 0.0 110.363 169.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.99 -16.55 64.43 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.275 1.03 . . . . 0.0 111.604 171.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.2 mt -53.61 128.0 51.86 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.814 1.246 . . . . 0.0 109.999 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.23 -9.29 15.21 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.916 2.411 . . . . 0.0 113.419 -174.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -52.66 112.27 0.8 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.748 1.219 . . . . 0.0 111.11 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 56.85 5.65 0.24 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.73 2.412 . . . . 0.0 115.436 -176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -61.93 -35.51 78.64 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 120.044 1.293 . . . . 0.0 110.258 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.01 -9.22 9.27 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 175.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -112.46 -4.85 14.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.281 0.946 . . . . 0.0 111.618 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 3.3 p90 32.4 57.52 0.39 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.635 2.374 . . . . 0.0 113.816 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 p -54.94 -28.46 51.26 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.62 -12.18 55.7 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 119.593 1.088 . . . . 0.0 113.976 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -129.32 -10.37 4.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.049 1.74 . . . . 0.0 112.721 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -64.7 125.94 26.36 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.914 0.486 . . . . 0.0 111.358 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.76 -21.18 20.24 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.199 0.904 . . . . 0.0 112.46 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 mt -84.85 -31.69 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 118.457 1.129 . . . . 0.0 110.514 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.41 -35.4 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 131.65 3.98 . . . . 0.0 116.341 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -66.78 -35.21 79.56 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.517 1.127 . . . . 0.0 111.571 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -67.86 150.8 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.632 1.173 . . . . 0.0 107.959 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.44 143.78 35.75 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 p -79.8 155.44 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.402 0.62 . . . . 0.0 109.523 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.1 mt -129.2 162.78 27.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.927 1.691 . . . . 0.0 107.312 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.5 m -137.17 44.58 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.572 1.549 . . . . 0.0 110.323 -169.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -48.32 -36.03 13.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -169.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -50.82 -25.96 5.12 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.801 1.182 . . . . 0.0 114.182 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.7 ttt85 -60.19 -22.65 63.2 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.072 0.851 . . . . 0.0 112.376 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -127.79 -19.16 4.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.758 1.623 . . . . 0.0 111.955 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.3 tpt 58.25 11.54 1.62 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 129.928 3.291 . . . . 0.0 114.402 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.6 m -69.6 -42.81 73.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.851 -1.071 . . . . 0.0 112.456 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -61.25 -37.03 81.62 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.654 1.57 . . . . 0.0 109.379 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.35 -53.16 21.03 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 125.617 1.579 . . . . 0.0 112.865 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.11 -37.02 69.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.351 0.575 . . . . 0.0 110.477 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.84 -32.91 73.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.009 0.924 . . . . 0.0 112.911 -173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.35 1.04 13.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.648 1.179 . . . . 0.0 111.744 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.53 37.81 94.08 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 119.123 0.874 . . . . 0.0 112.047 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.37 -1.94 9.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.678 . . . . 0.0 110.91 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.87 106.1 5.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 168.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.9 mt -69.42 120.9 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -64.49 -43.13 95.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -89.07 -6.08 57.38 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -170.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.2 tp -132.76 -13.23 2.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.582 0.753 . . . . 0.0 112.701 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . 0.251 39.3 ptt180 41.65 43.44 2.37 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.711 1.604 . . . . 0.0 113.036 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.1 mt -124.98 172.54 9.33 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 170.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.85 140.02 45.46 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.885 0.874 . . . . 0.0 109.634 173.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.65 157.56 35.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.366 1.067 . . . . 0.0 110.793 170.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -84.16 112.12 19.96 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.4 m -153.76 167.05 30.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.78 147.18 18.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -143.61 155.27 44.22 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.305 1.442 . . . . 0.0 108.575 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.16 139.76 45.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.3 mt -129.5 129.87 45.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.237 1.415 . . . . 0.0 108.334 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.28 166.71 9.48 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.015 0.926 . . . . 0.0 108.997 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -50.4 -31.03 13.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.924 1.29 . . . . 0.0 112.754 174.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -81.84 -4.43 56.47 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.483 1.113 . . . . 0.0 113.217 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.86 62.9 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.209 -0.932 . . . . 0.0 111.596 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -86.55 118.09 25.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.56 114.03 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 170.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 p -97.44 -14.44 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.167 0.987 . . . . 0.0 109.886 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 152.32 32.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.274 1.029 . . . . 0.0 108.659 169.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.25 137.55 13.85 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.378 1.871 . . . . 0.0 107.251 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.21 149.97 31.85 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.187 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -123.71 114.52 20.05 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.7 t -71.39 135.97 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.3 m -58.64 -21.48 54.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.539 1.136 . . . . 0.0 113.509 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -140.08 129.6 24.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -53.83 -35.04 61.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -80.67 -6.93 59.07 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.516 1.053 . . . . 0.0 112.715 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.57 -173.67 4.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.319 1.448 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -137.89 156.33 74.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 110.104 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.38 168.29 16.67 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.836 2.357 . . . . 0.0 110.287 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -74.89 113.99 12.83 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -80.76 -6.71 58.86 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -169.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -73.11 -32.29 64.86 Favored 'General case' 0 C--O 1.225 -0.215 0 O-C-N 120.995 -1.065 . . . . 0.0 108.572 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -60.4 -51.32 80.9 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.613 -1.184 . . . . 0.0 111.147 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.14 -33.0 41.93 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.453 1.555 . . . . 0.0 112.747 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.2 mm -59.9 -47.47 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 120.455 1.479 . . . . 0.0 109.51 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.52 -38.88 92.55 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 119.027 0.83 . . . . 0.0 110.554 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.78 92.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.324 0.249 . . . . 0.0 111.271 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.12 65.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 119.057 -0.497 . . . . 0.0 110.686 174.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -53.9 -41.64 67.84 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.069 0.849 . . . . 0.0 110.569 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.05 -30.45 64.27 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.571 0.749 . . . . 0.0 112.174 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 62.6 mt -90.43 -43.12 10.49 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.004 0.522 . . . . 0.0 111.68 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.6 t -71.49 -45.1 69.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.978 0.911 . . . . 0.0 111.331 -170.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.69 0.796 . . . . 0.0 109.642 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.94 14.71 1.47 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.593 1.957 . . . . 0.0 114.472 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -171.56 144.43 1.89 Allowed 'General case' 0 C--O 1.243 0.741 0 C-N-CA 131.293 3.837 . . . . 0.0 102.412 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.8 pt -142.08 171.9 10.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 122.575 1.179 . . . . 0.0 110.366 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -109.96 157.41 19.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.51 113.17 11.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 45.51 43.95 9.4 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.66 1.584 . . . . 0.0 111.556 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.9 4.61 82.03 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 173.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.46 126.15 7.59 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 145.9 63.98 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.643 2.222 . . . . 0.0 110.148 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 m -136.39 179.48 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.333 1.453 . . . . 0.0 108.778 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -127.54 158.98 35.98 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.5 mt -112.88 172.93 6.63 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.833 1.253 . . . . 0.0 109.35 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.74 149.82 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 56.99 19.09 29.02 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.925 1.726 . . . . 0.0 115.884 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -67.59 176.78 2.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.764 2.025 . . . . 0.0 114.976 -169.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.254 6.1 tt0 87.8 30.85 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.105 2.562 . . . . 0.0 113.325 169.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -61.16 143.44 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 168.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -149.45 165.19 32.85 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.872 1.269 . . . . 0.0 108.068 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 p -54.6 133.88 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.15 81.38 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.492 1.044 . . . . 0.0 113.806 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.71 -10.52 59.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.483 1.641 . . . . 0.0 114.177 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 71.37 127.71 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.463 1.905 . . . . 0.0 112.385 169.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.42 126.5 88.2 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.287 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -62.29 -30.31 81.03 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 114.147 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.6 t70 94.79 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 130.468 3.507 . . . . 0.0 106.838 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.04 174.2 10.77 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.821 2.049 . . . . 0.0 107.779 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 m -131.81 120.76 23.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -105.01 165.24 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.394 1.478 . . . . 0.0 107.506 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.07 143.32 38.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.3 p -76.58 179.29 6.06 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.087 0.955 . . . . 0.0 110.155 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -60.91 -24.46 66.01 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.162 -0.961 . . . . 0.0 111.114 168.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -89.93 3.79 52.01 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.784 2.034 . . . . 0.0 112.158 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 57.44 29.3 16.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.908 2.083 . . . . 0.0 113.188 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.24 144.48 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 169.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.61 142.23 42.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.469 0.708 . . . . 0.0 109.431 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -148.32 113.79 5.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 107.391 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 p -72.38 154.78 40.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.466 0.65 . . . . 0.0 109.321 172.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.52 -39.21 79.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.27 -25.69 15.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.101 0.961 . . . . 0.0 113.483 173.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.86 -28.5 55.45 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.791 1.178 . . . . 0.0 111.499 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 54.9 mtt -69.69 -30.93 68.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.045 0.938 . . . . 0.0 110.881 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -57.76 152.61 15.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.526 0.679 . . . . 0.0 110.467 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.93 -8.23 38.94 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.482 1.039 . . . . 0.0 113.094 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -152.66 152.76 32.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.815 1.646 . . . . 0.0 107.861 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.4 t -60.21 144.93 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.8 m -136.01 148.15 48.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.399 1.08 . . . . 0.0 108.582 -170.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.5 mt -130.62 137.74 55.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.5 mt -135.1 102.78 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -174.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -84.84 149.86 25.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -139.23 136.67 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -141.71 146.82 42.93 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 124.915 1.286 . . . . 0.0 109.316 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.48 -38.81 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.188 1.925 . . . . 0.0 111.496 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 p -162.77 148.66 12.34 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.26 1.424 . . . . 0.0 108.065 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 tp -71.23 -19.33 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.652 0.781 . . . . 0.0 111.014 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.6 -26.17 68.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.342 1.057 . . . . 0.0 112.087 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 p -62.8 138.97 58.66 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.313 0.578 . . . . 0.0 110.686 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.63 -4.29 69.91 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.729 0.68 . . . . 0.0 113.392 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.86 -25.99 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 124.523 1.129 . . . . 0.0 111.968 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.78 -42.75 85.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.856 0.753 . . . . 0.0 111.83 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.35 -37.52 80.56 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.409 0.549 . . . . 0.0 110.134 177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.82 -35.21 72.38 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.407 HE21 ' CB ' ' A' ' 67' ' ' PHE . 5.7 tm0? -155.3 -53.6 0.09 Allowed 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -169.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -39.76 79.07 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.631 1.559 . . . . 0.0 114.486 -167.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -64.91 -48.91 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.536 1.517 . . . . 0.0 110.179 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -61.33 -49.16 78.11 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 118.846 0.748 . . . . 0.0 109.806 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.407 ' CB ' HE21 ' A' ' 63' ' ' GLN . 61.1 t80 -56.98 -48.64 77.92 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.259 0.624 . . . . 0.0 110.797 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -61.98 -39.68 93.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.511 0.724 . . . . 0.0 110.856 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.84 -38.83 80.07 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.124 0.97 . . . . 0.0 111.075 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -68.94 -45.16 71.47 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.201 0.91 . . . . 0.0 110.309 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.56 -47.86 69.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.929 1.291 . . . . 0.0 110.856 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.93 -21.35 61.01 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.949 0.9 . . . . 0.0 113.127 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -120.13 7.67 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -171.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.41 -30.79 68.71 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.851 1.205 . . . . 0.0 111.626 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.65 -74.25 0.06 OUTLIER Glycine 0 C--N 1.336 0.551 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -162.91 110.16 1.23 Allowed 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.48 155.6 34.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.889 1.276 . . . . 0.0 107.987 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -76.45 144.26 40.02 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.66 129.66 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.56 157.69 45.38 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.27 1.028 . . . . 0.0 110.08 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 45.6 m -127.13 98.02 5.15 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 mt -76.69 128.61 37.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.9 m -139.32 170.03 16.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.617 1.567 . . . . 0.0 108.862 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.41 175.2 10.51 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.98 0.895 . . . . 0.0 111.612 176.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -86.44 -14.36 43.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.663 1.585 . . . . 0.0 110.854 169.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 tp -50.28 142.21 14.86 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 127.065 2.146 . . . . 0.0 110.867 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -52.52 -34.01 60.34 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.858 2.372 . . . . 0.0 113.672 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -79.67 35.53 0.3 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.047 1.339 . . . . 0.0 111.595 175.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.12 154.49 48.13 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.774 1.229 . . . . 0.0 109.139 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 62.45 -22.3 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.338 2.655 . . . . 0.0 117.202 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.1 -25.74 64.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.82 1.191 . . . . 0.0 114.056 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.12 39.93 3.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.481 1.512 . . . . 0.0 108.858 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -29.81 120.29 0.16 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.407 2.283 . . . . 0.0 113.601 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.3 m -77.78 46.76 0.58 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.659 1.583 . . . . 0.0 114.024 -169.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -34.33 0.19 Allowed Glycine 0 C--N 1.333 0.397 0 O-C-N 121.276 -0.89 . . . . 0.0 112.486 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.4 16.73 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.56 1.144 . . . . 0.0 114.071 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -136.1 65.85 1.52 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.871 1.668 . . . . 0.0 107.177 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.76 -37.57 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.805 1.193 . . . . 0.0 111.016 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.22 89.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.24 -23.55 9.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.494 1.918 . . . . 0.0 113.983 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.37 -32.26 72.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.858 0.863 . . . . 0.0 112.29 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -71.92 147.05 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -148.99 145.27 27.24 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.5 p -80.41 151.71 29.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.394 0.616 . . . . 0.0 109.586 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.44 156.64 29.79 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.171 1.388 . . . . 0.0 107.695 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 6.6 m -120.45 46.44 1.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.629 1.972 . . . . 0.0 110.326 -169.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -55.52 -32.1 62.63 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 120.967 -1.083 . . . . 0.0 113.217 -170.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -55.87 -17.26 5.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -58.37 -27.38 64.16 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.305 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -141.88 -3.35 1.12 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.801 1.182 . . . . 0.0 113.808 176.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.86 28.66 6.71 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.5 2.32 . . . . 0.0 113.802 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 m -59.33 -58.9 6.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.923 0.889 . . . . 0.0 110.773 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -61.97 -33.92 75.19 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.803 0.841 . . . . 0.0 109.792 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -49.19 -57.77 8.65 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 125.141 1.353 . . . . 0.0 112.08 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.4 -39.77 58.64 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.149 0.474 . . . . 0.0 110.15 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.17 85.6 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 -169.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.99 3.07 30.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.916 1.286 . . . . 0.0 110.672 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.62 29.06 71.56 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 121.553 -0.717 . . . . 0.0 113.625 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.06 -1.73 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.107 0.963 . . . . 0.0 110.612 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.44 105.73 1.24 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.638 1.108 . . . . 0.0 108.086 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.38 115.89 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -57.36 -43.42 83.49 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.623 1.169 . . . . 0.0 111.028 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -92.9 -4.62 52.49 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -169.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.79 -14.75 2.75 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.648 0.779 . . . . 0.0 112.402 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 48.92 40.4 16.6 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.84 1.656 . . . . 0.0 112.144 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 mt -126.27 173.9 8.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.73 126.97 31.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.394 1.478 . . . . 0.0 108.972 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 137.32 58.24 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 124.749 1.219 . . . . 0.0 110.637 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -60.55 108.63 0.85 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.322 1.049 . . . . 0.0 108.318 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 10.2 p -156.58 170.16 23.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.012 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.03 147.37 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -144.18 153.01 41.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.05 136.07 49.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 173.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.9 mp -129.56 133.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.728 1.211 . . . . 0.0 107.801 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.44 161.08 14.94 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.659 1.183 . . . . 0.0 109.825 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -33.14 -41.82 0.08 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.428 2.691 . . . . 0.0 115.413 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -91.1 -8.15 49.64 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.51 3.38 43.76 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.202 0.906 . . . . 0.0 113.567 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -71.47 118.69 14.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.85 1.825 . . . . 0.0 108.691 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.96 116.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 170.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.52 -15.41 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.294 1.038 . . . . 0.0 109.967 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -149.87 150.08 31.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.65 1.18 . . . . 0.0 108.081 171.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -158.72 127.02 5.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.126 1.77 . . . . 0.0 106.93 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -149.23 149.83 31.6 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.031 0.832 . . . . 0.0 110.076 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.28 113.82 20.96 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 t -67.69 126.87 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.6 m -63.98 -2.6 2.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.66 1.184 . . . . 0.0 114.168 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -141.52 124.39 16.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.08 -31.0 66.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.768 1.227 . . . . 0.0 113.501 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.5 p -86.73 15.81 5.37 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.004 0.82 . . . . 0.0 111.771 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -127.53 179.44 5.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.468 1.507 . . . . 0.0 110.085 -174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -137.81 159.16 69.88 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.772 1.229 . . . . 0.0 110.592 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -89.4 -178.64 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.436 2.758 . . . . 0.0 110.55 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -75.53 94.14 3.11 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -72.45 -6.3 42.67 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.708 0.803 . . . . 0.0 112.913 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -73.67 -28.59 61.84 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 119.658 1.117 . . . . 0.0 108.982 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -61.1 -49.96 86.42 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -64.11 -33.86 59.85 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.53 1.582 . . . . 0.0 112.732 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.92 -45.85 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.348 1.431 . . . . 0.0 109.639 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.67 -38.84 92.64 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 119.412 1.006 . . . . 0.0 110.53 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.43 91.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.53 0.332 . . . . 0.0 111.207 176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.44 -48.29 61.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.981 0.513 . . . . 0.0 110.761 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.21 -39.45 69.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.059 0.845 . . . . 0.0 110.957 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.32 -31.01 65.25 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.463 0.705 . . . . 0.0 111.89 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 63.1 mt -91.87 -43.89 9.24 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.353 0.524 . . . . 0.0 111.452 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.51 -39.6 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.352 1.061 . . . . 0.0 110.767 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.0 mttp . . . . . 0 C--O 1.249 1.038 0 C-N-CA 126.488 1.915 . . . . 0.0 110.069 -174.016 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.04 156.01 42.34 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.151 0.98 . . . . 0.0 109.59 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -152.19 152.26 32.03 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.9 pt -133.62 179.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.655 0.74 . . . . 0.0 109.53 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -129.04 145.14 51.34 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -144.54 130.02 18.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 45.93 38.9 4.95 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.634 1.174 . . . . 0.0 112.175 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.44 26.32 73.54 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.274 -0.737 . . . . 0.0 114.374 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.61 139.91 11.33 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.22 144.74 42.34 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.369 2.046 . . . . 0.0 110.25 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.94 134.0 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.246 1.018 . . . . 0.0 109.767 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -81.2 166.22 20.8 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.618 1.967 . . . . 0.0 110.62 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.4 mt -117.2 154.87 30.38 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.862 1.665 . . . . 0.0 109.539 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 79.1 t -85.65 -65.41 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.662 0.665 . . . . 0.0 110.24 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.63 4.22 86.38 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.68 0.657 . . . . 0.0 114.225 -170.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 52.59 176.31 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.779 2.831 . . . . 0.0 116.45 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.93 113.51 3.9 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.591 1.956 . . . . 0.0 111.573 -169.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.71 160.62 4.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -137.93 157.89 45.47 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 121.37 -0.831 . . . . 0.0 109.885 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.57 132.49 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.38 -2.1 87.43 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.667 -1.074 . . . . 0.0 114.279 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.57 -4.72 58.07 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.765 1.783 . . . . 0.0 112.596 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 59.16 177.2 0.08 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.561 1.544 . . . . 0.0 112.058 -169.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.09 135.29 21.08 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.287 1.835 . . . . 0.0 108.328 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 87.1 Cg_endo -72.23 156.4 55.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.179 1.919 . . . . 0.0 109.453 172.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.442 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 25.3 t70 -74.59 66.02 1.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.676 1.99 . . . . 0.0 110.66 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -61.33 155.21 21.88 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.295 1.438 . . . . 0.0 109.561 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.8 m -94.86 155.1 16.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.37 171.66 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.161 2.184 . . . . 0.0 106.955 172.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.9 mt -132.93 130.2 39.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -72.85 -176.89 2.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.697 1.199 . . . . 0.0 111.981 -173.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -57.37 -32.35 66.7 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 110.485 169.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -85.62 2.98 42.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.867 1.667 . . . . 0.0 112.047 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.2 mt 52.22 36.82 20.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.507 1.923 . . . . 0.0 112.315 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -91.75 149.53 21.56 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.3 144.81 49.83 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.159 0.981 . . . . 0.0 110.148 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -153.97 159.15 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.45 2.7 . . . . 0.0 104.838 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 m -142.53 166.45 24.63 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 53.9 tp -49.79 -42.03 45.86 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.683 0.393 . . . . 0.0 111.311 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.56 -21.9 63.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.38 -30.25 60.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.821 0.737 . . . . 0.0 111.06 175.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.8 mtt -72.45 -37.39 68.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.566 1.146 . . . . 0.0 110.662 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -55.98 152.77 9.71 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.008 0.908 . . . . 0.0 111.517 -173.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.53 11.59 66.05 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.977 1.275 . . . . 0.0 113.251 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -154.17 148.21 25.71 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.559 1.544 . . . . 0.0 107.699 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.17 141.49 16.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.8 m -133.19 143.09 48.96 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -172.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 77' ' ' VAL . 74.1 mt -135.92 132.55 50.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -172.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mt -139.56 134.28 38.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -169.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.92 144.76 42.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 168.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 t -121.7 126.8 75.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.35 127.82 5.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -173.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.97 -41.98 71.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.261 1.974 . . . . 0.0 112.43 -169.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.7 t -157.5 145.98 19.37 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -17.82 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 122.438 0.295 . . . . 0.0 111.129 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.19 -21.37 63.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 112.672 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.5 p -59.15 -24.62 63.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.659 0.784 . . . . 0.0 112.431 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.54 -10.29 59.68 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.881 0.753 . . . . 0.0 112.144 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.93 -18.21 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 118.85 1.325 . . . . 0.0 110.069 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.6 p -51.77 -43.63 63.07 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.972 0.909 . . . . 0.0 112.052 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.34 -41.13 63.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.849 0.749 . . . . 0.0 109.997 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.23 -30.88 71.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 -173.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -146.76 -49.02 0.19 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.317 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 m -55.49 -45.32 77.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.643 1.11 . . . . 0.0 113.451 -167.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -48.8 80.22 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 118.703 0.683 . . . . 0.0 109.892 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.65 -45.94 73.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.843 0.747 . . . . 0.0 109.548 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -52.64 -53.49 46.26 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.432 0.693 . . . . 0.0 110.276 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -29.78 53.49 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -63.75 -55.32 24.11 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.334 1.054 . . . . 0.0 109.915 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.71 -37.35 87.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.6 0.76 . . . . 0.0 109.559 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.58 69.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.76 0.824 . . . . 0.0 110.799 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.79 68.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.467 0.307 . . . . 0.0 111.65 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -75.44 -22.74 57.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.007 -0.997 . . . . 0.0 112.641 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.57 -40.63 95.91 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.204 1.365 . . . . 0.0 110.944 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.47 -168.15 41.06 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -173.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -74.15 29.02 0.08 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.024 1.33 . . . . 0.0 113.311 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 48' ' ' ILE . 23.9 m -62.08 154.6 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 120.482 -1.386 . . . . 0.0 110.832 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.62 149.71 29.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.58 123.59 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -133.91 149.02 51.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.097 0.559 . . . . 0.0 111.396 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -127.81 99.09 5.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.4 mt -84.67 130.48 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 m -142.95 172.99 11.95 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.013 1.325 . . . . 0.0 110.639 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.74 172.01 8.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.895 0.878 . . . . 0.0 111.5 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.84 -4.6 58.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.297 1.039 . . . . 0.0 111.31 173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.5 tp -46.73 126.07 8.19 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.706 1.602 . . . . 0.0 109.609 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -51.96 -27.44 28.24 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.622 2.881 . . . . 0.0 116.869 -169.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -75.53 -20.71 58.51 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.702 0.683 . . . . 0.0 112.261 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.42 172.29 9.73 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.494 0.718 . . . . 0.0 110.231 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.298 0.1 OUTLIER 42.93 20.06 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.926 2.491 . . . . 0.0 116.656 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.47 -7.37 56.1 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.514 1.126 . . . . 0.0 112.323 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.1 mtp85 55.69 30.84 16.26 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.033 1.733 . . . . 0.0 112.524 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -64.28 -25.83 68.23 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.981 -0.45 . . . . 0.0 111.421 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 p -158.78 171.87 19.28 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.018 1.727 . . . . 0.0 108.371 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.76 -84.41 1.11 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.94 36.9 0.64 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 -172.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -139.66 137.96 35.68 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.019 1.328 . . . . 0.0 108.197 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.99 -14.18 65.01 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.01 0.814 . . . . 0.0 112.024 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.91 93.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 126.335 1.854 . . . . 0.0 106.269 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.27 -25.63 48.84 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.501 1.52 . . . . 0.0 113.196 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -55.59 -36.67 67.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.987 1.315 . . . . 0.0 112.694 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.2 t -70.86 147.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -129.55 141.92 50.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.2 p -87.44 136.81 32.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.9 146.08 46.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 m -121.65 51.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.742 1.217 . . . . 0.0 109.687 -168.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -53.21 -31.48 43.32 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -56.66 -21.68 29.2 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 120.941 1.701 . . . . 0.0 114.05 -176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -76.49 -6.23 50.91 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.146 -0.971 . . . . 0.0 112.551 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.17 -39.88 0.6 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.028 1.331 . . . . 0.0 112.44 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.75 4.29 3.9 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 130.054 3.342 . . . . 0.0 114.815 170.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -58.81 -44.51 90.82 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.259 -1.353 . . . . 0.0 111.957 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.06 -41.58 90.6 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 121.064 1.756 . . . . 0.0 110.069 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.61 -43.11 96.35 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 123.996 0.808 . . . . 0.0 111.772 -176.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -72.76 -46.72 51.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.271 0.536 . . . . 0.0 109.994 173.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 25' ' ' PRO . . . -58.99 -39.19 81.06 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.241 1.016 . . . . 0.0 112.532 -172.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.04 5.83 26.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.0 110.618 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 55.6 32.45 58.34 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 123.717 0.675 . . . . 0.0 113.563 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.35 -8.75 9.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 123.45 0.7 . . . . 0.0 110.097 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -68.96 111.32 4.91 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.32 128.13 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -66.87 -47.36 72.12 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 110.933 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -90.83 0.05 57.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 tp -129.82 -13.55 4.14 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.629 1.172 . . . . 0.0 111.591 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 47.15 47.91 16.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.922 1.689 . . . . 0.0 111.193 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.3 tp -139.88 156.88 46.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.468 1.107 . . . . 0.0 108.206 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.08 131.24 45.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.326 0.65 . . . . 0.0 109.519 173.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.85 164.32 25.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.993 1.317 . . . . 0.0 112.407 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -86.03 113.5 22.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 169.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.5 m -148.14 173.53 12.87 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.709 0.804 . . . . 0.0 109.681 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 144.7 17.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.886 1.274 . . . . 0.0 108.454 177.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -148.34 158.87 44.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.573 1.149 . . . . 0.0 109.998 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.9 t -138.04 140.65 40.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 10.0 mp -131.75 135.73 47.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.235 1.414 . . . . 0.0 107.591 -173.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.35 166.67 7.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 110.04 169.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.32 -31.96 23.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.116 1.367 . . . . 0.0 113.012 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -80.91 -0.86 41.06 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.432 1.093 . . . . 0.0 112.67 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.12 -6.75 82.76 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.625 1.107 . . . . 0.0 112.608 -173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.2 124.9 22.37 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 118.719 1.259 . . . . 0.0 109.232 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.81 128.24 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.737 0.815 . . . . 0.0 110.112 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.2 t -116.79 -19.51 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.327 2.251 . . . . 0.0 109.917 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -145.08 147.05 32.13 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -152.81 131.94 12.69 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.037 1.335 . . . . 0.0 108.237 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.26 149.66 31.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.606 0.762 . . . . 0.0 109.365 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -128.06 117.19 21.2 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.823 2.049 . . . . 0.0 105.55 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.5 125.32 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.7 m -59.09 -25.02 63.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.693 1.197 . . . . 0.0 112.86 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -134.58 100.77 4.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.61 -22.09 66.64 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.563 1.145 . . . . 0.0 112.757 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.82 8.7 2.26 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.652 1.181 . . . . 0.0 112.422 170.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.68 162.48 30.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.252 1.821 . . . . 0.0 108.699 173.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -90.12 145.46 32.98 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.69 166.55 29.09 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.991 2.461 . . . . 0.0 111.579 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -85.44 139.39 31.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -104.07 -8.73 19.3 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -75.39 -39.29 59.27 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -51.36 -58.03 12.12 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.637 -1.173 . . . . 0.0 111.987 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.94 -34.41 23.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 121.493 1.569 . . . . 0.0 112.393 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 mm -59.58 -42.66 88.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 120.142 1.337 . . . . 0.0 109.998 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.39 -36.96 84.18 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.413 1.006 . . . . 0.0 110.716 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.45 87.24 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.376 -0.202 . . . . 0.0 110.884 175.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.59 -40.73 69.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.623 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.91 -40.65 76.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.92 1.236 . . . . 0.0 110.26 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.81 66.55 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.177 0.591 . . . . 0.0 112.317 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.09 -60.37 2.32 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.961 0.504 . . . . 0.0 110.46 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.39 -45.04 97.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.145 1.378 . . . . 0.0 111.905 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm . . . . . 0 C--O 1.25 1.094 0 C-N-CA 126.802 2.041 . . . . 0.0 110.936 -176.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.85 27.22 4.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.782 2.033 . . . . 0.0 114.959 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -83.51 171.84 12.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.483 0.713 . . . . 0.0 109.52 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 pt -131.43 171.82 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 123.18 1.467 . . . . 0.0 110.37 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -115.82 153.95 30.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -140.29 122.79 16.13 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt 42.17 39.13 1.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.365 1.466 . . . . 0.0 113.492 -171.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.33 6.18 89.47 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.674 -0.641 . . . . 0.0 114.396 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.77 125.42 7.93 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.185 1.374 . . . . 0.0 109.863 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.76 141.17 48.68 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 CA-C-N 120.995 2.397 . . . . 0.0 110.062 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.57 138.96 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.777 0.831 . . . . 0.0 109.844 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -86.02 155.59 20.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.644 1.178 . . . . 0.0 109.119 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.9 mt -118.9 153.38 34.66 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.194 1.398 . . . . 0.0 107.94 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -68.87 -15.58 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.58 33.8 0.45 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.971 0.805 . . . . 0.0 111.79 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -51.74 151.15 3.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.401 0.681 . . . . 0.0 112.209 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.262 8.6 tt0 108.44 23.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 129.242 3.017 . . . . 0.0 112.727 169.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -59.68 141.21 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -148.7 165.47 31.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.101 0.96 . . . . 0.0 109.167 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 p -54.01 132.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.02 -0.2 89.93 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.081 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.66 -12.04 59.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.546 1.673 . . . . 0.0 112.545 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 59.68 167.32 0.07 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.449 1.9 . . . . 0.0 113.101 -171.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.04 128.25 31.31 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.351 1.46 . . . . 0.0 108.466 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.39 -25.06 63.92 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.304 2.669 . . . . 0.0 114.428 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 66.81 100.67 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.995 2.518 . . . . 0.0 112.441 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -142.46 172.34 12.83 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.522 1.529 . . . . 0.0 109.274 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -89.21 154.38 20.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.76 1.224 . . . . 0.0 111.427 -169.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.83 164.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 128.087 2.555 . . . . 0.0 104.995 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 tp -116.85 140.4 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.8 p -79.11 168.12 20.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.23 -24.65 66.51 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.701 -0.624 . . . . 0.0 110.736 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -80.33 0.65 32.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.976 1.71 . . . . 0.0 112.011 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.6 mt 64.83 44.32 3.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.097 2.159 . . . . 0.0 111.946 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -119.73 145.98 46.04 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.26 1.024 . . . . 0.0 108.886 175.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.42 139.4 45.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.674 0.79 . . . . 0.0 109.312 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -142.01 102.18 4.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 m -71.03 153.59 42.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -58.94 -30.85 68.18 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.169 -0.957 . . . . 0.0 110.863 170.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.07 8.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.397 1.479 . . . . 0.0 113.286 169.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.06 -28.12 35.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.991 0.916 . . . . 0.0 111.676 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.2 mtt -72.41 -48.56 40.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.129 0.971 . . . . 0.0 110.496 176.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -64.36 171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.966 0.888 . . . . 0.0 110.291 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 -15.2 48.19 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.451 1.5 . . . . 0.0 110.575 -169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -153.02 159.81 42.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.542 2.737 . . . . 0.0 106.29 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.4 144.29 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 172.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.2 m -132.74 149.37 52.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.207 1.003 . . . . 0.0 109.551 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.5 138.64 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.3 mt -139.49 113.68 7.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 m -89.32 144.95 25.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.31 134.81 52.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 pt -147.67 159.39 41.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 107.928 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.02 -52.24 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 N-CA-C 108.513 -1.38 . . . . 0.0 108.513 168.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 m -150.9 146.72 26.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.703 1.601 . . . . 0.0 108.643 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -72.44 -20.7 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 111.047 171.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -60.1 -14.25 15.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.14 0.976 . . . . 0.0 113.319 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.5 p -56.65 -27.47 58.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.641 0.776 . . . . 0.0 111.866 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.43 4.67 84.79 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.167 0.889 . . . . 0.0 112.266 -173.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.02 -13.88 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 119.065 1.433 . . . . 0.0 111.976 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.6 m -57.75 -47.47 82.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.118 0.967 . . . . 0.0 110.539 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.38 -28.83 64.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.318 0.647 . . . . 0.0 111.35 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.82 -59.5 5.05 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -161.51 -14.22 0.04 OUTLIER 'General case' 0 C--N 1.341 0.203 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -69.59 -31.01 68.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.283 1.401 . . . . 0.0 112.825 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -61.88 -50.57 71.67 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.269 0.941 . . . . 0.0 108.841 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -62.37 -48.05 81.45 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.587 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.15 -50.75 71.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.641 0.777 . . . . 0.0 110.562 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -68.46 -33.03 73.46 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.388 -0.195 . . . . 0.0 110.757 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.7 -42.03 78.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.883 0.873 . . . . 0.0 111.426 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -61.33 -44.92 96.4 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.397 0.998 . . . . 0.0 109.678 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.02 -38.58 70.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.441 0.696 . . . . 0.0 111.402 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.89 -5.71 22.88 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -116.02 -12.3 11.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.689 1.596 . . . . 0.0 112.66 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -57.88 -32.47 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.643 1.11 . . . . 0.0 111.64 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.91 -159.69 32.88 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 107.744 -2.142 . . . . 0.0 107.744 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.61 22.21 0.14 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.469 -1.018 . . . . 0.0 112.386 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 77' ' ' VAL . 2.8 t -54.82 134.83 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.979 1.712 . . . . 0.0 108.817 -171.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.79 135.85 53.26 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -144.08 133.22 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -170.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.72 162.4 35.55 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.616 0.766 . . . . 0.0 110.926 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.8 m -133.03 124.46 27.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 169.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 56.1 mt -108.22 133.27 53.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -141.12 169.09 18.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.152 0.981 . . . . 0.0 110.484 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.3 -179.06 1.49 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.367 1.067 . . . . 0.0 112.003 174.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.13 -35.44 28.49 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -174.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.45 156.44 52.51 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 119.031 -0.509 . . . . 0.0 112.275 -169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.4 -38.59 63.44 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.545 2.83 . . . . 0.0 114.61 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -60.76 -8.78 3.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.0 1.32 . . . . 0.0 113.793 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HA ' HD13 ' A' ' 55' ' ' ILE . . . -118.5 -6.86 10.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.552 1.941 . . . . 0.0 111.978 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -139.81 15.57 2.5 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.826 1.193 . . . . 0.0 113.664 -169.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.41 155.05 44.3 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.948 1.299 . . . . 0.0 108.724 172.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 48.01 38.71 9.88 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.532 1.133 . . . . 0.0 111.213 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -62.92 157.89 20.54 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.232 1.013 . . . . 0.0 111.404 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.93 -28.58 13.37 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -172.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.33 -65.52 1.85 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.95 34.29 0.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.365 1.066 . . . . 0.0 111.981 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -67.18 -5.37 13.34 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.991 1.316 . . . . 0.0 114.272 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.32 -17.81 1.89 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.132 1.825 . . . . 0.0 109.376 -169.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.22 91.8 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 169.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.4 -27.44 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -66.75 -22.16 66.05 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.073 0.949 . . . . 0.0 112.256 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.0 t -91.37 154.09 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.3 147.43 47.45 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.9 m -104.14 138.98 39.84 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.6 mp -118.44 160.97 20.76 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.108 1.763 . . . . 0.0 108.233 -170.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.7 54.31 1.88 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.231 1.412 . . . . 0.0 108.776 -168.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.13 -24.92 57.55 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -56.39 -19.73 16.2 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 120.299 1.409 . . . . 0.0 112.895 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -81.64 -4.3 55.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.857 1.263 . . . . 0.0 112.845 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -141.87 -41.98 0.35 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.032 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.44 -3.07 1.41 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 129.529 3.132 . . . . 0.0 114.83 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -64.91 -45.76 84.53 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.586 1.539 . . . . 0.0 110.691 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.25 -42.66 95.77 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.18 0.9 . . . . 0.0 110.51 174.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.87 96.28 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.82 -43.74 92.15 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.521 0.66 . . . . 0.0 109.707 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.78 -47.06 86.87 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.583 0.753 . . . . 0.0 112.188 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -83.8 -1.9 55.24 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.093 0.957 . . . . 0.0 111.504 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.31 38.04 95.32 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.402 -0.666 . . . . 0.0 111.936 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.2 -0.2 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.292 1.437 . . . . 0.0 110.584 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -76.82 114.88 16.08 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.28 113.0 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -59.15 -40.95 87.1 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.285 1.034 . . . . 0.0 110.595 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -91.72 -4.46 55.05 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 tp -140.51 -0.38 1.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.027 0.831 . . . . 0.0 113.178 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 43.28 41.51 3.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.697 1.999 . . . . 0.0 114.431 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -132.06 167.94 18.83 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.861 0.865 . . . . 0.0 108.847 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -70.72 134.48 47.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.81 162.78 15.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.332 1.453 . . . . 0.0 111.22 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.406 ' CB ' ' HA ' ' A' ' 149' ' ' ALA . 16.9 tpt180 -88.75 116.98 27.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 169.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -159.88 171.32 19.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.216 0.531 . . . . 0.0 110.096 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 t -143.5 142.15 25.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -141.18 155.33 46.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.295 0.638 . . . . 0.0 109.442 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.9 t -137.42 135.67 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 42.8 mt -122.51 136.76 54.96 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.36 175.64 5.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.977 0.894 . . . . 0.0 110.208 169.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -56.88 -11.33 1.39 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.913 1.685 . . . . 0.0 114.897 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.96 14.83 7.96 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.487 1.494 . . . . 0.0 112.359 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.46 -1.87 67.12 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.418 1.009 . . . . 0.0 113.267 170.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -65.64 118.05 8.98 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 119.294 1.547 . . . . 0.0 108.114 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.06 110.95 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 p -91.73 -16.59 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 109.536 173.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -150.64 151.45 32.53 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.013 1.325 . . . . 0.0 107.504 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.96 132.94 9.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.798 1.639 . . . . 0.0 107.149 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -142.02 150.01 40.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.636 0.653 . . . . 0.0 110.472 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -122.83 111.23 16.42 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 127.226 2.21 . . . . 0.0 105.041 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 t -72.5 140.04 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 m -58.94 -21.62 58.47 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.656 1.182 . . . . 0.0 113.892 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.42 134.07 30.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.406 ' HA ' ' CB ' ' A' ' 129' ' ' ARG . . . -56.3 -31.64 63.86 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.9 p -83.78 -6.73 59.5 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.317 0.962 . . . . 0.0 112.606 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -93.6 179.95 5.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.886 1.274 . . . . 0.0 109.921 -175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -133.92 157.36 77.93 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.256 1.422 . . . . 0.0 110.898 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -82.72 -176.87 3.1 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.166 2.578 . . . . 0.0 110.188 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -69.74 138.06 52.51 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -82.53 -9.32 59.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -107.22 -32.28 7.86 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 119.077 0.853 . . . . 0.0 110.887 -169.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -52.47 -49.14 87.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 -36.33 21.13 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 CA-C-N 121.631 1.618 . . . . 0.0 111.43 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.76 -45.36 99.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.476 0.71 . . . . 0.0 110.03 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.83 -34.01 75.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 120.081 1.309 . . . . 0.0 110.498 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.61 91.86 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.482 0.313 . . . . 0.0 111.18 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.81 -47.34 59.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 119.123 -0.465 . . . . 0.0 111.075 174.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -55.91 -37.93 69.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.258 0.936 . . . . 0.0 110.901 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.8 -29.31 54.2 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.625 0.77 . . . . 0.0 112.005 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 85.6 mt -95.87 -43.84 7.66 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.681 0.792 . . . . 0.0 112.194 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 97.7 t -73.71 -43.82 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.159 0.984 . . . . 0.0 111.57 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 C--O 1.249 1.074 0 C-N-CA 124.108 0.963 . . . . 0.0 109.676 179.875 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.25 142.21 52.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.807 0.843 . . . . 0.0 109.35 175.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -157.68 141.28 15.62 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 169.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 pt -140.37 179.09 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 122.012 0.91 . . . . 0.0 109.458 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -126.36 156.82 39.87 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.01 1.724 . . . . 0.0 106.632 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -147.45 128.33 14.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 43.31 40.92 2.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.827 1.251 . . . . 0.0 112.924 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 24.22 69.14 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.364 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.19 136.81 8.92 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 169.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -70.49 146.25 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.26 1.973 . . . . 0.0 109.904 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -138.67 150.17 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.272 1.029 . . . . 0.0 109.291 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.5 m -98.62 163.09 12.8 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.961 1.304 . . . . 0.0 108.902 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -113.18 170.44 8.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.936 1.295 . . . . 0.0 109.239 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.0 t -127.36 133.07 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.55 -13.75 66.57 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.858 0.742 . . . . 0.0 114.202 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 53.44 167.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.935 3.294 . . . . 0.0 117.71 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.43 137.08 43.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.925 2.89 . . . . 0.0 112.639 -168.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.53 153.1 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.81 170.55 18.5 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 121.16 -0.962 . . . . 0.0 109.781 -171.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 p -50.12 131.92 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.372 0.669 . . . . 0.0 110.769 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.62 -5.87 79.83 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.595 1.093 . . . . 0.0 113.502 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -94.32 6.88 47.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.259 1.529 . . . . 0.0 113.516 -169.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 57.85 111.95 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.218 2.207 . . . . 0.0 114.915 169.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.11 132.33 89.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.876 169.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.03 -46.83 14.3 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.586 2.191 . . . . 0.0 113.49 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 121.57 127.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 1 C-N-CA 131.73 4.012 . . . . 0.0 105.451 -169.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.76 168.03 19.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.632 1.573 . . . . 0.0 109.067 -175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 m -122.27 146.15 47.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.751 1.22 . . . . 0.0 107.803 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.91 164.32 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.908 2.083 . . . . 0.0 107.731 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.3 mt -100.43 141.36 33.39 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -71.79 173.67 7.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.406 1.482 . . . . 0.0 110.941 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -67.49 -8.84 36.78 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.538 -0.726 . . . . 0.0 111.723 169.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.3 m -97.01 4.4 51.5 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.22 1.408 . . . . 0.0 111.835 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.97 51.98 13.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.388 1.875 . . . . 0.0 111.633 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -123.59 152.45 41.87 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -72.42 143.24 48.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.938 0.875 . . . . 0.0 110.301 -175.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -147.46 158.22 43.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 128.355 2.662 . . . . 0.0 105.73 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.4 p -137.25 166.64 23.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -55.47 -40.09 71.2 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 171.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -24.16 61.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.17 -33.08 50.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.924 0.784 . . . . 0.0 111.345 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.4 mtt -70.58 -36.35 73.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.426 1.09 . . . . 0.0 111.018 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -53.49 146.87 11.87 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.976 0.91 . . . . 0.0 110.784 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -17.79 11.43 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.106 1.336 . . . . 0.0 112.73 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -149.04 155.7 41.15 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.265 1.426 . . . . 0.0 108.87 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.2 136.94 19.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 76.8 m -133.19 145.0 50.21 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -134.22 134.31 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.0 mt -135.23 108.12 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.2 m -86.42 152.07 23.01 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 134.45 53.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 pt -144.06 154.88 58.62 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.001 1.72 . . . . 0.0 108.074 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.88 -44.04 6.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 121.906 1.737 . . . . 0.0 111.262 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 t -151.2 170.88 18.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.281 1.832 . . . . 0.0 107.344 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 56' ' ' ASP . 2.0 pp -96.47 -20.16 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.482 1.113 . . . . 0.0 109.387 168.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' N ' HD12 ' A' ' 55' ' ' ILE . 34.4 t70 -81.71 -25.89 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.998 0.919 . . . . 0.0 111.91 -174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 p -61.51 -17.6 55.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.057 1.343 . . . . 0.0 112.551 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.59 9.69 84.37 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.032 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.23 -18.42 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 119.096 1.448 . . . . 0.0 112.245 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 34.7 m -64.78 -16.42 63.02 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.548 1.139 . . . . 0.0 113.361 173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.79 -20.49 57.09 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.503 1.121 . . . . 0.0 112.938 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.44 32.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.751 1.221 . . . . 0.0 108.72 171.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? 61.34 -65.51 0.07 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 127.686 2.394 . . . . 0.0 114.579 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.46 -48.36 81.01 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 120.351 1.432 . . . . 0.0 114.649 -167.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -64.81 -52.32 57.4 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.175 1.352 . . . . 0.0 109.537 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.87 -45.88 89.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 110.464 -173.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -56.4 -53.46 57.08 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.321 1.048 . . . . 0.0 110.988 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -72.19 -34.54 68.49 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.148 0.431 . . . . 0.0 111.033 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -68.74 -39.19 80.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.888 0.875 . . . . 0.0 109.63 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -67.62 -45.23 76.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.774 0.829 . . . . 0.0 109.925 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.17 80.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.434 1.093 . . . . 0.0 110.943 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.96 -15.4 43.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.039 0.936 . . . . 0.0 113.082 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -95.58 -16.08 22.37 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.91 0.884 . . . . 0.0 112.373 176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.6 mt -62.78 -37.71 87.76 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.757 1.162 . . . . 0.0 110.846 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.47 -172.26 44.81 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.463 1.982 . . . . 0.0 108.269 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -77.71 36.06 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.0 0.92 . . . . 0.0 112.809 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.8 m -56.82 146.38 6.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 120.759 -1.213 . . . . 0.0 110.824 -177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -76.93 138.63 39.81 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.58 121.65 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.24 157.14 47.53 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.693 0.797 . . . . 0.0 110.029 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 65.0 m -134.3 108.01 7.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.1 mt -91.01 138.3 19.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.8 m -137.5 172.56 12.79 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.705 2.002 . . . . 0.0 109.947 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.35 -163.42 0.38 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -121.45 -41.23 2.51 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.402 -0.811 . . . . 0.0 111.836 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -26.12 2.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -90.44 44.19 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 CA-C-N 123.916 2.434 . . . . 0.0 111.871 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.5 t80 58.22 32.97 22.69 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.719 1.208 . . . . 0.0 111.756 -172.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.29 165.88 6.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.415 0.686 . . . . 0.0 111.667 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 61.09 -38.99 0.11 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 128.914 2.886 . . . . 0.0 115.136 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.96 -30.99 66.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.004 1.274 . . . . 0.0 114.117 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -127.55 42.49 3.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.927 1.691 . . . . 0.0 108.441 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -44.63 159.97 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.675 1.99 . . . . 0.0 114.53 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.9 m -130.32 146.65 51.94 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.097 1.359 . . . . 0.0 109.752 -169.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.77 -45.59 1.92 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.618 1.58 . . . . 0.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.58 36.25 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.308 2.243 . . . . 0.0 112.616 172.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.88 23.52 2.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.95 2.1 . . . . 0.0 110.531 -173.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.89 -20.34 0.19 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.236 0.922 . . . . 0.0 111.485 -171.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.45 84.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -55.53 -27.31 48.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.637 1.175 . . . . 0.0 113.606 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -62.88 -32.84 74.19 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.0 112.416 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.81 146.54 11.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -143.32 136.22 27.72 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.2 p -80.39 141.34 35.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -128.25 155.79 44.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.966 1.306 . . . . 0.0 108.541 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 m -124.19 133.87 53.44 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -113.31 -16.85 12.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.596 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -63.17 -11.37 20.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -51.2 -37.32 46.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.052 0.941 . . . . 0.0 111.422 169.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -148.28 -5.15 0.45 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 50.7 mmm 56.19 26.86 10.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.773 1.629 . . . . 0.0 112.671 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 m -58.91 -55.34 36.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.869 0.867 . . . . 0.0 111.021 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -63.41 -41.66 98.74 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.068 0.547 . . . . 0.0 109.735 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.94 -47.97 88.04 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 119.339 -0.7 . . . . 0.0 111.396 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.68 -45.31 68.6 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.832 0.816 . . . . 0.0 109.805 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.8 67.76 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.86 0.864 . . . . 0.0 113.097 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -112.39 3.2 16.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.942 1.297 . . . . 0.0 111.544 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.74 33.34 85.7 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 119.591 1.087 . . . . 0.0 112.92 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.8 m -115.13 -2.69 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.358 1.063 . . . . 0.0 111.021 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -69.63 108.74 3.98 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.0 mt -72.22 128.78 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -65.77 -46.75 77.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.498 1.119 . . . . 0.0 111.245 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -87.47 -56.84 3.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.07 0.395 . . . . 0.0 110.391 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.3 tp -62.62 -19.94 64.27 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.837 0.455 . . . . 0.0 112.078 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 53.83 38.92 29.66 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 110.967 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 mt -136.87 170.63 15.76 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.566 1.146 . . . . 0.0 108.649 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.14 133.67 41.44 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.15 154.54 41.88 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.612 0.765 . . . . 0.0 111.544 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.4 tpt85 -71.8 117.61 13.6 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 169.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.8 m -160.74 170.44 20.76 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.352 0.978 . . . . 0.0 108.488 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.49 146.41 17.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 118.741 0.701 . . . . 0.0 109.278 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -144.75 156.02 43.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.229 1.412 . . . . 0.0 109.21 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.404 ' C ' HD12 ' A' ' 134' ' ' LEU . 60.7 t -136.32 140.91 42.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.404 HD12 ' C ' ' A' ' 133' ' ' VAL . 9.1 mp -133.26 139.0 46.69 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.169 1.388 . . . . 0.0 108.79 -169.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -64.62 166.71 8.22 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.228 1.811 . . . . 0.0 109.941 169.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -52.28 -32.01 35.44 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 112.664 175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -80.64 -2.99 48.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.582 1.153 . . . . 0.0 112.707 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.74 0.53 89.18 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.31 0.957 . . . . 0.0 112.724 -174.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -68.07 124.78 24.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 119.312 1.556 . . . . 0.0 108.285 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.84 132.48 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.99 -9.87 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.919 1.288 . . . . 0.0 110.956 172.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -151.54 150.94 30.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.175 0.99 . . . . 0.0 108.51 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.16 137.61 15.87 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.373 1.869 . . . . 0.0 107.457 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.0 143.93 30.76 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.32 105.47 7.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.546 -2.391 . . . . 0.0 104.546 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.6 144.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.158 -0.339 . . . . 0.0 110.416 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.1 m -62.22 -20.58 64.36 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.671 0.788 . . . . 0.0 112.007 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -144.48 122.88 12.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.04 -22.77 65.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.965 1.306 . . . . 0.0 113.466 -176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.92 16.35 2.88 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.06 0.944 . . . . 0.0 111.55 173.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.73 161.3 35.07 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.025 2.53 . . . . 0.0 106.638 172.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -122.6 149.92 56.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 119.342 0.974 . . . . 0.0 112.468 -169.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.77 162.79 29.51 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.454 2.769 . . . . 0.0 112.247 -177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -70.94 112.85 7.43 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -75.39 -11.97 60.16 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -71.23 -32.91 69.34 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.923 1.238 . . . . 0.0 109.022 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -60.39 -53.36 65.45 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 117.533 -1.222 . . . . 0.0 112.063 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.37 -31.62 42.65 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 CA-C-N 121.96 1.736 . . . . 0.0 112.256 172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.5 mm -59.22 -42.73 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 120.169 1.35 . . . . 0.0 109.757 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.501 1.046 . . . . 0.0 110.937 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.24 -40.15 93.66 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.68 0.218 . . . . 0.0 110.92 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.71 77.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.398 174.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -55.44 -43.73 75.67 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.069 0.85 . . . . 0.0 110.395 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.99 -31.48 66.97 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.081 0.552 . . . . 0.0 112.085 -178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.35 -46.95 11.22 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.767 0.427 . . . . 0.0 111.801 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.71 -50.0 47.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 123.971 0.908 . . . . 0.0 111.745 -169.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.65 -171.895 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.47 44.33 1.74 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.425 1.09 . . . . 0.0 110.274 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -65.15 171.93 3.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.427 0.691 . . . . 0.0 110.394 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -133.79 179.04 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.004 0.921 . . . . 0.0 109.677 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -122.66 148.6 45.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -141.88 127.62 19.21 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 44.88 35.84 1.66 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.444 1.098 . . . . 0.0 112.397 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.98 21.47 78.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 121.393 -0.817 . . . . 0.0 114.294 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.68 8.82 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 169.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.44 139.93 35.59 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.355 2.037 . . . . 0.0 110.083 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.35 154.59 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.479 1.112 . . . . 0.0 109.186 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.9 m -109.11 158.93 17.31 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.075 1.35 . . . . 0.0 107.841 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.29 158.46 22.34 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.093 0.86 . . . . 0.0 109.247 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.35 -18.33 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.59 33.57 0.63 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.816 0.735 . . . . 0.0 111.329 -174.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -50.79 151.31 2.5 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.7 1.2 . . . . 0.0 113.069 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.252 10.7 tt0 93.19 30.07 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.306 2.643 . . . . 0.0 112.26 169.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.14 144.24 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -148.88 160.61 43.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 121.598 -0.689 . . . . 0.0 110.129 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -51.83 131.46 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.395 0.678 . . . . 0.0 109.648 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.63 -6.55 82.1 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.791 -1.005 . . . . 0.0 114.04 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.55 -6.5 59.47 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.554 1.677 . . . . 0.0 112.596 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.72 176.21 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.965 1.706 . . . . 0.0 112.451 -169.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.1 129.13 18.84 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 126.711 2.004 . . . . 0.0 107.723 -170.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.83 150.64 61.64 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.184 1.922 . . . . 0.0 112.133 170.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' LEU . 23.6 t0 -75.8 68.66 2.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.288 1.835 . . . . 0.0 110.314 173.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -60.37 162.81 5.73 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.162 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -123.51 143.48 50.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 170.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.12 170.68 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.545 1.938 . . . . 0.0 108.703 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.4 119.49 22.8 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 125.47 1.508 . . . . 0.0 107.019 -170.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.9 p -73.97 173.25 10.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.543 1.137 . . . . 0.0 111.977 -171.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -21.88 66.16 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.086 -1.009 . . . . 0.0 111.226 170.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 p -80.76 0.19 35.78 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.727 1.611 . . . . 0.0 111.972 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.1 mt 55.27 52.84 10.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.955 2.102 . . . . 0.0 111.719 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.8 153.13 42.97 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.224 1.41 . . . . 0.0 108.801 172.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.3 143.5 42.93 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.427 0.691 . . . . 0.0 109.325 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -150.26 160.26 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.252 2.221 . . . . 0.0 105.959 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.5 p -144.15 167.6 22.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.459 -0.775 . . . . 0.0 109.381 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 57.4 tp -53.98 -42.23 68.77 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 172.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.66 -20.74 65.12 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.06 -30.7 55.7 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.886 0.766 . . . . 0.0 111.013 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.1 mtt -72.14 -40.31 68.17 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.446 1.098 . . . . 0.0 110.546 173.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -53.06 131.88 37.14 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.7 -23.29 4.0 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.009 1.29 . . . . 0.0 112.334 -171.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -151.75 157.78 42.47 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.39 1.076 . . . . 0.0 109.415 -175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -56.83 140.86 14.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -134.75 146.79 49.73 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.899 0.88 . . . . 0.0 108.924 -174.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.6 mt -136.46 135.71 49.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.7 mt -137.05 128.62 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -170.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -107.71 143.36 36.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.16 143.32 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 121.18 -0.95 . . . . 0.0 108.437 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.1 pt -144.5 161.36 44.38 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.781 2.032 . . . . 0.0 108.163 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -48.04 2.15 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.573 1.515 . . . . 0.0 110.631 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -162.55 156.72 21.21 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.074 1.35 . . . . 0.0 107.36 -169.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.72 -30.72 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.981 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.81 -13.85 57.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 0.0 112.081 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -62.71 -20.47 64.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.276 0.631 . . . . 0.0 111.416 175.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.47 -25.57 3.8 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 124.31 0.957 . . . . 0.0 112.769 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 57' ' ' THR . 4.6 t -64.48 -17.03 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 119.019 1.409 . . . . 0.0 111.594 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.9 p -74.72 -30.07 61.4 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 120.768 -1.207 . . . . 0.0 111.558 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -78.5 -38.72 40.09 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.448 1.022 . . . . 0.0 109.839 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.53 -24.63 67.17 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -136.28 -62.71 0.66 Allowed 'General case' 0 C--N 1.342 0.242 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.676 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 m -57.76 -35.43 70.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.341 1.428 . . . . 0.0 113.159 -168.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -27.95 65.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 118.06 -0.972 . . . . 0.0 112.447 178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -103.41 -48.93 3.84 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.842 1.201 . . . . 0.0 109.94 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -51.92 -49.17 63.62 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 119.497 1.044 . . . . 0.0 111.249 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -79.95 -23.89 41.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.189 -0.319 . . . . 0.0 111.223 -172.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.7 -43.25 69.38 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.422 0.689 . . . . 0.0 110.12 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -64.3 -45.63 87.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.818 1.247 . . . . 0.0 108.919 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.87 68.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.556 1.142 . . . . 0.0 110.435 172.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.62 -9.93 23.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.212 1.005 . . . . 0.0 113.092 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.2 -1.38 10.86 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.6 -34.13 77.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.227 1.376 . . . . 0.0 109.146 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.35 -169.83 40.33 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.494 1.997 . . . . 0.0 108.66 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -73.96 17.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 113.01 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.53 149.46 5.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.235 1.814 . . . . 0.0 111.272 -169.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -68.75 144.14 54.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.3 123.97 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.59 152.8 48.47 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.054 0.542 . . . . 0.0 110.754 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -124.18 143.14 50.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 171.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.2 mt -127.4 135.99 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.3 m -135.49 168.19 19.69 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.325 1.45 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.23 172.61 4.57 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.834 0.826 . . . . 0.0 111.406 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -81.83 -7.34 59.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.166 0.986 . . . . 0.0 111.73 173.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.7 tp -52.31 136.08 40.97 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.257 1.423 . . . . 0.0 109.313 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -52.3 -25.28 23.5 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.566 2.844 . . . . 0.0 116.32 -174.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -74.92 40.98 0.15 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.7 1.6 . . . . 0.0 112.113 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.24 177.27 10.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.106 1.363 . . . . 0.0 110.361 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.296 0.1 OUTLIER 41.54 35.35 0.45 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.816 2.446 . . . . 0.0 115.51 178.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.88 3.44 38.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.275 1.03 . . . . 0.0 112.546 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.262 32.7 ptt-85 44.99 34.01 1.16 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.714 2.006 . . . . 0.0 113.025 -169.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -78.64 -167.74 1.19 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.776 1.231 . . . . 0.0 109.214 171.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.1 p 30.04 -90.19 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.147 2.979 . . . . 0.0 114.149 174.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -58.25 -21.28 46.79 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.389 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -123.58 11.03 9.15 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.051 1.426 . . . . 0.0 111.754 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -60.12 -27.81 67.35 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.0 25.3 0.71 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -173.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.88 91.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.71 -28.93 58.32 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.462 1.505 . . . . 0.0 113.477 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.7 -17.56 64.7 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -75.99 155.82 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 119.163 0.892 . . . . 0.0 109.975 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.72 151.68 49.5 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.2 m -118.1 139.82 50.67 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.93 155.12 30.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.72 0.808 . . . . 0.0 110.094 -172.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.3 m -126.57 43.15 3.16 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.137 1.775 . . . . 0.0 109.139 -171.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -46.13 -41.75 12.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 114.201 -169.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -57.62 -17.58 15.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.275 1.03 . . . . 0.0 113.672 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -61.59 -24.84 66.95 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.004 -1.06 . . . . 0.0 111.832 171.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -128.39 -28.4 2.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.833 1.653 . . . . 0.0 112.034 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.0 tpt 75.04 10.8 3.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.403 2.681 . . . . 0.0 113.911 170.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.45 -53.14 61.54 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.846 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -61.4 -39.62 91.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.193 1.361 . . . . 0.0 109.906 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -50.06 -53.16 24.07 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 125.537 1.541 . . . . 0.0 112.478 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.76 -40.95 63.1 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.053 0.427 . . . . 0.0 110.309 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.23 98.18 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.156 0.982 . . . . 0.0 112.371 -169.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -102.09 -0.12 33.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.381 1.072 . . . . 0.0 110.62 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.31 46.53 94.23 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.4 m -114.72 0.11 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.98 1.312 . . . . 0.0 110.874 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -76.36 119.09 19.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 168.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.46 122.3 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.2 -44.5 97.19 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.94 1.296 . . . . 0.0 110.723 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -95.5 -50.9 4.78 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.971 0.35 . . . . 0.0 111.16 -172.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.95 -19.03 65.73 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.728 -0.608 . . . . 0.0 112.001 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 53.15 51.79 14.98 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.904 1.281 . . . . 0.0 109.6 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -145.2 162.8 36.23 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.665 1.586 . . . . 0.0 107.577 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.3 tp -78.77 132.41 36.9 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.43 -0.794 . . . . 0.0 109.038 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.87 174.92 6.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.045 0.938 . . . . 0.0 112.858 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.91 117.77 34.87 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 169.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -151.19 177.51 10.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.38 145.81 18.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -147.57 156.75 43.12 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.36 1.064 . . . . 0.0 110.051 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.54 139.2 43.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.6 mt -128.55 143.53 50.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.76 1.224 . . . . 0.0 108.619 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -71.51 175.52 5.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.116 0.967 . . . . 0.0 110.252 169.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.06 -23.89 36.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.326 1.451 . . . . 0.0 113.566 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.424 ' H ' ' CG ' ' A' ' 135' ' ' ASP . 32.0 m-80 -98.31 5.46 48.27 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.854 1.662 . . . . 0.0 111.411 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.64 -0.51 88.17 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.837 -0.98 . . . . 0.0 113.021 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.49 127.49 32.52 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.696 1.748 . . . . 0.0 108.198 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.85 125.24 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.47 0.708 . . . . 0.0 109.324 171.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.4 t -108.59 -21.04 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.803 2.041 . . . . 0.0 109.208 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -146.87 150.25 34.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -155.74 132.63 10.58 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.942 1.697 . . . . 0.0 106.873 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.19 145.48 28.31 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 169.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -115.12 116.41 28.36 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 t -68.49 126.43 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -57.78 -27.31 62.96 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.606 1.163 . . . . 0.0 112.617 -173.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.35 103.1 6.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.787 -2.671 . . . . 0.0 103.787 169.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.86 -24.33 67.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.615 1.166 . . . . 0.0 112.471 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.8 p -87.44 19.95 3.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.229 1.012 . . . . 0.0 111.379 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.45 160.46 38.7 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.998 2.119 . . . . 0.0 107.665 175.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -86.66 147.29 43.41 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 121.755 -0.591 . . . . 0.0 112.076 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.03 167.6 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.398 2.732 . . . . 0.0 111.212 169.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -81.21 97.82 7.79 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 169.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -74.29 -4.55 36.85 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.81 -35.35 78.47 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.173 -0.954 . . . . 0.0 109.194 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -56.3 -57.36 23.28 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.34 1.456 . . . . 0.0 111.667 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.62 -33.18 46.25 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.486 1.566 . . . . 0.0 112.312 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 mm -59.05 -48.95 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.837 1.199 . . . . 0.0 109.613 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.54 -41.56 94.73 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 118.708 0.686 . . . . 0.0 110.537 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.14 87.72 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.686 0.395 . . . . 0.0 110.965 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.44 19.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.517 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -64.22 -26.65 68.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.048 1.294 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.05 -32.71 70.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.647 1.112 . . . . 0.0 112.073 171.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 70.7 mt -76.79 -43.87 35.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.646 0.657 . . . . 0.0 110.912 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.36 -48.94 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.38 0.672 . . . . 0.0 110.739 -173.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.057 0 C-N-CA 124.797 1.239 . . . . 0.0 109.969 178.829 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.91 67.76 1.7 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.999 1.32 . . . . 0.0 112.35 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.22 145.98 55.14 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 168.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.3 pt -137.1 -177.86 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 109.57 -174.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -126.83 152.49 46.92 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -140.06 128.97 23.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt 43.95 36.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.267 1.427 . . . . 0.0 112.739 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.91 16.95 79.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.55 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -117.63 120.9 4.92 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 171.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.37 138.64 84.59 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.019 2.479 . . . . 0.0 111.357 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 m -143.41 162.06 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.549 1.14 . . . . 0.0 109.36 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.7 m -118.78 161.83 19.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.463 1.505 . . . . 0.0 108.73 -169.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.96 163.06 14.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.659 1.584 . . . . 0.0 109.69 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.36 -62.39 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 118.524 0.602 . . . . 0.0 111.689 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.45 12.45 69.6 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -168.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 56.48 154.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.29 2.636 . . . . 0.0 114.602 -174.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -71.78 139.77 49.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.856 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.93 165.74 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 167.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -152.11 162.09 41.64 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.347 -0.846 . . . . 0.0 109.174 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.43 130.44 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.04 0.44 90.29 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.928 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -5.73 59.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.664 . . . . 0.0 112.332 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 58.38 180.0 0.07 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 111.527 -169.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.56 146.35 52.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.541 1.536 . . . . 0.0 110.015 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -56.41 -21.84 39.22 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.439 3.426 . . . . 0.0 116.114 174.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 73.49 66.63 0.1 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 108.621 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -69.69 169.12 13.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.401 1.88 . . . . 0.0 111.748 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.5 m -110.48 155.73 21.84 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 169.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.23 166.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 127.501 2.32 . . . . 0.0 106.387 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 tp -118.22 135.71 54.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.7 p -75.84 168.36 20.17 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.024 0.53 . . . . 0.0 110.195 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -62.94 -18.85 63.65 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.887 -0.508 . . . . 0.0 110.744 168.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -81.91 -0.64 44.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.61 1.564 . . . . 0.0 111.693 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.8 mt 62.1 47.12 5.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.277 2.231 . . . . 0.0 111.838 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.22 150.89 49.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.667 1.187 . . . . 0.0 108.971 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.93 145.23 44.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.821 0.82 . . . . 0.0 109.588 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -152.75 163.34 39.89 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.208 2.203 . . . . 0.0 106.064 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 p -143.51 168.6 19.46 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.302 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.6 tp -55.38 -35.92 65.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.251 -0.281 . . . . 0.0 110.541 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.06 -23.71 48.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.83 -32.19 67.29 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.435 1.016 . . . . 0.0 110.795 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 29.7 mtt -80.26 -37.33 33.13 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.776 1.63 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -53.27 145.31 14.19 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.841 0.857 . . . . 0.0 110.288 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.86 -18.49 14.63 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.369 1.461 . . . . 0.0 112.588 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -150.65 153.28 35.34 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 108.06 -176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 m -58.37 145.16 10.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 52.2 m -138.44 149.15 45.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.578 0.751 . . . . 0.0 109.4 -169.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.6 mt -133.42 136.68 54.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.28 112.71 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.6 m -93.8 155.12 17.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.74 139.21 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.5 pt -132.62 158.52 75.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.86 -48.93 5.9 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.326 1.351 . . . . 0.0 110.799 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 m -165.06 156.87 15.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.595 1.158 . . . . 0.0 109.224 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 tp -66.61 -21.42 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -171.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -67.07 -24.75 65.99 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.968 0.907 . . . . 0.0 111.895 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -72.12 151.29 43.13 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.039 -0.413 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.17 -24.9 75.81 Favored Glycine 0 CA--C 1.528 0.853 0 O-C-N 121.731 -0.606 . . . . 0.0 113.374 -172.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.5 m -60.9 -21.63 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 118.515 1.157 . . . . 0.0 112.662 -174.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.0 p -60.75 -31.47 70.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.988 0.813 . . . . 0.0 111.929 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -115.29 -33.89 5.16 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.086 0.954 . . . . 0.0 110.773 -172.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -29.87 70.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.593 0.757 . . . . 0.0 112.083 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -148.37 -36.46 0.19 Allowed 'General case' 0 C--N 1.343 0.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 113.296 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -64.62 -43.5 93.53 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.054 1.752 . . . . 0.0 111.031 -170.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -54.9 -50.51 68.59 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.084 0.954 . . . . 0.0 111.083 174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -61.21 -47.8 84.43 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 110.956 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.1 -46.43 90.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 118.106 0.412 . . . . 0.0 110.566 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -61.95 -39.13 91.05 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.758 0.823 . . . . 0.0 110.632 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.53 -49.27 77.37 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.617 0.767 . . . . 0.0 109.806 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -65.57 -39.9 92.18 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.963 0.505 . . . . 0.0 110.804 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.54 -47.85 82.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 110.954 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.79 -23.4 66.18 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -79.37 -25.39 42.22 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.206 0.912 . . . . 0.0 112.104 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.6 mt -62.22 -42.13 99.03 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.192 0.906 . . . . 0.0 109.908 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.18 -170.02 43.1 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.53 37.99 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.671 0.788 . . . . 0.0 112.34 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 77' ' ' VAL . 3.3 t -58.07 140.38 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 120.899 -1.125 . . . . 0.0 108.069 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.34 138.48 53.77 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 169.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.74 127.58 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.5 156.58 48.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.301 1.04 . . . . 0.0 109.362 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -140.18 119.86 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 173.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.8 mt -100.75 141.71 17.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -174.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -145.19 167.42 22.84 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.177 0.991 . . . . 0.0 110.176 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.01 176.07 4.67 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.268 0.556 . . . . 0.0 109.965 169.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -124.84 30.88 5.8 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.642 1.177 . . . . 0.0 109.71 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.3 mt -66.36 168.7 9.02 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.209 1.404 . . . . 0.0 109.436 169.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -51.62 -17.37 4.69 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.949 3.099 . . . . 0.0 115.675 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -61.87 -10.8 10.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.092 1.357 . . . . 0.0 113.654 170.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.72 -177.5 0.21 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.267 2.227 . . . . 0.0 116.17 168.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -126.03 -14.52 6.05 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.847 2.459 . . . . 0.0 110.594 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.94 -35.34 58.5 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.035 2.134 . . . . 0.0 115.947 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.16 -25.13 65.11 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.21 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.2 p90 34.95 38.27 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.806 2.442 . . . . 0.0 115.015 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -40.33 71.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.14 0.976 . . . . 0.0 111.953 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.09 -14.8 54.81 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.73 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.38 13.96 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.362 1.465 . . . . 0.0 112.289 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -79.54 76.29 6.15 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.32 0.581 . . . . 0.0 112.231 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.08 -18.23 0.54 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.26 1.409 . . . . 0.0 111.406 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.15 89.37 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.604 1.562 . . . . 0.0 107.438 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.61 -24.44 8.36 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.138 1.775 . . . . 0.0 113.607 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.65 -32.16 65.1 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.353 1.061 . . . . 0.0 112.892 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.55 137.89 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -121.67 124.82 45.19 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 172.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -80.52 141.88 34.72 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -129.52 148.63 51.44 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.727 1.611 . . . . 0.0 107.022 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.1 m -128.69 54.57 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.206 1.402 . . . . 0.0 108.494 -168.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -49.1 -34.5 14.01 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 124.788 1.235 . . . . 0.0 113.723 -169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -49.64 -25.06 2.54 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -62.69 -21.9 66.09 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.55 -21.64 2.8 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.461 1.504 . . . . 0.0 112.204 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 tpt 61.94 5.0 1.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 130.12 3.368 . . . . 0.0 114.725 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.3 m -66.59 -44.56 81.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 117.177 -1.392 . . . . 0.0 112.46 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.48 -40.31 96.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 121.298 1.863 . . . . 0.0 109.887 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.85 -46.44 92.39 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 123.918 0.77 . . . . 0.0 111.469 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.64 -41.78 65.11 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.672 0.736 . . . . 0.0 110.477 175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.02 94.16 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.216 1.006 . . . . 0.0 111.986 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -95.15 4.67 53.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.83 0.852 . . . . 0.0 110.4 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.78 -10.27 14.06 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.306 176.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.75 -13.4 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 125.816 1.647 . . . . 0.0 112.79 -169.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -62.79 108.41 1.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 95.4 mt -70.3 118.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -57.68 -45.31 85.79 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.952 1.701 . . . . 0.0 111.144 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -89.87 -1.56 58.01 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.292 0.637 . . . . 0.0 112.427 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.9 tp -136.56 -6.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.772 0.829 . . . . 0.0 112.492 -171.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 40.96 42.6 1.55 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.892 2.077 . . . . 0.0 113.337 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.6 tp -132.67 153.84 50.72 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -169.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.73 123.34 22.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.36 137.61 56.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.115 0.566 . . . . 0.0 110.511 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -60.76 119.24 7.78 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.1 p -156.85 166.16 34.15 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.939 1.296 . . . . 0.0 107.555 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -150.29 146.31 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -144.65 154.93 43.31 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.786 1.234 . . . . 0.0 108.772 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.93 137.81 48.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -131.91 137.78 48.12 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.831 1.253 . . . . 0.0 108.201 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.94 164.71 14.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.631 1.572 . . . . 0.0 110.748 170.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -50.05 -35.58 25.62 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.691 1.596 . . . . 0.0 113.043 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 7.71 33.34 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.848 0.859 . . . . 0.0 113.002 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.95 -6.33 76.46 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.592 1.092 . . . . 0.0 113.278 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.31 128.83 37.86 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.029 1.414 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -61.74 123.44 14.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 124.137 0.975 . . . . 0.0 109.415 172.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.23 -12.55 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.354 1.462 . . . . 0.0 110.133 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -148.12 148.59 30.77 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 169.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.32 138.32 17.25 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.639 1.576 . . . . 0.0 107.709 170.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -145.3 148.0 32.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.789 0.836 . . . . 0.0 109.5 170.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -135.7 107.1 6.85 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.749 2.42 . . . . 0.0 105.496 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 t -70.28 136.26 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -169.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -62.13 -21.98 65.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.605 1.162 . . . . 0.0 112.993 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -136.97 94.87 3.02 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 174.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.03 -13.95 60.82 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.577 1.151 . . . . 0.0 113.818 -170.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -0.49 18.05 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.201 0.909 . . . . 0.0 112.143 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.65 170.44 13.8 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 108.588 175.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -115.01 158.49 40.68 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 123.698 0.799 . . . . 0.0 112.325 -169.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -82.27 -179.72 4.88 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.218 2.612 . . . . 0.0 110.866 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -73.51 140.36 46.32 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 168.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -100.42 -8.18 23.52 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -79.79 -36.1 37.55 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.032 -1.042 . . . . 0.0 108.378 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -51.42 -56.27 22.05 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.71 -1.138 . . . . 0.0 111.816 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -66.95 -32.5 35.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 CA-C-N 121.535 1.584 . . . . 0.0 112.846 175.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.6 mm -58.94 -44.24 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 120.43 1.468 . . . . 0.0 109.865 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.64 -37.62 87.07 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.454 1.025 . . . . 0.0 110.602 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.24 89.89 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.444 -0.16 . . . . 0.0 111.298 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.59 66.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.333 0.653 . . . . 0.0 110.869 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -53.75 -40.97 66.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.164 0.893 . . . . 0.0 110.58 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.16 63.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.629 0.772 . . . . 0.0 112.33 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 48.4 mt -97.55 -36.79 10.19 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.261 0.624 . . . . 0.0 112.279 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.84 -48.29 88.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.452 1.101 . . . . 0.0 110.417 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--O 1.249 1.034 0 C-N-CA 124.583 1.153 . . . . 0.0 109.745 178.297 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.13 62.15 0.64 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.03 1.732 . . . . 0.0 112.389 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.0 146.62 53.79 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 169.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.7 pt -135.78 -175.75 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.267 1.027 . . . . 0.0 108.938 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -133.91 154.72 50.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.17 126.13 17.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 43.07 45.45 4.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.109 1.364 . . . . 0.0 112.344 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.62 19.61 79.82 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.16 0.886 . . . . 0.0 114.925 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.17 120.29 4.03 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 172.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.53 140.48 89.67 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.918 2.412 . . . . 0.0 111.366 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.03 165.24 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.998 1.319 . . . . 0.0 108.684 174.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.9 m -126.65 154.92 43.39 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.107 0.963 . . . . 0.0 110.781 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.9 147.48 23.33 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.1 1.36 . . . . 0.0 110.964 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.2 t -77.13 -55.19 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 123.931 0.892 . . . . 0.0 109.887 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.45 32.68 7.19 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 124.197 0.903 . . . . 0.0 112.102 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 55.09 -146.79 0.55 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.023 0.929 . . . . 0.0 110.157 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.99 123.87 29.74 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.589 1.155 . . . . 0.0 110.755 -172.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -70.41 160.09 5.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.11 165.66 25.54 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -174.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -56.54 131.33 20.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.46 -5.67 72.36 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.786 1.184 . . . . 0.0 113.563 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.81 -5.9 57.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.525 1.662 . . . . 0.0 113.738 -170.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 66.7 112.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.381 1.872 . . . . 0.0 112.38 169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.17 135.61 93.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.28 175.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.53 -46.74 13.43 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.579 2.186 . . . . 0.0 113.733 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 t70 122.51 126.81 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 131.471 3.908 . . . . 0.0 105.827 -169.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -138.84 165.74 26.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.691 1.596 . . . . 0.0 109.247 -175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.7 m -131.51 141.47 49.76 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.03 167.7 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.653 1.981 . . . . 0.0 108.41 -172.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.95 143.43 31.11 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.8 p -80.63 -179.64 7.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.29 1.436 . . . . 0.0 111.571 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -63.49 -24.52 67.86 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.425 -0.797 . . . . 0.0 110.836 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m -82.98 2.84 32.75 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.218 1.407 . . . . 0.0 111.768 173.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.2 mt 51.23 42.7 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.966 2.107 . . . . 0.0 112.774 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.82 160.55 21.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.182 0.993 . . . . 0.0 109.121 169.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.21 143.68 45.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.827 0.822 . . . . 0.0 110.691 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HE2' ' CE1' ' A' ' 80' ' ' TYR . 42.0 tttp -148.81 153.83 38.67 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.765 2.426 . . . . 0.0 105.894 176.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.6 p -137.5 167.69 21.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 118.689 0.677 . . . . 0.0 110.124 -176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.64 -39.57 65.1 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.75 -25.75 60.88 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.18 -30.5 43.48 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.777 0.717 . . . . 0.0 111.436 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 43.2 mtt -71.76 -37.61 70.48 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.447 1.099 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.93 146.61 13.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.763 0.825 . . . . 0.0 110.27 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.99 2.77 48.92 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.548 1.071 . . . . 0.0 114.051 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -150.45 157.24 42.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.894 1.278 . . . . 0.0 108.814 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.9 t -60.56 139.59 19.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -136.77 146.19 45.47 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -128.28 135.51 62.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.1 mt -132.33 101.28 4.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -174.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -80.85 146.28 30.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 169.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.21 135.62 54.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.0 pt -145.82 159.06 48.22 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 125.001 1.321 . . . . 0.0 109.104 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.81 -53.03 0.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 N-CA-C 107.978 -1.586 . . . . 0.0 107.978 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.5 t -157.83 -177.79 6.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.413 2.285 . . . . 0.0 106.199 170.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 pt -86.94 -42.89 15.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.839 0.856 . . . . 0.0 109.724 171.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -69.36 -18.72 63.82 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.445 1.098 . . . . 0.0 111.095 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -20.15 61.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.572 1.149 . . . . 0.0 112.73 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.85 -15.42 3.08 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.29 0.95 . . . . 0.0 114.229 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.16 -7.26 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.929 1.364 . . . . 0.0 113.684 -172.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.7 m -61.6 -33.75 74.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.442 1.019 . . . . 0.0 110.821 169.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -81.07 -18.75 45.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.934 0.894 . . . . 0.0 111.463 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.01 -173.9 2.08 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.331 1.053 . . . . 0.0 110.45 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -15.84 58.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.892 1.277 . . . . 0.0 113.688 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.91 64.75 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 125.324 1.449 . . . . 0.0 112.275 -169.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.8 tpt85 -57.94 -30.5 66.01 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.112 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 -42.93 7.53 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.833 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -59.36 -47.4 85.56 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.382 1.446 . . . . 0.0 111.914 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -67.3 -33.73 75.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.123 0.42 . . . . 0.0 110.377 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -65.12 -49.25 70.65 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.991 0.516 . . . . 0.0 109.678 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -61.32 -41.54 97.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.852 1.261 . . . . 0.0 110.195 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.52 -52.63 59.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.046 0.938 . . . . 0.0 110.62 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.91 -23.91 67.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -83.1 -18.53 39.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.822 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.89 -38.43 91.06 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.324 1.42 . . . . 0.0 110.982 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.7 -169.27 42.33 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -75.35 23.84 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.017 0.909 . . . . 0.0 113.212 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -57.03 144.84 8.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.643 1.177 . . . . 0.0 109.72 -173.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -67.95 139.35 56.39 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 169.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.66 126.14 57.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.475 ' CE1' ' HE2' ' A' ' 37' ' ' LYS . 59.9 m-85 -128.1 150.77 49.82 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.615 0.766 . . . . 0.0 109.157 -177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.0 m -132.51 95.4 3.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.2 mt -84.09 136.03 23.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.8 m -135.62 165.39 25.67 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.794 1.237 . . . . 0.0 110.905 -169.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.31 28.78 0.71 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.188 0.995 . . . . 0.0 113.63 -173.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 66.65 -5.03 0.67 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.216 2.206 . . . . 0.0 113.961 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.2 tp -53.1 121.42 24.07 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.185 1.394 . . . . 0.0 108.19 169.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -50.46 -36.4 48.59 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.482 2.788 . . . . 0.0 115.548 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -58.88 -29.42 66.98 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.878 0.471 . . . . 0.0 112.027 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.77 64.45 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -108.63 4.24 23.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.511 1.124 . . . . 0.0 111.68 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.15 -2.56 28.31 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.722 0.809 . . . . 0.0 112.721 170.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 57.45 26.26 12.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.858 1.663 . . . . 0.0 112.669 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -54.11 -37.22 64.08 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p -153.84 170.65 20.46 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.738 1.215 . . . . 0.0 108.728 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.55 -18.17 1.37 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.661 -1.077 . . . . 0.0 115.073 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -141.31 28.89 1.83 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.035 1.417 . . . . 0.0 111.787 -175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -136.94 146.84 45.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.97 -18.83 33.41 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.084 -0.842 . . . . 0.0 112.71 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.05 88.86 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 125.7 1.6 . . . . 0.0 107.839 175.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.58 -19.09 56.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.597 1.559 . . . . 0.0 114.049 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -60.43 -30.17 69.47 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.625 -0.672 . . . . 0.0 111.834 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.9 t -71.93 140.44 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -129.0 147.01 50.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 169.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 p -106.84 132.19 53.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.4 mt -128.07 155.29 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -170.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.2 m -125.77 134.03 51.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -121.4 -34.24 3.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -56.68 -15.2 4.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.711 1.205 . . . . 0.0 113.399 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 -56.3 -35.46 67.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.763 0.825 . . . . 0.0 112.003 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -140.78 -4.05 1.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.34 17.62 8.48 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.648 2.379 . . . . 0.0 114.493 173.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.5 m -60.51 -57.15 13.96 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.315 1.046 . . . . 0.0 111.776 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.86 -40.9 97.64 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 118.541 0.61 . . . . 0.0 109.627 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.01 -43.68 99.15 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -74.58 -39.59 62.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.713 1.256 . . . . 0.0 110.461 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.06 -45.97 92.58 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.132 0.973 . . . . 0.0 111.932 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.27 -10.63 43.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.317 1.047 . . . . 0.0 110.538 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.42 -5.44 73.2 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.286 1.898 . . . . 0.0 113.874 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.55 -9.7 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.736 2.014 . . . . 0.0 112.954 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.88 112.97 2.26 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 168.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 124' ' ' LEU . 91.2 mt -76.02 133.18 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.53 -59.76 4.89 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.577 1.151 . . . . 0.0 110.585 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -74.66 -47.69 30.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.377 0.671 . . . . 0.0 111.579 -169.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.528 ' H ' HG22 ' A' ' 121' ' ' ILE . 14.4 tp -78.05 -15.24 59.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.325 0.65 . . . . 0.0 112.024 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 47.5 44.04 16.4 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.999 1.72 . . . . 0.0 111.993 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.6 tp -139.04 165.04 28.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.279 1.032 . . . . 0.0 108.245 -170.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.34 127.18 32.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.36 150.43 48.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.054 0.454 . . . . 0.0 110.484 170.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.78 124.55 25.58 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.1 m -156.99 168.5 27.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -140.74 137.47 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -141.23 154.15 45.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.63 138.16 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.3 mp -130.64 135.95 48.36 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.032 0.933 . . . . 0.0 109.671 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.36 163.69 15.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.79 1.636 . . . . 0.0 109.313 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -52.21 -29.76 24.1 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.579 1.552 . . . . 0.0 113.265 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -71.56 -6.22 39.14 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.506 1.122 . . . . 0.0 113.09 177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.99 47.71 18.21 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -170.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -127.94 126.87 42.28 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -173.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -67.47 121.38 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.521 0.728 . . . . 0.0 109.439 -170.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.18 -7.68 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.05 1.34 . . . . 0.0 110.747 170.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -150.69 149.2 29.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -153.99 125.78 7.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.264 1.425 . . . . 0.0 108.177 173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -140.84 149.78 42.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.453 0.569 . . . . 0.0 109.954 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.65 116.91 17.97 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.56 133.52 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -171.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.9 m -55.27 -28.33 52.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.398 1.079 . . . . 0.0 111.667 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.78 111.98 9.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.85 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.423 1.489 . . . . 0.0 113.152 -176.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 8.64 6.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.874 0.87 . . . . 0.0 112.438 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.39 -174.91 3.63 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.952 1.301 . . . . 0.0 110.258 172.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -103.87 147.36 34.15 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.21 -0.931 . . . . 0.0 113.426 -169.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.04 178.8 6.07 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.693 2.929 . . . . 0.0 109.967 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.74 133.73 49.79 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 168.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -123.31 16.82 9.81 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.028 0.931 . . . . 0.0 111.684 -170.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.43 -42.28 4.38 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -51.17 -46.35 88.95 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 117.341 -1.314 . . . . 0.0 112.851 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.87 -38.39 30.03 Favored 'Trans proline' 0 C--N 1.352 0.753 0 CA-C-N 121.943 1.73 . . . . 0.0 111.644 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.7 mm -61.3 -42.37 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.34 -38.45 91.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.556 1.071 . . . . 0.0 111.088 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.09 99.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.56 0.344 . . . . 0.0 110.667 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.9 73.32 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.977 0.511 . . . . 0.0 110.823 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -55.09 -43.1 73.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.151 0.887 . . . . 0.0 110.285 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.255 0.622 . . . . 0.0 112.104 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.05 -41.9 18.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.871 0.469 . . . . 0.0 111.74 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.06 -52.54 32.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.975 0.91 . . . . 0.0 110.649 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 123.879 0.872 . . . . 0.0 110.004 177.361 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.28 63.99 1.59 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.034 1.734 . . . . 0.0 108.097 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -60.82 166.01 3.64 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.777 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 pt -129.86 172.75 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 123.225 1.488 . . . . 0.0 112.515 -175.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -118.56 156.67 28.75 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 128.597 2.759 . . . . 0.0 104.963 170.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -138.3 122.23 17.78 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? 48.1 36.69 6.82 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.927 1.291 . . . . 0.0 111.51 -175.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.93 85.47 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.39 -0.819 . . . . 0.0 114.694 176.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.47 118.1 5.07 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 171.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.41 143.42 77.2 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.808 2.339 . . . . 0.0 111.355 173.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -137.86 -175.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.958 1.303 . . . . 0.0 108.655 175.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -132.58 151.45 51.93 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.641 1.176 . . . . 0.0 108.154 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.3 mt -99.12 155.59 17.38 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.71 1.604 . . . . 0.0 109.046 176.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -74.83 -25.36 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.65 17.29 1.11 Allowed Glycine 0 C--N 1.337 0.593 0 CA-C-O 119.247 -0.752 . . . . 0.0 112.91 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 47.65 -168.61 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.682 1.993 . . . . 0.0 113.838 178.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 145' ' ' TYR . 6.8 pm0 -80.76 128.76 34.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 120.705 -1.247 . . . . 0.0 113.414 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -76.3 170.31 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 165.01 34.01 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 120.998 -1.064 . . . . 0.0 109.514 -172.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.46 132.36 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.22 -2.21 87.56 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.997 -0.891 . . . . 0.0 113.836 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.05 -13.29 59.97 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.311 1.556 . . . . 0.0 112.4 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 58.51 176.64 0.06 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.208 1.803 . . . . 0.0 112.192 -169.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -125.99 137.75 30.74 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.163 1.385 . . . . 0.0 110.451 -171.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -58.17 -20.13 45.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.727 3.618 . . . . 0.0 117.122 176.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.33 72.37 0.13 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.63 1.972 . . . . 0.0 109.287 -169.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -72.82 175.89 6.11 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.65 1.58 . . . . 0.0 110.709 177.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.1 m -131.97 144.56 50.9 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -138.86 176.42 6.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 126.739 2.016 . . . . 0.0 108.169 -177.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.9 mt -113.52 140.31 48.24 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.273 1.029 . . . . 0.0 109.474 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -72.59 176.23 5.65 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.383 1.473 . . . . 0.0 111.174 175.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -59.84 -22.58 62.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.154 0.582 . . . . 0.0 111.15 169.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.7 m -92.1 4.1 53.86 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.551 1.54 . . . . 0.0 112.212 178.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.6 mp 53.05 47.16 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.305 1.842 . . . . 0.0 112.164 -175.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -112.44 148.41 34.43 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 169.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -78.16 146.67 34.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.802 0.811 . . . . 0.0 111.1 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -150.41 114.98 5.21 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.79 1.636 . . . . 0.0 107.14 -172.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 p -79.93 161.89 25.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.209 0.603 . . . . 0.0 109.999 176.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.37 -36.5 73.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.68 44.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.924 0.89 . . . . 0.0 113.353 177.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -74.08 -32.64 63.35 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.444 1.02 . . . . 0.0 110.965 174.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.6 mtt -75.81 -34.61 60.16 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 111.371 177.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -54.67 158.29 2.65 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.607 1.163 . . . . 0.0 111.368 -177.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.85 67.01 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.335 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -146.33 159.67 43.05 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.038 2.135 . . . . 0.0 106.964 169.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 77' ' ' VAL . 74.9 t -65.74 113.96 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.3 m -92.44 138.44 31.51 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.4 mt -132.84 133.05 59.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.6 mt -138.19 139.93 41.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -172.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -123.04 152.51 40.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 169.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.61 124.92 35.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 pt -139.2 147.27 52.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.93 -47.87 1.65 Allowed 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 120.723 0.948 . . . . 0.0 110.794 174.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.04 173.25 16.75 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -169.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.38 -42.96 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.616 1.566 . . . . 0.0 107.661 174.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.41 -28.16 68.41 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.625 1.17 . . . . 0.0 112.36 -175.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.37 -4.95 9.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 176.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.41 -29.75 2.84 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 121.082 -1.011 . . . . 0.0 114.174 169.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.79 -25.38 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.972 1.386 . . . . 0.0 112.599 178.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.3 t -52.47 -39.86 61.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.091 1.356 . . . . 0.0 111.769 169.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -107.13 -36.8 6.47 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 123.814 0.846 . . . . 0.0 111.172 -174.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 -26.54 68.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.811 0.844 . . . . 0.0 112.564 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -145.44 -41.27 0.23 Allowed 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.038 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 m -67.22 -44.41 79.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.654 1.116 . . . . 0.0 110.649 -169.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 47.5 tpt85 -59.35 -30.44 68.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 113.449 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -85.25 -43.62 13.6 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.948 0.794 . . . . 0.0 110.193 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -58.47 -50.67 72.9 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.428 0.691 . . . . 0.0 110.421 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -60.66 -38.38 84.7 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.991 0.516 . . . . 0.0 110.888 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.64 -33.18 75.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.166 0.986 . . . . 0.0 112.135 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.75 -46.29 15.68 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.169 0.895 . . . . 0.0 109.945 172.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.95 -45.1 87.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.383 1.073 . . . . 0.0 111.017 -174.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.03 -15.06 55.2 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.082 0.953 . . . . 0.0 112.797 -173.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -117.14 3.99 12.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.14 -35.71 79.6 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.969 1.259 . . . . 0.0 110.719 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.03 -161.44 30.81 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.694 1.14 . . . . 0.0 110.278 -176.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -74.04 27.97 0.08 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.892 1.277 . . . . 0.0 112.42 177.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 46' ' ' VAL . 15.9 m -65.06 144.83 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 108.362 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -84.04 155.31 22.78 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 168.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.44 124.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -172.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -139.35 157.73 45.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.057 0.543 . . . . 0.0 110.443 -176.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.6 m -136.29 103.98 5.48 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.97 150.16 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.624 1.17 . . . . 0.0 108.295 -174.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.3 m -127.27 158.41 37.25 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.195 1.798 . . . . 0.0 111.223 -169.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -108.44 -179.21 3.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.34 1.056 . . . . 0.0 111.933 -178.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.71 -30.6 67.2 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -168.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.89 152.52 86.86 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 118.198 0.454 . . . . 0.0 111.958 -169.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -52.36 -40.33 71.0 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.883 3.055 . . . . 0.0 116.256 -169.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -78.81 30.98 0.2 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.669 1.188 . . . . 0.0 112.709 -172.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.44 178.42 4.62 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.077 -1.014 . . . . 0.0 112.075 178.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -68.98 162.93 25.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.049 1.74 . . . . 0.0 113.273 -169.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -155.58 62.87 0.6 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.235 2.214 . . . . 0.0 108.607 173.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 51.61 52.07 15.41 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.687 1.595 . . . . 0.0 112.399 -169.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -105.08 -164.94 1.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.397 1.079 . . . . 0.0 108.537 169.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.7 m 61.16 18.22 8.86 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.923 1.689 . . . . 0.0 114.808 169.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.12 -43.52 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -178.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.1 8.55 0.28 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.22 0.24 12.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.709 1.204 . . . . 0.0 112.144 176.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -137.68 -18.88 0.6 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.716 1.15 . . . . 0.0 112.38 177.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.93 95.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.13 -16.75 54.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.22 1.408 . . . . 0.0 114.049 -170.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -60.23 -30.39 69.37 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.689 -0.632 . . . . 0.0 111.314 172.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.1 t -75.34 147.45 8.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -138.18 142.98 40.04 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.1 p -87.54 132.41 34.05 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.02 168.86 11.06 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.546 1.938 . . . . 0.0 107.547 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.3 m -136.63 147.66 47.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.126 0.97 . . . . 0.0 109.091 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -125.86 -19.09 4.95 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.523 0.729 . . . . 0.0 111.466 173.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -55.45 -24.62 31.78 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -173.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -73.1 -16.17 61.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.373 -0.822 . . . . 0.0 112.815 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -139.9 -21.99 0.87 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.546 1.066 . . . . 0.0 113.636 -169.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.9 mmm 57.55 7.44 0.52 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.327 2.651 . . . . 0.0 115.816 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.2 m -62.39 -48.01 81.62 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.859 1.209 . . . . 0.0 111.846 -177.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -64.27 -40.33 95.75 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.445 1.475 . . . . 0.0 110.027 177.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -49.81 -57.28 9.93 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 125.749 1.642 . . . . 0.0 112.274 176.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.86 -42.58 81.1 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.134 0.467 . . . . 0.0 110.049 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.81 92.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.848 0.859 . . . . 0.0 112.2 -172.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -103.84 8.2 37.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.224 1.01 . . . . 0.0 110.896 -176.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.37 34.43 74.75 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.146 0.884 . . . . 0.0 111.704 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.454 HG23 ' HA2' ' A' ' 114' ' ' GLY . 9.3 m -108.87 -4.3 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.742 1.617 . . . . 0.0 110.316 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.63 113.52 8.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 103.668 -2.716 . . . . 0.0 103.668 168.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 84.3 mt -70.94 111.27 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 175.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -54.37 -40.91 68.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.442 1.497 . . . . 0.0 111.43 -177.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -91.95 -4.02 55.18 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.69 -16.97 1.99 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.938 0.79 . . . . 0.0 112.763 -170.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.4 ttm105 47.46 42.41 14.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.82 1.648 . . . . 0.0 111.989 -173.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.2 mt -122.09 163.03 20.17 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.04 131.52 36.3 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 175.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 138.8 56.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.162 1.385 . . . . 0.0 111.541 179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -58.57 113.64 2.1 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.377 1.071 . . . . 0.0 108.78 171.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.3 p -156.23 173.63 16.56 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 120.927 0.394 . . . . 0.0 110.667 -176.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -148.93 149.12 15.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.439 1.496 . . . . 0.0 107.85 174.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -147.79 155.45 41.69 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.773 1.229 . . . . 0.0 110.119 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.59 142.87 33.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 169.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 mp -138.93 142.29 38.47 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -173.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.65 165.06 5.37 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.28 1.432 . . . . 0.0 110.038 169.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -51.13 -32.53 23.1 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.982 1.313 . . . . 0.0 112.848 176.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -79.5 0.41 29.75 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.835 1.254 . . . . 0.0 112.834 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.05 88.62 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.004 -1.06 . . . . 0.0 112.884 -175.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -67.75 121.88 16.9 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.068 1.434 . . . . 0.0 107.236 172.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.07 132.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.295 0.638 . . . . 0.0 109.446 171.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.53 -18.75 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.664 1.985 . . . . 0.0 109.662 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -147.27 149.45 32.89 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.04 138.84 17.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.105 1.762 . . . . 0.0 107.475 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -146.91 146.78 30.27 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.31 0.644 . . . . 0.0 109.796 170.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 17' ' ' GLU . 12.8 m-85 -139.13 93.42 2.69 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.6 2.76 . . . . 0.0 104.837 -173.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.7 m -62.52 147.37 11.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 O-C-N 121.769 -0.582 . . . . 0.0 110.415 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -66.45 -11.09 50.19 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -175.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -143.35 125.64 15.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.36 -24.13 58.91 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -176.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 38.3 p -89.78 -4.17 57.78 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.001 0.819 . . . . 0.0 112.298 176.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -84.62 176.49 8.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.248 1.419 . . . . 0.0 109.268 173.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -148.05 146.54 23.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 175.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.46 176.83 7.57 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.414 2.743 . . . . 0.0 110.451 177.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -76.8 119.53 20.7 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -67.82 -14.36 62.89 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -70.0 -30.02 67.24 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.015 1.279 . . . . 0.0 109.435 -176.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -66.34 -49.78 52.0 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.357 -175.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -65.58 -35.79 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 121.366 1.524 . . . . 0.0 111.541 170.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.7 mm -61.14 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 119.755 1.161 . . . . 0.0 110.154 179.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.84 -30.15 67.57 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.59 1.086 . . . . 0.0 110.741 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.09 97.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.004 0.366 . . . . 0.0 110.544 172.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.33 -45.05 85.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.944 175.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -56.7 -41.32 77.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.202 0.91 . . . . 0.0 110.498 176.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.05 -33.22 71.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.65 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.85 -47.59 14.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.566 0.621 . . . . 0.0 111.89 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.05 -39.57 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 110.718 -172.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 56.2 mttm . . . . . 0 C--O 1.249 1.049 0 C-N-CA 126.039 1.735 . . . . 0.0 109.592 -175.829 . . . . . . . . 0 0 . 1 stop_ save_